Trade Name,Scientific Name,Registration Number,Registration Year,Strength,Dosage Form,Administration Route,Price (SAR),Manufacturer,Manufacturer Country,Selling Company,Company Country,Marketing Status,Legal Status,Storage Conditions,Distribution Area,Agents
0.9% W/V SODIUM CHLORIDE B.P,SODIUM CHLORIDE,1807245616,1995,0.9 %,Solution for injection,Parenteral use,0.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ORTHOVISC 15MG-ML SOLU FOR I-A Injection*,SODIUM HYALURONATE,1-585-09,2009,15 mg/ml,Solution for injection,Intravenous use,249.55,ANIKA THERAPEUTICS,United States,ANIKA THERAPEUTICS,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Pharma Serve Limited
ORS New (50 SACHET),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, TRI SODIUM CITRATE, DEXTROSE",33-390-08,2008,"0.52,0.3,0.58,2.7 g",Powder for oral solution in sachet,Oral use,30.3,Amman Pharmaceutical Industries (API),Jordan,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ORS New (10 SACHET),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, TRI SODIUM CITRATE, DEXTROSE",2710246119,2008,"0.52,0.3,0.58,2.7 g",Powder for oral solution in sachet,Oral use,7.2,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ORS 30GM SACHET,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, TRI SODIUM CITRATE, DEXTROSE",2710246117,2003,"3.5,1.5,2.9,20 g",Powder for oral solution in sachet,Oral use,9.30,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ORENCIA 250MG POWDER FOR SOLUTION FOR INFUSION,ABATACEPT,1811258617,2010,250 mg,Powder for solution for infusion,Intravenous use,1249.15,BRISTOL-MYERS SQUIBB,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
ORENCIA 125MG Solution for injection in pre-filled syringe,ABATACEPT,1-960-14,2014,125 mg,Solution for injection,Subcutaneous use,4501.5,"BRISTOL-MYERS SQUIBB HOLDINGS PHARMA, Ltd. LIABBILITY COMPANY",United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Salehiya Trading Co."
ORELOX 100MG TABLETS,CEFPODOXIME,21-37-10,2010,100 mg,Tablet,Oral use,30.8,SANOFI WINTHROP INDUSTRIE,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
OSELTA 75MG CAPSULES,OSELTAMIVIR,1506222204,2009,75 mg,Capsule,Oral use,79.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
OSPEN 500,PHENOXYMETHYLPENICILLIN,22-116-84,1984,500000 IU,Tablet,Oral use,21.25,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
OSPEN 1000,PHENOXYMETHYLPENICILLIN,23-116-84,1984,1000000 IU,Tablet,Oral use,27.4,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ORATAB 100MG F.C. TABLETS,SUMATRIPTAN,2401233159,2009,100 mg,Film-coated tablet,Oral use,49.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OPTIPRED 1% OPTHALMIC SUSP.,PREDNISOLONE,0209245851,2002,1 %,"Eye drops, suspension",Ophthalmic use,14.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTIMOL 0.5% OPHTHALMIC SOLUTION,TIMOLOL MALEATE,1506222210,2000,0.5 %,"Eye drops, solution",Ophthalmic use,31.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTIMOL 0.25% OPHTHALMIC SOLUTION,TIMOLOL MALEATE,1-368-00,2000,0.25 %,"Eye drops, solution",Ophthalmic use,25.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTIRAY 300MG-ML SOLUTION FOR IV. Injection,IOVERSOL,12-553-09,2009,300 mg/ml,Injection,Intravenous use,3180,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 300MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,13-553-09,2009,300 mg/ml,Injection,Intravenous use,1908,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
ORALITE 28GM SACHETS,"DEXTROSE, SODIUM CHLORIDE, SODIUM CITRATE, POTASSIUM CHLORIDE",1505245305,2007,"20,3.5,2.9,1.5 g",Powder for oral solution,Oral use,12.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
OPTIZOLIN OPTHALMIC SOLUTION,"ANTAZOLINE HYDROCHLORIDE, TETRAHYDROZOLINE",0409234104,2000,"0.5,0.4 mg","Ear drops, solution",Ophthalmic use,9.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ORATAB 100 mg,SUMATRIPTAN,201-277-09,2009,100 mg,Film-coated tablet,Oral use,128.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OPTIRAY 350MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,6-553-09,2009,350 mg/ml,Injection,Intravenous use,4637.5,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 350MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,4-553-09,2009,350 mg/ml,Injection,Intravenous use,3710,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 350MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,3-553-09,2009,350 mg/ml,Injection,Intravenous use,2226,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 320MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,16-553-09,2009,320 mg/ml,Injection,Intravenous use,3392,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 320MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,15-553-09,2009,320 mg/ml,Injection,Intravenous use,4240,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 320MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,7-553-09,2009,350 mg/ml,Injection,Intravenous use,1778.35,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 320MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,2-553-09,2009,320 mg/ml,Injection,Intravenous use,1852.45,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 300MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,14-553-09,2009,300 mg/ml,Injection,Intravenous use,1987.5,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTIRAY 350MG-ML SOLUTION FOR IV. Injection*,IOVERSOL,1801268934,2009,350 mg/ml,Injection,Intravenous use,2318.75,LIEBEL FLARSHEIM COMPANY LLC,United States,LIEBEL FLARSHEIM COMPANY LLC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
OPTILONE 0.1% OPTHALMIC SUSPENTION,FLUOROMETHOLONE,2012211487,2001,0.1 %,"Eye drops, suspension",Ophthalmic use,13.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
PANDA EXTRA CAPLETS,"PARACETAMOL, CAFFEINE",0407233843,2010,"500,65 mg",Tablet,Oral use,4.65,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Nomou United Medical Company, SAUDI ARABIAN DRUG STORE COMPANY"
PANDA 500MG CAPLET,PARACETAMOL,0603245023,2010,500 mg,Caplet,Oral use,3.20,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Nomou United Medical Company, SAUDI ARABIAN DRUG STORE COMPANY"
PANADREX 500 MG TAB,PARACETAMOL,2511246335,2000,500 mg,Tablet,Oral use,5.05,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
PANADREX 500 MG TAB,PARACETAMOL,2511246333,2000,500 mg,Tablet,Oral use,9.40,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Panadrex baby and infant,PARACETAMOL,2811246350,2001,24 mg/ml,Syrup,Oral use,5.80,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Panadrex baby and infant,PARACETAMOL,2811246352,2001,24 mg/ml,Syrup,Oral use,3.50,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
PANADOL SOLUBLE 500MG TAB,PARACETAMOL,3006222293,1998,500 mg,Tablet,Oral use,14.25,GLAXOSMITHKLINE (GSK),Ireland,GLAXOSMITHKLINE (GSK),Ireland,Marketed,OTC,store below 25°c,Pharmacy,"Haleon Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
PANADOL SINUS CAPLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE",0509222584,2003,"500,30 mg",Tablet,Oral use,13.60,Aspen Pharma Pty Ltd,Australia,Haleon Australia Pty Ltd,Australia,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
PANADOL NIGHT CAPLET,"PARACETAMOL, DIPHENHYDRAMINE HYDROCHLORIDE",2-385-03,2003,"500,25 mg",Tablet,Oral use,11.60,GLAXOSMITHKLINE DUNGARVAN LIMITED,Ireland,GLAXOSMITHKLINE (GSK),Australia,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
PANADOL EXTRA TAB,"PARACETAMOL, CAFFEINE CITRATE",0206257530,1998,"500,65 mg",Tablet,Oral use,8.00,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,GLAXOSMITHKLINE (GSK),Ireland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
PANADOL EXTEND 665MG F.C. TABLETS,PARACETAMOL,2207257788,2007,665 mg,Film-coated tablet,Oral use,15.75,Aspen Pharma Pty Ltd,Australia,Haleon Australia Pty Ltd,Australia,Marketed,OTC,store below 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
PANTOZOL 40MG TAB,PANTOPRAZOLE,2801256767,1996,40 mg,Gastro-resistant tablet,Oral use,49.25,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
PANTOZOL 40MG TAB,PANTOPRAZOLE,2801256768,1996,40 mg,Gastro-resistant coated tablet,Oral use,87.95,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
PANTOZOL 40MG I.V Powder for injection,PANTOPRAZOLE,2004257248,2005,40 mg,powder for solution for injection,Intravenous use,26.60,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
PANTOZOL 20MG E.C TAB,PANTOPRAZOLE,1009245899,2001,20 mg,Gastro-resistant coated tablet,Oral use,54.8,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
PANTOZOL 20MG E.C TAB,PANTOPRAZOLE,1009245900,2001,20 mg,Gastro-resistant coated tablet,Oral use,30.7,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
PANTOVER 40MG E.C. TABLETS,PANTOPRAZOLE,10-491-08,2008,40 mg,Gastro-resistant coated tablet,Oral use,50.8,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"AMC Pharma, Cigalah Group"
PANTOVER 40MG E.C. TABLETS,PANTOPRAZOLE,8-491-08,2008,40 mg,Gastro-resistant coated tablet,Oral use,26.6,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,AMC Pharma
PANTOVER 40MG E.C. TABLETS,PANTOPRAZOLE,9-491-08,2008,40 mg,Gastro-resistant coated tablet,Oral use,28.5,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"AMC Pharma, Cigalah Group"
PANTOMAX 40MG E.C.TABLETS,PANTOPRAZOLE,1609258229,2006,40 mg,Gastro-resistant coated tablet,Oral use,56.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PANTOMAX 20MG E.C. TABLETS,PANTOPRAZOLE,28-370-06,2006,20 mg,Gastro-resistant coated tablet,Oral use,39.4,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PANTOMAX 20MG E.C. TABLETS,PANTOPRAZOLE,29-370-06,2006,20 mg,Gastro-resistant coated tablet,Oral use,19.7,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
PANTOLOC 40MG TABLETS,PANTOPRAZOLE,2406257606,2010,40 mg,Tablet,Oral use,28.5,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
RIAPANTA 40 mg E.C. tablet,PANTOPRAZOLE,2509222634,2013,40 mg,Coated tablet,Oral use,50.8,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIAPANTA 40 mg E.C. tablet,PANTOPRAZOLE,243-325-13,2013,40 mg,Coated tablet,Oral use,28.5,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
PANTOMAX 40MG E.C.TABLETS,PANTOPRAZOLE,1609258230,2006,40 mg,Gastro-resistant coated tablet,Oral use,31.65,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OTOCOL EAR DROPS,"CHLORAMPHENICOL, BENZOCAINE",33-290-06,2006,"50,50 mg",Ear drops,Auricular use,7.6,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
PANADOL COLD & FLU CAPLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",0509222585,2003,"500,30,2 mg",Tablet,Oral use,12.30,GLAXO SAUDI ARABIA,Saudi Arabia,Haleon Australia Pty Ltd,Australia,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
PANADOL ADVANCE 500MG FILM COATED TABLET,PARACETAMOL,1-836-12,2012,500 mg,Film-coated tablet,Oral use,6.05,GLAXOSMITHKLINE (GSK),Ireland,Haleon Ireland Limited,Ireland,Marketed,OTC,store below 30°c,Pharmacy,Haleon Arabia Limited
OVITRELLE 250MCG-0.5ML PRE-FILLED SYRING,CHORIOGONADOTROPIN ALFA,1112246400,2008,0.5 mg/ml,Solution for injection/infusion,Intramuscular use,146.37,SERONO,Italy,SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
OTRIVIN NASAL DROPS 0.1%,XYLOMETAZOLINE HYDROCHLORIDE,2511211366,1996,0.1 %,"Nasal drops, solution",Nasal use,11.05,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Haleon Arabia Limited
OTRIVIN NASAL DROPS 0.05%,XYLOMETAZOLINE HYDROCHLORIDE,2511211367,1996,0.05 %,"Nasal drops, solution",Nasal use,10.10,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
OTRIVIN MENTHOL 0.1% NASAL SPRAY,"MENTHOL, XYLOMETAZOLINE HYDROCHLORIDE",2511211368,2009,0.1 %,"Nasal spray, solution",Nasal use,16.55,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
OTRIVIN DOSING SPRAY 0.1%,XYLOMETAZOLINE HYDROCHLORIDE,2511211365,1997,0.1 %,"Nasal spray, solution",Nasal use,16.55,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
OTOZOL 1% EAR DROP,CLOTRIMAZOLE,23-290-03,2003,1 %,Ear drops,Auricular use,8.3,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
OXALIPLATIN MEDAC 100MG POWDER,OXALIPLATIN,2-463-10,2010,100 mg,Powder for solution for infusion,Intravenous use,773.5,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
OXALIPLATIN MEDAC 150MG POWDER,OXALIPLATIN,3-463-10,2010,150 mg,Powder for solution for infusion,Intravenous use,1160.25,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PANADOL ACTIFAST FILM COATED TABLETE,"PARACETAMOL, SODIUM BICARBONATE",2207257789,2003,"500,173 mg",Film-coated tablet,Oral use,9.15,GLAXOSMITHKLINE (GSK),Ireland,GLAXOSMITHKLINE (GSK),Ireland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
PANADOL 500 mg film-coated tablet,PARACETAMOL,5-288-99,1999,500 mg,Film-coated tablet,Oral use,5.80,GlaxoSmithKline Dungarvan Ltd,Ireland,GLAXOSMITHKLINE (GSK),Ireland,Marketed,OTC,store below 30°c,Pharmacy,Haleon Arabia Limited
PALETA 75mg film-coated tablets,CLOPIDOGREL,1506233808,2014,75 mg,Film-coated tablet,Oral use,91.90,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PABAL RTS 100 mcg/ml Solution for Injection,CARBETOCIN,0910222697,2008,100 µ/ml,Solution for injection,Intramuscular and intravenous use,333.50,Ferring GmbH,Germany,FERRING,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Abdulrehman Algosaibi G.T.C.
PANADOL BABY & INFANT SUSP 120MG-5ML,PARACETAMOL,0602221678,1998,24 mg/ml,Oral suspension,Oral use,11.00,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Haleon Arabia Limited,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Haleon Arabia Limited
OXIMAL 7.5MG TABLETS,MELOXICAM,1211246202,2007,7.5 mg,Tablet,Oral use,19.65,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
OXIMAL 7.5MG TABLETS,MELOXICAM,1211246203,2007,7.5 mg,Tablet,Oral use,8.7,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
OXIMAL 15MG TABLETS,MELOXICAM,1911246281,2007,15 mg,Tablet,Oral use,9.90,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
OXIMAL 15MG TABLETS,MELOXICAM,1911246284,2007,15 mg,Tablet,Oral use,29.75,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
OXICLAV 625MG F.C.TABLETS,"AMOXICILLIN, CLAVULANIC ACID",24-584-21,2010,"500,125 mg",Film-coated tablet,Oral use,33.9,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
OXETINE 20MG F.C. TABLETS,FLUOXETINE,0701256530,2007,20 mg,Film-coated tablet,Oral use,37.35,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
OXALIPLATIN MEDAC 50MG POWDER,OXALIPLATIN,1-463-10,2010,50 mg,Powder for solution for infusion,Intravenous use,396.8,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PARAFON,"CHLORZOXAZONE, PARACETAMOL",159-325-05,2005,"250,300 mg",Capsule,Oral use,29.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OPTIFUCIN 1% EYE DROP,FUSIDIC ACID,27-290-03,2003,1 %,Eye drops,Ophthalmic use,11.25,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
OPTIFLOX OPTHALMIC SOLUTION,OFLOXACIN,1210222725,2001,0.3 %,"Eye drops, solution",Ophthalmic use,12.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OGLITON 15 MG Tablet,PIOGLITAZONE,1904221951,2014,15 mg,Tablet,Oral use,34,ACTAVIS,Malta,ACTAVIS,Malta,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OFLOX 0.3% EYE DROPS,OFLOXACIN,1605245319,1994,0.3 %,"Eye drops, solution",Ophthalmic use,13.5,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE LIMITED,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
OFLAM 50MG GRANULES FOR ORAL SOLUTION,DICLOFENAC POTASSIUM,2711222941,2006,50 mg,Granules for oral solution,Oral use,20.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OFLACIN 200MG TAB,OFLOXACIN,2512246490,2002,200 mg,Tablet,Oral use,27.9,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
OEDEMAX,FUROSEMIDE,3-152-87,1987,40 mg,Tablet,Oral use,5.85,MERCKLE,Germany,MERCKLE,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OEDEMAX,FUROSEMIDE,4-152-87,1987,40 mg,Tablet,Oral use,28.4,MERCKLE,Germany,MERCKLE,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OCURED,"ANTAZOLINE SULFATE, NAPHAZOLINE NITRATE",2001268951,2001,"5,0.25 mg",Eye drops,Ophthalmic use,8.10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
OCUMOL 0.5%,TIMOLOL MALEATE,29-325-01,2001,0.5 %,Eye drops,Ophthalmic use,24.4,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, RIYADH PHARMA"
OCULAC,"SODIUM CHLORIDE, HYPROMELLOSE 2208 (750 MPA.S)",2111222918,2002,"0.5,0.3 %",Eye drops,Ophthalmic use,10.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
OCUGESIC,DICLOFENAC SODIUM,1902244941,2003,0.1 %,Eye drops,Ophthalmic use,13.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
OCTANINE F 500 IU,FACTOR IX,0809245873,2002,500 IU,Powder and solvent for solution for injection,Parenteral use,610.25,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTANINE F 1000 I.U\10ML VIAL,FACTOR IX,0809245872,2003,1000 IU,Powder and solvent for solution for injection,Parenteral use,1213.85,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OGLITON 30 MG Tablet,PIOGLITAZONE,1904221953,2014,30 mg,Tablet,Oral use,57.75,ACTAVIS,Malta,ACTAVIS,Malta,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OGLITON 45 MG Tablet,PIOGLITAZONE,1904221952,2014,45 mg,Tablet,Oral use,74.9,ACTAVIS,Malta,ACTAVIS,Malta,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OLAZINE 10MG FILM COATED TABLETS,OLANZAPINE,1111246179,2014,10 mg,Film-coated tablet,Oral use,242.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OLAZINE 15MG FILM COATED TABLETS,OLANZAPINE,1111246180,2014,15 mg,Film-coated tablet,Oral use,364.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OLOPAT 0.1% OPHTHALMIC SOLUTION,OLOPATADINE,2405210752,2007,0.1 %,"Eye drops, solution",Ophthalmic use,22.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OLMETEC PLUS 40MG-25MG F.C. TABLETS,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",42-370-08,2008,"40,25 mg",Film-coated tablet,Oral use,87.30,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OLMETEC PLUS 40MG-12.5MG F.C. TABLETS,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",41-370-08,2008,"40,12.5 mg",Film-coated tablet,Oral use,87.30,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OLMETEC PLUS 20MG-12.5MG F.C. TABLETS,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",40-370-08,2008,"20,12.5 mg",Film-coated tablet,Oral use,65.60,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OLMETEC 40 mg film-coated tablet,OLMESARTAN MEDOXOMIL,24-370-06,2006,40 mg,Film-coated tablet,Oral use,83.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OLMETEC 20MG F.C. TABLETS,OLMESARTAN MEDOXOMIL,25-370-06,2006,20 mg,Film-coated tablet,Oral use,62.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OLFEN-75,"DICLOFENAC SODIUM, LIDOCAINE HYDROCHLORIDE",1901268940,1995,"75,20 mg/dose",Solution for injection,Parenteral use,23.6,Haupt Pharma Wulfing GmbH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
OLFEN-50,DICLOFENAC SODIUM,3-222-94,1994,50 mg,Film-coated tablet,Oral use,12.4,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
OLFEN-100,DICLOFENAC SODIUM,7-222-95,1995,100 mg,Capsule,Oral use,24.55,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
OLFEN,DICLOFENAC SODIUM,1901268941,1995,1 %,Gel,Topical,13.85,Sofarimex SA,Portugal,ACINO PHARMA AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
OLAZINE 5MG FILM COATED TABLETS,OLANZAPINE,1111246178,2014,5 mg,Film-coated tablet,Oral use,148.05,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OLAZINE 20MG FILM COATED TABLETS,OLANZAPINE,1211246200,2014,20 mg,Film-coated tablet,Oral use,398.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OLAZINE 2.5MG FILM COATED TABLETS,OLANZAPINE,1211246199,2014,2.5 mg,Film-coated tablet,Oral use,74,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
OCTANATE 500IU VIAL,HUMAN COAGULATION FACTOR VIII,2410234381,2002,500 IU,Powder and solvent for solution for injection,Parenteral use,888.60,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTANATE 250IU VIAL,HUMAN COAGULATION FACTOR VIII,2410234379,2002,250 IU,Powder and solvent for solution for injection,Parenteral use,444.25,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
NOVONORM 2MG TABLET,REPAGLINIDE,0206257527,2001,2 mg,Tablet,Oral use,29.15,BOEHRINGER INGELHEIM,Germany,NOVO NORDISK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVONORM 1MG TABLET,REPAGLINIDE,0206257528,2001,1 mg,Tablet,Oral use,29.15,BOEHRINGER INGELHEIM,Germany,NOVO NORDISK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVONORM 0.5MG TABLET,REPAGLINIDE,0206257526,2001,0.5 mg,Tablet,Oral use,29.15,BOEHRINGER INGELHEIM,Germany,NOVO NORDISK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOMIX 50 FLEXPEN,"INSULIN ASPART, INSULIN ASPART PROTAMINE",63-100-14,2014,"50,50 IU/ml",Suspension for injection,Subcutaneous use,156.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOMIX 30 FLEXPEN 100U\ML,"INSULIN ASPART, INSULIN ASPART PROTAMINE",2208222530,2004,"30,70 IU/ml",Solution for injection,Subcutaneous use,189.00,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVIRAX CREAM 15 GM,ACYCLOVIR,2205257447,2007,5 %,Cream,Topical,38.00,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
NO-URIC TAB 300MG,ALLOPURINOL,1807222312,1992,300 mg,Tablet,Oral use,8,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,Khalid Bin Saad Int. Company LTD
NOVORAPID FLEXPEN 100U\ML,INSULIN ASPART,1601256675,2004,100 IU/ml,Solution for injection,Subcutaneous use,189.00,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVORAPID PEN FILL 100 I.U - ML,INSULIN ASPART,1601256674,2004,100 IU/ml,Solution for injection,Subcutaneous use,134.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOSEVEN 1MG POWDER FOR SOLUTION FOR INJECTION,RECOMBINAT DNA COAGULATING FACTOR Vlla EPTACOG Alfa ACTIVATED,56-100-11,2011,1 mg,Powder and solvent for solution for injection,Intravenous use,3168,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store below 25°c,Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOSEVEN 2MG POWDER FOR SOLUTION FOR INJECTION,RECOMBINAT DNA COAGULATING FACTOR Vlla EPTACOG Alfa ACTIVATED,57-100-11,2011,2 mg,Powder and solvent for solution for injection,Intravenous use,6348.5,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store below 25°c,Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
OCTAGAM 1GM-20ML I.V,NORMAL HUMAN IMMUNOGLOBULIN,2106222244,2000,1 g,Solution,Intravenous use,1120.70,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,do not store above 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTAGAM 1GM-20ML I.V,NORMAL HUMAN IMMUNOGLOBULIN,2106222243,2000,1 g,Solution,Intravenous use,2241.40,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,do not store above 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTACAINE 100 CARTRIDGE,"LIDOCAINE HYDROCHLORIDE, EPINEPHRINE",1410258424,2009,"20,0.01 mg/ml",Solution,Dental use,118.60,NOVOCOL,Canada,NOVOCOL,Canada,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI MEDICAL SUPPLIES
OCTANATE 1000 I.U - ML,HUMAN COAGULATION FACTOR VIII,2410234382,2004,1000 IU,Powder and solvent for solution for injection,Parenteral use,1777.15,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
NUVARING VAGINAL RING,"ETONOGESTREL, ETHINYLESTRADIOL",1504257232,2007,"11.7,2.7 mg",Vaginal delivery system,Vaginal use,44.4,ORGANON,Netherlands,ORGANON,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
NUROFEN 200MG TAB,IBUPROFEN,1802256914,1981,200 mg,Coated tablet,Oral use,7.85,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
NUROFEN 100MG-5ML PAEDIATRIC SUSPENSION,IBUPROFEN,3110234407,1994,20 mg/ml,Suspension,Oral use,17.15,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
NOVOSEVEN 5MG POWDER FOR SOLUTION FOR INJECTION,RECOMBINAT DNA COAGULATING FACTOR Vlla EPTACOG Alfa ACTIVATED,58-100-11,2011,5 mg,Powder and solvent for solution for injection,Intravenous use,15842.65,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store below 25°c,Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
NUROFEN 200MG TAB,IBUPROFEN,2-65-81,1981,200 mg,Coated tablet,Oral use,20,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
OPTIFRESH OPTHALMIC SOLUTION,"POLYVINYL ALCOHOL, POVIDONE",1506222207,2001,"1.4,0.6 %","Eye drops, solution",Ophthalmic use,19.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OMACE 10MG TABLETS,LISINOPRIL,1303257058,2006,10 mg,Tablet,Oral use,26.00,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACE 5MG TABLETS,LISINOPRIL,1303257060,2006,5 mg,Tablet,Oral use,15.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMNITROPE 6.7 MG/ML Solution for injection in cartridge,SOMATROPIN,0411258540,2014,6.7 mg/ml,Solution for injection in cartridge,Subcutaneous use,4009.95,Novartis Pharmaceutical Manufacturing GmbH,Austria,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
OMNITROPE 3.3 MG/ML Solution for injection in cartridge,SOMATROPIN,411258541,2014,3.3 mg/ml,Solution for injection in cartridge,Subcutaneous use,2004.95,Novartis Pharmaceutical Manufacturing GmbH,Austria,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
OMNISCAN,GADODIAMIDE,1807245605,1999,287 mg/ml,Solution,Intravenous use,680.65,GE HEALTHCARE IRELAND LIMITED,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNISCAN,GADODIAMIDE,1807245606,1999,287 mg/ml,Solution,Intravenous use,408.40,GE HEALTHCARE IRELAND LIMITED,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNISCAN,GADODIAMIDE,20-315-99,1999,287 mg/ml,Solution,Intravenous use,510.45,GE HEALTHCARE IRELAND LIMITED,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE 350MG/ML SOLUTION FOR INJECTION,IOHEXOL,46-261-22,2012,350 mg/ml,Solution for injection,Intravenous use,1480.80,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE 350MG/ML SOLUTION FOR INJECTION,IOHEXOL,45-261-22,2012,350 mg/ml,Solution for injection,Intravenous use,692.25,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE 300MG/ML SOLUTION FOR INJECTION,IOHEXOL,44-261-22,2012,300 mg/ml,Solution for injection,Intravenous use,1320.20,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE 300MG/ML SOLUTION FOR INJECTION,IOHEXOL,43-261-22,2012,300 mg/ml,Solution for injection,Intravenous use,676.60,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE,IOHEXOL,15-315-99,1999,350 mg/ml,Solution for injection,Intravenous use,955.8,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE,IOHEXOL,16-315-99,1999,350 mg/ml,Solution for injection,Intravenous use,1894.25,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMOL 120MG\5ML SYRUP,PARACETAMOL,0801256546,2003,24 mg/ml,Syrup,Oral use,5.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMOL 500MG TABLET,PARACETAMOL,0805257358,2003,500 mg,Tablet,Oral use,2.65,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMOL EXTRA TABLETS,"PARACETAMOL, CAFFEINE CITRATE",2710246118,2008,"500,65 mg",Tablet,Oral use,3.85,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ONE-ALPHA CAPS 1.0 MICROGM,ALFACALCIDOL,10-5444-24,1984,1 µg,Capsule,Oral use,178.40,Leo Pharma,Denmark,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
OPTIDRIN EYE DROP,CROMOGLICATE SODIUM,0409234105,2003,2 %,"Eye drops, solution",Ophthalmic use,15.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTIDEX-T STERILE OPHTALMIC SUSP,"TOBRAMYCIN, DEXAMETHASONE",1506222195,2000,"0.3,0.1 %","Eye drops, suspension",Ophthalmic use,19.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTICYCLIN 1 % OINTMENT,TETRACYCLINE,29-290-04,2004,1 %,Ointment,Ophthalmic use,3,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
OPTICIN 0.3% EYE DROPS,CIPROFLOXACIN,3-368-00,2000,0.3 %,"Eye drops, solution",Ophthalmic use,14.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPTICHLOR 0.5% OPTHALMIC DROP,CHLORAMPHENICOL,0409234108,2002,0.5 %,"Eye drops, solution",Ophthalmic use,7.8,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OPRAZOLE 40MG- VIAL I.VI INFUSION,OMEPRAZOLE,0912246377,2010,40 mg,Powder for infusion,Intravenous use,24.4,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
OPRAZOLE 20MG E.C.TAB,OMEPRAZOLE,2503257164,2001,20 mg,Tablet,Oral use,41.35,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
OMNIPAQUE,IOHEXOL,11-315-99,1999,300 mg/ml,Solution for injection,Intravenous use,816.8,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OPIZOLE-B CREAM,"CLOTRIMAZOLE, BETAMETHASONE DIPROPIONATE",2307257820,2006,"1,0.05 % (W/W)",Cream,Topical,11,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
OPIZOLE 1% CREAM,CLOTRIMAZOLE,1111258563,2008,1 %,Cream,Topical,5.9,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
ONE-ALPHA DROPS 2MICROGRAM-ML,ALFACALCIDOL,11-5444-24,1987,2 µ/ml,"Oral drops, solution",Oral use,81.7,Leo Pharma,Denmark,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
ONE-ALPHA CAPS 0.25 MICROGM,ALFACALCIDOL,12-5444-24,1995,0.25 µg,Capsule,Oral use,68.10,Leo Pharma,Denmark,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ONE-ALPHA 2MCG-ML AMP.,ALFACALCIDOL,1002256862,1995,2 µg,Injection,Intravenous use,103.35,CENEXI,France,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
OMACE 20MG TABLETS,LISINOPRIL,1303257056,2006,20 mg,Tablet,Oral use,44.35,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMCET 5MG-5ML SYRUP,CETIRIZINE HYDROCHLORIDE,0801256547,2008,1 mg/ml,Syrup,Oral use,5.95,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMCET 10MG F.C. TABS,CETIRIZINE HYDROCHLORIDE,2710246116,2006,10 mg,Film-coated tablet,Oral use,6.75,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMATHROCIN 250 MG TABLET,ERYTHROMYCIN,0210258317,2006,250 mg,Tablet,Oral use,9.95,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMATHROCIN 200 ORAL SUSPENSION,ERYTHROMYCIN,2710246115,2008,40 mg/ml,Suspension,Oral use,7.05,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMATHROCIN ORAL DROPS 100 MG- 2.5 ML,ERYTHROMYCIN,18-390-06,2006,40 mg/ml,Oral drops,Oral use,4.4,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMAFEN 400 MG F.C TABLETS,IBUPROFEN,0801256548,2003,400 mg,Tablet,Oral use,6.5,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMIPURE 1000 MG SOFT GELATIN CAPSULES,OMEGA-3 POLYUNSATURATED FATTY ACIDS,2809222656,2008,1000 mg,"Capsule, soft",Oral use,103.9,Patheon Soft Gels BV,Netherlands,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OMACIP 500MG TABLETS,CIPROFLOXACIN,0210258315,2006,500 mg,Film-coated tablet,Oral use,33.05,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACIP 250MG TABLETS,CIPROFLOXACIN,22-390-06,2006,250 mg,Film-coated tablet,Oral use,20.1,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACILLIN 500MG CAPSULES,AMOXICILLIN,2710246114,2006,500 mg,Capsule,Oral use,9.9,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACILLIN 250MG CAP,AMOXICILLIN,2710246113,2003,250 mg,Capsule,Oral use,7.5,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACILLIN 125MG-5ML POWDER FOR ORAL SUSP,AMOXICILLIN,1303257054,2006,25 mg/ml,Powder for oral suspension,Oral use,7.4,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACILLIN 100MG-ML ORAL DROPS,AMOXICILLIN,15-390-06,2006,100 mg/ml,Oral drops,Oral use,9.8,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMACID CHEWABLE TABLETS,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",1011258559,2006,"200,200 mg",Chewable tablet,Oral use,2.95,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMERAL 10 mg capsule,OMEPRAZOLE,0408257918,2005,10 mg,Capsule,Oral use,22.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OMERAL 20 mg capsule,OMEPRAZOLE,59-334-01,2001,20 mg,Capsule,Oral use,45.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OMFORMIN 500MG F.C. TABLETS,METFORMIN HYDROCHLORIDE,2606257633,2006,500 mg,Film-coated tablet,Oral use,4.70,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
OMIZ 10MG CAP,OMEPRAZOLE,0709258179,2001,10 mg,Capsule,Oral use,23,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OMNIPAQUE,IOHEXOL,12-315-99,1999,300 mg/ml,Solution for injection,Intravenous use,1616.2,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE,IOHEXOL,6-315-99,1999,240 mg/ml,Solution for injection,Intravenous use,651.7,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE,IOHEXOL,5-315-99,1999,240 mg/ml,Solution for injection,Intravenous use,799.4,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNIPAQUE,IOHEXOL,8-315-99,1999,300 mg/ml,Solution for injection,Intravenous use,212.25,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
OMNICEF 125MG-5ML SUSP,CEFDINIR,1911246265,2001,25 mg/ml,Suspension,Oral use,71.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OMNICEF 125MG-5ML SUSP,CEFDINIR,2511246337,2000,25 mg/ml,Suspension,Oral use,45.8,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OMNIC OCAS 0.4 MG F-C TABLETS,TAMSULOSIN HYDROCHLORIDE,1803257099,2008,0.4 mg,Film-coated tablet,Oral use,71.70,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OMIZ PLUS 40MG CAPSULE,"OMEPRAZOLE, SODIUM BICARBONATE",1601244734,2012,"40,1100 mg",Capsule,Oral use,120.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OMIZ PLUS 20MG CAPSULE,"OMEPRAZOLE, SODIUM BICARBONATE",1501244718,2012,"20,1100 mg",Capsule,Oral use,52.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OMIZ 20MG CAP,OMEPRAZOLE,1707257772,2001,20 mg,Capsule,Oral use,45.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
OMNICEF 300MG CAPSULE,CEFDINIR,46-334-00,2000,300 mg,Capsule,Oral use,79.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PARAMOL SYRUP 120MG-5ML,PARACETAMOL,14-120-95,1995,24 mg/ml,Syrup,Oral use,2.85,MISR COMPANY FOR MEDICAL PRODUCTS,Egypt,MISR COMPANY FOR MEDICAL PRODUCTS,Egypt,Marketed,OTC,store below 25°c,Pharmacy,United Pharmaceutical Establishment
PARAXONE CAPSULE,"CHLORZOXAZONE, PARACETAMOL",0408257917,2005,"250,300 mg",Capsule,Oral use,26.30,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PROLIA 60MG/ML SOLUTION FOR INJECTION,DENOSUMAB,17-475-13,2013,60 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,974.00,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PROKININ 5MG-5ML SUSPENSION,DOMPERIDONE,2510222792,2006,0.1 %,Oral suspension,Oral use,17.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROKININ 10MG F-C TABLETS,DOMPERIDONE,1601244733,2006,10 mg,Film-coated tablet,Oral use,16.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROHAIR 1 mg film-coated tablet,FINASTERIDE,0211234428,2009,1 mg,Film-coated tablet,Oral use,44.05,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
PROGRAF 1 mg capsule,TACROLIMUS,2707257858,2000,1 mg,"Capsule, hard",Oral use,884.2,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PROGRAF 5 mg capsule,TACROLIMUS,2707257859,2000,5 mg,"Capsule, hard",Oral use,4033.6,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PROFILAR 1MG/5ML SYRUP,KETOTIFEN,18-271-03,2003,0.2 mg/ml,Syrup,Oral use,18.3,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
PROF Cold & Flu Film coated tablet,"IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",287-277-14,2014,"200,30,2 mg",Film-coated tablet,Oral use,12.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROF 600 MG TAB,IBUPROFEN,0902221710,2001,600 mg,Film-coated tablet,Oral use,15.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROF 400 MG TAB,IBUPROFEN,2102221748,2001,400 mg,Film-coated tablet,Oral use,13.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROF 100MG-5ML SUSP,IBUPROFEN,2507222348,2001,20 mg/ml,Oral suspension,Oral use,7.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROMAX 0.05% OINTMENT,CLOBETASOL PROPIONATE,5-368-00,2000,0.05 %,Ointment,Topical,8.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
PROMETIN 5MG\5ML SYRUP,PROMETHAZINE,0801256560,2002,1 mg/ml,Syrup,Oral use,4.45,GENERAL NUTRITION CORPORATION,United States,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
PROSTIN VR AMP,ALPROSTADIL,2411222932,1992,0.5 mg/ml,Concentrate for solution for infusion,Intravenous use,1325.65,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
PROSTIN E2 1MG VAGINAL GEL IN APPLICATOR,DINOPROSTONE,2411222931,1999,1 mg,Vaginal gel,Vaginal use,68.35,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
PROSTIN E2 0.75ML AMP,DINOPROSTONE,0407245480,1992,1 mg,Concentrate for solution for infusion,Intravenous use,46.9,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
PROSTIN E2 0.5ML I.V.AMP,DINOPROSTONE,0407245479,1994,10 mg/ml,Concentrate for solution for infusion,Intravenous use,112.6,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
PROSTA TAB,TAMSULOSIN HYDROCHLORIDE,1302256895,2013,0.4 mg,Prolonged-release tablet,Oral use,77.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROPOFOL-LIPURO1% INJ OR INF AMPOULE,PROPOFOL,1512246416,2005,1 %,Emulsion for injection/infusion,Intravenous use,68.95,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
PROPOFOL-LIPURO 1%INJ OR INF VIAL,PROPOFOL,1512246417,2005,1 %,Emulsion for injection/infusion,Intravenous use,37.7,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
PROPESS 10MG VAGINAL DELIVERY SYSTEM,DINOPROSTONE,0102233200,2013,10 mg,Vaginal delivery system,Vaginal use,210.05,FERRING CONTROLLED THERAPEUTICS,United Kingdom,FERRING Gmph,Germany,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Hospital,Abdulrehman Algosaibi G.T.C.
PROPECIA,FINASTERIDE,2003257113,2003,1 mg,Film-coated tablet,Oral use,110.1,AIAC INTERNATIONAL PHARMA LLC,United States,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PROSNORM,FINASTERIDE,1811211340,2009,5 mg,Film-coated tablet,Oral use,67.85,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
PROSULF 10MG/ML SOLUTION FOR INJECTION,PROTAMINE SULFATE,1908258060,2005,1 %,Solution for injection,Intravenous use,278.05,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
PROCTO GLYVENOL,"TRIBENOSIDE, LIDOCAINE HYDROCHLORIDE",2302221760,1996,"5,2 %",Cream,Topical,35.45,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Haleon Arabia Limited
PREXAL 10MG FILM COATED TABLETS,OLANZAPINE,17-535-14,2014,10 mg,Film-coated tablet,Oral use,159.55,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
PREX 75MG CAPSULE,PREGABALIN,165-334-12,2012,75 mg,"Capsule, hard",Oral use,74,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREX 75MG CAPSULE,PREGABALIN,152-334-12,2012,75 mg,"Capsule, hard",Oral use,37,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREX 50MG CAPSULE,PREGABALIN,164-334-12,2012,50 mg,"Capsule, hard",Oral use,50.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREX 50MG CAPSULE,PREGABALIN,151-334-12,2012,50 mg,"Capsule, hard",Oral use,25.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREX 150MG CAPSULE,PREGABALIN,166-334-12,2012,150 mg,"Capsule, hard",Oral use,92.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREX 150MG CAPSULE,PREGABALIN,153-334-12,2012,150 mg,"Capsule, hard",Oral use,46.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PRETERAX ARGININE 2.5MG-0.625MG F.C. TAB,"PERINDOPRIL ARGININE, INDAPAMIDE",5-597-09,2009,"2.5,0.625 mg",Film-coated tablet,Oral use,38.15,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
PREXAL 5MG FILM COATED TABLETS,OLANZAPINE,16-535-14,2014,5 mg,Film-coated tablet,Oral use,97.30,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
PRILA 5% CREAM,"LIDOCAINE HYDROCHLORIDE, PRILOCAINE",0407245483,2010,"2.5,2.5 %",Cream,Topical,55,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
PRIMOLUT N TAB 5 MG,NORETHISTERONE,1409234212,1980,5 mg,Tablet,Oral use,18.4,BAYER WEIMAR GmbH UND CO. KG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
PRIMOVIST 0.25MMOL-ML PRE-FILLED SYRINGS,GADOXETIC ACID,0502233209,2009,0.25 mmol/ml,Solution for injection in pre-filled syringe,Intravenous use,3487.70,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
PROCORALAN 7.5 MG F-C TABLET,IVABRADINE,2-597-07,2007,7.5 mg,Film-coated tablet,Oral use,149.45,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
PROCORALAN 5 MG F-C TABLETS,IVABRADINE,1-597-07,2007,5 mg,Film-coated tablet,Oral use,149.45,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
PRIZMA 4GM-0.5GM POWDER FOR I.V INFUSION,"PIPERACILLIN, Tazobactam",124-334-09,2009,"4,0.5 g",Powder for solution for infusion,Intravenous use,71.25,LABORATORIO REIG JOFRE,Spain,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
PRIZMA 2GM/0.25GM POWDER FOR I.V. INFUSION,"PIPERACILLIN, Tazobactam",138-334-11,2011,"2,0.25 g",Powder for solution for infusion,Intravenous use,35.6,LABORATORIO REIG JOFRE,Spain,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
PRIVIGEN 10% SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,4-470-12,2012,10 %,Solution for infusion,Intravenous use,1120.70,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PRIVIGEN 10% SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,3-470-12,2012,10 %,Solution for infusion,Intravenous use,2241.40,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PROCTO GLYVENOL,"TRIBENOSIDE, LIDOCAINE HYDROCHLORIDE",2012211492,1980,"400,40 mg",Suppository,Rectal use,26.70,DELPHARM HUNINGUE S.A.S.,France,Haleon Schweiz AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
PRIVIGEN 10% SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,2-470-12,2012,10 %,Solution for infusion,Intravenous use,4482.80,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PRIORIX-TETRA VACCINE,"MEASLES VIRUS (SCHWARZ) LIVE ATTENUATED, MUMPS VIRUS (JERYL LYNN, STRAIN RIT 4385) LIVE ATTENUATED, RUBELLA VIRUS (WISTAR RA 27/3) LIVE ATTENUATED, VARICELLA ZOSTER VIRUS (OKA STRAIN) LIVE ATTENUATED",94-276-12,2012,"1000,25119,1000,1995.26 PFU, CCID5",Solution for injection,Parenteral use,212.10,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PRIORIX 0.5ML VIAL,"MUMPS VIRUS (JERYL LYNN, STRAIN RIT 4385) LIVE ATTENUATED, MEASLES VIRUS (SCHWARZ) LIVE ATTENUATED, RUBELLA VIRUS (WISTAR RA 27/3) LIVE ATTENUATED",0109258139,2012,"5011.87,1000,1000 CCID50",Solution for injection,Intramuscular use,51.90,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PRIMPERAN TAB 10MG,METOCLOPRAMIDE HYDROCHLORIDE,1-90-82,1982,10 mg,Tablet,Oral use,6.7,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
PRISTIQ 50MG EXTENDED RELEASE TABLETS,DESVENLAFAXINE SUCCINATE,2904257311,2010,50 mg,Prolonged-release tablet,Oral use,78.5,PFIZER,Ireland,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
PREGADEX 75 MG CAPSULE,PREGABALIN,0603256997,2012,75 mg,"Capsule, hard",Oral use,75.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROTEC 2 GM Injection*,CEFEPIME HYDROCHLORIDE,2008245781,2007,2 g,Powder for injection,Intravenous use,63.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
RAMIPRIL SANDOZ 5MG TABLET,RAMIPRIL,20-349-11,2011,5 mg,Tablet,Oral use,23.4,LEK S.A,Poland,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
RAMIPRIL SANDOZ 2.5MG TABLET,RAMIPRIL,19-349-11,2011,2.5 mg,Tablet,Oral use,13.20,LEK S.A,Poland,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
RAMIPRIL SANDOZ 10MG TABLET,RAMIPRIL,21-349-11,2011,10 mg,Tablet,Oral use,24.75,LEK S.A,Poland,HEXAL,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
QUINOX 750MG F- C TABLET,CIPROFLOXACIN,1501256653,2005,750 mg,Film-coated tablet,Oral use,51.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
QUINOX 500 MG TAB,CIPROFLOXACIN,0606233766,2000,500 mg,Film-coated tablet,Oral use,63.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
QUINOX 250 MG F- C TAB,CIPROFLOXACIN,0606233768,2000,250 mg,Film-coated tablet,Oral use,35.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RAZON 40 MG E.C TAB,PANTOPRAZOLE,2207245621,2002,40 mg,Tablet,Oral use,35.15,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
RAZON 20 MG E.C. TABLET,PANTOPRAZOLE,72-171-10,2010,20 mg,Tablet,Oral use,37.65,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Dallah Health Care Company
RAPIFEN 500MCG-ML AMP,ALFENTANIL,56-6-92,1992,500 µ/ml,Solution for injection/infusion,Intravenous use,82.95,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 30°c,Hospital,
RAPIFEN 500MCG-ML AMP,ALFENTANIL,57-6-92,1992,500 µ/ml,Solution for injection/infusion,Intravenous use,19.45,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
RAPIDUS 50 MG F.C. TABLET,DICLOFENAC POTASSIUM,2201268979,1999,50 mg,Film-coated tablet,Oral use,29.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RAPIDUS 25MG F.C. TABLET,DICLOFENAC POTASSIUM,0412258732,1999,25 mg,Film-coated tablet,Oral use,17.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROTEC 1 GM Injection,CEFEPIME HYDROCHLORIDE,2008245784,2007,1 g,Powder for injection,Intramuscular use,40.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
PYRAZINAMIDE ANTIBIOTICE,PYRAZINAMIDE,2405233722,2011,500 mg,Tablet,Oral use,63.40,ANTIBIOTIC S.E,Romania,ANTIBIOTIC S.E,Romania,Marketed,Prescription,store below 25°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
PROTON 40MG E.C TAB,PANTOPRAZOLE,2005257431,2001,40 mg,Enteric-coated tablet,Oral use,43.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROTON 40MG E.C TAB,PANTOPRAZOLE,2307257832,2001,40 mg,Enteric-coated tablet,Oral use,78.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
PROTON 20MG E.C TABLET,PANTOPRAZOLE,0304221908,2003,20 mg,Enteric-coated tablet,Oral use,48.60,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROTON 20MG E.C TABLET,PANTOPRAZOLE,2005257430,2003,20 mg,Enteric-coated tablet,Oral use,27.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROTOGYN,TINIDAZOLE,1811211341,2002,500 mg,Film-coated tablet,Oral use,10.45,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
PULMICORT 0.5MG-ML (S.DOSE FOR NUB) SUSP,BUDESONIDE,0404233471,1997,0.5 mg/ml,Nebuliser suspension,Inhalation use,134.25,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PULMICORT TURBUHALER 100MCG-DOSE,BUDESONIDE,54-15-97,1997,0.1 mg,Inhalation powder,Inhalation use,67.15,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PULMICORT TURBUHALER 200MCG-DOSE,BUDESONIDE,1004233521,1997,0.2 mg,Inhalation powder,Inhalation use,96.60,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PYRALVEX,"ANTHRAQUINONE GLYCOSIDE, SALICYLIC ACID",0201233049,2006,"0.05,0.01 g",Cutaneous solution,Topical,15.10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
PUREGON 600 I.U CARTRIDGE,FOLLITROPIN BETA,19-262-24,2008,600 IU,Solution for injection,Subcutaneous use,884.4,VETTER PHARMA,Germany,N.V. Organon,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
PULMICORT0.25MG-ML SINGLE DOSE PLASTIC U,BUDESONIDE,0107245463,1997,0.25 mg/ml,Nebuliser suspension,Inhalation use,94.4,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PUREGON 300I.U CARTRIDGE,FOLLITROPIN BETA,18-262-24,2003,300 IU,Solution for injection,Subcutaneous use,573.05,VETTER PHARMA,Germany,N.V. Organon,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
PREGADEX 300 MG CAPSULE,PREGABALIN,0709258176,2012,300 mg,"Capsule, hard",Oral use,180.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PREGADEX 150 MG CAPSULE,PREGABALIN,0603256995,2012,150 mg,"Capsule, hard",Oral use,123.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PERITONEAL DIALYSIS (F-C) WITH 1.36% DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE",389-149-09,2009,"14.96,5.6,0.26,0.15,10,0.3 g/ml",Solution for peritoneal dialysis,Intraperitoneal,23.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS (F-B) WITH 7% DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",388-149-09,2009,"77,5.6,0.26,0.15,10 g/ml",Solution for peritoneal dialysis,Intraperitoneal,23.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS (F-A) WITH 1.36% DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE",386-149-09,2009,"14.96,5.6,0.26,0.15,10,0.3 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS (F-A) WITH 1.36% DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE",265-149-02,2002,"14.96,5.6,0.26,0.15,10,0.3 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIAL.(F- C)WITH1.36% DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE",373-149-09,2009,"14.96,5.6,0.26,0.15,10,0.3 g/ml",Solution for peritoneal dialysis,Intraperitoneal,59.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERIACTIN 4MG TABLETS,CYPROHEPTADINE HYDROCHLORIDE,1501244726,2010,4 mg,Tablet,Oral use,5.2,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
PERGOVERIS 150/75 IU vial,"FOLLITROPIN ALFA, LUTROPIN ALFA",1000001250,2014,"150,75 IU",Solution for injection,Subcutaneous use,230.25,PHARMALINK,Spain,Merck (Schweiz) AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, Merck Limited"
PEPTAZOLE 30MG CAPSULE,LANSOPRAZOLE,1005222005,2000,30 mg,Capsule,Oral use,45.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PEPTAZOLE 30MG CAPSULE,LANSOPRAZOLE,1005222007,2000,30 mg,Capsule,Oral use,91.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PEPTAZOLE 15MG CAPSULE,LANSOPRAZOLE,1005222006,2004,15 mg,Capsule,Oral use,22.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
PEPTAZOLE 15MG CAPSULE,LANSOPRAZOLE,196-212-04,2004,15 mg,Capsule,Oral use,45.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PERITONEAL DIALYSIS 1.5%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",228-149-01,2001,"16.50,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 1.5%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",230-149-01,2001,"16.50,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 1.5%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",227-149-01,2001,"16.50,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 1.5%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",229-149-01,2001,"16.50,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS SOLN 4.25%DEXT(LOWNa,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",103-149-95,1995,"46.75,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS SOLN 2.5%DEXT(LOW Na,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",102-149-95,1995,"27.5,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS SOLN 1.5%DEXT& POTAS,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",101-149-95,1995,"16.50,5.61,0.298,0.294,0.203,6.12 g/ml, g",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 7% DEX 140.21MMOL SO,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",243-149-02,2002,"77,5.65,0.294,0.153,9.76 g/ml",Solution for peritoneal dialysis,Intraperitoneal,16.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 4.25%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",242-149-01,2001,"46.75,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 4.25%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",241-149-01,2001,"46.75,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 4.25%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",240-149-01,2001,"46.75,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PEPSOLAN 40 MG Powder for solution for injection,PANTOPRAZOLE,89-116-14,2014,40 mg,Powder for injection,Intravenous use,130.7,LEK PHARMACEUTICALS D.D.,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
PERITONEAL DIALYSIS 4.25%DEX,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",239-149-01,2001,"46.75,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3%DEX 1.5MMOLELCTR,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",233-149-01,2001,"25.3,5.7,0.221,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3%DEX 1.5MMOLELCTR,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",234-149-01,2001,"25.3,5.7,0.221,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3%DEX 1.5MMOLELCTR,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",231-149-01,2001,"25.3,5.7,0.221,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3% DEX 1.75MMOL EL,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",237-149-01,2001,"25.3,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3% DEX 1.75MMOL EL,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",236-149-01,2001,"25.3,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3% DEX 1.75MMOL EL,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",238-149-01,2001,"25.3,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3% DEX 1.75MMOL EL,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",235-149-01,2001,"25.3,5.669,0.2573,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS 2.3%DEX 1.5MMOLELCTR,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",232-149-01,2001,"25.3,5.7,0.221,0.1525,7.847 g/l",Solution for peritoneal dialysis,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PENTOLATE 1% EYE DROPS,CYCLOPENTOLATE,0308222394,2006,1 %,Eye drops,Ophthalmic use,9,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
PECTAL 100MG\5ML SYRUP,GUAIFENESIN,2504245213,2002,20 mg/ml,Syrup,Oral use,7.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PAXITAB 40MG TABLET,PAROXETINE,1601244741,2012,40 mg,Tablet,Oral use,89.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PAXITAB 20MG TABLET,PAROXETINE,1601244742,2012,20 mg,Tablet,Oral use,54.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PAROXAT 30MG F-C TABLETS,PAROXETINE,246-212-08,2008,30 mg,Film-coated tablet,Oral use,78.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PAROXAT 20 MG F-C TABLETS,PAROXETINE,247-212-08,2008,20 mg,Film-coated tablet,Oral use,60.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PAROXAT 10 MG F-C TABLETS,PAROXETINE,248-212-08,2008,10 mg,Film-coated tablet,Oral use,30.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
PARIET 20MG E.C TAB,RABEPRAZOLE SODIUM,1312223012,2007,20 mg,Tablet,Oral use,19.7,Bushu Pharmaceuticals Ltd.,Japan,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PEDIAMOL 100MG-ML ORAL DROPS,PARACETAMOL,23-390-06,2006,100 mg/ml,"Oral drops, solution",Oral use,7.50,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
PEGASYS 180 MCG-0.5ML PRE-FILLED SYRINGE,PEGINTERFERON ALFA-2A,236-24-02,2002,180 µg,Injection,Subcutaneous use,1134.3,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
PENTASA 500 MG SLOW RELEASE TABLET,MESALAZINE,2208234023,2007,500 mg,Prolonged-release tablet,Oral use,85.70,FERRING PHARMA INTERNATIONAL CENTER,Switzerland,FERRING,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTASA 1GM SUPP.,MESALAZINE,0407245484,2008,1 g,Suppository,Rectal use,107.50,PHARBIL PHARMA,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTASA 1GM PROLONGED RELEASE GRANULES,MESALAZINE,2811222946,2013,1 g,Prolonged-release granules,Oral use,166.05,FERRING,Switzerland,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTASA 1% ENEMA,MESALAZINE,2402256927,2007,1 g,Enema,Rectal use,78.50,FERRING,Czech Republic,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTASA 1 G CONTROLLED RELEASE TABLET,MESALAZINE,2811222947,2013,1 g,Prolonged-release tablet,Oral use,167.30,FERRING,Switzerland,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTAGLOBIN AMP I.V,PLASMA PROTEIN FRACTION,2009234228,1998,50 mg/ml,Solution for infusion,Intravenous use,224.15,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PENTAGLOBIN,PLASMA PROTEIN FRACTION,2009234227,2000,50 mg/ml,Solution for infusion,Intravenous use,2241.40,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PENTAGLOBIN,PLASMA PROTEIN FRACTION,2009234226,2000,50 mg/ml,Solution for infusion,Intravenous use,1120.70,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PERITONEAL DIALYSIS SOLN1.5%DEXT(HIGH Na,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",106-149-95,1995,"16.50,5.61,0.294,0.203,6.12 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS SOLN1.5%DEXT(LOW Na),"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",105-149-95,1995,"16.50,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PONSTAN FORTE 500 mg film-coated tablet,MEFENAMIC ACID,1901210429,1998,500 mg,Film-coated tablet,Oral use,15.3,PFIZER,Germany,PFIZER,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
POLYVALENT SNAKE ANTIVENUM-EQUINE 10 ML AMPULE,ANTIVENUM IMMUNOGLOBULIN AGAINST SIX TYPES OF SNAKES AMP,0709234150,1998,10 ml,Solution,Intravenous use,7256.00,NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER,Saudi Arabia,NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALHAYA MEDICAL CO
POLYTAR 1% LIQUID SHAMPOO,"COAL TAR, JUNIPER, PINE",1-247-96,1996,1 %,Shampoo,Topical,12.35,STIEFEL LABORATORIES,Ireland,STIEFEL LABORATORIES,Ireland,Marketed,OTC,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PLAVIX 75 MG TABLET,CLOPIDOGREL,2-5143-21,2001,75 mg,Film-coated tablet,Oral use,230.00,SANOFI WINTHROP INDUSTRIE,France,Sanofi Clir SNC,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
POTASSIUM ACETATE INJ F.T.V. 40MEQ,POTASSIUM ACETATE,2609211077,1990,40 mEq,Injection,Intravenous use,11.20,HOSPIRA INC. ROCKY MOUNT,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
POTASSIUM CHLORIDE 7.5% AMP,POTASSIUM CHLORIDE,147-149-98,1998,7.5 %,Solution for haemodialysis,Intravenous use,1.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
PREDO 5MG-5ML SYRUP,PREDNISOLONE SODIUM PHOSPHATE,131-334-10,2010,1 mg/ml,Syrup,Oral use,20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREDO 5MG TABLETS,PREDNISOLONE,2108258092,2010,5 mg,Tablet,Oral use,15.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREDO 25MG TABLETS,PREDNISOLONE,2108258091,2010,25 mg,Tablet,Oral use,52.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREDO 15MG-5ML SYRUP,PREDNISOLONE SODIUM PHOSPHATE,1911246256,2010,3 mg/ml,Syrup,Oral use,42,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PREDNISOLONE,PREDNISOLONE SODIUM PHOSPHATE,26-5083-20,1981,5 mg,Tablet,Oral use,17.1,Globopharm Pharmazeutische Produktions und Handelsgesellschaft GmbH,Austria,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Acino Arabia for trading LLC"
PRED FORTE OPTH. SUSP,PREDNISOLONE,1003221835,1986,1 %,"Eye drops, suspension",Ophthalmic use,16.05,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE LIMITED,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PRECEDEX 100 MCG -ML IV. VIAL,DEXMEDETOMIDINE,1305245278,2002,100 µ/ml,Injection,Intravenous use,102.5,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
PRADAXA 75MG CAPSULES,DABIGATRAN ETEXILATE,0110258291,2009,75 mg,"Capsule, hard",Oral use,154,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
PRADAXA 150MG CAPSULES,DABIGATRAN ETEXILATE,110258289,2013,150 mg,"Capsule, hard",Oral use,308,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
PRADAXA 110MG CAPSULES,DABIGATRAN ETEXILATE,92-68-09,2009,110 mg,"Capsule, hard",Oral use,308,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
PRADAXA 110MG CAPSULES,DABIGATRAN ETEXILATE,0110258292,2009,110 mg,"Capsule, hard",Oral use,154,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
POTASSIUM CHLORIDE 7.5% AMP,POTASSIUM CHLORIDE,137-149-97,1997,7.5 %,Solution for haemodialysis,Intravenous use,2.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
POTASSIUM CHLORIDE 7.5% AMP,POTASSIUM CHLORIDE,146-149-98,1998,7.5 %,Solution for haemodialysis,Intravenous use,1.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
PRADAXA 75MG CAPSULES,DABIGATRAN ETEXILATE,90-68-09,2009,75 mg,"Capsule, hard",Oral use,308,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
PLASMANATE 5% SOLUTION FOR I.V. INJECTION,PLASMA PROTEIN FRACTION,3-228-10,2010,5 %,Solution for injection,Intravenous use,158.9,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
PLASMA PROTEIN FRACTION 5% SOLUTION,PLASMA PROTEIN FRACTION,2410234380,2000,5 %,Solution for injection,Intravenous use,278,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,Store between (2°C – 25°C),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PHENTOLEP 50MG-ML AMPOULE,PHENYTOIN SODIUM,2701256752,2010,50 mg/ml,Solution for injection,Intravenous use,71.4,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Abdulrehman Algosaibi G.T.C.
PHENICOL 1% OPTHALMIC OINTMENT,CHLORAMPHENICOL,22-290-03,2003,1 %,Ointment,Ophthalmic use,2.25,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
PERJETA 420 mg Concentrate for solution for infusion,PERTUZUMAB,311258533,2014,420 mg,Concentrate for solution for infusion,Intravenous use,10178.05,ROCHE DIAGNOSTICS,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
PERITONEAL DIALYSIS(F- B)WITH7% DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",374-149-09,2009,"77,5.6,0.26,0.15,10 g/ml",Solution for peritoneal dialysis,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS WITH 4.25%DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",291-149-04,2004,"46.75,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Parenteral use,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS WITH 4.25%DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",190-149-99,1999,"46.75,5.61,0.294,0.203,5.45 g/ml",Solution for peritoneal dialysis,Parenteral use,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS WITH 1.5%DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",292-149-04,2004,"16.50,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Parenteral use,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS WITH 1.5%DEXTROSE,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",189-149-99,1999,"16.50,5.38,0.184,0.051,5.45 mg/ml",Solution for peritoneal dialysis,Parenteral use,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
PERITONEAL DIALYSIS SOLN4.25%DEXT(HIGHNa,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",104-149-95,1995,"46.75,5.61,0.294,0.203,4.76 g/ml",Solution for peritoneal dialysis,Intraperitoneal,8.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NO-URIC 100 mg tablet,ALLOPURINOL,2209258255,1990,100 mg,Tablet,Oral use,16.3,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
PHILAQUIN FORTE 4% CREAM,HYDROQUINONE,0107257650,2003,4 %,Cream,Topical,24.1,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
PLASBUMIN 20%,ALBUMIN HUMAN,1706257571,2010,20 %,Suspension for injection,Intravenous use,146.40,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
PLASBUMIN 20%,ALBUMIN HUMAN,1706257570,2010,20 %,Suspension for injection,Intravenous use,213.85,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
PK-MERZ,AMANTADINE SULFATE,12-113-98,1998,100 mg,Tablet,Oral use,66.20,MERZ PHARMACEUTICAL,Germany,MERZ PHARMACEUTICAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PIPERACILLIN - TAZOPACTAM SANDOZ 2.25GM VIAL,"PIPERACILLIN, Tazobactam",0409222581,2012,"2,0.25 g",Powder for solution for infusion,Intravenous use,23.25,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
PIGMANORM,"HYDROQUINONE, HYDROCORTISONE, TRETINOIN",1111246181,2008,"4,1,0.1 %",Cream,Topical,63.1,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Pharmacy,RIYADH PHARMA
PICOPREP POWDER FOR ORAL SOLUTION,"CITRIC ACID ANHYDROUS, MAGNESIUM OXIDE, SODIUM PICOSULFATE",2107222341,2013,"12,3.5,10 mg, g",Powder for oral solution,Oral use,26.75,Ferring Pharmaceutical China Co Ltd,China,FERRING,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PICO 7.5MG-ML ORAL DROPS,SODIUM PICOSULFATE,0401244670,2009,7.5 mg/ml,Oral drops,Oral use,12.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PHYSIOTENS O.4 MG F.C.TAB,MOXONIDINE,3105222112,2001,0.4 mg,Film-coated tablet,Oral use,65.15,ROTTENDORF PHARMA GMBH,Germany,Abbott Laboratories GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PHYSIOTENS 0.2 MG F.C TAB,MOXONIDINE,3105222111,2001,0.2 mg,Film-coated tablet,Oral use,45.05,ROTTENDORF PHARMA GMBH,Germany,Abbott Laboratories GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
REBIF 22 MCG PRE-FILLED SYRINGE,INTERFERON BETA-1A,2-363-04,2004,22 µg,Solution for injection,Subcutaneous use,1984.1,SERONO,Italy,SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
NOSPASM 10 MG TAB,HYOSCINE BUTYLBROMIDE,2005257439,1999,10 mg,Tablet,Oral use,16.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,SPIMACO
MABTHERA 10MG-1ML CONC. FOR I.V INFUSION,RITUXIMAB,1311258587,2008,10 mg/ml,Concentrate and diluent for solution for infusion,Intravenous use,4795.95,Roche Diagnostics GmbH,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ARAC HEALTHCARE
MAALOX SUSPENSION,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",1-289-99,1999,"45,40 mg",Oral suspension,Oral use,5.9,sanofi-aventis,Ireland,sanofi-aventis,Ireland,Marketed,OTC,store below 25°c,Pharmacy,Opella Arabia Limited Co
MAALOX PLUS SUSP.,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE",2-289-99,1999,"45,40,5 mg",Oral suspension,Oral use,9.1,sanofi-aventis,Ireland,sanofi-aventis,Ireland,Marketed,OTC,store below 25°c,Pharmacy,Opella Arabia Limited Co
LYRICA 75 MG CAPSULES,PREGABALIN,2909222676,2013,75 mg,"Capsule, hard",Oral use,140.65,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LYRICA 75,PREGABALIN,2605222074,2013,75 mg,"Capsule, hard",Oral use,48.05,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LYRICA 50,PREGABALIN,2605222071,2013,50 mg,"Capsule, hard",Oral use,43.95,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LYRICA 300,PREGABALIN,2909222677,2013,300 mg,"Capsule, hard",Oral use,373.50,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LYRICA 25,PREGABALIN,25-211-06,2006,25 mg,"Capsule, hard",Oral use,18.65,PFIZER,Germany,PFIZER,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LYRICA 150,PREGABALIN,2605222075,2013,150 mg,"Capsule, hard",Oral use,256.45,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
LUVERIS 75 I.U. POWDER FOR SOLU. FOR INJ,LUTROPIN ALFA,2702256955,2009,75 IU,Powder and solvent for solution for injection,Intravenous use,302.55,SERONO,Switzerland,SERONO,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Merck Limited"
LUSTRAL 50MG TAB,SERTRALINE,0206257519,1997,50 mg,Tablet,Oral use,95.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MABTHERA 10MG-1ML CONC. FOR I.V INFUSION,RITUXIMAB,1311258586,2008,10 mg/ml,Concentrate and diluent for solution for infusion,Intravenous use,1914.70,Roche Diagnostics GmbH,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ARAC HEALTHCARE
MALARONE,"ATOVAQUONE, PROGUANIL HYDROCHLORIDE",93-8-03,2003,"250,100 mg",Film-coated tablet,Oral use,124.05,GLAXOWELLCOME,United Kingdom,GLAXOWELLCOME,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
MAGNESIUM SULPHATE 10% Injection*,MAGNESIUM SULFATE,2107222330,2000,10 %,Solution for injection,Parenteral use,3.20,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MAGNESIUM SULPHATE 10% Injection*,MAGNESIUM SULFATE,1108222470,2000,10 %,Solution for injection,Parenteral use,1.80,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
MAGNESIUM SULFATE 50% I.V. Injection*,MAGNESIUM SULFATE,0602256838,2009,50 %,Solution for injection,Parenteral use,7.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
LUMIGAN 0.1MG/ML EYE DROPS,BIMATOPROST,0709234156,2013,0.1 mg/ml,"Eye drops, solution",Ophthalmic use,39.35,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MAGNESIUM SULFATE 50% AMPOULE,MAGNESIUM SULFATE,2107222332,2002,50 %,Solution for injection,Parenteral use,4.20,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MAGNACEF 200MG CAP.,CEFIXIME,2501256744,2003,200 mg,Capsule,Oral use,46.65,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MAGNACEF 100MG\5ML SUSP,CEFIXIME,2501256745,2002,20 mg/ml,Oral suspension,Oral use,36.6,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MADOPAR 250 MG TABS,"LEVODOPA, BENSERAZIDE",1607257767,1984,"200,50 mg",Tablet,Oral use,62.8,"Delpharm Milano, S.r.l.",Italy,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MAGNACEF 400MG CAP,CEFIXIME,2501256743,2002,400 mg,Capsule,Oral use,67.55,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
LORINEX 0.5MG-1ML SYRUP,DESLORATADINE,0801256557,2009,0.5 mg/ml,Syrup,Oral use,17.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LORINE 5MG-5ML SYRUP,LORATADINE,62-212-97,1997,1 mg/ml,Syrup,Oral use,18.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
LORINE 10MG TAB,LORATADINE,65-212-97,1997,10 mg,Tablet,Oral use,17.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
LORINE 10MG FAST MELTING TABLETS,LORATADINE,1803257091,2010,10 mg,Tablet,Oral use,17.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
LORINASE SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, LORATADINE",2212211498,2004,"12,1 mg/ml",Syrup,Oral use,22.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
Purout 100 MG TABLETS,ALLOPURINOL,19-498-08,2008,100 mg,Tablet,Oral use,22.75,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LORANO 10MG TABLETS,LORATADINE,2807222356,2009,10 mg,Tablet,Oral use,5.9,HEXAL,Germany,HEXAL,Germany,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
LORAMAX 10 mg tablet,LORATADINE,86-334-03,2003,10 mg,Tablet,Oral use,14.3,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LORAHIST 10 mg tablet,LORATADINE,1211246201,2006,10 mg,Tablet,Oral use,16.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
LORAHIST syrup,LORATADINE,1211246196,2004,1 mg/ml,Syrup,Oral use,17.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
LORADAY 5 MG - 5 ML SYRUP,LORATADINE,0801256555,2004,1 mg/ml,Syrup,Oral use,15.10,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
LORINEX 5MG FILM COATED TABLETS,DESLORATADINE,0501221564,2012,5 mg,Film-coated tablet,Oral use,20.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LORVAST 10 MG F-C TABLETS,ATORVASTATIN CALCIUM,2201256732,2007,10 mg,Film-coated tablet,Oral use,43.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LORVAST 20 MG F-C TABLETS,ATORVASTATIN CALCIUM,2201256728,2007,20 mg,Film-coated tablet,Oral use,43.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LORVAST 40 MG F-C TABLETS,ATORVASTATIN CALCIUM,2201256723,2007,40 mg,Film-coated tablet,Oral use,86.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOXTRA EYE DROP,"OFLOXACIN, PREDNISOLONE, TETRAHYDROZOLINE",0806222155,2003,"3,2,0.4 mg/ml",Eye drops,Ophthalmic use,18.1,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
LOXOL 50MG TABLET,LAMOTRIGINE,0802221697,2011,50 mg,Tablet,Oral use,45.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LOXOL 25MG TABLET,LAMOTRIGINE,0802221698,2011,25 mg,Tablet,Oral use,28.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LOXOL 200MG TABLET,LAMOTRIGINE,0802221695,2011,200 mg,Tablet,Oral use,135.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LOXOL 100MG TABLET,LAMOTRIGINE,0802221693,2011,100 mg,Tablet,Oral use,82.4,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LOWVASC 5MG CAPSULE,AMLODIPINE BESILATE,126-119-22,2005,5 mg,Capsule,Oral use,27.35,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LOWRAC 5MG CAPSULE,AMLODIPINE BESILATE,1111246167,2006,5 mg,Capsule,Oral use,21,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
LOTEVAN 5/160MG FILM COATED TABLET,"VALSARTAN, AMLODIPINE BESILATE",1501256627,2012,"160,5 mg",Film-coated tablet,Oral use,65.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN 10/320MG FILM COATED TABLET,"VALSARTAN, AMLODIPINE BESILATE",0810258374,2012,"320,10 mg",Film-coated tablet,Oral use,93.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN 10/160MG FILM COATED TABLET,"VALSARTAN, AMLODIPINE BESILATE",1501256636,2012,"160,10 mg",Film-coated tablet,Oral use,62.9,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTENSE 5MG CAP,AMLODIPINE BESILATE,0902221711,2003,5 mg,"Capsule, hard",Oral use,53.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTENSE 10MG CAPSULES,AMLODIPINE BESILATE,175-277-06,2006,10 mg,"Capsule, hard",Oral use,64.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOSEC MUPS 20MG TAB,OMEPRAZOLE,2502256930,2000,20 mg,Gastro-resistant tablet,Oral use,45.95,AstraZeneca,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LOSEC MUPS 10 MG TAB,OMEPRAZOLE,2601256748,2000,10 mg,Gastro-resistant tablet,Oral use,23,AstraZeneca AB,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LOTEVAN 5/320MG FILM COATED TABLET,"VALSARTAN, AMLODIPINE BESILATE",0810258372,2012,"320,5 mg",Film-coated tablet,Oral use,79.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MEGION 0.5GM I.V INJECTION,CEFTRIAXONE,71-116-07,2007,500 mg,Solution for injection,Intravenous use,20.1,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MEGAMOX 625 MG TAB,"AMOXICILLIN, CLAVULANIC ACID",44-334-00,2000,"500,125 mg",Tablet,Oral use,40.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 625 MG TAB,"AMOXICILLIN, CLAVULANIC ACID",2503245086,2002,"500,125 mg",Tablet,Oral use,57.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 457MG SUSP,"AMOXICILLIN, CLAVULANIC ACID",2503245088,2001,"400,57 mg",Powder for oral suspension,Oral use,29.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 312MG SUSP,"AMOXICILLIN, CLAVULANIC ACID",1209234191,2000,"250,62.5 mg",Powder for oral suspension,Oral use,29.30,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 228 MG SUSP,"AMOXICILLIN, CLAVULANIC ACID",0807245495,2000,"600,42.9 mg",Powder for oral suspension,Oral use,16.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 1GM TAB,"AMOXICILLIN, CLAVULANIC ACID",2503245087,2000,"875,125 mg",Tablet,Oral use,70.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX 156 MG SUSP,"AMOXICILLIN, CLAVULANIC ACID",2503245084,2000,"125,31.25 mg",Powder for oral suspension,Oral use,15.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZOYLEX  5% CREAM,ACYCLOVIR,38-490-08,2008,5 %,Cream,Topical,38.00,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MEGION 1GM I.V - I.M INJECTION,CEFTRIAXONE,72-116-07,2007,1 g,Solution for injection,Intramuscular use,21,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MEIACT 200 MG FILM COATED TABLETS,CEFDITOREN PIVOXIL,0802244876,2005,200 mg,Film-coated tablet,Oral use,79.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MESPORIN 1000 I.V,CEFTRIAXONE,2207257796,2005,1 g,Powder and solvent for suspension for injection,Intravenous use,30.55,LABESFAL,Portugal,Acino AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
MESPORIN 1000 I.M.,CEFTRIAXONE,1901268939,2005,1000 mg,Powder and solvent for suspension for injection,Intramuscular use,30.55,LABESFAL,Portugal,Acino AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
MEPHAQUIN LACTAB,MEFLOQUINE,1-222-93,1993,250 mg,Film-coated tablet,Oral use,28.05,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MENTEX SYRUP,"DIPHENHYDRAMINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE",2008245785,1999,"2.50,3,6 mg/ml",Syrup,Oral use,11.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MENOGON 75 I.U FSH & 75 I.U LH AMPOULES,"FOLLICLE STIMULATING HORMONE (FSH), LUTEINIZING HORMONE (LH)",2-367-01,2001,"75,75 IU",Powder and solvent for solution for injection,Intramuscular use,364.05,FERRING,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
MENACTRA 4 MCG SOLUTION FOR INJECTION,"MENINGOCOCCAL GROUP A (NEISSERIA MENINGITIDIS) POLYSACCHARIDE VACCINE, MENINGOCOCCAL GROUP C (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP W (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP Y (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, DIPHTHERIA TOXOID",2-780-11,2011,"4,4,4,4,48 µg",Solution for injection,Intramuscular use,1232.1,SANOFI PASTEUR,United States,SANOFI PASTEUR,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
MENACTRA,"MENINGOCOCCAL GROUP A (NEISSERIA MENINGITIDIS) POLYSACCHARIDE VACCINE, MENINGOCOCCAL GROUP C (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP Y (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP W (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, DIPHTHERIA TOXOID",1-780-11,2011,"4,4,4,4,48 µg",Solution for injection,Intramuscular use,246.4,SANOFI PASTEUR,United States,SANOFI PASTEUR,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
MENOGON 75 I.U FSH & 75 I.U LH AMPOULES,"FOLLICLE STIMULATING HORMONE (FSH), LUTEINIZING HORMONE (LH)",1-367-01,2001,"75,75 IU",Powder and solvent for solution for injection,Intramuscular use,223.9,FERRING,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
MANNITOL 10% INFUSION,MANNITOL,174-149-99,1999,10 %,Solution for infusion,Intravenous use,9.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
MEDROL 4 mg tablet,METHYLPREDNISOLONE,1308233980,2003,4 mg,Tablet,Oral use,19.5,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
MEDICAINE 2% CARTRIDGE,"MEPIVACAINE HYDROCHLORIDE, ADRENALINE",2207257803,2012,"20,0.01819 mg",Solution for injection in cartridge,Dental use,94.60,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MAXIL 1500 VIAL,CEFUROXIME SODIUM,0902221721,1993,1.5 g,Powder for injection,Parenteral use,14.90,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
MARVELON TAB,"DESOGESTREL, ETHINYLESTRADIOL",1802256912,1988,"150,30 µg",Tablet,Oral use,14.6,ORGANON,Netherlands,ORGANON,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
MANNITOL 20% INFUSION,MANNITOL,2208245810,1992,20 %,Solution for infusion,Intravenous use,9.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MANNITOL 20% INFUSION,MANNITOL,3009245989,1991,20 %,Solution for infusion,Intravenous use,12.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MANNITOL 20% INFUSION,MANNITOL,3-303-99,1999,20 %,Solution for infusion,Intravenous use,11.1,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,AL EWAN MEDICAL COMPANY
MANNITOL 20 % I.V INFUSION 500 ML,MANNITOL,1802244934,2002,20 %,Solution for infusion,Intravenous use,10.55,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MANNITOL 10% W-V INFUSION BOTTLES,MANNITOL,4-303-99,1999,10 %,Solution for infusion,Intravenous use,9.95,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,AL EWAN MEDICAL COMPANY
MAXIL 750 VIAL,CEFUROXIME SODIUM,0902221722,1993,750 mg,Powder for injection,Parenteral use,7.50,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
MAXIM 400MG FILM COATED TABLETS,MOXIFLOXACIN HYDROCHLORIDE,119-368-09,2009,400 mg,Tablet,Oral use,61.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
MAXIM 400MG FILM COATED TABLETS,MOXIFLOXACIN HYDROCHLORIDE,120-368-09,2009,400 mg,Tablet,Oral use,80.4,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
MEBAGEN,MEBEVERINE HYDROCHLORIDE,1211246195,2002,135 mg,Film-coated tablet,Oral use,21.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
MEDAFEN 100MG-5ML SUSPENSION,IBUPROFEN,27-490-06,2006,20 mg/ml,Oral suspension,Oral use,6.90,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MEDACIN -T 1% TOPICAL SOLUTION,CLINDAMYCIN PHOSPHATE,0804257207,2006,10 mg/ml,Cutaneous solution,Topical,19.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MEDICAINE 3% CARTRIDGE,MEPIVACAINE HYDROCHLORIDE,2207257802,2012,30 mg,Solution for injection in cartridge,Dental use,94.60,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MEDACIN -T 1% GEL,CLINDAMYCIN PHOSPHATE,37-490-08,2008,1 %,Gel,Topical,16.7,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MEDACEF 500MG CAPSULES,CEFACLOR,21-490-06,2006,500 mg,"Capsule, hard",Oral use,48.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MEDACEF 250MG CAPSULES,CEFACLOR,20-490-06,2006,250 mg,"Capsule, hard",Oral use,28.2,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
MESPORIN 2000 I.V,CEFTRIAXONE,2207257797,2005,2 g,Powder and solvent for suspension for injection,Intravenous use,61.10,LABESFAL,Portugal,Acino AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
LOPRAM 20MG F.C. TABLETS,CITALOPRAM,24-498-08,2008,20 mg,Film-coated tablet,Oral use,72.05,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LOPID,GEMFIBROZIL,0106233759,1994,600 mg,Film-coated tablet,Oral use,49.35,PFIZER,Germany,Pfizer Pharma GmbH,Germany,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
LEJAM 30MG FILM COATED TABLET,DAPOXETINE,289-212-13,2013,30 mg,Film-coated tablet,Oral use,67,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
LEDO 5% W-W OINTMENT,LIDOCAINE HYDROCHLORIDE,14-590-10,2010,5 %,Ointment,Topical,4.4,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
LECITAL 20MG F.C. CAPLETS,CITALOPRAM,1601256676,2008,20 mg,Film-coated tablet,Oral use,34.45,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
LAXOLAC SYRUP,LACTULOSE,4-251-97,1997,0.65 g/ml,Syrup,Oral use,7,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
LAXOLAC SYRUP,LACTULOSE,3-251-97,1997,0.65 g/ml,Syrup,Oral use,15.25,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
LAXO,"SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE, POLYETHYLENE GLYCOL",1208245758,2010,"350.7,178.5,46.6,13.125 mg, g",Granules,Oral use,30.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LATANOCOM OPHTHALMIC SOLUTION,"TIMOLOL MALEATE, LATANOPROST",2611246342,2009,"5,0.05 mg/ml",Ophthalmic solution,Ophthalmic use,33.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
LATANO 0.005% W-V OPHTHALMIC SOLUTION,LATANOPROST,1610234333,2009,0.05 mg/ml,"Eye drops, solution",Ophthalmic use,40.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
LEJAM 60MG FILM COATED TABLET,DAPOXETINE,290-212-13,2013,60 mg,Film-coated tablet,Oral use,67,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
LENDOMAX 70 MG TABLETS,ALENDRONIC ACID,2510222794,2008,70 mg,Tablet,Oral use,35.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LERCADIP 10MG F.C.TABLET,LERCANIDIPINE HYDROCHLORIDE,2805233742,2004,10 mg,Film-coated tablet,Oral use,44.35,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
LEVOZAL 5 MG FILM COATED TABLET,LEVOCETIRIZINE DIHYDROCHLORIDE,128-368-12,2012,5 mg,Film-coated tablet,Oral use,20.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LEVOX 750MG FILM COATED TABLET,LEVOFLOXACIN,274-212-11,2011,750 mg,Film-coated tablet,Oral use,71.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LEVOX 500MG FILM COATED TABLET,LEVOFLOXACIN,273-212-11,2011,500 mg,Film-coated tablet,Oral use,67.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LEVOPHED,NOREPINEPHRINE BITARTRATE,1411234466,2002,1 mg/ml,Solution for injection,Intravenous use,189.75,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
LASIX TAB 40 MG,FUROSEMIDE,1708222505,1980,40 mg,Tablet,Oral use,20.2,Opella Healthcare International,France,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
LEVONIC 500MG FILM COATED TABLETS,LEVOFLOXACIN,162-334-12,2012,500 mg,Film-coated tablet,Oral use,60.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVITRA 5MG TABLET,VARDENAFIL,1506233816,2004,5 mg,Film-coated tablet,Oral use,48.30,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Bayer Saudi Arabia
LEVITRA 20MG TABLET,VARDENAFIL,1506233814,2004,20 mg,Film-coated tablet,Oral use,93.95,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
LEVITRA 10MG TABLET,VARDENAFIL,1506233813,2004,10 mg,Film-coated tablet,Oral use,64.35,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Bayer Saudi Arabia
LEVEMIR FLEX PEN 100IU\ML,INSULIN DETEMIR,55-100-05,2005,100 IU/ml,Solution for injection,Subcutaneous use,262.55,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
LEUKAST 10MG FILM COATED TABLETS,MONTELUKAST SODIUM,1902233261,2013,10 mg,Film-coated tablet,Oral use,94.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVOFLOX 500MG F.C. TABLET,LEVOFLOXACIN,1810222753,2012,500 mg,Tablet,Oral use,49.9,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
LAMISIL ONCE 1% CUTANEOUS SOLUTION,TERBINAFINE,46-53-08,2008,1 %,Solution,Topical,26.65,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
LAMISIL 250 mg tablet,TERBINAFINE,1-358-02,2002,250 mg,Tablet,Oral use,68.85,NOVARTIS PHARMA PRODUKTIONS GMBH,Germany,NOVARTIS,United Kingdom,Marketed,Prescription,do not store above 25°c,Pharmacy,Novartis Saudi Limited
LAMISIL 1% SPRAY,TERBINAFINE,6-5448-23,2001,1 %,Spray,Topical,43.2,DELPHARM HUNINGUE S.A.S.,France,GSK CONSUMER HEALTHCARE SCHWEIZ AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
LAMISIL 1% CREAM,TERBINAFINE,7-5448-23,2004,1 %,Cream,Topical,23.15,GSK Consumer Healthcare SARL,Switzerland,GSK CONSUMER HEALTHCARE SCHWEIZ AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
LAMIFEN 250MG TABLET,TERBINAFINE,68-368-04,2004,250 mg,Tablet,Oral use,34.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LAMIFEN 250MG TABLET,TERBINAFINE,0111222862,2004,250 mg,Tablet,Oral use,68.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LAMIFEN 1% CREAM,TERBINAFINE,1108222467,2002,1 %,Cream,Topical,19.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LAMICTAL,LAMOTRIGINE,2101256695,2002,50 mg,Tablet,Oral use,57.20,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
LAMICTAL,LAMOTRIGINE,2101256696,2002,25 mg,Tablet,Oral use,32.65,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
LAMICTAL,LAMOTRIGINE,0702221681,2002,5 mg,Chewable tablet,Oral use,11.1,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
LAMICTAL,LAMOTRIGINE,0702221680,2002,25 mg,Chewable tablet,Oral use,50.95,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
LAMICTAL,LAMOTRIGINE,0702221682,2002,100 mg,Chewable tablet,Oral use,169.50,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
LAMOTRIX 100MG TABLET,LAMOTRIGINE,3-718-13,2013,100 mg,Tablet,Oral use,74.15,MEDOCHEMIE LTD.,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LAMOTRIX 25MG TABLET,LAMOTRIGINE,1401268914,2013,25 mg,Tablet,Oral use,25.85,MEDOCHEMIE LTD.,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, TAMER ARABIA TRADING COMPANY"
LAMOTRIX 50MG TABLET,LAMOTRIGINE,2-718-13,2013,50 mg,Tablet,Oral use,41,MEDOCHEMIE LTD.,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LAPRIL 5 mg tablet,ENALAPRIL MALEATE,14-346-05,2005,5 mg,Tablet,Oral use,12.35,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
LAPRIL 20MG TABLETS,ENALAPRIL MALEATE,32-346-10,2010,20 mg,Tablet,Oral use,39.8,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
LAPRIL 20 MG TABLET,ENALAPRIL MALEATE,16-346-05,2005,20 mg,Tablet,Oral use,33.15,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,United Pharmaceutical Establishment
LAPRIL 10 mg tablet,ENALAPRIL MALEATE,15-346-05,2005,10 mg,Tablet,Oral use,20.2,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
LAPRIX 5MG COATED TABLET,OLANZAPINE,0810258357,2014,5 mg,Film-coated tablet,Oral use,133.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LAPRIX 10MG COATED TABLET,OLANZAPINE,1011258558,2014,10 mg,Film-coated tablet,Oral use,218.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LANTUS 100 I.U - ML VIAL,INSULIN GLARGINE,45-23-03,2003,100 IU/ml,Solution,Subcutaneous use,220.10,sanofi-aventis,Germany,sanofi-aventis,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
LANSOMID 30 MG CAPSULE,LANSOPRAZOLE,7-346-02,2002,30 mg,Capsule,Oral use,35.15,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
LANTUS SOLOSTAR 100I.U-ML DISPOSABLE PEN,INSULIN GLARGINE,2705257464,2007,100 IU/ml,Solution,Subcutaneous use,296.45,sanofi-aventis,Germany,sanofi-aventis,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
LIVOSTIN NASAL SPRAY 0.5MG-ML,LEVOCABASTINE,63-6-94,1994,0.5 mg/ml,"Nasal spray, suspension",Nasal use,33.6,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
LIVOSTIN EYE DROPS 0.5MG-ML,LEVOCABASTINE,2112234620,1994,0.5 mg/ml,"Eye drops, suspension",Ophthalmic use,36,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
LIVIAL 2.5MG TAB,TIBOLONE,0904257217,1998,2.5 mg,Tablet,Oral use,76.8,ORGANON,Netherlands,ORGANON,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LIVAZO 4 mg film-coated tablets,PITAVASTATIN,0710258343,2014,4 mg,Film-coated tablet,Oral use,79.4,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LIVAZO 2 mg film-coated tablets,PITAVASTATIN,0710258342,2014,2 mg,Film-coated tablet,Oral use,67.5,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LOCERYL 5% NAIL LACQUER,AMOROLFINE,11-274-01,2001,5 %,Cutaneous liquid,Topical,78.10,GALDERMA,France,GALDERMA,France,Marketed,OTC,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
LONZET 30MG CAPSULES,LANSOPRAZOLE,0810258368,2008,30 mg,"Capsule, hard",Oral use,26.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LONZET 15MG CAPSULES,LANSOPRAZOLE,0810258360,2008,15 mg,"Capsule, hard",Oral use,13.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOHIST 5 MG-5 ML SYRUP,LORATADINE,0801256549,2008,1 mg/ml,Syrup,Oral use,8,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
LOHIST 10 MG TABLETS,LORATADINE,0801256550,2007,10 mg,Tablet,Oral use,10.4,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
LOFRAL 5MG TABLETS,AMLODIPINE BESILATE,0403256979,2007,5 mg,Tablet,Oral use,16.2,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
LOFRAL 10MG TABLETS,AMLODIPINE BESILATE,0403256978,2007,10 mg,Tablet,Oral use,26.6,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
LOCOID OINT 0.1%,HYDROCORTISONE BUTYRATE,0804257204,1982,0.1 %,Ointment,Topical,9.45,Temmler ltalia S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LOGYNON TAB,"ETHINYLESTRADIOL, LEVONORGESTREL",2208210964,1989,"30,125 µg",Tablet,Oral use,12.1,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
LISINO 5MG TABLET,LISINOPRIL,0701256531,2006,5 mg,Film-coated tablet,Oral use,16.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LINOPRIL 10MG TABLET,LISINOPRIL,0511258547,2004,10 mg,Tablet,Oral use,26.00,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
LIDOCAINE HCL EMERGENCY SYRINGE 2%,LIDOCAINE HYDROCHLORIDE,2405222059,1990,2 %,Solution for injection,Intravenous use,21.45,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
LIDOCAINE HCL EMERGENCY SYRINGE 1%,LIDOCAINE HYDROCHLORIDE,2405222058,1990,1 %,Solution for injection,Intravenous use,21.45,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
LIDOCAINE HCL 2% INJ 20ML,LIDOCAINE HYDROCHLORIDE,0401244677,1994,2 %,Solution for injection,Intravenous use,80.10,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
LIDOCAINE HCL 1% AMPOULE,LIDOCAINE HYDROCHLORIDE,2911211391,2000,1 %,Solution for injection,Intravenous use,4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
LIDOCAINE HCL 1% AMPOULE,LIDOCAINE HYDROCHLORIDE,217-149-00,2000,1 %,Solution for injection,Intravenous use,3.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
LIDOCAINE HCL 1% AMPOULE,LIDOCAINE HYDROCHLORIDE,2107222336,2000,1 %,Solution for injection,Intravenous use,3.80,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
LEXOTANIL TAB. 3MG,BROMAZEPAM,1810234357,1980,3 mg,Tablet,Oral use,17.05,Aesica Pharmaceuticals GmbH.,Germany,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LINOPRIL 20MG TABLET,LISINOPRIL,0910258379,2004,20 mg,Tablet,Oral use,41.25,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
LINOPRIL 5MG TABLET,LISINOPRIL,0910258378,2004,5 mg,Tablet,Oral use,15.80,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
LINZ 20 MG CAPSULE,FLUOXETINE,0812258756,2002,20 mg,"Capsule, hard",Oral use,84.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LIOCAINE 2% GEL,LIDOCAINE HYDROCHLORIDE,2610222823,2013,2 %,Gel,Topical,7.70,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
LISINO 20MG TABLETS,LISINOPRIL,0707245490,2006,20 mg,Film-coated tablet,Oral use,47.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LISINO 10MG TABLETS,LISINOPRIL,2611246341,2006,10 mg,Film-coated tablet,Oral use,27.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
LIPOFUNDIN MCT-LCT 20% Infusion*,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL",1501256618,1995,"100,100 g/l",Emulsion for infusion,Intravenous use,103.10,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
LIPOFUNDIN MCT-LCT 20% INFUSION,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL",1501256619,1995,"100,100 g/l",Emulsion for infusion,Intravenous use,64.25,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
LIORESAL 25MG TAB,BACLOFEN,3107245707,1987,25 mg,Tablet,Oral use,61.15,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
LIORESAL 10MG TAB,BACLOFEN,3107245708,1987,10 mg,Tablet,Oral use,33.70,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
LIPOFUNDIN MCT-LCT 20% Infusion*,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL",1501256617,1995,"100,100 g/l",Emulsion for infusion,Intravenous use,42.75,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
MESPORIN 500 I.M.,CEFTRIAXONE,1901268942,2005,500 mg,Powder and solvent for suspension for injection,Intramuscular use,15.25,LABESFAL,Portugal,Acino AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
NERVAX 75MG CAPSULES,PREGABALIN,1601244738,2012,75 mg,"Capsule, hard",Oral use,58.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NERVAX 300MG CAPSULES,PREGABALIN,0802244877,2012,300 mg,"Capsule, hard",Oral use,319.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NERVAX 150MG CAPSULES,PREGABALIN,0802244878,2012,150 mg,"Capsule, hard",Oral use,219.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NEOXIDIL 2% SOLN.,MINOXIDIL,1-274-97,1997,2 %,Solution,Topical,55.3,GALDERMA,France,GALDERMA,France,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
NEOXICAM 7.5MG TABLETS,MELOXICAM,6-584-08,2008,7.5 mg,Tablet,Oral use,5.15,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOXICAM 15MG TABLETS,MELOXICAM,7-584-08,2008,15 mg,Tablet,Oral use,7.75,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOVENTIL 2MG-5ML SYRUP,SALBUTAMOL,1-584-08,2008,0.4 mg/ml,Syrup,Oral use,3.1,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOTIGASON 25MG CAPS,ACITRETIN,8-170-14,2014,25 mg,"Capsule, hard",Oral use,195.2,PATHEON INC,Canada,ACTAVIS,Iceland,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
NEOTIGASON 10MG CAPS,ACITRETIN,7-170-14,2014,10 mg,"Capsule, hard",Oral use,97.6,PATHEON INC,Canada,ACTAVIS,Iceland,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
NEOSTIGMINE METHYLSULFATE 0.5 MG/ML AMPOULE,NEOSTIGMINE METHYLSULFATE,0901256570,2012,0.5 mg/ml,Solution for injection,Intramuscular use,13.75,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
NEORIN 5MG F.C. TABLET,DESLORATADINE,1803257092,2009,5 mg,Film-coated tablet,Oral use,25.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
NEORIN 2.5MG -5ML SYRUP,DESLORATADINE,2307257837,2005,0.5 mg/ml,Syrup,Oral use,22.7,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
NEURO-B FILM COATED TABLETS,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",1501256661,2005,"100,100,0.15 mg",Film-coated tablet,Oral use,13.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NEUROBION ampoules,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",1303233364,2003,"100,100,1 mg",Solution for injection,Intramuscular use,13.65,CENEXI,France,P&G Health GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
NEXAVAR 200 MG F-C TABLETS,SORAFENIB,1407210864,2009,200 mg,Film-coated tablet,Oral use,7885.10,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 30°c,Hospital,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
NEUROVIT AMPOULES,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",2709234278,2011,"150,100,1 mg",Injection,Intramuscular and intravenous use,9.85,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
NEURORUBINE SOLUTION,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",32-222-09,2009,"100,100,1 mg",Solution for injection,Intramuscular use,12.9,Haupt Pharma Wulfing GmbH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
NEURORUBINE-FORTE,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",2808245840,1999,"200,50,1 mg",Film-coated tablet,Oral use,12.05,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,OTC,do not store above 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
NEOPRED - P,"POLYMYXIN B, PREDNISOLONE, NEOMYCIN SULFATE",15-290-01,2001,"10000,5,5 IU, mg/ml","Eye drops, suspension",Ophthalmic use,10.45,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
NEUROPLEX 400MG CAPSULES,GABAPENTIN,1501256642,2009,400 mg,Capsule,Oral use,94.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NEURONTIN,GABAPENTIN,2-5825-23,1997,400 mg,"Capsule, hard",Oral use,128.10,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
NEURONTIN,GABAPENTIN,1-5825-23,1997,300 mg,"Capsule, hard",Oral use,109.50,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
NEUROCOMB I.M INJECTION,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",15-368-01,2001,"100,100,1000 mg, µg",Solution for injection,Intramuscular use,15.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,JAMJOOM PHARMACEUTICALS CO. LTD.
NEUROPLEX 300MG CAPSULES,GABAPENTIN,1501256648,2009,300 mg,Capsule,Oral use,80.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NEOMOX 250MG-5ML SUSPENSION,AMOXICILLIN,2-584-08,2008,50 mg/ml,Powder for oral suspension,Oral use,10.35,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOMOL 120MG-5ML SUSPENSION,PARACETAMOL,4-584-08,2008,24 mg/ml,Suspension,Oral use,1.75,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NAROPIN 7.5MG-ML AMP,ROPIVACAINE,47-887-19,1999,7.5 mg/ml,Solution for injection,Inhalation use,121.65,AstraZeneca,Sweden,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
NAROPIN 2MG-ML PLASTIC AMP,ROPIVACAINE,46-887-19,1999,2 mg/ml,Solution for injection,Inhalation use,67.1,AstraZeneca,Sweden,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
NAPROX D.S 500MG TAB,NAPROXEN,107-172-97,1997,500 mg,Tablet,Oral use,14.95,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NAPROX 250MG TAB,NAPROXEN,106-172-97,1997,250 mg,Tablet,Oral use,17.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NAPROTEX 500 mg tablet,NAPROXEN,0912211460,1999,500 mg,Tablet,Oral use,18.9,APOTEX,Canada,APOTEX,Canada,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
NAPHCON-A EYE DROPS,"PHENIRAMINE, NAPHAZOLINE HYDROCHLORIDE",0203233313,1994,"3,0.025 %",Eye drops,Ophthalmic use,17.25,Alcon Singapore Manufacturing Pte. Ltd,Singapore,ALCON N.V.,Belgium,Marketed,OTC,store below 25°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
NATRILIX 1.5 MG S.R TAB,INDAPAMIDE,9-17-99,1999,1.5 mg,Prolonged-release film-coated tablet,Oral use,27.60,LES LABORATOIRES SERVIER INDUSTRIE,France,SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
NAVELBINE 10MG-ML I-V VIAL,VINORELBINE,2011234522,1996,10 mg/ml,Solution for injection,Intravenous use,117.5,FAREVA PAU 1,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
NAVELBINE 10MG-ML I-V VIAL,VINORELBINE,2011234523,1996,10 mg/ml,Solution for injection,Intravenous use,533.85,FAREVA PAU 1,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
NEODEX 0.1 E-E DROP,"DEXAMETHASONE, NEOMYCIN SULFATE",0509211008,1999,"1,5 mg","Ear/eye drops, solution",Auricular use,11.30,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
NEODAY 5MG-5ML SYRUP,LORATADINE,5-584-08,2008,1 mg/ml,Syrup,Oral use,7.2,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEODAY 10MG TABLETS,LORATADINE,8-584-09,2009,10 mg,Tablet,Oral use,8.4,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOMOX 125MG-5ML SUSPENSION,AMOXICILLIN,3-584-08,2008,25 mg/ml,Powder for oral suspension,Oral use,5.95,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEOCIPRO 500MG F.C. TABLETS,CIPROFLOXACIN,9-584-09,2009,500 mg,Film-coated tablet,Oral use,24.05,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEBILET 5MG TABLETS,NEBIVOLOL HYDROCHLORIDE,3005245386,2006,5 mg,Tablet,Oral use,31.95,BERLIN CHEMIE AG,Germany,A MENARINI INDUSTRIE FARMACEUTICHE S.R.L,Italy,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Saudi Import Company - BANAJA"
NEBIDO 1000 MG- 4 ML SOLUTION FOR INJ,TESTOSTERONE UNDECANOATE,100-10-07,2007,250 mg/ml,Solution,Intramuscular use,333.75,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
NAXONE 0.4MG-ML INJ,NALOXONE HYDROCHLORIDE,139-172-03,2003,0.4 mg/ml,Solution for injection/infusion,Intravenous use,93.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
NAXONE 0.02MG-ML INJ 2ML,NALOXONE HYDROCHLORIDE,138-172-03,2003,0.02 mg/ml,Solution for injection/infusion,Intravenous use,80.35,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
NORACTONE,SPIRONOLACTONE,0907245514,1985,25 mg,Tablet,Oral use,9.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
NORPROLAC 75MCG TABLETS,QUINAGOLIDE,5-367-06,2006,75 µg,Tablet,Oral use,136.75,JELFA PHARMACEUTICAL,Poland,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NORPROLAC 25MCG-50MCG TABLETS,QUINAGOLIDE,6-367-06,2006,0.0273 mg,Tablet,Oral use,17.9,JELFA PHARMACEUTICAL,Poland,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NOROXIN 400MG TABLETS,NORFLOXACIN,1501244724,2010,400 mg,Tablet,Oral use,23.65,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
NORMOTEN 50 MG F.C. TAB,ATENOLOL,0408222403,1999,50 mg,Tablet,Oral use,18.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NORMOTEN 100 MG F.C TAB,ATENOLOL,0908222450,1999,100 mg,Tablet,Oral use,19.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NORMOTEN 100 MG F.C TAB,ATENOLOL,0908222449,1999,100 mg,Tablet,Oral use,9.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NORMAL SALINE I.V. INFUSION,SODIUM CHLORIDE,9-149-91,1991,0.9 %,Solution,Parenteral use,5.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NORMAL SALINE I.V. INFUSION,SODIUM CHLORIDE,10-149-91,1991,0.9 %,Solution,Parenteral use,6.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NORMAL SALINE I.V. INFUSION,SODIUM CHLORIDE,0109222573,1993,0.9 %,Solution,Parenteral use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NORMAL SALINE I.V. INFUSION,SODIUM CHLORIDE,11-149-91,1991,0.9 %,Solution,Parenteral use,9.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NORMAL SALINE I.V. INFUSION,SODIUM CHLORIDE,66-149-93,1993,0.9 %,Solution,Parenteral use,3.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
NIMOTOP 30MG TAB,NIMODIPINE,2510234394,1996,30 mg,Tablet,Oral use,46.5,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
NIMOTOP 10MG-50ML Infusion,NIMODIPINE,1506233815,1996,0.2 mg/ml,Solution for infusion,Intravenous use,41.15,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
NICOTINELL 1MG LOZENGES,NICOTINE DITATRATE DIHYDRATE,1207233863,2009,1 mg,Lozenge,Oral use,65.20,SwissCo Services AG,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
NITRODERM TTS 5 PATCHES,NITROGLYCERIN,3007245699,1986,25 mg,Transdermal patch,Transdermal use,58.30,NOVARTIS,Switzerland,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
NOMAL 50 MG CAPSULE,TRAMADOL HYDROCHLORIDE,2503257165,2002,50 mg,Capsule,Oral use,7.1,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
NOLVADEX-D TAB 20MG,TAMOXIFEN,2-5761-23,1988,20 mg,Tablet,Oral use,65.80,AstraZeneca,United Kingdom,AstraZeneca,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
NOLVADEX 10 MG TABs,TAMOXIFEN,1-5761-23,1983,10 mg,Tablet,Oral use,37.80,AstraZeneca,United Kingdom,AstraZeneca,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
NIZORAL CREAM 2%,KETOCONAZOLE,0311222864,1991,2 %,Cream,Topical,19.35,JANSSEN PHARMACEUTICA N.V.,Belgium,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, STADA Arabia Limited Company"
NITRODERM TTS-10 SYSTEM,NITROGLYCERIN,3007245700,1988,50 mg,Transdermal patch,Topical,33.75,NOVARTIS,Switzerland,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
NITRODERM TTS-10 SYSTEM,NITROGLYCERIN,131-11-94,1994,50 mg,Transdermal patch,Topical,62.6,NOVARTIS,Switzerland,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
NITRODERM TTS 5 PATCHES,NITROGLYCERIN,12-5773-23,1986,25 mg,Transdermal patch,Transdermal use,17.6,NOVARTIS,Switzerland,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MYFORTIC 360 MG E.C.TABLET,MYCOPHENOLATE SODIUM,161-11-04,2004,360 mg,Gastro-resistant tablet,Oral use,828.10,NOVARTIS PHARMA PRODUKTIONS GMBH,Germany,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
MYDRIACYL 1% EYE DROPS,TROPICAMIDE,2-5870-25,2000,1 %,"Eye drops, solution",Ophthalmic use,18.95,S.A. Alcon Couvreur N.V,Belgium,ALCON N.V.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
MYDFRIN 2.5% DROPS,PHENYLEPHRINE HYDROCHLORIDE,1610246063,1982,2.5 %,"Eye drops, solution",Ophthalmic use,9.3,ALCON LABORATORIES,United States,ALCON LABORATORIES,United States,Marketed,OTC,store below 25°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
MIDROXIL 500MG\5ML SUSP.,CEFADROXIL,5-346-02,2002,100 mg/ml,Oral suspension,Oral use,20.4,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDROXIL 500 MG CAPSULE,CEFADROXIL,6-346-02,2002,500 mg,Capsule,Oral use,19.25,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDROXIL 250MG\5ML SUSP,CEFADROXIL,4-346-02,2002,50 mg/ml,Oral suspension,Oral use,12.85,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDRONE EXTRA TAB,"PARACETAMOL, CAFFEINE CITRATE",1109234175,2000,"500,60 mg",Tablet,Oral use,5.75,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,OTC,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDAFLEX 500MG CAPSULE,CEFALEXIN,9-346-04,2004,500 mg,Capsule,Oral use,15.1,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDAFLEX 250 mg capsule,CEFALEXIN,8-346-04,2004,250 mg,Capsule,Oral use,9.1,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDAFLEX 250 mg oral suspension,CEFALEXIN,3-346-02,2002,50 mg/ml,Oral suspension,Oral use,9.1,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MIDAFLEX 125MG-5MLSUSP,CEFALEXIN,2-346-02,2002,25 mg/ml,Oral suspension,Oral use,5.9,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
MICONAZ 2% POWDER,MICONAZOLE NITRATE,2412234627,1997,2 %,Cutaneous powder,Topical,4.7,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
MINIMS TROPICAMIDE 1% W-V,TROPICAMIDE,1311234465,1992,1 %,"Eye drops, solution",Ophthalmic use,48.05,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
MINIMS TROPICAMIDE 0.5% EYE DROPS,TROPICAMIDE,3-312-05,2005,0.5 %,"Eye drops, solution",Ophthalmic use,60.05,CHAUVIN BAUSCH & LOMB,France,CHAUVIN BAUSCH & LOMB,France,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
MINIMS TETRACAINE HCL 1%,TETRACAINE HYDROCHLORIDE,2009234231,1987,1 %,"Eye drops, solution",Ophthalmic use,60.05,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS PHENYLEPHRINE HCL 10%,PHENYLEPHRINE HYDROCHLORIDE,2009234233,1987,10 %,"Eye drops, solution",Ophthalmic use,60.10,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS PHENYLEPHRINE 2.5% W-V,PHENYLEPHRINE HYDROCHLORIDE,1501244721,1992,2.5 %,"Eye drops, solution",Ophthalmic use,60.10,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,ALNAGHI COMPANY
MICONAZ 2% CREAM,MICONAZOLE NITRATE,2802245002,1997,2 %,Cream,Topical,3.15,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
MINIMS OXYBUPROCAINE HCL 0.4%,OXYBUPROCAINE,2009234232,1987,0.4 %,"Eye drops, solution",Ophthalmic use,60.05,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS FLUORESCEIN SODIUM 2%,FLUORESCEIN SODIUM,1006245403,1987,2 %,"Eye drops, solution",Ophthalmic use,60.10,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS CYCLOPENTOLATE HCL 1%,CYCLOPENTOLATE,1501244723,2005,1 %,"Eye drops, solution",Ophthalmic use,60.10,CHAUVIN BAUSCH & LOMB,France,CHAUVIN BAUSCH & LOMB,France,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS CYCLOPENTOLATE HCL 0.5%,CYCLOPENTOLATE,1501244722,1987,0.5 %,"Eye drops, solution",Ophthalmic use,60.05,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MINIMS LIDOCAINE and FLUORESCEIN,"FLUORESCEIN SODIUM, LIDOCAINE HYDROCHLORIDE",1311234464,1987,"4,0.25 %","Eye drops, solution",Ophthalmic use,60.05,CHAUVIN BAUSCH & LOMB,United Kingdom,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
MICOCORT CREAM,"MICONAZOLE NITRATE, HYDROCORTISONE",42-539-10,2010,"2,1 %",Cream,Topical,16.90,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
MICARDIS PLUS,"TELMISARTAN, HYDROCHLOROTHIAZIDE",86-68-05,2005,"40,12.5 mg",Tablet,Oral use,65.05,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
METHOTREXATE 1G-10ML INJ.FOR I.V OR I.M,METHOTREXATE,22-5287-22,1997,100 mg/ml,Solution for injection,Intravenous use,301.55,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
"METHOTREXATE ""EBEWE"" 10MG-ML VIAL",METHOTREXATE,8-355-01,2001,10 mg/ml,Solution for injection,Intravenous use,29.35,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
"METHOTREXATE ""EBEWE"" 100MG-ML VIAL",METHOTREXATE,12-355-01,2001,100 mg/ml,Solution for injection,Intravenous use,301.55,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
"METHOTREXATE ""EBEWE"" 100MG-ML VIAL",METHOTREXATE,9-355-01,2001,100 mg/ml,Solution for injection,Intravenous use,187.60,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
"METHOTREXATE ""EBEWE"" 100MG-ML VIAL",METHOTREXATE,10-355-01,2001,100 mg/ml,Solution for injection,Intravenous use,1304.55,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
METHERGINE 0.2MG-ML AMPULES,METHYLERGONOVINE MALEATE,1-6154-25,1981,0.2 mg/ml,Solution for injection,Intravenous use,10.15,NOVARTIS,Switzerland,Essential Pharma Switzerland GmbH,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,AcedrA Pharmaceutical Company
METFORMIN HEXAL 1000 MG FILM COATED TABLETS,METFORMIN HYDROCHLORIDE,16-349-10,2010,1000 mg,Film-coated tablet,Oral use,25.00,LEK S.A,Poland,HEXAL,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
METFOR 850 MG TAB,METFORMIN HYDROCHLORIDE,1110211115,2000,850 mg,Film-coated tablet,Oral use,29.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
METFOR 500,METFORMIN HYDROCHLORIDE,1110211114,2001,500 mg,Film-coated tablet,Oral use,15.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
METALYSE 10000 U I.V VIAL,TENECTEPLASE,0212246358,2002,10000 IU,Powder and solvent for solution for injection,Intravenous use,5040.7,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Boehringer Ingelheim Scientific Office, Cigalah Group"
MESPORIN 500 I.V,CEFTRIAXONE,2207257795,2005,500 mg,Powder and solvent for suspension for injection,Intravenous use,15.25,LABESFAL,Portugal,Acino AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
METHOTREXATE 2.5MG TAB.,METHOTREXATE,7-355-01,2001,2.5 mg,Tablet,Oral use,51.60,HAUPT PHARMA AMAREG GmbH,Germany,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MICARDIS 80 MG TAB,TELMISARTAN,1707245589,2000,80 mg,Tablet,Oral use,65.95,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
MICARDIS 40 MG TAB,TELMISARTAN,1707245590,2000,40 mg,Tablet,Oral use,49.60,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
MIACIN 500MG-2ML AMP,AMIKACIN,0601256517,1993,250 mg/ml,Solution,Parenteral use,125.4,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MIACIN 100MG-2ML AMP,AMIKACIN,0906245398,1993,50 mg/ml,Solution,Parenteral use,28.55,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MIACALCIC AMP 50 IU-ML,CALCITONIN SALMON,1-5588-21,1988,50 IU/ml,Solution for infusion,Subcutaneous use,77.95,NOVARTIS,Switzerland,NT Pharma International Company Limited,Hong Kong,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
MIACALCIC 100 IU-ML AMP,CALCITONIN SALMON,2-5588-21,1984,100 IU/ml,Solution for infusion,Subcutaneous use,118.9,NOVARTIS,Switzerland,NT Pharma International Company Limited,Hong Kong,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
MEVA 135MG F.C.TABLET,MEBEVERINE HYDROCHLORIDE,1506222203,2004,135 mg,Film-coated tablet,Oral use,15.8,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
MICARDIS PLUS,"TELMISARTAN, HYDROCHLOROTHIAZIDE",1707245588,2005,"80,12.5 mg",Tablet,Oral use,65.05,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
METRONIDAZOLE 500MG/100ML INTRAVENOUS INFUSION,METRONIDAZOLE,1108222475,1991,5 mg/ml,Solution for infusion,Intravenous use,10.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
METRONIDAZOLE 500MG-100ML INFUSION,METRONIDAZOLE,1108222464,2010,5 mg/ml,Solution for infusion,Intravenous use,8.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
METHYCOBAL 500 MCG TABLET,METHYLCOBALAMIN,26-50-98,1998,500 µg,Tablet,Oral use,24,EISAI,Japan,EISAI,Japan,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
METHYCOBAL 500 mcg injection,METHYLCOBALAMIN,27-50-98,1998,500 µg,Injection,Intravenous use,59.8,Nipro Pharma Corporation Ise Plant,Japan,EISAI,Japan,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Metronidazole intravenous infusion,METRONIDAZOLE,2204245189,1994,5 mg/ml,Solution for infusion,Intravenous use,10.5,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
MINIRIN MELT 240MCG ORAL LYOPHILISATE TABLET,DESMOPRESSIN ACETATE,24-367-13,2013,240 µg,Oral lyophilisate,Oral use,338.5,CATALENT,United Kingdom,FERRING Gmph,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
MINIRIN MELT 120 MCG LYOPHILIZED TABLET,DESMOPRESSIN ACETATE,3010222851,2012,120 µg,Oral lyophilisate,Oral use,191.95,CATALENT,United Kingdom,FERRING,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
MUCOFALK,PSYLLIUM HUSK,2-318-02,2002,5 g,Granules,Oral use,8.65,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
MUCINEX 600MG EXTENDED RELEASE BI-LAYER TABLET,GUAIFENESIN,0805245258,2011,600 mg,Extended-release tablet,Oral use,28.85,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER I.N.C,United States,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MOVEN 7.5MG CAPSULE,MELOXICAM,1312211473,2005,7.5 mg,"Capsule, hard",Oral use,21.85,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MOVEN 7.5MG CAPSULE,MELOXICAM,1303221844,2006,7.5 mg,"Capsule, hard",Oral use,9.65,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MOVEN 15MG CAPSULE,MELOXICAM,2402221767,2005,15 mg,"Capsule, hard",Oral use,35.9,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MOVEN 15MG CAPSULE,MELOXICAM,2402221766,2006,15 mg,"Capsule, hard",Oral use,14.1,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MOTILIUM TAB 10MG,DOMPERIDONE,1-5876-23,1981,10 mg,Film-coated tablet,Oral use,17.1,LUSOMEDICAMENTA,Portugal,Johnson & Johnson Consumer NV/SA,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MONUROL 3G SACHETS,FOSFOMYCIN,2403257149,2008,3 g,Granules,Oral use,32.25,ZAMBON SWITZERLAND LTD,Switzerland,ZAMBON SWITZERLAND LTD,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"---, Cigalah Group"
MONTEL 5MG CHEWABLE TABLET,MONTELUKAST SODIUM,284-212-13,2013,5 mg,Chewable tablet,Oral use,88.25,Organon Pharma (UK) Limited,United Kingdom,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
MONTEL 4MG GRANULES,MONTELUKAST SODIUM,285-212-13,2013,4 mg,Granules,Oral use,100.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
MONTEL 4MG CHEWABLE TABLET,MONTELUKAST SODIUM,283-212-13,2013,4 mg,Chewable tablet,Oral use,88.25,Organon Pharma (UK) Limited,United Kingdom,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
MUCOFREE 4MG-5ML SYRUP,BROMHEXINE,4-491-06,2006,0.8 mg/ml,Syrup,Oral use,4.85,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 25°c,Pharmacy,almoghera commericial company
MUCOGEL,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, OXETHAZAINE",8-201-90,1990,"81,20,2 mg",Suspension,Oral use,7.15,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
MUCOSOLVAN 30MG-5ML ORAL LIQUID,AMBROXOL HYDROCHLORIDE,0302256797,2009,6 mg/ml,Oral liquid,Oral use,17.40,DELPHARM REIMS S.A.S,France,Sanofi-Aventis Deutschland GmbH,Germany,Marketed,OTC,do not store above 30°c,Pharmacy,Opella Arabia Limited Co
MULTIPARIN 1000 UNITS-ML INJ,HEPARIN SODIUM,0801233065,1987,1000 IU/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,27.85,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
"MYCOSAT 100, 000IU\ML ORAL SUSP",NYSTATIN,20-290-03,2003,100000 IU/ml,Suspension,Oral use,7.4,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
MYCOLESS CREAM,MICONAZOLE NITRATE,2003233396,2010,2 %,Cream,Topical,5.75,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
MONTEL 10MG FILM COATED TABLET,MONTELUKAST SODIUM,282-212-13,2013,10 mg,Film-coated tablet,Oral use,79.4,Organon Pharma (UK) Limited,United Kingdom,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
MYCOHEAL 400MG VAGINAL SUPPOSITORIES,MICONAZOLE NITRATE,2012234608,1995,400 mg,Suppository,Vaginal use,12.25,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
MYCOHEAL 2% ORAL GEL,MICONAZOLE NITRATE,1409234213,2001,2 %,Gel,Oral use,12.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
MYCAMINE 50-10ML VIAL,MICAFUNGIN,1-316-20,2007,5 mg/ml,Injection,Intramuscular use,382.50,Astellas Pharma Inc Takaoka Plant,Japan,ASTELLAS PHARMA INC.,Japan,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
MULTIPARIN 5000 UNITS-ML INJ,HEPARIN SODIUM,0712222993,1987,5000 IU/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,63.1,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
MULTIPARIN 25000 UNITS-ML INJ,HEPARIN SODIUM,4-178-87,1987,25000 IU/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,114,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
MONOZIDE 25MG TAB,HYDROCHLOROTHIAZIDE,2706245454,2000,25 mg,Tablet,Oral use,14.2,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
MONOZIDE 12.5MG TAB,HYDROCHLOROTHIAZIDE,2304245198,2000,12.5 mg,Tablet,Oral use,8.4,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
MITOXANTRON EBEWE 2MG-1ML SOL. FOR INFU,MITOXANTRONE HYDROCHLORIDE,38-355-06,2006,2 mg/ml,Solution,Intravenous use,396.70,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MIRZAGEN 30 mg film-coated tablet,MIRTAZAPINE,1211246198,2008,30 mg,Coated tablet,Oral use,78.40,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
MIRZAGEN 15 mg film-coated tablet,MIRTAZAPINE,0602221677,2008,15 mg,Coated tablet,Oral use,39.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
MIRENA 52 MG INTRAUTERINE DELIVERY SYSTEM (IUS),LEVONORGESTREL,1310222732,1998,52 mg,Intrauterine delivery system,Vaginal use,379.6,BAYER OY,Finland,BAYER OY,Finland,Marketed,Prescription,store below 25°c,Pharmacy,Bayer Saudi Arabia
MIRCERA 75MCG-0.3ML SOLN. FOR INJ,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,1310258422,2010,75 µg,Solution for injection,Intravenous use,667.45,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
MIRCERA 50MCG-0.3ML SOLN. FOR INJ,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,1310258420,2010,50 µg,Solution for injection,Intravenous use,444.95,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
MIXTARD 30,"INSULIN ISOPHANE, INSULIN HUMAN",0311222870,1989,"70,30 IU/ml",Suspension,Subcutaneous use,65,NOVO NORDISK PRODUCTION S.A.S,France,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
MIRCERA 200MCG-0.3ML SOLN. FOR INJ,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,1310258418,2010,200 µg,Solution for injection,Intravenous use,1780,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
MIRCERA 100MCG-0.3ML SOLN. FOR INJ,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,1310258419,2010,100 µg,Solution for injection,Intravenous use,889.95,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
MIRAGEL 2% ORAL GEL,MICONAZOLE NITRATE,3101221648,2009,2 %,Gel,Oral use,14.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
MINOXIL 5% SOLUTION,MINOXIDIL,2410246106,2008,5 %,Cutaneous solution,Topical,64.15,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
MINIRIN NASAL SPRAY 0.1MG-ML,DESMOPRESSIN ACETATE,1208245743,2007,0.1 mg/ml,"Nasal spray, solution",Nasal use,148.55,FERRING,Germany,FERRING,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
MINIRIN MILT 60 MCG LYOPHILIZED TABLET,DESMOPRESSIN ACETATE,3010222852,2012,60 µg,Oral lyophilisate,Oral use,104.95,CATALENT,United Kingdom,FERRING,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
MIRCERA 150MCG-0.3ML SOLN. FOR INJ,METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,1310258421,2010,150 µg,Solution for injection,Intravenous use,1334.95,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
MIXTARD 30 PENFILL,"INSULIN ISOPHANE, INSULIN HUMAN",18-100-95,1995,"70,30 IU/ml",Suspension for injection,Subcutaneous use,103.35,Novo Nordisk,Brazil,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
MONOPARIN 25000 U-ML INJ,HEPARIN SODIUM,1610222736,1987,25000 IU/ml,Solution for injection,Intravenous use,6.5,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
MONOCEF 500MG CAPSULE,CEFALEXIN,2610222815,2000,500 mg,Capsule,Oral use,29.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MONOCEF 250MG-5ML SUSPENSION,CEFALEXIN,0807245498,2000,50 mg/ml,Powder for suspension,Oral use,16.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MONOCEF 250MG CAPSULE,CEFALEXIN,0807245494,2000,250 mg,Capsule,Oral use,19.2,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MONOCEF 125MG-5ML SUSPENSION,CEFALEXIN,2401233157,2000,25 mg/ml,Powder for suspension,Oral use,10.2,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MOMETAMED 0.1% W-W CREAM,MOMETASONE FUROATE,0610258332,2010,0.1 %,Cream,Topical,10.45,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
MODURETIC 5-50MG TABLETS,"HYDROCHLOROTHIAZIDE, AMILORIDE",3107245715,2010,"50,5 mg",Tablet,Oral use,17.6,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
MOBIC 7.5MG TAB,MELOXICAM,71-68-97,1997,7.5 mg,Tablet,Oral use,27,ROTTENDORF PHARMA GMBH,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
MOBIC 15MG TAB,MELOXICAM,73-68-97,1997,15 mg,Tablet,Oral use,44.45,ROTTENDORF PHARMA GMBH,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
MOFETAB 500 MG FILM COATED TABLET,MYCOPHENOLATE MOFETIL,2605257457,2011,500 mg,Film-coated tablet,Oral use,715.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LACTULOSE syrup,LACTULOSE,2209258252,1994,0.65 g/ml,Syrup,Oral use,17,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
REBIF 44 MCG PRE-FILLED SYRINGE,INTERFERON BETA-1A,1609258226,2004,44 µg,Solution for injection,Subcutaneous use,3968.2,SERONO,Italy,SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
RECOFOL 10MG-ML INJECTION,PROPOFOL,19-205-01,2001,10 mg/ml,Solution for injection,Intravenous use,55.35,BAYER OY,Finland,BAYER OY,Finland,Marketed,Prescription,store below 25°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
UNIFED DM SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN, TRIPROLIDINE",1103210600,2001,"6,2,0.25 mg/ml",Syrup,Oral use,5.1,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
UNI FRESH 0.5% UNIT DOSE EYE DROPS,CARBOXYMETHYLCELLULOSE SODIUM,2311211350,2012,0.5 %,Eye drops,Ophthalmic use,17.20,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
UNASYN 500:250MG VIAL,"AMPICILLIN, SULBACTAM",3012246503,1997,"250,125 mg",powder for solution for injection,Intramuscular and intravenous use,9.2,HAUPT PHARMA LATINA S.R.I.,Italy,PFIZER,Italy,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
UNASYN 1000:500MG VIAL,"AMPICILLIN, SULBACTAM",3012246504,1997,"1000,500 mg",powder for solution for injection,Intramuscular and intravenous use,12.75,HAUPT PHARMA LATINA S.R.I.,Italy,PFIZER,Italy,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
UMAN ALBUMIN 20% SOLUTION FOR INFUSION,ALBUMIN HUMAN,1-476-07,2007,20 %,Solution,Intravenous use,122.75,KEDRION,Italy,KEDRION,Italy,Marketed,Prescription,store below 30°c,Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
UMAN ALBUMIN 20% SOLUTION FOR INFUSION,ALBUMIN HUMAN,2-476-07,2007,20 %,Solution,Intravenous use,245.5,KEDRION,Italy,KEDRION,Italy,Marketed,Prescription,store below 30°c,Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
ULTRAVIST300,IOPROMIDE,2308234029,1992,623 mg/ml,Solution for injection,Intravenous use,1066.05,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ULTRAVIST300,IOPROMIDE,2308234028,1992,623 mg/ml,Solution for injection,Intravenous use,556.00,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ULTRAVIST 370,IOPROMIDE,2308234031,1992,"769 mg, mg/ml",Solution for injection,Intravenous use,555.85,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ULTRAVIST 370,IOPROMIDE,2308234030,1992,769 mg/ml,Solution for injection,Intravenous use,1066.15,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
UNIFED SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",13-271-01,2001,"6,0.25 mg/ml",Syrup,Oral use,2.95,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
UNIPROST 4 MG TABLETS,DOXAZOSIN,2803233433,2010,4 mg,Tablet,Oral use,24.9,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
UNITUM 5% GEL,BENZYDAMINE HYDROCHLORIDE,2702256953,2009,5 %,Gel,Topical,15.2,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
V-2 PLUS CAPS,"SODIUM MOLYBDATE, COPPER, MANGANESE, CALCIUM PHOSPHATE, POTASSIUM IODIDE, MAGNESIUM OXIDE, BIOTIN, PHOSPHORUS, ZINC OXIDE, PHOSPHOLIPIDS, ASCORBIC ACID, CYANOCOBALAMIN, PYRIDOXINE (VITAMIN B6), RIBOFLAVIN (VITAMIN B2), THIAMINE, TOCOPHEROL, GINSENG, FERROUS FUMARATE, MAGNESIUM SULFATE, CHOLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, CALCIUM PANTOTHENATE",2602256945,1994,"0.2,1,1,88.2,5,6,0.015,68.1,1.2,10,75,3,2,5,5,30,50,10,6,400,0.4,25,5 mg, IU, µg",Capsule,Oral use,16.30,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
V-2 CAPS,"PHOSPHORUS, CALCIUM PHOSPHATE, MAGNESIUM OXIDE, POTASSIUM IODIDE, ZINC OXIDE, MANGANESE, COPPER, SODIUM MOLYBDATE, BIOTIN, NICOTINAMIDE, ASCORBIC ACID, CYANOCOBALAMIN, PYRIDOXINE (VITAMIN B6), RIBOFLAVIN (VITAMIN B2), THIAMINE, TOCOPHEROL, GINSENG, FERROUS FUMARATE, MAGNESIUM SULFATE, CHOLECALCIFEROL, FOLIC ACID, CALCIUM PANTOTHENATE, PHOSPHOLIPIDS",7-206-94,1994,"1,2.68,6.88,2.5,1,1,1,0.2,0.015,25,75,3,2,5,5,30,50,10,6,400,0.4,5,10 mg",Capsule,Oral use,6.2,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
UVAMIN 100MG RETARD CAPSULES,NITROFURANTOIN,40-222-10,2010,100 mg,"Capsule, hard",Oral use,27.25,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
URSOFALK 250MG CAPSULE,URSODEOXYCHOLIC ACID,1705222032,2004,250 mg,Capsule,Oral use,103.70,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
"UROMITEXAN 600 MG, film coated tablet",MESNA,1112246396,2001,600 mg,Film-coated tablet,Oral use,280.95,Temmler Pharma GmbH,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
UROMITEXAN 400MG-4ML AMP,MESNA,1112246398,1987,100 mg/ml,Solution for injection,Intravenous use,166.30,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
"UROMITEXAN 400 MG, film coated tablet",MESNA,1112246397,2001,400 mg,Film-coated tablet,Oral use,198.60,Temmler Pharma GmbH,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
URITAB XL 10MG EXTENDED RELEASE TABLETS,ALFUZOSIN,0408222406,2009,10 mg,Extended-release tablet,Oral use,93.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
URILAX 10MG FILM COATED TABLET,SOLIFENACIN SUCCINATE,2201268980,2014,10 mg,Film-coated tablet,Oral use,149.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
URALYT-U GRANULES,POTASSIUM SODIUM HYDROGEN CITRATE,1408245768,1985,2.4 g,Granules,Oral use,52.1,Rottapharm|Madaus Group,Germany,Viatris Healthcare GmbH,Germany,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
UNIZYM SYRUP,"CALCIUM PANTOTHENATE, NICOTINAMIDE, THIAMINE, RIBOFLAVIN (VITAMIN B2), PYRIDOXINE (VITAMIN B6)",18-590-11,2011,"5,2,20,2,3 mg",Syrup,Oral use,7.45,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
UNIVIT-E 100MG CAPSULE,DL-ALPHA TOCOFERIL ACETATE,0108210895,2010,100 mg,Capsule,Oral use,7.75,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
UNIVIT-A FORT 50000 I.U. CAPSULE,RETINOL,0803221827,2010,50000 IU,Capsule,Oral use,5.85,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
UNITUM VERDE 7.5 MG/5ML MOUTHWASH AND GARGLE,BENZYDAMINE HYDROCHLORIDE,0203233312,2011,1.5 mg/ml,Mouthwash,Oral use,15.65,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
URILAX 5MG FILM COATED TABLET,SOLIFENACIN SUCCINATE,2201268984,2014,5 mg,Film-coated tablet,Oral use,116.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TYMER 0.3% EYE DROP,GATIFLOXACIN,0203256964,2004,0.3 %,Eye drops,Ophthalmic use,28.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TYLENOL SUPP 350 MG,PARACETAMOL,13-51-80,1980,350 mg,Suppository,Rectal use,12.95,LUSOMEDICAMENTA,Portugal,Janssen-Cilag International NV,Belgium,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
TYLENOL SUPP 200 MG,PARACETAMOL,12-51-80,1980,200 mg,Suppository,Rectal use,11.4,LUSOMEDICAMENTA,Portugal,Janssen-Cilag International NV,Belgium,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
TYLENOL SUPP 100 MG,PARACETAMOL,11-51-80,1980,100 mg,Suppository,Rectal use,10.15,LUSOMEDICAMENTA,Portugal,Janssen-Cilag International NV,Belgium,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
TYLENOL FORTE TAB 500MG,PARACETAMOL,25-51-86,1986,500 mg,Tablet,Oral use,7.55,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
TYGACIL 50MG LYOP. POW. FOR I.V.INFUSION,TIGECYCLINE,0909245885,2013,50 mg,Powder for solution for infusion,Intravenous use,1285.50,WYETH,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 25°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
TWYNSTA,"TELMISARTAN, AMLODIPINE BESILATE",0112258701,2014,"80,5 mg",Tablet,Oral use,72.85,Cipla Limited,India,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TWYNSTA,"TELMISARTAN, AMLODIPINE BESILATE",0112258700,2014,"80,10 mg",Tablet,Oral use,72.85,Cipla Limited,India,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TWINRIX ADULT MONODOSE PREFLLED SYRINGE,"HEPATITIS A VIRUS, HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN",1810234349,2000,"720,20 µg, ELISA",Suspension for injection,Intramuscular use,130.20,GLAXOSMITHKLINE (GSK),Belgium,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
TRUXAL TABLETS 50MG,CHLORPROTHIXENE,4-136-83,1983,50 mg,Film-coated tablet,Oral use,26.55,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
TRIVASTAL RETARD 50MG TAB,PIRIBEDIL,3001256782,1981,50 mg,Prolonged-release tablet,Oral use,31.7,SERVIER,France,SERVIER,France,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
"TYPHIM VI, solution for injection in prefilled syringe polysaccharide typhoid vaccine",POLYSACCHARIDES OF SALMONELLA TYPHI (TY2 STRAIN),8-191-98,1998,25 µg,Solution for injection,Intramuscular use,50,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
ULTRADERM,"NYSTATIN, NEOMYCIN SULFATE, TRIAMCINOLONE ACETONIDE, GRAMICIDIN",91-119-98,1998,"19.763,3.709,1.0,0.25 mg/g",Ointment,Topical,7.05,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ULTRADERM,"NYSTATIN, NEOMYCIN SULFATE, TRIAMCINOLONE ACETONIDE, GRAMICIDIN",84-119-97,1997,"19.763,3.709,1.0,0.25 mg/g",Cream,Topical,7.45,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
UCIDERM -B CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",0711246159,2003,"2,0.1 %",Cream,Topical,10.45,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
UCIDERM 2% W-W GEL,FUSIDIC ACID,1411246222,2005,2 %,Gel,Topical,7.1,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
UCIDERM 2% OINTMENT,FUSIDIC ACID,0711246158,2003,2 %,Ointment,Topical,6.6,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
UCIDERM 2 % CREAM,FUSIDIC ACID,0711246160,2003,2 %,Cream,Topical,8.25,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
U-CEF 500MG F.C. TABLETS,CEFUROXIME AXETIL,372-334-23,2006,500 mg,Film-coated tablet,Oral use,52.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
VALCYTE 450MG FILM - COATED TABLETS,Valganciclovir,0402244833,2006,450 mg,Film-coated tablet,Oral use,3791.75,PATHEON INC,Canada,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
VALIUM AMP 10MG-2ML,DIAZEPAM,0909245876,2005,5 mg/ml,Solution for injection,Intravenous use,23.85,CENEXI,France,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
VERO 50 mg film-coated tablets,SILDENAFIL,285-277-14,2014,50 mg,Film-coated tablet,Oral use,13.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VERO 50 mg film-coated tablets,SILDENAFIL,282-277-14,2014,50 mg,Film-coated tablet,Oral use,53.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VERMOX SUSPN 2%,MEBENDAZOLE,0408222397,1981,2 %,Oral suspension,Oral use,12.3,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
VERMOX 100MG TABLET,MEBENDAZOLE,0212222959,2003,100 mg,Tablet,Oral use,9.5,LUSOMEDICAMENTA,Portugal,JANSSEN-CILAG,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VERINE SR 200MG SUSTAINED RELEASED CAP,MEBEVERINE HYDROCHLORIDE,2608200138,2007,200 mg,Modified-release capsule,Oral use,43.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
VERINE 135MG TAB,MEBEVERINE HYDROCHLORIDE,2307257836,2002,135 mg,Tablet,Oral use,21.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VENTOLIN RESPIRATORY SOLUTIN,SALBUTAMOL,1606222218,1997,0.5 %,Nebuliser solution,Inhalation use,18.65,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
VENTOLIN EVOHALER,SALBUTAMOL,0912211446,1997,100 µg,"Pressurised inhalation, solution",Inhalation use,18.75,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
VERSATIS 5% MEDICATED PLASTER,LIDOCAINE HYDROCHLORIDE,2912258829,2011,5 %,Medicated plaster,Topical,98.05,TEIKOKU SEIYAKU,Japan,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., STADA Arabia Limited Company, Salehiya Trading Co."
VERSATIS 5% MEDICATED PLASTER,LIDOCAINE HYDROCHLORIDE,2609222650,2011,5 %,Medicated plaster,Topical,465.90,TEIKOKU SEIYAKU,Japan,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., STADA Arabia Limited Company, Salehiya Trading Co."
VESICARE 10 mg film-coated tablet,SOLIFENACIN SUCCINATE,0407210840,2008,10 mg,Film-coated tablet,Oral use,174.70,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VESICARE 5 mg film-coated tablet,SOLIFENACIN SUCCINATE,0407210841,2008,5 mg,Film-coated tablet,Oral use,135.85,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VICTOZA 6MG/ML SOLUTION FOR INJECTION,LIRAGLUTIDE,0602256841,2011,6 mg/ml,Solution for injection in pre-filled pen,Intravenous use,317.60,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
VICKS VAPORUB OINT,"CAMPHOR, TURPENTINE OIL, MENTHOL, EUCALYPTUS OIL",1-501-82,1982,"5.5,4.7,2.8,1.4 g",Ointment,Topical,5.35,LASHART,France,LASHART,France,Marketed,OTC,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
VICKS SINEX NASAL SPRAY.,OXYMETAZOLINE,1-505-82,1982,0.05 %,Spray,Nasal use,3.6,RICHARD SUN MRIL,United Kingdom,RICHARD SUN MRIL,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
VIAGRA 50MG F.C TAB,SILDENAFIL,0409234118,2013,50 mg,Film-coated tablet,Oral use,70.10,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
VIAGRA 25MG F.C TAB,SILDENAFIL,4-5728-22,1999,25 mg,Film-coated tablet,Oral use,68.1,Fareva Amboise,France,UPJOHN EESV,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
VIAGRA 100MG TABLETS,SILDENAFIL,1811258607,2013,100 mg,Film-coated tablet,Oral use,70.10,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
VEXAL XR 75 MG EXTENDED RELEASE CAPSULE,VENLAFAXINE HYDROCHLORIDE,139-334-11,2011,75 mg,Modified-release capsule,Oral use,60.1,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VEXAL XR 37.5 MG EXTENDED RELEASE CAPSULE,VENLAFAXINE HYDROCHLORIDE,140-334-11,2011,37.5 mg,Modified-release capsule,Oral use,30.05,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VEXAL XR 150 MG EXTENDED RELEASE CAPSULE,VENLAFAXINE HYDROCHLORIDE,141-334-11,2011,150 mg,Modified-release capsule,Oral use,95.05,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VALDOXAN 25MG FILM COATED TABLET,AGOMELATINE,1107233856,2012,25 mg,Film-coated tablet,Oral use,104.95,SERVIER,Ireland,SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
VENTOLIN,SALBUTAMOL,1709200158,1997,0.4 mg/ml,Syrup,Oral use,8.35,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
VAQTA VACCINE 50 U VIAL,HEPATITIS A VIRUS,0309258152,2001,50 IU/ml,Suspension for injection in pre-filled syringe,Intramuscular use,114,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
VAQTA 25U SYRINGE I.M,HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED),2905245379,2001,25 U,Suspension for injection in pre-filled syringe,Intramuscular use,74.50,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
VALTREX,VALACICLOVIR,2312200360,2002,500 mg,Tablet,Oral use,319.80,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VALTREX,VALACICLOVIR,2312200358,2002,500 mg,Tablet,Oral use,86.35,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VALOPRA 57.64 MG-ML SYRUP,VALPROATE SODIUM,136-334-10,2010,57.64 mg/ml,Syrup,Oral use,11.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VALOPRA 200 MG-ML SOLUTION,VALPROATE SODIUM,137-334-10,2010,200 mg/ml,Solution,Oral use,11.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VALIUM TAB 5MG,DIAZEPAM,8-5357-23,1980,5 mg,Tablet,Oral use,16.8,RECIPHARM LEGANES S.L.U,Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
VALIUM TAB 2 MG,DIAZEPAM,180-24-80,1980,2 mg,Tablet,Oral use,11,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
VALIUM TAB 10 MG,DIAZEPAM,184-24-80,1980,10 mg,Tablet,Oral use,24.05,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
VARILRIX 2000 PFU -0.5ML VIAL,VARICELLA ZOSTER VIRUS OKA STRAIN LIVE ATTENUATED,2810258492,2012,1995.26 PFU,Solution for injection,Intramuscular use,166.60,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VASCODIPINE,AMLODIPINE BESILATE,0408222409,2004,10 mg,Tablet,Oral use,64.40,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
VASCODIPINE,AMLODIPINE BESILATE,0408222410,2004,2.5 mg,Tablet,Oral use,27.45,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
VASCODIPINE,AMLODIPINE BESILATE,0408222408,2004,5 mg,Tablet,Oral use,53.35,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
VENEX XR 75MG CAPSULE,VENLAFAXINE HYDROCHLORIDE,2306222256,2014,75 mg,Modified-release capsule,Oral use,54.1,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
VENEX XR 150MG CAPSULE,VENLAFAXINE HYDROCHLORIDE,2306222253,2014,150 mg,Modified-release capsule,Oral use,90.30,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
VELCADE 3.5MG POWDER FOR I.V. INJECTION,BORTEZOMIB,89-6-06,2006,3.5 mg,powder for solution for injection,Subcutaneous use,3960.05,BSP PHARMACEUTICALS,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
VECTIBIX 20MG/ML CONC. SOLUTION FOR INFUSION,PANITUMUMAB,16-475-13,2013,20 mg/ml,Concentrate for solution for infusion,Intravenous use,2323.30,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
VENORUTON 300MG CAP,TROXERUTIN,1506222193,2003,300 mg,Capsule,Oral use,30.15,Recipharm Pharma Services Limited,India,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"STADA Arabia Limited Company, Salehiya Trading Co."
VAVO 2% SHAMPOO,KETOCONAZOLE,1109234172,2001,2 %,Shampoo,Topical,26.50,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VASTA 40MG F.C. TABLETS,SIMVASTATIN,2807257871,2007,40 mg,Film-coated tablet,Oral use,66.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VASTA 20MG F.C TAB,SIMVASTATIN,2307233917,2003,20 mg,Film-coated tablet,Oral use,66.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VASTA 10MG F.C TAB,SIMVASTATIN,0408222404,2003,10 mg,Film-coated tablet,Oral use,66.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VASTAREL MR 35MG MODIFIED RELEASE TABLET,TRIMETAZIDINE,17-17-05,2005,35 mg,Modified-release film-coated tablet,Oral use,62.1,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
TRIPOFED SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",1505245302,2002,"6,0.25 mg/ml",Syrup,Oral use,2.95,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
TRIPOFED DM SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN, TRIPROLIDINE",0801256553,2004,"6,2,0.25 mg/ml",Syrup,Oral use,7.30,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
TEGRETOL TAB 200MG,CARBAMAZEPINE,0710258335,1980,200 mg,Tablet,Oral use,30.10,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
TEGRETOL 2% oral suspension,CARBAMAZEPINE,121-11-88,1988,2 mg/ml,Oral suspension,Oral use,21.90,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
TEGRETOL CR 400MG SCORED TAB,CARBAMAZEPINE,1401268913,1993,400 mg,Prolonged-release tablet,Oral use,34.70,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
TAZORAX 4.5 GM Powder for injection,"PIPERACILLIN, Tazobactam",1501256660,2013,"4,0.5 g",powder for solution for injection,Intravenous use,64.1,LABORATOIRES PANPHARMA S.A,France,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZORAX 2.25 GM Powder for injection,"PIPERACILLIN, Tazobactam",1501256649,2013,"2,0.25 g",powder for solution for injection,Intravenous use,32.05,LABORATOIRES PANPHARMA S.A,France,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZOLINE0.5GM VIAL I.M+5MLSOLV.LIDOCAINE,CEFAZOLIN,52-277-99,1999,0.5 g,powder for solution for injection,Intramuscular use,9.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZOLINE 1GM VIAL IV+10ML WATER FOR INJ.,CEFAZOLIN,0810258377,1999,1 g,powder for solution for injection,Intravenous use,19.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZOLINE 1GM VIAL I.M+5MLSOLV.LIDOCAINE,CEFAZOLIN,1501256654,1999,1 g,powder for solution for injection,Intramuscular use,19.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZOLINE 0.5GM VIAL IV+10MLWATER FOR INJ,CEFAZOLIN,53-277-99,1999,500 mg,powder for solution for injection,Intravenous use,9.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZOCIN 4.5GM VIAL + EDTA,"PIPERACILLIN, Tazobactam",2207245622,2005,"4,0.5 g",Powder for solution for infusion,Intravenous use,92.85,NUTRA MANUFACTURING INC,United States,WYETH,Italy,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
TEKAM 50MG-ML 10ML VIAL,KETAMINE,1505245312,1994,50 mg/ml,Injection,Intravenous use,26.55,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
TERRELL 100% VAPOUR LIQUID FOR INHALATION,ISOFLURANE,287-186-14,2014,100 %,"Inhalation vapour, liquid",Inhalation use,41.1,PIRAMAL CRITICAL CARE INC,United States,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TERFINA CREAM,TERBINAFINE,30-498-10,2010,1.02 %,Cream,Topical,10.95,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
TENORMIN TAB 50MG,ATENOLOL,2309258260,1986,50 mg,Film-coated tablet,Oral use,18.65,Corden Pharma GmbH,Germany,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
TENORMIN TAB 100MG,ATENOLOL,1410258425,1981,100 mg,Film-coated tablet,Oral use,19.25,Corden Pharma GmbH,Germany,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
TENORETIC TAB,"ATENOLOL, CHLORTHALIDONE",2104257260,1986,"100,25 mg",Film-coated tablet,Oral use,28.95,Corden Pharma GmbH,Germany,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
TENORMIN TAB 100MG,ATENOLOL,11-5357-24,1981,100 mg,Film-coated tablet,Oral use,9.6,Corden Pharma GmbH,Germany,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
TESTOVIRON DEPOT 250MG-1ML AMP,TESTOSTERONE,0511234431,1981,250 mg/ml,Solution for injection,Intramuscular use,26.25,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
TAVANIC 5 MG -1 ML SOLUTION I.V INFUSION,LEVOFLOXACIN,0112222957,2003,5 mg/ml,Solution for infusion,Intravenous use,113.20,sanofi-aventis,Germany,sanofi-aventis,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
TABUVAN 160 MG FILM COATED TABLET,VALSARTAN,1501256637,2012,160 mg,Film-coated tablet,Oral use,36.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABUNEX 0.05% NASAL SPRAY,MOMETASONE FUROATE,1302256896,2008,0.05 %,"Nasal spray, suspension",Nasal use,46.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABUFLU 75MG CAPSULES,OSELTAMIVIR,242-277-12,2012,75 mg,Capsule,Oral use,75.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABOCINE 100,DOXYCYCLINE,0512211424,1997,100 mg,"Capsule, hard",Oral use,28.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABIXA 10MG FILM COATED TABLET,MEMANTINE HYDROCHLORIDE,1109234171,2012,10 mg,Film-coated tablet,Oral use,103.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABIVIR 300MG F-C TABLETS,LAMIVUDINE,205-277-10,2010,300 mg,Film-coated tablet,Oral use,283.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABIVIR 150MG F-C TABLETS,LAMIVUDINE,3010222838,2010,150 mg,Film-coated tablet,Oral use,283.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABIFLEX COOL 1% GEL,DICLOFENAC SODIUM,2011246299,1997,1 %,Gel,Topical,13.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABIFLEX 50MG E.C.TAB,DICLOFENAC SODIUM,0709258177,1997,50 mg,Gastro-resistant coated tablet,Oral use,19.80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABICLOR MR 750MG F.C TAB,CEFACLOR,2008245783,2002,750 mg,Modified-release film-coated tablet,Oral use,44.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABICLOR 500MG CAPS,CEFACLOR,2201268982,1998,500 mg,"Capsule, hard",Oral use,53.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABICLOR 375 MG- 5ML ORAL SUSPNSION,CEFACLOR,2401233161,2002,75 mg/ml,Powder for oral suspension,Oral use,32.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABICLOR 250MG-5ML SUSP,CEFACLOR,0802244872,1998,50 mg,Powder for oral suspension,Oral use,34,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABICLOR 125MG-5ML SUSP,CEFACLOR,0802244874,1998,25 mg/ml,Powder for oral suspension,Oral use,18.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABETA 0.1%SCALP APPLICATION,BETAMETHASONE VALERATE,0310222685,2002,0.1 %,Cutaneous suspension,Topical,10.9,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABUVAN 320 MG FILM COATED TABLET,VALSARTAN,1501256650,2012,320 mg,Film-coated tablet,Oral use,46.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABUVAN 40 MG FILM COATED TABLET,VALSARTAN,1501256647,2012,40 mg,Film-coated tablet,Oral use,19.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TABUVAN 80 MG FILM COATED TABLET,VALSARTAN,1501256658,2012,80 mg,Film-coated tablet,Oral use,32.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TachoSil sealant matrix,"HUMAN FIBRINOGEN, HUMAN THROMBIN",0102233198,2009,"5.5,2 mg, IU",Sealant matrix,Topical,1194.00,Corza Medical Distribution GmbH,Austria,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
TASIGNA 200MG CAPSULES,NILOTINIB,0906222172,2008,200 mg,Capsule,Oral use,11456.25,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
TASIGNA 150MG CAPSULES,NILOTINIB,29-665-24,2012,150 mg,Capsule,Oral use,9038.45,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
TAVANIC 500MG F.C TAB,LEVOFLOXACIN,0112222956,2002,500 mg,Film-coated tablet,Oral use,71.30,Opella Healthcare International,France,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
TAMIFLU 75 MG CAPSULE,OSELTAMIVIR,232-24-01,2001,75 mg,Capsule,Oral use,79.85,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
TAKEPRON 30MG CAPS,LANSOPRAZOLE,86-119-97,1997,30 mg,"Capsule, hard",Oral use,45.95,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
TAKEPRON 15MG CAP.,LANSOPRAZOLE,108-119-01,2001,15 mg,"Capsule, hard",Oral use,22.95,APM,Jordan,APM,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
TRIPOFED EXPECTORANT SYRUP,"GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",1505245304,2004,"20,6,0.25 mg/ml",Syrup,Oral use,7.30,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
TETAVAX 40 I.U INJ.,TETANUS TOXOID,22-191-07,2007,40 IU,Suspension for injection,Intramuscular use,15.7,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
TEVETEN 600MG TAB,EPROSARTAN MESILATE,1704245169,2003,600 mg,Film-coated tablet,Oral use,76.50,Mylan Laboratories SAS,France,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TRACTOCILE concentrate for solution for infusion,ATOSIBAN,0809222593,2007,7.5 mg/ml,Solution for injection,Intravenous use,335.00,FERRING,Germany,FERRING INTERNATIONAL CENTER SA,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
TRACTOCILE solution for injection,ATOSIBAN,0809222595,2007,7.5 mg/ml,Solution for injection,Intravenous use,87.60,FERRING,Germany,FERRING INTERNATIONAL CENTER SA,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
TRACLEER 62.5 MG FILM COATED TABLET,BOSENTAN,2708234053,2013,62.5 mg,Film-coated tablet,Oral use,7526.95,Haupt Pharma Wulfing GmbH,Germany,ACTELTION PHARMACEUTICALS LTD,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
TRACLEER 125 MG FILM COATED TABLET,BOSENTAN,2708234054,2013,125 mg,Film-coated tablet,Oral use,7526.95,Haupt Pharma Wulfing GmbH,Germany,ACTELTION PHARMACEUTICALS LTD,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
TRABILIN 100MG AMPOULES,TRAMADOL HYDROCHLORIDE,2004257249,2010,100 mg,Solution for injection,Intravenous use,17,MERCKLE,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group"
TOVAST 40 MG F-C TABLETS,ATORVASTATIN CALCIUM,1411211319,2007,40 mg,Film-coated tablet,Oral use,86.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
TOVAST 20 MG F-C TABLETS,ATORVASTATIN CALCIUM,1411211318,2007,20 mg,Film-coated tablet,Oral use,43.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
TOVAST 10 MG F-C TABLETS,ATORVASTATIN CALCIUM,1411211317,2007,10 mg,Film-coated tablet,Oral use,43.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
TOTAM 1GM IV\IM INJECTION,CEFOTAXIME,1611211332,2004,1 g,powder for solution for injection,Parenteral use,29.6,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
TORVACOL 40MG F.C. TABLETS,ATORVASTATIN CALCIUM,2909245967,2007,40 mg,Film-coated tablet,Oral use,86.9,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
TORVACOL 20MG F.C. TABLETS,ATORVASTATIN CALCIUM,2509305987,2007,20 mg,Film-coated tablet,Oral use,43.45,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
TORVACOL 10MG F.C. TABLETS,ATORVASTATIN CALCIUM,0909258190,2007,10 mg,Film-coated tablet,Oral use,43.45,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Dallah Health Care Company
TRACUTIL SOLUSION FOR INFUSION AMPOULE,"IRON CHLORIDE TETRAHYDRATE, ZINC CHLORIDE, SODIUM FLUORIDE, SODIUM SELENITE PENTAHYDRATE, CHROMIUM CHLORIDE HEXAHYDRATE, SODIUM MOLYBDATE",63-188-04,2004,"695.8,681.5,126,7.89,5.3,2.42 mg",Concentrate for solution for infusion,Intravenous use,22.65,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
TRAJENTA 5MG FILM COATED TABLET,LINAGLIPTIN,2204257266,2013,5 mg,Film-coated tablet,Oral use,113.40,Dragenopharm Apotheker Puschl GmbH,Germany,BOEHRINGER INGELHEIM,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
TRIPACEL VACCINE,"DIPHTHERIA TOXOID, TETANUS TOXOID, ACELLULAR PERTUSSIS",20-191-05,2005,"15,5,23 µg, LfU",Suspension for injection,Intramuscular use,69.6,SANOFI PASTEUR,Canada,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
TRIAXONE 1GM VIAL I.V +10ML WATER FOR INJ,CEFTRIAXONE,46-277-98,1998,1 g,Solution,Intravenous use,59.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TRIAXONE 500MG VIAL I.V+5MLWATER FOR INJ,CEFTRIAXONE,2510211227,1998,500 mg,Solution,Intravenous use,36.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TRIAXONE 1GM VIAL I.M+5ML SOLV.LIDOCAINE,CEFTRIAXONE,45-277-98,1998,1 g,Solution,Intramuscular use,59.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TOPRAZOLE 40 MG E.C TABLETS,PANTOPRAZOLE,0411246139,2004,40 mg,Enteric-coated tablet,Oral use,62.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TRIAXONE 0.5G I.M VIAL+5ML SOLV.LIDOCAIN,CEFTRIAXONE,0810258364,1998,500 mg,Solution,Intramuscular use,36.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TRENTAL TAB 400MG,PENTOXIFYLLINE,2205233686,1987,400 mg,Prolonged-release tablet,Oral use,99.6,sanofi S.R.L,Italy,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
TRENTAL TAB 400MG,PENTOXIFYLLINE,2205233685,1987,400 mg,Prolonged-release tablet,Oral use,27,sanofi S.R.L,Italy,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
TOPRAZOLE 40 MG E.C TABLETS,PANTOPRAZOLE,0411246141,2004,40 mg,Enteric-coated tablet,Oral use,35.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TIGER BALSAM,"MENTHOL, METHYL SALICYLATE, CAMPHOR, EUCALYPTUS OIL",3010246130,1980,"8.5,8,6,2 %, % (W/W)",Solution,Topical,6.05,TIGER MEDICALS,Singapore,TIGER MEDICALS,Singapore,Marketed,OTC,store below 25°c,Pharmacy,Noorwali Medical Store Co. Ltd.
TIDILOR 5 MG - 5 ML SYRUP,LORATADINE,2601233185,2004,1 mg/ml,Syrup,Oral use,13.15,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,store below 25°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
TIDILOR 10MG TABLET,LORATADINE,0709211014,2004,10 mg,Tablet,Oral use,13.6,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
TICANASE 0.05% NASAL SPRAY,FLUTICASONE PROPIONATE,2709234279,2011,0.05 %,"Nasal drops, suspension",Nasal use,24.70,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,Marketed,OTC,store below 30°c,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, ZIMMO TRADING ESTABLISHMENT"
THEO-DUR TAB 300MG,THEOPHYLLINE,9-151-88,1988,300 mg,Prolonged-release tablet,Oral use,15.55,RECORDATI,Italy,RECORDATI,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Annhdah Medical Company
THEO-DUR TAB 200MG,THEOPHYLLINE,8-151-88,1988,200 mg,Prolonged-release tablet,Oral use,12.85,RECORDATI,Italy,RECORDATI,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Annhdah Medical Company
TEVETEN PLUS 600-12.5MG FILM COATED TAB.,"HYDROCHLOROTHIAZIDE, EPROSARTAN MESILATE",1704245170,2005,"12.5,600 mg",Film-coated tablet,Oral use,76.50,Mylan Laboratories SAS,France,Abbott Laboratories GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TILAX 2 MG TABLET,TIZANIDINE,3001233193,2011,2 mg,Tablet,Oral use,17.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
TILAX 4 MG TABLET,TIZANIDINE,2901233187,2011,4 mg,Tablet,Oral use,29.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
TILCOTIL TAB 20MG,TENOXICAM,1-864-13,2013,20 mg,Tablet,Oral use,21.3,ROCHE,Switzerland,MEDA PHARMA GmbH & Co KG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Viatris Arabia Limited, ZIMMO TRADING ESTABLISHMENT"
TOPAMAX 25MG-TAB. F.C.TAB.,TOPIRAMATE,1109222596,1999,25 mg,Film-coated tablet,Oral use,33.1,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TOPAMAX 200MG F.C.TAB.,TOPIRAMATE,37-51-99,1999,200 mg,Film-coated tablet,Oral use,221.5,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
TOPAMAX 15MG SPRINKLE CAPSULES,TOPIRAMATE,48-51-08,2008,15 mg,Capsule,Oral use,37.3,JANSSEN - ORTHO,Puerto Rico,JANSSEN - ORTHO,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
TOPAMAX 100MG F.C.TAB.,TOPIRAMATE,36-51-99,1999,100 mg,Film-coated tablet,Oral use,122.55,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TOPRAZOLE 20MG ENTERIC COATED TABLETS,PANTOPRAZOLE,2204257264,2006,20 mg,Coated tablet,Oral use,21.9,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TOFRANIL 25 MG 50 TAB,IMIPRAMINE HYDROCHLORIDE,3-849-13,2013,25 mg,Tablet,Oral use,16.85,PATHEON,Canada,AMDIPHARMA,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
TOBRACIN 0.3% EYE OINTMENT,TOBRAMYCIN,36-290-09,2009,0.3 %,Eye ointment,Ophthalmic use,10.65,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
TOBRACIN 0.3% EYE DROPS,TOBRAMYCIN,37-290-09,2009,0.3 %,Eye drops,Ophthalmic use,11.35,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
TIVICAY 50 mg Tablet,DOLUTEGRAVIR,2508210984,2014,50 mg,Film-coated tablet,Oral use,2239.95,Delpharm Poznań Spółka Akcyjna,Poland,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VIDROP ORAL DROPS,COLECALCIFEROL,1006245400,2010,2800 IU/ml,Oral drops,Oral use,7.75,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
ZINOPRIL 20 MG TABLET,LISINOPRIL,1911246270,2002,20 mg,Tablet,Oral use,44.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZINOPRIL 10 MG TAB,LISINOPRIL,2610222809,2002,10 mg,Tablet,Oral use,26.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZINNAT,CEFUROXIME AXETIL,2505210754,1996,250 mg,Coated tablet,Oral use,57.40,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,store below 25°c,Pharmacy,Sandoz Limited Trading
ZINNAT,CEFUROXIME AXETIL,0811211282,2003,50 mg/ml,Granules for oral suspension,Oral use,52.10,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,do not store above 30°c,Pharmacy,Sandoz Limited Trading
ZINNAT,CEFUROXIME AXETIL,0811211281,1997,25 mg/ml,Granules for oral suspension,Oral use,41.05,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,do not store above 30°c,Pharmacy,Sandoz Limited Trading
ZINNAT,CEFUROXIME AXETIL,2505210753,1999,500 mg,Coated tablet,Oral use,69.60,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,do not store above 30°c,Pharmacy,Sandoz Limited Trading
ZINACEF 750 mg,CEFUROXIME SODIUM,1-5954-24,1997,750 mg,powder for solution for injection,Parenteral use,37.50,ACS Dobfar S.P.A,Italy,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,store below 25°c,Hospital,Sandoz Limited Trading
ZINACEF 1.5 g,CEFUROXIME SODIUM,2-5954-24,1997,1.5 g,powder for solution for injection,Parenteral use,14.90,ACS Dobfar S.P.A,Italy,Sandoz Pharmaceuticals d.d,Slovenia,Marketed,Prescription,store below 25°c,Hospital,Sandoz Limited Trading
AZOLID 500MG F.C. TABLETS,AZITHROMYCIN,4-809-14,2014,500 mg,Film-coated tablet,Oral use,26.4,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
AZOLID 250MG F.C. TABLETS,AZITHROMYCIN,3-809-14,2014,250 mg,Film-coated tablet,Oral use,25.00,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
ZIMAX 250MG CAP.,AZITHROMYCIN,1106245409,2002,250 mg,Capsule,Oral use,62.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZIMAX 250MG CAP.,AZITHROMYCIN,2001268964,2002,250 mg,Capsule,Oral use,41.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ZINOPRIL 5 MG TABLETS,LISINOPRIL,2610222817,2002,5 mg,Tablet,Oral use,15.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZINOXIME 1.5GM VIAL FOR I.V,CEFUROXIME SODIUM,1401256611,1998,1.5 g,Powder for injection,Parenteral use,14.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ZINOXIME 750MG VIAL FOR I.V- I.M,CEFUROXIME SODIUM,1401256612,1998,750 mg,Powder for injection,Parenteral use,7.50,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ZOLECIN 1GM VIAL I.V,CEFAZOLIN,2502256934,1988,1 g,Powder for injection,Intravenous use,19.25,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ZOLADEX DEPOT 3.6MG S-C INJ SYRINGE,GOSERELIN,8-5518-25,1993,3.6 mg,Implant,Subcutaneous use,307.65,AstraZeneca,United Kingdom,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
ZOCIN 250MG CAPSULE,AZITHROMYCIN,2-347-03,2003,250 mg,Capsule,Oral use,36.2,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ZOCIN 300 mg/7.5 ml suspension,AZITHROMYCIN,17-347-07,2007,40 mg/ml,Suspension,Oral use,15.15,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ZOCIN 200MG-5ML POW. FOR ORAL SUSPENSION,AZITHROMYCIN,16-347-07,2007,40 mg/ml,Suspension,Oral use,11.05,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ZITHROMAX 250MG CAPS,AZITHROMYCIN,7-892-13,1997,250 mg,Capsule,Oral use,44.05,PFIZER SAUDI LIMITED,Saudi Arabia,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZITHROMAX 250MG CAPS,AZITHROMYCIN,8-892-13,1997,250 mg,Capsule,Oral use,66.10,PFIZER SAUDI LIMITED,Saudi Arabia,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZITHROMAX 200MG-5ML SUSP.AFTER RECONSTIT,AZITHROMYCIN,1010222699,2013,40 mg/ml,Powder for oral suspension,Oral use,43.60,PFIZER SAUDI LIMITED,Saudi Arabia,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZITHROMAX 200MG-5ML SUSP.AFTER RECONSTIT,AZITHROMYCIN,1010222700,2013,40 mg/ml,Powder for oral suspension,Oral use,53.05,PFIZER SAUDI LIMITED,Saudi Arabia,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZITHROMAX 200MG-5ML SUSP.AFTER RECONSTIT,AZITHROMYCIN,1010222701,2013,40 mg/ml,Powder for oral suspension,Oral use,31.90,PFIZER SAUDI LIMITED,Saudi Arabia,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZINOXIMOR 500MG F.C.TABLET,CEFUROXIME AXETIL,0801233062,2003,500 mg,Film-coated tablet,Oral use,76.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZINOXIMOR 250 MG F.C.TAB,CEFUROXIME AXETIL,2510222796,1999,250 mg,Film-coated tablet,Oral use,57.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZITHROMAX 500 MG POWDER FOR IV INFUSION,AZITHROMYCIN,2003257114,2011,500 mg,Powder for solution for infusion,Parenteral use,45.20,PHARMACIA UPJOHN,United States,PFIZER ITALY S.R.I,Italy,Marketed,Prescription,do not store above 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ZIMAX 200MG\5ML SUSP,AZITHROMYCIN,1212211464,2002,40 mg/ml,Suspension,Oral use,33.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ZIDIME 2GM I.V INJ,CEFTAZIDIME,2201268975,1999,2 g,Powder for injection,Intravenous use,95.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ZEROX 200MG-5ML POWDER FOR ORAL SUSP.,AZITHROMYCIN,167-172-09,2009,40 mg/ml,Suspension,Oral use,9.95,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ZENORIT 8 mg film-coated tablets,LORNOXICAM,0810258370,2014,8 mg,Film-coated tablet,Oral use,19.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZEMITRON 8MG F-C TABLET,ONDANSETRON,127-119-22,2007,8 mg,Tablet,Oral use,145.05,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
ZEMITRON 4MG F-C TABLET,ONDANSETRON,125-119-22,2007,4 mg,Tablet,Oral use,100.80,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ZELAX 20MG FILM COATED CAPLET,ESCITALOPRAM,2403257155,2011,20 mg,Film-coated tablet,Oral use,81.95,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ZELAX 10MG FILM COATED CAPLET,ESCITALOPRAM,2403257156,2011,10 mg,Film-coated tablet,Oral use,54.9,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ZEFFIX,LAMIVUDINE,2312200354,2013,100 mg,Film-coated tablet,Oral use,303.70,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
ZEROX 200MG-5ML POWDER FOR ORAL SUSP.,AZITHROMYCIN,168-172-09,2009,40 mg/ml,Suspension,Oral use,13.65,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ZEROX 500MG F.C. TABLETS,AZITHROMYCIN,162-172-08,2008,500 mg,Film-coated tablet,Oral use,26.4,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ZEROX 500MG F.C. TABLETS,AZITHROMYCIN,2104221970,2008,500 mg,Film-coated tablet,Oral use,19.2,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ZERTAZINE 5MG\5ML SYRUP,CETIRIZINE HYDROCHLORIDE,0510200184,2004,1 mg/ml,Syrup,Oral use,8.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
ZIDIME 1GM GLASS VIAL IV-IM,CEFTAZIDIME,2201268981,1999,1 g,Powder for injection,Intravenous use,51.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ZIAGEN 300MG TAB,ABACAVIR,1303257069,2003,300 mg,Film-coated tablet,Oral use,944.75,Delpharm Poznan,Poland,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZETRON 250 MG CAPSULE,AZITHROMYCIN,0606222134,2003,250 mg,Capsule,Oral use,50.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZETRON 300 per 7.5 ml,AZITHROMYCIN,0706222149,2003,40 mg/ml,Powder for oral suspension,Oral use,39.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZETRON 200 mg per 5 ml,AZITHROMYCIN,0706222148,2003,40 mg/ml,Powder for oral suspension,Oral use,28.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZETEX 10 mg tablet,EZETIMIBE,2201268976,2014,10 mg,Tablet,Oral use,146.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZIMAX 200MG\5ML SUSP,AZITHROMYCIN,1212211466,2002,40 mg/ml,Suspension,Oral use,24.60,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
ZETACORT CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",171-277-05,2005,"2,0.1 %",Cream,Topical,11.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZETA 20MG OINTMENT TUBE,FUSIDIC ACID,1605245314,1999,2 %,Ointment,Topical,11.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZESTRIL 5MG TAB,LISINOPRIL,0406257548,1991,5 mg,Tablet,Oral use,15.8,Rovi Pharma Industrial Service,Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ZESTRIL 20MG TAB,LISINOPRIL,0406257546,1991,20 mg,Tablet,Oral use,44.35,Rovi Pharma Industrial Service,Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ZESTRIL 10MG TAB,LISINOPRIL,0406257547,1991,10 mg,Tablet,Oral use,26,Rovi Pharma Industrial Service,Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ZERTAZINE,CETIRIZINE HYDROCHLORIDE,144-325-04,2004,10 mg,Film-coated tablet,Oral use,18.50,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
ZERTAZINE,CETIRIZINE HYDROCHLORIDE,2705245351,2004,10 mg,Film-coated tablet,Oral use,9.25,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
ZETA 20MG-GM CREAM,FUSIDIC ACID,1109234170,2000,2 %,Cream,Topical,10.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ZOLPIGEN,ZOLPIDEM,0712222990,2005,10 mg,Film-coated tablet,Oral use,27.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ZOMIDOR 2% EYE DROPS,DORZOLAMIDE,1301256588,2010,2 %,"Eye drops, solution",Ophthalmic use,29.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
LOCASONE 0.1% cream,MOMETASONE FUROATE,68-539-14,2014,0.1 %,Cream,Topical,13.50,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LOCASONE 0.1% cream,MOMETASONE FUROATE,67-539-14,2014,0.1 %,Cream,Topical,9.05,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
FLUDARA 50 mg injection,FLUDARABINE PHOSPHATE,2-832-12,2014,50 mg,Powder for solution for injection/infusion,Intravenous use,500.80,BAXTER ONCOLOGY,Germany,Sanofi B.V,Netherlands,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Sanofi Arabia Trading Co. Ltd"
HYDROLYTE ORAL REHYDRATION SOLUTION,ORAL REHYDRATION SALTS,0812246370,2014,,Solution,Oral use,7,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
YONDELIS 1 mg powder for concentrate for solution for infusion,TRABECTEDIN,0711258554,2014,1 mg,Powder for concentrate for solution for infusion,Intravenous use,9479.6,BAXTER ONCOLOGY,Germany,Pharma Mar S.A,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
LIPICURE 40 mg film-coated tablet,ATORVASTATIN CALCIUM,1108257983,2015,40 mg,Film-coated tablet,Oral use,86.90,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DAMMAM PHARMA
LIPICURE 20 mg film-coated tablet,ATORVASTATIN CALCIUM,1108257977,2015,20 mg,Film-coated tablet,Oral use,43.45,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DAMMAM PHARMA
LIPICURE 10 mg film-coated tablet,ATORVASTATIN CALCIUM,1108257996,2015,10 mg,Film-coated tablet,Oral use,43.45,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DAMMAM PHARMA
RENNIE TAB,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",1-949-14,2014,"680,80 mg",Tablet,Oral use,11.15,DELPHARM GAILLARD,France,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
LOCASONE 0.1% cream,MOMETASONE FUROATE,69-539-14,2014,0.1 %,Cream,Topical,22.50,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LOCASONE 0.1% cream,MOMETASONE FUROATE,70-539-14,2014,0.1 %,Cream,Topical,45.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
IRBETEL 150 mg film-coated tablet,IRBESARTAN,306-212-14,2014,150 mg,Film-coated tablet,Oral use,53.55,SANOFI WINTHROP INDUSTRIE,France,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-IRBETEL 162.5 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",308-212-14,2014,"150,12.5 mg",Film-coated tablet,Oral use,53.55,SANOFI WINTHROP INDUSTRIE,France,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-VALISTA,"VALSARTAN, HYDROCHLOROTHIAZIDE",316-212-14,2014,"160,25 mg",Film-coated tablet,Oral use,30.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-VALISTA,"VALSARTAN, HYDROCHLOROTHIAZIDE",315-212-14,2014,"160,12.5 mg",Film-coated tablet,Oral use,30.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-VALISTA,"VALSARTAN, HYDROCHLOROTHIAZIDE",314-212-14,2014,"80,12.5 mg",Film-coated tablet,Oral use,27.8,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VALISTA 320 mg film-coated tablet,VALSARTAN,313-212-14,2014,320 mg,Film-coated tablet,Oral use,39.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VALISTA 160 mg film-coated tablet,VALSARTAN,312-212-14,2014,160 mg,Film-coated tablet,Oral use,30.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VALISTA 80 mg film-coated tablet,VALSARTAN,311-212-14,2014,80 mg,Film-coated tablet,Oral use,27.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
IRBETEL 300 mg film-coated tablet,IRBESARTAN,1208210934,2014,300 mg,Film-coated tablet,Oral use,65.75,SANOFI WINTHROP INDUSTRIE,France,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
XGEVA 120 mg solution for injection,DENOSUMAB,18-475-14,2014,70 mg/ml,Solution for injection,Subcutaneous use,1623.00,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
RENVELA 800 mg film-coated tablet,SEVELAMER CARBONATE,3-832-15,2015,800 mg,Film-coated tablet,Oral use,623.25,GENZYME IRELAND LIMITED,Ireland,GENZYME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
NEUROVIT tablet,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",2810258495,2014,"250,100,250 mg, µg",Coated tablet,Oral use,10.00,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, ZIMMO TRADING ESTABLISHMENT"
CO-IRBETEL 325 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",310-212-14,2014,"300,25 mg",Film-coated tablet,Oral use,65.45,SANOFI WINTHROP INDUSTRIE,France,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-IRBETEL 312.5 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",309-212-14,2014,"300,12.5 mg",Film-coated tablet,Oral use,65.45,SANOFI WINTHROP INDUSTRIE,France,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
STIVARGA 40 mg film-coated tablet,REGORAFENIB,57-4-14,2014,40 mg,Film-coated tablet,Oral use,11620.10,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ZOVIRAX 200MG\5ML SUSP,ACYCLOVIR,1402256900,2003,40 mg/ml,Oral suspension,Oral use,75.30,ASPEN,Germany,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZOVIRAX,ACYCLOVIR,2801256773,1987,5 %,Cream,Topical,25.35,GLAXOWELLCOME,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZOVIRAX,ACYCLOVIR,2801256772,1987,5 %,Cream,Topical,16.3,GLAXOWELLCOME,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZOVIRAX,ACYCLOVIR,0912211445,2003,800 mg,Tablet,Oral use,235.45,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
ZOVIRAX,ACYCLOVIR,0912211444,2003,400 mg,Tablet,Oral use,299.70,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
ZOVIRAX,ACYCLOVIR,0912211447,2002,200 mg,Tablet,Oral use,74.40,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
ZYNOVATE 0.1% CREAM,MOMETASONE FUROATE,14-498-06,2006,0.1 %,Cream,Topical,9.05,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZYNOVATE 0.1% CREAM,MOMETASONE FUROATE,21-498-08,2008,0.1 %,Cream,Topical,12.9,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
AXOR 30 mg film-coated tablet,PAROXETINE,5-801-20,2014,30 mg,Film-coated tablet,Oral use,60.1,RIYADH PHARMA,Saudi Arabia,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AXOR 40 mg film-coated tablet,PAROXETINE,6-801-20,2014,40 mg,Film-coated tablet,Oral use,80.15,RIYADH PHARMA,Saudi Arabia,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AXOR 20 mg film-coated tablet,PAROXETINE,4-801-20,2014,20 mg,Film-coated tablet,Oral use,48.85,RIYADH PHARMA,Saudi Arabia,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ENDOLET 90 mg film-coated tablet,CINACALCET,2201268977,2014,90 mg,Film-coated tablet,Oral use,1589.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ENDOLET 60 mg film-coated tablet,CINACALCET,2201268983,2014,60 mg,Film-coated tablet,Oral use,1300.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ENDOLET 30 mg film-coated tablet,CINACALCET,2201268978,2014,30 mg,Film-coated tablet,Oral use,672.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DESOGEST 0.075 mg tablet,DESOGESTREL,39-498-14,2014,0.075 mg,Tablet,Oral use,14.5,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
ZYRTEC 10MG F.C.TAB,CETIRIZINE HYDROCHLORIDE,0409234100,1994,10 mg,Film-coated tablet,Oral use,16.20,U.C.B.,Switzerland,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZYRTEC 0.1% ORAL SOLN.,CETIRIZINE HYDROCHLORIDE,0409234099,1997,1 mg/ml,Oral solution,Oral use,19.35,Aesica Pharmaceuticals S.r.l.,Italy,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZYNOVATE 0.1% OINTMENT,MOMETASONE FUROATE,22-498-08,2008,0.1 %,Ointment,Topical,12.9,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
ZYNOVATE 0.1% OINTMENT,MOMETASONE FUROATE,13-498-06,2006,0.1 %,Ointment,Topical,9.05,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZYVOX 2 MG/ML SOLUTION FOR INFUSION,LINEZOLID,24-102-22,2012,2 mg/ml,Solution for infusion,Intravenous use,1601.75,HP Halden Pharma AS,Norway,PFIZER INC,United States,Marketed,Prescription,store below 25°c,Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C."
WAFI 100 mg film-coated tablets,SILDENAFIL,297-212-14,2014,100 mg,Film-coated tablet,Oral use,59.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VOTREX 75MG-3ML AMP,DICLOFENAC SODIUM,1102256867,1993,25 mg/ml,Solution for injection,Parenteral use,16.3,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
VOTREX 50 TAB,DICLOFENAC SODIUM,2610222812,1996,50 mg,Tablet,Oral use,10.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
VOMINORE TAB,"PYRIDOXINE, MECLOZINE",0907245515,1985,"50,25 mg",Tablet,Oral use,10,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
VOLTIC -D 50MG DISPERSIBLE TABLETS,DICLOFENAC SODIUM,116-368-09,2009,50 mg,Dispersible tablet,Oral use,26.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
VOLTIC 75 mg solution for injection,DICLOFENAC SODIUM,1506222208,2003,25 mg/ml,Solution for injection,Parenteral use,26.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
VOLTIC 50MG E.C.TABLET,DICLOFENAC SODIUM,1506222201,2004,50 mg,Coated tablet,Oral use,18.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
VOLTAREN RETARD 100MG TAB,DICLOFENAC SODIUM,2204245194,1982,100 mg,modified-release tablet,Oral use,70.45,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VOLTAREN RETARD 100MG TAB,DICLOFENAC SODIUM,2204245193,1982,100 mg,modified-release tablet,Oral use,27.3,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
WAFI 25 mg film-coated tablets,SILDENAFIL,298-212-14,2014,25 mg,Film-coated tablet,Oral use,55.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
WAFI 50 mg film-coated tablets,SILDENAFIL,296-212-14,2014,50 mg,Film-coated tablet,Oral use,59.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
WATER FOR INJECTION,WATER,167-149-98,1998,,Solution for injection/infusion,Intravenous use,8.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR INJECTION,WATER FOR INJECTIONS,2107222329,1993,1 ml,Solution for injection/infusion,Intravenous use,6.30,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VOLTAREN EMULGEL 1%,DICLOFENAC DIETHYLAMINE,5-5448-23,2013,1 %,Gel,Topical,26,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
WATER FOR INJ AMP,WATER,1309234207,1995,1 %,Solution for injection/infusion,Intravenous use,0.90,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR INJ AMP,WATER,3005222091,1995,,Solution for injection/infusion,Intravenous use,1.70,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
WATER FOR INJ AMP,WATER,0109222577,1995,1 %,Solution for injection/infusion,Intravenous use,0.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATENE 0.1% GEL,ADAPALENE,2610222814,2011,0.1 %,Gel,Topical,21.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
WATENE 0.1% CREAM,ADAPALENE,2401233153,2011,0.1 %,Cream,Topical,21.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
WARTEC 0.15% W-W CREAM,PODOPHYLLOTOXIN,8-247-04,2004,0.15 %,Cream,Topical,63.6,STIEFEL LABORATORIES,Ireland,STIEFEL LABORATORIES,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
WATER FOR INJECTION,WATER FOR INJECTIONS,0901233070,1993,100 ml,Solution for injection/infusion,Intravenous use,4.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VOLTAREN EMULGEL 1%,DICLOFENAC DIETHYLAMINE,4-5448-23,1991,1 %,Gel,Topical,17.05,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
VISCOR 20MG F.C. TABLETS,SIMVASTATIN,1011258560,2008,20 mg,Film-coated tablet,Oral use,48.2,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
VISCODRIL EXPECTORANT 100ML SYRUP,"AMMONIUM CHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE",2-498-06,2006,"2.8,27.6 mg/ml",Syrup,Oral use,4.65,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
VISANNE 2MG TABLETS,DIENOGEST,2306257594,2012,2 mg,Tablet,Oral use,209.20,BAYER WEIMAR GmbH UND CO. KG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
VIRUSTAT 200MG TAB,ACYCLOVIR,1-295-98,1998,200 mg,Tablet,Oral use,80.35,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
VIROL,ACYCLOVIR,1405245284,2000,5 %,Cream,Topical,25.35,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
VISIPAQUE,IODIXANOL,29-261-96,1999,270 mg/ml,Solution for injection,Intravenous use,1343,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,27-315-99,1999,270 mg/ml,Solution for injection,Intravenous use,1363.25,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VIVIDRIN 2% EYE DROPS,CROMOGLICATE SODIUM,7-368-00,2000,2 %,"Eye drops, solution",Ophthalmic use,19.2,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
VITANERVE F.C TAB,"NIACINAMIDE, CALCIUM PANTOTHENATE, RIBOFLAVIN, THIAMINE, PYRIDOXINE",1501256624,1998,"20,4,2.267,2.20,2.10 mg",Film-coated tablet,Oral use,22.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VISIPAQUE 320MG/ML SOLUTION FOR INJECTION,IODIXANOL,39-315-12,2012,652 mg/ml,Solution for injection,Intravenous use,1304.80,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VOCORT CREAM,"DIFLUCORTOLONE VALERATE, ISOCONAZOLE NITRATE",1411246221,2003,"0.1,0.1 %",Cream,Topical,8,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
VISIPAQUE 320MG/ML SOLUTION FOR INJECTION,IODIXANOL,38-315-12,2012,652 mg/ml,Solution for injection,Intravenous use,690.00,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE 270MG/ML SOLUTION FOR INJECTION,IODIXANOL,36-315-12,2012,550 mg/ml,Solution for injection,Intravenous use,590.40,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,33-261-96,1999,320 mg/ml,Solution for injection,Intravenous use,1480.15,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,28-315-99,1999,320 mg/ml,Solution for injection,Intravenous use,425.4,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,32-261-96,1999,320 mg/ml,Solution for injection,Intravenous use,886.3,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,31-315-99,1999,320 mg/ml,Solution for injection,Intravenous use,1556.45,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,28-261-96,1999,270 mg/ml,Solution for injection,Intravenous use,764.65,GE HEALTHCARE,Ireland,GE Healthcare AS,Norway,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE,IODIXANOL,24-315-99,1999,270 mg/ml,Solution for injection,Intravenous use,370.8,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VISIPAQUE 270MG/ML SOLUTION FOR INJECTION,IODIXANOL,37-315-12,2012,550 mg/ml,Solution for injection,Intravenous use,1134.8,GE HEALTHCARE,Ireland,GE HEALTHCARE,Ireland,Marketed,Prescription,store below 25°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
WATER FOR INJECTION,WATER,28-149-91,1991,,Solution for injection/infusion,Intravenous use,6.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR INJECTION,WATER FOR INJECTIONS,0109222572,1993,50 ml,Solution for injection/infusion,Intravenous use,3.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
XYLOCAINE DENTAL ADRENALINE SOLU FOR INJ,"LIDOCAINE HYDROCHLORIDE, EPINEPHRINE",0303256972,2009,"20,12.5 µ/ml, mg/m",Solution for injection,Intravenous use,183.10,PIERREL,Italy,PIERREL PHARMA S.P.A,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Biogen Arabia
XOLAMOL EYE DROP,"DORZOLAMIDE, TIMOLOL MALEATE",1008210922,2002,"2,0.5 %","Eye drops, solution",Ophthalmic use,39.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
XYLO-MEPHA 0.1% NASAL SPRAY,XYLOMETAZOLINE HYDROCHLORIDE,42-222-10,2010,0.1 %,Nasal spray,Nasal use,9.65,MERCKLE,Germany,ACINO PHARMA AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
XYLOMET Adult nasal drops,XYLOMETAZOLINE HYDROCHLORIDE,1211246189,2001,0.1 %,Nasal drops,Nasal use,9.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
XYLOMET Peadiatric nasal drops,XYLOMETAZOLINE HYDROCHLORIDE,1211246188,2001,0.05 %,Nasal drops,Nasal use,9.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
XYLONOR SPRAY,"LIDOCAINE HYDROCHLORIDE, CETRIMIDE",1-258-98,1998,"15,0.15 %",Spray,Nasal use,22.6,SEPTODENT,France,SEPTODENT,France,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrauf Ibrahim Batterjee & Bros. Company
ZAMUR 500 MG F- C TABLETS,CEFUROXIME AXETIL,22-222-06,2006,500 mg,Film-coated tablet,Oral use,37.85,Steiner,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
XOLAIR 150MG Powder for injection,OMALIZUMAB,2410222786,2006,150 mg,powder for solution for injection,Subcutaneous use,1796.85,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
XYNTHA 500 I.U. POWDER FOR SOLUTION FOR INJECTION,MOROCTOCOG ALFA,6-752-12,2012,500 IU,Powder and solvent for solution for injection,Intravenous use,831.65,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
XYNTHA 250 I.U. POWDER FOR SOLUTION FOR INJECTION,MOROCTOCOG ALFA,5-752-12,2012,250 IU,Powder and solvent for solution for injection,Intravenous use,415.85,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
XYNTHA 2000 I.U. POWDER FOR SOLUTION FOR INJECTION,MOROCTOCOG ALFA,8-752-12,2012,2000 IU,Powder and solvent for solution for injection,Intravenous use,3325.60,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
XYNTHA 1000 I.U. POWDER FOR SOLUTION FOR INJECTION,MOROCTOCOG ALFA,7-752-12,2012,1000 IU,Powder and solvent for solution for injection,Intravenous use,1662.80,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
XYLOPHIL 2% GEL,LIDOCAINE HYDROCHLORIDE,1411246223,2005,2 %,Gel,Topical,6,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
XYZAL 5MG F.C.TABLET,LEVOCETIRIZINE DIHYDROCHLORIDE,0708257953,2004,5 mg,Film-coated tablet,Oral use,21.60,U.C.B.,Switzerland,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
XOLA OPTHALMIC SOLUTION,DORZOLAMIDE,0702221687,2002,2 %,"Eye drops, solution",Ophthalmic use,37.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
XERACTAN 20 MG SOFT GELATIN CAPSULE,ISOTRETINOIN,2805257489,2011,20 mg,"Capsule, soft",Oral use,106.75,GAP SA PHARMACEUTICAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
XERACTAN 10 MG SOFT GELATIN CAPSULE,ISOTRETINOIN,0206257531,2011,10 mg,"Capsule, soft",Oral use,76.1,GAP SA PHARMACEUTICAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
WINEX 400MG CAP,CEFIXIME,2410211221,2003,400 mg,Capsule,Oral use,67.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
WINEX 200MG CAP,CEFIXIME,2510211228,2003,200 mg,Capsule,Oral use,49.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
WINEX 100MG\5ML ORAL SUSP,CEFIXIME,2605257458,2007,20 mg/ml,Suspension,Oral use,40.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
XALACOM EYE DROP,"TIMOLOL MALEATE, LATANOPROST",2802244997,2003,"5,0.05 mg/ml","Eye drops, solution",Ophthalmic use,33.4,Pfizer Manufacturing Belgium N.V.,Belgium,Viatris Healthcare,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Viatris Arabia Limited"
WAXSOL,DOCUSATE SODIUM,1212246409,2006,0.5 %,Ear drops,Auricular use,6.45,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
WATER FOR IRRIGATION,WATER,3005222092,1996,,Irrigation solution,Topical,12.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR IRRIGATION,WATER,411-149-12,2012,,Irrigation solution,Topical,5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR IRRIGATION,WATER,1106233781,2012,,Irrigation solution,Topical,21,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
WATER FOR IRRIGATION,WATER,3005222105,2012,,Irrigation solution,Topical,12.38,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
XALATAN 50MCG\ML EYE DROP,LATANOPROST,1602256904,2003,0.05 mg/ml,"Eye drops, solution",Ophthalmic use,42.65,Pfizer Manufacturing Belgium N.V.,Belgium,Upjohn SRL,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
XANAX 0.5 MG TABLET,ALPRAZOLAM,2206257591,2011,0.5 mg,Tablet,Oral use,20.2,SANICO,Belgium,Viatris Healthcare,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
XENICAL 120MG CAPSULE,ORLISTAT,13-5444-23,2000,120 mg,Capsule,Oral use,142.65,Delpharm Milano S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Roche Products Saudi Arabia"
XENETIX 350MG IODINE-ML SOLN.FOR INJ,IOBITRIDOL,2711234563,2000,350 mg/ml,Solution for injection,Intravenous use,183.70,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
XENETIX 350MG IODINE-ML SOLN.FOR INJ,IOBITRIDOL,2711234564,2000,350 mg/ml,Solution for injection,Intravenous use,105.35,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
XENETIX 300MG IODINE-ML SOLN FOR INJ.,IOBITRIDOL,2711234562,2000,300 mg/ml,Solution for injection,Intravenous use,99.60,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
XENETIX 300MG IODINE-ML SOLN FOR INJ.,IOBITRIDOL,2711234561,2000,300 mg/ml,Solution for injection,Intravenous use,173.05,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
XELODA 500MG TABLET,Capecitabine,0402244832,2004,500 mg,Film-coated tablet,Oral use,1174.75,EXCELLA GMBH CO. KG,Germany,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
XELODA 150MG TABLET,Capecitabine,250-24-04,2004,150 mg,Film-coated tablet,Oral use,218.3,"PRODUCTOSE ROCHE , S.A. DE C.V",Mexico,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
XANAX 0.25 MG TABLET,ALPRAZOLAM,2108258081,2011,0.25 mg,Tablet,Oral use,12.2,SANICO,Belgium,Viatris Healthcare,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
XEFO 8MG TAB,LORNOXICAM,0306257541,2002,8 mg,Film-coated tablet,Oral use,23.95,TAKEDA,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
XARELTO 20MG FILM COATED TABLET,RIVAROXABAN,54-4-13,2013,20 mg,Film-coated tablet,Oral use,260.95,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
XARELTO 15MG FILM COATED TABLET,RIVAROXABAN,55-4-13,2013,15 mg,Film-coated tablet,Oral use,391.45,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
XARELTO 15MG FILM COATED TABLET,RIVAROXABAN,53-4-13,2013,15 mg,Film-coated tablet,Oral use,260.95,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
XARELTO 10MG FILM COATED TABLET,RIVAROXABAN,0108245716,2011,10 mg,Film-coated tablet,Oral use,88.55,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
XANAX 1 MG TABLET,ALPRAZOLAM,2206257592,2011,1 mg,Tablet,Oral use,13.7,SANICO,Belgium,Viatris Healthcare,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
XEFO 8MG Powder for injection,LORNOXICAM,3006222294,2004,8 mg,Powder and solvent for solution for injection,Intravenous use,18.35,TAKEDA AUSTRIA GmbH,Austria,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
RECOFOL 10MG-ML INJECTION,PROPOFOL,18-205-01,2001,10 mg/ml,Solution for injection,Intravenous use,101.4,BAYER OY,Finland,BAYER OY,Finland,Marketed,Prescription,store below 25°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
SYSTANE LUBRICANT EYE DROPS,"POLYETHYLENE GLYCOL, PROPYLENE GLYCOL",58-115-08,2008,"0.4,0.3 %",Eye drops,Ophthalmic use,31.05,ALCON LABORATORIES,United States,ALCON LABORATORIES,United States,Marketed,OTC,store below 30°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
SYNFLORIX VACCINE,"PNEUMOCOCCAL (STREPTOCOCCUS PNEUMONIAE) POLYSACCHARIDE CONJUGATE (SEROTYPE 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F AND 23F) VACCINE",0109258138,2012,"0.5 µ/ml, ml",Suspension for injection,Subcutaneous use,165.5,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ROACCUTANE 20MG CAPS,ISOTRETINOIN,1208245755,1987,20 mg,Capsule,Oral use,106.75,CATALENT GERMANY EBERBACH GmbH,Germany,ROCHE,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Roche Products Saudi Arabia"
ROACCUTANE 10MG CAPS,ISOTRETINOIN,1208245756,1987,10 mg,Capsule,Oral use,77.50,CATALENT GERMANY EBERBACH GmbH,Germany,ROCHE,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Roche Products Saudi Arabia"
RIZINO 5MG/5ML SYRUP,CETIRIZINE HYDROCHLORIDE,1-590-07,2007,1 mg/ml,Syrup,Oral use,6.6,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
RIVOTRIL TAB 2 MG,CLONAZEPAM,1607257766,1980,2 mg,Tablet,Oral use,19.2,RECIPHARM LEGANES S.L.U,Spain,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Roche Products Saudi Arabia
RIVOTRIL TAB 0.5MG,CLONAZEPAM,1308258019,1980,0.5 mg,Tablet,Oral use,15.3,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Roche Products Saudi Arabia
RIVOTRIL 2.5MG-ML ORAL SOLUTION,CLONAZEPAM,2407222344,2007,2.5 mg/ml,"Oral drops, solution",Oral use,12.1,Delpharm Milano S.r.l,Italy,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Roche Products Saudi Arabia
RITALIN TAB. 10MG,METHYLPHENIDATE,0602244855,1980,10 mg,Tablet,Oral use,29.30,Siegfried Barbera S.L,Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
RISPERDAL CONSTA 50MG I.M VIAL,RISPERIDONE,3107222368,2004,50 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,418.40,ALKEREMES INC.,United States,Janssen Cilag AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
RISPERDAL CONSTA 37.5 MG I.M VIAL,RISPERIDONE,3107222369,2004,37.5 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,350.35,ALKEREMES INC.,United States,Janssen Cilag AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
RISPERDAL CONSTA 25MG I.M VIAL,RISPERIDONE,3107222367,2004,25 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,251.70,ALKEREMES INC.,United States,Janssen Cilag AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
RISPERDAL 4MG TAB,RISPERIDONE,2206222248,1997,4 mg,Tablet,Oral use,64.45,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ROLIP ointment,"BETAMETHASONE DIPROPIONATE, Calcipotriol",2205257445,2014,"500,50 µg",Ointment,Topical,70.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ROFENAC-D 50MG TAB,DICLOFENAC SODIUM,2407222342,1996,50 mg,Tablet,Oral use,29.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ROFENAC GEL 1%,DICLOFENAC SODIUM,1801221603,1997,1 %,Gel,Topical,8.7,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
ROFENAC GEL 1%,DICLOFENAC SODIUM,1508222489,1997,1 %,Gel,Topical,13.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
RISPERDAL 3MG TAB,RISPERIDONE,67-6-97,1997,3 mg,Tablet,Oral use,19.35,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ROFENAC 75MG AMP,DICLOFENAC SODIUM,1801221606,1993,25 mg/ml,Injection,Parenteral use,30.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SPIMACO
ROFENAC 25MG SUPPOSITORES,DICLOFENAC SODIUM,1008257972,2007,25 mg,Suppository,Rectal use,12.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ROFENAC 12.5 MG SUPP,DICLOFENAC SODIUM,94-212-99,1999,12.5 mg,Suppository,Rectal use,9.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ROFENAC 50MG TAB,DICLOFENAC SODIUM,1801221604,1992,50 mg,Coated tablet,Oral use,19.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
RISPERDAL 2MG TAB,RISPERIDONE,2206222249,1997,2 mg,Tablet,Oral use,39.75,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RINGERS INJECATION 500 ML SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",0907245526,2002,"0.85,0.03,0.33 %",Solution,Intravenous use,4.75,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
RINGER SOLUTION I.V INFUSION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",9-303-00,2000,"8.6,0.30,0.33 g/ml",Intravenous infusion,Intravenous use,4.95,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
RIFADIN CAP 300 MG,RIFAMPICIN,0706233772,1983,300 mg,"Capsule, hard",Oral use,64.45,sanofi S.R.L,Italy,sanofi-aventis,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
RIFADIN CAP 150 MG,RIFAMPICIN,0706233773,1983,150 mg,"Capsule, hard",Oral use,35.65,sanofi S.R.L,Italy,sanofi-aventis,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
RINGERS SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",3005222103,2010,"8.6,0.30,0.33 g/ml",Solution,Intravenous use,11.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
RINGERS SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",69-149-93,1993,"8.6,0.30,0.33 g/ml",Solution,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
RISPERDAL 1MG-ML SOLUTION,RISPERIDONE,0505210719,1999,1 mg/ml,Oral solution,Oral use,134.95,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RISPERDAL 1MG TAB,RISPERIDONE,2706222268,1997,1 mg,Tablet,Oral use,7.75,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RISIDONE 1MG/1ML ORAL SOLUTION,RISPERIDONE,2503257160,2010,1 mg/ml,Oral solution,Oral use,170.75,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
Rinofed Cold & Allergy Tablets,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",64-334-02,2002,"60,2.5 mg",Tablet,Oral use,8,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RINOFED,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",0608257949,1999,"6,0.25 mg/ml",Syrup,Oral use,3.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RINOFED PLUS TAB,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",0408257916,2002,"300,50,2.5 mg",Tablet,Oral use,8.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RINOFED PLUS SYRUP,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",56-334-01,2001,"25,5,0.25 mg/ml",Syrup,Oral use,10.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RISPERDAL 2MG TAB,RISPERIDONE,2706222267,1997,2 mg,Tablet,Oral use,13.25,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RINOFED EXPECTORANT SYRUP 100 ML,"GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",0408257919,1999,"20,6,0.25 mg/ml",Syrup,Oral use,7.3,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RINOCLENIL 100MCG-DOSE NASAL SPRAY,BECLOMETHASONE DIPROPIONATE,2805245364,2010,100 µg,Nasal spray,Nasal use,44.95,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
RINGERS SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",165-149-98,1998,"8.6,0.30,0.33 g/ml",Solution,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
RINGERS SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",26-149-91,1991,"8.6,0.3,0.33 g/ml",Solution,Intravenous use,8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
RINGERS SOLUTION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",0108222381,1993,"8.6,0.30,0.33 g/ml",Solution,Intravenous use,9.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
RIFACIN 300 MG CAPS,RIFAMPICIN,1302256894,1998,300 mg,Capsule,Oral use,64.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ROMIN 15 MG-5 ML SYRUP,DEXTROMETHORPHAN,1911246269,2002,3 mg/ml,Syrup,Oral use,11.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RONEM 500MG,MEROPENEM,2608245825,2013,500 mg,Powder for solution for injection/infusion,Parenteral use,344.85,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
SAPOFEN JUNIOR 100MG-5ML SUSPENSION,IBUPROFEN,105-212-99,1999,20 mg/ml,Oral suspension,Oral use,11.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
SAPOFEN JUNIOR 100MG-5ML SUSPENSION,IBUPROFEN,0908222433,1999,20 mg/ml,Oral suspension,Oral use,7.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
SAPOFEN COLD & FLU TABLET,"IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE",0311258532,2001,"200,30 mg",Film-coated tablet,Oral use,9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,SPIMACO
SAPOFEN 600 MG TAB,IBUPROFEN,2307257826,1999,600 mg,Film-coated tablet,Oral use,17.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
SAPOFEN 400MG TAB,IBUPROFEN,3110211251,1994,400 mg,Film-coated tablet,Oral use,13.60,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
SANDOSTATIN LAR 30MG VIAL,OCTREOTIDE ACETATE,2305233703,2010,30 mg,Powder and solvent for suspension for injection,Intramuscular use,5227.65,Novartis Pharmaceutical Manufacturing GmbH,Austria,NOVARTIS,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
SANDOSTATIN 0.1MG-ML AMP,OCTREOTIDE ACETATE,233-11-94,1994,0.1 mg/ml,Solution for injection/infusion,Subcutaneous use,153.85,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
SANCUSO 34.3 mg transdermal patch,GRANISETRON,5-5499-22,2014,34.3 mg,Transdermal patch,Topical,408.35,3M Drug Delivery Systems,United States,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SAMIXON 500MG VIAL + SOLVENT,CEFTRIAXONE,121-172-99,1999,500 mg,Solution for injection,Intravenous use,15.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
SARTAN 100 mg Film coated Tablets,LOSARTAN POTASSIUM,2805257483,2014,100 mg,Film-coated tablet,Oral use,47.50,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
SARTAN 50 mg Film coated Tablets,LOSARTAN POTASSIUM,2905257496,2014,50 mg,Film-coated tablet,Oral use,40.80,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
SELEKTINE,MELOXICAM,2812211519,2009,15 mg,Tablet,Oral use,18,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SELECTA PLUS 5MG-12.5MG F.C. TABLETS,"HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE",1506222196,2009,"12.5,5 mg",Film-coated tablet,Oral use,19.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SELECTA 5MG F.C. TABLETS,BISOPROLOL FUMARATE,0912211443,2009,5 mg,Film-coated tablet,Oral use,27.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SELECTA 2.5MG F.C. TABLETS,BISOPROLOL FUMARATE,1108222462,2009,2.5 mg,Film-coated tablet,Oral use,18.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SELECTA 10MG F.C. TABLETS,BISOPROLOL FUMARATE,1506222200,2009,10 mg,Film-coated tablet,Oral use,33.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SEDACORON 200MG TAB,AMIODARONE,28-355-02,2002,200 mg,Tablet,Oral use,25.35,HAUPT PHARMA AMAREG GmbH,Germany,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
SAMIXON 500MG VIAL,CEFTRIAXONE,120-172-98,1998,500 mg,Solution for injection,Intravenous use,15.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
SEDACORON solution for injection,AMIODARONE,27-355-02,2002,50 mg/ml,Concentrate for solution for infusion,Intravenous use,17.25,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
SECNID 500MG TABLETS,SECNIDAZOLE,0311222869,2010,500 mg,Tablet,Oral use,13,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
SECNEZOLE 500MG TABLETS,SECNIDAZOLE,0909258191,2011,500 mg,Tablet,Oral use,11.7,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Dallah Health Care Company
POLYVALENT SCORPION ANTIVENOM-EQUINE,ANTIVENOM IMMUNOGLOBULIN (AGAINST SCORPION VENOM),0709234149,1998,1 ml,Solution,Intravenous use,1283.75,NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER,Saudi Arabia,NATIONAL ANTIVENOM AND VACCINE PRODUCTION CENTER,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALHAYA MEDICAL CO
SCANDICAINE 3% CARTRIDGE 1.8ML,MEPIVACAINE HYDROCHLORIDE,2503245094,1998,3 %,Solution,Dental use,99.60,SEPTODENT,France,SEPTODENT,France,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, Manarh United Medical, Medical Care Solutions Company"
SCANDICAINE 2% SPECIALE CARTRIDGE,"MEPIVACAINE HYDROCHLORIDE, ADRENALINE",0603245028,1998,"0.020 ,0.010 mg, g/ml",Solution for injection,Dental use,99.60,SEPTODENT,France,SEPTODENT,France,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, Manarh United Medical, Medical Care Solutions Company"
SAXID 4MG TABLET,RISPERIDONE,75-171-11,2011,4 mg,Tablet,Oral use,21.50,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
SAXID 2MG TABLET,RISPERIDONE,76-171-11,2011,2 mg,Tablet,Oral use,13.25,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
SEDACID 20 MG COATED TABLETS,OMEPRAZOLE,3-32-09,2009,20 mg,Gastro-resistant tablet,Oral use,16.9,S.M.B.,Belgium,S.M.B.,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Annhdah Medical Company
RONEM 1GM,MEROPENEM,2608245824,2013,1 g,Powder for solution for injection/infusion,Parenteral use,662.45,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
SAMIXON 1GM VIAL + SOLVENT,CEFTRIAXONE,122-172-99,1999,1 mg,Solution for injection,Intravenous use,30.55,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
SALOFALK 500MG TAB,MESALAZINE,1705222031,2002,500 mg,Gastro-resistant tablet,Oral use,68.30,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
ROXONIN 60MG TABLET,LOXOPROFEN,2307245639,2005,60 mg,Tablet,Oral use,30.4,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ROXIL 500MG CAPS,CEFADROXIL,1601244736,1997,500 mg,"Capsule, hard",Oral use,56.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ROXIL 250MG-5ML SUSP.,CEFADROXIL,1601244735,1996,50 mg/ml,Powder for oral suspension,Oral use,24.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ROTATEQ ORAL VACCINE,"G1 REASSORTANT, G2 REASSORTANT, G3 REASSORTANT, G4 REASSORTANT, PIA 8 REASSORTANT",0309258153,2009,"nlt2.2*106,nlt2.8*106,nlt2.2*106,nlt2.0*106,nlt2.3*106 IU",Oral solution,Oral use,210.8,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
ROTARIX ORAL SUSPENSION VACCINE,"HUMAN ROTAVIRUS, LIVE ATTENUATED VACCINE",0508257935,2013,1000000 CCID50,Oral suspension,Oral use,200.65,GlaxoSmithKline Biologicals,Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,GLAXO SAUDI ARABIA
ROZEX GEL 0.75% W-W,METRONIDAZOLE,0903257012,1998,0.75 %,Gel,Topical,19.75,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
RUMAFEN,DICLOFENAC SODIUM,2310222774,2001,1 %,Gel,Oral use,13.45,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
SALOFALK 4GM-60ML ENEMA,MESALAZINE,1705222030,2002,4 g,Rectal suspension,Rectal use,138.05,CORDEN PHARMA FRIBOURG AG,Switzerland,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SALIPAX 20,FLUOXETINE,0412258740,2001,20 mg,Capsule,Oral use,84.45,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SALIDEX TOPICAL SOLUTION,"DEXAMETHASONE, SALICYLIC ACID",10-407-04,2004,"1.2,20 mg",Solution,Topical,11.4,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SALIDEX OINTMENT,"SALICYLIC ACID, DEXAMETHASONE",11-407-04,2004,"30,1.2 mg",Ointment,Topical,11.4,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SALIBET OINTMENT,"SALICYLIC ACID, BETAMETHASONE DIPROPIONATE",19-368-01,2001,"3,0.05 % (W/W)",Ointment,Topical,14.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SAMIXON 1GM VIAL,CEFTRIAXONE,119-172-98,1998,1 mg,Solution for injection,Intravenous use,30.55,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
RUMAFEN,DICLOFENAC SODIUM,1405245285,2001,50 mg,Coated tablet,Oral use,21.05,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
SALBULASE 2MG-5ML SYRUP,SALBUTAMOL,2811246353,2001,0.4 mg/ml,Syrup,Oral use,6.70,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SELEKTINE,MELOXICAM,2610222820,2009,7.5 mg,Tablet,Oral use,11.95,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
RIFACIN 150MG CAP.,RIFAMPICIN,1302256893,1997,150 mg,Capsule,Oral use,35.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RIDON 4 MG FILM COATED TABLETS,RISPERIDONE,1501256633,2010,4 mg,Film-coated tablet,Oral use,142.30,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
REPADERM GEL,"DIETHYLAMINE SALICYLATE, AESCIN",1905257417,2003,"50,10 mg",Gel,Topical,26.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RENITEC,ENALAPRIL MALEATE,1308258023,1988,5 mg,Tablet,Oral use,37.00,Organon Pharma (UK) Limited,United Kingdom,ORGANON,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
RENITEC,ENALAPRIL MALEATE,1308258022,1988,20 mg,Tablet,Oral use,61.60,Organon Pharma (UK) Limited,United Kingdom,ORGANON,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
RENITEC,ENALAPRIL MALEATE,1308258024,1988,10 mg,Tablet,Oral use,47.60,Organon Pharma (UK) Limited,United Kingdom,ORGANON,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
REMOX 500 MG CAPSULES,AMOXICILLIN,2510222806,1999,500 mg,Capsule,Oral use,43.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REMOX 250MG -5ML SUSPENSION,AMOXICILLIN,2508245821,1999,50 mg/ml,Powder for oral suspension,Oral use,27.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REMOX 250 MG CAPSULES,AMOXICILLIN,2510222804,1999,250 mg,Capsule,Oral use,21.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REMOX 125MG-5ML SUSPENSION,AMOXICILLIN,2510222805,1999,25 mg/ml,Powder for oral suspension,Oral use,13.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REPADERM GEL,"DIETHYLAMINE SALICYLATE, AESCIN",1905257416,2003,"50,10 mg",Gel,Topical,17.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REPARIL 20MG TAB,AESCIN,3-5927-24,1983,20 mg,Coated tablet,Oral use,20.6,Rottapharm|Madaus Group,Germany,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
REPARIL GEL N,"DIETHYLAMINE SALICYLATE, AESCIN",6-5927-25,1987,"5,1 g, %",Gel,Topical,27.9,Rottapharm|Madaus Group,Germany,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
REPARIL GEL N,"DIETHYLAMINE SALICYLATE, AESCIN",5-5927-25,1983,"5,1 g, %",Gel,Topical,18.45,Rottapharm|Madaus Group,Germany,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
RESPAL 4 MG TABLETS,RISPERIDONE,1003257034,2010,4 mg,Tablet,Oral use,21.50,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
RESPAL 2 MG TABLETS,RISPERIDONE,1003257033,2010,2 mg,Tablet,Oral use,13.25,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
RESOVA 20MG FILM COATED TABLETS,ROSUVASTATIN,0501221566,2013,20 mg,Film-coated tablet,Oral use,115.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RESOVA 10MG FILM COATED TABLETS,ROSUVASTATIN,0501221559,2013,10 mg,Film-coated tablet,Oral use,68.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REMINYL 4 MG - ML ORAL SOLUTION,GALANTAMINE,88-6-04,2004,4 mg/ml,Oral solution,Oral use,137.8,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RESCLAR 500MG TABLETS,CLARITHROMYCIN,12-584-10,2010,500 mg,Film-coated tablet,Oral use,36.1,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
RESOLVE PLUS 1.0 CREAM,"MICONAZOLE NITRATE, HYDROCORTISONE",1501244727,2006,"2,1 %",Cream,Topical,13.8,EGO PHARMACEUTICALS,Australia,EGO PHARMACEUTICALS,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
RECORMON PFS 10000IU-0.6ML SOLU. FOR INJ,EPOETIN BETA,1310258415,2008,10000 IU,Solution for injection,Intravenous use,3545.15,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
RECORMON 2000 I.U PREFILLED SYRINGE,EPOETIN BETA,41-91-01,2001,2000 IU,Solution for injection,Intravenous use,811.4,ROCHE DIAGNOSTICS,Germany,ROCHE DIAGNOSTICS,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Saudi Import Company - BANAJA
RECOFOL 20MG-ML I.V. EMULSION FOR INFU,PROPOFOL,22-205-07,2007,20 mg/ml,Emulsion for infusion,Intravenous use,80.05,BAYER OY,Finland,BAYER OY,Finland,Marketed,Prescription,store below 25°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
RECOFOL 10MG-ML INJECTION,PROPOFOL,20-205-01,2001,10 mg/ml,Solution for injection,Intravenous use,101.4,BAYER OY,Finland,BAYER OY,Finland,Marketed,Prescription,store below 25°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
RECORMON PFS 30000IU-0.6ML SOLU. FOR INJ,EPOETIN BETA,229-212-08,2008,30000 IU,Solution for injection,Intravenous use,7090.25,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
RECORMON PFS 4000IU-0.3ML SOLU. FOR INJ,EPOETIN BETA,1310258414,2008,4000 IU,Solution for injection,Intravenous use,1418.05,ROCHE DIAGNOSTICS,Germany,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
REMICADE 100MG VIAL FOR INJ,INFLIXIMAB,1-842-13,2013,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1650,JANSSEN-CILAG,Switzerland,JANSSEN-BIOLOGICS B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
RELESTAT 0.05% EYE DROPS,EPINASTINE HYDROCHLORIDE,0505257335,2008,0.05 %,"Eye drops, solution",Ophthalmic use,26.2,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE LIMITED,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RELENZA 5MG POWDER FOR INHALATION,ZANAMIVIR,0603256991,2004,5 mg,Inhalation powder,Inhalation use,60.95,GLAXOWELLCOME,France,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
RELAXON CAP,"CHLORZOXAZONE, PARACETAMOL",2609245952,2003,"250,300 mg",Capsule,Oral use,27.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
REGAINE TOPICAL SOLN 2%,MINOXIDIL,3-671-22,1989,2 %,Cutaneous solution,Topical,67.65,ASM Aerosol-Service AG,Switzerland,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
REGAINE 5% TOPICAL SOLUTION,MINOXIDIL,4-671-22,2002,5 %,Cutaneous solution,Topical,86.35,ASM Aerosol-Service AG,Switzerland,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
REFRESH TEARS 0.5% EYE DROPS,CARMELLOSE,1311222898,2006,0.5 %,"Eye drops, solution",Ophthalmic use,15.8,ALLERGAN PHARMACEUTICALS LTD,United States,AbbVie Inc,United States,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
REFRESH P.M.EYE OINT.,"WHITE PETROLATUM, Mineral Oil",1003221836,1995,"57.3,42.5 %",Eye ointment,Ophthalmic use,28.20,ALLERGAN PHARMACEUTICALS LTD,United States,AbbVie Inc,United States,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
REFRESH LIQUIGEL 1% EYE DROPS,CARMELLOSE,1605245318,2008,1 %,"Eye drops, solution",Ophthalmic use,15.8,ALLERGAN PHARMACEUTICALS LTD,United States,AbbVie Inc,United States,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
RECTACURE,"TRIBENOSIDE, LIDOCAINE HYDROCHLORIDE",0312258713,2005,"5,2 %",Cream,Rectal use,15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RIASERTAL 100 mg film-coated tablet,SERTRALINE,2209258247,2007,100 mg,Film-coated tablet,Oral use,191.40,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIAPHYLLIN 60MG/5ML SYRUP,THEOPHYLLINE,1407245565,1999,12 mg/ml,Syrup,Oral use,18.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,RIYADH PHARMA
RIAPHAN 15 mg per 5 ml,DEXTROMETHORPHAN,0408222407,1999,3 mg/ml,Syrup,Oral use,9.60,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIANEST,NYSTATIN,1111246182,2000,100000 IU,Cream,Topical,7.5,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIANEST,NYSTATIN,1211234452,2001,100000 IU,Ointment,Topical,10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIANEST,NYSTATIN,1111258573,2004,100000 IU,Oral suspension,Oral use,9.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIALOX,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",9-325-00,2000,"45,40 mg",Effervescent granules,Oral use,7.4,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
RIALOCAINE 2 % Gel,LIDOCAINE HYDROCHLORIDE,2509222636,2001,2 %,Gel,Topical,7.35,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
RIASERTAL 50 mg film-coated tablet,SERTRALINE,2304257273,2007,50 mg,Film-coated tablet,Oral use,95.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIDON 2 MG FILM COATED TABLETS,RISPERIDONE,1501256635,2010,2 mg,Film-coated tablet,Oral use,86.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RIDON 1 MG FILM COATED TABLETS,RISPERIDONE,1501256644,2010,1 mg,Film-coated tablet,Oral use,58.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RIBAVIN 200 MG CAPSULES,RIBAVIRIN,2001268970,2004,200 mg,Capsule,Oral use,590.05,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
RIAZOLIN,NAPHAZOLINE NITRATE,1211246187,2001,0.1 %,Eye drops,Ophthalmic use,16.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIAZOLE,METRONIDAZOLE,1111246183,2001,500 mg,Film-coated tablet,Oral use,19.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIAXINE,BROMHEXINE,1301256590,1999,0.8 mg/ml,Oral solution,Oral use,9.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
RIATROPINE 1%,ATROPINE SULFATE,63-325-02,2002,1 %,Eye drops,Ophthalmic use,12.55,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIATROPINE 0.5%,ATROPINE SULFATE,2807257872,2002,0.5 %,Eye drops,Ophthalmic use,12.55,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIAGESIC,PARACETAMOL,1901256679,2003,100 mg/ml,"Oral drops, solution",Oral use,9.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
RHEUFACT 20MG FILM COATED TABLETS,LEFLUNOMIDE,161-334-12,2012,20 mg,Film-coated tablet,Oral use,152.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RHEUFACT 10MG FILM COATED TABLETS,LEFLUNOMIDE,160-334-12,2012,10 mg,Film-coated tablet,Oral use,105.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RETROVIR CAPS 100MG,ZIDOVUDINE,0701256540,1984,100 mg,Capsule,Oral use,549.20,Delpharm Poznań Spółka Akcyjna,Poland,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
RETROVIR 50MG\5ML ORAL SUSPENTION,ZIDOVUDINE,1706210799,2003,10 mg/ml,Oral suspension,Oral use,53.20,Bora Pharmaceutical Services Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
RETARPEN 1.2MEGA U.WITH SOLVENT,BENZATHINE PENICILLIN,16-116-83,1983,1200000 IU,Powder and solvent for suspension for injection,Intramuscular use,6.45,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
RHINASE 0.05% AQUEOUS NASAL SPRAY,FLUTICASONE PROPIONATE,0206245388,2012,0.05 %,Nasal spray,Nasal use,24.70,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Rhinathiol Promethazine,"PROMETHAZINE, CARBOCISTEINE",2-5827-24,1985,"0.5,2 g",Syrup,Oral use,10.10,sanofi-aventis,France,Opella Healthcare France,France,Marketed,Prescription,store below 25°c,Pharmacy,Opella Arabia Limited Co
RIACHOL EYE OINT.1%,CHLORAMPHENICOL,44-325-01,2001,1 %,Eye ointment,Auricular use,10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
RIACHOL 5% EAR DROPS,CHLORAMPHENICOL,0309234088,2000,5 %,Ear drops,Ophthalmic use,11.4,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,RIYADH PHARMA
RIACHOL 0.5% EYE DROP,CHLORAMPHENICOL,1701244760,2002,0.5 %,Eye drops,Ophthalmic use,7,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,RIYADH PHARMA
RIACAVILOL 6.25 MG TABLET,CARVEDILOL,194-325-07,2007,6.25 mg,Film-coated tablet,Oral use,15.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RIACAVILOL 12.5 MG TAB,CARVEDILOL,195-325-07,2007,12.5 mg,Film-coated tablet,Oral use,24.1,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RHOPHYLAC 300MCG-2ML SOL. FOR INJ.IN PFS,ANTI-D (RH0) IMMUNOGLOBULIN,0606222136,2008,300 µg,Solution for injection,Intravenous use,228.75,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
RHINOCORT AQUA 64MCG NASAL SPRAY,BUDESONIDE,1-5629-21,2004,0.064 mg,"Nasal spray, suspension",Nasal use,50.65,AstraZeneca,Sweden,McNeil Sweden AB,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
RHINATHIOL EXPECTORANT CARBOCISTEINE 5% SYRUP FOR ADULT,CARBOCYSTEINE,1009245902,1985,500 mg/ml,Syrup,Oral use,13.60,Unither Liquid Manufacturing,France,Opella Healthcare France,France,Marketed,Prescription,store below 25°c,Pharmacy,Opella Arabia Limited Co
RHINATHIOL SYRUP 20MG-ML CHILDREN,CARBOCYSTEINE,3-5827-25,1985,20 mg/ml,Syrup,Oral use,9.30,sanofi-aventis,France,Opella Healthcare France,France,Marketed,Prescription,store below 25°c,Pharmacy,Opella Arabia Limited Co
RIACAVILOL 25MG TABLET,CARVEDILOL,196-325-07,2007,25 mg,Film-coated tablet,Oral use,42.5,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
SEPTANEST N 1-200000 DENTAL CARTRIDGE,"EPINEPHRINE, ARTICAINE HYDROCHLORIDE",2407233922,2001,"0.005,40 mg",Solution for injection,Dental use,104.35,SEPTODENT,France,SEPTODENT,France,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, Medical Care Solutions Company"
SEPTANEST SP 1-100000 DENTAL CARTRIDGE,"EPINEPHRINE, ARTICAINE HYDROCHLORIDE",2407233923,2001,"0.01,40 mg",Solution for injection,Dental use,104.35,SEPTODENT,France,SEPTODENT,France,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrauf Ibrahim Batterjee & Bros. Company, Manarh United Medical, Medical Care Solutions Company"
SORTIVA FORTE 100MG F.C. TABLETS,LOSARTAN POTASSIUM,215-212-07,2007,100 mg,Film-coated tablet,Oral use,52.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
SORTIVA 50 MG FILM COATED TABLETS,LOSARTAN POTASSIUM,203-212-04,2004,50 mg,Film-coated tablet,Oral use,45.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
SORTIVA H 50-12.5MG F.C. TABLETS,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",213-212-07,2007,"50,12.5 mg",Film-coated tablet,Oral use,41.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
SORTIVA H 100-25MG F.C. TABLETS,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",214-212-07,2007,"100,25 mg",Film-coated tablet,Oral use,48.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
SORBIT 5 G POWDER PACKET,SORBITOL,6-251-02,2002,5 g,Powder for oral solution,Oral use,4.8,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
SOLVEX 4MG-5ML SYRUP,BROMHEXINE,1911246260,2000,0.8 mg/ml,Syrup,Oral use,6.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
SOLU-MEDROL-INJ. 125 MG,METHYLPREDNISOLONE,2305210742,1987,125 mg,Solution for injection,Intramuscular use,30.35,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SOLU-MEDROL 1000 mg powder and solvent for solution for injection,METHYLPREDNISOLONE,0703221819,1987,1000 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,116.20,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SOLU-MEDROL MOV 40 MG INJ.,METHYLPREDNISOLONE,2305210743,1983,40 mg,Solution for injection,Intramuscular and intravenous use,12.25,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SPASMEX 30MG FILM COATED TABLET,TROSPIUM,1002256863,2010,30 mg,Film-coated tablet,Oral use,115.65,Dr. Pfleger Arzneimittle GmbH,Germany,Dr. Pfleger Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SPASMOPAN 10MG TAB.,HYOSCINE BUTYLBROMIDE,3101221658,1990,10 mg,Tablet,Oral use,7.40,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
STALORAL MITES MAINTENANCE,"ALLERGEN EXTRACT ""MITES MAINTENANCE""",0912246382,2008,"0 mg/ml, IR/",Solution,Sublingual use,568.70,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STALORAL MITES INITIAL,"ALLERGEN EXTRACT ""MITES INITIAL""",0912246381,2008,"0 mg/ml, IR/",Solution,Sublingual use,568.70,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STALORAL ANIMAL ORIGIN INITIAL,"ALLERGEN EXTRACT ""ANIMAL ORIGIN INITIAL""",8-409-08,2008,"0 mg/ml, IR/",Solution,Sublingual use,477.20,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STALORAL ANIMAL ORIGIN MAINTENANCE,"ALLERGEN EXTRACT ""ORIGIN MAINTENANCE""",7-409-08,2008,"0 mg/ml, IR/",Solution,Sublingual use,477.20,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STALEVO 50-12.5-200MG FILM COATED TAB.,"ENTACAPONE, LEVODOPA, CARBIDOPA",2808234062,2006,"200,50,12.5 mg",Film-coated tablet,Oral use,107.10,ORION PHARMA,Finland,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
STALEVO 200-50-200MG FILM COATED TAB.,"ENTACAPONE, LEVODOPA, CARBIDOPA",2204245190,2010,"200,200,50 mg",Film-coated tablet,Oral use,107.10,TISHCON CORPORATION,United States,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
STALEVO 150-37.5-200MG FILM COATED TAB.,"ENTACAPONE, LEVODOPA, CARBIDOPA",2808234061,2006,"200,150,37.5 mg",Film-coated tablet,Oral use,107.10,NUTRA MANUFACTURING INC.,United States,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SOLU-MEDROL INJ. 500 MG.,METHYLPREDNISOLONE,2305210744,1987,500 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,77.15,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
STALEVO 100-25-200MG FILM COATED TAB.,"ENTACAPONE, LEVODOPA, CARBIDOPA",0109222578,2006,"200,100,25 mg",Film-coated tablet,Oral use,107.10,ORION PHARMA,Finland,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SPIRIVA 18MCG HARD CAPSULE,TIOTROPIUM,85-68-04,2004,18 µg,"Inhalation powder, hard capsule",Inhalation use,142.15,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SPEDIFEN 600MG GRANULES,IBUPROFEN,1811211336,2010,600 mg,Granules,Oral use,43.80,ZAMBON SWITZERLAND LTD,Switzerland,ZAMBON SWITZERLAND LTD,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SPEDIFEN 400MG GRANULES,IBUPROFEN,2-462-10,2010,400 mg,Granules,Oral use,7.85,ZAMBON SWITZERLAND LTD,Switzerland,ZAMBON SWITZERLAND LTD,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SPASMOTALIN 100MG TAB,MEBEVERINE HYDROCHLORIDE,5-216-95,1995,100 mg,Tablet,Oral use,11.75,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SPASMOPAN 20MG AMP.,HYOSCINE BUTYLBROMIDE,1203257037,1990,20 mg/ml,Injection,Intravenous use,12.70,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
STALORAL MOULDS INITIAL,ALLERGEN EXTRACT -MOULDS INITIAL,6-409-08,2008,"0 mg/ml, IR/",Solution,Sublingual use,477.20,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
SOLU CORTEF Act-O-Vial 100 mg powder and solvent for solution for injection,HYDROCORTISONE SODIUM SUCCINATE,1306210786,1983,100 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,18.65,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SODIUM CHLORIDE 5.85% AMP,SODIUM CHLORIDE,144-149-98,1998,5.85 %,Solution,Parenteral use,1.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 5.85% AMP,SODIUM CHLORIDE,143-149-98,1998,5.85 %,Solution,Parenteral use,1.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 018% I.V INFUSION,SODIUM CHLORIDE,274-149-03,2003,0.18 %,Intravenous infusion,Parenteral use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 018% I.V INFUSION,SODIUM CHLORIDE,273-149-03,2003,0.18 %,Intravenous infusion,Parenteral use,5.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION SOLN,SODIUM CHLORIDE,1-303-99,1999,0.9 %,Solution for infusion,Parenteral use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,AL EWAN MEDICAL COMPANY
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,3005222088,1992,0.9 %,Intravenous infusion,Parenteral use,6.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,293-149-04,2004,0.9 %,Intravenous infusion,Parenteral use,2.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,295-149-04,2004,0.9 %,Intravenous infusion,Parenteral use,3.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,2107222337,2009,0.9 %,Intravenous infusion,Parenteral use,4.70,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,2911211394,2009,0.9 %,Intravenous infusion,Parenteral use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 5.85% AMP,SODIUM CHLORIDE,142-149-98,1998,5.85 %,Solution,Parenteral use,1.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE IRRIGATION 0.9%,SODIUM CHLORIDE,0801256556,2007,0.9 %,Irrigation solution,Topical,16.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE IRRIGATION 0.9%,SODIUM CHLORIDE,1203245039,2007,0.9 %,Irrigation solution,Topical,23.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SODIUM CHLORIDE IRRIGATION 0.9%,SODIUM CHLORIDE,1203245042,2007,0.9 %,Irrigation solution,Topical,26.65,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SOLPADEINE SOLUBLE TABLET,"PARACETAMOL, CAFFEINE CITRATE, CODEINE",1806257575,2013,"500,30,8 mg",Soluble tablet,Oral use,13.15,GlaxoSmithKline Dungarvan Ltd,Ireland,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SOLOTIK 50MG F-C TABLETS,SERTRALINE,180-172-14,2014,50 mg,Film-coated tablet,Oral use,46.55,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SOLOTIK 50MG F-C TABLETS,SERTRALINE,170-172-10,2010,50 mg,Film-coated tablet,Oral use,20.5,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SOLOTIK 100MG F-C TABLETS,SERTRALINE,2407222345,2014,100 mg,Film-coated tablet,Oral use,67.20,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SOLOTIK 100MG F-C TABLETS,SERTRALINE,169-172-10,2010,100 mg,Film-coated tablet,Oral use,33.6,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SOJOURN 100% VAPOUR LIQUID FOR INHALATION,SEVOFLURANE,288-186-14,2014,100 %,"Inhalation vapour, liquid",Inhalation use,318.05,PIRAMAL CRITICAL CARE INC,United States,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SOLU CORTEF AOV 250 mg powder and solvent for solution for injection,HYDROCORTISONE SODIUM SUCCINATE,0508245727,1987,250 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,16.2,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SODIUM CHLORIED 7.5 % W- V SOLUTION,SODIUM CHLORIDE,264-149-02,2002,7.5 %,Solution for infusion,Parenteral use,13.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIED 7.5 % W- V SOLUTION,SODIUM CHLORIDE,263-149-02,2002,7.5 %,Solution for infusion,Parenteral use,8.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIED 7.5 % W- V SOLUTION,SODIUM CHLORIDE,262-149-02,2002,7.5 %,Solution for infusion,Parenteral use,18.90,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIED 10 % W- V SOLUTION,SODIUM CHLORIDE,253-149-02,2002,10 %,Solution,Parenteral use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIED 10 % W- V SOLUTION,SODIUM CHLORIDE,252-149-02,2002,10 %,Solution,Parenteral use,9.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIED 10 % W- V SOLUTION,SODIUM CHLORIDE,266-149-02,2002,10 %,Solution,Parenteral use,16.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE0.225% & GLUCOSE 5% I.V,"DEXTROSE, SODIUM CHLORIDE",7-303-00,2000,"5,0.225 g",Solution,Intravenous use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
SODIUM LACTATE 1-6 MOLAR INFUSION,SODIUM LACTATE,38-149-92,1992,18.5 g,Solution,Intravenous use,9.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,2107222338,2009,0.9 %,Intravenous infusion,Parenteral use,4.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
STALORAL MOULDS MAINTENANCE,ALLERGEN EXTRACT- MOULDS MAINTENANCE,2401221633,2008,"0 mg/ml, IR/",Solution,Sublingual use,477.20,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STALORAL POLLENS MAINTENANCE,ALLERGENIC EXTRACTS,1-409-08,2008,300 IR/ml,Solution,Sublingual use,568.70,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
SUFENTA FORTE AMP 50MCG-ML,SUFENTANIL,5-5592-21,1997,50 µ/ml,Solution for injection,Parenteral use,191.65,PIRAMAL CRITICAL CARE INC,United States,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
SUFENTA AMP 5MCG-ML,SUFENTANIL,2-5592-21,1997,5 µ/ml,Solution for injection,Parenteral use,66.7,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
SUFENTA AMP 5MCG-ML,SUFENTANIL,1-5592-21,1997,5 µ/ml,Solution for injection,Parenteral use,18.8,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
STUGERON 25MG TAB,CINNARIZINE,93-6-03,2003,25 mg,Tablet,Oral use,10.85,LUSOMEDICAMENTA,Portugal,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
STRAVIS 50MG FILM COATED TABLETS,LOSARTAN POTASSIUM,2705245352,2014,50 mg,Film-coated tablet,Oral use,40.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
SUPRAX 100 SUSP,CEFIXIME,384-334-24,1993,20 mg/ml,Oral suspension,Oral use,44.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SUPRAX 200 CAPS,CEFIXIME,1911246266,1992,200 mg,Capsule,Oral use,48.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
SUPRAX 400 CAPS,CEFIXIME,1911246273,1992,400 mg,Capsule,Oral use,72.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
SYMBICORT TURBUHALER,"BUDESONIDE, FORMTEROL",1704233555,2002,"160,4.5 µg",Inhalation powder,Inhalation use,169.80,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SYMBICORT 80 MCG/4.5 MCG TURBOHALER,"BUDESONIDE, FORMTEROL",86-15-12,2012,"80,4.5 µg",Inhalation powder,Inhalation use,116.70,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SUTENT 50 MG CAPSULE,SUNITINIB,1703257084,2010,50 mg,"Capsule, hard",Oral use,15707.95,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
SUTENT 12.5 MG CAPSULE,SUNITINIB,1703257083,2010,12.5 mg,"Capsule, hard",Oral use,4124.90,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
SURECURE 0.1% TOPICAL GEL,ADAPALENE,1610234341,2008,0.1 %,Gel,Topical,18.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SUPRAZOLE 200 MG TABLETS,METRONIDAZOLE,1203245040,2004,200 mg,Tablet,Oral use,6.65,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SUPRAX D 400MG TABLET,CEFIXIME,1911246257,2008,400 mg,Dispersible tablet,Oral use,72.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
SUTENT 25 MG CAPSULE,SUNITINIB,1703257085,2010,25 mg,"Capsule, hard",Oral use,8029.25,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
STALORAL POLLENS INITIAL,ALLERGEN EXTRACT - POLLENS INITIAL,2-409-08,2008,"0 mg/ml, IR/",Solution,Sublingual use,568.70,STALLERGENS,France,STALLERGENS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
STELAZINE 5MG TABLETS,TRIFLUOPERAZINE,2-522-09,2009,5 mg,Tablet,Oral use,15.4,BRISTOL LABORATORIES,United Kingdom,GOLDSHIELD PHARMACEUTICAL LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
STELAZINE 1MG TABLETS,TRIFLUOPERAZINE,1-522-09,2009,1 mg,Tablet,Oral use,10.65,BRISTOL LABORATORIES,United Kingdom,GOLDSHIELD PHARMACEUTICAL LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
STELARA 90mg/1ml SOLUTION FOR INJECTION,USTEKINUMAB,1511222905,2013,90 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,8882.65,BAXTER PHARMACEUTICAL SOLUTION LLC,United States,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
STELARA 45MG/0.5ML SOLUTION FOR INJECTION,USTEKINUMAB,1711222906,2013,90 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,8882.65,BAXTER PHARMACEUTICAL SOLUTION LLC,United States,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
STANDACILLIN 500MG INJ WITH SOLVENT,AMPICILLIN,40-116-88,1988,500 mg,Powder and solvent for solution for injection/infusion,Intravenous use,7.75,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
STANDACILLIN 1G VIAL WITH SOLVENT,AMPICILLIN,41-116-88,1988,1 g,Powder and solvent for solution for injection/infusion,Intravenous use,14.65,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
STERILE WATER FOR INJ 500 ML,WATER,0907245520,2001,NA,Injection,Intravenous use,5,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
STIEPROX 1.5% SHAMPOO,CICLOPIROX OLAMINE,9-247-06,2006,1.5 %,Shampoo,Topical,28.85,STIEFEL LABORATORIES,Ireland,STIEFEL LABORATORIES,Ireland,Marketed,OTC,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
STERILE WATER FOR IRRIGATION,STERILIZED APYROGENIC DISTILLED WATER,0907245519,2007,,Injection,Topical,15.85,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
STERILE WATER FOR IRRIGATION,STERILIZED APYROGENIC DISTILLED WATER,1203245044,2002,,Injection,Topical,5,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
STERILE WATER FOR IRRIGATION,STERILIZED APYROGENIC DISTILLED WATER,1802244935,2007,,Injection,Topical,21.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
STERILE WATER FOR IRRIGATION,STERILIZED APYROGENIC DISTILLED WATER,1802244933,2007,,Injection,Topical,9.50,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,1210222712,2009,0.9 %,Intravenous infusion,Parenteral use,3.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,2911211392,2009,0.9 %,Intravenous infusion,Parenteral use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,294-149-04,2004,0.9 %,Intravenous infusion,Parenteral use,3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SMOFKABIVEN PERIPHERAL EMULSION for infusion,"TRYPTOPHAN, LYSINE, GLUCOSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, CALCIUM CHLORIDE, VALINE, TYROSINE, THREONINE, GLYCINE, SERINE, PROLINE, PHENYLALANINE, METHIONINE, LEUCINE, ISOLEUCINE5, HISTIDINE, TAURINE, ARGININE, ALANINE, FISH OIL, OLIVE OIL, TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL, ZINC SULPHATE, SODIUM GLYCEROPHOSPHATE HYDRATED",1007257731,2014,"2,6.6 - 9.3,130 - 143,3.4 - 5.62,4.48,1.2 - 2.47,0.74 - 0.56,6.4,0.4,4.4,11,6.5,11.2,5.1,4.3,7.4,5,3,1,12,14,30,50,60,60,0.023 - 0.01,4.18 g",Emulsion for infusion,Intravenous use,219.45,FRESENIUS KABI,Sweden,FRESENIUS KABI,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SINEMET 25-250MG TABLETS,"LEVODOPA, CARBIDOPA",1205222017,2010,"250,25 mg",Tablet,Oral use,44.25,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
SINATEN 100000 I.U VAGINAL TAB.,NYSTATIN,2102221750,2001,100000 IU,Vaginal tablet,Vaginal use,28.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SIMVAGEN 40 mg film-coated tablet,SIMVASTATIN,154-325-04,2004,40 mg,Film-coated tablet,Oral use,66.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
SIMVAGEN 20 mg film-coated tablet,SIMVASTATIN,153-325-04,2004,20 mg,Film-coated tablet,Oral use,66.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
SIMVAGEN 10 mg film-coated tablet,SIMVASTATIN,152-325-04,2004,10 mg,Film-coated tablet,Oral use,66.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
SIMVA 40 MG COATED TABLET,SIMVASTATIN,2901256778,2007,40 mg,Film-coated tablet,Oral use,65.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SIMVA 20 MG COATED TABLET,SIMVASTATIN,2901256777,2007,20 mg,Film-coated tablet,Oral use,56.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SMOFKABIVEN PERIPHERAL EMULSION for infusion,"GLUCOSE, SOYA OIL, TRIGLYCERIDES MEDIUM CHAIN, OLIVE OIL, FISH OIL, ALANINE, ARGININE, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, TAURINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, CALCIUM CHLORIDE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, SODIUM ACETATE, LYSINE, ZINC SULPHATE, SODIUM GLYCEROPHOSPHATE HYDRATED",1007257730,2014,"130 - 143,60,60,50,30,14,12,11,3,5,7.4,4.3,5.1,11.2,6.5,1,4.4,2,0.40,6.4,0.56 - 0.74,1.2 - 2.47,4.48,3.4 - 5.62,6.6 - 9.3,0.023 - 0.01,4.18 g",Emulsion for infusion,Intravenous use,166.90,FRESENIUS KABI,Sweden,FRESENIUS KABI,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SMOFKABIVEN PERIPHERAL EMULSION for infusion,"GLUCOSE, SOYA OIL, TRIGLYCERIDES MEDIUM CHAIN, OLIVE OIL, FISH OIL, ALANINE, ARGININE, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, TAURINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, CALCIUM CHLORIDE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, SODIUM ACETATE, LYSINE, ZINC SULPHATE, SODIUM GLYCEROPHOSPHATE HYDRATED",4-734-14,2014,"130 - 143,60,60,50,30,14,12,11,3,5,7.4,4.3,5.1,11.2,6.5,1.0,4.4,2.0,0.40,6.4,0.56 - 0.74,1.2 - 2.47,4.48,3.4 - 5.62,6.6 - 9.3,0.023 - 0.01,4.18 g",Emulsion for infusion,Intravenous use,157.95,FRESENIUS KABI,Sweden,FRESENIUS KABI,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SNAFI 20MG TAB,TADALAFIL,2307257841,2003,20 mg,Film-coated tablet,Oral use,88.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
SOD. CHLORIDE 3% I.V SOLUTION,SODIUM CHLORIDE,1311246220,1999,3 %,Solution,Parenteral use,12.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 3% I.V INJECTION AMP,SODIUM CHLORIDE,244-149-02,2002,3 %,Solution,Parenteral use,1.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 3% I.V INJECTION AMP,SODIUM CHLORIDE,245-149-02,2002,3 %,Solution,Parenteral use,6.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 3% I.V INJECTION AMP,SODIUM CHLORIDE,1108222463,1999,3 %,Solution,Parenteral use,5.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 23.4% SOLUTION,SODIUM CHLORIDE,2107222334,2008,23.4 %,Solution,Parenteral use,11.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 20% SOLUTION,SODIUM CHLORIDE,369-149-08,2008,20 %,Solution,Parenteral use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 14.61% SOLU. FOR INJECTION,SODIUM CHLORIDE,2107222331,2008,14.61 %,Solution,Parenteral use,12.30,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SIMVA 10 MG COATED TABLET,SIMVASTATIN,2901256776,2007,10 mg,Film-coated tablet,Oral use,56.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SOD. CHLORIDE 0.9% FOR IRRIGATION,SODIUM CHLORIDE,408-149-12,2012,0.9 %,Irrigation solution,Intravenous use,8.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.9% FOR IRRIGATION,SODIUM CHLORIDE,3005222104,2012,0.9 %,Irrigation solution,Intravenous use,16,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.45%+DEXTROSE 5% I.V INF.,"DEXTROSE, SODIUM CHLORIDE",0907245521,2004,"5,0.45 %",Solution,Intravenous use,4.95,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SOD. CHLORIDE 0.225% I.V SOLUTION,SODIUM CHLORIDE,188-149-99,1999,0.225 %,Intravenous infusion,Parenteral use,6.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.225% I.V SOLUTION,SODIUM CHLORIDE,187-149-99,1999,0.225 %,Intravenous infusion,Parenteral use,5.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.225% I.V SOLUTION,SODIUM CHLORIDE,251-149-02,2002,0.225 %,Intravenous infusion,Parenteral use,5.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.225% I.V SOLUTION,SODIUM CHLORIDE,0108222385,2002,0.225 %,Intravenous infusion,Parenteral use,6.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.225% I.V SOLUTION,SODIUM CHLORIDE,249-149-02,2002,0.225 %,Intravenous infusion,Parenteral use,5.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 0.9% FOR IRRIGATION,SODIUM CHLORIDE,2107222335,2012,0.9 %,Irrigation solution,Intravenous use,26.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOD. CHLORIDE 30% SOLUTION,SODIUM CHLORIDE,371-149-08,2008,30 %,Solution,Parenteral use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SIMCOR 20 MG F-C TABLETS,SIMVASTATIN,36-399-08,2008,20 mg,Film-coated tablet,Oral use,48.2,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
SEROQUEL 300MG F-C TABS,QUETIAPINE,8-5641-22,2006,300 mg,Film-coated tablet,Oral use,165.5,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL 25 MG TAB,QUETIAPINE,5-5641-22,2001,25 mg,Film-coated tablet,Oral use,32.25,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL 200 MG TAB,QUETIAPINE,7-5641-22,2001,200 mg,Film-coated tablet,Oral use,220.65,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL 100 MG TAB,QUETIAPINE,6-5641-22,2001,100 mg,Film-coated tablet,Oral use,110.3,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SERMION TAB 5MG,NICERGOLINE,25-92-85,1985,5 mg,Coated tablet,Oral use,16.1,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SERMION 10MG TAB,NICERGOLINE,40-92-90,1990,10 mg,Coated tablet,Oral use,31.6,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
SERETIDE EVOHALER 25/50,"FLUTICASONE PROPIONATE, SALMETEROL",0603233325,2005,"50,25 µg","Pressurised inhalation, suspension",Inhalation use,79.90,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
SERETIDE EVOHALER,"FLUTICASONE PROPIONATE, SALMETEROL",0603233326,2005,"250,25 µg","Pressurised inhalation, suspension",Inhalation use,148.85,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
SERETIDE EVOHALER,"FLUTICASONE PROPIONATE, SALMETEROL",0603233327,2005,"125,25 µg","Pressurised inhalation, suspension",Inhalation use,112.80,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
SERETIDE DISKUS 50\500 MCG,"FLUTICASONE PROPIONATE, SALMETEROL",1411211312,2013,"500,50 µg",Inhalation powder,Inhalation use,166.75,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
SERETIDE DISKUS,"FLUTICASONE PROPIONATE, SALMETEROL",1411211314,2013,"250,50 µg",Inhalation powder,Inhalation use,126.45,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
SERETIDE DISKUS,"FLUTICASONE PROPIONATE, SALMETEROL",1411211313,2013,"100,50 µg",Inhalation powder,Inhalation use,89.60,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
SEROQUEL XL 200MG FILM COATED TABLET,QUETIAPINE,2-5641-21,2012,200 mg,Film-coated tablet,Oral use,132.35,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL XL 300MG FILM COATED TABLET,QUETIAPINE,1512258791,2012,300 mg,Film-coated tablet,Oral use,185.55,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL XL 400MG FILM COATED TABLET,QUETIAPINE,1512258792,2012,400 mg,Film-coated tablet,Oral use,231.30,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SEROQUEL XL 50MG FILM COATED TABLET,QUETIAPINE,1512258793,2012,50 mg,Film-coated tablet,Oral use,51.4,AstraZeneca,United Kingdom,Luye Pharma Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SIFROL 0.7MG (EQU. 1.00MG) TAB,PRAMIPEXOLE,2805257479,2000,700 mg,Tablet,Oral use,188.75,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SIFROL 0.18 MG (EQU.0.25MG) TAB,PRAMIPEXOLE,81-68-00,2000,180 mg,Tablet,Oral use,57.70,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SEVIKAR 40/5MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",47-370-13,2013,"40,5 mg",Film-coated tablet,Oral use,92.35,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SEVIKAR 40/10MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",48-370-13,2013,"40,10 mg",Film-coated tablet,Oral use,99.05,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SIMCOR 10 MG F-C TABLETS,SIMVASTATIN,35-399-08,2008,10 mg,Film-coated tablet,Oral use,43.55,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
SEVIKAR 20/5MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",49-370-13,2013,"20,5 mg",Film-coated tablet,Oral use,70.60,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SETRAL 50MG F.C. TABLETS,SERTRALINE,1709245919,2006,50 mg,Film-coated tablet,Oral use,54.15,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
SETRAL 50MG F.C. TABLETS,SERTRALINE,1109245903,2006,50 mg,Film-coated tablet,Oral use,18.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
SETRAL 100MG F.C. TABLETS,SERTRALINE,0907245513,2006,100 mg,Film-coated tablet,Oral use,27.2,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
SEROXAT CR 25MG TABLETS,PAROXETINE,2312200356,2011,25 mg,Tablet,Oral use,82.30,Bora Pharmaceutical Services Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
SEROXAT CR 12.5MG TABLETS,PAROXETINE,2312200355,2011,12.5 mg,Tablet,Oral use,61.90,Bora Pharmaceutical Services Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
SEROXAT 20MG TABLETS,PAROXETINE,2306210824,2011,20 mg,Tablet,Oral use,60.30,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
SEVIKAR 20/10MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",50-370-13,2013,"20,10 mg",Film-coated tablet,Oral use,86.90,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SOD.CHLORIDE 0.18%+DEXTROSE 5 % INFUSION,"DEXTROSE, SODIUM CHLORIDE",0907245523,2003,"5,0.18 %",Solution for injection/infusion,Parenteral use,4.75,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORID 5% I.V SOLUTION,SODIUM CHLORIDE,215-149-00,2000,5 %,Solution,Parenteral use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 840GM POWDER,SODIUM BICARBONATE,222-149-01,2001,840 g,Powder for concentrate for solution for haemodialysis,Parenteral use,9.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 8.4% INJ.,SODIUM BICARBONATE,1703257081,1990,8.4 %,Solution for injection,Intravenous use,7.85,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
SODIUM BICARBONATE 8.4% INJ.,SODIUM BICARBONATE,1311246213,1995,8.4 %,Solution for injection,Intravenous use,8.2,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
SODIUM BICARBONATE 8.4% INF.,SODIUM BICARBONATE,1108222476,1991,8.4 %,Solution for infusion,Intravenous use,16.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 8.4% INF.,SODIUM BICARBONATE,1309234208,1993,8.4 %,Solution for infusion,Intravenous use,8.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 7.5% I.V SOLUTION,SODIUM BICARBONATE,278-149-03,2003,7.5 %,Solution,Intravenous use,5.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 7.5% I.V SOLUTION,SODIUM BICARBONATE,279-149-03,2003,7.5 %,Solution,Intravenous use,6.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 7.5% I.V SOLUTION,SODIUM BICARBONATE,280-149-03,2003,7.5 %,Solution,Intravenous use,10.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 7.5% I.V SOLUTION,SODIUM BICARBONATE,277-149-03,2003,7.5 %,Solution,Intravenous use,5.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM BICARBONATE 650GM POWDER,SODIUM BICARBONATE,221-149-01,2001,650 g,Powder for concentrate for solution for haemodialysis,Parenteral use,9.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
5%W/V SODIUM BICARBONATE intravenous infusion B.P,SODIUM BICARBONATE,1210222711,1991,5 %,Solution for infusion,Intravenous use,10.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORID 5% I.V SOLUTION,SODIUM CHLORIDE,214-149-00,2000,5 %,Solution,Parenteral use,8.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE .9% + DEXTROSE 5%,"DEXTROSE, SODIUM CHLORIDE",2204257270,2002,"5,0.9 %",Intravenous infusion,Intravenous use,5.15,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE 0.18%-GLUCOSE 4.3%,"DEXTROSE, SODIUM CHLORIDE",2-303-99,1999,"4.3,0.18 %",Solution,Parenteral use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,AL EWAN MEDICAL COMPANY
SODIUM CHLORIDE 0.18%I.V SOLUTION,SODIUM CHLORIDE,186-149-99,1999,0.18 %,Intravenous infusion,Parenteral use,5.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,157-149-98,1998,0.9 %,Intravenous infusion,Parenteral use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,156-149-98,1998,0.9 %,Intravenous infusion,Parenteral use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% INFUSION,SODIUM CHLORIDE,1705222033,2009,0.9 %,Intravenous infusion,Intravenous use,8.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.9% I.V INFUSION,SODIUM CHLORIDE,0907245529,2000,0.9 %,Intravenous infusion,Parenteral use,5.2,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE 0.9% & GLUCOSE 5% I.V,"DEXTROSE, SODIUM CHLORIDE",5-303-00,2000,"5,0.9 %",Solution for infusion,Intravenous use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
SODIUM CHLORIDE 0.45% W-V I.V INFUSION,SODIUM CHLORIDE,0907245528,2004,0.45 %,Solution,Parenteral use,5.7,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE 0.45% INF.,SODIUM CHLORIDE,155-149-98,1998,0.45 %,Intravenous infusion,Parenteral use,5.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% INF.,SODIUM CHLORIDE,171-149-99,1999,0.45 %,Intravenous infusion,Parenteral use,5.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% INF.,SODIUM CHLORIDE,173-149-99,1999,0.45 %,Intravenous infusion,Parenteral use,7.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% INF.,SODIUM CHLORIDE,0901233074,1999,0.45 %,Intravenous infusion,Parenteral use,7.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% AND GLUCOSE 5% I.V,"DEXTROSE, SODIUM CHLORIDE",8-303-00,2000,"5,0.45 %",Solution,Intravenous use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
SODIUM CHLORIDE 0.225&+DEXTROSE5%I.V INF,"DEXTROSE, SODIUM CHLORIDE",0907245527,2007,"5,0.225 %",Intravenous infusion,Intravenous use,4.1,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
SODIUM CHLORIDE 0.18%I.V SOLUTION,SODIUM CHLORIDE,185-149-99,1999,0.18 %,Intravenous infusion,Parenteral use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% INF.,SODIUM CHLORIDE,16-149-91,1991,0.45 %,Intravenous infusion,Parenteral use,6.9,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM ACETATE F.T.V.40mEq,ACETATE SODIUM,3012246505,1989,2 mEq/ml,Injection,Intravenous use,8.05,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
SOD.CHLORIDE 0.9% FOR IRRIGATION,SODIUM CHLORIDE,22-149-91,1991,0.9 %,Irrigation solution,Topical,9.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.9% w/v SODIUM CHLORIDE for irrigation,SODIUM CHLORIDE,3005222095,2004,0.9 %,Irrigation solution,Topical,23.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
LACTATED RINGERS INJECTION USP 500 ML,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",1203245043,2002,"0.598,0.03,0.02,0.31 %",Solution for injection,Intravenous use,5.45,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CLIMEN TABLETS,"CYPROTERONE ACETATE, ESTRADIOL",3009245993,2013,"2,1 mg",Coated tablet,Oral use,23.7,BAYER WEIMAR GmbH UND CO. KG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
CLENIL FORTE 250MCG PUFF METERED INHALER,BECLOMETHASONE DIPROPIONATE,1504257231,2001,250 µg,"Pressurised inhalation, solution",Inhalation use,73.60,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CLAVODAR 625GM FILM COATED TABLET,"AMOXICILLIN, CLAVULANIC ACID",0801256563,2011,"500,125 mg",Film-coated tablet,Oral use,24.80,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CLAVODAR 457MG/5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",93-124-10,2010,"80,11.4 mg/ml",Suspension,Oral use,16.5,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLAVODAR 1GM F.C. TABLETS,"AMOXICILLIN, CLAVULANIC ACID",0402256820,2010,"875,125 mg",Tablet,Oral use,44.60,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLARIXIN 500 MG TABLET,CLARITHROMYCIN,0504210662,2005,500 mg,Film-coated tablet,Oral use,51.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CLARITT XL 500MG EXTENDED RELEASE TABLETS,CLARITHROMYCIN,2410211222,2011,500 mg,Extended-release tablet,Oral use,72.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLINDASOL 10MG-ML Solution,CLINDAMYCIN PHOSPHATE,8-609-10,2010,10 %,Solution,Topical,27.1,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
CLIOCORT,"HYDROCORTISONE ACETATE, CLIOQUINOL",1405245283,2000,"1,3 %",Rectal ointment,Topical,16.75,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
CLOPIXOL-ACUPHASE 50MG-ML OILY AMP,ZUCLOPENTHIXOL ACETATE,25-136-93,1993,50 mg/ml,Injection,Intramuscular use,8.05,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CLOPIXOL-ACUPHASE 50MG-ML OILY AMP,ZUCLOPENTHIXOL ACETATE,27-136-94,1994,50 mg/ml,Injection,Intramuscular use,16.1,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CLARITT XL 500 MG EXTENDED RELEASE TAB.,CLARITHROMYCIN,2410211223,2005,500 mg,Extended-release tablet,Oral use,48.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLOPIXOL DEPOT INJ 500MG-ML OILY AMP,ZUCLOPENTHIXOL DECANOATE,0503245017,1993,500 mg/ml,Injection,Intramuscular use,231.95,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CLOFAST 1% GEL,DICLOFENAC SODIUM,1310258401,2006,1 %,Gel,Topical,3.5,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CLODERM 0.05% OINTMENT,CLOBETASOL PROPIONATE,4-271-98,1998,0.05 %,Ointment,Topical,5.95,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CLODERM 0.05% CREAM,CLOBETASOL PROPIONATE,5-271-98,1998,0.05 %,Cream,Topical,5.95,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CLOBESON,CLOBETASONE BUTYRATE,2411211355,2010,0.05 %,Cream,Topical,4.5,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CLOBEDERM,CLOBETASOL PROPIONATE,1109234165,2004,0.05 %,Cream,Topical,7.55,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
CLOPIXOL DEPOT INJ 200MG-ML,ZUCLOPENTHIXOL DECANOATE,0711246161,1987,200 mg/ml,Injection,Intramuscular use,168.20,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CLORACEF 250MG/5ML SUSP,CEFACLOR,2303257138,1999,50 mg/ml,Suspension,Oral use,29.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
CLARITT 500 MG FILM COATED TAB,CLARITHROMYCIN,0310222684,2002,500 mg,Film-coated tablet,Oral use,70.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLARITT 250 MG - 5 ML SUSPENSION,CLARITHROMYCIN,150-277-03,2003,50 mg/ml,Suspension,Oral use,51.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CITANEST 3% DENTAL OCTAPRESSIN CARTRIDGE,"PRILOCAINE, FELYPRESSIN",0303256971,2009,"30,0.54 µ/ml, mg/m",Solution for injection,Dental use,191.10,PIERREL,Italy,PIERREL PHARMA S.P.A,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Biogen Arabia
CITALOPRAM HEXAL 40MG F.C. TABLETS,CITALOPRAM,2807222360,2008,40 mg,Film-coated tablet,Oral use,54.25,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CITALOPRAM HEXAL 20MG F.C. TABLETS,CITALOPRAM,2807222357,2008,20 mg,Film-coated tablet,Oral use,32,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CITALOGEN 20 mg film-coated tablet,CITALOPRAM,1401256606,2005,20 mg,Film-coated tablet,Oral use,85.8,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CITALOGEN 10 mg film-coated tablet,CITALOPRAM,1401256605,2005,10 mg,Film-coated tablet,Oral use,54.1,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CISPLATIN 0.5MG-ML INJ.,CISPLATIN,0409222580,2001,0.5 mg/ml,Concentrate for dispersion for injection,Parenteral use,86.50,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CISPLATIN 0.5MG-ML INJ.,CISPLATIN,0409222579,2001,0.5 mg/ml,Concentrate for dispersion for injection,Parenteral use,24.4,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CITRIN 5MG-5ML SYRUP,CETIRIZINE HYDROCHLORIDE,4-539-08,2008,1 mg/ml,Syrup,Oral use,11.80,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
CLARITT 125 MG - 5 ML SUSPENSION,CLARITHROMYCIN,149-277-03,2003,25 mg/ml,Suspension,Oral use,26.9,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLARITINE 5MG-5ML SYRUP,LORATADINE,0704257199,1997,1 mg/ml,Syrup,Oral use,20.75,SPIMACO,Saudi Arabia,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Bayer Saudi Arabia
CLARITINE 10MG TAB,LORATADINE,0312246362,1997,10 mg,Tablet,Oral use,19.6,SPIMACO,Saudi Arabia,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Bayer Saudi Arabia
CLARIMAC 500 mg film-coated tablet,CLARITHROMYCIN,2001268952,2005,500 mg,Film-coated tablet,Oral use,54.10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CLARIDAR,CLARITHROMYCIN,81-124-08,2008,25 mg/ml,Suspension,Oral use,24.2,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CLARITT 250 MG FILM COATED,CLARITHROMYCIN,2510222797,2002,250 mg,Extended-release tablet,Oral use,46.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLARAZOLE 2% CREAM,KETOCONAZOLE,41-490-08,2008,2 %,Cream,Topical,13.15,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CLARA 5MG\5ML SYRUP,LORATADINE,1610234340,2003,1 mg/ml,Syrup,Oral use,17.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
CLARA 10MG TABLET,LORATADINE,2410234387,2003,10 mg,Tablet,Oral use,17.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
CLARAZOLE 2% SHAMPOO,KETOCONAZOLE,6-490-05,2005,2 %,Shampoo,Topical,16.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CLORACEF 375MG- 5ML SUSPENSION,CEFACLOR,2702256956,2010,75 mg/ml,Powder for oral suspension,Oral use,29.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CONCOR COR,BISOPROLOL FUMARATE,3107257908,2002,2.5 mg,Film-coated tablet,Oral use,19.55,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
CONCOR 5 PLUS F.C. TABLETS,"HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE",2904257310,1999,"12.5,5 mg",Film-coated tablet,Oral use,19.5,MERCK HEALTHCARE KGAA,Germany,Merck Healthcare KGAA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
CONCOR,BISOPROLOL FUMARATE,3107257907,1991,5 mg,Film-coated tablet,Oral use,29.25,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
CONCOR,BISOPROLOL FUMARATE,0810246017,1991,10 mg,Film-coated tablet,Oral use,35.4,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
CONCERTA EXTENDED RELEASE 36MG TABLET,METHYLPHENIDATE,1501256620,2005,36 mg,Extended-release tablet,Oral use,155.1,JANSSEN-CILAG,United States,Janssen Cilag AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CONCERTA EXTENDED RELEASE 18MG TABLET,METHYLPHENIDATE,1501256621,2005,18 mg,Extended-release tablet,Oral use,111.65,JANSSEN-CILAG,United States,Janssen Cilag AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CONAZOLE VAGINAL CREAM 20MG-1GM,MICONAZOLE NITRATE,2708245834,2010,2 %,Vaginal cream,Vaginal use,14.1,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
CONAZOLE VAGINAL CREAM 20MG-1GM,MICONAZOLE NITRATE,2509305981,2010,2 %,Vaginal cream,Vaginal use,21.4,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
CONAZOL 2% CREAM,MICONAZOLE NITRATE,2907245690,2010,2 %,Cream,Topical,6.4,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
CONTRACTUBEX,"HEPARIN SODIUM, LIQUID EXTRACT FROM ONION, ALLANTOIN",0609234145,1986,"5000,10,1 IU, g",Gel,Topical,34.60,MERZ PHARMACEUTICAL,Germany,MERZ PHARMACEUTICAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
CONTRACTUBEX,"HEPARIN SODIUM, LIQUID EXTRACT FROM ONION, ALLANTOIN",0609234146,1986,"5000,10,1 IU, g",Gel,Topical,20.90,MERZ PHARMACEUTICAL,Germany,MERZ PHARMACEUTICAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
COVERAM 5MG-10MG TABLETS,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",8-597-09,2009,"10,5 mg",Tablet,Oral use,82.9,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
COVERAM 10MG-5MG TABLETS,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",9-597-09,2009,"5,10 mg",Tablet,Oral use,102.7,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
COVERAM 10MG-10MG TABLETS,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",10-597-09,2009,"10,10 mg",Tablet,Oral use,117.2,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
CO-TABUVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2208245814,2012,"80,12.5 mg",Film-coated tablet,Oral use,33.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CO-TABUVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2208245812,2012,"320,25 mg",Film-coated tablet,Oral use,49.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CONAZOL 2% CREAM,MICONAZOLE NITRATE,2907245678,2010,2 %,Cream,Topical,9.6,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
CO-TABUVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2208245905,2012,"320,12.5 mg",Film-coated tablet,Oral use,49.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CO-TABUVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2208245815,2012,"160,12.5 mg",Film-coated tablet,Oral use,36.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
COSMOFER 625MG-2ML AMPOULES,IRON DEXTRAN,1-574-08,2008,312.5 mg/ml,Solution for injection/infusion,Intravenous use,88.9,WEIMER PHARMA GMBH,Germany,PHARMACOSMOS A/S,Denmark,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
CORTIDERM 1% CREAM,HYDROCORTISONE ACETATE,24-212-94,1994,1 %,Cream,Topical,7.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
CORTIDERM 1% CREAM,HYDROCORTISONE,81-212-98,1998,10 mg,Cream,Topical,16.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
CO-RENITEC,"ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE",0609211013,1994,"20,12.5 mg",Tablet,Oral use,66.5,Organon Pharma (UK) Limited,United Kingdom,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CORDARONE 150MG-3ML AMP.,AMIODARONE,2310246095,1993,50 mg/ml,Solution for injection,Intravenous use,82.20,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
COPEGUS 200 MG FILM COATED TABLET,RIBAVIRIN,252-24-05,2005,200 mg,Film-coated tablet,Oral use,0,PATHEON,Canada,ROCHE & CO LTD,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
CO-TABUVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2208245813,2012,"160,25 mg",Film-coated tablet,Oral use,36.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLORACEF FORTE,CEFACLOR,0409234123,1997,500 mg,Capsule,Oral use,55.95,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
COMPOUND SODIUM LACTATE INFUSION,LACTATED RINGER(S),413-149-14,2014,,Solution,Intravenous use,6.9,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
COBAL 500MCG TAB,METHYLCOBALAMIN,0802256852,2003,500 µg,Film-coated tablet,Oral use,20.75,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Dallah Health Care Company
Co-Aprovel 150-12.5 MG TABLET,"IRBESARTAN, HYDROCHLOROTHIAZIDE",5-244-03,2003,"150,12.5 mg",Film-coated tablet,Oral use,63,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
CO-DIOVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2204245191,2008,"320,25 mg",Film-coated tablet,Oral use,57.85,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Novartis Saudi Limited
CO-DIOVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",2204245192,2008,"320,12.5 mg",Film-coated tablet,Oral use,57.85,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Novartis Saudi Limited
CLOVIR 5% CREAM,ACYCLOVIR,1307257749,1995,5 %,Cream,Topical,25.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CLOVIR 200MG TAB,ACYCLOVIR,59-212-97,1997,200 mg,Tablet,Oral use,267.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
CLOVAINE 10% W/W GEL,BENZOCAINE,2708245833,2010,10 %,Gel,Topical,4.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
CLOTRIZOLE 100MG VAGINAL TABLETS,CLOTRIMAZOLE,4-590-09,2009,100 mg,Tablet,Vaginal use,12.55,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
CLOTRIM 100 MG VAGINAL TABLETS,CLOTRIMAZOLE,6-491-08,2008,100 mg,Tablet,Vaginal use,14.9,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 25°c,Pharmacy,"AMC Pharma, Cigalah Group"
CLOTREX,CLOTRIMAZOLE,11-371-04,2004,1 %,Oral drops,Auricular use,10.8,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CO-DIOVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",1408222483,2003,"160,25 mg",Film-coated tablet,Oral use,42.5,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Novartis Saudi Limited
CO-DIOVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",1408222488,2002,"160,12.5 mg",Film-coated tablet,Oral use,42.5,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Novartis Saudi Limited
CO-DIOVAN,"VALSARTAN, HYDROCHLOROTHIAZIDE",1408222487,2000,"80,12.5 mg",Film-coated tablet,Oral use,38.95,NOVARTIS,Italy,NOVARTIS,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Novartis Saudi Limited
COMPOUND SODIUM LACTATE INFUSION,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",3005222102,2010,"6,0.40,0.27,3.2 g/ml",Solution,Intravenous use,16.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
COMPOUND SODIUM LACTATE I.V INFUSION,SODIUM LACTATE,11-303-00,2000,1.9 %,Solution,Intravenous use,4.95,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,AL EWAN MEDICAL COMPANY
COMPOUND SODIUM LACTATE INF.,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",13-149-91,1991,"6,0.40,0.27,3.20 g/ml",Solution for infusion,Intravenous use,11.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
COMPOUND SODIUM LACTATE INF.,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",12-149-91,1991,"6,0.40,0.27,3.2 g/ml",Solution,Intravenous use,7.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
COMPOUND SODIUM LACTATE INF.,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",0108222380,1993,"6,0.40,0.27,3.20 g/ml",Solution for infusion,Intravenous use,6.80,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
COMPOUND SODIUM LACTATE INF.,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",166-149-98,1998,"6,0.40,0.27,3.20 g/ml",Solution for infusion,Intravenous use,10.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
COMBIVIR F.C TAB,"LAMIVUDINE, ZIDOVUDINE",2312200359,2002,"300,150 mg",Film-coated tablet,Oral use,1091.55,Glaxo Operations UK Limited,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
COMPOUND SODIUM LACTATE INFUSION,LACTATED RINGER(S),1210222718,2014,,Solution,Intravenous use,6.9,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
COLPERMIN 187MG CAPS,PEPPERMINT OIL,2008245786,2002,187 mg,Capsule,Oral use,18.55,SwissCo Services AG,Switzerland,TILLOTTS,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
COLI-URINAL effervescent granules,"KHELLIN, METHENAMINE, PIPERAZINE",2602256943,1985,"21,6,2.34 g",Effervescent granules,Oral use,6.75,MISR COMPANY FOR MEDICAL PRODUCTS,Egypt,MISR COMPANY FOR MEDICAL PRODUCTS,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,United Pharmaceutical Establishment
COMBIGAN,"TIMOLOL MALEATE, BRIMONIDINE TARTRATE",2506257614,2009,"5,2 mg, mg/ml",Eye drops,Ophthalmic use,31.80,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE LIMITED,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
COVERAM 5MG-5MG TABLETS,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",7-597-09,2009,"5,5 mg",Tablet,Oral use,68.45,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
CIPROXEN 750MG FILM COATED TABLET,CIPROFLOXACIN,0409234101,2002,750 mg,Film-coated tablet,Oral use,80.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
CIPROXEN 250MG FILM COATED TABLET,CIPROFLOXACIN,32-368-02,2002,250 mg,Film-coated tablet,Oral use,30.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
CEFUREX 250MG-5ML POWDER FOR SUSPENSION,CEFUROXIME AXETIL,29-346-09,2009,50 mg/ml,Powder for suspension,Oral use,27.45,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CEFUREX 250MG F-C TABLETS,CEFUROXIME AXETIL,31-346-10,2010,250 mg,Film-coated tablet,Oral use,20.8,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CEFUREX 125MG-5ML POWDER FOR SUSPENSION,CEFUROXIME AXETIL,28-346-09,2009,25 mg/ml,Powder for suspension,Oral use,18.5,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CEFRAX 400MG CAPSULES,CEFIXIME,35-390-11,2011,400 mg,Capsule,Oral use,49.55,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
CEFPROZ 250MG-5ML POWDR FOR ORAL SUSP,CEFPROZIL,0809258188,2009,50 mg/ml,Powder for oral suspension,Oral use,32.25,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CEFPROZ 250MG/5ML POWDER FOR ORAL SUSPENSION,CEFPROZIL,2104257261,2013,50 mg/ml,Powder for oral suspension,Oral use,64.5,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CEFUREX 500MG F-C TABLETS,CEFUROXIME AXETIL,30-346-10,2010,500 mg,Film-coated tablet,Oral use,34.05,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CEFUTIL 250MG F.C TABLET,CEFUROXIME AXETIL,0312258717,2004,250 mg,Film-coated tablet,Oral use,23.50,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEFUTIL 500 MG TABLETS,CEFUROXIME AXETIL,0312258718,2004,500 mg,Film-coated tablet,Oral use,36.05,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEPHALEX ORAL SUSP 250MG-5ML,CEFALEXIN,0802244873,1997,50 mg/ml,Suspension,Oral use,17.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CEPHALEX 500MG CAPS,CEFALEXIN,0802244875,1997,500 mg,Capsule,Oral use,32.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CEFPROZ 125MG-5ML POWDER FOR ORAL SUSP,CEFPROZIL,42-490-09,2009,25 mg/ml,Powder for oral suspension,Oral use,18.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CEPHADAR CAPSULES 250MG,CEFALEXIN,2211222923,1992,250 mg,Capsule,Oral use,10.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CELSENTRI 300MG F.C. TABLETS,MARAVIROC,1906257588,2013,300 mg,Film-coated tablet,Oral use,2861.70,PFIZER,Germany,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CELSENTRI 150MG F.C. TABLETS,MARAVIROC,1906257587,2013,150 mg,Film-coated tablet,Oral use,2861.70,PFIZER,Germany,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CELLCEPT 250 MG CAPS,MYCOPHENOLATE MOFETIL,227-24-00,2000,250 mg,Capsule,Oral use,313.95,Delpharm Milano S.r.l,Italy,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
CEPHADAR,CEFALEXIN,14-124-87,1987,25 mg/ml,Granules for oral suspension,Oral use,6.7,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CEFOFIX 750 MG VIALS,CEFUROXIME SODIUM,0807245502,2003,750 mg,Solution for infusion,Parenteral use,11,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFODOX 200 MG FILM COATED TABLETS,CEFPODOXIME,24-399-06,2006,200 mg,Film-coated tablet,Oral use,68.95,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEFADROX 500MG-5ML SUSPENSION,CEFADROXIL,39-334-00,2000,100 mg/ml,Suspension,Oral use,44.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CEFADROX 500MG CAPSULE,CEFADROXIL,37-334-00,2000,500 mg,Capsule,Oral use,30.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CEFADROX 250MG-5ML SUSPENSION,CEFADROXIL,38-334-00,2000,50 mg/ml,Suspension,Oral use,22.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CEECAL EFFERVESCENT TABLETS,"ASCORBIC ACID, CALCIUM CARBONATE, COLECALCIFEROL, PYRIDOXINE (VITAMIN B6)",2201244782,2010,"1000,625,200,5 mg, IU",Effervescent tablet,Oral use,9.15,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Nomou United Medical Company, SAUDI ARABIAN DRUG STORE COMPANY"
CECLOR MR 750 MG TAB,CEFACLOR,149-212-01,2001,750 mg,Modified-release film-coated tablet,Oral use,52.3,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CECLOR MR 500MG TAB,CEFACLOR,109-212-99,1999,500 mg,Modified-release film-coated tablet,Oral use,42.85,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CECLOR MR 375 MG TAB,CEFACLOR,108-212-99,1999,375 mg,Modified-release film-coated tablet,Oral use,35.6,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CECLOR 500MG CAPSULE,CEFACLOR,132-212-00,2000,500 mg,Capsule,Oral use,59.4,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CECLOR 250MG CAPSULE,CEFACLOR,131-212-00,2000,250 mg,Capsule,Oral use,32.3,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CECLOR 250 MG-5ML SUSP,CEFACLOR,116-212-00,2000,50 mg/ml,Powder for oral suspension,Oral use,41.65,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CEFAXON 1GM I.M+5 ML LIDOCAINE VIAL,CEFTRIAXONE,3105222109,2004,1 g,Solution,Intramuscular use,48.05,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFAXON 1GM I.V VIAL,CEFTRIAXONE,94-334-04,2004,1 g,Solution for injection,Intravenous use,48.05,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFAXON 500 MG I.M+5 ML LIDOCAINE VIAL,CEFTRIAXONE,3105222108,2004,500 mg,Solution,Intramuscular use,29.3,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFODOX 100MG-5ML SUSPENSION,CEFPODOXIME,25-399-06,2006,20 mg/ml,Powder for oral suspension,Oral use,53,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEFIZOX 1000 VIAL I-V,CEFTIZOXIME,3103221904,1990,1 g,Injection,Intravenous use,30.35,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CEFIX 200MG CAPSULES,CEFIXIME,2009211068,2005,200 mg,"Capsule, hard",Oral use,36.3,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEFIX 100MG-5ML SUSPENSION,CEFIXIME,1011211296,2005,20 mg/ml,Suspension,Oral use,34.75,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CEFIM 400MG CAPSULES,CEFIXIME,26-498-09,2009,400 mg,Capsule,Oral use,45.95,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CEFIM 200MG CAPSULES,CEFIXIME,2411211356,2009,200 mg,Capsule,Oral use,44.7,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CEFAXON 500 MG I.V VIAL,CEFTRIAXONE,1606257558,2004,500 mg,Solution,Intravenous use,14.85,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFIX 400MG CAPSULES,CEFIXIME,1901268935,2005,400 mg,"Capsule, hard",Oral use,45.80,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
CIPROXEN 500MG FILM COATED TABLET,CIPROFLOXACIN,0309234097,2002,500 mg,Film-coated tablet,Oral use,54.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
CERAZETTE 75MCG TAB,DESOGESTREL,2604221983,2002,75 µg,Film-coated tablet,Oral use,17.85,MERCK SHARP & DOHME,Netherlands,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CIPROGEN,CIPROFLOXACIN,1109234166,2003,500 mg,Film-coated tablet,Oral use,54.25,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
CIPROFLACIN 500 MG FILM COATED TABLETS,CIPROFLOXACIN,1710234346,2004,500 mg,Film-coated tablet,Oral use,21.05,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CIPROCIN 500MG TAB,CIPROFLOXACIN,0607233849,2002,500 mg,Film-coated tablet,Oral use,29.1,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
CIPROCIN 250MG TAB,CIPROFLOXACIN,0607233850,2002,250 mg,Film-coated tablet,Oral use,14.95,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
CIPROCIN 0.3%,CIPROFLOXACIN,1212246410,2001,3 mg,"Ear/eye drops, solution",Topical,13.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CIPROBAY 500MG TAB,CIPROFLOXACIN,23-4-91,1991,500 mg,Film-coated tablet,Oral use,63.85,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CIPROHEXAL 250MG F.C. TABLETS,CIPROFLOXACIN,2807222362,2010,250 mg,Film-coated tablet,Oral use,7.85,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CIPROHEXAL 500MG F.C. TABLETS,CIPROFLOXACIN,2807222359,2010,500 mg,Film-coated tablet,Oral use,13.8,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CIPRO-SOL 200MG / 100 ML Glass bottle,CIPROFLOXACIN,1210222713,2004,2 mg/ml,Solution for infusion,Parenteral use,64.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
CIPROQUIN,CIPROFLOXACIN,0909245888,2002,500 mg,Film-coated tablet,Oral use,23.85,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CIPROPHARM 500MG TABLET,CIPROFLOXACIN,2604221989,2004,500 mg,Film-coated tablet,Oral use,45.25,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CIPROMID 750MG F.C. TABLETS,CIPROFLOXACIN,21-346-07,2007,750 mg,Film-coated tablet,Oral use,20,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CIPROMID 500MG F-C TABLET,CIPROFLOXACIN,17-346-05,2005,500 mg,Film-coated tablet,Oral use,17.05,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CIPROBAY 200 mg solution for infusion,CIPROFLOXACIN,3001233191,1991,200 mg,Solution for infusion,Parenteral use,434.80,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CIPROMID 250MG F-C TABLET,CIPROFLOXACIN,18-346-05,2005,250 mg,Film-coated tablet,Oral use,8.75,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
CIPROMAX 500 MG TABLET,CIPROFLOXACIN,1803257093,2000,500 mg,Film-coated tablet,Oral use,62.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CIPROLON 200 VIAL 100ML,CIPROFLOXACIN,2805245363,2001,200 mg,Solution for infusion,Parenteral use,54.25,Hikma Pharmaceuticals PLC,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
CIPROMAX 750MG TAB,CIPROFLOXACIN,1803257096,2002,750 mg,Film-coated tablet,Oral use,80.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CEPROTIN 500 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION,PROTEIN C,0912258761,2010,500 IU,Powder for solution for injection/infusion,Intravenous use,3782.30,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
CIPRAM 20MG TAB,CITALOPRAM,0204245145,1994,20 mg,Film-coated tablet,Oral use,111.30,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CIFLOX 500MG TABLET,CIPROFLOXACIN,0801256562,2004,500 mg,Tablet,Oral use,37.45,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CETROTIDE 0.25MG POW. FOR SOLU. FOR INJ.,CETRORELIX,2412246485,2007,0.25 mg,Powder and solvent for solution for injection,Intravenous use,156.5,FAREVA PAU,France,Merck Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Cigalah Group, Merck Limited"
CERVARIX VACCINE,"HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN",1612200341,2012,"20,20 µg",Suspension for injection,Intramuscular use,266.25,GLAXO SMITHKLINE BIOLOGICALS,Germany,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CERTICAN 0.75MG TABLETS,EVEROLIMUS,0605257345,2006,0.75 mg,Tablet,Oral use,1149.05,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
CERTICAN 0.25MG TABLETS,EVEROLIMUS,1809245932,2006,0.25 mg,Tablet,Oral use,493.15,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
CERNEVIT,MULTIVITAMINS,0304221906,2007,,Powder for solution for injection/infusion,Intravenous use,215.30,FAREVA PAU 1,France,BAXTER,Belgium,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
CEVITIL 1 g effervescent tablet,ASCORBIC ACID,2209258251,1992,1 g,Effervescent tablet,Oral use,5.1,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
CHAMPIX 0.5 MG F-C TAB,VARENICLINE,1810211194,2008,0.5 mg,Film-coated tablet,Oral use,138.50,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CIFLOX 250MG TABLET,CIPROFLOXACIN,0801256554,2004,250 mg,Tablet,Oral use,22.85,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CIFLOX 200MG-100ML I.V. INFUSION,CIPROFLOXACIN,1102256874,2009,200 mg,Solution for infusion,Parenteral use,120.5,Al Hikma Pharmaceutical Portugal Lda,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CHORIOMON 5000 I.U VIAL+AMP OF SOLVENT,GONADOTROPHIN CHORIONIC HUMAN,0604257182,2000,5000 IU,Injection,Intramuscular use,142.3,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
CHLOROQUINE,CHLOROQUINE PHOSPHATE,93-325-03,2003,150 mg,Film-coated tablet,Oral use,5.25,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
CHLOROQUINE,CHLOROQUINE PHOSPHATE,1301256591,2000,10 mg/ml,Syrup,Oral use,8.75,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CHAMPIX 1MG F-C TABLETS,VARENICLINE,1810211195,2008,1 mg,Film-coated tablet,Oral use,224.55,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CHAMPIX 1MG F-C TABLETS,VARENICLINE,1810211193,2008,1 mg,Film-coated tablet,Oral use,133.40,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CHAMPIX 0.5 MG 11 tablets +1 MG 14 tablets,VARENICLINE,1810211192,2008,0.5-1 mg,Film-coated tablet,Oral use,133.40,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
COVERSYL 10MG F.C. TABLETS,PERINDOPRIL ARGININE,4-597-08,2008,10 mg,Film-coated tablet,Oral use,45.45,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
COVERSYL 5MG F.C. TABLETS,PERINDOPRIL ARGININE,3-597-08,2008,5 mg,Film-coated tablet,Oral use,34.55,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
DEXTROSE 10% I.V.INFUSION,DEXTROSE,62-149-93,1993,10 %,Solution for injection,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% I.V.INFUSION,DEXTROSE,153-149-98,1998,10 %,Solution for injection,Intravenous use,5.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
10% Dextrose intravenous infusion,DEXTROSE,1108222477,1993,10 %,Solution for injection,Intravenous use,6.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% I.V.INFUSION,DEXTROSE,154-149-98,1998,10 %,Solution for injection,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% IN 1-2 NORMAL SALINE,"DEXTROSE, SODIUM CHLORIDE",54-149-93,1993,"10,0.45 %",Solution for injection,Intravenous use,8.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% IN 1-2 NORMAL SALINE,"DEXTROSE, SODIUM CHLORIDE",224-149-01,2001,"10,0.45 %",Solution for injection,Intravenous use,6.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10%+ SOD.CHLORIDE 0.18%,"DEXTROSE, SODIUM CHLORIDE",259-149-02,2002,"10,0.18 % (W/V)",Infusion,Intravenous use,6.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% SOLUTION FOR INJ,DEXTROSE,0907245524,2002,10 %,Solution for injection,Intravenous use,4.3,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DEXTROSE 10% IN0.225% SOD.CHLORIDE INFS,"DEXTROSE, SODIUM CHLORIDE",223-149-01,2001,"10,0.225 %",Solution for injection,Intravenous use,6.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% IN 1-5NORMAL SALINE INFUSIO,"DEXTROSE, SODIUM CHLORIDE",37-149-92,1992,"10,0.18 %",Solution for injection,Intravenous use,8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10% IN 1-5NORMAL SALINE INFUSIO,"DEXTROSE, SODIUM CHLORIDE",0109222570,1992,"10,0.81 %",Solution for injection,Intravenous use,6.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10%+ SOD.CHLORIDE 0.18%,"DEXTROSE, SODIUM CHLORIDE",257-149-02,2002,"10,0.18 % (W/V)",Infusion,Intravenous use,4.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, RINGER LACTATE","SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",164-149-98,1998,"6,3.2,0.4,0.27 mg/ml",Solution for injection,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, RINGER","DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",131-149-96,1996,"55,8.60,0.30,0.33 g/ml",Solution for injection,Intravenous use,5.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, RINGER","DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",163-149-98,1998,"55,8.60,0.30,0.33 g/ml",Solution for injection,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROKUF 15MG\5ML SYRUP,DEXTROMETHORPHAN,1203245041,2003,3 mg/ml,Syrup,Oral use,7.20,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DEXTRAN-70 6% IN N.SALINE INF,"HYPROMELLOSE 2208 (750 MPA.S), DEXTRAN 70",275-149-03,2003,"3,1 mg",Solution,Intravenous use,24.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-70 6% IN N.SALINE INF,"DEXTRAN 70, SODIUM CHLORIDE",136-149-97,1997,"6,0.9 %",Solution,Intravenous use,24.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-70 6% IN DEXTROSE 5% Infusion*,"DEXTRAN 70, DEXTROSE",276-149-03,2003,"6,5 %",Solution,Intravenous use,25.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-70 6% IN DEXTROSE 5% Infusion*,"DEXTRAN 70, DEXTROSE",135-149-97,1997,"6,5 %",Solution,Intravenous use,25.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-40 IN N.SALINE,"DEXTRAN 40, SODIUM CHLORIDE",75-149-94,1994,"10,0.9 %",Solution,Intravenous use,24.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-40 IN N.SALINE,"DEXTRAN 40, SODIUM CHLORIDE",8-149-91,1991,"10,0.9 % (W/V)",Solution,Intravenous use,27.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-40 IN 5% DEXTROSE INJ,"DEXTRAN 40, DEXTROSE",7-149-91,1991,"10,5 % (W/V)",Solution,Intravenous use,27.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN-40 IN 5% DEXTROSE INJ,"DEXTRAN 40, DEXTROSE",194-149-99,1999,"10,5 % (W/V)",Solution,Intravenous use,25.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
DEXTRAN 40 10% IN NORMAL SALINE,DEXTRAN 40,20-352-02,2002,10 %,Solution for infusion,Intravenous use,23.7,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
"DEXTROSE, RINGER LACTATE","SODIUM LACTATE, SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, DEXTROSE",0109222566,1996,"3.20,6,0.27,0.4,55 g",Solution for injection,Intravenous use,6.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, RINGER LACTATE","SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",15-149-91,1991,"6,3.2,0.4,0.27 g/l, mg/ml",Solution for injection,Intravenous use,11.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",300-149-05,2005,"4,0.18 %",Solution for infusion,Intravenous use,8.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",301-149-05,2005,"4,0.18 %",Solution for infusion,Intravenous use,4.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",193-149-99,1999,"2.5,0.45 %",Solution for injection,Intravenous use,7.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",180-149-99,1999,"5,0.45 %",Solution for injection,Intravenous use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",17-149-91,1991,"5,0.45 %",Solution for injection,Intravenous use,7.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",3005222089,1994,"5,0.45 %",Solution for injection,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",159-149-98,1998,"5,0.45 %",Solution for injection,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",179-149-99,1999,"5,0.225 %",Solution for injection,Intravenous use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",42-149-92,1992,"5,0.225 %",Solution for injection,Intravenous use,10.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",160-149-98,1998,"5,0.225 %",Solution for injection,Intravenous use,9.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",0108222383,1994,"5,0.225 %",Solution for injection,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10%+ SOD.CHLORIDE 0.18%,"DEXTROSE, SODIUM CHLORIDE",0109222567,2002,"10,0.18 % (W/V)",Infusion,Intravenous use,9.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10%+N.SALINE INJ,"DEXTROSE, SODIUM CHLORIDE",5-149-91,1991,"10,0.9 %",Solution for injection,Intravenous use,8.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.45% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",3005222101,2010,"5,0.45 %",Intravenous infusion,Intravenous use,7.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.45% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",3005222100,2010,"5,0.45 %",Intravenous infusion,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.45% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",3005222099,2010,"5,0.45 %",Intravenous infusion,Intravenous use,15.90,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.225% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",3005222098,2010,"5,0.225 %",Intravenous infusion,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.225% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",1409222606,2010,"5,0.225 %",Intravenous infusion,Intravenous use,11,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN 0.225% SOD. CHLORIDE INF,"DEXTROSE, SODIUM CHLORIDE",1108222461,2010,"5,0.225 %",Intravenous infusion,Intravenous use,9.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% I.V INFUSION,DEXTROSE,0907245522,2000,5 %,Solution for injection,Intravenous use,6.2,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DEXTROSE 5% + 0.9% SODIUM CHLORIDE INFUSION,"DEXTROSE, SODIUM CHLORIDE",1705222036,2014,"5,0.9 %",Solution,Intravenous use,6.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% + 0.9% SODIUM CHLORIDE INFUSION,"DEXTROSE, SODIUM CHLORIDE",1705222037,2014,"5,0.9 %",Solution,Intravenous use,7.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% & RINGER LACTATE INFUSION SOLUTION,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE",1705222038,2010,"55,6,0.4,0.27,3.20 g/ml",Solution for injection,Intravenous use,11.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% IN RINGER SOLUTION,"DEXTROSE, RINGER(S) SOLUTION",403-149-10,2010,5 %,Intravenous infusion,Intravenous use,11.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5% INFUSION,DEXTROSE,1705222035,2014,5 %,Intravenous infusion,Intravenous use,5.80,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 10%+N.SALINE INJ,"DEXTROSE, SODIUM CHLORIDE",63-149-93,1993,"10,0.9 %",Solution for injection,Intravenous use,6.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 4.3%IN 0.18%SOD.CHLORIDE INFU,"DEXTROSE, SODIUM CHLORIDE",161-149-98,1998,"4.3,0.18 %",Solution for injection,Intravenous use,9.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 4.3%IN 0.18%SOD.CHLORIDE INFU,"DEXTROSE, SODIUM CHLORIDE",0108222382,1994,"4.3,0.18 %",Solution for injection,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 25% INJ,DEXTROSE,195-149-00,2000,25 %,Solution for injection,Intravenous use,0.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 25% INJ,DEXTROSE,197-149-00,2000,25 %,Solution for injection,Intravenous use,2.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 25% INJ,DEXTROSE,2208245809,1991,25 %,Solution for injection,Intravenous use,8.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 25% INJ,DEXTROSE,196-149-00,2000,25 %,Solution for injection,Intravenous use,0.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 25% INJ,DEXTROSE,0108222384,2001,25 %,Solution for injection,Intravenous use,11.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 20% W-V INFUSION,DEXTROSE,94-149-95,1995,20 %,Solution for injection,Intravenous use,8.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 20% W-V INFUSION,DEXTROSE,1705222039,1997,20 %,Solution for injection,Intravenous use,9.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 20% INJ,DEXTROSE,254-149-02,2002,20 %,Solution for injection,Intravenous use,0.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 20% INJ,DEXTROSE,256-149-02,2002,20 %,Solution for injection,Intravenous use,1.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"20%W/V DEXTROSE injection, USP",DEXTROSE,255-149-02,2002,20 %,Solution for injection,Intravenous use,0.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 40% INFUSION,DEXTROSE,141-149-97,1997,40 %,Solution for injection,Intravenous use,9,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 40% INFUSION,DEXTROSE,176-149-99,1999,40 %,Solution for injection,Intravenous use,1.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 40% INFUSION,DEXTROSE,175-149-99,1999,40 %,Solution for injection,Intravenous use,1.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 40% INFUSION,DEXTROSE,93-149-95,1995,40 %,Solution for injection,Intravenous use,10.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,0109222569,1991,5 %,Solution for injection,Intravenous use,6.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,3005222096,2009,5 %,Solution for injection,Intravenous use,8.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,1210222708,2009,5 %,Solution for injection,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,1210222705,2009,5 %,Solution for injection,Intravenous use,4.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,1210222706,2009,5 %,Solution for injection,Intravenous use,4.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,1705222034,2009,5 %,Solution for injection,Intravenous use,8.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,151-149-98,1998,5 %,Solution for injection,Intravenous use,5.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,152-149-98,1998,5 %,Solution for injection,Intravenous use,8.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,284-149-04,2004,5 %,Solution for injection,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,285-149-04,2004,5 %,Solution for injection,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,283-149-04,2004,5 %,Solution for injection,Intravenous use,3.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
40% w/v DEXTROSE Injection USP,DEXTROSE,0109222575,1999,40 %,Solution for injection,Intravenous use,2.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 5%,DEXTROSE,3005222086,1992,5 %,Solution for injection,Intravenous use,6.90,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DAKTACORT CREAM 20MG-GM,"MICONAZOLE NITRATE, HYDROCORTISONE",2-5876-23,1981,"2,1 %",Cream,Topical,11.95,JANSSEN PHARMACEUTICA N.V.,Belgium,Johnson & Johnson Consumer NV/SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
DAIVONEX OINT. 50MCG-G,CALCIPOTRIENE,1201233094,1993,0.005 µg,Ointment,Topical,35.35,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
DAIVONEX CREAM 50MCG-G,CALCIPOTRIENE,48-19-96,1996,0.005 %,Cream,Topical,45.55,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
DAIVOBET OINTMENT,"BETAMETHASONE DIPROPIONATE, Calcipotriol",0806222154,2013,"500,50 µg",Ointment,Topical,148.35,Leo Laboratories Limited,Ireland,Leo Pharma,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
DAIVOBET GEL,"BETAMETHASONE DIPROPIONATE, Calcipotriol",69-19-13,2013,"500,50 µg",Gel,Topical,148.35,Leo Laboratories Limited,Ireland,Leo Pharma,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
DAFLON 500MG TAB,"DIOSMIN, HESPERIDIN",2807257866,2001,"450,50 mg",Film-coated tablet,Oral use,34.80,LES LABORATOIRES SERVIER INDUSTRIE,France,SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
DAKTARIN CREAM 2%,MICONAZOLE NITRATE,3-5876-23,1981,2 %,Cream,Topical,15.85,JANSSEN PHARMACEUTICA N.V.,Belgium,Johnson & Johnson Consumer NV/SA,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
DAKTARIN ORAL GEL 2%,MICONAZOLE NITRATE,0311222865,1985,2 %,Oral gel,Oral use,16.5,JANSSEN PHARMACEUTICA N.V.,Belgium,Johnson & Johnson Consumer NV/SA,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
DAKTARIN POWDER 2%,MICONAZOLE NITRATE,12-6-81,1981,2 %,Powder,Topical,11.35,LUSOMEDICAMENTA,Portugal,JANSSEN-CILAG,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
DAROXIME,CEFUROXIME AXETIL,2303257137,2006,500 mg,Film-coated tablet,Oral use,32.95,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
DAROXIME 250 mg film-coated tablet,CEFUROXIME AXETIL,2712211514,2006,250 mg,Film-coated tablet,Oral use,25.85,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
DAONIL M 500/5MG TABLETS,"METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE",3-848-12,2012,"500,5 mg",Tablet,Oral use,21.1,SPIMACO,Saudi Arabia,sanofi-aventis,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DAONIL M 500/2.5MG TABLETS,"METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE",2-848-12,2012,"500,2.5 mg",Tablet,Oral use,14.85,SPIMACO,Saudi Arabia,sanofi-aventis,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DAONIL M 250/1.25MG TABLETS,"METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE",1-848-12,2012,"250,1.25 mg",Tablet,Oral use,8.75,SPIMACO,Saudi Arabia,sanofi-aventis,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DAONIL 5MG TAB,GLIBENCLAMIDE,2111246317,1983,5 mg,Tablet,Oral use,24.6,SANOFI WINTHROP INDUSTRIE,France,sanofi-aventis FRANCE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DANSETRON 2MG\ML AMP. FOR I.V INJECTION,ONDANSETRON,3101221664,2006,2 mg/ml,Solution for injection,Intravenous use,157.35,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Abdulrehman Algosaibi G.T.C.
DALACIN-C 150 mg/ml ampoule,CLINDAMYCIN PHOSPHATE,1409211047,1987,150 mg/ml,Solution for injection,Intravenous use,27.65,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
DALACIN-C 150 mg/ml ampoule,CLINDAMYCIN PHOSPHATE,0309234086,1987,150 mg/ml,Solution for injection,Intravenous use,14.55,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
DALACIN VAGINAL CREAM 2%,CLINDAMYCIN PHOSPHATE,1703257082,1995,2 %,Vaginal cream,Vaginal use,35.8,PHARMACIA UPJOHN,United States,PFIZER INC,United States,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DALACIN T LOTION 1%,CLINDAMYCIN PHOSPHATE,2003257115,2013,1 %,Lotion,Topical,19.55,PHARMACIA UPJOHN,United States,PFIZER INC,United States,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DANSETRON 2 mg/ml solution for injection,ONDANSETRON,151-172-06,2006,2 mg/ml,Solution for injection,Intravenous use,78.65,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Abdulrehman Algosaibi G.T.C.
CURAM 1.2GM POW. FOR SOLN. FOR INJECTION- INFUSION,"AMOXICILLIN, CLAVULANIC ACID",80-116-10,2010,"1000,200 mg",Powder for solution for injection/infusion,Parenteral use,94.85,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CURACNE 40MG SOFT GELATIN CAPSULE,ISOTRETINOIN,2210246093,2014,40 mg,"Capsule, soft",Oral use,134.5,CATALENT,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CURACNE 20MG SOFT GELATIN CAPSULE,ISOTRETINOIN,2407257845,2012,20 mg,"Capsule, soft",Oral use,68.45,CATALENT,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CURACNE 10MG SOFT GELATIN CAPSULE,ISOTRETINOIN,2407257844,2012,10 mg,"Capsule, soft",Oral use,44.75,CATALENT,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CUPIDO,CLOPIDOGREL,0811222883,2013,75 mg,Film-coated tablet,Oral use,115.55,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
CROTAPHIL 10% LOTION,CROTAMITON,1708258034,2006,10 %,Lotion,Topical,11.15,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CROTAPHIL 10% CREAM,CROTAMITON,1208258014,2006,10 %,Cream,Topical,7.55,PHILADELPHIA PHARMACEUTICAL,Jordan,PHILADELPHIA PHARMACEUTICAL,Jordan,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CROMA EYE DROP,"SODIUM CROMOGLICATE, TETRAHYDROZOLINE",2007222319,2002,"4,0.05 %",Ophthalmic solution,Ophthalmic use,31.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
CRESTOR 20 MG FILM COATED TABLETS,ROSUVASTATIN,1506233820,2004,20 mg,Film-coated tablet,Oral use,130.65,IPR PHARMACEUTICALS,United States,AstraZeneca,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CRESTOR 10 MG FILM COATED TABLETS,ROSUVASTATIN,1506233818,2004,10 mg,Film-coated tablet,Oral use,77.25,IPR PHARMACEUTICALS,United States,AstraZeneca,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
COZAAR 100 mg film-coated tablet,LOSARTAN POTASSIUM,0609211012,2003,100 mg,Film-coated tablet,Oral use,52.80,Organon Pharma (UK) Limited,United Kingdom,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
COZAAR,LOSARTAN POTASSIUM,0302210491,1997,50 mg,Film-coated tablet,Oral use,45.35,Organon Pharma (UK) Limited,United Kingdom,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
COXICAM,MELOXICAM,0706222151,2004,7.5 mg,Tablet,Oral use,24.3,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
COXICAM,MELOXICAM,1610234334,2004,7.5 mg,Tablet,Oral use,10.85,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
COXICAM,MELOXICAM,0706222150,2004,15 mg,Tablet,Oral use,13.3,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CURAM 156.25MG-5ML POWDER FOR SUSP,"AMOXICILLIN, CLAVULANIC ACID",0909258196,1999,"125,31.25 mg",Powder for oral suspension,Oral use,10.35,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CURAM 1GM TABLET,"AMOXICILLIN, CLAVULANIC ACID",65-116-04,2004,"875,125 mg",Film-coated tablet,Oral use,44.15,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CURAM 312.5 MG-5ML POWDER FOR SUSP,"AMOXICILLIN, CLAVULANIC ACID",0909258199,1999,"250,62.5 mg",Powder for oral suspension,Oral use,18.1,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CYKLOKAPRON INJ 100MG-ML INJECTION,TRANEXAMIC ACID,0704257187,2013,100 mg/ml,Solution for injection,Intravenous use,73,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Manufacturing Belgium N.V.,Belgium,Marketed,Prescription,store below 25°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
CUTIVATE 0.005% ointment,FLUTICASONE PROPIONATE,1111258577,2014,0.005 %,Ointment,Topical,18.05,GLAXO,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CURAM 625 MG F.C TAB,"AMOXICILLIN, CLAVULANIC ACID",51-116-99,1999,"500,125 mg",Film-coated tablet,Oral use,21.85,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CURAM 600MG POW. FOR SOLN. FOR INJECTION- INFUSION,"AMOXICILLIN, CLAVULANIC ACID",79-116-10,2010,"500,100 mg",Powder for solution for injection/infusion,Parenteral use,46.90,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CURAM 457MG-5ML POW. FOR ORAL SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0909258198,2009,"400,57 mg/ml",Powder for oral suspension,Oral use,18.35,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CUTIVATE 0.05% cream,FLUTICASONE PROPIONATE,1111258576,2014,0.05 %,Cream,Topical,18.05,GLAXO,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
DERMOFUCIN 2% OINTMENT,FUSIDIC ACID,24-290-03,2003,2 %,Ointment,Topical,5.95,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
DERMOFUCIN 2% CREAM,FUSIDIC ACID,25-290-03,2003,2 %,Cream,Topical,7.9,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
DERMOFIX 2% CREAM,SERTACONAZOLE NITRATE,2007222323,2011,2 %,Cream,Topical,17,FERRER INTERNATIONAL,Spain,FERRER INTERNATIONAL,Spain,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
DERMATIN SOLUTION 1%,CLOTRIMAZOLE,1805257411,1991,1 %,Solution,Topical,14.50,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DERMATIN CREAM 1%,CLOTRIMAZOLE,0901256571,1991,1 %,Cream,Topical,10.00,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DERMA-T SOLUTION,CLINDAMYCIN PHOSPHATE,0706222147,1999,10 mg/ml,Solution,Topical,22.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DERMAMED 0.05% OINTMENT,CLOBETASOL PROPIONATE,35-490-08,2008,0.05 %,Ointment,Topical,6.2,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DERMA T 10MG TOPICAL LOTION,CLINDAMYCIN PHOSPHATE,0706222146,2000,10 mg/ml,Emulsion,Topical,22.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DERMOVATE 0.05% SCALP APPLICATION,CLOBETASOL PROPIONATE,2410211224,1997,0.05 %,Scalp solution,Topical,17,ASPEN Bad Oldesloe GmbH,Germany,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
DERMOVATE CREAM 0.05%,CLOBETASOL PROPIONATE,1411246227,1997,0.05 %,Cream,Topical,9.45,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
DERMOVATE OINTMENT 0.05%,CLOBETASOL PROPIONATE,0505257343,1997,0.05 %,Ointment,Topical,9.45,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
DEXANOL CREAM 30 GM,DEXPANTHENOL,1411246226,2007,5 %,Cream,Topical,7.25,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
DEXAMETHASONE SOD.PHOSPHATE 8MG-2ML AMP,DEXAMETHASONE SODIUM PHOSPHATE,16-201-92,1992,4 mg/ml,Solution,Intravenous use,10.85,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,do not store above 30°c,Hospital,Khalid Bin Saad Int. Company LTD
DEXAMETHASONE SOD.PHOSPHATE 8MG-2ML AMP,DEXAMETHASONE SODIUM PHOSPHATE,17-201-92,1992,4 mg/ml,Solution,Intravenous use,217.25,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,do not store above 30°c,Hospital,Khalid Bin Saad Int. Company LTD
DEXAFLOX OPHTHALMIC SUSPENSION,"OFLOXACIN, DEXAMETHASONE",1506222211,2004,"3,1 mg/ml","Eye drops, solution",Ophthalmic use,14.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
DETRUSITOL RETARD 4 mg capsule,TOLTERODINE TARTRATE,2605222073,2008,4 mg,"Prolonged-release capsule, hard",Oral use,71.55,PFIZER,Italy,VIATRIS PHARMA S.R.L.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
DETRUSITOL RETARD 2 mg capsule,TOLTERODINE TARTRATE,2605222072,2008,2 mg,"Prolonged-release capsule, hard",Oral use,71.55,PFIZER,Italy,VIATRIS PHARMA S.R.L.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
DETRUSITOL 2 mg tablet,TOLTERODINE TARTRATE,2903233440,2002,2 mg,Film-coated tablet,Oral use,52.85,PFIZER,Italy,VIATRIS PHARMA S.R.L.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
DESLOR 5 MG FILM COATED TABLET,DESLORATADINE,2504221977,2010,5 mg,Film-coated tablet,Oral use,23.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DESFERAL VIAL 500MG,DEFEROXAMINE,0310234286,1984,500 mg,Powder and solvent for solution for injection/infusion,Intravenous use,110.95,NOVARTIS PHARMA AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 25°c,Hospital,Novartis Saudi Limited
DEWAX 5MG-ML OTIC DROPS,DOCUSATE SODIUM,18-290-01,2001,5 %,Ear drops,Auricular use,6.45,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
DEPRAN 40 mg film-coated tablet,CITALOPRAM,23-346-07,2007,40 mg,Tablet,Oral use,87.5,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
DEPRAN 20 mg film-coated tablet,CITALOPRAM,22-346-07,2007,20 mg,Tablet,Oral use,56.3,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
DEPRALEX 20MG FILM COATED TABLET,ESCITALOPRAM,810258375,2014,20 mg,Film-coated tablet,Oral use,103.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DEFLAT 40 MG/ML ORAL DROPS,SIMETHICONE,0908222442,2012,40 mg/ml,Drops,Oral use,13.65,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DEFLAT,SIMETHICONE,2812211518,2005,40 mg/ml,Drops,Oral use,10.25,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DEFLAT,SIMETHICONE,0908222441,2009,120 mg,Chewable tablet,Oral use,10.25,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DEFADOL 160MG-5ML SUGAR FREE SYRUP,PARACETAMOL,0401244669,2008,32 mg/ml,Syrup,Oral use,5.90,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEFADOL 160MG-5ML SUGAR FREE SYRUP,PARACETAMOL,0401244672,2009,32 mg/ml,Syrup,Oral use,4.15,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEFADOL 160MG-5ML SUGAR FREE SYRUP,PARACETAMOL,0401244671,2007,32 mg/ml,Syrup,Oral use,10.05,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DECOZAL NASAL SPRAY,XYLOMETAZOLINE HYDROCHLORIDE,38-290-13,2013,0.1 %,Spray,Nasal use,7.55,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
DEFONASE SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, LORATADINE",9-539-08,2008,"12,1 mg/ml",Syrup,Oral use,21.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DECOZAL 0.1% NASAL DROPS,XYLOMETAZOLINE HYDROCHLORIDE,4-290-98,1998,0.1 %,Nasal drops,Nasal use,5.6,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
DECAPEPTYL CR 3.75MG SYRINGE,TRIPTORELIN,1208245744,2001,3.75 mg,Powder and solvent for suspension for injection,Intramuscular use,527.05,FERRING,Germany,FERRING,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
DECAPEPTYL 0.1MG S.C. Injection*,TRIPTORELIN,4-367-02,2002,0.1 mg,Solution for injection,Subcutaneous use,211.45,FERRING,Germany,FERRING,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Abdulrehman Algosaibi G.T.C.
DECAL B12,"CHOLECALCIFEROL, CYANOCOBALAMIN, CALCIUM LEVULINATE",0402256807,2012,"200,0.002,10 mg/ml, IU/",Syrup,Oral use,7.40,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DECOZAL 0.05% NASAL DROPS,XYLOMETAZOLINE HYDROCHLORIDE,3-290-98,1998,0.05 %,Nasal drops,Nasal use,5.5,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
CECLOR 125MG-5ML SUSP,CEFACLOR,115-212-00,2000,25 mg/ml,Powder for oral suspension,Oral use,20.85,ACS Dobfar S.P.A,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
DEFONEX 0.05% NASAL SPRAY,MOMETASONE FUROATE,3007257893,2014,0.05 %,Nasal spray,Nasal use,37.45,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
DEFORAX 5% CREAM,ACYCLOVIR,10-539-08,2008,5 %,Cream,Topical,25.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEPRALEX 10MG FILM COATED TABLET,ESCITALOPRAM,0810258362,2014,10 mg,Film-coated tablet,Oral use,63.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DEPOVIT B12 1000 AMP 1ML,HYDROXOCOBALAMIN,2701256755,1993,1.04 mg,Solution for injection,Intramuscular use,7.85,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
DEPO-PROVERA VIAL I-M 150MG-ML,MEDROXYPROGESTERONE ACETATE,1812246448,1989,150 mg/ml,Suspension for injection,Intramuscular use,42.55,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
DEPO MEDROL VIAL 40MG-ML SAS,METHYLPREDNISOLONE,2-44-83,1983,40 mg/ml,Suspension for injection,Intravenous use,10.75,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
DEPO MEDROL VIAL 40MG-ML SAS,METHYLPREDNISOLONE,0803210588,1983,40 mg/ml,Suspension for injection,Intravenous use,19.55,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
DEPAKINE 400MG-4ML Powder for injection,VALPROATE SODIUM,1112258784,2020,100 mg/ml,Powder and solvent for solution for injection,Intravenous use,128.35,Sanofi S.r.l.,Italy,Sanofi Aventis France,France,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
DEFOPAN 5MG-5ML SYRUP,HYOSCINE BUTYLBROMIDE,5-539-08,2008,1 mg/ml,Syrup,Oral use,10.80,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEMENTILE 10MG TABLET,DONEPEZIL HYDROCHLORIDE,1008257968,2013,10 mg,Film-coated tablet,Oral use,358.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DEFOSALIC OINTMENT,"SALICYLIC ACID, BETAMETHASONE DIPROPIONATE",16-539-08,2008,"30,0.5 mg",Ointment,Topical,13.70,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEFOSALIC OINTMENT,"SALICYLIC ACID, BETAMETHASONE DIPROPIONATE",20-539-09,2009,"30,0.5 mg",Ointment,Topical,6.85,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEFOSALIC LOTION,"SALICYLIC ACID, BETAMETHASONE DIPROPIONATE",8-539-08,2008,"20,0.5 mg",Scalp solution,Topical,18.70,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEFORAX 5% CREAM,ACYCLOVIR,6-539-08,2008,5 %,Cream,Topical,12.65,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
DEMENTILE 5MG TABLET,DONEPEZIL HYDROCHLORIDE,1008257966,2013,5 mg,Film-coated tablet,Oral use,211.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CAVERJECT 20MCG VIAL,ALPROSTADIL,0202221673,2001,20 µg,Powder and solvent for solution for injection,Intravenous use,44.55,PFIZER,Belgium,PFIZER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CARVIDOL 6.25MG TABLET,CARVEDILOL,2802210559,2004,6.25 mg,Tablet,Oral use,26.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ANTACID JEDCO 480MG CHEWABLE TABLETS,MAGALDRATE,0203233320,2007,480 mg,Chewable tablet,Oral use,4.45,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,OTC,store below 30°c,Pharmacy,AL JEDAANI STORE
ANEXATE 0.5MG AMP 5ML,FLUMAZENIL,2807245665,1991,0.1 mg/ml,Solution for injection,Intravenous use,270.65,CENEXI,France,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,"Abdulrehman Algosaibi G.T.C., Roche Products Saudi Arabia"
ANAZOL 500 MG F.C. TAB,METRONIDAZOLE,1911246271,1999,500 mg,Film-coated tablet,Oral use,14.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ANAZOL 250 MG F.C. TAB,METRONIDAZOLE,2504245218,1999,250 mg,Film-coated tablet,Oral use,6.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ANAZOL 200MG-5ML SUSPENSION,METRONIDAZOLE,2504245215,2000,40 mg/ml,Suspension,Oral use,10.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ANAZOL   125MG-5ML SUSP.,METRONIDAZOLE,2504245217,2000,25 mg/ml,Suspension,Oral use,6.9,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ANTIPLATE 75MG TAB,DIPYRIDAMOLE,1303257063,1997,75 mg,Film-coated tablet,Oral use,20.1,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ANZATAX 6MG-ML VIAL,PACLITAXEL,1301256586,1998,6 mg/ml,concentrate for solution for injection,Intravenous use,135.15,HOSPIRA AUSTRALIA,Australia,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
ANZATAX 6MG-ML VIAL,PACLITAXEL,1301256585,1998,6 mg/ml,concentrate for solution for injection,Intravenous use,636.95,HOSPIRA AUSTRALIA,Australia,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
APIMOL 0.5% EYE DROPS,TIMOLOL MALEATE,9-290-98,1998,0.5 %,Eye drops,Ophthalmic use,9.95,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APIMOL 0.25% EYE DROPS,TIMOLOL MALEATE,10-290-98,1998,0.25 %,Eye drops,Ophthalmic use,9.15,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APILLERG EYE DROPS,"ANTAZOLINE HYDROCHLORIDE, TETRAHYDROZOLINE",1009258206,1998,"0.5,0.4 mg",Eye drops,Ophthalmic use,8.60,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Netherlands,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
APIHIST EYE\NOSE DROP,"ANTAZOLINE PHOSPHATE, NAPHAZOLINE HYDROCHLORIDE",30-290-04,2004,"5,0.25 mg",Eye/nose drops,Ophthalmic use,1.7,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APIGEN 0.3% EYE OINTEMENT,GENTAMICIN,19-290-03,2003,0.3 %,Eye ointment,Topical,3.25,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APIGEN 0.3% E-E DROPS,GENTAMICIN,14-290-00,2000,0.3 %,"Ear/eye drops, solution",Ophthalmic use,3.4,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
AMVASC 5MG CAPSULE,AMLODIPINE BESILATE,1108222469,2004,5 mg,Capsule,Oral use,53.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
APIFLOX 0.3% EYE DROPS,NORFLOXACIN,0912211451,1998,0.3 %,Eye drops,Ophthalmic use,13.85,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
APICROM 2% EYE DROPS,CROMOLYN SODIUM,0603221809,1998,2 %,Eye drops,Ophthalmic use,10.6,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
APICORT FORTE 10MG-ML EYE SUSP.,PREDNISOLONE,0904233511,2001,1 %,Eye drops,Ophthalmic use,10.6,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APICORT 0.12% EYE DROPS,PREDNISOLONE,0904233510,1998,0.12 %,Eye drops,Ophthalmic use,7.75,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APICARPINE 4% EYE DROPS,PILOCARPINE HYDROCHLORIDE,7-290-98,1998,4 %,Eye drops,Ophthalmic use,7.75,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APICARPINE 2% EYE DROPS,PILOCARPINE HYDROCHLORIDE,6-290-98,1998,2 %,Eye drops,Ophthalmic use,4.05,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
APIDRA SOLOSTAR 100 U- ML DISPOSABLE PEN,INSULIN GLULISINE,3005233746,2007,100 U/ml,Solution for injection,Subcutaneous use,169.10,Sanofi aventis Deutschland GmbH,Germany,sanofi-aventis,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
AMVASC 2.5MG CAPSULE,AMLODIPINE BESILATE,2111211346,2004,2.5 mg,Capsule,Oral use,27.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AMRIZOLE SUSP 125MG-5ML,METRONIDAZOLE,2108245794,1993,25 mg/ml,Suspension,Oral use,6.55,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
AMLOR CAPS 5MG,AMLODIPINE BESILATE,0202233207,2013,5 mg,"Capsule, hard",Oral use,60.65,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
AMLOR 10MG CAPSULES,AMLODIPINE BESILATE,0202233206,2013,10 mg,"Capsule, hard",Oral use,64.40,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
AMLOPINE 5MG CAPSULE,AMLODIPINE BESILATE,1803257094,2004,5 mg,Capsule,Oral use,53.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AMLOPINE 10MG CAPSULES,AMLODIPINE BESILATE,0711211264,2009,10 mg,Capsule,Oral use,64.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AMLOCARD 5MG TABLETS,AMLODIPINE BESILATE,0904233509,2010,5 mg,Tablet,Oral use,26.45,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
AMISTOP 5MG-5ML SUSPENSION,DOMPERIDONE,11-539-08,2008,0.1 %,Suspension,Oral use,15.40,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
AMINOVEN,"AMINO ACIDS, SOURCE UNSPECIFIED",1-706-10,2010,15 %,Solution for infusion,Intravenous use,54.8,FRESENIUS KABI,Austria,FRESENIUS KABI,Austria,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
AMINOPLASMAL B BRAUN 10%,"TYROSINE, SERINE, PROLINE, GLUTAMIC ACID, ASPARTIC ACID, GLYCINE, ALANINE, ARGININE, TRYPTOPHAN, THREONINE, PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, VALINE, HISTIDINE",1610246060,2012,"0.40,2.30,5.50,7.20,5.60,12,10.50,11.5,1.60,4.2,4.70,4.4,5.74,8.9,5,6.20,3 g",Solution for infusion,Intravenous use,84.4,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
AMINOPLASMAL B BRAUN 10%,"TYROSINE, SERINE, PROLINE, GLUTAMIC ACID, ASPARTIC ACID, GLYCINE, ALANINE, ARGININE, TRYPTOPHAN, THREONINE, PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, VALINE, HISTIDINE",0210246006,2012,"0.40,2.30,5.50,7.20,5.6,12,10.5,11.5,1.60,4.2,4.7,4.4,5.74,8.9,5,6.20,3 g",Solution for infusion,Intravenous use,42.2,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
AMINOPLASMAL 15 % I.V INFUSION SOLN,"TYROSINE, SERINE, GLUTAMIC ACID, ACETYLCYSTEINE, ASPARTIC ACID, PROLINE, ALANINE, HISTIDINE, VALINE, TRYPTOPHAN, THREONINE, PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, ARGININE, GLYCINE",0210246005,2004,"0.50,3.00,16.20,0.50,7.95,7.35,22.35,5.25,7.20,2.10,5.40,5.70,5.70,8.93,11.40,5.85,16.05,19.20 g",Solution for infusion,Intravenous use,87.4,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
AMINOPLASMAL 15 % I.V INFUSION SOLN,"TYROSINE, SERINE, GLUTAMIC ACID, ACETYLCYSTEINE, ASPARTIC ACID, PROLINE, ALANINE, HISTIDINE, VALINE, TRYPTOPHAN, THREONINE, PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, ARGININE, GLYCINE",1610246061,2004,"0.50,3.00,16.20,0.50,7.95,7.35,22.35,5.25,7.20,2.10,5.40,5.70,5.70,8.93,11.40,5.85,16.05,19.20 g",Solution for infusion,Intravenous use,54.8,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
AMINOPHYLLINE INJ 250MG,AMINOPHYLLINE,1703257079,1989,25 mg/ml,Injection,Intravenous use,4.15,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
AMOCLAN 1.2 GM VIAL,"AMOXICILLIN, CLAVULANIC ACID",394-334-24,2002,"1000,200 mg",Powder for solution for injection/infusion,Parenteral use,14.6,LABORATORIO REIG JOFRE,Spain,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
AMRIZOLE INJ 500MG-100ML BOTTLE,METRONIDAZOLE,1510246042,1993,5 mg/ml,Solution,Intravenous use,9.50,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
AMRIZOLE 500MG VAGINAL SUPPOSITORIES,METRONIDAZOLE,1711246232,1998,500 mg,Suppository,Vaginal use,7.80,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
AMRIZOLE 250 Mg TABLET,METRONIDAZOLE,2709234280,1998,250 mg,Film-coated tablet,Oral use,9.55,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
AMPIPLUS 1.5GM POWDER FOR INGECTION,"AMPICILLIN, SULBACTAM",1005233628,2011,"1000,500 mg",powder for solution for injection,Parenteral use,637.50,ANTIBIOTIC S.E,Romania,ANTIBIOTIC S.E,Romania,Marketed,Prescription,store below 25°c,Hospital,"AL HOBAIL MEDICAL OFFICE COMPANY LTD., Cigalah Group"
AMVASC 10MG CAPSULE,AMLODIPINE BESILATE,0811211271,2004,10 mg,Capsule,Oral use,64.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AMOXIPLUS 1.2GM Powder for injection,"AMOXICILLIN, CLAVULANIC ACID",1309234199,2011,"1000,200 mg",powder for solution for injection,Parenteral use,333.00,ANTIBIOTIC S.E,Romania,ANTIBIOTIC S.E,Romania,Marketed,Prescription,store below 25°c,Hospital,"AL HOBAIL MEDICAL OFFICE COMPANY LTD., Cigalah Group"
AMOXIL POWDER FOR ORAL SUSPENSION 125MG-5ML,AMOXICILLIN,1912223027,1990,25 mg/ml,Powder for oral suspension,Oral use,16.8,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
AMOXIL 500MG CAP.,AMOXICILLIN,6-212-90,1990,500 mg,Capsule,Oral use,44.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
AMOXIL 250MG CAP.,AMOXICILLIN,5-212-90,1990,250 mg,Capsule,Oral use,22.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
AMOXIL POWDER FOR ORAL SUSPENSION FORTE 250MG-5ML,AMOXICILLIN,1912223026,1990,50 mg/ml,Powder for oral suspension,Oral use,27.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
APO-DICLO 50 mg enteric-coated tablet,DICLOFENAC SODIUM,0902221703,1997,50 mg,Enteric-coated tablet,Oral use,19.80,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ATACAND 8 MG TAB,CANDESARTAN CILEXETIL,15-5444-25,2000,8 mg,Tablet,Oral use,55.10,AstraZeneca,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ATACAND 32MG TABLETS,CANDESARTAN CILEXETIL,17-5444-25,2012,32 mg,Tablet,Oral use,94.85,AstraZeneca,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ATACAND 16 MG TAB,CANDESARTAN CILEXETIL,16-5444-25,2000,16 mg,Tablet,Oral use,67.35,AstraZeneca,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ASTATIN 40MG F.C TABLETS,ATORVASTATIN CALCIUM,1111211302,2007,40 mg,Film-coated tablet,Oral use,86.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ASTATIN 20MG F.C TABLETS,ATORVASTATIN CALCIUM,0912211440,2007,20 mg,Film-coated tablet,Oral use,43.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ASTATIN 10MG F.C TABLETS,ATORVASTATIN CALCIUM,0912211439,2007,10 mg,Film-coated tablet,Oral use,43.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ASPICOT 100 MG E.C. TABLETS,ACETYLSALICYLIC ACID,3-404-09,2009,2 mg,Enteric-coated tablet,Oral use,2,PHARMALINE,Lebanon,PHARMALINE,Lebanon,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ASPICOT 100 MG E.C. TABLETS,ACETYLSALICYLIC ACID,2-404-09,2009,100 mg,Enteric-coated tablet,Oral use,0.7,PHARMALINE,Lebanon,PHARMALINE,Lebanon,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ASPICARD 81MG TAB,ACETYLSALICYLIC ACID,0902221712,1999,81 mg,Enteric-coated tablet,Oral use,30.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ASMADIL TABS 2MG,SALBUTAMOL,69-119-90,1990,2 mg,Tablet,Oral use,3.4,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ASMADIL SYRUP,SALBUTAMOL,68-119-90,1990,0.4 mg/ml,Syrup,Oral use,4.4,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ATACURE 50 MG per 5 ML,ATRACURIUM BESILATE,1901256681,2003,10 mg/ml,Solution for injection/infusion,Parenteral use,46.9,Hikma Pharmaceuticals PLC,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
ATACURE 25 MG per 2.5 ML,ATRACURIUM BESILATE,1405245300,2004,10 mg/ml,Solution for injection/infusion,Parenteral use,26.95,Hikma Pharmaceuticals PLC,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
ATAPINA 100MG FILM COATED TABLET,QUETIAPINE,1908258064,2013,100 mg,Film-coated tablet,Oral use,93.75,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
ATORVA 10MG F.C. TABLETS,ATORVASTATIN CALCIUM,0807245492,2007,10 mg,Film-coated tablet,Oral use,43.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ATORVA 80MG F.C. TABLETS,ATORVASTATIN CALCIUM,0807245496,2007,80 mg,Film-coated tablet,Oral use,86.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ATORVA 40MG F.C. TABLETS,ATORVASTATIN CALCIUM,0807245497,2007,40 mg,Film-coated tablet,Oral use,86.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ATORVA 20MG F.C. TABLETS,ATORVASTATIN CALCIUM,0807245491,2007,20 mg,Film-coated tablet,Oral use,43.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ASACOL 800MG GASTRO-RESISTANT TABLETS,MESALAZINE,0109258135,2007,800 mg,Gastro-resistant tablet,Oral use,129.60,WULFING PHARMA,Germany,TILLOTTS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
ATAPINA 300MG FILM COATED TABLET,QUETIAPINE,1908258061,2013,300 mg,Film-coated tablet,Oral use,140.65,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
ATAPINA 25MG FILM COATED TABLET,QUETIAPINE,1908258062,2013,25 mg,Film-coated tablet,Oral use,27.40,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
ATAPINA 200MG FILM COATED TABLET,QUETIAPINE,1908258066,2013,200 mg,Film-coated tablet,Oral use,187.55,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
ASACOL 500MG SUPPOSITORIES,MESALAZINE,0109258136,2007,500 mg,Suppository,Rectal use,58.70,WULFING PHARMA,Germany,TILLOTTS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
ARTIZ 10 MG F.C TABLET,CETIRIZINE HYDROCHLORIDE,0801233063,2002,10 mg,Film-coated tablet,Oral use,9.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ARANESP 300MCG-0.6ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,11-475-06,2006,300 µ/ml,Solution for injection,Subcutaneous use,2160.35,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 20MCG-0.5ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,3-475-06,2006,20 µ/ml,Solution for injection,Subcutaneous use,630.55,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 150MCG-0.3ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,10-475-06,2006,150 µ/ml,Solution for injection,Subcutaneous use,5496.60,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 10MCG-0.4ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,1-475-06,2006,10 µ/ml,Solution for injection,Subcutaneous use,373.55,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 100MCG-0.5ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,9-475-06,2006,100 µ/ml,Solution for injection,Subcutaneous use,3096.30,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
APPI- D 0.5MG-10ML SYRUP,PIZOTIFEN,2907245691,2008,50 µ/ml,Syrup,Oral use,18.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DEEF MARKITING COMPANY
APO-DOXY 100MG CAPS,DOXYCYCLINE,2204257267,1997,100 mg,Capsule,Oral use,28.85,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ARANESP 30MCG-0.3ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,4-475-06,2006,30 µ/ml,Solution for injection,Subcutaneous use,936.80,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 40MCG-0.4ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,5-475-06,2006,40 µ/ml,Solution for injection,Subcutaneous use,1292.45,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 500MCG-1ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,12-475-06,2006,500 µ/ml,Solution for injection,Subcutaneous use,3600.55,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 50MCG-0.5ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,6-475-06,2006,50 µ/ml,Solution for injection,Subcutaneous use,1552.95,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
AROMASIN 25MG COATED TAB,EXEMESTANE,0901233077,2003,25 mg,Coated tablet,Oral use,303.10,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 25°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ARIMIDEX 1MG TAB,ANASTROZOLE,49-7-00,2000,1 mg,Film-coated tablet,Oral use,184.45,AstraZeneca,United Kingdom,AstraZeneca,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ARENA 300MG TABLET,IRBESARTAN,1001233083,2012,300 mg,Tablet,Oral use,58.9,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ARENA 150MG TABLET,IRBESARTAN,1001233082,2012,150 mg,Tablet,Oral use,45.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ARBITEN PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",1301256602,2012,"80,12.5 mg",Film-coated tablet,Oral use,29.8,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ASACOL 400MG F.C TAB,MESALAZINE,0109258134,2001,400 mg,Gastro-resistant tablet,Oral use,68.20,WULFING PHARMA,Germany,TILLOTTS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
ARBITEN PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",1102256877,2012,"160,25 mg",Film-coated tablet,Oral use,32.5,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ARBITEN 80MG FILM COATED TABLETS,VALSARTAN,1301256600,2012,80 mg,Film-coated tablet,Oral use,29.65,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ARBITEN 160MG FILM COATED TABLETS,VALSARTAN,1102256878,2012,160 mg,Film-coated tablet,Oral use,32.5,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ARAVA 20MG FILM COATED TABLETS,LEFLUNOMIDE,52-23-09,2009,20 mg,Film-coated tablet,Oral use,160.60,Opella Healthcare International,France,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ARAVA 10MG FILM COATED TABLETS,LEFLUNOMIDE,51-23-08,2008,10 mg,Film-coated tablet,Oral use,111.40,Opella Healthcare International,France,sanofi-aventis,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ARAPENTA Injection*,"DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN, HAEMOPHILUS INFLUENZAE TYPE B",3-800-12,2012,"15,10,4<,10,10 µg, LfU",Solution for injection,Intramuscular use,80.75,"LG CHEM , OSONG PLANT",KOREA,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
ARANESP 80MCG-0.4ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,8-475-06,2006,80 µ/ml,Solution for injection,Subcutaneous use,2573.40,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARANESP 60MCG-0.3ML PRE-FILLED SYRINGE,DARBEPOETIN ALFA,7-475-06,2006,60 µ/ml,Solution for injection,Subcutaneous use,1909.35,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ARBITEN PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",1102256879,2012,"160,12.5 mg",Film-coated tablet,Oral use,32.5,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ACTEMRA 20 MG/ML Solution for injection/infusion,TOCILIZUMAB,273-24-14,2014,20 mg/ml,Solution for infusion,Intravenous use,2936.40,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ACTEMRA 20 MG/ML Solution for injection/infusion,TOCILIZUMAB,272-24-14,2014,20 mg/ml,Solution for infusion,Intravenous use,1468.20,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ACTEMRA 20 MG/ML Solution for injection/infusion,TOCILIZUMAB,271-24-14,2014,20 mg/ml,Solution for infusion,Intravenous use,587.30,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ACRETIN,TRETINOIN,8-368-00,2000,0.05 %,Cream,Topical,19.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACRETIN,TRETINOIN,9-368-00,2000,0.025 %,Cream,Topical,18.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACNEZOYL 5% GEL,BENZOYL PEROXIDE,0707245489,2002,5 %,Gel,Topical,8.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACNELIN,TRETINOIN,2610222822,2003,0.05 %,Cream,Topical,15.80,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ACLASTA 5MG-100ML SOLUTION FOR Infusion*,ZOLEDRONIC ACID,5-5773-23,2006,0.05 mg/ml,Solution for infusion,Intravenous use,1482.25,NOVARTIS,Switzerland,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ACILOC,OMEPRAZOLE,102-368-08,2008,40 mg,"Gastro-resistant capsule, hard",Oral use,120.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACILOC,OMEPRAZOLE,64-368-04,2004,40 mg,"Gastro-resistant capsule, hard",Oral use,30.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACTILYSE SET(2VLS+2SOLV&INFSET),ALTEPLASE,3007245698,1989,50 mg,Powder and solvent for solution for injection,Intravenous use,5336.10,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Boehringer Ingelheim Scientific Office, Cigalah Group"
ADENOHARDT 6MG/2ML SOLUTION FOR INFUSION,ADENOSINE,0801233066,2013,3 mg/ml,Solution for injection,Intravenous use,140.50,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
ADENOHARDT 30MG/10ML SOLUTION FOR INFUSION,ADENOSINE,12-178-13,2013,3 mg/ml,Solution for injection,Intravenous use,339.40,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
ACILOC,OMEPRAZOLE,63-368-04,2004,40 mg,"Gastro-resistant capsule, hard",Oral use,61,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ADALAT 30MG LA TAB,NIFEDIPINE,44-4-01,2001,30 mg,modified-release tablet,Oral use,46.40,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ACTRAPID,INSULIN NEUTRAL,0805245257,1989,100 IU/ml,Solution,Subcutaneous use,65,NOVO NORDISK PRODUCTION S.A.S,France,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
ACTOS 30MG TAB,PIOGLITAZONE,1209245904,2002,30 mg,Tablet,Oral use,87.75,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ACTOS 15MG TABLET,PIOGLITAZONE,2112234623,2004,15 mg,Tablet,Oral use,51.7,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ACULAR LS 0.4% OPHTHALMIC SOLUTION,KETOROLAC TROMETHAMINE,0505257334,2009,0.4 %,Ophthalmic solution,Ophthalmic use,19.2,ALLERGAN PHARMACEUTICALS LTD,United States,AbbVie Inc,United States,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ADOLIN 0.1% W-W CREAM,ADAPALENE,2207257798,2010,0.1 %,Cream,Topical,17.15,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ACILOC,OMEPRAZOLE,101-368-08,2008,20 mg,"Gastro-resistant capsule, hard",Oral use,88.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACILOC,OMEPRAZOLE,0709234151,2004,20 mg,"Gastro-resistant capsule, hard",Oral use,45.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACC LONG 600MG EFFERVESCENT TABLETS,ACETYLCYSTEINE,7-349-09,2009,600 mg,Effervescent tablet,Oral use,16.55,Hermes Pharma GmbH,Germany,HEXAL,Germany,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ACC 200MG POWDER FOR ORAL SOLUTION,ACETYLCYSTEINE,6-349-09,2009,200 mg,Powder for oral solution,Oral use,11.4,HEXAL,Germany,HEXAL,Germany,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
2% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,3005222094,2002,2 %,Solution for injection,"intramuscular, subcutaneous",8.40,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
2% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,0108222386,2002,2 %,Solution for injection,"intramuscular, subcutaneous",7.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
2% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,0108222388,2002,2 %,Solution for injection,"intramuscular, subcutaneous",6.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
2% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,246-149-02,2002,2 %,Solution for injection,"intramuscular, subcutaneous",4.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
15% W-V POTASSIUM CHLORIDE FOR INJ. USP,POTASSIUM CHLORIDE,133-149-96,1996,15 %,Solution for injection,Intravenous use,0.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
15% W-V POTASSIUM CHLORIDE FOR INJ. USP,POTASSIUM CHLORIDE,1807245613,1996,15 %,Concentrate for solution for infusion,Intravenous use,2.20,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
15% W-V POTASSIUM CHLORIDE FOR INJ. USP,POTASSIUM CHLORIDE,1807245612,1998,15 %,Concentrate for solution for infusion,Intravenous use,3.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
1% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,0108222387,2000,1 %,Solution for injection,"intramuscular, subcutaneous",9.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
1% W-V LIDOCAINE HCL INJECTION USP,LIDOCAINE HYDROCHLORIDE,0108222389,2000,1 %,Solution for injection,"intramuscular, subcutaneous",8.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
0.9% W/V SODIUM CHLORIDE INJECTION B.P,SODIUM CHLORIDE,1807245614,1995,0.9 %,Solution for injection,Parenteral use,1.70,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
0.9% W/V SODIUM CHLORIDE INJECTION B.P,SODIUM CHLORIDE,1807245615,1995,0.9 %,Solution for injection,Parenteral use,1.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ACETAB 25 MG TABLETS,CAPTOPRIL,2511246334,2004,25 mg,Tablet,Oral use,20.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACETAB 50 MG TABLETS,CAPTOPRIL,0801256558,2004,50 mg,Tablet,Oral use,34.2,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACID CONC. HAEMODIALYSIS KSP-06 (1+34),"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",61-352-05,2005,"210.7,77,9,6.242,5.22,3.558 g/l",Concentrate for solution for haemodialysis,Parenteral use,25.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACID CONC. HAEMODIALYSIS KSP-05 (1+44),"SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE",62-352-05,2005,"263,9.92,6.71,5.42,3.43 g/l",Solution,Intravenous use,25.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACID CONC. HAEMODIALYSIS KSP-04 (1+44),"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE",63-352-05,2005,"263,99,9.92,6.71,5.42,3.43 g/l",Concentrate for solution for haemodialysis,Parenteral use,25.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACID CONC. HAEMODIALYSIS KSP-03 (1+44),"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE, ACETIC ACID",64-352-05,2005,"263,9.92,3.43,99,5.42 g/l",Concentrate for solution for haemodialysis,Parenteral use,25.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ACILOC,OMEPRAZOLE,0409234107,2004,20 mg,"Gastro-resistant capsule, hard",Oral use,22.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACICONE - S 720 MG CHEWABLE TAB,"MAGALDRATE, SIMETHICONE",10-251-02,2002,"720,25 mg",Chewable tablet,Oral use,4.95,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
ACICONE - S 540MG-5ML SUSP,"MAGALDRATE, SIMETHICONE",8-251-02,2002,"108,8 mg/ml",Suspension,Oral use,4.95,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
ACICAL PLUS CHEWABLE TABLETS,"DIHYDROXYALUMINIUM SODIUM CARBONATE, SIMETHICONE",1702221732,2008,"320,20 mg",Chewable tablet,Oral use,7,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
ACICONE 540MG-5ML SUSP,MAGALDRATE,9-251-02,2002,108 mg/ml,Suspension,Oral use,4.95,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
ADOLIN 0.1% W-W GEL,ADAPALENE,1505257401,2010,0.1 %,Gel,Topical,17.15,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ALLERFIN AMP 10MG-ML,CHLORPHENIRAMINE MALEATE,0811222888,1990,10 mg/ml,Solution,Intravenous use,6.05,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ALKA-UR EFFERVES. 4GM GRANULES SUGARFREE,"SODIUM BICARBONATE, TARTARIC ACID, CITRIC ACID ANHYDROUS, TRI SODIUM CITRATE",2710246112,2008,"1.760,0.890,0.720,0.630 g",Effervescent granules,Oral use,9.75,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ALKA-UR EFFERVES. 4GM GRANULES SUGARFREE,"SODIUM BICARBONATE, TARTARIC ACID, CITRIC ACID ANHYDROUS, TRI SODIUM CITRATE",1112246403,2008,"1.76,0.890,0.72,0.630 g",Effervescent granules,Oral use,29.25,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ALEXAN 2000MG- 40ML VIAL,CYTARABINE,41-355-07,2007,50 mg/ml,Solution for injection/infusion,Intravenous use,173.15,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ALEXAN 1000MG- 20ML VIAL,CYTARABINE,32-355-05,2005,50 mg/ml,Solution for injection/infusion,Intravenous use,103.70,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ALEXAN 500MG- 10ML,CYTARABINE,31-355-05,2005,50 mg/ml,Solution for injection/infusion,Intravenous use,51.75,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ALEXAN 20MG-1ML VIAL,CYTARABINE,37-355-06,2006,20 mg/ml,Solution for injection/infusion,Intravenous use,36.20,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ALLERFIN TABLETS 4MG,CHLORPHENIRAMINE MALEATE,3-119-82,1982,4 mg,Tablet,Oral use,2.55,APM,Jordan,APM,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ALLERGETIN SYRUP,"CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE",1006245402,2004,"2,30 mg, g",Syrup,Oral use,2.55,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
ALLERGODIL NASAL SPRAY WITH SPRAYER,AZELASTINE,8-5927-25,1997,1 mg/ml,"Nasal spray, solution",Nasal use,35,Madaus GmbH,Germany,Viatris Healthcare GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
AMBOLAR,AMBROXOL HYDROCHLORIDE,3107222372,1996,3 mg/ml,Syrup,Oral use,7.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
AMBISOME 50 MG VIAL,AMPHOTERICIN B,2807257870,2013,50 mg,Powder for concentrate for dispersion for infusion,Intravenous use,4645.90,GILEAD SCIENCES INC,United States,GILEAD SCIENCES LIMITED (CORK),Ireland,Marketed,Prescription,store below 25°c,Hospital,"Cigalah Group, Gilead Sciences Arabia Ltd"
AMARYL 3MG TAB,GLIMEPIRIDE,42-23-99,1999,3 mg,Tablet,Oral use,47.15,Sanofi S.r.l.,Italy,sanofi-aventis,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
AMARYL 2MG TAB,GLIMEPIRIDE,41-23-99,1999,2 mg,Tablet,Oral use,33.90,Sanofi S.r.l.,Italy,sanofi-aventis,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ALENDRONATE SANDOZ 70MG F/C TABLET,ALENDRONATE SODIUM,2807222355,2012,70 mg,Film-coated tablet,Oral use,28.5,LEK PHARMACEUTICAL D.D,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
AMARYL 1MG TAB,GLIMEPIRIDE,40-23-99,1999,1 mg,Tablet,Oral use,20.80,Sanofi S.r.l.,Italy,sanofi-aventis,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ALPHAGAN-P 0.15% OPHTHALMIC SOLUTION,BRIMONIDINE TARTRATE,1611258599,2006,0.15 %,Ophthalmic solution,Ophthalmic use,38.50,ALLERGAN,United States,AbbVie Inc,United States,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ALPAX AMP. 2MG-ML,PANCURONIUM BROMIDE,140-172-03,2003,2 mg/ml,Solution,Intravenous use,13.4,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
ADRENALINE 1:1000 INJ,ADRENALINE,1-239-86,1986,1 mg/ml,Solution for injection,Intravenous use,12.45,ANTIGEN,Ireland,ANTIGEN,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ALENDRO,ALENDRONIC ACID,0409234106,2008,70 mg,Tablet,Oral use,43.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ALDOMET 250MG TABLETS,METHYLDOPA,2702244995,2010,250 mg,Tablet,Oral use,18.35,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
AGGRASTAT 0.25MG/ML I.V. VIAL,TIROFIBAN,2208234024,2010,0.25 mg/ml,Concentrate for solution for infusion,Intravenous use,980.15,Patheon Manufacturing Services LLC,United States,Algorithm SAL,Lebanon,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
AFINITOR 5 MG TABLET,EVEROLIMUS,2307245638,2010,5 mg,Tablet,Oral use,11047.60,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
AERIUS 5MG TABLETS,DESLORATADINE,1108210927,2003,5 mg,Film-coated tablet,Oral use,23.30,SPIMACO,Saudi Arabia,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,Bayer Saudi Arabia
AERIUS 2.5 MG-5ML SYRUP,DESLORATADINE,1108210928,2005,0.5 mg/ml,Oral solution,Oral use,23.95,SPIMACO,Saudi Arabia,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,Bayer Saudi Arabia
ADVIL COLD AND SINUS CAPLET,"IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE",2610211236,2003,"200,30 mg",Tablet,Oral use,11.75,PFIZER,Canada,GLAXOSMITHKLINE (GSK),Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
ADVIL COLD AND SINUS CAPLET,"IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE",42-31-01,2001,"200,30 mg",Tablet,Oral use,6.7,PFIZER,Canada,PFIZER,Canada,Marketed,OTC,store below 30°c,Pharmacy,ALNAGHI COMPANY
ADVATE 500 IU,HUMAN COAGULATION FACTOR VIII,2-5603-21,2014,500 IU,Powder and solvent for solution for injection,Intravenous use,1236.45,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ADVATE 250 IU,HUMAN COAGULATION FACTOR VIII,1-5603-21,2014,250 IU,Powder and solvent for solution for injection,Intravenous use,618.20,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ADVAGRAF 5MG PROLONGED RELEASE CAPSULE,TACROLIMUS,2803245120,2013,5 mg,"Prolonged-release capsule, hard",Oral use,3478.75,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ADVAGRAF 3MG PROLONGED RELEASE CAPSULE,TACROLIMUS,2803245121,2013,3 mg,"Prolonged-release capsule, hard",Oral use,2087.25,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ADVAGRAF 1MG PROLONGED RELEASE CAPSULE,TACROLIMUS,2803245122,2013,1 mg,"Prolonged-release capsule, hard",Oral use,695.75,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ADVAGRAF 0.5MG PROLONGED RELEASE CAPSULE,TACROLIMUS,2803245119,2013,0.5 mg,"Prolonged-release capsule, hard",Oral use,347.90,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
AGIOLAX GRANULES,"ISPAGHULA SEED, TINNEVELLY SENNA PODS, ISPAGHULA HUSK",9-813-21,1983,"2.6,0.5,0.11 g",Granules,Oral use,22.45,Rottapharm|Madaus Group,Germany,MEDA Pharma GmbH & Co. KG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
AGOUT 120 mg film-coated tablets,FEBUXOSTAT,2503245089,2014,120 mg,Film-coated tablet,Oral use,106.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ALDARA 5% CREAM,IMIQUIMOD,1-813-11,2011,5 %,Cream,Topical,242.85,3M,United Kingdom,MEDA PHARMA GmbH & Co KG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ALBUTEIN 20% SOLN. FOR INJ,ALBUMIN HUMAN,1706257572,2000,20 %,Intravenous infusion,Intravenous use,146.40,GRIFOLS BIOLOGICALS,United States,GRIFOLS BIOLOGICALS LLC,United States,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
ALBOTHYL VAGINAL OVULE 90MG,POLICRESULEN,0801233064,1983,90 mg,Suppository,Vaginal use,14.25,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
AIRFAST 4MG GRANULES,MONTELUKAST SODIUM,0608257948,2014,4 mg,Granules,Oral use,95.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
AIRFAST 4MG CHEWABLE TABLETS,MONTELUKAST SODIUM,1501256626,2013,4 mg,Chewable tablet,Oral use,100.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
AIRFAST 10MG FILM COATED TABLET,MONTELUKAST SODIUM,1501256622,2011,10 mg,Film-coated tablet,Oral use,100.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
AIMAFIX 500I.U. POW. FOR SOLU. FOR INFU,HUMAN PLASMA COAGULATION FACTOR IX,0602244854,2008,500 IU,Powder and solvent for solution for infusion,Parenteral use,554.6,KEDRION,Italy,KEDRION,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
AGOUT 80 mg film-coated tablets,FEBUXOSTAT,2008258070,2014,80 mg,Film-coated tablet,Oral use,106.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AGOUT 40 mg film-coated tablets,FEBUXOSTAT,1208258008,2014,40 mg,Film-coated tablet,Oral use,106.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AIRFAST 5MG CHEWABLE TABLETS,MONTELUKAST SODIUM,1501256623,2013,5 mg,Chewable tablet,Oral use,100.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ATROPINE SULF. E.S 50MCG-ML,ATROPINE SULFATE,37-549-90,1990,50 µ/ml,Solution for injection,Parenteral use,30.65,HOSPIRA INC. ROCKY MOUNT,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
BRIMO-P OPHTHALMIC SOLUTION 0.1%,BRIMONIDINE TARTRATE,0203256965,2011,0.1 %,"Eye drops, solution",Ophthalmic use,25.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
BRIMO,BRIMONIDINE TARTRATE,91-368-06,2006,0.2 %,Eye drops,Ophthalmic use,38.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
BRILINTA 90 MG FILM COATED TABLET,TICAGRELOR,1210258399,2013,90 mg,Film-coated tablet,Oral use,195.60,AstraZeneca AB,Sweden,AstraZeneca,Sweden,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BOTOX 100UNITS,CLOSTRIDIUM BOTULINUM NEUROTOXIN A COMPLEX,2508258103,1998,100 U,powder for solution for injection,Intramuscular use,671.05,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE LIMITED,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
BONVIVA 150 MG F.C. TABLETS,IBANDRONIC ACID,0711222880,2006,150 mg,Film-coated tablet,Oral use,81.30,Penn Pharmaceutical Services Ltd,United Kingdom,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
BRONCLYN 1.5MG-5ML SYRUP,TERBUTALINE,1804221946,2008,0.3 mg/ml,Syrup,Oral use,5.6,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BRUFEN 400 MG TAB,IBUPROFEN,1308258025,1981,400 mg,Coated tablet,Oral use,13.6,Astrea Fontaine,France,Abbott Laboratories,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BRUFEN TAB 600MG,IBUPROFEN,16-138-87,1987,600 mg,Film-coated tablet,Oral use,19.55,Astrea Fontaine,France,Abbott Laboratories,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CADUET 10-40,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",8-5825-23,2013,"40,10 mg",Tablet,Oral use,154.6,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
CADUET 10-20,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",7-5825-23,2013,"20,10 mg",Tablet,Oral use,111.25,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
CADUET 10-10,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",6-5825-23,2013,"10,10 mg",Tablet,Oral use,111.25,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
BUDIAIR 200 MCG PRESSURISED INH SOLUTION,BUDESONIDE,4-340-07,2007,200 µg,"Pressurised inhalation, solution",Inhalation use,83.45,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BUCAINE 0.5% solution for injection,BUPIVACAINE,0608257950,1998,0.5 %,Solution,Intravenous use,16.95,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
BUCAINE 0.25% VIAL,BUPIVACAINE,1502244924,1998,0.25 %,Injection,Intravenous use,16.5,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CADUET 5-10,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",3-5825-23,2013,"10,5 mg",Tablet,Oral use,107.3,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
BLOPRESS 8 PLUS TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",118-119-09,2009,"8,12.5 mg",Tablet,Oral use,47.7,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BILAXTEN 20MG TABLET,BILASTINE,163-334-12,2012,20 mg,Tablet,Oral use,29.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BI PRETERAX ARGININE 5MG-1.25MG F.C. TAB,"PERINDOPRIL ARGININE, INDAPAMIDE",6-597-09,2009,"5,1.25 mg",Film-coated tablet,Oral use,47.70,SERVIER,Ireland,SERVIER,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
BEVASON 0.1% OINTMENT,BETAMETHASONE VALERATE,2411211359,2006,0.1 %,Ointment,Topical,4,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
BEVASON 0.1% CREAM,BETAMETHASONE VALERATE,2411211362,2006,0.1 %,Cream,Topical,4,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
BEVACOL 135MG TABLET,MEBEVERINE HYDROCHLORIDE,42-171-04,2004,135 mg,Film-coated tablet,Oral use,14.45,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
BETNOVATE-N OINTMENT,"NEOMYCIN SULFATE, BETAMETHASONE VALERATE",13-276-97,1997,"0.5,0.1 % (W/W)",Ointment,Topical,10.7,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE-N 0.1% CREAM,"NEOMYCIN SULFATE, BETAMETHASONE VALERATE",14-276-97,1997,"0.5,0.1 %",Cream,Topical,10.7,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE-C OINT.,"CLIOQUINOL, BETAMETHASONE VALERATE",51-276-98,1998,"3,0.1 % (W/W)",Ointment,Topical,13.1,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE-C CREAM,"CLIOQUINOL, BETAMETHASONE VALERATE",49-276-98,1998,"3,0.1 % (W/W)",Cream,Topical,13.1,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE OINTMENT 0.1%,BETAMETHASONE VALERATE,2312258817,1997,0.1 %,Ointment,Topical,10.1,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE CREAM 0.1%,BETAMETHASONE VALERATE,2312258816,1997,0.1 %,Cream,Topical,10.1,GLAXO SAUDI ARABIA,Saudi Arabia,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
BETNOVATE 0.1% SCALP APPLICATION,BETAMETHASONE VALERATE,2410211225,1997,0.1 %,Scalp solution,Topical,13.65,ASPEN Bad Oldesloe GmbH,Germany,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
BETAZOL,"MICONAZOLE NITRATE, BETAMETHASONE DIPROPIONATE",1509222609,2001,"2,0.05 % (W/W)",Cream,Topical,16.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
BILTRICIDE 600MG TABS,PRAZIQUANTEL,2610234398,1984,600 mg,Film-coated tablet,Oral use,65.90,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
BLOPRESS 16 PLUS TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",119-119-09,2009,"16,12.5 mg",Tablet,Oral use,54.65,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BLOPRESS 16 MG TABLETS,CANDESARTAN CILEXETIL,115-119-02,2002,16 mg,Tablet,Oral use,54.65,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BISOLVON 8MG TABLETS,BROMHEXINE,52-68-87,1987,8 mg,Tablet,Oral use,11.9,DELPHARM REIMS S.A.S,France,BOEHRINGER INGELHEIM,Germany,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
BLOPRESS 8MG TAB.,CANDESARTAN CILEXETIL,107-119-01,2001,8 mg,Tablet,Oral use,47.7,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BISCOR 5MG F.C. TABLETS,BISOPROLOL FUMARATE,17-631-24,2009,5 mg,Film-coated tablet,Oral use,22.3,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
BIOVIT 12 DEPOT,"FOLIC ACID, HYDROXOCOBALAMIN, PYRIDOXINE (VITAMIN B6)",2802245001,2010,"1000/2ml,1000/2ml,20/2ml mg, µg",Solution,Intravenous use,4.05,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 25°c,Hospital,"Annhdah Medical Company, Cigalah Group"
BIOCEF 500MG CAPSULE,CEFACLOR,1902233258,2000,500 mg,Capsule,Oral use,48.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BISCOR 10MG F.C. TABLETS,BISOPROLOL FUMARATE,18-631-24,2009,10 mg,Film-coated tablet,Oral use,31.6,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CADUET 5-20,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",4-5825-23,2013,"20,5 mg",Tablet,Oral use,107.30,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
"CARBOPLATIN ""EBEWE"" 50MG-5ML",CARBOPLATIN,2-355-01,2001,10 mg/ml,Concentrate for solution for infusion,Parenteral use,141.4,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CAPRIL 50MG TAB,CAPTOPRIL,91-212-98,1998,50 mg,Tablet,Oral use,31.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CAPRIL 25MG TAB,CAPTOPRIL,90-212-98,1998,25 mg,Tablet,Oral use,18.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CAPD4 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",82-149-95,1995,"25,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD4 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",115-149-95,1995,"25,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD4 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",114-149-95,1995,"25,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD4 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",113-149-95,1995,"25,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD3 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",112-149-95,1995,"46.750,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD3 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",111-149-95,1995,"46.750,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD3 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",81-149-95,1995,"46.750,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD3 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",110-149-95,1995,"46.750,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD2 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",109-149-95,1995,"16.50,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,19.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CAPD2 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",80-149-95,1995,"16.50,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,30.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
"CARBOPLATIN ""EBEWE"" 50MG-5ML",CARBOPLATIN,3-355-01,2001,10 mg/ml,Concentrate for solution for infusion,Parenteral use,281.35,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CARVIDOL 25 MG TAB,CARVEDILOL,2802210560,2003,25 mg,Tablet,Oral use,47.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
CARDURA XL 4 mg tablet,DOXAZOSIN,1-5745-22,2013,4 mg,Prolonged-release tablet,Oral use,34,Pfizer Pharmaceutical LLC,United States,PFIZER OFG GERMANY GMBH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
CAPD2 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",108-149-95,1995,"16.5,5.78,0.257,0.101,3.92 g",Solution,Intraperitoneal,17.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CARDIOPROL 5MG TABLETS,BISOPROLOL FUMARATE,2307257818,2011,5 mg,Tablet,Oral use,16.25,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
CARDIOPROL 10MG TABLETS,BISOPROLOL FUMARATE,1408258028,2011,10 mg,Tablet,Oral use,23.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
CARDICOR PLUS 5/12.5MG FILM COATED TABLET,"HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE",0501221563,2013,"12.5,5 mg",Film-coated tablet,Oral use,22.7,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CARDICOR 5MG FILM COATED TABLET,BISOPROLOL FUMARATE,0501221562,2012,5 mg,Film-coated tablet,Oral use,24.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CARDICOR 2.5MG FILM COATED TABLET,BISOPROLOL FUMARATE,0501221565,2012,2.5 mg,Film-coated tablet,Oral use,16.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CARDICOR 10MG FILM COATED TABLET,BISOPROLOL FUMARATE,0501221560,2012,10 mg,Film-coated tablet,Oral use,30.10,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CADUET 5-40,"ATORVASTATIN CALCIUM, AMLODIPINE BESILATE",5-5825-23,2013,"40,5 mg",Tablet,Oral use,150.75,PFIZER,Germany,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
CAPD2 PERITONEAL DIALYSIS SOLN,"DEXTROSE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM LACTATE",107-149-95,1995,"16.50,5.7860,0.2573,0.1017,7.847 g/l",Solution,Intraperitoneal,15.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CALCIUM FOLINATE 50MG-5ML VIAL,FOLINIC ACID,1710222744,1997,10 mg/ml,Solution,Intravenous use,82.15,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Pfizer Saudi Trading
Calciumfolinat Sandoz 10MG-ML VIAL,FOLINIC ACID,131-116-23,2010,10 mg/ml,Solution for injection,Intravenous use,53.80,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,Sandoz GmbH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Calciumfolinat Sandoz 10MG-ML VIAL,FOLINIC ACID,132-116-23,2010,10 mg/ml,Solution for injection,Intravenous use,164.75,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,SANDOZ GMBH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CALCIUM CHLORIDE 7.35% INJECTION,CALCIUM CHLORIDE,299-149-04,2004,7.35 %,Solution for injection,Intravenous use,0.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
CALCIUM CHLORIDE 7.35% INJECTION,CALCIUM CHLORIDE,298-149-04,2004,7.35 %,Solution for injection,Intravenous use,0.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
CALCIUM CHLORIDE 7.35% INJECTION,CALCIUM CHLORIDE,297-149-04,2004,7.35 %,Solution for injection,Intravenous use,0.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
CALCIUM CHLORIDE 10% INJECTION,CALCIUM CHLORIDE,1108222466,2008,10 %,Solution for injection,Intravenous use,2.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
CALCIUM CHLORIDE 10% EMERGENCY SYRINGE,CALCIUM CHLORIDE,1710222742,1991,10 %,Solution,Intravenous use,45.45,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
CALCINATE,CALCIUM CARBONATE,1111246171,2006,600 mg,Film-coated tablet,Oral use,30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,RIYADH PHARMA
CAFERGOT 1 MG TAB,"CAFFEINE, ERGOTAMINE TARTRATE, HYDROCHLOROTHIAZIDE, EPROSARTAN MESILATE",7-849-13,1980,"100,1,12.5,600 mg",Tablet,Oral use,16.3,NOVARTIS,United Kingdom,AMDIPHARMA,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CALCIUM GLUCONATE 10% AMP,CALCIUM GLUCONATE,2207245624,2003,"10 mg, %",Solution for injection,Intravenous use,50.25,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
CANDIZOLE 2% VAGINAL CREAM,MICONAZOLE NITRATE,2209258257,2006,2 %,Vaginal cream,Vaginal use,17.65,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
CANDIVAST 50MG CAP,FLUCONAZOLE,3101221659,2003,50 mg,Capsule,Oral use,45.45,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CANDIVAST 150MG CAP,FLUCONAZOLE,3101221660,2003,150 mg,Capsule,Oral use,19.45,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CANDEUR 150MG CAPSULES,FLUCONAZOLE,1008257969,2006,150 mg,Capsule,Oral use,17.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CalSource Ca-C1000,"CALCIUM LACTATE GLUCONATE, ASCORBIC ACID, CALCIUM CARBONATE",3011211403,1981,"1,1,0.327 g",Effervescent tablet,Oral use,11.65,Delpharm Orleans,France,GSK CONSUMER HEALTHCARE SCHWEIZ AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
CALCIUM SANDOZ EFF TAB FORTE,"CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE",197-11-80,1980,"1132,875 mg",Effervescent tablet,Oral use,11,FAMAR,France,NOVARTIS,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
CALCIUM GLUCONATE 10% W-V INJECTION,CALCIUM GLUCONATE,302-149-06,2006,10 %,Solution for injection,Intravenous use,3.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CALCIUM GLUCONATE 10% W-V INJECTION,CALCIUM GLUCONATE,304-149-06,2006,10 %,Solution for injection,Intravenous use,4.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CALCIUM GLUCONATE 10% W-V INJECTION,CALCIUM GLUCONATE,2107222333,2006,10 %,Solution for injection,Intravenous use,6.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CALSYR  SYRUP,"CALCIUM GLUBIONATE, CALCIUM LACTOBIONATE",0502256829,2004,"0.287,0.295 g",Syrup,Oral use,7.1,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
AZI-ONCE,AZITHROMYCIN,0912211442,2006,40 mg/ml,Powder for oral suspension,Oral use,24.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AZI-ONCE,AZITHROMYCIN,85-368-06,2006,40 mg/ml,Powder for oral suspension,Oral use,33.70,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AZI-ONCE,AZITHROMYCIN,2210246092,2006,40 mg/ml,Powder for oral suspension,Oral use,43.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AZI-ONCE,AZITHROMYCIN,0409234110,2002,250 mg,Capsule,Oral use,50.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AZIMAC 500 mg,AZITHROMYCIN,1111246173,2007,500 mg,Film-coated tablet,Oral use,50.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AZIMAC 250 mg,AZITHROMYCIN,1111246174,2007,250 mg,Film-coated tablet,Oral use,50.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AVOTIN- A,TRETINOIN,1106245406,2008,0.05 %,Cream,Topical,17.40,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVORAL 2% SHAMPOO,KETOCONAZOLE,0108222391,2012,2 %,Shampoo,Topical,18.3,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOQUIN,HYDROQUINONE,2111234524,2006,4 %,Cream,Topical,33.65,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOMACK,"SALICYLIC ACID, LACTIC ACID",2509245949,2014,"16.7,16.7 % (W/W)",Cutaneous solution,Topical,18.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOMACK,"SALICYLIC ACID, LACTIC ACID",2509245948,2014,"16.7,16.7 % (W/W)",Cutaneous solution,Topical,24.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Avocom-M Cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2004257237,2014,"2,0.1 %",Cream,Topical,37.25,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Avocom-M Cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2004257238,2014,"2,0.1 %",Cream,Topical,23,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOGAIN,MINOXIDIL,1002256860,2007,5 %,Cutaneous solution,Topical,66,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BALAD,FUSIDIC ACID,1111246172,2001,2 %,Cream,Topical,9.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
BACTROBAN OINT 2%,MUPIROCIN CALCIUM,172-276-20,1988,2 %,Ointment,Topical,27.7,GLAXO,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
BACTROBAN NASAL OINTMENT 2%,MUPIROCIN CALCIUM,156-276-20,2000,2 %,Nasal ointment,Nasal use,35.05,GLAXO,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
BACTRIM SUSP,"SULFAMETHOXAZOLE, TRIMETHOPRIM",2307257824,1997,"40,8 mg/ml",Oral suspension,Oral use,19,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,SPIMACO
AVOGAIN,MINOXIDIL,1002256857,2007,2 %,Cutaneous solution,Topical,55.5,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BACTALL 500MG TABLET,CIPROFLOXACIN,0701256528,2004,500 mg,Film-coated tablet,Oral use,23.4,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
BACTALL 250MG TABLET,CIPROFLOXACIN,0701256527,2004,250 mg,Film-coated tablet,Oral use,12.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
BABYLYTE ORAL SOLUTION,"DEXTROSE, SODIUM CHLORIDE, SODIUM CITRATE, potassium citrate",2107222328,1992,"27.5,2.045,0.980,2.162 g/l",Oral solution,Oral use,10.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BABYLYTE,"DEXTROSE, SODIUM CHLORIDE, SODIUM CITRATE, POTASSIUM CHLORIDE",149-149-98,1998,"27.5,2.045,0.980,2.162 g/l",Oral solution,Oral use,7.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BABYLYTE,"DEXTROSE, SODIUM CHLORIDE, SODIUM CITRATE, POTASSIUM CHLORIDE",150-149-98,1998,"27.5,2.045,0.980,2.162 g/l",Oral solution,Oral use,4.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BABYLYTE,"DEXTROSE, SODIUM CHLORIDE, SODIUM CITRATE, POTASSIUM CHLORIDE",148-149-98,1998,"27.5,2.045,0.980,2.162 g/l",Oral solution,Oral use,12.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BACTRIM FORTE TAB,"SULFAMETHOXAZOLE, TRIMETHOPRIM",1004257224,1998,"800,160 mg/ml",Tablet,Oral use,23.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,SPIMACO
AVODART 0.5MG CAPSULE,DUTASTERIDE,2306210821,2013,0.5 mg,Capsule,Oral use,111.90,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
AVOCOM,MOMETASONE FUROATE,0407245482,2006,0.1 %,Ointment,Topical,17.10,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AUGMENTIN 457MG-5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0809211026,2013,"400,57 mg",Suspension,Oral use,33.05,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
AUGMENTIN 312 MG-5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0809211029,2013,"50,12.5 mg, mg/ml",Powder for oral suspension,Oral use,32.55,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
AUGMENTIN 228 MG-5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0809211024,2013,"200,28.5 mg",Suspension,Oral use,19.20,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
AUGMENTIN 156 Mg-5 ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0809211027,2013,"125,31.25 mg",Powder for oral suspension,Oral use,17.35,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
AUGMENTIN 1 G TAB,"AMOXICILLIN, CLAVULANIC ACID",0809211030,2013,"875,125 mg",Tablet,Oral use,78.30,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
AUGMENTIN ES SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",1101221582,2013,"600,42.9 mg",Powder for oral suspension,Oral use,32.65,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,GLAXO SAUDI ARABIA
ATROPINE SULPHATE 0.6MG\ML AMPOULE,ATROPINE SULFATE,290-149-04,2004,0.6 mg/ml,Solution,Intravenous use,1.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ATROPINE SULPHATE 0.6MG\ML AMPOULE,ATROPINE SULFATE,1210222717,2004,0.6 mg/ml,Solution,Intravenous use,1.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ATROPINE SULPHATE 0.5MG\ML AMPOULE,ATROPINE SULFATE,0901233072,2004,0.5 mg/ml,Solution,Intravenous use,3.70,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
ATROPINE SULPHATE 0.5MG\ML AMPOULE,ATROPINE SULFATE,288-149-04,2004,0.5 mg/ml,Solution,Intravenous use,0.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ATROPINE SULF.E.S 100MCG-ML,ATROPINE SULFATE,39-549-90,1990,100 µ/ml,Solution for injection,Parenteral use,30.65,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
ATROPINE SULF.E.S 100MCG-ML,ATROPINE SULFATE,38-549-90,1990,100 µ/ml,Solution for injection,Parenteral use,30.65,HOSPIRA,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
AUGMENTIN 625 MG TAB,"AMOXICILLIN, CLAVULANIC ACID",0809211028,2013,"500,125 mg",Tablet,Oral use,63.80,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
AUGMENTIN INFANT DROP,"AMOXICILLIN, CLAVULANIC ACID",2306210825,2013,"50,12.5 mg",Powder for oral suspension,Oral use,19.10,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,GLAXO SAUDI ARABIA
AVOCOM,MOMETASONE FUROATE,2003257123,2008,0.1 %,Cream,Topical,16.95,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOCIN,CLINDAMYCIN PHOSPHATE,2805257481,2008,2 %,Cream,Vaginal use,40.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOCIN,CLINDAMYCIN PHOSPHATE,2702256952,2008,1 %,Solution,Topical,15.05,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOBAN 2% W-W OINTMENT,MUPIROCIN CALCIUM,0909245886,2010,2 %,Ointment,Topical,19.4,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVAXIM 80U-0.5ML PEDIATRIC VACCINE,HEPATITIS A VIRUS,1301256599,2006,80 U,Suspension for injection in pre-filled syringe,Intramuscular use,66.25,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
AVAXIM 160 UNITS VACCINE S.D SYRINGE,HEPATITIS A GBM STRAIN,16-191-00,2000,160 U,Suspension for injection in pre-filled syringe,Intramuscular use,99.1,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
AVASTIN 400 solution for infusion,Bevacizumab,270-24-14,2014,25 mg/ml,Concentrate for solution for infusion,Intravenous use,4271.40,ROCHE DIAGNOSTICS,Germany,ROCHE & CO LTD,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
AVOCOM 0.05% AQUEOUS NASAL SPRAY,MOMETASONE FUROATE,2509245945,2011,0.05 %,"Nasal spray, suspension",Nasal use,41.6,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVASTIN 100 solution for infusion,Bevacizumab,269-24-14,2014,25 mg/ml,Concentrate for solution for infusion,Intravenous use,1235.55,ROCHE DIAGNOSTICS,Germany,ROCHE & CO LTD,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
AVALOX 400MG SOLUTION FOR I.V. INFUSION,MOXIFLOXACIN HYDROCHLORIDE,49-4-06,2006,400 mg,Solution for infusion,Intravenous use,474.40,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
AVALOX 400MG TAB,MOXIFLOXACIN HYDROCHLORIDE,42-4-01,2001,400 mg,Film-coated tablet,Oral use,61.90,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Bayer Saudi Arabia
AVALOX 400MG TAB,MOXIFLOXACIN HYDROCHLORIDE,43-4-01,2001,400 mg,Film-coated tablet,Oral use,80.40,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Bayer Saudi Arabia
AVALON AVOCAINE,LIDOCAINE HYDROCHLORIDE,1109234161,2008,10 %,Spray,Topical,24.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AURORIX 300MG TAB,MOCLOBEMIDE,5-813-13,2013,300 mg,Tablet,Oral use,67.25,ROCHE,Switzerland,MEDA PHARMA GmbH & Co KG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
AURORIX 150MG TAB,MOCLOBEMIDE,4-813-13,2013,150 mg,Tablet,Oral use,41.4,ROCHE,Switzerland,MEDA PHARMA GmbH & Co KG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Import Company - BANAJA
AUGMENTIN TAB 375 MG,"AMOXICILLIN, CLAVULANIC ACID",0809211025,2013,"250,125 mg",Tablet,Oral use,36.75,SMIITHKLINE BEECHAM,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
AVAMYS SUSPENSION FOR NASAL SPRAY,FLUTICASONE FUROATE,2306210826,2013,27.5 µg,"Nasal spray, suspension",Nasal use,44.30,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
BALANCED SALT SOLUTION BOTTLE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",0109222565,2000,"0.64,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Intravenous use,51.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED SALT SOLUTION BOTTLE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",212-149-00,2000,"0.46,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Topical,46.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
BETADERM 0.1% cream,BETAMETHASONE VALERATE,3004257314,1990,0.1 %,Cream,Topical,4.2,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
BERTIGO 8 MG TABLET,BETAHISTINE DIHYDROCHLORIDE,0312258715,2012,8 mg,Tablet,Oral use,16.8,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BERTIGO 24 MG TABLET,BETAHISTINE DIHYDROCHLORIDE,0312258716,2012,24 mg,Tablet,Oral use,30.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BERTIGO 16 MG TABLET,BETAHISTINE DIHYDROCHLORIDE,0312258714,2012,16 mg,Tablet,Oral use,28.4,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BENZAL 25% LOTION,BENZYL BENZOATE,2207257799,2008,25 %,Lotion,Topical,18.00,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Dallah Health Care Company
BENZAC AC 5% GEL,BENZOYL PEROXIDE,3004257320,1998,5 %,Gel,Topical,17.45,GALDERMA,France,GALDERMA,France,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
BENZAC AC 2.5% GEL,BENZOYL PEROXIDE,8-274-98,1998,2.5 %,Gel,Topical,12.45,GALDERMA,France,GALDERMA,France,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
BENLYSTA 400MG POWDER FOR SOLUTION FOR INFUSION,BELIMUMAB,0508257934,2013,400 mg,Powder for concentrate for solution for infusion,Intravenous use,1509.1,HOSPIRA,United States,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BETADERM 0.1% ointment,BETAMETHASONE VALERATE,2804257289,1993,0.1 %,Ointment,Topical,4.2,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
BETAFERON 8MIU\ML VIAL,INTERFERON BETA-1B,99-10-03,2003,8000000 IU/ml,Powder and solvent for solution for injection,Subcutaneous use,3071.60,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
BETAGEN,BETAHISTINE DIHYDROCHLORIDE,3003221897,2005,16 mg,Tablet,Oral use,34.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,RIYADH PHARMA
BETATEN 50MG F.C.TABLET,ATENOLOL,2907245695,2005,50 mg,Film-coated tablet,Oral use,11.3,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
BETATEN 25MG F.C. TABLETS,ATENOLOL,2907245694,2008,25 mg,Film-coated tablet,Oral use,6.65,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
BETATEN 100MG F.C. TABS,ATENOLOL,1303257066,2005,100 mg,Film-coated tablet,Oral use,18.5,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
BETASERC 8 MG TAB,BETAHISTINE DIHYDROCHLORIDE,2201233136,1985,8 mg,Tablet,Oral use,90.45,Mylan Laboratories SAS,France,Abbott Healthcare Products B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BENLYSTA 120MG POWDER FOR SOLUTION FOR INFUSION,BELIMUMAB,0508257933,2013,120 mg,Powder for concentrate for solution for infusion,Intravenous use,452.7,HOSPIRA,United States,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BETASERC 24 MG TABLETS,BETAHISTINE DIHYDROCHLORIDE,2201233135,2005,24 mg,Tablet,Oral use,77.05,Mylan Laboratories SAS,France,Abbott Healthcare Products B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BETASAL OINTMENT,"SALICYLIC ACID, BETAMETHASONE",19-590-11,2011,"30,5 mg",Ointment,Topical,6.95,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
BETAMED-N CREAM,"NEOMYCIN SULFATE, BETAMETHASONE",24-490-06,2006,"0.5,0.1 % (W/W)",Cream,Topical,11.7,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BETAMED 0.1% TOPICAL OINTMENT,BETAMETHASONE VALERATE,29-490-06,2006,0.1 %,Ointment,Topical,2.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BETAMED 0.1% CREAM,BETAMETHASONE VALERATE,23-490-06,2006,0.1 %,Cream,Topical,2.95,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BETAGEN,BETAHISTINE DIHYDROCHLORIDE,2102221753,2005,8 mg,Tablet,Oral use,40.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,RIYADH PHARMA
BETASERC 16MG TAB,BETAHISTINE DIHYDROCHLORIDE,16-137-94,1994,16 mg,Tablet,Oral use,50.3,Mylan Laboratories SAS,France,Abbott Healthcare Products B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BENEFIX 500 I.U. POWDER FOR SOLUTION FOR INJECTION,COAGULATION FACTOR IX RECOMBINANT HUMAN,1012246390,2011,500 IU,Powder and solvent for solution for injection,Parenteral use,1333.85,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
BENEFIX 250 I.U. POWDER FOR SOLUTION FOR INJECTION,COAGULATION FACTOR IX RECOMBINANT HUMAN,1012246391,2011,250 IU,Powder and solvent for solution for injection,Parenteral use,655.6,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
BENEFIX 2000 I.U. POWDER FOR SOLUTION FOR INJECTION,COAGULATION FACTOR IX RECOMBINANT HUMAN,1012246388,2011,2000 IU,Powder and solvent for solution for injection,Parenteral use,5018.75,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
BANEOCIN POWDER,"NEOMYCIN SULFATE, BACITRACIN",0702221685,1986,"5000,250 IU",Cutaneous powder,Topical,7.25,Pharmazeutische Fabrik Montavit GesmbH,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BALKATRIN TAB,"SULFAMETHOXAZOLE, TRIMETHOPRIM",40-119-82,1982,"400,80 mg",Tablet,Oral use,8.9,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BALKATRIN SUSP,"SULFAMETHOXAZOLE, TRIMETHOPRIM",41-119-82,1982,"40,8 mg/ml",Syrup,Oral use,6.05,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BANEOCIN POWDER,"NEOMYCIN SULFATE, BACITRACIN",21-116-84,1984,"5000,250 IU",Cutaneous powder,Topical,17.05,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BALANCED SALT SOLUTION BOTTLE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",396-149-10,2010,"0.46,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Topical,51.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
BALANCED SALT SOLUTION BOTTLE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",397-149-10,2010,"0.46,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Topical,46.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
BALANCED SALT SOLUTION AMPOULE,"POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",198-149-00,2000,"0.075,0.64,0.048,0.03,0.39,0.17 g",Solution,Topical,2.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED SALT SOLUTION AMPOULE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",200-149-00,2000,"0.64,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Topical,3.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
BALANCED SALT SOLUTION AMPOULE,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",199-149-00,2000,"0.64,0.075,0.048,0.03,0.39,0.17 g/ml",Solution,Topical,3.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
CATALIN OPH. SOLUTION,PIRFENOXONE SODIUM,1-519-83,1983,,Eye drops,Ophthalmic use,19.05,TAKEDA,Japan,TAKIDA,Japan,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
BENEFIX 1000 I.U. POWDER FOR SOLUTION FOR INJECTION,COAGULATION FACTOR IX RECOMBINANT HUMAN,1012246389,2011,1000 IU,Powder and solvent for solution for injection,Parenteral use,2520.7,WYETH,Spain,WYETH,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
BENDAZOLE 100 MG TAB,MEBENDAZOLE,1911246285,2000,100 mg,Tablet,Oral use,5.45,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
BEKUNIS TABLET,"BISACODYL, SENNA FRUITS, SENNA LEAVES, SENNA FRUITS DRY EXTRACT",1-235-86,1986,"5,60,20,25 mg",Tablet,Oral use,11.7,ROHA PHARMA,Germany,ROHA PHARMA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Salem Bawazeer Establishment for Trade
BEFOLVIT 5 MG TAB,FOLIC ACID,1807245611,2005,5 mg,Tablet,Oral use,9.20,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BEFOLVIT 1MG TAB,FOLIC ACID,1807245610,2005,1 mg,Tablet,Oral use,9.20,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BASIC BICARBONATE CONCENTRATE 8.125% INF,SODIUM BICARBONATE,206-149-00,2000,8.125 %,Solution,Intravenous use,35.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
BE BE VIT ORAL DROPS,"RETINOL, COLECALCIFEROL (VITAMIN D3), TOCOPHEROL, ASCORBIC ACID, THIAMINE, RIBOFLAVIN (VITAMIN B2), PYRIDOXINE (VITAMIN B6), NICOTINAMIDE",18-251-10,2010,"0.88,400,5,40,0.5,0.6,0.6,8 mg, IU",Oral drops,Oral use,2.9,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
BCG VACCINE AJ Vaccines 0.75MG-VIAL,Mycobacterium bovis (M. bovis) Bacillus Calmette-Guérin (BCG),2208210969,2004,0.75 mg/ml,Solution,Intradermal use,453.75,AJ VACCINES A/S,Denmark,AJ VACCINES A/S,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
GRANITRON 3MG-3ML SOLUTION FOR Injection,GRANISETRON,134-334-10,2010,1 mg/ml,Solution for injection,Intravenous use,232.50,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
GRANITRON 1MG-ML SOLUTION FOR Injection,GRANISETRON,133-334-10,2010,1 mg/ml,Solution for injection,Intravenous use,130.40,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
GONAL-F 900 IU solution for injection in pre-filled pen,FOLLITROPIN ALFA,3010258527,2008,900 IU,Solution for injection in pre-filled pen,Subcutaneous use,1089,MERCK SERONO,Italy,MERCK SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Cigalah Group, Merck Limited"
GONAL-F 75 IU AMPOULE,FOLLITROPIN ALFA,1-335-00,2000,75 IU,Powder and solvent for solution for injection,Subcutaneous use,155.3,SERONO,Switzerland,SERONO,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
GONAL-F 450 IU solution for injection in pre-filled pen,FOLLITROPIN ALFA,3010258521,2008,450 IU,Solution for injection in pre-filled pen,Subcutaneous use,544.5,MERCK SERONO,Italy,MERCK SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Cigalah Group, Merck Limited"
GONAL-F 300 IU solution for injection in pre-filled pen,FOLLITROPIN ALFA,3010258520,2008,300 IU,Solution for injection in pre-filled pen,Subcutaneous use,363,MERCK SERONO,Italy,MERCK SERONO,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Cigalah Group, Merck Limited"
GLYPRESSIN 1MG POWDER FOR I.V. Injection*,TERLIPRESSIN DIACETATE PENTAHYDRATE,11-367-07,2007,1 mg,Solution for injection,Intravenous use,737.55,RENTSCHLER BIOTECHNOLOGIE,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
GLYPRESSIN 0.1 mg/ml solution for injection,TERLIPRESSIN DIACETATE PENTAHYDRATE,0102233199,2014,0.1 mg/ml,Solution for injection,Intravenous use,625.85,ZENTIVA K.S.,Czech Republic,FERRING,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
GUAPHAN,GUAIFENESIN,1211246194,2001,20 mg/ml,Syrup,Oral use,6.50,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
GUAPHAN DM,"GUAIFENESIN, DEXTROMETHORPHAN",1211246193,2001,"100,10 mg, mg/ml",Syrup,Oral use,12.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
GYNO-DAKTARIN OVULES 400 MG.,MICONAZOLE NITRATE,33-6-85,1985,400 mg,Suppository,Vaginal use,23.9,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GYNO-DAKTARIN CREAM WITH 16 APPLICATORS,MICONAZOLE NITRATE,4-5876-24,1981,2 %,Cream,Topical,25.2,JANSSEN PHARMACEUTICA N.V.,Belgium,Johnson & Johnson Consumer NV/SA,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GLYCOPHOS 216MG/ML,SODIUM GLYCEROPHOSPHATE HYDRATED,1202256887,2013,216 mg/ml,Concentrate for solution for infusion,Intravenous use,191.45,FRESENIUS KABI NORGE AS,Norway,FRESENIUS KABI AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
GYNO-CORYL 150 MG VAGINAL OVULES,ECONAZOLE,2812211520,2004,150 mg,"Vaginal capsule, soft",Vaginal use,18.2,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
GYNO-CANDIZOL 400 MG VAGINAL OVULES,MICONAZOLE NITRATE,83-5286-21,2003,400 mg,"Vaginal capsule, soft",Vaginal use,11,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GYNO-CANDIZOL 200 MG VAGINAL OVULES,MICONAZOLE NITRATE,82-5286-21,2003,200 mg,"Vaginal capsule, soft",Vaginal use,13.4,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GYNERA 21 TAB,"ETHINYLESTRADIOL, GESTODENE",0206222126,1991,"30,75 µg",Coated tablet,Oral use,17.65,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
GUTRON TAB 2.5 MG TAB,MIDODRINE HYDROCHLORIDE,18-62-82,1982,2.5 mg,Tablet,Oral use,16.55,TAKEDA AUSTRIA GmbH,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
GUTRON TAB 2.5 MG TAB,MIDODRINE HYDROCHLORIDE,17-62-82,1982,2.5 mg,Tablet,Oral use,8.75,TAKEDA AUSTRIA GmbH,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
GYNO-DAKTARIN 1200MG VAGINAL CAPSULE,MICONAZOLE NITRATE,2-280-08,2008,1200 mg,Capsule,Vaginal use,20.7,CATALENT,France,JANSSEN-CILAG,Belgium,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GLYCINE IRRIGATION SOLN 1.5%,GLYCINE,1108222478,1995,1.5 %,Irrigation solution,Topical,29,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLYCINE IRRIGATION SOLN 1.5%,GLYCINE,96-149-95,1995,1.5 %,Irrigation solution,Topical,14.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLUCARE 500MG TAB,METFORMIN HYDROCHLORIDE,2504245216,2002,500 mg,Film-coated tablet,Oral use,14.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCAGEN HYPOKIT,GLUCAGON,23-100-98,1998,1 mg,Powder and solvent for solution for injection,Subcutaneous use,86.55,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store below 25°c,Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
GLORA 10MG TABLETS,LORATADINE,2905257499,2008,10 mg,Tablet,Oral use,9.35,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
GLOMOX 500MG CAP,AMOXICILLIN,3107245706,2003,500 mg,Capsule,Oral use,13.20,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
GLUCARE 850 TAB.,METFORMIN HYDROCHLORIDE,2504245214,2001,850 mg,Film-coated tablet,Oral use,27.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCOBAY 100MG TAB,ACARBOSE,28-4-95,1995,100 mg,Tablet,Oral use,19.75,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
GLUCOBAY 50MG TAB,ACARBOSE,27-4-95,1995,50 mg,Tablet,Oral use,15.15,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
GLUCOPHAGE 1 g tablet,METFORMIN HYDROCHLORIDE,5-331-03,2003,1000 mg,Film-coated tablet,Oral use,19.85,MERCK SANTE,France,MERCK SANTE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
GLYCINE IRRIGATION SOLN 1.5%,GLYCINE,97-149-95,1995,1.5 %,Irrigation solution,Topical,18.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLYCINE IRRIGATION SOLN 1.5%,GLYCINE,1205222019,1995,1.5 %,Irrigation solution,Topical,28.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLYCINE IRRIGATION,GLYCINE,95-149-95,1995,1.5 %,Irrigation solution,Topical,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLYCINE 1.5% IRRIGATION SOLUTION,GLYCINE,0907245525,2003,1.5 %,Irrigation solution,Topical,26.7,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
GLYCINE IRRIGATION SOLN 1.5%,GLYCINE,100-149-95,1995,1.5 %,Irrigation solution,Topical,43.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
GLUCOVANCE 2.5/500,"GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE",0801256552,2012,"2.5,500 mg",Film-coated tablet,Oral use,16.5,MERCK SANTE,France,MERCK SANTE,France,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
GLUCOSE 5% I.V INFUSION,DEXTROSE,6-303-00,2000,5 %,Intravenous infusion,Intravenous use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
GLUCOSE 10%I.V INFUSION,DEXTROSE,10-303-00,2000,10 %,Intravenous infusion,Intravenous use,4.55,GULF INJECT,United Arab Emirates,GULF INJECT,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,AL EWAN MEDICAL COMPANY
GLUCOPHAGE XR 750MG TABLET,METFORMIN HYDROCHLORIDE,1-5564-21,2012,750 mg,Prolonged-release tablet,Oral use,25,MERCK HEALTHCARE KGAA,Germany,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
GLUCOPHAGE 850 mg tablet,METFORMIN HYDROCHLORIDE,3-331-00,2000,850 mg,Film-coated tablet,Oral use,15.4,MERCK SANTE,France,MERCK SANTE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
GLUCOPHAGE 500 mg tablet,METFORMIN HYDROCHLORIDE,1-331-00,2000,500 mg,Film-coated tablet,Oral use,16.55,RIYADH PHARMA,Saudi Arabia,MERCK SANTE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
GLUCOVANCE 5/500,"GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE",1609245916,2012,"5,500 mg",Film-coated tablet,Oral use,23.45,MERCK SANTE,France,MERCK SANTE,France,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
HAEMODIALYSIS ACETATE CONC. SOLU.35X F-6,"SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",315-149-08,2008,"210.7,9,5.22,3.56 g/l",Solution,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACETATE CONC.SOLU.35X F-40,"SODIUM CHLORIDE, SODIUM ACETATE, DEXTROSE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",307-149-08,2008,"199.22,174.34,17.325,6.78,6.43,5.34 g/l",Solution,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-8,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",332-149-08,2008,"99,11.58,5.4,6.71,3.43,263 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-6,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",330-149-08,2008,"263,99,6.615,10.81,6.71,3.43 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-16,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",366-149-08,2008,"263,99,7.49,10.8,6.71,1.61 g/l",Solution for haemodialysis,Parenteral use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-16,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",367-149-08,2008,"263,99,7.49,10.80,6.71,1.61 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-15,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",334-149-08,2008,"263,49.5,9.9,10.8,3.43,6.71 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-13,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",363-149-08,2008,"270.87,49.5,8.27,8.11,6.71,4.57 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-10,"SODIUM CHLORIDE, ACETIC ACID, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",365-149-08,2008,"263,10.80,9.92,6.71,3.43 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-9,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",348-149-08,2008,"38.50,7.72,6.30,2.61,3.56,210.70 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-12,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",353-149-08,2008,"99,6.615,5.40,6.71,3.43,263 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(9),"SODIUM CHLORIDE, SODIUM ACETATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",118-149-96,1996,"212.72,171.49,5.22,9,3.56 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(7),"SODIUM CHLORIDE, SODIUM ACETATE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",117-149-96,1996,"204.54,181,5.34,5.22,9 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(5),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",116-149-96,1996,"214.77,5.22,9,7.12,166.72 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(33),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",122-149-96,1996,"208.63,7.83,9,3.56,181.01 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(3),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",123-149-96,1996,"192.27,5.22,9,5.33,209.6 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(19),"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",121-149-96,1996,"200.45,9,5.34,190.54 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(18),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",120-149-96,1996,"218.86,5.22,7.72,3.56,166.72 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35X FORM.(12),"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",119-149-96,1996,"214.77,9,5.34,166.72 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC36.83xF(G-1)BICAR,"SODIUM CHLORIDE, ACETIC ACID, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",183-149-99,1999,"161.3,11.06,9.48,5.48,3.76 g/l",Solution for haemodialysis,Hemodialysis,41.05,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC36.83xF(G-1)BICAR,"SODIUM CHLORIDE, ACETIC ACID, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",168-149-98,1998,"161.3,11.06,9.48,5.48,3.76 g/l",Solution for haemodialysis,Hemodialysis,28.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU.35X F-19,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",356-149-08,2008,"38.5,7.72,6.3,7.84,3.56,210.70 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 45X C-5,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE",351-149-08,2008,"99,9.92,5.40,3.43,10.06,263 g/l",Solution for haemodialysis,Parenteral use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONC.SOLU.35 X FORM.(4),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE",124-149-96,1996,"204.54,5.22,9,7.12,166.72 g/l",Concentrate for solution for haemodialysis,Parenteral use,45.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACETATE CONC. SOLU.35X F-6,"SODIUM CHLORIDE, SODIUM ACETATE, DEXTROSE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",316-149-08,2008,"214.77,166.72,77,9,5.34,5.22 g/l",Solution,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-18,"SODIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",335-149-08,2008,"210.7,7.35,5.22,5.15,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-17,"DEXTROSE, ACETIC ACID, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",354-149-08,2008,"35.5,6.25,5.22,3.86,3.56,120.70 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-24,"DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE",320-149-08,2008,"77,9,6.30,5.22,3.56,210.7 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-21,"DEXTROSE, ACETIC ACID, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE",306-149-08,2008,"77,6.24,3.56,7.72,5.22,210.70 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-10,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",324-149-08,2008,"210.7,69.30,3.86,6.3,3.56,2.61 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACETATE CONC.SOLU.35X F-40,"SODIUM CHLORIDE, SODIUM ACETATE, DEXTROSE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",308-149-08,2008,"199.22,174.34,17.325,6.78,6.43,5.34 g/l",Solution,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-25,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",328-149-08,2008,"210.7,77,9,6.30,3.56,2.61 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-25,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",327-149-08,2008,"210.7,77,9,6.30,3.56,3.56 g/l",Solution for haemodialysis,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-27,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",361-149-08,2008,"210.7,77,9,8.42,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-27,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",360-149-08,2008,"210.7,77,9,8.42,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-16,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",355-149-08,2008,"210.7,38.50,7.72,6.30,5.34,5.22 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-13,"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, ACETIC ACID",350-149-08,2008,"210.69,10.09,7.54,5.53,4.69 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-12,"SODIUM CHLORIDE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",338-149-08,2008,"210.7,7.72,7.35,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-12,"SODIUM CHLORIDE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",349-149-08,2008,"210.7,7.72,7.35,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-7,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",326-149-08,2008,"210.7,38.50,6.43,6.30,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-5,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",322-149-08,2008,"210.68,38.50,9,6.30,3.56,2.61 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-3,"SODIUM CHLORIDE, CALCIUM CHLORIDE, ACETIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE",309-149-08,2008,"210.70,9,6.30,3.56,2.61 g/l",Solution for haemodialysis,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-29,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",318-149-08,2008,"210.7,38.50,9,8.42,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-28,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",358-149-08,2008,"210.7,75,9,8.30,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS ACID CONC. SOLU. 35X F-28,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",359-149-08,2008,"210.7,75,9,8.30,5.22,3.56 g/l",Solution for haemodialysis,Intravenous use,41,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONCENTRATE 35 F2 SOLUTION,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",204-149-00,2000,"210.68,38.50,9,6.50,5.22,3.56 g/l",Irrigation solution,Parenteral use,39,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
GLODIP 5MG CAPSULE,AMLODIPINE BESILATE,2104257263,2012,5 mg,Capsule,Oral use,23.8,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
GLOCLAV 375MG TAB,"AMOXICILLIN, CLAVULANIC ACID",0412258737,2004,"250,125 mg",Film-coated tablet,Oral use,27.7,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
FUSIBACT-B CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",1305257380,2002,"2,0.1 %",Cream,Topical,12.9,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FUSIBACT OINTMENT2%,FUSIDIC ACID,23-368-01,2001,2 %,Ointment,Topical,8.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FUSIBACT CREAM 2% W-W,FUSIDIC ACID,0707245488,2001,2 %,Cream,Topical,8.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FURAZOL TAB,"DILOXANIDE FUROATE, METRONIDAZOLE",4-201-90,1990,"250,200 mg",Tablet,Oral use,11.4,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,do not store above 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
FUNZOL 150MG CAPSULES,FLUCONAZOLE,0701256534,2007,150 mg,Capsule,Oral use,15.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
FUNGYZOLE 2% TOPICAL CREAM,MICONAZOLE NITRATE,0810258356,2006,2 %,Cream,Topical,10.7,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FUNGO 1% CREAM,CLOTRIMAZOLE,17-590-11,2011,1 g,Cream,Topical,7.05,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
FUNGIMID 50MG CAPSULE,FLUCONAZOLE,19-346-07,2007,50 mg,Capsule,Oral use,19.45,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
FUNGIMID 150MG CAPSULE,FLUCONAZOLE,20-346-07,2007,150 mg,Capsule,Oral use,16.7,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
FUDION 2% CREAM,FUSIDIC ACID,2307257819,2006,2 %,Cream,Topical,7.85,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
FUSIDERM 2% CREAM,FUSIDIC ACID,1306233796,2000,2 %,Cream,Topical,11.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FUSIDERM 2% OINTMENT,FUSIDIC ACID,1002221723,2000,2 %,Ointment,Topical,10.1,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FUSIDERM B CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",3101221657,2002,"2,0.1 %",Cream,Topical,11.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
FUSIVER 2% OINTMENT,FUSIDIC ACID,1-491-06,2006,2 %,Ointment,Topical,5.35,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,AMC Pharma
GALVUS MET,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",285-11-10,2010,"850,50 mg",Film-coated tablet,Oral use,100.40,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
GALVUS MET,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",286-11-10,2010,"1000,50 mg",Film-coated tablet,Oral use,105.75,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
GALVUS 50MG TABLETS,VILDAGLIPTIN,0910234319,2009,50 mg,Tablet,Oral use,112.3,Siegfried Barbera S.L,Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
GALVUS 50MG TABLETS,VILDAGLIPTIN,0910234317,2009,50 mg,Tablet,Oral use,56.1,Siegfried Barbera S.L,Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
GADOVIST 1MMOL-ML PRE-FILLED SYRINGE,GADOBUTROL,1506233812,2009,1 mmol/ml,Solution for injection,Intravenous use,1085.25,BAYER AG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,store below 25°c,Hospital,Bayer Saudi Arabia
FUCIDIN H CREAM,"FUSIDIC ACID, HYDROCORTISONE ACETATE",2211222920,2013,"20,10 mg",Cream,Topical,38.5,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
GABIN 400MG CAPSULE,GABAPENTIN,65-539-14,2014,400 mg,Capsule,Oral use,170.9,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GABIN 300MG CAPSULE,GABAPENTIN,63-539-14,2014,300 mg,Capsule,Oral use,145.45,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GABIN 300MG CAPSULE,GABAPENTIN,62-539-14,2014,300 mg,Capsule,Oral use,72.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GABIN 100MG CAPSULE,GABAPENTIN,61-539-14,2014,100 mg,Capsule,Oral use,70.85,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GABIN 100MG CAPSULE,GABAPENTIN,60-539-14,2014,100 mg,Capsule,Oral use,14.15,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GABANET 400MG CAPSULE,GABAPENTIN,2104257253,2010,400 mg,Capsule,Oral use,61.90,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
GABANET 300MG CAPSULE,GABAPENTIN,2104257254,2010,300 mg,Capsule,Oral use,53.15,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
FUSIZONE CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",13-590-10,2010,"2,0.1 %",Cream,Topical,8.45,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
GABIN 400MG CAPSULE,GABAPENTIN,64-539-14,2014,400 mg,Capsule,Oral use,85.45,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
FUCIDIN 2% CREAM,FUSIDIC ACID,1601268928,2013,2 %,Cream,Topical,19.75,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
FORTICEF 500MG CAPSULES,CEFACLOR,2702256947,2006,500 mg,Capsule,Oral use,35.75,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
FORMIT 850 MG TABLETS,METFORMIN HYDROCHLORIDE,1611234489,2001,850 mg,Tablet,Oral use,26.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FOLIC ACID,FOLIC ACID,2505233724,2000,5 mg,Tablet,Oral use,6.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
FOLIC ACID,FOLIC ACID,1407245564,2003,1 mg,Tablet,Oral use,6.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
FML 0.1% ophthalmic suspension,FLUOROMETHOLONE,2011246289,1983,0.1 %,"Eye drops, suspension",Ophthalmic use,14.5,ALLERGAN PHARMACEUTICALS LTD,United States,AbbVie Inc,United States,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FORTZAAR 100/25 mg film-coated tablet,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",3003221896,2003,"100,25 mg",Film-coated tablet,Oral use,45.00,Organon Pharma (UK) Limited,United Kingdom,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FOSAMAX ONCE WEEKLY 70MG TAB,ALENDRONIC ACID,1-5804-23,2002,70 mg,Tablet,Oral use,45.95,AESICA PHARMACEUTICALS GmbH,Germany,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
FUCICORT 2% CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",1008222458,2013,"2,0.1 %",Cream,Topical,38.5,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
FUCIDIN 2% OINTMENT,FUSIDIC ACID,1601268929,2013,2 %,Ointment,Topical,19.75,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
FOXITIN 1GM VIAL I.V OR I.M ADMINISTRATI,CEFOXITIN SODIUM,2605257459,1998,1 g,powder for solution for injection,Parenteral use,30.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
FOXIME 500MG VIAL+AMP OF WATER IM-IV USE,CEFOTAXIME,0810258359,1998,500 mg,Powder and solvent for solution for injection,Parenteral use,22.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
FOXIME 1GM VIAL+5ML WATER FOR INJ IV USE,CEFOTAXIME,0709258178,1998,1 g,Powder and solvent for solution for injection,Parenteral use,36.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
FOXIME 1GM VIAL+5ML SOLVENT LIDOCAINE IM,CEFOTAXIME,41-277-98,1998,1 g,Powder and solvent for solution for injection,Intramuscular use,36.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
FOSTIMON HP 75 IU VIAL (IM) USE,UROFOLLITROPIN,2303257133,2000,75 IU,Powder and solvent for solution for injection,Intramuscular use,74.1,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
FOSTIMON HP 150 IU VIAL IM(WOMEN URIN),UROFOLLITROPIN,2303257132,2000,150 IU,Powder and solvent for solution for injection,Intramuscular use,138.35,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
FOSTER PRESSURISED SOLUTION FOR INHALATION,"BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE",3110246132,2010,"100,6 µg","Pressurised inhalation, solution",Inhalation use,102.9,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ZIMMO TRADING ESTABLISHMENT
GLOCLAV 625MG TABLET,"AMOXICILLIN, CLAVULANIC ACID",1712258807,2004,"500,125 mg",Film-coated tablet,Oral use,48,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
GANFORT EYE DROPS,"TIMOLOL MALEATE, BIMATOPROST",2-921-25,2009,"5,0.3 mg/ml","Eye drops, solution",Ophthalmic use,51.05,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
GLIDE 3MG TABLET,GLIMEPIRIDE,52-539-11,2011,3 mg,Tablet,Oral use,23.6,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GLIDE 2MG TABLET,GLIMEPIRIDE,51-539-11,2011,2 mg,Tablet,Oral use,13.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GLIDE 1MG TABLET,GLIMEPIRIDE,50-539-11,2011,1 mg,Tablet,Oral use,10.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GLIBIL-5 TABS,GLIBENCLAMIDE,1712246445,1990,5 mg,Tablet,Oral use,9.75,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
GLAZE 80MG TAB,GLICLAZIDE,141-212-01,2001,80 mg,Tablet,Oral use,34.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GLAZE 80MG TAB,GLICLAZIDE,140-212-01,2001,80 mg,Tablet,Oral use,13.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GLADOS 30MG TABLET,PIOGLITAZONE,1601244739,2012,30 mg,Tablet,Oral use,71.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
GLADOS 15MG TABLET,PIOGLITAZONE,1601244740,2012,15 mg,Tablet,Oral use,42,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
GLACERA 30MG TABLET,PIOGLITAZONE,1211246192,2014,30 mg,Tablet,Oral use,64.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
GLACERA 15MG TABLET,PIOGLITAZONE,1211246190,2014,15 mg,Tablet,Oral use,37.8,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
GINSANA TONIC 140MG-15ML,GINSENOSIDES,1-516-83,1983,9.33 mg/ml,Oral solution,Oral use,29.75,GINSANA,Switzerland,GINSANA,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
GLIDE 4MG TABLET,GLIMEPIRIDE,53-539-11,2011,4 mg,Tablet,Oral use,24.95,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GLIM 1MG TABLETS,GLIMEPIRIDE,232-212-08,2008,1 mg,Tablet,Oral use,19.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
GLIM 2MG TABLETS,GLIMEPIRIDE,233-212-08,2008,2 mg,Tablet,Oral use,32.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
GLIM 3MG TABLETS,GLIMEPIRIDE,234-212-08,2008,3 mg,Tablet,Oral use,44.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
GLOCLAV 1GM FILM COATED TABLETS,"AMOXICILLIN, CLAVULANIC ACID",0901244687,2009,"875,125 mg",Film-coated tablet,Oral use,56.8,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
GLIVEC 400MG TABLET,IMATINIB MESILATE,165-11-05,2005,400 mg,Film-coated tablet,Oral use,7653.25,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
GLIVEC 100MG TABLET,IMATINIB MESILATE,164-11-05,2005,100 mg,Film-coated tablet,Oral use,3826.65,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
GLITRA 4MG TABLETS,GLIMEPIRIDE,0803221826,2010,4 mg,Tablet,Oral use,26.80,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
GLITRA 3MG TABLETS,GLIMEPIRIDE,2403257143,2010,3 mg,Tablet,Oral use,23.6,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
GLITRA 2MG TABLETS,GLIMEPIRIDE,1911246280,2010,2 mg,Tablet,Oral use,16.9,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
GLITRA 1MG TABLETS,GLIMEPIRIDE,1911246282,2010,1 mg,Tablet,Oral use,10.35,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
GINSANA 100MG CAPS,GINSENOSIDES,2-516-83,1983,100 mg,Capsule,Oral use,28.85,GINSANA,Switzerland,GINSANA,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
GLIPTEN 100MG F.C. TABLET,SITAGLIPTIN PHOSPHATE,280-212-13,2013,100 mg,Film-coated tablet,Oral use,98.20,Organon Pharma (UK) Limited,United Kingdom,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
GLIPTAMET,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",2307257840,2013,"1000,50 mg",Film-coated tablet,Oral use,106.40,PATHEON INC,Puerto Rico,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
GLIPOM 5MG TABLETS,GLIPIZIDE,16-390-06,2006,5 mg,Tablet,Oral use,5.4,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Pharmacy,EBRAHIM M. ALMANA & BROS. CO.
GLIM 6MG TABLETS,GLIMEPIRIDE,281-212-13,2013,6 mg,Tablet,Oral use,49.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
GLIM 4MG TABLETS,GLIMEPIRIDE,235-212-08,2008,4 mg,Tablet,Oral use,47.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
GLIPTAMET,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",2307257835,2013,"850,50 mg",Film-coated tablet,Oral use,102.70,PATHEON INC,Puerto Rico,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
GILENYA 0.5 MG CAPSULE,FINGOLIMOD HYDROCHLORIDE,1601256670,2011,0.5 mg,Capsule,Oral use,5915.40,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
GENURIN FORT 200 mg tablet,FLAVOXATE HYDROCHLORIDE,7-151-85,1985,200 mg,Film-coated tablet,Oral use,11.55,RECORDATI,Italy,RECORDATI,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Annhdah Medical Company
GAVISCON DOUBLE ACTION CHEWABLE TABLET,"SODIUM ALGINATE, CALCIUM CARBONATE, SODIUM BICARBONATE",1901268947,2012,"250,187.5,106.5 mg",Chewable tablet,Oral use,21.10,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
GAVISCON ADVANCE PEPPERMINT FLAVOR ORAL SUSPENSION,"SODIUM ALGINATE, POTASSIUM BICARBONATE",0801256561,2010,"500,100 mg",Oral suspension,Oral use,26.70,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE COMPANY,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GASTROZOLE,OMEPRAZOLE,61-325-02,2002,20 mg,Gastro-resistant capsule,Oral use,41.35,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,RIYADH PHARMA
GASTROFAIT TAB 500MG,SUCRALFATE,6-201-90,1990,500 mg,Tablet,Oral use,11.80,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
GASEC 40MG GASTRO CAPSULES,OMEPRAZOLE,2004257246,2008,40 mg,"Gastro-resistant capsule, hard",Oral use,79.35,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alpha Pharma Industry
GASEC 40MG GASTRO CAPSULES,OMEPRAZOLE,2004257247,2008,40 mg,"Gastro-resistant capsule, hard",Oral use,45.10,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alpha Pharma Industry
GASEC 20MG GASTRO CAPS,OMEPRAZOLE,2004257244,2006,20 mg,"Gastro-resistant capsule, hard",Oral use,48.4,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alpha Pharma Industry
GASEC 20MG GASTRO CAPS,OMEPRAZOLE,2004257245,2006,20 mg,"Gastro-resistant capsule, hard",Oral use,27.5,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alpha Pharma Industry
GARDASIL RECOMBINANT VACCINE,"HUMAN PAPILLOMAVIRUS TYPE 6 L1, HUMAN PAPILLOMAVIRUS TYPE 11 L1, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",48-82-08,2008,"20,40,40,20 µg",Solution for injection,Intramuscular use,411.9,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
GAPENTIN,GABAPENTIN,1807222311,2009,400 mg,Capsule,Oral use,105.5,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
GAPENTIN,GABAPENTIN,1807222310,2009,300 mg,Capsule,Oral use,89.8,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
GAVISCON DOUBLE ACTION CHEWABLE TABLET,"SODIUM ALGINATE, CALCIUM CARBONATE, SODIUM BICARBONATE",8-417-12,2012,"250,187.5,106.5 mg",Chewable tablet,Oral use,10.55,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
GAVISCON DOUBLE ACTION ORAL SUSPENSION,"SODIUM ALGINATE, CALCIUM CARBONATE, SODIUM BICARBONATE",1807245607,2012,"500,325,213 mg",Oral suspension,Oral use,25.10,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
GAVISCON EXTRA STRENGTH PEPPER.CHEW. TAB,"SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE",0305233587,2009,"500,267,160 mg",Chewable tablet,Oral use,11.80,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GAVISCON ORIGINAL ANISEED ORAL SUSP,"SODIUM ALGINATE, SODIUM BICARBONATE, CALCIUM CARBONATE",1102244901,2007,"500,267,160 mg",Oral suspension,Oral use,15.20,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Cigalah Group
GENTAM 80MG-2ML AMP,GENTAMICIN,15-212-93,1993,40 mg/ml,Solution for injection,Intravenous use,67.7,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SPIMACO
GENTAM 20MG-2ML AMP,GENTAMICIN,14-212-93,1993,10 mg/ml,Solution for injection,Intravenous use,26.1,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SPIMACO
GENTACIN,GENTAMICIN,2802233303,2001,0.3 %,"Ear/eye drops, solution",Ophthalmic use,12,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
GENTACIN,GENTAMICIN,2705245353,2001,0.3 %,"Ear/eye drops, solution",Topical,8.10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
GENPRID,SULPIRIDE,0411246137,2003,200 mg,Tablet,Oral use,27.8,RIYADH PHARMA,Saudi Arabia,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
GENPRID,SULPIRIDE,0411246136,2003,50 mg,Capsule,Oral use,12.4,RIYADH PHARMA,Saudi Arabia,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GIAD 50 mg film-coated tablets,SILDENAFIL,66-539-14,2014,50 mg,Film-coated tablet,Oral use,43.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GEMCITABIN EBEWE 200MG-20ML VAIL,GEMCITABINE,48-355-11,2011,200 mg,Concentrate for solution for infusion,Intravenous use,74.30,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
GEMCITABIN EBEWE 1000MG-100ML VAIL,GEMCITABINE,50-355-11,2011,1000 mg,Concentrate for solution for infusion,Intravenous use,321.95,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
GAVISCON PEPPERMINT LIQUID,"SODIUM ALGINATE, SODIUM BICARBONATE, CALCIUM CARBONATE",2905245378,2005,"500,267,160 mg",Oral suspension,Oral use,15.20,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,"Do not store above 30°C, do not freeze, do not refrigerate",Pharmacy,Cigalah Group
GAVISCON PEPPERMINT CHEWABLE TABLETS,"SODIUM ALGINATE, SODIUM BICARBONATE, CALCIUM CARBONATE",0305233588,2008,"250,133.50,80 mg",Chewable tablet,Oral use,9.60,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Cigalah Group
HAEMODIALYSIS CONCENTRATE 35 F2 SOLUTION,"SODIUM CHLORIDE, DEXTROSE, CALCIUM CHLORIDE, ACETIC ACID, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",203-149-00,2000,"210.68,38.50,9,6.50,5.22,3.56 g/l",Concentrate for solution for haemodialysis,Parenteral use,27.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONCENTRATE 35X (F-38),WATER,169-149-98,1998,0.5 g/l,Concentrate for solution for haemodialysis,Hemodialysis,30.75,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
ISOPTIN S.R 240MG F.COATED TAB,VERAPAMIL HYDROCHLORIDE,22-63-97,1997,240 mg,Prolonged-release tablet,Oral use,41.95,FAMAR,Greece,Abbott Laboratories,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ISOPTIN RETARD TAB 120MG,VERAPAMIL HYDROCHLORIDE,10-63-82,1982,120 mg,Prolonged-release tablet,Oral use,20.15,Abbott Laboratories,Germany,Abbott Laboratories,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
ISOPTIN AMP 2.5MG-ML,VERAPAMIL HYDROCHLORIDE,9-63-82,1982,2.5 mg/ml,Solution for injection,Intravenous use,14.20,Abbott Laboratories,Germany,Abbott Laboratories,Germany,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
ISOCAINE 3 % CARTRIDGE,MEPIVACAINE HYDROCHLORIDE,1-343-09,2009,3 %,Solution for injection,Dental use,70.70,NOVOCOL,Canada,NOVOCOL,Canada,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI MEDICAL SUPPLIES
ISOBIDE,ISOSORBIDE DINITRATE,2111222917,2006,40 mg,Modified-release capsule,Oral use,27.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ISOBIDE,ISOSORBIDE DINITRATE,0108222392,2006,20 mg,Modified-release capsule,Oral use,18.85,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
IROKID 50MG-5ML SYRUP,IRON POLYMALTOSE,40-490-08,2008,10 mg/ml,Syrup,Oral use,12.9,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
I-PROFEN 400MG TABLET,IBUPROFEN,2811246349,2004,400 mg,Tablet,Oral use,10.10,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
IPRAMAX 25 MG FILM COATED TABLET,TOPIRAMATE,2307233919,2011,25 mg,Film-coated tablet,Oral use,31.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IPRAMAX 100 MG FILM COATED TABLET,TOPIRAMATE,2307233911,2011,100 mg,Film-coated tablet,Oral use,104.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ISOPTIN TABLETS 40 MG.,VERAPAMIL HYDROCHLORIDE,6-63-82,1982,40 mg,Tablet,Oral use,18.10,FAMAR,Greece,Abbott Laboratories,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ISOPTIN TABLETS 80 MG.,VERAPAMIL HYDROCHLORIDE,7-63-82,1982,80 mg,Tablet,Oral use,14.70,FAMAR,Greece,Abbott Laboratories,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JOINTACE COLLAGEN TABLET,"GLUCOSAMINE SULFATE, COLLAGEN TYPE II, CHONDROITIN, COPPER, GINGER EXTRACT, MANGANESE, TOCOPHEROL, ZINC OXIDE, ASCORBIC ACID, CHOLECALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, SELENIUM SULFIDE",1-805-12,2012,"500,150,50,0.50,40,2,20,5,30,5,10,200,60 mg, µg",Tablet,Oral use,27.3,THOMPSON & CAPPER,United Kingdom,VITABIOTICS LTD,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,MANAYER NAJD TRADING MEDICAL NEEDS CO.
JOINT CARE MAX CAPSULES AND TABLETS,"GLUCOSAMINE SULFATE, COD LIVER OIL, Fish collagen",1112246399,2009,"1500,975,100 mg",Tablet,Oral use,81.9,THOMPSON & CAPPER,United Kingdom,SEVEN SEAS LIMITED,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
JOFLAM 50MG F.C. TABLETS,DICLOFENAC POTASSIUM,0603245024,2006,50 mg,Film-coated tablet,Oral use,12.4,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"AMC Pharma, Cigalah Group"
JEDCORENE EFFERVESCENT GRANULES,"HEXAMINE, PIPERAZINE, KHELLIN",0203233318,2010,"0.475,0.150,0.0015 mg, g",Effervescent granules,Oral use,6.75,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,AL JEDAANI STORE
JEDCOMAG EFFERVESCENT GRANULES5GM SACHET,"EFFERVESCENT BASE, CITRIC ACID ANHYDROUS, MAGNESIUM OXIDE",2304245196,2007,"5,2.755,0275 g",Effervescent granules,Oral use,2.95,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,OTC,do not store above 30°c,Pharmacy,AL JEDAANI STORE
JEDCOFLACIN 200MG TABLETS,OFLOXACIN,4-461-10,2010,200 mg,Tablet,Oral use,23.70,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,AL JEDAANI STORE
JEDCO CAL - C EFFERVESCENT GRANULES,"EFFERVESCENT BASE, ASCORBIC ACID, CALCIUM CARBONATE",0203233321,2007,"4,1000,800 mg, g",Effervescent granules,Oral use,9.15,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,OTC,do not store above 30°c,Pharmacy,AL JEDAANI STORE
OMECURE 40 MG POWDER FOR I.V. INJECTION,OMEPRAZOLE,3008222563,2009,40 mg,powder for solution for injection,Intravenous use,270.9,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
JAZOFEN 200 MG TAB,IBUPROFEN,19-334-99,1999,200 mg,Tablet,Oral use,6.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
IVARIN 5MG FILM COATED TABLET,ROSUVASTATIN,2201256730,2013,5 mg,Film-coated tablet,Oral use,37.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IVARIN 40MG FILM COATED TABLET,ROSUVASTATIN,2201256726,2013,40 mg,Film-coated tablet,Oral use,210.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IVARIN 20MG FILM COATED TABLET,ROSUVASTATIN,2201256729,2013,20 mg,Film-coated tablet,Oral use,128.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IVARIN 10MG FILM COATED TABLET,ROSUVASTATIN,2201256727,2013,10 mg,Film-coated tablet,Oral use,75.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ITRAZOL 100 mg capsule,ITRACONAZOLE,2807257875,2006,100 mg,Capsule,Oral use,34.55,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ITRAZOL 100 mg capsule,ITRACONAZOLE,2807257874,2006,100 mg,Capsule,Oral use,112.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JAZOFEN 400MG TAB,IBUPROFEN,2401233158,1999,400 mg,Tablet,Oral use,12.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
JOINTACE COLLAGEN TABLET,"GLUCOSAMINE SULFATE, COLLAGEN TYPE II, CHONDROITIN, COPPER, GINGER EXTRACT, MANGANESE, TOCOPHEROL, ZINC OXIDE, ASCORBIC ACID, CHOLECALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, SELENIUM SULFIDE",2206222245,2013,"500,150,50,0.50,40,2,20,5,30,5,10,200,60 mg, µg",Tablet,Oral use,54.6,THOMPSON & CAPPER,United Kingdom,VITABIOTICS LTD,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,MANAYER NAJD TRADING MEDICAL NEEDS CO.
INSULATARD,INSULIN HUMAN,1901233126,1989,100 IU/ml,Suspension for injection,Subcutaneous use,65,NOVO NORDISK PRODUCTION S.A.S,France,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
INNOHEP 20000 ANTI-XA IU-ML VIAL,TINZAPARIN SODIUM,58-19-02,2002,20000 IU/ml,Solution,Subcutaneous use,113.7,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
INNOHEP 20000 ANTI-XA IU-ML VIAL,TINZAPARIN SODIUM,2412246476,2002,20000 IU/ml,Solution,Subcutaneous use,1087.75,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
INNOHEP 20000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,1909222616,2002,20000 IU/ml,Solution for injection,Subcutaneous use,100.6,LABORATOIRES LEO,France,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 20000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,2412246474,2002,20000 IU/ml,Solution for injection,Subcutaneous use,128.15,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 20000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,2412246475,2002,20000 IU/ml,Solution for injection,Subcutaneous use,81.25,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 10000 ANTI-XA IU-ML VIAL,TINZAPARIN SODIUM,2412246477,2002,10000 IU/ml,Solution,Subcutaneous use,543.9,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 10000 ANTI-XA IU-ML VIAL,TINZAPARIN SODIUM,52-19-02,2002,10000 IU/ml,Solution,Subcutaneous use,113.7,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 10000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,2001256690,2002,10000 IU/ml,Solution for injection,Subcutaneous use,137.85,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 10000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,2001256689,2002,10000 IU/ml,Solution for injection,Subcutaneous use,177.05,LABORATOIRES LEO,France,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INNOHEP 10000 ANTI-XA IU-ML SYRING,TINZAPARIN SODIUM,54-19-02,2002,10000 IU/ml,Solution for injection,Subcutaneous use,91.35,Leo Pharma,Denmark,Leo Pharma,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
INFLUVAC VACCINE,"A/Victoria/2570/2019 (H1N1)pdm09- like virus, A/Darwin/9/2021 (H3N2)-like virus, B/Austria/1359417/2021 (B/Victoria lineage)-like virus",1-728-96,1996,"15,15,15 µg",Solution,Subcutaneous use,28,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
INTELENCE 100 MG TABLETS,ETRAVIRINE,10-266-10,2010,100 mg,Tablet,Oral use,1575.20,JANSSEN-CILAG,Italy,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
INVEGA 6MG EXTENDED- RELEASE TABLETS,PALIPERIDONE,2002221742,2009,6 mg,Extended-release tablet,Oral use,319.85,JANSSEN-CILAG,United States,JANSSEN-CILAG,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
INVEGA 3MG EXTENDED- RELEASE TABLETS,PALIPERIDONE,2002221739,2009,3 mg,Extended-release tablet,Oral use,319.85,JANSSEN-CILAG,United States,JANSSEN-CILAG,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
INTRATECT 50MG-ML SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,22-160-09,2009,50 mg/ml,Solution for infusion,Intravenous use,4482.80,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
INTRATECT 50MG-ML SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,21-160-09,2009,50 mg/ml,Solution for infusion,Intravenous use,2241.40,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
INTRATECT 50MG-ML SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,20-160-09,2009,50 mg/ml,Solution for infusion,Intravenous use,1120.70,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
INTRATECT 50MG-ML SOLUTION FOR INFUSION,HUMAN IMMUNOGLOBULIN G,19-160-09,2009,50 mg/ml,Solution for infusion,Intravenous use,448.30,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
INVEGA 9MG EXTENDED- RELEASE TABLETS,PALIPERIDONE,2002221741,2009,9 mg,Extended-release tablet,Oral use,346.70,JANSSEN-CILAG,United States,JANSSEN-CILAG,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
INFLA-BAN 50MG SUPP.,DICLOFENAC SODIUM,89-119-98,1998,50 mg,Suppository,Rectal use,7.1,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
JOINTACE TABLET,"GLUCOSAMINE SULFATE, CHOLECALCIFEROL, CHONDROITIN, COPPER, CYANOCOBALAMIN, FOLIC ACID, GINGER EXTRACT, MANGANESE, TOCOPHEROL, SELENIUM SULFIDE, ZINC OXIDE, ASCORBIC ACID",2-805-12,2012,"500,5,200,0.50,10,200,40,2,20,60,5,30 mg, µg",Tablet,Oral use,27.3,THOMPSON & CAPPER,United Kingdom,VITABIOTICS LTD,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,MANAYER NAJD TRADING MEDICAL NEEDS CO.
KONAKION MM 10MG-ML AMP I.V.,PHYTOMENADIONE,2012211489,1997,10 mg,Solution for injection,Intravenous use,27.95,CENEXI,France,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
KOATE DVI 500 IU VIAL,OMFILOCTOCOG ALFA,1501268918,2010,500 IU,powder for solution for injection,Intravenous use,612.55,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
KOATE DVI 250 IU VIAL,OMFILOCTOCOG ALFA,1501268917,2010,250 IU,powder for solution for injection,Intravenous use,306.3,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
KOATE DVI 1000 IU VIAL,OMFILOCTOCOG ALFA,6-228-10,2010,1000 IU,powder for solution for injection,Intravenous use,1225.1,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
KLAVOX SUSPENSION 156MG-5ML,"AMOXICILLIN, CLAVULANIC ACID",71-212-97,1997,"125,31.25 mg",Powder for oral suspension,Oral use,17.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,SPIMACO
KLAVOX 625MG F.C.TAB,"AMOXICILLIN, CLAVULANIC ACID",75-212-98,1998,"500,125 mg",Film-coated tablet,Oral use,57.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
KLAVOX 457MG\5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",175-212-02,2002,"400,57 mg",Powder for oral suspension,Oral use,26.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,SPIMACO
KONAKION MM PAED 2MG-0.2ML AMP,PHYTOMENADIONE,2104257262,2001,2 mg,Solution for injection,Intravenous use,24.55,CENEXI,France,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
KORANDIL,ENALAPRIL MALEATE,1202256892,2007,20 mg,Tablet,Oral use,14.75,REMEDICA,Cyprus,REMEDICA,Cyprus,Marketed,Prescription,store below 25°c,Pharmacy,International Teriaqi for medicines ESt
KULAX 65MG-100ML SYRUP,LACTULOSE,1505245309,2005,0.65 mg/ml,Syrup,Oral use,15.25,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
LACINE 50MG F.C. TABLETS,LOSARTAN POTASSIUM,1012246387,2007,50 mg,Film-coated tablet,Oral use,42.2,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
KLAVOX 375MG F.C.TAB,"AMOXICILLIN, CLAVULANIC ACID",74-212-98,1998,"250,125 mg",Film-coated tablet,Oral use,33.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
KULAX 65MG-100ML SYRUP,LACTULOSE,1505245307,2007,0.65 mg/ml,Syrup,Oral use,10.15,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
JOINTACE TABLET,"GLUCOSAMINE SULFATE, CHONDROITIN, COPPER, GINGER EXTRACT, MANGANESE, TOCOPHEROL, ZINC OXIDE, ASCORBIC ACID, CHOLECALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, SELENIUM SULFIDE",4-805-13,2013,"500,200,0.5,40,2,20,5,30,5,10,200,60 mg, µg",Tablet,Oral use,54.6,THOMPSON & CAPPER,United Kingdom,VITABIOTICS LTD,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,MANAYER NAJD TRADING MEDICAL NEEDS CO.
KLAVOX 312.5 MG-5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",77-212-98,1998,"250,62.5 mg",Powder for oral suspension,Oral use,29.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
KLAVOX 1GM TAB,"AMOXICILLIN, CLAVULANIC ACID",150-212-01,2001,"875,125 mg",Tablet,Oral use,70.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
KETONIL 1MG-5ML SYRUP,KETOTIFEN,0701256525,1999,0.2 mg/ml,Syrup,Oral use,22.7,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
KETOFAN 25MG TAB,KETOPROFEN,2004257250,2006,25 mg,Tablet,Oral use,8.20,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
KETESSE 25MG F.C.TABLET,DEXKETOPROFEN,1702256905,2004,25 mg,Film-coated tablet,Oral use,16.9,A MENARINI INDUSTRIE FARMACEUTICHE S.R.L,Italy,A MENARINI INDUSTRIE FARMACEUTICHE S.R.L,Italy,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Saudi Import Company - BANAJA"
KERASAL 10 % OINTMENT,SALICYLIC ACID,2108245792,2008,10 %,Ointment,Topical,14.8,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
KENACORT-A 40MG\ML INJ,TRIAMCINOLONE ACETONIDE,0901233075,2003,40 mg/ml,Suspension for injection,Intramuscular use,25.60,CATALENT ANGANI S.R.L,Italy,BRISTOL-MYERS SQUIBB,Italy,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
KAPECT SUSP.,"KAOLIN, PECTIN",1510246053,1990,"193,4.3 mg/ml",Suspension,Oral use,9.30,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,Khalid Bin Saad Int. Company LTD
KAFOSED SYRUP 15MG-5ML,DEXTROMETHORPHAN,11-212-92,1992,3 mg/ml,Syrup,Oral use,10.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
KLARIMID 500MG F.C. TABLETS,CLARITHROMYCIN,27-346-09,2009,500 mg,Film-coated tablet,Oral use,36.1,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
KLARIMID 250MG-5ML SUSPENSION,CLARITHROMYCIN,25-346-08,2008,50 mg/ml,Suspension,Oral use,55.05,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
KLARIMID 250MG F.C. TABLETS,CLARITHROMYCIN,26-346-09,2009,250 mg,Film-coated tablet,Oral use,22,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
KLACID XL 500MG TAB,CLARITHROMYCIN,0404233478,2004,500 mg,Extended-release tablet,Oral use,85.95,ABBVIE SRL,Italy,Abbott Laboratories,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
KLACID XL 500MG TAB,CLARITHROMYCIN,10-138-01,2001,500 mg,Extended-release tablet,Oral use,59.1,Abbott Laboratories,United Kingdom,Abbott Laboratories,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
KLAVOX 228MG\5ML SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",174-212-02,2002,"200,28.5 mg",Powder for oral suspension,Oral use,15.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,SPIMACO
KLACID 500MG COATED TAB,CLARITHROMYCIN,0404233481,1999,500 mg,Coated tablet,Oral use,90.2,ABBVIE SRL,Italy,Abbott Laboratories,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
KIOVIG 100MG/ML SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,8-5603-21,2012,100 mg/ml,Solution for infusion,Intravenous use,8965.60,Baxalta Belgium Manufacturing S.A,Belgium,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
KIOVIG 100MG/ML SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,2400001783,2012,100 mg/ml,Solution for infusion,Intravenous use,4482.80,Baxalta Belgium Manufacturing S.A,Belgium,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
KIOVIG 100MG/ML SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,6-5603-21,2012,100 mg/ml,Solution for infusion,Intravenous use,2241.40,Baxalta Belgium Manufacturing S.A,Belgium,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
KIOVIG 100MG/ML SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,5-5603-21,2012,100 mg/ml,Solution for infusion,Intravenous use,1120.70,Baxalta Belgium Manufacturing S.A,Belgium,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
KIOVIG 100MG/ML SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,4-5603-21,2012,100 mg/ml,Solution for infusion,Intravenous use,448.30,Baxalta Belgium Manufacturing S.A,Belgium,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
KLACID 250MG TAB,CLARITHROMYCIN,0404233483,1993,250 mg,Tablet,Oral use,60.4,ABBVIE SRL,Italy,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
INFLABAN 12.5MG SUPP.,DICLOFENAC SODIUM,90-119-98,1998,12.5 mg,Suppository,Rectal use,5.15,APM,Jordan,APM,Jordan,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Abdulrehman Algosaibi G.T.C.
INFLA-BAN 100MG SUPP.,DICLOFENAC SODIUM,88-119-98,1998,100 mg,Suppository,Rectal use,7.1,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Zistan SYRUP,CHLORPHENIRAMINE MALEATE,2801256765,2001,0.4 mg/ml,Syrup,Oral use,5.4,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Zistan 4 MG TABLETS,CHLORPHENIRAMINE MALEATE,2801256766,2004,4 mg,Tablet,Oral use,6.1,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
HIKMA MIDAZOLAM 5MG-1ML AMPOULES,MIDAZOLAM,2304245200,2006,5 mg/ml,Solution for injection,Parenteral use,36.9,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
HIKMA HEPARIN 5000 IU/ML,HEPARIN SODIUM,2707257856,1999,5000 IU/ml,Solution for injection,Intravenous use,317.4,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HI-CAL,CALCIUM GLUBIONATE,13-251-02,2002,240 mg/ml,Syrup,Oral use,6.5,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
HIBOR 7500 I.U. - 0.3 ML PREFILLED SYRINGE,BEMIPARIN SODIUM,177-172-10,2010,7500 IU,Solution for injection in pre-filled syringe,Parenteral use,84.95,Rovi Pharma Industrial Service,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HIBOR 5000 I.U. - 0.2 ML PREFILLED SYRINGE,BEMIPARIN SODIUM,173-172-10,2010,5000 IU,Solution for injection in pre-filled syringe,Parenteral use,56.65,Rovi Pharma Industrial Service,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HIBOR 3500 I.U. - 0.2 ML PREFILLED SYRINGE,BEMIPARIN SODIUM,176-172-10,2010,3500 IU,Solution for injection in pre-filled syringe,Parenteral use,39.65,Rovi Pharma Industrial Service,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HIBOR 2500 I.U. - 0.2 ML PREFILLED SYRINGE,BEMIPARIN SODIUM,174-172-10,2010,2500 IU,Solution for injection in pre-filled syringe,Parenteral use,28.3,Rovi Pharma Industrial Service,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HIBOR 10000 I.U.- 0.4 ML PREFILLED SYRINGE,BEMIPARIN SODIUM,175-172-10,2010,10000 IU,Solution for injection in pre-filled syringe,Parenteral use,113.3,Rovi Pharma Industrial Service,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HISTOFEN SYRUP 1MG/5ML,KETOTIFEN,2705245354,1999,0.2 mg/ml,Eye drops,Ocular use,22.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
HISTOP 2MG-5ML SYRUP,CHLORPHENIRAMINE MALEATE,0908222432,1994,0.4 mg/ml,Syrup,Oral use,6.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
HUMAN ALBUMIN 5%,ALBUMIN HUMAN,6-163-00,2000,5 %,Solution,Intravenous use,187.05,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
HUMAN ALBUMIN 200G-I TAKEDA,ALBUMIN HUMAN,0403256981,1989,20 %,Solution,Intravenous use,141,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
HUMAN ALBUMIN 20% +INFUSION SET,ALBUMIN HUMAN,3003233450,2000,20 %,Solution,Intravenous use,138.55,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HUMAN ALBUMIN 20% +INFUSION SET,ALBUMIN HUMAN,3003233452,2000,20 %,Solution,Intravenous use,262.9,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HUMAN ALBUMIN 20%,ALBUMIN HUMAN,7-163-00,2000,20 %,Solution,Intravenous use,146.4,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
HUMAN ALBUMIN 20%,ALBUMIN HUMAN,8-163-00,2000,20 %,Solution,Intravenous use,213.85,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
HI- QUIN 4% CREAM,HYDROQUINONE,1506222209,2009,4 %,Cream,Topical,29.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
HOLOXAN 500MG VIAL IV,IFOSFAMIDE,2611258658,1987,500 mg,Powder for injection,Intravenous use,84.85,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
HOLOXAN 2GM IV. VIAL,IFOSFAMIDE,2611258659,1987,2 g,Powder for injection,Intravenous use,324.60,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
HOLOXAN 1GM I.V. VIAL,IFOSFAMIDE,5-6063-25,1987,1 g,Powder for injection,Intravenous use,169.70,BAXTER ONCOLOGY,Germany,BAXTER ONCOLOGY,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
HISTOP TAB 4MG,CHLORPHENIRAMINE MALEATE,0709258175,1994,4 mg,Tablet,Oral use,6.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
HUMALOG 100 I.U VIALS,INSULIN LISPRO,0907245509,1998,100 IU/ml,Solution for injection,Subcutaneous use,89.80,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
HUMAN ALBUMIN 5%,ALBUMIN HUMAN,3003233451,1985,5 %,Solution,Intravenous use,190.6,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HI- QUIN 2% CREAM,HYDROQUINONE,1506222206,2009,2 %,Cream,Topical,23.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
HAVRIX 720 EFISA UNITS-.5ML JUNIOR VACCI,HEPATITIS A VIRUS,91-276-12,2012,,Solution for injection,Intramuscular use,73.90,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
HARTMANNS SOLUTION 1\2,SODIUM LACTATE,281-149-03,2003,1.9 %,Solution,Intravenous use,5.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HARNAL 0.4MG MODIFIED RELEASE CAPSULES,TAMSULOSIN HYDROCHLORIDE,0909245890,2005,0.4 mg,Modified-release capsule,Oral use,86.90,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
HALDOL DECANOAS INJ 50MG,HALOPERIDOL,1610222735,1988,50 mg/ml,Solution for injection,Intramuscular use,21.85,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HALDOL DECANOAS INJ 100MG-ML,HALOPERIDOL,1610258429,1988,100 mg/ml,Solution for injection,Intramuscular use,41.35,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HALDOL 5MG-ML AMP,HALOPERIDOL,20-6-81,1981,5 mg/ml,Solution for injection,Parenteral use,23.15,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
HALDOL 5MG TABLET,HALOPERIDOL,2010222764,2003,5 mg,Tablet,Oral use,19.75,LUSOMEDICAMENTA,Portugal,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
HALDOL 2MG-ML DROPS,HALOPERIDOL,3005222085,1981,2 mg/ml,Oral drops,Oral use,11.45,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
HAIRGROW,MINOXIDIL,2012234610,2005,5 %,Solution,Topical,59.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
HAIRGROW,MINOXIDIL,2012234609,1994,2 %,Solution,Topical,52.7,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
HAIRGAIN 5% W-V SOLUTION FOR MEN,MINOXIDIL,2110258452,2010,5 %,Solution,Topical,57.75,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
HAIRGAIN 2% W-V SOLUTION FOR WOMEN,MINOXIDIL,0809258187,2010,2 %,Solution,Topical,57.75,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
HAEMODIALYSIS CONCENTRATE SOLUTION 35 F1,"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, DEXTROSE",202-149-00,2000,"200.45,9,5.34,190.54,77 g/l",Concentrate for solution for haemodialysis,Parenteral use,39,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HAEMODIALYSIS CONCENTRATE SOLUTION 35 F1,"SODIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, DEXTROSE",201-149-00,2000,"200.45,9,5.34,190.54,77 g/l",Concentrate for solution for haemodialysis,Parenteral use,27.7,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
HEMAMAX 100 MG CHEWABLE OR SWALLOWABLE TABLETS,IRON POLYMALTOSE,25-539-10,2010,100 mg,Chewable tablet,Oral use,17.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
HEMAMAX 50 MG-5ML SYRUP,IRON POLYMALTOSE,24-539-10,2010,10 mg/ml,Syrup,Oral use,11.6,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
HEMAMAX F CHEWABLE TABLETS,"FERRIC HYDROXIDE, FOLIC ACID",31-539-10,2010,"100,0.35 mg",Chewable tablet,Oral use,17.45,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
HERCEPTIN 150MG VIAL,Trastuzumab,0311258535,2008,150 mg,Powder for concentrate for solution for infusion,Intravenous use,1949.55,ROCHE,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Roche Products Saudi Arabia
HEPSAL AMP 10 UNITS-ML,HEPARIN SODIUM,1-178-87,1987,10 IU/ml,Solution,Intravenous use,2.7,CP PHARMACEUTICAL LIMITED,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HEPIX 100MG F-C TABLETS,LAMIVUDINE,0902221715,2010,100 mg,Film-coated tablet,Oral use,283.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HEPATECT CP,HUMAN HEPATITIS B IMMUNOGLOBULIN,1202244909,2000,50 IU/ml,Solution for infusion,Intravenous use,1528.4,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
HI CARE CREAM,HYDROQUINONE,1107245534,2013,1.9 %,Cream,Topical,20.8,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
HEPATECT CP,HUMAN HEPATITIS B IMMUNOGLOBULIN,1202244908,1998,50 IU/ml,Solution for infusion,Intravenous use,382.1,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Hepa-Merz,ORNITHINE,0307257695,1999,5 g/ml,Concentrate for solution for infusion,Intravenous use,82,MERZ PHARMACEUTICAL,Germany,MERZ PHARMACEUTICAL,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Hepa-Merz,ORNITHINE,2207257800,1999,3 g,Granules,Oral use,32.8,MERZ PHARMACEUTICAL,Germany,MERZ PHARMACEUTICAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
HEMOFIL M 500 IU VIAL,OMFILOCTOCOG ALFA,59-253-06,2006,500 IU,Solution,Parenteral use,855.85,BAXTER,United States,BAXTER,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Health Care Co.
HEMOFIL M 250 IU VIAL+10ML STERIL WATER,OMFILOCTOCOG ALFA,60-253-06,2006,250 IU,Powder and solvent for solution for injection,Parenteral use,427.95,BAXTER,United States,BAXTER,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Health Care Co.
HEMOFIL M 1000 IU VIAL+10ML STERIL WATER,OMFILOCTOCOG ALFA,58-253-06,2006,1000 IU,Powder and solvent for solution for injection,Parenteral use,1711.75,BAXTER,United States,BAXTER,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Health Care Co.
HUMAN ALBUMIN 50G-I TAKEDA 250ML,ALBUMIN HUMAN,0403256980,1989,5 %,Solution,Intravenous use,209.55,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
Human Albumin Grifols 20%,ALBUMIN HUMAN,0404233472,2009,20 %,Solution for infusion,Intravenous use,213.85,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
IMPLANON NXT IMPLANT 68MG,ETONOGESTREL,2406257613,2004,68 mg,Implant,Subcutaneous use,444.85,N.V. Organon,Netherlands,ORGANON,Netherlands,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
IMODIUM 2MG CAPSULE,LOPERAMIDE,91-6-04,2004,2 mg,Capsule,Oral use,6.45,LUSOMEDICAMENTA,Portugal,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
IMMUNATE S-D 500 I.U. POWDER FOR INJ,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",1401256603,2007,"500,375 IU",Powder and solvent for solution for injection,Parenteral use,663.80,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
IMMUNATE S-D 250 I.U. POWDER FOR INJ,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",2101256719,2007,"250,190 IU",Powder and solvent for solution for injection,Parenteral use,331.90,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
IMMUNATE S-D 1000 I.U. POWDER FOR INJ,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",1401256604,2008,"1000,750 IU",Powder and solvent for solution for injection,Parenteral use,1138.90,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
IMIGRAN 6MG-0.5ML AMP,SUMATRIPTAN,2701256760,1994,12 mg/ml,Solution,Subcutaneous use,125.50,GLAXO,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IMIGRAN,SUMATRIPTAN,1309211043,1999,50 mg,Tablet,Oral use,100.85,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
INFASURF 35 MG/ML INTRATRACHEAL SUSPENSION,CALFACTANT,2701256753,2013,35 mg/ml,Suspension,Intratracheal use,892.25,O.N.Y INC,United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
INFASURF 35 MG/ML INTRATRACHEAL SUSPENSION,CALFACTANT,2701256754,2013,35 mg/ml,Suspension,Intratracheal use,1726.2,O.N.Y INC,United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
INFANRIX HEXA VACCINE,"HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, INACTIVATED POLIO VIRUS (IPV) TYPE 1, INACTIVATED POLIO VIRUS (IPV) TYPE 3, HAEMOPHILUS INFLUENZAE TYPE B, INACTIVATED POLIO VIRUS (IPV) TYPE 2",3108200144,2012,"10,30,40,25,40,32,10,8 IU, µg, DA",Powder and suspension for suspension for injection,Intramuscular use,198.15,GLAXOSMITHKLINE BIOLOGICALS,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
INDOMIN CAP 25MG,INDOMETACIN,36-172-87,1987,25 mg,Capsule,Oral use,2.25,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
IMIGRAN,SUMATRIPTAN,1309211041,1999,50 mg,Tablet,Oral use,38.30,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
INDICARDIN 10 mg tablet,PROPRANOLOL,94-119-00,2000,10 mg,Tablet,Oral use,7,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
INDICARDIN 40 mg tablet,PROPRANOLOL,95-119-00,2000,40 mg,Tablet,Oral use,15,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
INDERAL TABLETS 40 MG.,PROPRANOLOL,16-7-81,1981,40 mg,Tablet,Oral use,40,FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED - INDIA,India,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
INDERAL TABLETS 10 MG.,PROPRANOLOL,15-7-81,1981,10 mg,Tablet,Oral use,20,FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED - INDIA,India,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
VERORAB VACCINE,RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED),2-164-94,1994,2.5 IU,Powder and solvent for suspension for injection in pre-filled syringe,Intramuscular use,106.6,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
INDOCID 100MG SUPPOSITORIES,INDOMETACIN,0311222872,2010,100 mg,Suppository,Rectal use,25.35,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
IMIGRAN,SUMATRIPTAN,1309211044,2003,100 mg,Tablet,Oral use,150.05,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IMIGRAN,SUMATRIPTAN,1309211042,2003,100 mg,Tablet,Oral use,57.00,DELPHARM POZNAN SPOLKA AKCYJNA,Poland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IMAVIR 5% CREAM,ACYCLOVIR,35-290-06,2006,5 %,Cream,Topical,12.65,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
HYMOX 125MG-5ML POWDER FOR ORAL SUSPENSION,AMOXICILLIN,0603256998,1998,25 mg/ml,Powder for oral suspension,Oral use,12.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
HYLO-COMOD 0.1% EYE DROP,SODIUM HYALURONATE,1203257041,2004,0.1 %,Eye drops,Ophthalmic use,43.15,URSAPHARMA,Germany,URSAPHARMA,Germany,Marketed,OTC,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
HYFRESH 2 MG- ML OPHTHALMIC SOLUTION,HYALURONIC ACID,2510211234,2004,2 %,Eye drops,Ophthalmic use,34.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
HYDROSONE 20MG TABLET,HYDROCORTISONE,145-172-04,2004,20 mg,Tablet,Oral use,31.05,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
HYMOX 250MG CAPS,AMOXICILLIN,0307222297,1998,250 mg,Capsule,Oral use,20.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
HYDROCORTISONE 100M VIAL+SOLVENT 2ML AMP,HYDROCORTISONE SODIUM SUCCINATE,31-201-02,2002,100 mg,Solution,Parenteral use,9.85,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
HYALGAN 20MG-2ML PRE-FILLED SYRINGE,SODIUM HYALURONATE,1-427-05,2005,10 mg/ml,Solution for injection,Intraarticular use,144.65,FIDIA,Italy,FIDIA,Italy,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
HUMULIN-R-REGULAR 100 U-ML,INSULIN HUMAN,27-42-85,1985,100 IU/ml,Solution for injection,Subcutaneous use,53.55,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
HUMULIN-N-NPH 100 U-ML,INSULIN ISOPHANE,26-42-85,1985,100 IU/ml,Suspension for injection,Subcutaneous use,53.55,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
HUMULIN 70-30 100U-ML,INSULIN ISOPHANE,36-42-92,1992,100 IU/ml,Suspension for injection,Subcutaneous use,53.55,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Human Albumin Grifols 20%,ALBUMIN HUMAN,1505257397,2009,20 %,Solution for infusion,Intravenous use,146.40,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
HYDRODERM CREAM PLUS,"HYDROQUINONE, RETINOIC ACID, DEXAMETHASONE SODIUM PHOSPHATE",9-609-11,2011,"4,0.05,0.1 %",Cream,Topical,63.1,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Pharma Factory
FLUZYN 20MG CAPSULES,FLUOXETINE,23-498-08,2008,20 mg,Capsule,Oral use,28.7,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
HYMOX 250MG-5ML POWDER FOR ORAL SUSPENSION,AMOXICILLIN,1501256667,1998,50 mg/ml,Powder for oral suspension,Oral use,25.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
HYMOX 500MG CAPS,AMOXICILLIN,0307222296,1998,500 mg,Capsule,Oral use,40.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
IMAVIR 5% CREAM,ACYCLOVIR,21-290-03,2003,5 %,Cream,Topical,38.00,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ICHTHAMMOL 10% OINTMENT,ICHTHAMMOL,2207257801,2009,10 %,Ointment,Topical,15.4,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
Brofenex 5GM- 100GM CREAM,IBUPROFEN,1009245893,2010,5 %,Cream,Topical,12.25,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
HYZAAR 50/12.5 mg film-coated tablet,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",1802256913,2001,"50,12.5 mg",Film-coated tablet,Oral use,39.10,Organon Pharma (UK) Limited,United Kingdom,ORGANON,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
HYPOSEC 20 MG CAPSULE,OMEPRAZOLE,2203257125,2002,20 mg,Capsule,Oral use,31.6,Ram Pharmaceutical Industries,Jordan,Ram Pharmaceutical Industries,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
HYPODIPINE 5MG CAPSULES,AMLODIPINE BESILATE,24-346-08,2008,5 mg,Capsule,Oral use,21.8,SPIMACO,Jordan,Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co.,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,"Nomou United Medical Company, United Pharmaceutical Establishment"
HYOPAN SYRUP 5 MG-5 ML,HYOSCINE BUTYLBROMIDE,1505245303,2004,1 mg/ml,Syrup,Oral use,10.80,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
HYMOX 875 mg film-coated tablet,AMOXICILLIN,2212211499,2009,875 mg,Film-coated tablet,Oral use,49.50,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
FLUTAB TABLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE",100-212-99,1999,"500,30,25 mg",Tablet,Oral use,14.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
FLUTAB Sinus TABLETS,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE",101-212-99,1999,"500,30 mg",Tablet,Oral use,9.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,SPIMACO
DOBUTAMINE HCL 250MG-20ML VIAL,DOBUTAMINE,1506257553,1998,12.5 mg/ml,Solution for injection,Intravenous use,31.55,HOSPIRA AUSTRALIA,Australia,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
DOBUJECT 50MG-ML(250MG-5ML) AMPOULE,DOBUTAMINE,1-881-13,2013,50 mg/ml,Concentrate for peritoneal dialysis solution,Intravenous use,101.55,Berlimed S.A.,Spain,PRIMEX PHARMACEUTICALS OY,Finland,Marketed,Prescription,store below 25°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
DIVIDO 75MG DUAL RELEASE CAP,DICLOFENAC SODIUM,0902221709,2002,75 mg,Modified-release capsule,Oral use,30.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DIUSEMIDE 40 MG TAB,FUROSEMIDE,10-119-82,1982,40 mg,Tablet,Oral use,7,APM,Jordan,APM,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
DIUSEMIDE 20MG-2ML AMP,FUROSEMIDE,2806222277,1996,10 mg/ml,Solution for injection,Intravenous use,17.70,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
DISPRIN,ACETYLSALICYLIC ACID,0706222152,2005,81 mg,Enteric-coated tablet,Oral use,25.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,RIYADH PHARMA
DISPERCAM GEL 0.5%,PIROXICAM,15-251-08,2008,0.5 %,Gel,Topical,2.8,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
DISPERCAM 20MG-ML AMP.FOR I-M USE,PIROXICAM,14-251-05,2005,20 mg/ml,Solution for injection,Intramuscular use,2.65,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 25°c,Hospital,"Annhdah Medical Company, Cigalah Group"
DOGMATIL AMP 100MG,SULPIRIDE,8-90-82,1982,100 mg,Solution for injection,Intravenous use,10.8,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
DOGMATIL CAPS 50MG,SULPIRIDE,32-883-21,1982,50 mg,"Capsule, hard",Oral use,21.4,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DOPAMIN HCL 40MG-ML INJ VIAL,DOPAMINE HYDROCHLORIDE,7-549-89,1989,40 mg/ml,Concentrate for solution for infusion,Intravenous use,33.7,HOSPIRA INC. ROCKY MOUNT,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
DOMPY 10MG TABLET,DOMPERIDONE,0309245854,2004,10 mg,Tablet,Oral use,16.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DOMPY 0.1% ORAL SUSPENTION,DOMPERIDONE,1109234167,2004,0.1 mg/ml,Suspension,Oral use,19.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DOLVIC- K 50 MG F- C TABLETS,DICLOFENAC POTASSIUM,2706222269,2008,50 mg,Film-coated tablet,Oral use,26.95,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
DOLGIT CREAM 50MG-G,IBUPROFEN,1-224-93,1993,5 %,Cream,Topical,12.25,DOLORGIET PHARMACEUTICALS,Germany,DOLORGIET PHARMACEUTICALS,Germany,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
DOGMATIL FORT TAB 200MG,SULPIRIDE,5-90-82,1982,200 mg,Scored tablet,Oral use,22.5,Delpharm Dijon,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DOPAMIN HCL INJ 40MG-ML,DOPAMINE HYDROCHLORIDE,9-549-89,1989,40 mg/ml,Injection,Intravenous use,25.3,HOSPIRA INC. ROCKY MOUNT,United States,HOSPIRA INC,United States,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
DIPROFOS INJ. 2ML,"BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE",1305257384,1987,"5,2 mg/ml",Suspension for injection,Intramuscular use,25.40,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DIFFERIN 0.1% GEL,ADAPALENE,3004257319,1998,0.1 %,Gel,Topical,18.75,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
DIFFERIN 0.1% CREAM,ADAPALENE,3004257321,2004,0.1 %,Cream,Topical,18.75,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
DICYNONE 500 MG TABLETS,ETHAMSYLATE,6-165-07,2007,500 mg,Tablet,Oral use,50.6,OM PHARMA,Switzerland,OM Pharma SA,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
DICYNONE 2ML-AMP 250MG,ETHAMSYLATE,0608257937,1985,125 mg/ml,Solution for injection,Intravenous use,21.15,OM PHARMA,Switzerland,OM PHARMA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ARAC HEALTHCARE
DICLON 1% EMULGEL,DICLOFENAC SODIUM,26-490-06,2006,1 %,Gel,Topical,9.30,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DICLOMAX 50 MG TAB,DICLOFENAC SODIUM,2711222937,1999,50 mg,Tablet,Oral use,19.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DICLOMAX 25MG TAB,DICLOFENAC SODIUM,0807245493,1999,25 mg,Tablet,Oral use,14.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DICLOMAX 1% EMULGEL,DICLOFENAC SODIUM,2711222939,2003,1 %,Gel,Topical,10.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DICLOGESIC 50MG SUPPOSITORY,DICLOFENAC SODIUM,2706222265,1998,50 mg,Suppository,Rectal use,6.35,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
DICLOGESIC,DICLOFENAC SODIUM,2702256958,1998,"12.5 mg, %",Suppository,Rectal use,4.6,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
DILANYL SYRUP,TERBUTALINE,1006245401,2004,0.3 mg/ml,Syrup,Oral use,10.35,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DIPEPTIVEN 20GM/100ML CONC,ALANYL GLUTAMINE,2-706-10,2010,0.2 g/ml,Concentrate for solution for infusion,Parenteral use,169.85,FRESENIUS KABI,Austria,FRESENIUS KABI,Austria,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
DIOVAN 80MG TAB,VALSARTAN,1408222484,2002,80 mg,Film-coated tablet,Oral use,38.75,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
DIOVAN 40MG F.C. TABLETS,VALSARTAN,1408222485,2007,40 mg,Film-coated tablet,Oral use,23.05,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
DIOVAN 160MGTAB,VALSARTAN,1408222486,2002,160 mg,Film-coated tablet,Oral use,42.5,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
DILZEM RETARD,DILTIAZEM HYDROCHLORIDE,1710222743,1992,90 mg,Prolonged-release tablet,Oral use,27.7,PFIZER,Germany,Pfizer Pharma GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
DIOVAN 320MG F.C. TABLETS,VALSARTAN,1408222482,2007,320 mg,Film-coated tablet,Oral use,54.85,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
DICLOGESIC,DICLOFENAC SODIUM,27-124-89,1989,100 mg,Suppository,Rectal use,11.4,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
EARCALM,"PHENAZONE, BENZOCAINE",1405245286,2003,"50,10 mg",Ear drops,Auricular use,9.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
DUSPATALIN 200MG PROLONGED RELEASE CAPS,MEBEVERINE HYDROCHLORIDE,0604233492,2000,200 mg,Modified-release capsule,Oral use,48.15,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DUSPAMEN 135MG TAB,MEBEVERINE HYDROCHLORIDE,2401233156,2003,135 mg,Film-coated tablet,Oral use,20.70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DUROGESIC TTS 75 Ug-HOUR,FENTANYL,84-6-99,1999,75 µg,Transdermal patch,Transdermal use,276.05,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DUROGESIC TTS 50 Ug-HOUR,FENTANYL,1808258039,1999,50 µg,Transdermal patch,Transdermal use,206.75,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DUROGESIC TTS 25 Ug-HOUR,FENTANYL,1808258038,1999,25 µg,Transdermal patch,Transdermal use,110.5,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DUROGESIC TTS 100 Ug-HOUR,FENTANYL,1808258037,1999,100 µg,Transdermal patch,Transdermal use,339.95,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DUROGESIC 12MCG-H TRASDERMAL PATCHES,FENTANYL,91-6-09,2009,12 µg,Transdermal patch,Transdermal use,79.75,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DURATEARS OCULAR OINT.,WOOL FAT HYDROUS,1-5870-23,1997,30.0 mg,Eye ointment,Topical,16.20,S.A. Alcon Couvreur N.V,Belgium,ALCON N.V.,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
DURACAN 150MG CAPSULE,FLUCONAZOLE,1612246425,2004,150 mg,"Capsule, soft",Oral use,19.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Ebetaxel 30mg/5ml,PACLITAXEL,36-355-06,2006,6 mg/ml,Concentrate for solution for infusion,Intravenous use,220.40,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Ebetaxel 300mg/50ml,PACLITAXEL,33-355-06,2006,6 mg/ml,Concentrate for solution for infusion,Intravenous use,1762.85,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
EBETAXEL 6MG-ML SOLU. FOR I.V. INFUSION,PACLITAXEL,35-355-06,2006,6 mg/ml,Concentrate for solution for infusion,Intravenous use,736.15,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Ebetaxel 150mg/25ml,PACLITAXEL,34-355-06,2006,6 mg/ml,Concentrate for solution for infusion,Intravenous use,992.15,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ELDOQUIN CREAM 2%,HYDROQUINONE,14-230-96,1996,2 %,Cream,Topical,27.25,I.C.N.PHARMACEUTICALS,United States,I.C.N.PHARMACEUTICALS,United States,Marketed,OTC,store below 25°c,Pharmacy,ALNAGHI COMPANY
DUPHALAC ORAL SOLUTION,LACTULOSE,4-137-85,1985,667 g/l,Oral solution,Oral use,24.4,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
EFEXOR XR 150 MG CAPSULES,VENLAFAXINE HYDROCHLORIDE,10-5825-23,2013,150 mg,Prolonged-release capsule,Oral use,95.05,PFIZER,Ireland,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
ECZADERM 0.1% W-W OINTMENT,MOMETASONE FUROATE,0907257720,2010,0.1 %,Ointment,Topical,11.6,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
ECZADERM 0.1% W-W CREAM,MOMETASONE FUROATE,1210258397,2010,0.1 %,Cream,Topical,18.00,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
ECALTA 100MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION,ANIDULAFUNGIN,56-44-12,2012,100 mg,Powder for concentrate for solution for infusion,Intravenous use,612.55,PHARMACIA UPJOHN,United States,PFIZER,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
EBIXA 20MG FILM COATED TABLETS,MEMANTINE HYDROCHLORIDE,38-136-11,2011,20 mg,Film-coated tablet,Oral use,252.35,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
EBIXA 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,33-136-07,2007,10 mg,Film-coated tablet,Oral use,115.40,ROTTENDORF PHARMA GMBH,Germany,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
EFEXOR XR 75 MG CAPSULES,VENLAFAXINE HYDROCHLORIDE,9-5825-23,2013,75 mg,Prolonged-release capsule,Oral use,56.40,PFIZER,Ireland,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
DOXORUBICIN 2MG-MLVIAL,DOXORUBICIN HYDROCHLORIDE,39-355-07,2007,2 mg/ml,Concentrate for solution for infusion,Intravenous use,211.1,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DOXORUBICIN 2MG-MLVIAL,DOXORUBICIN HYDROCHLORIDE,5-355-01,2001,2 mg/ml,Concentrate for solution for infusion,Intravenous use,105.25,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DOXORUBICIN 2MG-MLVIAL,DOXORUBICIN HYDROCHLORIDE,4-355-01,2001,2 mg/ml,Concentrate for solution for infusion,Intravenous use,40.15,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DOXIVENIL,CALCIUM DOBESILATE MONOHYDRATE,0102233203,2007,500 mg,Capsule,Oral use,28.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
DOTAREM 376MG-ML PREFILLED SYRINGE,GADOTERIC ACID,9-229-01,2001,376 mmol/ml,Suspension for injection in pre-filled syringe,Intravenous use,323,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DOTAREM 376MG-ML PREFILLED SYRINGE,GADOTERIC ACID,10-229-01,2001,376 mmol/ml,Suspension for injection in pre-filled syringe,Intravenous use,398.35,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DOTAREM 0.5MOL-L GLASS BOTTLE W-STOPPER,"GADOTERIC ACID, GADOLINIUM OXIDE, DOTA",8-229-01,2001,"27.932,9.062,20.246 g",Solution for injection,Intravenous use,370.95,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DOTAREM 0.5MOL-L GLASS BOTTLE W-STOPPER,"GADOTERIC ACID, GADOLINIUM OXIDE, DOTA",6-229-01,2001,"27.932,9.062,20.246 g",Solution for injection,Intravenous use,169.05,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DOTAREM 0.5MOL-L GLASS BOTTLE W-STOPPER,GADOTERIC ACID,7-229-01,2001,27.932 g,Solution for injection,Intravenous use,247.3,LABORATORIES GUERBET,France,LABORATORIES GUERBET,France,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
DOSTINEX 0.5MG TABLET,CABERGOLINE,0309234087,2000,0.5 mg,Tablet,Oral use,132.80,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
DOSTINEX 0.5MG TABLET,CABERGOLINE,0309234085,2000,0.5 mg,Tablet,Oral use,41.40,PFIZER,Italy,PFIZER,Italy,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
DOROFEN 500-50 MG CAPSULE,"GLUCOSAMINE SULFATE, GINKGO BILOBA",2305233708,2010,"500,50 mg",Capsule,Oral use,36.4,LIPTIS PHARMACEUTICALS,United States,LIPTIS PHARMACEUTICALS,United States,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DORMICUM 15MG-3ML  AMP.,MIDAZOLAM,2807245666,2000,5 mg/ml,Solution for injection,Parenteral use,55.7,CENEXI,France,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,"Abdulrehman Algosaibi G.T.C., Roche Products Saudi Arabia"
DOXYCIN,DOXYCYCLINE,2403257142,2004,100 mg,Capsule,Oral use,21.65,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
DRAMYLIN PEDIATRIC SYRUP,"DIPHENHYDRAMINE HYDROCHLORIDE, SODIUM CITRATE, MENTHOL",1505245308,2002,"0.14,0.57,0.011 g",Syrup,Oral use,7.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DRAMYLIN SYRUP,"AMMONIUM CHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE",2811246348,2002,"2.63,0.27 g",Syrup,Oral use,8.30,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
DUODART Capsule,"DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE",2306210822,2014,"0.5,0.4 mg","Capsule, hard",Oral use,103.60,CATALENT,Germany,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
DROLATE 70 MG FILM COATED TABLETS,ALENDRONIC ACID,2307257816,2010,70 mg,Tablet,Oral use,28.5,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Dallah Health Care Company
DROF 2% SHAMPOO,KETOCONAZOLE,3-539-08,2008,2 %,Shampoo,Topical,15.25,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
DICLOGESIC,DICLOFENAC DIETHYLAMINE,2102244965,1994,1 %,Gel,Topical,7.8,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
DICLAC 75MG ID TABLETS,DICLOFENAC SODIUM,13-349-10,2010,75 mg,Prolonged-release tablet,Oral use,24.85,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DIAMICRON MR TABLET,GLICLAZIDE,2807257865,2001,30 mg,modified-release tablet,Oral use,24,LES LABORATOIRES SERVIER INDUSTRIE,France,SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
DIAMICRON 60MG MR TABLET,GLICLAZIDE,2807257863,2013,60 mg,modified-release tablet,Oral use,24,LES LABORATOIRES SERVIER INDUSTRIE,France,SERVIER,France,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Servier Saudi Arabia Trading LLC"
0.18% W/V SODIUM CHLORIDE and 5% W/V DEXTROSE intravenous infusion,"DEXTROSE, SODIUM CHLORIDE",162-149-98,1998,"5,0.18 %",Solution,Intravenous use,9.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.18% W/V SODIUM CHLORIDE and 5% W/V DEXTROSE intravenous infusion,"DEXTROSE, SODIUM CHLORIDE",3005222106,1994,"5,0.18 %",Solution,Intravenous use,6.35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 50%,DEXTROSE,208-149-00,2000,50 %,Intravenous infusion,Intravenous use,1.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 50%,DEXTROSE,18-149-91,1991,50 %,Intravenous infusion,Intravenous use,10.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
50% w/v DEXTROSE intravenous infusion,DEXTROSE,1309234206,1993,50 %,Intravenous infusion,Intravenous use,5.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 50%,DEXTROSE,207-149-00,2000,50 %,Intravenous infusion,Intravenous use,1.1,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 50%,DEXTROSE,1210222703,2000,50 %,Intravenous infusion,Intravenous use,2.10,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
50%W/V DESTROSE intravenous infusion,DEXTROSE,0109222568,2001,50 %,Intravenous infusion,Intravenous use,12.70,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.18% W/V SODIUM CHLORIDE and 5% W/V DEXTROSE intravenous infusion,"DEXTROSE, CALCIUM CHLORIDE DIHYDRATE, MAGNESIUM CHLORIDE 6H2O, SODIUM CHLORIDE, POTASSIUM CHLORIDE, DISODIUM PHOSPHATE DIHYDRATE, SODIUM HYDROGEN CARBONATE",178-149-99,1999,"5,0.18 %",Solution,Intravenous use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, N.SALINE","DEXTROSE, SODIUM CHLORIDE",181-149-99,1999,"5,0.9 %",Intravenous infusion,Intravenous use,5.3,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, N.SALINE","DEXTROSE, SODIUM CHLORIDE",39-149-92,1992,"5,0.9 %",Intravenous infusion,Intravenous use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",3005222087,1992,"5,0.9 %",Intravenous infusion,Intravenous use,6.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",158-149-98,1998,"5,0.9 %",Intravenous infusion,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
"DEXTROSE, SOD.CHLORIDE","DEXTROSE, SODIUM CHLORIDE",2911211393,2009,"5,0.9 %",Intravenous infusion,Intravenous use,9.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DEXTROSE 70% SOLUTION,DEXTROSE,0409234124,2005,70 %,Solution,Intravenous use,435.60,BAXTER CORPORATION,United States,BAXTER CORPORATION,United States,Marketed,Prescription,store below 25°c,Pharmacy,Arabian Health Care Co.
DEXTROSE SOLUTION 70%,DEXTROSE,51-253-05,2005,70 %,Solution,Intravenous use,20.6,BAXTER CORPORATION,United States,BAXTER CORPORATION,United States,Marketed,Prescription,store below 25°c,Pharmacy,Arabian Health Care Co.
"DEXTROSE, HARTMANNS","DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",282-149-03,2003,"55,3,3.2,0.20,0.135 g/ml",Solution,Intravenous use,7.85,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DIANEAL PD4 GLUCOSE 3.86% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222510,2011,"0.567,0.392,0.257,3.86,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 2.27% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",2108222526,2011,"0.567,0.392,0.0257,2.27,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,100,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 2.27% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222509,2011,"0.567,0.392,0.0257,2.27,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 2.27% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222517,2011,"0.567,0.392,0.0257,2.27,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 2.27% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222515,2011,"0.567,0.392,0.0257,2.27,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 3.86% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222513,2011,"0.567 ,0.392,0.0257,3.86,0.0185 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 3.86% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222514,2011,"0.567 ,0.392,0.0257,3.86,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 3.86% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222511,2011,"0.567 ,0.392, 0.0257,3.86,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,100,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DICETEL TAB 50MG,PINAVERIUM BROMIDE,27-137-21,1986,50 mg,Film-coated tablet,Oral use,16.05,ABBOTT HEALTHCARE SAS,France,Abbott Healthcare Products B.V,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ELDOQUIN CREAM 2%,HYDROQUINONE,2-230-83,1983,2 %,Cream,Topical,17.4,I.C.N.PHARMACEUTICALS,United States,I.C.N.PHARMACEUTICALS,United States,Marketed,OTC,store below 25°c,Pharmacy,ALNAGHI COMPANY
DIANEAL PD4 GLUCOSE 1.36% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222518,2011,"0.567,0.392,0.0257,1.36,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,100,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 1.36% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM LACTATE, SODIUM CHLORIDE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222519,2011,"0.392,0.567,0.0257,1.36,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 1.36% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222512,2011,"0.567 ,0.392 ,0.0257 ,1.36,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
DIANEAL PD4 GLUCOSE 1.36% SOLUTION FOR PERITONEAL DIALYSIS,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE",1808222516,2011,"0.567,0.392,0.0257,1.36,0.0184 %",Solution for peritoneal dialysis,Intraperitoneal,60,BAXTER CO LIMITED,Saudi Arabia,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BAXTER CO LIMITED
CO-VALISTA,"VALSARTAN, HYDROCHLOROTHIAZIDE",317-212-14,2014,"320,12.5 mg",Film-coated tablet,Oral use,41.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ELDOQUIN FORT 4% CREAM,HYDROQUINONE,3-939-22,1995,4 %,Cream,Topical,19.15,RIYADH PHARMA,Saudi Arabia,MEDA AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ELICA 0.1% CREAM,MOMETASONE FUROATE,1801233116,2002,0.1 %,Cream,Topical,19.2,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FEVADOL FAST 500MG TABLETS,"SODIUM BICARBONATE, PARACETAMOL",1306233792,2009,"630,500 mg",Tablet,Oral use,10.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL EXTRA TAB.,"PARACETAMOL, CAFFEINE CITRATE",92-212-98,1998,"500,65 mg",Tablet,Oral use,5.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
FEVADOL COLD & FLU TABLETS,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",1306233797,2009,"500,30,2 mg",Tablet,Oral use,15.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL 500MG TAB,PARACETAMOL,1706257567,1992,500 mg,Tablet,Oral use,6.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL 350MG SUPPOSITORY,PARACETAMOL,2307257838,1998,350 mg,Suppository,Rectal use,10.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL 200MG SUPPOSITORY,PARACETAMOL,2307257827,1998,200 mg,Suppository,Rectal use,8.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL 100MG SUPPOSITORY,PARACETAMOL,2307257831,1998,100 mg,Suppository,Rectal use,7.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FERTAB 50MG TAB,CLOMIFENE,31-498-11,2011,50 mg,Tablet,Oral use,15.75,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
FERRO-FOL CAPSULE,"FERROUS SULFATE, FOLIC ACID",1610246062,2012,"150,0.5 mg",Capsule,Oral use,8.40,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
FERRIPROX 500MG F.C.TABLET,DEFERIPRONE,2301256740,2005,500 mg,Film-coated tablet,Oral use,526.35,APOTEX,Canada,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
FERRIPROX 100MG/ML ORAL SOLUTION,DEFERIPRONE,2301256737,2010,100 mg/ml,Oral solution,Oral use,547.35,APOTEX,Canada,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
FEROTON 20MG-ML SOLU. FOR I.V. INJECTION,IRON SUCROSE,108-368-09,2009,20 mg/ml,Solution for injection,Intravenous use,84.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,JAMJOOM PHARMACEUTICALS CO. LTD.
FEROSE TAB (EQV.TO 100MG OF IRON),IRON POLYMALTOSE,2110258450,1997,100 mg,Tablet,Oral use,19.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
FEVADOL PLUS TAB,"PARACETAMOL, CAFFEINE CITRATE, CODEINE",53-212-97,1997,"500,30,8 mg",Tablet,Oral use,9.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FEVADOL SF 120MG\5ML SYRUP,PARACETAMOL,156-212-02,2002,24 mg/ml,Syrup,Oral use,5.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
FIXIT 300MG CAPSULE,NIZATIDINE,73-368-04,2004,300 mg,"Capsule, hard",Oral use,52.4,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FIXIT 150MG CAPSULE,NIZATIDINE,1506222205,2004,150 mg,"Capsule, hard",Oral use,26.2,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FIXIT 150MG CAPSULE,NIZATIDINE,72-368-04,2004,150 mg,"Capsule, hard",Oral use,52.4,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FIRMAGON 80MG POWDER FOR SOLUTION FOR INJECTION,DEGARELIX,2408234047,2010,80 mg,Powder and solvent for solution for injection,Subcutaneous use,605.45,RENTSCHLER BIOTECHNOLOGIE,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
FIRMAGON 120 MG POWDER FOR SOLUTION FOR INJECTION,DEGARELIX,2408234045,2010,120 mg,Powder and solvent for solution for injection,Subcutaneous use,1097.80,RENTSCHLER BIOTECHNOLOGIE,Germany,FERRING,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
FEROSE SYRUP 50MG-5ML,IRON POLYMALTOSE,2307257823,1996,10 mg/ml,Syrup,Oral use,14.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FINISCAR 5MG F.C. TABLETS,FINASTERIDE,196-277-08,2008,5 mg,Film-coated tablet,Oral use,75.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FINALLERG 1MG-1ML ORAL SOLUTION,CETIRIZINE HYDROCHLORIDE,0406245390,2006,1 mg/ml,Oral solution,Oral use,6.6,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
FINALLERG 10MG F.C TABLET,CETIRIZINE HYDROCHLORIDE,0603233335,2004,10 mg,Film-coated tablet,Oral use,7.45,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
FEXOTEL 120MG TABLET,FEXOFENADINE HYDROCHLORIDE,1807245601,2010,120 mg,Tablet,Oral use,15.15,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
FEXODINE 180MG TABLET,FEXOFENADINE HYDROCHLORIDE,0411246140,2004,180 mg,Film-coated tablet,Oral use,16.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FEXODINE 120MG TABLET,FEXOFENADINE HYDROCHLORIDE,0411246142,2004,120 mg,Film-coated tablet,Oral use,16.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FEVADOL SYRUP 160MG-5ML SUGAR FREE,PARACETAMOL,1210211139,1998,32 mg/ml,Syrup,Oral use,10.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FEVADOL SYRUP 160MG-5ML SUGAR FREE,PARACETAMOL,110-212-00,2000,32 mg/ml,Syrup,Oral use,5.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
FINASID 5MG FILM COATED TABLET,FINASTERIDE,1308258026,2008,5 mg,Film-coated tablet,Oral use,80.50,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FEROSAC INJ 20MG-ML AMP,IRON SUCROSE,0210258304,1998,20 mg/ml,concentrate for solution for injection,Intravenous use,94,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SPIMACO
FENAM 250MG TAB,MEFENAMIC ACID,2401233152,2000,250 mg,Film-coated tablet,Oral use,5.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FENADEX 180MG F.C. TABLETS,FEXOFENADINE HYDROCHLORIDE,2307257817,2009,180 mg,Film-coated tablet,Oral use,15.15,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
FENADEX 120 MG F- CTABLETS,FEXOFENADINE HYDROCHLORIDE,3007245705,2006,120 mg,Film-coated tablet,Oral use,16.25,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
FEMOSTON 2-10 TABLET,"ESTRADIOL, DYDROGESTERONE",2201268987,1997,"2,10 mg",Film-coated tablet,Oral use,29.5,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FEMOSTON 1-5 TABLET,"ESTRADIOL, DYDROGESTERONE",23-137-04,2004,"1,5 mg",Film-coated tablet,Oral use,32.75,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FEMOSTON 1-10 TABLET,"DYDROGESTERONE, ETHINYLESTRADIOL",25-137-05,2005,"10,1 mg",Film-coated tablet,Oral use,26.4,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FELDENE 20MG-ML AMP.,PIROXICAM,48-212-96,1996,20 mg/ml,Solution for injection,Intramuscular use,29.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SPIMACO
FELDENE 20MG DISPERSABLE TAB,PIROXICAM,2307257821,1996,20 mg,Dispersible tablet,Oral use,22.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
FEIBA  25 U/ml POWDER & SOLVENT,FACTOR VIII INHIBITOR BYPASSING FRACTION,15-5603-22,2007,25 U/ml,Powder and solvent for solution for infusion,Parenteral use,1645.3,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
FAWAR LEMON EFFERVESCENT SALT SACHETS 5G,"SODIUM BICARBONATE, TARTARIC ACID, CITRIC ACID ANHYDROUS",2108245793,1993,"2.8,1.33,0.82 g",Effervescent granules,Oral use,6.45,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
FAWAR FRUIT EFFERVESCENT SALT SACHETS 5G,"SODIUM BICARBONATE, TARTARIC ACID, CITRIC ACID ANHYDROUS",0909245887,1993,"2.8,1.33,0.82 g",Effervescent granules,Oral use,6.45,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,OTC,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
FENAM 50MG-5ML SYRUP,MEFENAMIC ACID,1105257374,1999,10 mg/ml,Syrup,Oral use,12.6,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FENAM FORTE 500MG TAB,MEFENAMIC ACID,1911246264,1999,500 mg,Film-coated tablet,Oral use,9.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FENAMIC 250 MG CAP,MEFENAMIC ACID,1505245310,2002,250 mg,Capsule,Oral use,5.65,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FEROMIN ORAL DROPS,FERROUS SULFATE,10-325-00,2000,125 mg/ml,Oral drops,Oral use,12.60,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
FEROMIN,FERROUS SULFATE,1210222721,2002,190 mg,Film-coated tablet,Oral use,15.60,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
Fentanyl Piramal  0.05MG-ML AMPOULES,FENTANYL,8-5592-21,1998,0.05 mg/ml,Solution for injection,Intravenous use,49.65,GLAXO SMITHKLINE MANUFACTURING S.P.A. PHARMA,Italy,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Fentanyl Piramal 0.05MG-ML AMPOULES,FENTANYL,6-5592-21,1998,0.05 mg/ml,Solution for injection,Intravenous use,10.6,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Fentanyl Piramal 0.05MG-ML AMPOULES,FENTANYL,9-5592-21,1998,0.05 mg/ml,Solution for injection,Intravenous use,192.25,DEMO S.A.,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Fentanyl Piramal 0.05MG-ML AMPOULES,FENTANYL,7-5592-21,1998,0.05 mg/ml,Solution for injection,Intravenous use,93.75,DEMO S.A,Greece,Piramal Critical Care B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
FEROSE - F TABLET,"FERRIC HYDROXIDE, FOLIC ACID",1706257563,2000,"100,0.35 mg",Tablet,Oral use,19.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,SPIMACO
FENISTIL GEL,DIMETHINDENE MALEATE,2012211493,1995,1 mg,Gel,Topical,12.30,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
FENISTIL DROPS 0.1G-100ML,DIMETHINDENE MALEATE,0802221690,1982,1 mg/ml,Drops,Oral use,12.05,Haleon CH SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
FENOGAL 200MG LIDOSE CAPSULES,FENOFIBRATE,1-32-07,2007,200 mg,"Capsule, hard",Oral use,31.5,S.M.B.,Belgium,S.M.B.,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,Annhdah Medical Company
FAVERIN 50MG EC TABS,FLUVOXAMINE MALEATE,1406233806,1990,50 mg,Film-coated tablet,Oral use,82.85,Mylan Laboratories SAS,France,ABBOTT HEALTHCARE PRODUCTS,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FLAMAZINE CREAM,SULFADIAZINE SILVER,1407245563,2001,1 %,Cream,Topical,23.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,RIYADH PHARMA
FLAMAZINE CREAM 1%,SULFADIAZINE SILVER,2-300-82,1982,1 %,Cream,Topical,34.05,SMITH & NEPHEW PHARMACEUTICALS,United Kingdom,SMITH & NEPHEW PHARMACEUTICALS,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
FLUDREX SYRUP,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",2702256954,2004,"120,15,0.75 mg",Syrup,Oral use,12.00,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FLUDARA 10MG F.C TABLETS,FLUDARABINE PHOSPHATE,1-832-12,2012,10 mg,Film-coated tablet,Oral use,1986.4,"Delpharm Lille S.A.S,",France,Sanofi B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
FLUCO-SOL 2MG/ML SOLUTION FOR I.V. INFUSION,FLUCONAZOLE,1108222474,2012,2 mg/ml,Solution for injection,Intravenous use,57.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
FLUCAND 200MG-100ML INFUSION VIAL,FLUCONAZOLE,1206245416,2003,2 mg/ml,Solution for infusion,Intravenous use,56.55,Hikma Farmaceutica,Portugal,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
FLUCA OPTHALMIC SUSP.,"FLUOROMETHOLONE, SODIUM CROMOGLICATE",1506222199,2002,"1,20 mg","Eye drops, suspension",Ophthalmic use,23.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
FLUANXOL DEPOT INJ 20MG-ML,FLUPENTIXOL,2601256746,1983,20 mg/ml,Solution for injection,Intramuscular use,139.45,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUANXOL DEPOT 100MG-ML I.M AMP,FLUPENTIXOL,0204245144,1991,100 mg/ml,Solution for injection,Intramuscular use,50.00,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUANXOL 3MG TAB,FLUPENTIXOL,31-136-97,1997,3 mg,Film-coated tablet,Oral use,36.5,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUANXOL 1MG TAB,FLUPENTIXOL,30-136-97,1997,1 mg,Film-coated tablet,Oral use,18.7,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUANXOL 0.5MG TAB,FLUPENTIXOL,34-136-08,2008,0.5 mg,Film-coated tablet,Oral use,22.05,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUDREX SYRUP,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",1505245306,2002,"1440,180,9 mg",Syrup,Oral use,2.9,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FLUDREX TAB,"PARACETAMOL, CAFFEINE CITRATE, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",1807245609,2003,"400,32,30,3 mg",Tablet,Oral use,12.30,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FLUIMUCIL 200MG/1GM GRANULES FOR ORAL SOLUTION,ACETYLCYSTEINE,4-462-11,2011,0.2 mg,Effervescent granules,Oral use,17.10,ZAMBON SWITZERLAND LTD,Switzerland,ZAMBON SWITZERLAND LTD,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FLUOXETIN HEXAL 20MG CAPSULES,FLUOXETINE,2807222358,2009,20 mg,Capsule,Oral use,33.85,HEXAL,Germany,HEXAL,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Fluorouracil Ebewe  500mg/10ml,FLUOROURACIL,16-355-01,2001,50 mg/ml,Solution for injection,Parenteral use,39.35,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Fluorouracil Ebewe  1000mg/20ml,FLUOROURACIL,18-355-01,2001,50 mg/ml,Solution for injection,Intravenous use,38.45,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Fluorouracil Ebewe  5000mg/100ml,FLUOROURACIL,42-355-07,2007,50 mg/ml,Solution for injection,Intravenous use,123.15,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
FLUANXOL 0.5MG TAB,FLUPENTIXOL,29-136-97,1997,0.5 mg,Film-coated tablet,Oral use,14.4,H. LUNDBECK,Denmark,H. LUNDBECK,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLUMED DM PAED SYRUP,"PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE",2605222077,2001,"15,5,1 mg",Syrup,Oral use,11.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,RIYADH PHARMA
FLUKAS 200 VIAL,FLUCONAZOLE,1704257236,2012,2 mg/ml,Solution for injection,Intravenous use,29.4,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
FLUKAS 100 VIAL,FLUCONAZOLE,1704257235,2012,2 mg/ml,Solution for injection,Intravenous use,21.05,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
FLAMAZINE CREAM 1%,SULFADIAZINE SILVER,1-300-82,1982,1 %,Cream,Topical,17.3,SMITH & NEPHEW PHARMACEUTICALS,United Kingdom,SMITH & NEPHEW PHARMACEUTICALS,United Kingdom,Marketed,OTC,store below 25°c,Pharmacy,ALHAYA MEDICAL CO
FLIXOTIDE 125 MCG EVOHALER,FLUTICASONE PROPIONATE,0601221576,2013,125 µg,Nebuliser suspension,Inhalation use,85.45,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
FLIXOTIDE 0.5MG-2ML NEBULE,FLUTICASONE PROPIONATE,152-276-20,2003,0.25 mg/ml,Nebuliser suspension,Inhalation use,45,GLAXOSMITHKLINE (GSK),Australia,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Otri Allergy Nasal Spray,FLUTICASONE PROPIONATE,2301244787,1998,0.05 %,Nasal spray,Nasal use,26,GLAXOWELLCOME,Spain,HALEON UK TRADING LIMITED,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Haleon Arabia Limited
FLEET ENEMA,"PHOSPHATE SODIUM MONOBASIC, SODIUM PHOSPHATE",1208258012,1987,"12.8,10.24 g",Enema,Rectal use,10,C.P FLIT,United States,C.P FLIT,United States,Marketed,OTC,store below 25°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
FLEET ENEMA,"PHOSPHATE SODIUM MONOBASIC, SODIUM PHOSPHATE",1208258013,1987,"12.8,10.24 g",Enema,Rectal use,9.75,C.P FLIT,United States,C.P FLIT,United States,Marketed,OTC,store below 25°c,Pharmacy,Jamjoom Medicine Store
FLECTOR EP TISSUGEL 1GM PATCHES,DICLOFENAC EPOLAMINE,7-5976-25,2003,13-10 mg,Medicated plaster,Topical,49.35,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"---, Abdulrehman Algosaibi G.T.C."
FLAZOL 500MG TAB,METRONIDAZOLE,1008257967,1998,500 mg,Film-coated tablet,Oral use,19.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FLAZOL 125MG-5ML ORAL SUSP,METRONIDAZOLE,2102221749,1998,25 mg/ml,Suspension,Oral use,9.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FLATICON 60MG CHEWABLE TABLETS,SIMETHICONE,1111246175,2010,60 mg,Chewable tablet,Oral use,15.40,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,RIYADH PHARMA
FLATICON 40MG CHEWABLE TABLETS,SIMETHICONE,1111246170,2010,40 mg,Chewable tablet,Oral use,14.10,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,RIYADH PHARMA
FLIXOTIDE 2MG-2ML NEBULE,FLUTICASONE PROPIONATE,153-276-20,2003,1 mg/ml,Nebuliser suspension,Inhalation use,118.05,GLAXOSMITHKLINE (GSK),Australia,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FLIXOTIDE 50 MCG EVOHALER,FLUTICASONE PROPIONATE,0601221577,2013,50 µg,Nebuliser suspension,Inhalation use,51.20,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
FLOZAK,FLUOXETINE,1111246176,2002,20 mg,"Capsule, hard",Oral use,83.85,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
FLOCAZOLE 150 MG CAPSULES,FLUCONAZOLE,1003221838,2004,150 mg,Capsule,Oral use,19.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
FLIXOTIDE EVOHALER 250MCG,FLUTICASONE PROPIONATE,0601221578,2013,250 µg,Nebuliser suspension,Inhalation use,125.60,GLAXOWELLCOME,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,GLAXO SAUDI ARABIA
FLOCAZOLE 50 MG CAPSULES,FLUCONAZOLE,200-212-04,2004,50 mg,Capsule,Oral use,45.45,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
FAVERIN 100MG EC TABS,FLUVOXAMINE MALEATE,0404233479,1990,100 mg,Film-coated tablet,Oral use,82.85,Mylan Laboratories SAS,France,ABBOTT HEALTHCARE PRODUCTS,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FATLOS 120MG CAPSULES,ORLISTAT,0812258755,2014,120 mg,Capsule,Oral use,115.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FATLOS 120MG CAPSULES,ORLISTAT,279-277-14,2014,120 mg,Capsule,Oral use,57.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EPICOCILLIN VIAL 1G,AMPICILLIN,0805245256,1991,1 g,powder for solution for injection,Intravenous use,9.05,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
EPENTAL 1G VIAL,THIOPENTAL SODIUM,28-201-02,2002,1000 mg,Solution,Intravenous use,124.4,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 25°c,Hospital,Khalid Bin Saad Int. Company LTD
EPENTAL 0.5G VIAL,THIOPENTAL SODIUM,27-201-02,2002,500 mg,Solution,Intravenous use,96.5,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 25°c,Hospital,Khalid Bin Saad Int. Company LTD
EPANUTIN,PHENYTOIN SODIUM,0102244819,1997,100 mg,Capsule,Oral use,28.10,PFIZER,Germany,Viatris AB,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
ENTAPRO 20MG FILM COATED TABLETS,ESCITALOPRAM,2101256693,2010,20 mg,Film-coated tablet,Oral use,123.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ENTAPRO 10MG FILM COATED TABLETS,ESCITALOPRAM,2101256691,2010,10 mg,Film-coated tablet,Oral use,75.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ENEMACORT 0.02MG-ML TABLET FOR ENEMA,BUDESONIDE,0502256828,2011,2.3 mg/ml,Enema,Rectal use,20.95,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
ENDOXAN. VIAL 200 MG,CYCLOPHOSPHAMIDE,2-6063-25,1981,200 mg,powder for solution for injection,Intravenous use,14.65,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
ENDOXAN. VIAL 1 GM.,CYCLOPHOSPHAMIDE,1-6063-25,1981,1 g,powder for solution for injection,Intravenous use,64.75,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
ENDOXAN. VIAL 500 MG,CYCLOPHOSPHAMIDE,3-6063-25,1981,500 mg,powder for solution for injection,Intravenous use,35.30,BAXTER ONCOLOGY,Germany,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
ENDOXAN SUGAR COATED TABLET,CYCLOPHOSPHAMIDE,7-6063-25,1981,50 mg,Film-coated tablet,Oral use,48.45,PRASFARMA S.L.,Spain,Baxter Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
EPICOCILLIN VIAL 500MG,AMPICILLIN,2311234532,1991,500 mg,powder for solution for injection,Intravenous use,6.45,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
EPICOGEL SUSPENSION,"ALUMINIUM HYDROXIDE DRIED, MAGNESIUM HYDROXIDE, DIMETHICONE",2209258254,1991,"81,20,25 mg/ml",Suspension,Oral use,6.20,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,store below 25°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EPIFASI 5000 IU LYOPHILIZED POWDER FOR I.M. Injection*,GONADOTROPHIN CHORIONIC HUMAN,0710258341,2010,5000 IU,Powder for injection,Intramuscular use,27.15,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
EPIVIR 150MG F.C TABLET,LAMIVUDINE,2312200357,2007,150 mg,Film-coated tablet,Oral use,336.30,GLAXO OPERATION,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
EPIVIR 10 MG \ ML ORAL SOLUTION,LAMIVUDINE,2312200361,2004,10 mg/ml,Oral solution,Oral use,89.65,Bora Pharmaceutical Services Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
EPISTIGMIN 2.5MG/ML VIAL,NEOSTIGMINE METHYLSULFATE,2209258253,2012,2.5 mg/ml,Solution for injection,Intravenous use,7.75,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Epirubicin “Ebewe” 200mg/100ml,EPIRUBICIN HYDROCHLORIDE,40-355-07,2007,2 mg/ml,Concentrate for solution for infusion,Intravenous use,509.90,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Epirubicin “Ebewe” 50mg/25ml,EPIRUBICIN HYDROCHLORIDE,30-355-04,2004,2 mg/ml,Concentrate for solution for infusion,Intravenous use,240.25,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
EPIRAZOLE 20MG CAPS(E.C.PELLETS),OMEPRAZOLE,2304245195,2002,20 mg,Capsule,Oral use,23.35,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EPIMAG EFFERVESCENT GRANULE SACHET,MAGNESIUM CITRATE,1411246225,1990,2.125 g,Effervescent powder,Oral use,6.20,EIPICO,Egypt,EIPICO,Egypt,Marketed,OTC,do not store above 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EPILAT 10MG CAPS,NIFEDIPINE,30-201-02,2002,10 mg,"Capsule, soft",Oral use,6.45,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EPIGONAL 75 I.U. LYOPHILIZED POWDER FOR I.M. Injection*,"FOLLICLE STIMULATING HORMONE (FSH), LUTEINIZING HORMONE (LH)",0710258340,2010,"75,75 IU",Powder for injection,Intramuscular use,30.55,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
EPIFENAC 75MG/3ML SOLUTION FOR INJECTION,DICLOFENAC SODIUM,1009245892,2009,25 mg/ml,Solution for injection,Parenteral use,8.30,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Epirubicin “Ebewe” 10mg/5ml,EPIRUBICIN HYDROCHLORIDE,29-355-04,2004,2 mg/ml,Concentrate for solution for infusion,Intravenous use,54.20,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
EPIZOLONE DEPOT 40MG/ML VIAL,METHYLPREDNISOLONE,1904221963,2012,40 mg/ml,powder for solution for injection,Intravenous use,10.35,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
EMICIPRO 500MG F.C. TABLETS,CIPROFLOXACIN,110258302,2007,500 mg,Film-coated tablet,Oral use,29.7,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
ELIQUIS 5MG FILM COATED TABLET,APIXABAN,1-5550-20,2014,5 mg,Film-coated tablet,Oral use,308,PFIZER,Ireland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ELIQUIS 2.5MG FILM COATED TABLET,APIXABAN,3-5550-20,2014,2.5 mg,Film-coated tablet,Oral use,102.70,PFIZER,Ireland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ELIQUIS 2.5MG FILM COATED TABLET,APIXABAN,2-5550-20,2014,2.5 mg,Film-coated tablet,Oral use,308,PFIZER,Ireland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ELIDEL 1% CREAM,PIMECROLIMUS,7-5927-25,2012,1 %,Cream,Topical,118.25,MEDA Manufacturing,France,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
ELICASAL OINTMENT,"SALICYLIC ACID, MOMETASONE FUROATE",2111211345,2004,"5,0.1 %",Ointment,Topical,25.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ELICA-M CREAM,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2111211347,2002,"2,0.1 %",Cream,Topical,25.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ELICA 0.1% OINTMENT,MOMETASONE FUROATE,2311211349,2004,0.1 %,Ointment,Topical,18,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
EMIDOL 120MG-5ML SUSPENSION,PARACETAMOL,3010234403,2005,24 mg/ml,Suspension,Oral use,6.00,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
EMIDOL 500MG TABLET,PARACETAMOL,2805257484,2004,500 mg,Tablet,Oral use,3.45,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
ENAPRIL 10 MG TAB,ENALAPRIL MALEATE,166-212-02,2002,10 mg,Tablet,Oral use,44.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ENABLEX 7.5MG PROLONGED RELEASE TABLETS,DARIFENACIN HYDROBROMIDE,2907257883,2013,7.5 mg,Prolonged-release tablet,Oral use,133.30,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ENABLEX 15MG PROLONGED RELEASE TABLETS,DARIFENACIN HYDROBROMIDE,3007257892,2013,15 mg,Prolonged-release tablet,Oral use,133.30,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
E-MOX 250MG DRY MIX.,AMOXICILLIN,2209258250,1996,50 mg/ml,Powder for suspension,Oral use,10.25,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
E-MOX 125MG DRY MIX.,AMOXICILLIN,2209258256,1996,125 mg/ml,Powder for suspension,Oral use,6.15,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EMIMYCIN 500 MG TABLETS,CLARITHROMYCIN,0110258301,2008,500 mg,Film-coated tablet,Oral use,40.1,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
EMILOK 20MG CAPSULES,OMEPRAZOLE,1003257027,2006,20 mg,Capsule,Oral use,37.20,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
EMIFENAC 50 MG DISPERSABLE TAB.,DICLOFENAC SODIUM,15-444-05,2005,50 mg,Dispersible tablet,Oral use,23.35,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
EMIFEN 600 MG F-C TAB,IBUPROFEN,0910258380,2006,600 mg,Film-coated tablet,Oral use,8.25,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
EMIFEN 100MG-5ML SUSPENSION,IBUPROFEN,3010234404,2005,20 mg/ml,Suspension,Oral use,5.8,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO., Sanofi Arabia Trading Co. Ltd"
E-MOX 500MG CAPS,AMOXICILLIN,2209258249,1996,500 mg,Capsule,Oral use,10.25,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
EPREX 1000 U-0.5ML PREFILLED SYRING,EPOETIN ALFA,2312246471,1997,1000 IU,Solution for injection,Intravenous use,135.4,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
EPREX 10000 U -ML PREFILLED SYRING,EPOETIN ALFA,2312246470,1997,10000 IU,Solution for injection,Intravenous use,1354,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
EPREX 2000 U-0.5ML PREFILLED SYRING,EPOETIN ALFA,2312246472,1997,2000 IU,Solution for injection,Intravenous use,270.8,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
EXJADE 250MG DISPERSIBLE TABLETS,DEFERASIROX,0901244697,2006,250 mg,Dispersible tablet,Oral use,1116.6,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
EXJADE 125MG DISPERSIBLE TABLETS,DEFERASIROX,0610222693,2006,125 mg,Dispersible tablet,Oral use,562,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE HCT 5MG/160MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2010222769,2011,"160,25,5 mg",Film-coated tablet,Oral use,71.00,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE HCT 5MG/160MG/12.5MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2010222768,2011,"160,12.5,5 mg",Film-coated tablet,Oral use,71.00,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE HCT 10MG/320MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2010222766,2011,"320,25,10 mg",Film-coated tablet,Oral use,111.50,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE HCT 10MG/160MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2010222770,2011,"160,25,10 mg",Film-coated tablet,Oral use,83.00,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE HCT 10MG/160MG/12.5MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2010222767,2011,"160,12.5,10 mg",Film-coated tablet,Oral use,83.00,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE 5MG-160 MG F.C. TABLETS,"VALSARTAN, AMLODIPINE BESILATE",3010246129,2007,"160,5 mg",Film-coated tablet,Oral use,66.9,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXFORGE 10 MG-160 MG F-C TABLETS,"VALSARTAN, AMLODIPINE BESILATE",3010246128,2007,"160,10 mg",Film-coated tablet,Oral use,74,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXELON 9.5MG-24H TRANSDERMAL PATCHES,RIVASTIGMINE,0504233490,2009,9.5 mg,Transdermal patch,Topical,271.25,LTS LOHMANN Therapie-Systeme,Germany,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXELON 6 mg capsule,RIVASTIGMINE,1208258016,2000,6 mg,Capsule,Oral use,162.9,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXELON 4.6MG-24H TRANSDERMAL PATCHES,RIVASTIGMINE,0504233491,2009,4.6 mg,Transdermal patch,Topical,271.25,LTS LOHMANN Therapie-Systeme,Germany,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXELON 3 mg capsule,RIVASTIGMINE,1208258015,2000,3 mg,Capsule,Oral use,154.1,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,Novartis Saudi Limited
EXELON 1.5 mg capsule,RIVASTIGMINE,1208258017,2000,1.5 mg,Capsule,Oral use,147.4,"Siegfried Barbera, S.L",Spain,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EXJADE 500MG DISPERSIBLE TABLETS,DEFERASIROX,0901244698,2006,500 mg,Dispersible tablet,Oral use,2218.45,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
EXYLIN PEDIATRIC SYRUP,"DIPHENHYDRAMINE HYDROCHLORIDE, MENTHOL",1208258009,1997,"140,11 mg",Syrup,Oral use,6.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
EXYLIN SYRUP 14MG-5ML,DIPHENHYDRAMINE HYDROCHLORIDE,0112258696,1994,2.8 mg/ml,Syrup,Oral use,7.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,SPIMACO
FASTUM 2.5% GEL,KETOPROFEN,3005245387,2001,2.5 %,Gel,Topical,10.3,A MENARINI INDUSTRIE FARMACEUTICHE S.R.L,Italy,A MENARINI INDUSTRIE FARMACEUTICHE S.R.L,Italy,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Saudi Import Company - BANAJA"
FAST- FLAM 50MG F.C. TABLETS,DICLOFENAC POTASSIUM,109-368-09,2009,50 mg,Film-coated tablet,Oral use,26.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FARCOLIN 0.5% RESPIRATOR Solution,SALBUTAMOL,2108245795,2002,0.5 %,Nebuliser solution,Inhalation use,12.50,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICAL,Egypt,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,ZIMMO TRADING ESTABLISHMENT
FAMPYRA 10MG Prolonged-release tablet,FAMPRIDINE,3112258837,2014,10 mg,Prolonged-release tablet,Oral use,1133.90,ALKERMES PHARMA,Ireland,Acorda Therapeutics lreland Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FALLAH 50 mg film-coated tablets,SILDENAFIL,0908222446,2014,50 mg,Film-coated tablet,Oral use,43.7,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EVRA TRANSDERMAL PATCHES,"ETHINYLESTRADIOL, NORELGESTROMIN",4-376-22,2006,"0.6,6 mg",Transdermal patch,Topical,37.25,LTS LOHMANN Therapie-Systeme,Germany,GEDEON RICHTER,Hungary,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
FALLAH 25 mg film-coated tablets,SILDENAFIL,0908222447,2014,25 mg,Film-coated tablet,Oral use,40.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FACTIVE 320MG F.C. TABLETS,GEMIFLOXACIN MESILATE,2008245779,2006,320 mg,Film-coated tablet,Oral use,78.50,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FACTIVE 320MG F.C. TABLETS,GEMIFLOXACIN MESILATE,2008245780,2006,320 mg,Film-coated tablet,Oral use,58.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZOLVIN 8MGTAB,BROMHEXINE,2204257271,2002,8 mg,Tablet,Oral use,8.85,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
EZOLVIN 4MG\5ML SYRUP,BROMHEXINE,2811246351,2002,0.8 mg/ml,Syrup,Oral use,7.60,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 25°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
EZIPECT 12.5MG-5ML SYRUP,DIPHENHYDRAMINE HYDROCHLORIDE,1109234169,2001,2.5 mg/ml,Syrup,Oral use,7.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZILAX 10G-15ML SYRUP,LACTULOSE,1501256657,1996,0.67 g/ml,Syrup,Oral use,21.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,"Store below 30°C, Do not Refrigerator or Freeze.",Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EYLOX 0.3% EYE DROPS,OFLOXACIN,26-290-03,2003,0.3 %,Eye drops,Ophthalmic use,13.15,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
FALLAH 100 mg film-coated tablets,SILDENAFIL,0908222452,2014,100 mg,Film-coated tablet,Oral use,43.7,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EVIT 400MG CAPSULES,ALPHA TOCOFERIL,712258746,2010,400 mg,"Capsule, soft",Oral use,36.3,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
ERECTA 50 mg film-coated tablets,SILDENAFIL,1808258043,2014,50 mg,Film-coated tablet,Oral use,48.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ERACID 500MG FILM COATED TABLETS,CLARITHROMYCIN,69-171-10,2010,500 mg,Film-coated tablet,Oral use,37.3,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
ERACID 250MG TABLET,CLARITHROMYCIN,1911246283,2004,250 mg,Film-coated tablet,Oral use,19.35,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
EPREX 4000IU-0.4ML PROFILLED SYRING,EPOETIN ALFA,2801256771,1996,4000 IU,Solution for injection,Intravenous use,541.6,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
EPREX 40000 IU\ML PRE-FILLED SYRINGE,EPOETIN ALFA,2312246469,2004,40000 IU,Solution for injection,Intravenous use,902.65,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
ERECTA 100 mg film-coated tablets,SILDENAFIL,0309245853,2014,100 mg,Film-coated tablet,Oral use,48.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ELDOQUIN FORT 4% CREAM,HYDROQUINONE,2-939-22,1995,4 %,Cream,Topical,30.3,RIYADH PHARMA,Saudi Arabia,MEDA AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ESMERON 10MG\ML VIAL,ROCURONIUM BROMIDE,2509222632,2003,10 mg/ml,Solution for injection,Intravenous use,215.05,N.V. Organon,Netherlands,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
"ETOPOSID ""EBEWE"" 20MG-ML VIAL",ETOPOSIDE,25-355-01,2001,20 mg/ml,Concentrate for solution for infusion,Intravenous use,42.6,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
EUTHYROX,LEVOTHYROXINE SODIUM,3010258524,2006,0.05 mg,Tablet,Oral use,22.25,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
EUTHYROX,LEVOTHYROXINE SODIUM,3010258523,2006,0.025 mg,Tablet,Oral use,17.05,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
EUTHYROX,LEVOTHYROXINE SODIUM,3010258525,2006,0.15 mg,Tablet,Oral use,36.55,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
EUTHYROX,LEVOTHYROXINE SODIUM,3010258522,2006,0.1 mg,Tablet,Oral use,31.35,Merck Healthcare KGaA,Germany,Merck Healthcare KGaA,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"ALHAYA MEDICAL CO, Merck Limited, Salehiya Trading Co."
"ETOPOSID ""EBEWE"" 200MG VIAL",ETOPOSIDE,26-355-01,2001,20 mg/ml,Concentrate for solution for infusion,Intravenous use,78.35,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
EUCARBON TAB,CHARCOAL,2-518-92,1992,,Tablet,Oral use,23.45,F TRNKA AUSTRIA,Austria,F TRNKA AUSTRIA,Austria,Marketed,OTC,store below 25°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
EUCARBON,CHARCOAL,1-5644-21,1983,,Tablet,Oral use,48.05,F TRNKA AUSTRIA,Austria,F TRNKA AUSTRIA,Austria,Marketed,OTC,store below 25°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
ETRIVEX 0.05% SHAMPOO,CLOBETASOL PROPIONATE,13-274-10,2010,0.05 %,Shampoo,Topical,60.55,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
ETORIA 90MG FILM COATED TABLETS,Etoricoxib,1512211481,2013,90 mg,Film-coated tablet,Oral use,60.45,Rovi Pharma Industrial Service,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
ETORIA 60MG FILM COATED TABLETS,Etoricoxib,1512211483,2013,60 mg,Film-coated tablet,Oral use,60.45,Rovi Pharma Industrial Service,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
ETORIA 120MG FILM COATED TABLETS,Etoricoxib,1512211482,2013,120 mg,Film-coated tablet,Oral use,15.1,Rovi Pharma Industrial Service,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
CO-VALISTA,"VALSARTAN, HYDROCHLOROTHIAZIDE",318-212-14,2014,"320,25 mg",Film-coated tablet,Oral use,41.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
L-CET 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,38-498-14,2014,5 mg,Film-coated tablet,Oral use,19.40,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
STABLIX 0.5 ML SUSPENSION FOR INJECTION Vials,TETANUS TOXOID,5-800-18,2018,0.5 ml,Suspension for injection,Intramuscular use,67.5,PT Bio Farma ( Persero ),Indonesia,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
VITREAL S OPHTHALMIC SUSPENSION,TRIAMCINOLONE ACETONIDE,0406245392,2018,4 %,Suspension,Ophthalmic use,295.05,Sooft Italia SBA,Italy,Fidia Farmaceutici S.p.A.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
ENCIFER 20MG/ML SOLU. FOR I.V. INJECTION,IRON SUCROSE,0911258556,2019,20 mg/ml,Solution for injection,Intravenous use,13.7,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
IMTUS 20MG/ML SOL. FOR INFUSION,IRINOTECAN,1301268897,2019,20 mg/ml,Solution for infusion,Intravenous use,247.40,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
IMTUS 20MG/ML SOL. FOR INFUSION,IRINOTECAN,1901268950,2019,20 mg/ml,Solution for infusion,Intravenous use,179.35,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
ZOLEDRONIC ACID SPC 5MG/100ML SOL. FOR INFUSION,ZOLEDRONIC ACID,0205245243,2019,0.05 mg/ml,Solution for infusion,Intravenous use,1321.8,Gland Pharma Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
ROFLAST 500 mcg,ROFLUMILAST,2809258274,2019,500 µg,Film-coated tablet,Oral use,109.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Genotropin GoQuick 5.3 mg,SOMATROPIN,2609245954,2019,5.3 mg,Powder and solvent for solution for injection,Subcutaneous use,384.10,Pfizer Manufacturing Belgium N.V,Belgium,PFIZER SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
HUMALOG KWIK-PEN MIX 25,"INSULIN LISPRO, INSULIN PROTAMINE",1405245297,2019,"25,75 %, IU/ml",Suspension for injection,Subcutaneous use,161.30,ELI LILLY,France,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
HUMALOG KWIK-PEN 100IU/ML,INSULIN LISPRO,1405245298,2019,100 IU/ml,Solution for injection,Subcutaneous use,161.30,ELI LILLY,France,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
OTEZLA 30MG F.C.TAB,APREMILAST,1507245578,2018,30 mg,Film-coated tablet,Oral use,1998.50,PATHEON INC,Canada,Amgen Europe BV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
FLORYL 50 MG/ML SOLUTION FOR INJECTION/INFUSION,FLUOROURACIL,2706245455,2019,50 mg/ml,Solution for injection/infusion,Intravenous use,98.5,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
AREKSA 25MG F.C.TAB,EXEMESTANE,3107245710,2019,25 mg,Film-coated tablet,Oral use,79.95,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
ACCEPT 500MG F.C.TAB,MYCOPHENOLATE MOFETIL,1707245595,2019,500 mg,Film-coated tablet,Oral use,194.55,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ALLERCET 5MG F.C.TABLET,LEVOCETIRIZINE DIHYDROCHLORIDE,20-584-19,2019,5 mg,Film-coated tablet,Oral use,23.9,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ALLERCET 5MG F.C.TABLET,LEVOCETIRIZINE DIHYDROCHLORIDE,21-584-19,2019,5 mg,Film-coated tablet,Oral use,7.95,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Relaxon Forte 500MG TAB,CHLORZOXAZONE,1707245587,2019,500 mg,Tablet,Oral use,24.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets,APREMILAST,1507245581,2018,10-20-30 mg,Film-coated tablet,Oral use,963.60,PATHEON INC,Canada,Amgen Europe BV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
AZACITIDINE SPC 100 MG INJECTION,AZACITIDINE,2606245441,2019,100 mg,Powder for suspension for injection,"Intravenous, Subcutaneous",1157.4,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
DETREMIN 20000IU/ML ORAL DROPS,CHOLECALCIFEROL,0110246004,2018,20000 IU/ml,"Oral drops, solution",Oral use,50.75,NextPharma SAS,France,Renapharma AB,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
ZOTIMOS 4MG VIAL,ZOLEDRONIC ACID,2811246354,2019,4 mg,powder for solution for injection,Intravenous use,82.2,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
ARXIA 60MG F.C.TABLET,Etoricoxib,2403257148,2019,60 mg,Film-coated tablet,Oral use,41.1,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ARXIA 120MG F.C.TABLET,Etoricoxib,2403257153,2019,120 mg,Film-coated tablet,Oral use,11,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ROXARDIO 20MG F.C.TABLET,ROSUVASTATIN,1112246405,2018,20 mg,Film-coated tablet,Oral use,47.75,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ROXARDIO 10MG F.C.TABLET,ROSUVASTATIN,1112246404,2018,10 mg,Film-coated tablet,Oral use,29.55,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZINFORO 600 MG I.V. VIAL,CEFTAROLINE FOSAMIL,0603245031,2018,600 mg,Powder for concentrate for solution for infusion,Intravenous use,1897.6,ACS DOBFAR SPA,Italy,PFIZER,Ireland,Marketed,Prescription,store below 30°c,Hospital,Pfizer Saudi Trading
COVATEL,"TELMISARTAN, AMLODIPINE BESILATE",0810258369,2019,"80,5 mg",Tablet,Oral use,59.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
COVATEL,"TELMISARTAN, AMLODIPINE BESILATE",0810258367,2019,"80,10 mg",Tablet,Oral use,59.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VERCANZA 450 MG FILM COATED TABLET,Valganciclovir,2005257434,2019,450 mg,Film-coated tablet,Oral use,3686.50,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LEUKAIR 10MG F.C.TABLET,MONTELUKAST SODIUM,1303245045,2019,10 mg,Film-coated tablet,Oral use,71.45,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
ZORON 2MG/ML INJECTION,ONDANSETRON,0707245487,2018,2 mg/ml,Solution for injection,Intramuscular and intravenous use,91.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ZORON 2MG/ML INJECTION,ONDANSETRON,0707245486,2018,2 mg/ml,Solution for injection,Intramuscular and intravenous use,141.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
FOSTER NEXTHALER 100MCG/6MCG INHALATION POWDER,"BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE",3110246131,2018,"100,6 µg",Inhalation powder,Inhalation use,109.10,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
LETIREM 1000 MG FILM COATED TABLET,LEVETIRACETAM,3-5128-19,2019,1000 mg,Film-coated tablet,Oral use,274.4,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LETIREM 500 MG FILM COATED TABLET,LEVETIRACETAM,4-5128-19,2019,500 mg,Film-coated tablet,Oral use,132.55,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LETIREM 250 MG FILM COATED TABLET,LEVETIRACETAM,5-5128-19,2019,250 mg,Film-coated tablet,Oral use,83.45,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
Fostimon 300 I.U,UROFOLLITROPIN,6-5976-25,2019,300 IU,Powder and solvent for solution for injection,Intramuscular and intravenous use,264.65,IBSA Institut Biochimique SA,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
Fostimon 225 I.U,UROFOLLITROPIN,3-5186-19,2019,225 IU,Powder and solvent for solution for injection,Intramuscular and intravenous use,202.5,IBSA Institut Biochimique SA,Switzerland,IBSA Istitut Biochimique SA,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
SARFEX 180MG F.C.TAB.(30S),FEXOFENADINE HYDROCHLORIDE,19-586-19,2019,180 mg,Film-coated tablet,Oral use,32.5,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SARFEX 180MG F.C.TAB.(10S),FEXOFENADINE HYDROCHLORIDE,18-586-19,2019,180 mg,Film-coated tablet,Oral use,10.85,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Azeptil 100 mg/ml Injection,TRANEXAMIC ACID,1808245775,2019,100 mg/ml,Solution for injection,Intravenous use,62.05,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
VELTASSA 16.8G SACHET,PATIROMER SORBITEX CALCIUM,3110246134,2019,16.8 g,Powder for oral suspension,Oral use,1126.60,Corden Pharma Lisbon S.A,Portugal,Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAC HEALTHCARE
VELTASSA 8.4G SACHET,PATIROMER SORBITEX CALCIUM,3110246133,2019,8.4 g,Powder for oral suspension,Oral use,1088.95,Corden Pharma Lisbon S.A,Portugal,Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAC HEALTHCARE
VARIVAX 1350 PFU VIAL,VARICELLA VIRUS VACCINE LIVE (OKA-MERCK),1405245287,2019,1350 PFU/ml,Powder and solvent for suspension for injection,Intramuscular and intravenous use,152.1,MERCK SHARP & DOHME,United Kingdom,MERCK SHARP & DOHME,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
MEBAGEN SR 200MG CAPSULE,MEBEVERINE HYDROCHLORIDE,1211246197,2019,200 mg,Capsule,Oral use,40.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AERIALLERG 5MG FILM COATED TABLET,DESLORATADINE,0406245391,2018,5 mg,Film-coated tablet,Oral use,16.75,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
GENOTROPIN GOQUICK 12MG PRE-FILLED PEN,SOMATROPIN,2609245953,2019,12 mg,Powder and solvent for solution for injection,Subcutaneous use,869.70,Pfizer Manufcaturing Belgium N. V.,Belgium,PFIZER SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
VITOPEINE IV,PARACETAMOL,0901256574,2019,10 mg/ml,Solution for infusion,Intravenous use,130.90,S.M. Farmaceutici SRL,Italy,Pharma Bavaria Internacional (PBI),Portugal,Marketed,Prescription,store below 30°c,Hospital,"Bait AlBatterjee Medical Company For Pharmaceutical Industries, Cigalah Group"
SENERGY 10 MG/160 MG F.C. TABLET,"VALSARTAN, AMLODIPINE BESILATE",2201256734,2019,"160,10 mg",Film-coated tablet,Oral use,42.2,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SENERGY 5 MG/160 MG F.C. TABLET,"VALSARTAN, AMLODIPINE BESILATE",2201256733,2019,"160,5 mg",Film-coated tablet,Oral use,42.2,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GLERAN 15MG TABLET,PIOGLITAZONE,3112246509,2019,15 mg,Tablet,Oral use,22.6,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GLERAN 30MG TABLET,PIOGLITAZONE,3112246510,2019,30 mg,Tablet,Oral use,45.2,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DIROGIT 500 MG F. C. TABLET,Capecitabine,2105245332,2019,500 mg,Film-coated tablet,Oral use,954.5,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
OROTIX 60MG F.C.TABLET,Etoricoxib,65-399-19,2019,60 mg,Film-coated tablet,Oral use,20.55,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
OROTIX 90MG F.C.TABLET,Etoricoxib,2312246468,2019,90 mg,Film-coated tablet,Oral use,20.55,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
OROTIX 120MG F.C.TABLET,Etoricoxib,2111246309,2019,120 mg,Film-coated tablet,Oral use,11,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
MEROPENEM KABI.,MEROPENEM,1012246383,2018,1000 mg,Powder for solution for injection/infusion,Intravenous use,356.4,ACS Dobfar S.p.A.,Italy,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
MEROPENEM KABI.,MEROPENEM,0912246378,2018,500 mg,Powder for solution for injection/infusion,Intravenous use,211.95,ACS Dobfar S.p.A.,Italy,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
LUKRA 5MG CHEWABLE TABLET,MONTELUKAST SODIUM,16-584-18,2018,5 mg,Chewable tablet,Oral use,64.3,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
MONOCLOX 250MG VIAL,CLOXACILLIN,0602256848,2019,250 mg,Powder for solution for injection/infusion,Intramuscular and intravenous use,51.75,MEDOCHEMIE LTD (FACTORY B),Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
LUKRA 4MG CHEWABLE TABLET,MONTELUKAST SODIUM,15-584-18,2018,4 mg,Chewable tablet,Oral use,64.3,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
TERA D 50000IU CAPSULE,COLECALCIFEROL,1407245562,2019,50000 IU,Capsule,Oral use,44.65,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
OMEGANA 1000MG SOFT CAPSULE,OMEGA-3-ACID ETHYL ESTERS,0608245730,2019,1000 mg,Capsule,Oral use,48.95,SWISS CAPS AG,Switzerland,VIANEX S.A,Greece,Marketed,OTC,store below 30°c,Pharmacy,ARAC HEALTHCARE
OMEGANA 1000MG SOFT CAPSULE,OMEGA-3-ACID ETHYL ESTERS,0608245729,2019,1000 mg,Capsule,Oral use,174.8,SWISS CAPS AG,Switzerland,VIANEX S.A,Greece,Marketed,OTC,store below 30°c,Pharmacy,ARAC HEALTHCARE
REDEX 5 MG F.C.TABLET,TADALAFIL,0907245505,2019,5 mg,Film-coated tablet,Oral use,136.15,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
REDEX 20MG F.C.TABLET,TADALAFIL,0907245506,2019,20 mg,Film-coated tablet,Oral use,63.2,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ROZLET 2.5 MG FILM COATED TABLET,LETROZOLE,0710258339,2019,2.5 mg,Film-coated tablet,Oral use,56.2,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ABIRATERONE SPC 250MG F.C.TABLET,ABIRATERONE ACETATE,1007245531,2019,250 mg,Film-coated tablet,Oral use,6519.15,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
OXYNORM 5MG CAPSULE,OXYCODONE HYDROCHLORIDE,1111258571,2019,5 mg,"Capsule, hard",Oral use,70.7,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited UK,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYNORM 10MG CAPSULE,OXYCODONE HYDROCHLORIDE,1111258570,2019,10 mg,"Capsule, hard",Oral use,141.45,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited UK,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYNORM 20MG CAPSULE,OXYCODONE HYDROCHLORIDE,1111258572,2019,20 mg,"Capsule, hard",Oral use,270.55,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited UK,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
LUKRA 10 MG FILM COATED TABLET,MONTELUKAST SODIUM,17-584-18,2018,10 mg,Film-coated tablet,Oral use,71.45,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
JULPHACEF 1GM I.M.-I.V. INJECTION,CEFRADINE,0805257364,2008,1 g,Solution for injection,Intravenous use,5.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Juvamox,AMOXICILLIN,136-186-01,2001,50 mg,Powder for oral suspension,Oral use,16.7,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Juvamox 500MG CAPSULES,AMOXICILLIN,0606222138,2000,500 mg,Capsule,Oral use,22.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
JUSPRIN 81MG ENTERIC COATED TABLETS,ACETYLSALICYLIC ACID,2102221746,1999,81 mg,Enteric-coated tablet,Oral use,7.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
KAPTIN SUSP,"KAOLIN, PECTIN",0308222395,1985,"1972,4.4 mg/ml",Oral suspension,Oral use,6.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
KDIRON DROPS,FERROUS SULFATE,177-186-02,2002,25 mg/ml,Drops,Oral use,8.4,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
LANFAST 30MG CAPSULE,LANSOPRAZOLE,215-186-04,2004,30 mg,Capsule,Oral use,58.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
LAXOCODYL 10MG SUPP,BISACODYL,193-186-03,2003,10 mg,Suppository,Rectal use,7.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
LAXOCODYL 5 MG TABLET,BISACODYL,83-186-99,1999,5 mg,Enteric-coated tablet,Oral use,5.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
LAXOCODYL 5MG SUPP,BISACODYL,195-186-03,2003,5 mg,Suppository,Rectal use,7.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LAXOLYNE SUPP FOR CHILDREN,GLYCERIN,82-186-99,1999,900 mg,Suppository,Rectal use,6.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
LAXOLYNE SUPPOSITORIES,GLYCERIN,0307257687,1999,1800 mg,Suppository,Rectal use,6.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
JULMENTIN FORTE 312.5MG POWDER FOR SUSP,"AMOXICILLIN, CLAVULANIC ACID",0805257363,2000,"250,62.5 mg",Powder for oral suspension,Oral use,27.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
JULMENTIN 625 MG TAB,"AMOXICILLIN, CLAVULANIC ACID",117-186-00,2000,"500,125 mg",Tablet,Oral use,53.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
JULMENTIN 600MG INJ.,"AMOXICILLIN, CLAVULANIC ACID",224-186-04,2004,"500,100 mg",Powder for injection,Parenteral use,6.75,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
JULMENTIN 600MG INJ.,"AMOXICILLIN, CLAVULANIC ACID",223-186-04,2004,"500,100 mg",Powder for injection,Parenteral use,67.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
GLYPRIDE 3 MG TABLET,GLIMEPIRIDE,286-186-12,2012,3 mg,Tablet,Oral use,21.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GUPISONE TAB 5MG,PREDNISOLONE,10-186-85,1985,5 mg,Tablet,Oral use,8.45,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
GYNO-MIKOZAL 200MG VAG.OVULE,MICONAZOLE NITRATE,0307257690,1997,200 mg,Pessary,Vaginal use,21.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GYNO-MIKOZAL 400MG VAG.OVULE,MICONAZOLE NITRATE,2909222663,1997,400 mg,Pessary,Vaginal use,18.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
GYNO-MIKOZAL CREAM 78 GM,MICONAZOLE NITRATE,162-186-02,2002,2 %,Cream,Topical,23.8,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
HAEMOPROCT,"TRIBENOSIDE, LIDOCAINE HYDROCHLORIDE",275-186-09,2009,"5,2 %",Rectal ointment,Rectal use,11.6,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
HISTALOC 25MG F.C. TABLETS,PROMETHAZINE,264-186-09,2009,25 mg,Film-coated tablet,Oral use,4.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
HISTALOC 5MG-5ML SYRUP,PROMETHAZINE,72-186-98,1998,1 mg/ml,Syrup,Oral use,4.75,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
JULMENTIN 1.2GM INJ.,"AMOXICILLIN, CLAVULANIC ACID",226-186-04,2004,"1000,200 mg",Powder for injection,Parenteral use,12.80,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
JULMENTIN 1.2GM INJ.,"AMOXICILLIN, CLAVULANIC ACID",225-186-04,2004,"1000,200 mg",Powder for injection,Parenteral use,127.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
JULMENTIN 156.25 MG POWDER FOR SUSP,"AMOXICILLIN, CLAVULANIC ACID",118-186-00,2000,"125,31.25 mg",Powder for oral suspension,Oral use,14.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
JULMENTIN 2X. 1000MG TABLETS,"AMOXICILLIN, CLAVULANIC ACID",1407257750,2006,"875,125 mg",Tablet,Oral use,63.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
JULMENTIN 2X. 457MG-5ML ORAL SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",0805257361,2006,"400,57 mg",Powder for oral suspension,Oral use,24,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
JULMENTIN 375 MG TAB,"AMOXICILLIN, CLAVULANIC ACID",0307257686,2000,"250,125 mg",Tablet,Oral use,23.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
IBUGESIC,IBUPROFEN,43-124-96,1996,200 mg/ml,Oral suspension,Oral use,3.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
LIDOCAINE 5 % OINTMENT,LIDOCAINE HYDROCHLORIDE,2201269004,2001,5 %,Ointment,Topical,8.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
AMCOCID 100MG-2ML INJ,AMIKACIN,142-186-01,2001,50 mg/ml,Solution for injection,Parenteral use,66.8,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
AMCOCID 500MG-2 ML AMP,AMIKACIN,1007257736,2002,250 mg/ml,Solution for injection,Parenteral use,108.75,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
MIKOSTAT 100000 U OINTMENT,NYSTATIN,94-186-99,1999,100000 IU/g,Ointment,Topical,10.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MIKOSTAT 100000U CREAM,NYSTATIN,0501268855,1999,100000 IU,Cream,Topical,7.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MIKOSTAT 100000U\ML ORAL SUSP,NYSTATIN,1912234597,2002,100000 IU/ml,Oral suspension,Oral use,9.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MIKOZAL 2% cream,MICONAZOLE NITRATE,31-186-88,1988,2 %,Cream,Topical,14.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MIXAVIT SYRUP,MULTIVITAMINS,13-186-85,1985,5 ml,Syrup,Oral use,9.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
MIXAVIT TAB,MULTIVITAMINS,0901233079,1995,,Film-coated tablet,Oral use,6.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MODODOM 10MG F.C. TABLETS,DOMPERIDONE,0901233078,2009,10 mg,Film-coated tablet,Oral use,7.45,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MODODOM 1MG-1ML SUSPENSION,DOMPERIDONE,1807222308,2009,0.1 %,Oral suspension,Oral use,8.4,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MOXAL PLUS Suspension,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE",0509234133,1999,"215,80,25 mg",Oral suspension,Oral use,5.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MOXAL PLUS Tablet,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",1009245895,1999,"400,100 mg",Chewable tablet,Oral use,7.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
MOXAL SUSPENSION,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",15-186-85,1985,"405,100 mg",Oral suspension,Oral use,9.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MOXAL Tablet,"ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE",14-186-85,1985,"405,100 mg",Chewable tablet,Oral use,6.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MIXAVIT DROPS 15ML,MULTIVITAMINS,2106222235,1999,,"Oral drops, solution",Oral use,4.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
GLYPRIDE 2 MG TABLET,GLIMEPIRIDE,283-186-11,2011,2 mg,Tablet,Oral use,15.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LOJOUR 5MG\5ML SYRUP,LORATADINE,0509234139,2003,1 mg/ml,Syrup,Oral use,15.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
LOMAX 400MG TAB,LOMEFLOXACIN,125-186-00,2000,400 mg,Film-coated tablet,Oral use,61.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
LOMAX 400MG TAB,LOMEFLOXACIN,185-186-02,2002,400 mg,Film-coated tablet,Oral use,34.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
LORADAY 10MG TABLET,LORATADINE,41-352-04,2004,10 mg,Tablet,Oral use,13,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Purout 300 MG TABLETS,ALLOPURINOL,20-498-08,2008,300 mg,Tablet,Oral use,16.45,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 25°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LOVRAK 5% cream,ACYCLOVIR,87-186-99,1999,5 %,Cream,Topical,25.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LOVRAK 250MG POWDER FOR I.V. INFUSION,ACYCLOVIR,0509234135,2008,250 mg,Powder for solution for infusion,Intravenous use,21.5,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
LOVRAK 5% OINTMENT,ACYCLOVIR,98-186-99,1999,5 %,Ointment,Topical,25.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
LOVRAK 800 mg tablet,ACYCLOVIR,1807222306,2004,800 mg,Film-coated tablet,Oral use,121.10,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LORADAD 10MG TABLETS,LORATADINE,2103233400,2006,10 mg,Tablet,Oral use,9.8,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
GLYPRIDE 1 MG TABLET,GLIMEPIRIDE,282-186-11,2011,1 mg,Tablet,Oral use,8.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DEXIPAN 5%  CREAM,DEXPANTHENOL,2909222664,1999,5 %,Cream,Topical,5.9,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
DIALON 1000MG F.C. TABLETS,METFORMIN HYDROCHLORIDE,1807222307,2009,1000 mg,Film-coated tablet,Oral use,6.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DIALON 500 MG F.C TAB,METFORMIN HYDROCHLORIDE,1310222729,2002,500 mg,Film-coated tablet,Oral use,6.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DIALON 850MG F.C. TABLETS,METFORMIN HYDROCHLORIDE,1310222731,2009,850 mg,Film-coated tablet,Oral use,3.8,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DICLOGESIC RETARD,DICLOFENAC SODIUM,0912246371,1995,100 mg,Film-coated tablet,Oral use,9.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
DIZINIL 50MG TAB,DIMENHYDRINATE,8-186-95,1995,50 mg,Tablet,Oral use,9.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
DOXYDAR,DOXYCYCLINE,2002221740,1996,100 mg,Capsule,Oral use,12.1,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
DURADOX 100 MG CAPS,DOXYCYCLINE,0805257366,1999,100 mg,"Capsule, hard",Oral use,25.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ENOXIRT 0.25GM I.M. VIAL + SOLVENT,CEFTRIAXONE,132-186-01,2001,250 mg,powder for solution for injection,Intramuscular use,11.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Hospital,Cigalah Group
ENOXIRT 0.25GM I.V. VIAL + SOLVENT,CEFTRIAXONE,131-186-01,2001,250 mg,powder for solution for injection,Intravenous use,11.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
ENOXIRT 0.25 g I.V. VIAL,CEFTRIAXONE,196-186-03,2003,250 mg,powder for solution for injection,Intravenous use,135,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
DICLOGESIC RETARD,DICLOFENAC SODIUM,29-124-89,1989,100 mg,Capsule,Oral use,17.2,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
ENOXIRT 1GM I.M. VIAL + SOLVENT,CEFTRIAXONE,0307257681,2001,1 g,powder for solution for injection,Intramuscular use,45.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
CYNOVIT 1MG-1ML I.M. Injection*,CYANOCOBALAMIN,0805257365,2001,1 mg,Injection,Intramuscular use,7.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
CIPRODAR 500,CIPROFLOXACIN,2210234367,2001,500 mg,Film-coated tablet,Oral use,46.95,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLAMYCIN 500 MG TABLET,CLARITHROMYCIN,1303257067,2002,500 mg,Film-coated tablet,Oral use,63.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CLARIDAR,CLARITHROMYCIN,1801221612,2006,250 mg,Film-coated tablet,Oral use,24.45,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLARIDAR 500 mg film-coated tablet,CLARITHROMYCIN,1801221613,2006,500 mg,Film-coated tablet,Oral use,41.45,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLOFEN 75MG INJECTION,DICLOFENAC SODIUM,1007257734,2001,25 mg/ml,Solution for injection,Parenteral use,25.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
CLOFEN CREAMAGEL 1%,DICLOFENAC SODIUM,2605257461,1999,1 %,Cream,Topical,3.9,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
CLOFEN CREAMAGEL 1%,DICLOFENAC SODIUM,160-186-02,2002,1 %,Cream,Topical,8,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
CLAREX 500MG TABLET,CLARITHROMYCIN,0802221701,2004,500 mg,Film-coated tablet,Oral use,51.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
MUCOLYTE SYRUP,BROMHEXINE,1807222305,1991,0.8 mg/ml,Syrup,Oral use,6.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ENOXIRT 1 g I.V. VIAL,CEFTRIAXONE,1007257738,2003,1 g,powder for solution for injection,Intravenous use,413.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
FOLICUM 1 MG TABLET,FOLIC ACID,166-186-02,2002,1 mg,Tablet,Oral use,6.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
FOLICUM 5MG TAB,FOLIC ACID,0307257688,1998,5 mg,Tablet,Oral use,6.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
FUSIX 40MG TABLET,FUROSEMIDE,0804257208,2004,40 mg,Tablet,Oral use,24.65,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
FUTASOLE 2% OINTMENT,FUSIDIC ACID,1007257735,2001,2 %,Ointment,Topical,7.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FUTASOLE 2%CREAM,FUSIDIC ACID,1004221928,2003,2 %,Cream,Topical,8.75,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
GAMAVATE 0.05% ointment,CLOBETASOL PROPIONATE,1904221959,1997,0.05 %,Ointment,Topical,8.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GAMAVATE 0.05% cream,CLOBETASOL PROPIONATE,1904221962,1997,0.05 %,Cream,Topical,8.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ENOXIRT 1GM I.V. VIAL + SOLVENT,CEFTRIAXONE,0307257680,2001,1 g,powder for solution for injection,Intravenous use,45.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
ENOXIRT 500MG I.M. VIAL + SOLVENT,CEFTRIAXONE,187-186-02,2002,500 mg,powder for solution for injection,Intramuscular use,22.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
ENOXIRT 500MG I.V. VIAL + SOLVENT,CEFTRIAXONE,0307257693,2002,500 mg,powder for solution for injection,Intravenous use,22.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
ENOXIRT 500 mg I.V. Vial,CEFTRIAXONE,0307257682,2003,500 mg,powder for solution for injection,Intravenous use,239,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
EROMYCIN 200MG-5ML SUSP,ERYTHROMYCIN,101-186-99,1999,40 mg/ml,Granules for oral suspension,Oral use,15.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ERYTHRODAR,ERYTHROMYCIN,16-124-85,1985,250 mg,Coated tablet,Oral use,7.55,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
ERYTHRODAR 400MG FORT TAB,ERYTHROMYCIN,1708233996,1996,400 mg,Film-coated tablet,Oral use,10.25,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
FLOXACIN 500 MG COATED TABLET,CIPROFLOXACIN,2909222661,2002,500 mg,Film-coated tablet,Oral use,45.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FAMODAR,FAMOTIDINE,3006210836,2021,20 mg,Film-coated tablet,Oral use,38.70,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
FAMODAR,FAMOTIDINE,3006210835,2021,40 mg,Film-coated tablet,Oral use,25.75,DAR ALDAWA,Jordan,DAR ALDAWA,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
FEROMAX 20MG/ML Injection*,IRON SUCROSE,285-186-12,2012,20 mg/ml,Solution for injection,Intravenous use,76.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
CHLOROHISTOL TAB 4 MG.,CHLORPHENIRAMINE MALEATE,0801256559,1986,4 mg,Tablet,Oral use,6.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
MUCUM 15MG-5ML SYRUP,AMBROXOL HYDROCHLORIDE,0509234140,2009,3 ml,Syrup,Oral use,7.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
TRIMOL SUSP,"SULFAMETHOXAZOLE, TRIMETHOPRIM",1310222730,1986,"40,8 mg/ml",Syrup,Oral use,8.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TRIMOL SUSP.,"SULFAMETHOXAZOLE, TRIMETHOPRIM",0509234131,1986,"40,8 mg/ml",Syrup,Oral use,17.10,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
UROXIN 400MG TAB,NORFLOXACIN,103-186-99,1999,400 mg,Film-coated tablet,Oral use,41.5,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
VANCOLON 0.5GM-VIAL I.V.,VANCOMYCIN,3001233194,2001,50 mg/ml,Powder for solution for injection/infusion,Parenteral use,46.55,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
VANCOLON 1GM POWDER FOR I.V. INFUSION,VANCOMYCIN,1907233882,2006,1 g,Powder for solution for injection/infusion,Parenteral use,58.6,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
VIT. A +D ORAL DROPS,"RETINOL, COLECALCIFEROL (VITAMIN D3)",189-186-02,2002,"1500,400 IU/ml",Oral drops,Oral use,8.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
THIAVIT 100MG TAB,THIAMINE,163-186-02,2002,100 mg,Tablet,Oral use,8.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SOFLAX SOLUTION,LACTULOSE,157-186-02,2002,0.67 g/ml,Solution,Oral use,9.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SUCRAZIDE 5MG TAB,GLIPIZIDE,42-124-96,1996,5 mg,Tablet,Oral use,7.6,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
SUPRAPROCT-S OINT.,"CINCHOCAINE, BETAMETHASONE VALERATE",2106222240,1998,"5,1 mg",Ointment,Topical,10.7,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
TENSOTIN 100 MG TAB,ATENOLOL,2909222665,2003,100 mg,Film-coated tablet,Oral use,20.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TETRACYCLINE SKIN OINT 3%,TETRACYCLINE,23-186-86,1986,3 %,Ointment,Topical,3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
XYLOLIN 0.05%CHILD NASAL SPRAY,XYLOMETAZOLINE HYDROCHLORIDE,91-186-99,1999,0.05 %,Nasal spray,Nasal use,5.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
XYLOLIN 0.1% ADULT NASAL SPRAY,XYLOMETAZOLINE HYDROCHLORIDE,92-186-99,1999,0.1 %,Nasal spray,Nasal use,9.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
MOTRINEX 5 mg Chewable Tablet,MONTELUKAST SODIUM,1708233994,2017,5 mg,Chewable tablet,Oral use,40.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
VEGGIE VITAMIN D3 50000 I.U. Soft Gelatin Capsule,COLECALCIFEROL,2307233904,2018,50000 IU,"Capsule, soft",Oral use,64.1,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Taqnyet Addawa Pharma Co.
VEGGIE VITAMIN D3 50000 I.U. Soft Gelatin Capsule,COLECALCIFEROL,2307233905,2018,50000 IU,"Capsule, soft",Oral use,192.3,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Taqnyet Addawa Pharma Co.
BERESAR 300 mg Film-coated Tablet,IRBESARTAN,2-5128-18,2018,300 mg,Film-coated tablet,Oral use,51.35,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
BERESAR 150 mg Film-coated Tablet,IRBESARTAN,1-5128-18,2018,150 mg,Film-coated tablet,Oral use,40.55,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
XEMADERM 0.1 % Ointment,MOMETASONE FUROATE,1907233881,2018,0.1 %,Ointment,Topical,10.45,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CINFAVAL 80 mg Film-coated Tablet,VALSARTAN,9-5015-17,2018,80 mg,Film-coated tablet,Oral use,20.9,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CINFAVAL 160 mg Film-coated Tablet,VALSARTAN,10-5015-17,2018,160 mg,Film-coated tablet,Oral use,22.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MOTRINEX 4 mg Chewable Tablet,MONTELUKAST SODIUM,1302233243,2017,4 mg,Chewable tablet,Oral use,40.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CINFAVAL 320 mg Film-coated Tablet,VALSARTAN,11-5015-17,2018,320 mg,Film-coated tablet,Oral use,29.6,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CO-CINFAVAL,"VALSARTAN, HYDROCHLOROTHIAZIDE",1211246205,2018,"160,12.5 mg",Film-coated tablet,Oral use,22.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CO-CINFAVAL,"VALSARTAN, HYDROCHLOROTHIAZIDE",1211246208,2018,"160,25 mg",Film-coated tablet,Oral use,22.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
"VEGGIE Vitamin D3 5, 000 IU",COLECALCIFEROL,2104245180,2018,5000 IU,"Capsule, soft",Oral use,33.00,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Taqnyet Addawa Pharma Co.
COVAZ,"VALSARTAN, HYDROCHLOROTHIAZIDE",1109234163,2018,"160,12.5 mg",Film-coated tablet,Oral use,30.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
COVAZ,"VALSARTAN, HYDROCHLOROTHIAZIDE",1109234162,2018,"80,12.5 mg",Film-coated tablet,Oral use,27.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
COVAZ,"VALSARTAN, HYDROCHLOROTHIAZIDE",1109234164,2018,"160,25 mg",Film-coated tablet,Oral use,30.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
DIVAD 10000 I.U Capsule,COLECALCIFEROL,1409234214,2018,10000 IU,Capsule,Oral use,64.1,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
DIVAD 50000 I.U Capsule,COLECALCIFEROL,1409234215,2018,50000 IU,Capsule,Oral use,25.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CLARIDAR XL 500 mg Tablet,CLARITHROMYCIN,0409234122,2018,500 mg,Extended-release tablet,Oral use,43.9,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ESPERAL 25 mg Film Coated Tablet,QUETIAPINE,1601244745,2018,25 mg,Film-coated tablet,Oral use,19.9,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ESPERAL 100 mg Film Coated Tablet,QUETIAPINE,1601244744,2018,100 mg,Film-coated tablet,Oral use,46.9,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ESPERAL 200 mg Film Coated Tablet,QUETIAPINE,1601244747,2018,200 mg,Film-coated tablet,Oral use,87,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CO-CINFAVAL,"VALSARTAN, HYDROCHLOROTHIAZIDE",1211246209,2018,"80,12.5 mg",Film-coated tablet,Oral use,11.45,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MOTRINEX 10 mg Film Coated Tablet,MONTELUKAST SODIUM,0502233213,2017,10 mg,Film-coated tablet,Oral use,36.2,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
LEBALIN 150 MG CAPSULE,PREGABALIN,3005233747,2017,150 mg,"Capsule, hard",Oral use,154.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PANTONIX 40 mg powder for infusion,PANTOPRAZOLE,292-186-15,2015,40 mg,Powder for infusion,Intravenous use,28.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
NEGAFEN 1% cream,TERBINAFINE,291-186-15,2015,1 %,Cream,Topical,10.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
NEGAFEN 250 mg tablet,TERBINAFINE,290-186-15,2015,250 mg,Tablet,Oral use,68.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LEBALIN 300 MG CAPSULE,PREGABALIN,3005233748,2017,300 mg,"Capsule, hard",Oral use,217.3,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LOVRAK 200 mg suspension,ACYCLOVIR,0702221679,2016,40 mg/ml,Oral suspension,Oral use,71.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
JULMENTIN ES SUSPENSION,"AMOXICILLIN, CLAVULANIC ACID",2106222236,2017,"600,42.9 mg",Powder for oral suspension,Oral use,29.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
IRSOTAN 150 mg Film Coated Tablet,IRBESARTAN,9-972-17,2017,150 mg,Film-coated tablet,Oral use,43.4,MEDOCHEMIE LTD.,Cyprus,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
IRSOTAN 300 mg Film Coated Tablet,IRBESARTAN,10-972-17,2017,300 mg,Film-coated tablet,Oral use,53.25,MEDOCHEMIE LTD.,Cyprus,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
LEBALIN 75 MG CAPSULE,PREGABALIN,2305233706,2017,75 mg,"Capsule, hard",Oral use,29.95,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LEBALIN 75 MG CAPSULE,PREGABALIN,3005233750,2017,75 mg,"Capsule, hard",Oral use,119.8,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TYRA 20 mg film-coated tablet,TADALAFIL,3008222564,2017,20 mg,Film-coated tablet,Oral use,72.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
PARAZOLE 100MG TABLET,MEBENDAZOLE,221-186-04,2004,100 mg,Tablet,Oral use,6.8,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PANDERM SKIN OINTMENT,"NYSTATIN, NEOMYCIN SULFATE, TRIAMCINOLONE ACETONIDE, GRAMICIDIN",41-186-89,1989,"2.272,0.416,0.1,0.025 g",Ointment,Topical,11.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
POTENCORT 0.005% OINTMENT,FLUTICASONE PROPIONATE,201-186-03,2003,0.005 %,Ointment,Topical,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
POTENCORT 0.05% CREAM,FLUTICASONE PROPIONATE,202-186-03,2003,0.05 %,Cream,Topical,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PREMOSAN 10 mg tablet,METOCLOPRAMIDE HYDROCHLORIDE,46-186-89,1989,10 mg,Tablet,Oral use,6.70,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PREMOSAN 10 mg injection,METOCLOPRAMIDE HYDROCHLORIDE,124-186-00,2000,10 mg,Injection,Parenteral use,9,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
PREMOSAN ORAL DROPS 4MG-ML,METOCLOPRAMIDE HYDROCHLORIDE,44-186-89,1989,4 mg/ml,Oral drops,Oral use,2.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PREMOSAN SYRUP 5MG-5ML,METOCLOPRAMIDE HYDROCHLORIDE,45-186-89,1989,1 mg/ml,Syrup,Oral use,3.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
PRIMOCEF 0.5 GM I.M- I.V VIAL,CEFOTAXIME,151-186-01,2001,500 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,17.4,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
PRIMOCEF 1 g Powder for injection,CEFOTAXIME,2102221745,2001,1 g,Powder and solvent for solution for injection,Intramuscular use,28.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
PRIMOCEF 1 GM I.V VIAL,CEFOTAXIME,152-186-01,2001,1 g,Powder and solvent for solution for injection,Intravenous use,28.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
PANDERM CREAM,"NYSTATIN, NEOMYCIN SULFATE, TRIAMCINOLONE ACETONIDE, GRAMICIDIN",40-186-89,1989,"100000,0.25,0.1,0.025 IU, g",Cream,Topical,11.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ORAMAX 150MG CAPSULES,FLUCONAZOLE,0509234132,2008,150 mg,Capsule,Oral use,15.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MYOGESIC,"PARACETAMOL, ORPHENADRINE CITRATE",2706222263,1986,"450,35 mg",Tablet,Oral use,6.60,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
NASIVIN DROPS 0.025%,OXYMETAZOLINE,28-186-87,1987,0.025 %,Nasal drops,Nasal use,4.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
NASIVIN DROPS 0.05%,OXYMETAZOLINE,27-186-87,1987,0.05 %,Nasal drops,Nasal use,5.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
NEGACEF 1GM VIAL,CEFTAZIDIME,0805257362,2001,1 g,Powder for injection,Intravenous use,43.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
NEGACEF 2GM Injection,CEFTAZIDIME,2106222239,2010,2 g,Injection,Intravenous use,69.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
NEGAZOLE 500MG TAB.,METRONIDAZOLE,149-186-01,2001,500 mg,Tablet,Oral use,12.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OMEPREX 20 mg capsule,OMEPRAZOLE,7-370-03,2003,20 mg,Capsule,Oral use,45.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OMEPREX 20 mg capsule,OMEPRAZOLE,8-370-03,2003,20 mg,Capsule,Oral use,91.90,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
NEGAZOLE 250MG TAB.,METRONIDAZOLE,148-186-01,2001,250 mg,Tablet,Oral use,5.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
MUCUM 30MG TABLETS,AMBROXOL HYDROCHLORIDE,3004233563,2009,30 mg,Tablet,Oral use,8.45,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
PROFINAL 200MG TAB,IBUPROFEN,0307257689,1985,200 mg,Film-coated tablet,Oral use,7.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
PROFINAL 5% GEL,IBUPROFEN,102-186-99,1999,5 %,Gel,Topical,6.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ROXAMED,ROXITHROMYCIN,68-124-03,2003,150 mg,Film-coated tablet,Oral use,29.75,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
RUBICALM CREAM,DIETHYLAMINE SALICYLATE,0308222396,1998,1 %,Cream,Topical,3.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SALINAL 41.2MG-ML ORAL DROPS,SIMETHICONE,69-186-98,1998,41.2 mg/ml,"Oral drops, solution",Oral use,7.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SALINAL 42MG CHEWABLE TAB,SIMETHICONE,0801268890,2000,42 mg,Chewable tablet,Oral use,10.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
SALURIN 20MG-2ML AMPOULES,FUROSEMIDE,1807222309,2008,10 mg/ml,Solution for injection,Intravenous use,14.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
SALURIN 40 MG TABLETS,FUROSEMIDE,205-186-03,2003,40 mg,Tablet,Oral use,14.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SARF 500MG TAB,CIPROFLOXACIN,145-186-01,2001,500 mg,Film-coated tablet,Oral use,55.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SARF 750MG TAB.,CIPROFLOXACIN,146-186-01,2001,750 mg,Film-coated tablet,Oral use,72.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SCOPINAL 20MG AMPOULE,HYOSCINE BUTYLBROMIDE,0509234138,2000,20 mg,Solution for injection,Intravenous use,12.7,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
SCOPINAL 5MG-5ML SYRUP,HYOSCINE BUTYLBROMIDE,0307257694,1998,1 mg/ml,Syrup,Oral use,10.80,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SCOPINAL TAB 10MG,HYOSCINE BUTYLBROMIDE,36-186-89,1989,10 mg,Film-coated tablet,Oral use,7.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SEDOFAN SYRUP.,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",77-186-98,1998,"6,0.25 mg/ml",Syrup,Oral use,3.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SEDOFAN,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",75-186-98,1998,"60,2.5 mg",Tablet,Oral use,8.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
SALURIN 5MG-5ML SYRUP,FUROSEMIDE,183-186-02,2002,1 mg/ml,Syrup,Oral use,15.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PROFINAL 400 mg film-coated tablets,IBUPROFEN,1311222897,1989,400 mg,Film-coated tablet,Oral use,12.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
PROFINAL 600 mg tablet,IBUPROFEN,2106222237,1997,600 mg,Film-coated tablet,Oral use,10.75,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PROFINAL Pediatric Suspension,IBUPROFEN,1910234361,1998,20 mg/ml,Oral suspension,Oral use,7.90,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
PROFINAL XP 400MG F.C TABLET,"IBUPROFEN, CAFFEINE CITRATE",0509234130,2005,"400,65 mg",Film-coated tablet,Oral use,11.05,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
ROTHACIN 100MG SUPPOSITORIES,INDOMETACIN,0307257679,2008,100 mg,Suppository,Rectal use,13.2,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
RISEK,OMEPRAZOLE,138-186-01,2001,10 mg,"Capsule, hard",Oral use,23.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RISEK 20 MG CAPS,OMEPRAZOLE,2608258119,2000,20 mg,"Capsule, hard",Oral use,45.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
RISEK 40MG INJ,OMEPRAZOLE,2102221744,2002,40 mg,Powder for solution for infusion,Intravenous use,25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ARXIA 90MG F.C.TABLET,Etoricoxib,2403257150,2019,90 mg,Film-coated tablet,Oral use,41.1,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CHLOROHISTOL SYRUP 2 MG - 5 ML,CHLORPHENIRAMINE MALEATE,2106222234,1988,0.4 mg/ml,Syrup,Oral use,5.65,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
CHLOROHISTOL 10MG-ML Injection*,CHLORPHENIRAMINE MALEATE,0307257691,2009,10 mg/ml,Solution for injection,Intravenous use,6.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
AMURETIC 5MG/50MG TAB,"HYDROCHLOROTHIAZIDE, AMILORIDE",56-124-00,2000,"50,5 mg",Tablet,Oral use,8.75,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
AMYDRAMINE EXPECTORANT SYRUP,"DIPHENHYDRAMINE HYDROCHLORIDE, SODIUM CITRATE, AMMONIUM CHLORIDE",3-186-85,1985,"2.7,11.4,26.3 mg/ml",Syrup,Oral use,8.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
AMYDRAMINE EXPECTORANT SYRUP SUGAR FREE,"SODIUM CITRATE, DIPHENHYDRAMINE HYDROCHLORIDE",0307257683,2005,"5.7,1.4 mg/ml",Syrup,Oral use,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
AMYDRAMINE II SUGAR FREE SYRUP,DIPHENHYDRAMINE HYDROCHLORIDE,104-186-99,1999,2.5 mg/ml,Syrup,Oral use,7.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
AMYDRAMINE PAEDIATRIC SYRUP,"SODIUM CITRATE, DIPHENHYDRAMINE HYDROCHLORIDE",78-186-99,1999,"5.7,1.4 mg/ml",Syrup,Oral use,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ANXETIN 20MG CAPSULES,FLUOXETINE,2809222659,2008,20 mg,Capsule,Oral use,37.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
APHRODIL 50 mg Film coated tablet,SILDENAFIL,97-124-14,2014,50 mg,Film-coated tablet,Oral use,43.7,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ASMAFORT 1MG\5ML SYRUP,KETOTIFEN,194-186-03,2003,0.2 mg/ml,Syrup,Oral use,20.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ASMAFORT 1MGTAB,KETOTIFEN,174-186-02,2002,1 mg,Tablet,Oral use,15.6,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AMLOPRESS 5MG CAPSULES,AMLODIPINE BESILATE,2811211383,2006,5 mg,Capsule,Oral use,32.65,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
3V AMPOULES,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",243-186-06,2006,"100,100,1000 mg, µg",Solution for injection,Intramuscular use,8.6,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), Protect from light and heat",Hospital,Cigalah Group
ADOL 125 MG RECTAL SUPPOSITORIES,PARACETAMOL,1904221960,1999,125 mg,Suppository,Rectal use,4.90,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,Cigalah Group
ADOL 250 MG RECTAL SUUPPOSITORIES,PARACETAMOL,1007257737,1999,250 mg,Suppository,Rectal use,6.10,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,Cigalah Group
ADOL 500 MG RECTAL SUPPOSITORIES,PARACETAMOL,2102221743,1999,500 mg,Suppository,Rectal use,7.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,Cigalah Group
ADOL 500MG CAPLET,PARACETAMOL,2711258669,1996,500 mg,Caplet,Oral use,5.05,ALPHA PHARMA INDUSTRY,Saudi Arabia,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ADOL ALLERGY SINUS 325MG-2MG-30MG CAPLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE",108-186-99,1999,"325,30,2 mg",Tablet,Oral use,10.90,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ADOL COLD CAPLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN",105-186-99,1999,"325,30,15 mg",Caplet,Oral use,10.90,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ADOL DROPS 100MG-ML,PARACETAMOL,54-186-93,1993,100 mg/ml,Drops,Oral use,7.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ADOL PM 325MG-25MG CAPLET,"PARACETAMOL, DIPHENHYDRAMINE HYDROCHLORIDE",107-186-99,1999,"325,25 mg",Caplet,Oral use,9.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ADOL SYRUP 120MG-5ML,PARACETAMOL,2-186-96,1996,24 mg/ml,Syrup,Oral use,5.80,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ADVAQUIN 500MG FILM COATED TABLET,LEVOFLOXACIN,36-498-14,2014,500 mg,Film-coated tablet,Oral use,40.4,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,do not store above 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
ALBENDA 100MG\5ML SUSP,ALBENDAZOLE,184-186-02,2002,20 mg/ml,Suspension,Oral use,12.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ALFACORT 1% CREAM,HYDROCORTISONE ACETATE,0509234136,1998,1 %,Cream,Topical,8.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ALFACORT 1% OINTMENT,HYDROCORTISONE ACETATE,0202221669,1998,1 %,Ointment,Topical,8.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
AMOLAR 10MG CAPSULES,AMLODIPINE BESILATE,0710258337,2010,10 mg,Capsule,Oral use,29.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
AMLOPHAR 5MG CAPSULES,AMLODIPINE BESILATE,0805257360,2010,5 mg,"Capsule, hard",Oral use,29.4,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
ADOL SINUS 325MG-30MG CAPLET,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE",2003245065,1999,"325,30 mg",Tablet,Oral use,10.90,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
CAPOCARD 25MG TAB,CAPTOPRIL,38-124-95,1995,25 mg,Tablet,Oral use,15.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
CAPOCARD 50MG TAB,CAPTOPRIL,39-124-95,1995,50 mg,Tablet,Oral use,25.4,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
CARBATOL 200MG TAB,CARBAMAZEPINE,0910246024,1996,200 mg,Film-coated tablet,Oral use,12.75,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
CEFIM 100 POWDER FOR ORAL SUSPENTION,CEFIXIME,0410222687,2012,20 mg/ml,Suspension,Oral use,36.3,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CEFOVEX 500MG TABLET,CEFUROXIME AXETIL,35-498-12,2012,500 mg,Tablet,Oral use,49.3,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LEXEK 125MG-5ML SUSP,CEFALEXIN,0307257696,1998,25 mg/ml,Powder for oral suspension,Oral use,10.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
LEXEK 250MG-5ML SUSP,CEFALEXIN,0307257684,1989,250 mg/ml,Powder for oral suspension,Oral use,18.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Lexek 500MG CAPS,CEFALEXIN,0501268854,1998,500 mg,"Capsule, hard",Oral use,22.5,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
CEFUZIME 125MG-5ML POWDER FOR ORAL SUSP,CEFUROXIME AXETIL,244-186-06,2006,25 mg/ml,Powder for oral suspension,Oral use,23.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
CEFUZIME 500 MG TAB,CEFUROXIME AXETIL,0210222682,2002,500 mg,Film-coated tablet,Oral use,63.95,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
"CEFUZIME 750 MG INJECTION, I.M - I.V VIAL",CEFUROXIME SODIUM,0307257685,2005,750 mg,Powder for injection,Parenteral use,7.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
CEPHADAR FORTE,CEFALEXIN,2104221971,1992,500 mg,"Capsule, hard",Oral use,18.1,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CETRALON 10 MG TAB,CETIRIZINE HYDROCHLORIDE,181-186-02,2002,10 mg,Film-coated tablet,Oral use,10.25,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
CETRALON 5MG-5ML SYRUP,CETIRIZINE HYDROCHLORIDE,182-186-02,2002,1 mg/ml,Syrup,Oral use,10.1,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
LEXEK 250MG CAPS,CEFALEXIN,0501268850,1998,250 mg,"Capsule, hard",Oral use,14.3,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
3V TABLETS,"PYRIDOXINE, THIAMINE, CYANOCOBALAMIN",0805257367,2003,"200,100,200 mg, µg",Film-coated tablet,Oral use,12.4,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
BUTALIN TABS 4MG,SALBUTAMOL,0509234137,1991,4 mg,Tablet,Oral use,8.30,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BUTALIN SYRUP 2MG-5ML,SALBUTAMOL,1904221961,1991,0.4 mg/ml,Syrup,Oral use,10.35,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AZOMAX 250MG CAPSULE,AZITHROMYCIN,19-370-05,2005,250 mg,Capsule,Oral use,32.6,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
AZOMYCIN 200MG\5ML SUSP.,AZITHROMYCIN,0501268853,2003,40 mg/ml,Powder for oral suspension,Oral use,24.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
AZOMYCIN 200MG\5ML SUSP.,AZITHROMYCIN,0501268851,2003,40 mg/ml,Powder for oral suspension,Oral use,43.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BUTALIN 2 mg tablet,SALBUTAMOL,2608210987,1991,2 mg,Tablet,Oral use,6.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BETASONE 0.1% CREAM,BETAMETHASONE VALERATE,2510222791,1987,0.1 %,Cream,Topical,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BETASONE 500MCG TAB,BETAMETHASONE SODIUM PHOSPHATE,5-186-95,1995,0.5 mg,Tablet,Oral use,6.7,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
BUTALIN 0.5% SOLUTION FOR NEBULISER,SALBUTAMOL,0509234134,2005,0.5 %,Nebuliser solution,Inhalation use,14.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BUTALIN 100MCG-DOSE INHALER,SALBUTAMOL,239-186-06,2006,100 µg,Pressurised inhalation,Inhalation use,14.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Cigalah Group
BETASONE 0.1% OINTMENT,BETAMETHASONE VALERATE,0307257692,1987,0.1 %,Ointment,Topical,5.15,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ESPERAL 300 mg Film Coated Tablet,QUETIAPINE,1601244746,2018,300 mg,Film-coated tablet,Oral use,71.4,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
TELFAST 120 MG FILM COATED TAB,FEXOFENADINE HYDROCHLORIDE,1405245296,2017,120 mg,Film-coated tablet,Oral use,26.55,SANOFI WINTHROP INDUSTRIE,France,Sanofi Consumer Healthcare,Australia,Marketed,OTC,store below 30°c,Pharmacy,Opella Arabia Limited Co
ATOXIA 120 mg Film-coated Tablet,Etoricoxib,3-5286-19,2019,120 mg,Film-coated tablet,Oral use,11,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ARBAVAL 320 mg film-coated tablet,VALSARTAN,1901233123,2015,320 mg,Film-coated tablet,Oral use,35.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVAL PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2803221891,2015,"160,12.5 mg",Film-coated tablet,Oral use,27.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVAL PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2803221889,2015,"160,25 mg",Film-coated tablet,Oral use,27.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVAL PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2803221890,2015,"320,25 mg",Film-coated tablet,Oral use,37.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Feradef 100 mg injection,IRON SUCROSE,0902221706,2016,20 mg/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,68.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ZOLIX 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,2507222346,2016,5 mg,Film-coated tablet,Oral use,17.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NEUROGAB 150 mg capsule,PREGABALIN,2501221636,2015,150 mg,Capsule,Oral use,82.9,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ZENORIT 8 mg lyophilisate for solution for injection,LORNOXICAM,2205222049,2016,8 mg,Powder and solvent for solution for injection,Intravenous use,14.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LETARA 2.5 mg tablet,LETROZOLE,1906222219,2016,2.5 mg,Film-coated tablet,Oral use,156.55,DOUGLAS MANUFACTURING Ltd,New Zealand,DOUGLAS MANUFACTURING Ltd,New Zealand,Marketed,Prescription,do not store above 30°c,Pharmacy,Thimar Aljazirah Company
MOXIFLOX 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,2501221640,2015,400 mg,Film-coated tablet,Oral use,49.45,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
MOXIFLOX 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,2501221637,2015,400 mg,Film-coated tablet,Oral use,65.1,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LASIX AMP 20MG-2ML,FUROSEMIDE,2111246318,2016,10 mg/ml,Solution for injection,Intravenous use,20.80,SANOFI WINTHROP INDUSTRIE,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
LANOXIN 0.05MG-ML ELIXIR,DIGOXIN,10-887-16,2016,0.05 µ/ml,Solution,Oral use,22.75,ASPEN,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
DESTAMIN 5 mg film-coated tablet,DESLORATADINE,3010222834,2016,5 mg,Film-coated tablet,Oral use,18.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
COLAT 500 mg powder for solution for infusion,VANCOMYCIN,0512211425,2016,500 mg,Solution for infusion,Intravenous use,37.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
NORMATEC 20 mg film-coated tablet,OLMESARTAN MEDOXOMIL,3010222837,2016,20 mg,Film-coated tablet,Oral use,53.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NORMATEC 40 mg film-coated tablet,OLMESARTAN MEDOXOMIL,0902221716,2016,40 mg,Film-coated tablet,Oral use,70.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ARBAVAL 160 mg film-coated tablet,VALSARTAN,1901233120,2015,160 mg,Film-coated tablet,Oral use,27.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVAL 80 mg film-coated tablet,VALSARTAN,1901233121,2015,80 mg,Film-coated tablet,Oral use,24.9,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVAL 40 mg film-coated tablet,VALSARTAN,1901233122,2015,40 mg,Film-coated tablet,Oral use,12.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LEVAQUIN 500 mg film-coated tablet,LEVOFLOXACIN,0411211261,2016,500 mg,Film-coated tablet,Oral use,40.4,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BUTAFYL 1% cream,BUTENAFINE,0808222419,2016,1 %,Cream,Topical,20.85,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AMAGLIME 1 mg tablet,GLIMEPIRIDE,1210211147,2016,1 mg,Tablet,Oral use,10.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AMAGLIME 1 mg tablet,GLIMEPIRIDE,1210211148,2016,1 mg,Tablet,Oral use,16.7,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AMAGLIME 2 mg tablet,GLIMEPIRIDE,1210211152,2016,2 mg,Tablet,Oral use,13.7,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AMAGLIME 3 mg tablet,GLIMEPIRIDE,1210211156,2016,3 mg,Tablet,Oral use,23.60,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AMAGLIME 3 mg tablet,GLIMEPIRIDE,1210211154,2016,3 mg,Tablet,Oral use,42.5,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CLOVIRAX 5% cream,ACYCLOVIR,2410211214,2016,5 %,Cream,Topical,25.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CLOVIRAX 5% cream,ACYCLOVIR,2410211215,2016,5 %,Cream,Topical,12.15,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
LYRGABA 75 mg capsule,PREGABALIN,1210211150,2016,75 mg,"Capsule, hard",Oral use,85.6,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
LYRGABA 75 mg capsule,PREGABALIN,1410211181,2016,75 mg,"Capsule, hard",Oral use,128.4,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
LYRGABA 150 mg capsule,PREGABALIN,1210211157,2016,150 mg,"Capsule, hard",Oral use,110.55,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
NORMATEC PLUS 40/12.5 mg film-coated tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",2906222282,2016,"40,12.5 mg",Film-coated tablet,Oral use,78.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LYRGABA 150 mg capsule,PREGABALIN,1210211158,2016,150 mg,"Capsule, hard",Oral use,165.8,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
DUETACT 30/4 mg tablet,"PIOGLITAZONE, GLIMEPIRIDE",0802221696,2016,"30,4 mg",Tablet,Oral use,125.8,TAKEDA GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DUETACT 30/2 mg tablet,"PIOGLITAZONE, GLIMEPIRIDE",0802221700,2016,"30,2 mg",Tablet,Oral use,108.65,TAKEDA,Japan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVACIN 750 mg film-coated tablet,LEVOFLOXACIN,2907245685,2016,750 mg,Film-coated tablet,Oral use,64.75,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
GLANDY 60 mg film-coated tablet,CINACALCET,0711211263,2016,60 mg,Film-coated tablet,Oral use,1232.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
10% DEXTROSE W/V intravenous infusion,DEXTROSE,0901233076,2016,10 %,Intravenous infusion,Intravenous use,6.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
MEMAXIA 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,1506222202,2016,10 mg,Film-coated tablet,Oral use,91.1,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ALLAIR 4 mg chewable tablet,MONTELUKAST SODIUM,0411211260,2016,4 mg,Chewable tablet,Oral use,64.3,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ALLAIR 5 mg chewable tablet,MONTELUKAST SODIUM,0411211262,2016,5 mg,Chewable tablet,Oral use,64.3,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FERROVEN 20 mg/ml injection,FERRIC HYDROXIDE,2911211395,2016,20 mg/ml,Concentrate for solution for infusion,Intravenous use,68.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Alburex,ALBUMIN HUMAN,0808222425,2015,200 g/l,Solution,Intravenous use,249.1,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Alburex,ALBUMIN HUMAN,0808222424,2015,200 g/l,Solution,Intravenous use,154.95,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
ACTOSMET 15/850 mg tablet,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE",0206222125,2016,"850,15 mg",Film-coated tablet,Oral use,104.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NORMATEC PLUS 20/12.5 mg film-coated tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",2906222284,2016,"20,12.5 mg",Film-coated tablet,Oral use,59.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NORMATEC PLUS 40/25 mg film-coated tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",2906222283,2016,"40,25 mg",Film-coated tablet,Oral use,78.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VFONAZ 50 mg film-coated tablet,VORICONAZOLE,0404221914,2016,50 mg,Film-coated tablet,Oral use,583.56,Pfizer Italia S.R.L,Italy,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
QUETTA XR 300 mg tablet,QUETIAPINE,0906222174,2016,300 mg,Extended-release tablet,Oral use,146.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
QUETTA XR 400 mg tablet,QUETIAPINE,0906222175,2016,400 mg,Extended-release tablet,Oral use,208.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CERUXIM 750 mg powder for solution for injection or infusion,CEFUROXIME SODIUM,2305233710,2016,750 mg,powder for solution for injection,Parenteral use,67.1,MEDOCHEMIE LTD,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CERUXIM 1.5 g powder for solution for injection or infusion,CEFUROXIME SODIUM,2305233709,2016,1.5 g,powder for solution for injection,Parenteral use,134.2,MEDOCHEMIE LTD,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
AMODIP 5 mg capsule,AMLODIPINE BESILATE,0201221545,2016,5 mg,Capsule,Oral use,26.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVOBAN 2% nasal ointment,MUPIROCIN CALCIUM,0201221546,2016,2 %,Nasal ointment,Nasal use,28.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ATROPINE SULPHATE 600 mcg/ml injection,ATROPINE SULFATE,0510234302,2016,0.6 mg/ml,Solution,Intramuscular and intravenous use,28.20,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
ATOZET 10/10 mg film-coated tablet,"ATORVASTATIN CALCIUM, EZETIMIBE",22-262-10,2016,"10,10 mg",Film-coated tablet,Oral use,124.55,MSD International GmbH (PUERTO RICO Branch),United States,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ATOZET 10/20 mg film-coated tablet,"ATORVASTATIN CALCIUM, EZETIMIBE",22-262-11,2016,"10,20 mg",Film-coated tablet,Oral use,129.20,MSD International GmbH (PUERTO RICO Branch),United States,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ATOZET 10/40 mg film-coated tablet,"ATORVASTATIN CALCIUM, EZETIMIBE",22-262-12,2016,"10,40 mg",Film-coated tablet,Oral use,135.10,MSD International GmbH (PUERTO RICO Branch),United States,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
QUETTA XR 200 mg tablet,QUETIAPINE,0906222173,2016,200 mg,Extended-release tablet,Oral use,110.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
MODEXA 30 mg gastro-resistant capsule,DULOXETINE,2510222800,2016,30 mg,"Capsule, hard",Oral use,20.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MINOCET 300 mg capsule,CEFDINIR,1501233100,2016,300 mg,"Capsule, hard",Oral use,64.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MINOCET 125 mg/5 ml powder for oral suspension,CEFDINIR,3105222107,2016,25 mg/ml,Oral suspension,Oral use,58.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MINOCET 125 mg/5 ml powder for oral suspension,CEFDINIR,1501233099,2016,25 mg/ml,Oral suspension,Oral use,37.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
RYZODEG FlexTouch 100 u/ml,"INSULIN DEGLUDEC, INSULIN ASPART",2308222536,2016,"70,30 %, IU/ml",Solution for injection,Subcutaneous use,378.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
MIRAN 0.5 g powder for injection,MEROPENEM,0606222137,2016,500 mg,Powder for injection,Intravenous use,23.55,ACS DOBFAR S.P.A,Italy,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
MIRAN 1 g powder for injection,MEROPENEM,2903221895,2016,1 g,Powder for injection,Intravenous use,39.6,ACS DOBFAR S.P.A,Italy,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ALEVE 220 mg film-coated tablet,NAPROXEN,1008222459,2016,220 mg,Film-coated tablet,Oral use,11.65,Bayer Bitterfeld GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OCUFLOXIN 3 mg/ml ophthamic solution,OFLOXACIN,3001244809,2016,3 mg/ml,"Eye drops, solution",Ophthalmic use,20,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
DICLOPID 50 mg film-coated tablet,DICLOFENAC POTASSIUM,1810222754,2016,50 mg,Film-coated tablet,Oral use,9.1,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
VALPOHARDT 100 mg/ml solution for injection or infusion,VALPROATE SODIUM,2403257140,2016,100 mg/ml,Solution for injection/infusion,Intravenous use,246.1,CP PHARMACEUTICAL Ltd,United Kingdom,WOCKHARDT UK LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ASPIRIN PROTECT 100MG E.C. TABLETS,ACETYLSALICYLIC ACID,0902221714,2016,100 mg,Enteric-coated tablet,Oral use,19.05,Bayer Bitterfeld GmbH,Germany,BAYER CONSUMER CARE AG,Germany,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
MODEXA 60 mg gastro-resistant capsule,DULOXETINE,2610222808,2016,60 mg,"Capsule, hard",Oral use,80.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CIPROGRAM 750 mg film-coated tablet,CIPROFLOXACIN,1210211153,2016,750 mg,Film-coated tablet,Oral use,75.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CEREZYME 400 U powder for concentrate for solution for infusion,IMIGLUCERASE,1210234332,2016,400 U,Powder for concentrate for solution for infusion,Intravenous use,5984.85,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
VFONAZ 200 mg film-coated tablet,VORICONAZOLE,2510222793,2016,200 mg,Film-coated tablet,Oral use,2334.30,Pfizer Italia S.R.L,Italy,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VFONAZ 200 mg powder for solution for infusion,VORICONAZOLE,0902221719,2016,200 mg,Solution,Intravenous use,295.00,Pfizer Manufacturing Deutschland GmbH,Germany,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
REZAL XR 50 mg extended-release tablet,QUETIAPINE,0901233080,2016,50 mg,Prolonged-release tablet,Oral use,37.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
REZAL XR 200 mg extended-release tablet,QUETIAPINE,2012234598,2016,200 mg,Prolonged-release tablet,Oral use,122.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
REZAL XR 300 mg extended-release tablet,QUETIAPINE,355-277-16,2016,300 mg,Prolonged-release tablet,Oral use,162.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PHLEBODIA 600 mg film-coated tablet,DIOSMIN,0902221720,2016,600 mg,Film-coated tablet,Oral use,41.6,INNOTHERA CHOUZY,France,LABORATOIRES INNOTHERA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
VEGA 50 mg film-coated tablet,SILDENAFIL,2811211377,2016,50 mg,Film-coated tablet,Oral use,43.7,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
KLARE 500 mg film-coated tablet,CLARITHROMYCIN,2811211380,2016,500 mg,Film-coated tablet,Oral use,46.05,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CANDAN 16 mg tablet,CANDESARTAN CILEXETIL,2811211381,2016,16 mg,Tablet,Oral use,45.85,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CANDAN PLUS 16/12.5 mg tablet,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",2811211379,2016,"16,12.5 mg",Tablet,Oral use,51.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
SNAFI 20MG TAB,TADALAFIL,2808222555,2016,20 mg,Film-coated tablet,Oral use,133.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ADVATE 1000 IU,HUMAN COAGULATION FACTOR VIII,0912211450,2014,1000 IU,Powder and solvent for solution for injection,Intravenous use,2504.7,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
SAVIR 5% cream,ACYCLOVIR,2811211376,2016,5 %,Cream,Topical,38.00,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PROTENSE 40 mg/5 ml oral solution,PROPRANOLOL,1902233259,2016,8 mg/ml,Oral solution,Oral use,110,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ARCHIFAR 500 mg powder for solution for injection or infusion,MEROPENEM,2305222052,2016,500 mg,Powder for solution for injection/infusion,Intravenous use,232.85,MEDOCHEMIE LTD,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
ARCHIFAR 1000 mg powder for solution for injection or infusion,MEROPENEM,2305222053,2016,1000 mg,Powder for solution for injection/infusion,Intravenous use,395.9,MEDOCHEMIE LTD,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
LANOXIN 0.25MG/ML INJ,DIGOXIN,1607257768,2016,0.25 mg/ml,Solution for injection,Intravenous use,13.2,CENEXI,France,ASPEN,Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
EZECHOL 10 mg tablet,EZETIMIBE,1412211477,2016,10 mg,Tablet,Oral use,131.65,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SETAPRO 20 mg film-coated tablet,ESCITALOPRAM,2007222320,2016,20 mg,Film-coated tablet,Oral use,93.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SETAPRO 10 mg film-coated tablet,ESCITALOPRAM,2007222318,2016,10 mg,Film-coated tablet,Oral use,46.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ENTYVIO 300 mg powder for concentrate for solution for infusion,VEDOLIZUMAB,1403221847,2016,300 mg,Powder for concentrate for solution for infusion,Intravenous use,7019.30,HOSPIRA,United States,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
CIPROGRAM 500 mg film-coated tablet,CIPROFLOXACIN,1210211151,2016,500 mg,Film-coated tablet,Oral use,54.25,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
G-PRIDE 4 mg tablet,GLIMEPIRIDE,2411211361,2016,4 mg,Tablet,Oral use,24.95,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
VANCO 1000 mg powder for solution for injection or infusion,VANCOMYCIN,0311211257,2016,1000 mg,Powder for solution for injection/infusion,Parenteral use,57.9,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VANCO 500 mg powder for solution for injection or infusion,VANCOMYCIN,2501221643,2016,500 mg,Powder for solution for injection/infusion,Parenteral use,41.9,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VERO 100 mg film-coated tablets,SILDENAFIL,2211211348,2016,100 mg,Film-coated tablet,Oral use,53.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
INVOKANA 100 mg film-coated tablet,CANAGLIFLOZIN,0703221821,2016,100 mg,Film-coated tablet,Oral use,159,JANSSEN - ORTHO,Puerto Rico,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
EPITAM 250 mg film-coated tablet,LEVETIRACETAM,2110211206,2016,250 mg,Film-coated tablet,Oral use,59.6,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EPITAM 500 mg film-coated tablet,LEVETIRACETAM,2010211205,2016,500 mg,Film-coated tablet,Oral use,82.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EPITAM 100 mg/ml syrup,LEVETIRACETAM,2010211204,2016,100 mg/ml,Syrup,Oral use,103.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DOBUTAMINE JPI 250 mg/20 ml solution for IV infusion,DOBUTAMINE,0911211295,2016,12.5 mg/ml,Solution for infusion,Intravenous use,31.55,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX ES 600 mg powder for oral suspension,"CLAVULANIC ACID, AMOXICILLIN",2503245085,2016,"42.9,600 mg",Powder for oral suspension,Oral use,29.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PROLAX ER 15 mg extended-release capsule,CYCLOBENZAPRINE HYDROCHLORIDE,0902221717,2016,15 mg,Extended-release capsule,Oral use,34.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PROLAX ER 30 mg extended-release capsule,CYCLOBENZAPRINE HYDROCHLORIDE,2401221631,2016,30 mg,Extended-release capsule,Oral use,69.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Avysk Plus 5/160 mg film-coated tablet,"VALSARTAN, AMLODIPINE BESILATE",0404221910,2016,"160,5 mg",Film-coated tablet,Oral use,51.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Avysk Plus 10/160 mg film-coated tablet,"VALSARTAN, AMLODIPINE BESILATE",1907222315,2016,"160,10 mg",Film-coated tablet,Oral use,56.6,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
LEVACIN 500 mg film-coated tablet,LEVOFLOXACIN,2907245683,2016,500 mg,Film-coated tablet,Oral use,40.4,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ARPENIA 15 mg tablet,ARIPIPRAZOLE,0512211426,2016,15 mg,Tablet,Oral use,248.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ARPENIA 10 mg tablet,ARIPIPRAZOLE,0712211434,2016,10 mg,Tablet,Oral use,200,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CRESCHOL 5 mg film-coated tablet,ROSUVASTATIN,2905222083,2016,5 mg,Film-coated tablet,Oral use,34,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CRESCHOL 10 mg film-coated tablet,ROSUVASTATIN,2905222081,2016,10 mg,Film-coated tablet,Oral use,61.3,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CRESCHOL 20 mg film-coated tablet,ROSUVASTATIN,2905222082,2016,20 mg,Film-coated tablet,Oral use,103.9,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
ZEMENTA 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,1212211465,2016,10 mg,Film-coated tablet,Oral use,101.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZEMENTA 20 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,1212211462,2016,20 mg,Film-coated tablet,Oral use,184.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GLANDY 30 mg film-coated tablet,CINACALCET,0711211266,2016,30 mg,Film-coated tablet,Oral use,636.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CALMTROL 1 mg film-coated tablet,RISPERIDONE,1005222012,2016,1 mg,Film-coated tablet,Oral use,58.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CALMTROL 2 mg film-coated tablet,RISPERIDONE,1005222010,2016,2 mg,Film-coated tablet,Oral use,58.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CALMTROL 4 mg film-coated tablet,RISPERIDONE,1005222009,2016,4 mg,Film-coated tablet,Oral use,142.30,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
RIBOMUSTIN 25 mg powder for concentrate for solution for infusion,BENDAMUSTINE HYDROCHLORIDE,1808222506,2016,25 mg,Powder for concentrate for solution for infusion,Intravenous use,1299.25,CENEXI-LABORATORIES,Belgium,ASTELLAS PHARMA,Germany,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
RIBOMUSTIN 100 mg powder for concentrate for solution for infusion,BENDAMUSTINE HYDROCHLORIDE,1808222508,2016,100 mg,Powder for concentrate for solution for infusion,Intravenous use,5196.75,CENEXI-LABORATORIES,Belgium,ASTELLAS PHARMA,Germany,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
RIBOMUSTIN 100 mg powder for concentrate for solution for infusion,BENDAMUSTINE HYDROCHLORIDE,1808222507,2016,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1039.35,CENEXI-LABORATORIES,Belgium,ASTELLAS PHARMA,Germany,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
CEFAJECT 500 mg IV,CEFTRIAXONE,2107222325,2016,500 mg,Powder for solution for injection/infusion,Intravenous use,23.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CEFAJECT 1 g IV,CEFTRIAXONE,2107222326,2016,1 g,Powder for solution for injection/infusion,Intravenous use,40.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CEFAJECT 500 mg IM,CEFTRIAXONE,2107222324,2016,500 mg,Powder for solution for injection/infusion,Intramuscular use,23.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CEFAJECT 1 g IM,CEFTRIAXONE,2107222327,2016,1 g,Powder for solution for injection/infusion,Intramuscular use,40.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
IBRANCE 75 mg capsule,PALBOCICLIB,1111211308,2016,75 mg,Capsule,Oral use,12172.95,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER,United States,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
IBRANCE 100 mg capsule,PALBOCICLIB,1111211306,2016,100 mg,Capsule,Oral use,12172.95,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER,United States,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ALOPEXY 5% topical solution,MINOXIDIL,1902256918,2015,5 %,Cutaneous solution,Topical,84.25,FAREVA PAU 1,France,PIERRE FABRE DERMATOLOGIE,France,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, Saudi Import Company - BANAJA"
ALOPEXY 5% topical solution,MINOXIDIL,1902256917,2015,5 %,Cutaneous solution,Topical,37.4,FAREVA PAU 1,France,PIERRE FABRE DERMATOLOGIE,France,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, Saudi Import Company - BANAJA"
HEROX 5 mg film-coated tablet,TADALAFIL,2307233916,2016,5 mg,Film-coated tablet,Oral use,186.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HEROX 5 mg film-coated tablet,TADALAFIL,2307233921,2016,5 mg,Film-coated tablet,Oral use,62.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HEROX 20 mg film-coated tablet,TADALAFIL,2307233915,2016,20 mg,Film-coated tablet,Oral use,80.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HEROX 20 mg film-coated tablet,TADALAFIL,2307233914,2016,20 mg,Film-coated tablet,Oral use,20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FORTA-Z 1 g powder for solution for injection,CEFTAZIDIME,2012211494,2016,1 g,powder for solution for injection,Parenteral use,38.95,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
DOMINE 40 mg/ml concentrate for solution for infusion,DOPAMINE HYDROCHLORIDE,2212211500,2016,40 mg/ml,Concentrate for solution for infusion,Intravenous use,113.85,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VEGA 100 mg film-coated tablet,SILDENAFIL,2209211074,2016,100 mg,Film-coated tablet,Oral use,43.7,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
GAZYVA 25 mg/ml concentrate for solution for infusion,OBINUTUZUMAB,2804245223,2016,25 mg/ml,Concentrate for solution for infusion,Intravenous use,14662.70,ROCHE DIAGNOSTICS,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
ENDOMETRIN 100 mg vafinal tablet,PROGESTERONE,3010222853,2016,100 mg,Vaginal tablet,Vaginal use,84.20,Sever Pharma Solutions AB,Sweden,FERRING,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LOCASONE M cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2907245682,2016,"2,0.1 %",Cream,Topical,21.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LERCADIP 20 mg film-coated tablet,LERCANIDIPINE HYDROCHLORIDE,2402221763,2016,20 mg,Film-coated tablet,Oral use,71.15,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LOCASONE M cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2907245686,2016,"2,0.1 %",Cream,Topical,35.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LOCASONE M cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2907245676,2016,"2,0.1 %",Cream,Topical,70.00,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ADACEL 0.5 ml suspension for injection,"TETANUS TOXOID, DIPHTHERIA TOXOID, ACELLULAR PERTUSSIS",2212223035,2016,"5,2,2.5 µg, LfU",Suspension,Intramuscular use,69.6,SANOFI PASTEUR,Canada,SANOFI PASTEUR,Canada,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
FORXIGA 10 mg film-coated tablet,DAPAGLIFLOZIN,7-5518-22,2016,10 mg,Film-coated tablet,Oral use,159,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FORXIGA 5 mg film-coated tablet,DAPAGLIFLOZIN,6-5518-22,2016,5 mg,Film-coated tablet,Oral use,159,AstraZeneca,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BUTRANS 5 mcg/hour transdermal patch,BUPRENORPHINE,3010222831,2016,5 mg,Transdermal patch,Transdermal use,95.5,LTS LOHMANN Therapie-Systeme,Germany,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
BUTRANS 10 mcg/hour transdermal patch,BUPRENORPHINE,3010222832,2016,10 mg,Transdermal patch,Transdermal use,173.65,LTS LOHMANN Therapie-Systeme,Germany,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
BUTRANS 20 mcg/hour transdermal patch,BUPRENORPHINE,3010222833,2016,20 mg,Transdermal patch,Transdermal use,301.95,LTS LOHMANN Therapie-Systeme,Germany,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
PLEGRIDY 125 mcg solution for injection,PEGINTERFERON BETA-1A,0912211448,2016,125 µg,Solution for injection in pre-filled pen,Subcutaneous use,3455.70,VETTER PHARMA,Germany,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Biogen Arabia, Salehiya Trading Co."
PLEGRIDY 63-94 mcg solution for injection,PEGINTERFERON BETA-1A,0912211449,2016,63 µg,Solution for injection in pre-filled pen,Subcutaneous use,3455.70,VETTER PHARMA,Germany,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Biogen Arabia, Salehiya Trading Co."
EPITAM 750 mg film-coated tablet,LEVETIRACETAM,227-334-16,2016,750 mg,Film-coated tablet,Oral use,123.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
G-PRIDE 3 mg tablet,GLIMEPIRIDE,2411211360,2016,3 mg,Tablet,Oral use,21.25,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LOCASONE M cream,"MICONAZOLE NITRATE, MOMETASONE FUROATE",2907245680,2016,"2,0.1 %",Cream,Topical,10.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
CIPROGRAM 250 mg film-coated tablet,CIPROFLOXACIN,1210211149,2016,250 mg,Film-coated tablet,Oral use,30.65,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
IBRANCE 125 mg capsule,PALBOCICLIB,1111211307,2016,125 mg,Capsule,Oral use,12172.95,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER,United States,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
PROF 400 mg,IBUPROFEN,2410211217,2016,100 mg/ml,Solution for infusion,Intravenous use,93.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
IROVEL PLUS 150/12.5 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0712211432,2016,"150,12.5 mg",Film-coated tablet,Oral use,48.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IROVEL PLUS 300/12.5 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0712211435,2016,"300,12.5 mg",Film-coated tablet,Oral use,58.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IROVEL PLUS 300/25 mg film-coated tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0712211436,2016,"300,25 mg",Film-coated tablet,Oral use,58.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LEVETAM 1000 mg film-coated tablet,LEVETIRACETAM,2306222255,2016,1000 mg,Film-coated tablet,Oral use,178.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CREVAST 5 mg film-coated tablet,ROSUVASTATIN,0103221772,2016,5 mg,Film-coated tablet,Oral use,30.6,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CREVAST 10 mg film-coated tablet,ROSUVASTATIN,0103221775,2016,10 mg,Film-coated tablet,Oral use,55.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CREVAST 20 mg film-coated tablet,ROSUVASTATIN,0103221773,2016,20 mg,Film-coated tablet,Oral use,93.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CREVAST 40 mg film-coated tablet,ROSUVASTATIN,0103221774,2016,40 mg,Film-coated tablet,Oral use,183,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AVONEX 30 mcg/0.5 ml pre-filled pen,INTERFERON BETA-1A,2311211353,2016,30 µg,Solution for injection,Intramuscular use,3329.40,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Biogen Arabia, Salehiya Trading Co."
TECFIDERA 240 mg capsule,Dimethyl Fumarate,2009211069,2016,240 mg,Capsule,Oral use,4558.15,CORDEN PHARMA FRIBOURG AG,Switzerland,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Biogen Arabia, Salehiya Trading Co."
TECFIDERA 120 mg capsule,Dimethyl Fumarate,2009211070,2016,120 mg,Capsule,Oral use,569.75,CORDEN PHARMA FRIBOURG AG,Switzerland,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Biogen Arabia, Salehiya Trading Co."
OXYCONTIN 15 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234040,2016,15 mg,Prolonged-release tablet,Oral use,297.20,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYCONTIN 20 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234039,2016,20 mg,Prolonged-release tablet,Oral use,379.70,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYCONTIN 30 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234041,2016,30 mg,Prolonged-release tablet,Oral use,537.55,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYCONTIN 40 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234043,2016,40 mg,Prolonged-release tablet,Oral use,673.45,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OXYCONTIN 60 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234044,2016,60 mg,Prolonged-release tablet,Oral use,980.55,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
0.4% LIDOCAINE HCL AND 5% DEXTROSE IV infusion USP,"DEXTROSE, LIDOCAINE HYDROCHLORIDE",1210222707,2016,"5,0.4 %",Solution,Intravenous use,35,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
CLOPRAM 10 mg/2 ml solution for injection,METOCLOPRAMIDE HYDROCHLORIDE,0911211294,2016,5 mg/ml,Solution for injection,Intramuscular and intravenous use,9,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CONTRA 15/200 mg softgel capsule,"DEXTROMETHORPHAN, GUAIFENESIN",2104221966,2016,"15,200 mg","Capsule, soft",Oral use,29.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ELOXATIN 50MG VIAL,OXALIPLATIN,54-23-17,2017,50 mg,Concentrate for solution for infusion,Intravenous use,966.1,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS DEUTSCHLAND GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
ELOCTA 3000 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222826,2017,3000 IU,Powder and solvent for solution for injection,Intravenous use,8878.35,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
CANESTEN SOLUTION 1%,CLOTRIMAZOLE,1312211469,2017,1 %,Cutaneous solution,Topical,16.15,KVP PHARMA,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
CANESTEN CREAM 1%,CLOTRIMAZOLE,1312211468,2017,1 %,Cream,Topical,16.15,GP Grenzach Produktion GmbH (GP),Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
CANESTEN-1 VAG. CREAM 10%,CLOTRIMAZOLE,1203233353,2017,10 %,Vaginal cream,Vaginal use,29.2,Kern Pharma S.L.,Spain,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
ASPIRIN EFFERVESCENT WITH VITAMIN C,"ACETYLSALICYLIC ACID, ASCORBIC ACID",11-949-17,2017,"400,240 mg",Effervescent tablet,Oral use,8.15,Bayer Bitterfeld GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
TYKERB 250MG F.C. TABLETS,LAPATINIB,0605257344,2016,250 mg,Film-coated tablet,Oral use,3374.80,GLAXO OPERATION,United Kingdom,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
REVOLADE 25MG FILM COATED TABLET,ELTROMBOPAG OLAMINE,2307257814,2016,25 mg,Film-coated tablet,Oral use,2469.80,"Siegfried Barbera, S.L",Spain,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
REVOLADE 50MG FILM COATED TABLET,ELTROMBOPAG OLAMINE,2307257815,2016,50 mg,Film-coated tablet,Oral use,4939.70,Siegfried Barbera S.L,Spain,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ZOFRAN 8 mg tablet,ONDANSETRON,7-5773-23,2017,8 mg,Film-coated tablet,Oral use,145.05,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
POTASSIUM CHLORIDE in  DEXTROSE and  SODIUM CHLORIDE Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",460-149-16,2016,"5,0.2,0.15 %",Solution,Intravenous use,31.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
POTASSIUM CHLORIDE in DEXTROSE and SODIUM CHLORIDE Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",1210222715,2016,"5,0.45,0.15 %",Solution,Intravenous use,31.6,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
POTASSIUM CHLORIDE in DEXTROSE and SODIUM CHLORIDE Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",1210222710,2016,"5,0.45,0.15 %",Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
ESBRIET 267 mg HARD CAPSULES,PIRFENIDONE,283-24-16,2016,267 mg,"Capsule, hard",Oral use,7342.55,CATALENT PHARMA SOLUTIONS,United States,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
OZAPIN 5 mg orally disintegrating tablet,OLANZAPINE,2205233687,2017,5 mg,Orodispersible tablet,Oral use,107.90,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
OZAPIN 10 mg orally disintegrating tablet,OLANZAPINE,2205233688,2017,10 mg,Orodispersible tablet,Oral use,177,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
DARZALEX 100 mg per 5 ml,DARATUMUMAB,0602233215,2017,20 mg/ml,Concentrate for solution for infusion,Intravenous use,1816.60,"Cilag AG, Schaffhausen, Switzerland",Switzerland,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
DARZALEX 400 mg per 20 ml,DARATUMUMAB,0602233214,2017,20 mg/ml,Concentrate for solution for infusion,Intravenous use,7266.50,"Cilag AG, Schaffhausen, Switzerland",Switzerland,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
TAVFLOX 500 mg film-coated tablet,LEVOFLOXACIN,2007222321,2017,500 mg,Film-coated tablet,Oral use,40.4,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
QUETAL 50 mg XR extended-release tablet,QUETIAPINE,0908222455,2017,50 mg,Extended-release tablet,Oral use,33.8,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MIDIXIME 100MG\5ML,CEFIXIME,2102233278,2017,20 mg/ml,Powder for oral suspension,Oral use,28.5,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
ELOCTA 2000 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222829,2017,2000 IU,Powder and solvent for solution for injection,Intravenous use,5918.70,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ELOCTA 1500 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222825,2017,1500 IU,Powder and solvent for solution for injection,Intravenous use,4438.85,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ELOCTA 1000 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222827,2017,1000 IU,Powder and solvent for solution for injection,Intravenous use,2959.05,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ELOCTA 500 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222828,2017,500 IU,Powder and solvent for solution for injection,Intravenous use,1479.25,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
VENCLEXTA 100 mg film-coated tablet,VENETOCLAX,2707222354,2017,100 mg,Film-coated tablet,Oral use,31020.00,ABBVIE IRELAND NL B.V.,Ireland,ABBVIE Inc.,United States,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
DIPHERELINE P.R. 11.25 mg Powder for Suspension for Injection,TRIPTORELIN,0112222955,2017,11.25 mg,Powder and solvent for suspension for injection,Intramuscular use,1204,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
LAVIE ORAL SOLUTION 150 ML,LEVETIRACETAM,2809222657,2017,100 mg/ml,Oral solution,Oral use,92.9,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ROZAVI 10 mg film-coated tablet,ROSUVASTATIN,2906222289,2017,10 mg,Film-coated tablet,Oral use,51.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ROZAVI 20 mg film-coated tablet,ROSUVASTATIN,2906222288,2017,20 mg,Film-coated tablet,Oral use,87.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RUCORON 50MG\5ML SOLUTION FOR IV BOLUS OR INFUSION,ROCURONIUM BROMIDE,1406222190,2017,10 mg/ml,Solution for injection,Intravenous use,182.8,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
DOBUTAMINE JPI 250 mg/20 ml solution for IV infusion,DOBUTAMINE,1406222191,2017,12.5 mg/ml,Solution for infusion,Intravenous use,203.1,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
DOROFEN 500-50 MG CAPSULE,"GLUCOSAMINE SULFATE, GINKGO BILOBA",2305233707,2017,"500,50 mg",Capsule,Oral use,81.9,LIPTIS PHARMACEUTICALS,United States,LIPTIS PHARMACEUTICALS,United States,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ESSENTIAL D-3 5000 IU CAPSULE,COLECALCIFEROL,3009222681,2017,5000 IU,Capsule,Oral use,33,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,Prescription,store below 30°c,Pharmacy,GULF NEOCARE
ESSENTIAL D-3 10000 IU CAPSULE,COLECALCIFEROL,3009222680,2017,10000 IU,Capsule,Oral use,38.45,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,Prescription,store below 30°c,Pharmacy,GULF NEOCARE
VENCLEXTA 10 mg / 50 mg / 100 mg film-coated tablet,VENETOCLAX,2707222353,2017,"10, 50, 100 mg",Film-coated tablet,Oral use,6695.15,ABBVIE IRELAND NL B.V.,Ireland,ABBVIE Inc.,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TIMOLOL 0.5% OPHTHALMIC SOLUTION,TIMOLOL MALEATE,3001244811,2017,0.5 %,Ophthalmic solution,Ophthalmic use,35.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VIMPAT 10 mg/ml SYRUP,LACOSAMIDE,2607222351,2017,10 mg/ml,Syrup,Oral use,96.80,Unither Manufacturing LLC,United States,U.C.B.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
NUROFEN 400 DOUBLE STRENGTH TABLET,IBUPROFEN,2101244775,2017,400 mg,Coated tablet,Oral use,7.20,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER PTY LTD,Australia,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
EFRAM XR 500 mg TABLET,LEVETIRACETAM,1108257991,2017,500 mg,Extended-release tablet,Oral use,91.5,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
EFRAM XR 750 mg TABLET,LEVETIRACETAM,1108257984,2017,750 mg,Extended-release tablet,Oral use,137.2,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LEVETAM XR 500 mg TABLET,LEVETIRACETAM,0311222871,2017,500 mg,Extended-release tablet,Oral use,101.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ELIGARD 7.5 MG POWDER FOR SOLUTION FOR INJECTION,LEUPRORELIN,2504245205,2016,7.5 mg,Powder and solvent for solution for injection,Subcutaneous use,313.90,TOLMAR INC.,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION,LEUPRORELIN,2504245206,2016,22.5 mg,Powder and solvent for solution for injection,Subcutaneous use,796.80,TOLMAR INC.,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ELIGARD 45 MG POWDER FOR SOLUTION FOR INJECTION,LEUPRORELIN,2504245207,2016,45 mg,Powder and solvent for solution for injection,Subcutaneous use,1750.85,TOLMAR INC.,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ORFADIN 2 MG CAPSULE,NITISINONE,0708222414,2017,2 mg,"Capsule, hard",Oral use,2970.50,APOTEK PRODUKTION & LABORATORIER AB,Sweden,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Arabian Trade House
ORFADIN 5 MG CAPSULE,NITISINONE,0708222417,2017,5 mg,"Capsule, hard",Oral use,6169.30,APOTEK PRODUKTION & LABORATORIER AB,Sweden,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Arabian Trade House
ORFADIN 10 MG CAPSULE,NITISINONE,0708222415,2017,10 mg,"Capsule, hard",Oral use,11160.45,APOTEK PRODUKTION & LABORATORIER AB,Sweden,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Arabian Trade House
ORFADIN 20 MG CAPSULE,NITISINONE,0708222413,2017,20 mg,"Capsule, hard",Oral use,23260.70,APOTEK PRODUKTION & LABORATORIER AB,Sweden,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Arabian Trade House
ELOCTA 250 IU POWDER FOR SOLUTION FOR INJECTION,EFMOROCTOCOG ALFA,2610222824,2017,250 IU,Powder and solvent for solution for injection,Intravenous use,739.30,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
0.18% SODIUM CHLORIDE and 5% DEXTROSE intravenous infusion,"DEXTROSE, SODIUM CHLORIDE",1210222714,2017,"5,0.18 %",Solution,Intravenous use,5.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VIMPAT 10 mg/ml SOLUTION FOR INFUSION,LACOSAMIDE,2607222350,2017,10 mg/ml,Solution for infusion,Intravenous use,517.70,Patheon Italia S.P.A.,Italy,U.C.B.,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
VULGA 80 mg XR film-coated tablet,MINOCYCLINE,2610222816,2017,80 mg,Prolonged-release tablet,Oral use,100,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VULGA 105 mg XR film-coated tablet,MINOCYCLINE,2510222803,2017,105 mg,Prolonged-release tablet,Oral use,130,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
KEPPRA 1000MG F.C.TAB,LEVETIRACETAM,2701256757,2017,1000 mg,Film-coated tablet,Oral use,231.7,U.C.B.,Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
KEPPRA 100MG-ML ORAL SOLUTION,LEVETIRACETAM,2701256759,2008,100 mg/ml,Oral solution,Oral use,282.3,NEXT PHARMA,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CANESTEN VAGINAL TAB 100MG,CLOTRIMAZOLE,1312211470,2017,100 mg,Vaginal tablet,Vaginal use,21.70,Haupt Pharma Wulfing GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Bayer Saudi Arabia
MYLERAN,BUSULFAN,2011246303,2017,2 mg,Tablet,Oral use,877.25,EXCELLA GmbH & Co. KG,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
OXYCONTIN 10 mg controlled release tablet,OXYCODONE HYDROCHLORIDE,2408234042,2016,10 mg,Prolonged-release tablet,Oral use,207.70,PURDUE PHARMACEUTICALS LP,United States,PURDUE PHARMA LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CENTRUM SILVER TABLETS,"IODINE, SELENIUM SULFIDE, CHROMIUM CHLORIDE HEXAHYDRATE, FOLIC ACID, CALCIUM PHOSPHATE, PHOSPHORUS, BIOTIN, ASCORBIC ACID, FERROUS FUMARATE, SODIUM MOLYBDATE, VITAMIN K1, NICOTINAMIDE, DL-ALPHA TOCOFERIL ACETATE, BETA CAROTENE, COPPER, MANGANESE, MAGNESIUM OXIDE, CYANOCOBALAMIN, RIBOFLAVIN (VITAMIN B2), PYRIDOXINE (VITAMIN B6), ZINC OXIDE, PANTOTHENIC ACID, LUTEIN, POTASSIUM CHLORIDE, THIAMINE, COLECALCIFEROL (VITAMIN D3)",2507245659,2017,"100,30,40,195,162,125,100,60,10,50,30,18,14.9,4000,0.5,1,50,1,1.6,2,5,6,1000,40,1.4,400 mg, IU, µg",Film-coated tablet,Oral use,20.4,PFIZER,Canada,GlaxoSmithKline Consumer Healthcare ULC,Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
CENTRUM SILVER TABLETS,"BETA CAROTENE, LUTEIN, COLECALCIFEROL (VITAMIN D3), FOLIC ACID, CALCIUM PHOSPHATE, PHOSPHORUS, BIOTIN, IODINE, ASCORBIC ACID, MAGNESIUM OXIDE, SODIUM MOLYBDATE, CHROMIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, VITAMIN K1, SELENIUM SULFIDE, NICOTINAMIDE, DL-ALPHA TOCOFERIL ACETATE, FERROUS FUMARATE, PANTOTHENIC ACID, ZINC OXIDE, PYRIDOXINE (VITAMIN B6), RIBOFLAVIN (VITAMIN B2), THIAMINE, CYANOCOBALAMIN, MANGANESE, COPPER",2507245660,2017,"4000,1000,400,195,162,125,100,100,60,50,50,40,40,30,30,18,14.9,10,6,5,2,1.6,1.4,1,1,0.5 mg, IU, µg",Film-coated tablet,Oral use,55,PFIZER,Canada,GlaxoSmithKline Consumer Healthcare ULC,Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
CENTRUM WITH LUTEIN TABLETS,"BETA CAROTENE, LUTEIN, COLECALCIFEROL (VITAMIN D3), FOLIC ACID, CALCIUM PHOSPHATE, PHOSPHORUS, IODINE, BIOTIN, ASCORBIC ACID, SODIUM MOLYBDATE, POTASSIUM CHLORIDE, CHROMIUM CHLORIDE HEXAHYDRATE, VITAMIN K1, SELENIUM SULFIDE, NICOTINAMIDE, FERROUS FUMARATE, PANTOTHENIC ACID, ZINC OXIDE, PYRIDOXINE (VITAMIN B6), RIBOFLAVIN (VITAMIN B2), THIAMINE, CYANOCOBALAMIN, MANGANESE, COPPER",0608245732,2017,"4000,250,200,195,162,125,100,100,60,50,40,40,30,30,18,10,6,5,2,1.6,1.4,1,1,0.5 mg, IU, µg",Film-coated tablet,Oral use,20.4,PF Consumer Healthcare Canada ULC,Canada,GlaxoSmithKline Consumer Healthcare ULC,Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
CENTRUM WITH LUTEIN TABLETS,"COPPER, MANGANESE, CYANOCOBALAMIN, THIAMINE, RIBOFLAVIN (VITAMIN B2), PYRIDOXINE (VITAMIN B6), ZINC OXIDE, PANTOTHENIC ACID, FERROUS FUMARATE, SELENIUM SULFIDE, CHROMIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM MOLYBDATE, ASCORBIC ACID, BIOTIN, IODINE, PHOSPHORUS, CALCIUM PHOSPHATE, FOLIC ACID, COLECALCIFEROL (VITAMIN D3), LUTEIN, BETA CAROTENE, VITAMIN K1, NICOTINAMIDE",0608245731,2017,"0.5,1,1,1.4,1.6,2,5,6,10,30,40,40,50,60,100,100,125,162,195,200,250,4000,30,18 mg, IU, µg",Film-coated tablet,Oral use,55,PF Consumer Healthcare Canada ULC,Canada,GlaxoSmithKline Consumer Healthcare ULC,Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
MIRTAZA 30 mg film-coated tablet,MIRTAZAPINE,2609222644,2017,30 mg,Film-coated tablet,Oral use,64.5,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MIRTAZA 15 mg film-coated tablet,MIRTAZAPINE,2609222649,2017,15 mg,Film-coated tablet,Oral use,38.05,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Australia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CAPRELSA 100 mg film-coated tablet,VANDETANIB,2102233282,2017,100 mg,Film-coated tablet,Oral use,7149.00,IPR PHARMACEUTICALS INC.,Puerto Rico,GENZYME EUROPE B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
CAPRELSA 300 mg film-coated tablet,VANDETANIB,2102233283,2017,300 mg,Film-coated tablet,Oral use,19053.40,IPR PHARMACEUTICALS INC.,Puerto Rico,GENZYME EUROPE B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
MOVICOL SACHET POWDER FOR RECONSTITUTION,"MACROGOL, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE",1012258769,2017,"13.8,350.7,178.5,46.6 mg, g",Powder for oral solution,Oral use,35.30,NORGINE,United Kingdom,ACINO PHARMA AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
TELFAST 180 MG FILM COATED TAB,FEXOFENADINE HYDROCHLORIDE,2-5893-23,2017,180 mg,Film-coated tablet,Oral use,28.65,SANOFI WINTHROP INDUSTRIE,France,Sanofi Consumer Healthcare,Australia,Marketed,OTC,store below 30°c,Pharmacy,Opella Arabia Limited Co
TIMOPTOL .DROPS,TIMOLOL MALEATE,2205233682,2017,0.25 %,"Eye drops, solution",Ocular use,27.25,FAREVA MIRABEL,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
TIMOPTOL .DROPS,TIMOLOL MALEATE,1302233234,2017,0.5 %,"Eye drops, solution",Ocular use,33.1,FAREVA MIRABEL,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
TYSABRI 300 MG/15ML,NATALIZUMAB,5-5547-21,2017,20 mg/ml,Concentrate for solution for infusion,Intravenous use,5558.25,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Biogen Arabia, Salehiya Trading Co."
BENZAFLEX 5 mg Film-Coated Tablets,CYCLOBENZAPRINE HYDROCHLORIDE,2010222765,2016,5 mg,Film-coated tablet,Oral use,11.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
BENZAFLEX 10 mg Film-Coated Tablets,CYCLOBENZAPRINE HYDROCHLORIDE,0206222129,2016,10 mg,Film-coated tablet,Oral use,23.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LEVANIX 500 mg film-coated tablet,LEVOFLOXACIN,13-584-17,2017,500 mg,Film-coated tablet,Oral use,40.4,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
KEPPRA 250MG F.C.TAB,LEVETIRACETAM,2701256756,2017,250 mg,Film-coated tablet,Oral use,81.5,U.C.B.,Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
KEPPRA 500MG F.C.TAB,LEVETIRACETAM,2701256758,2017,500 mg,Film-coated tablet,Oral use,141.7,U.C.B.,Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VULGA 55 mg XR film-coated tablet,MINOCYCLINE,2610222810,2017,55 mg,Prolonged-release tablet,Oral use,70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEUKAST 4 mg chewable tablet,MONTELUKAST SODIUM,244-334-17,2017,4 mg,Chewable tablet,Oral use,64.3,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEUKAST 5 mg chewable tablet,MONTELUKAST SODIUM,245-334-17,2017,5 mg,Chewable tablet,Oral use,64.3,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
POSICAINE 200 INJECTION,"ARTICAINE, NOREPINEPHRINE BITARTRATE",0707245485,2016,"40,0.009 mg/ml",Injection,Parenteral use,71.50,NOVOCOL,Canada,NOVOCOL,Canada,Marketed,Prescription,store below 25°c,Hospital,AL RAZI MEDICAL SUPPLIES
LOTEVAN PLUS 5MG/160MG/12.5MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2011246298,2017,"160,12.5,5 mg",Film-coated tablet,Oral use,63.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN PLUS 5MG/160MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2011246296,2017,"160,25,5 mg",Film-coated tablet,Oral use,63.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN PLUS10MG/160MG/12.5MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2011246301,2017,"160,12.5,10 mg",Film-coated tablet,Oral use,74.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN PLUS 10MG/160MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2011246302,2017,"160,25,10 mg",Film-coated tablet,Oral use,74.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LOTEVAN PLUS 10MG/320MG/25MG FILM COATED TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2011246294,2017,"320,25,10 mg",Film-coated tablet,Oral use,99.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
AGRIPLAT 12.5 MG SOLUTION FOR INFUSION,TIROFIBAN,0308222393,2017,0.25 mg/ml,Concentrate for solution for infusion,Intravenous use,796.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LEVERA 60 mg film-coated tablet,DACLATASVIR,2505233732,2017,60 mg,Film-coated tablet,Oral use,5600,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
RESOLOR 1 mg film-coated tablet,PRUCALOPRIDE,0502233210,2016,1 mg,Film-coated tablet,Oral use,98.40,JANSSEN-CILAG SPA,Italy,Amdipharm Mercury (Australia) Pty Limited,Australia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IRESSA 250 mg film coated tablet,GEFITINIB,0408222399,2016,250 mg,Film-coated tablet,Oral use,4437.65,ASTRAZENECA UK LIMITED,United Kingdom,AstraZeneca,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ZEMPLAR 1 mcg Capsule,PARICALCITOL,3010222849,2016,1 µg,Capsule,Oral use,419.40,CATALENT PHARMA SOLUTIONS,United States,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
ZEMPLAR 2 mcg Capsule,PARICALCITOL,1004233519,2016,2 µg,Capsule,Oral use,852.45,CATALENT PHARMA SOLUTIONS,United States,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
OCUDINE 0.15% EYE DROPS SOLUTION,BRIMONIDINE TARTRATE,3001244812,2017,0.15 %,Ophthalmic solution,Ophthalmic use,34.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
NEVOTIC 500 mg film-coated tablet,LEVOFLOXACIN,0408222411,2017,500 mg,Film-coated tablet,Oral use,47.6,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ZYLANZA 5 mg Orodispersible Tablet,OLANZAPINE,1907233884,2017,5 mg,Orodispersible tablet,Oral use,64.4,GENEPHARM S.A.,Greece,GENEPHARM S.A,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
ZYLANZA 10 mg Orodispersible Tablet,OLANZAPINE,1907233883,2017,10 mg,Orodispersible tablet,Oral use,118.8,GENEPHARM S.A.,Greece,GENEPHARM S.A,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
ADRENALINE/EPINEPHRINE INJ 1:1000 INJECTION,ADRENALINE,1810222749,2016,1 mg/ml,Solution for injection,Intramuscular use,19.15,MACARTHYS LABORATORIES LIMITED T\A MARTINDALE PHARMA,United Kingdom,MARTINDALE PHARMACEUTICALS LTD TRADING AS MARTINDALE PHARMA,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
SEFARIX 125mg/5ml Powder For Suspension,CEFDINIR,2507222349,2017,25 mg/ml,Powder for oral suspension,Oral use,41.85,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
SEFARIX 125mg/5ml Powder For Suspension,CEFDINIR,2107222340,2017,25 mg/ml,Powder for oral suspension,Oral use,65.3,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
RESOLOR 2 mg film-coated tablet,PRUCALOPRIDE,0502233211,2016,2 mg,Film-coated tablet,Oral use,161.75,JANSSEN-CILAG SPA,Italy,Amdipharm Mercury (Australia) Pty Limited,Australia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SAXENDA 6 mg/ml sloution for injection in pre-filled pen,LIRAGLUTIDE,2606222257,2016,6 mg/ml,Solution for injection,Subcutaneous use,709.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
CLOVAINE 10% w/wgel,BENZOCAINE,2808245837,2016,10 %,Gel,Topical,18.8,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
TENORYL 5 MG film-coated tablet,PERINDOPRIL ARGININE,2205222048,2016,5 mg,Film-coated tablet,Oral use,31.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TENORYL 10 MG film-coated tablet,PERINDOPRIL ARGININE,2205222047,2016,10 mg,Film-coated tablet,Oral use,40.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
GAMUNEX 10% solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2106222228,2016,10 %,Solution for infusion,"Intravenous, Subcutaneous",1120.70,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
GAMUNEX 10% solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2106222230,2016,10 %,Solution for infusion,"Intravenous, Subcutaneous",2241.40,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
GAMUNEX 10% solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2106222231,2016,10 %,Solution for infusion,"Intravenous, Subcutaneous",4482.80,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
REPLAGAL 1mg/ml concetrate for solution for infusion,AGALSIDASE ALFA,1905222044,2016,1 mg/ml,Concentrate for solution for infusion,Intravenous use,7509.56,Cangene BioPharma Inc. (CBI),United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Salehiya Trading Co."
TRIUMEQ 50mg/600mg/300mg film-coated tablet,"DOLUTEGRAVIR, LAMIVUDINE, ABACAVIR",1310222734,2016,"50,300,600 mg",Film-coated tablet,Oral use,3128.80,Delpharm Poznan,Poland,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
AERRANE LIQUID FOR INHALATION,ISOFLURANE,2305233696,2017,,"Inhalation vapour, liquid",Inhalation use,406.50,BAXTER HEALTHCARE,Puerto Rico,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
D-CURA 2500 IU oral ampule,CHOLECALCIFEROL,0202221672,2016,25000 IU,Solution,Oral use,26.25,SMB Technology SA,Belgium,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
VOTRIENT,PAZOPANIB HYDROCHLORIDE,0907245517,2016,200 mg,Film-coated tablet,Oral use,1267.95,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VOTRIENT,PAZOPANIB HYDROCHLORIDE,0907245516,2016,400 mg,Film-coated tablet,Oral use,2910.90,Novartis Pharmaceutical Manufacturing LLC,Slovenia,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ZOFRAN 4 mg tablet,ONDANSETRON,6-5773-23,2017,4 mg,Film-coated tablet,Oral use,100.80,GLAXO SAUDI ARABIA,Saudi Arabia,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZOFRAN,ONDANSETRON,1603233377,2017,0.8 mg/ml,Oral solution,Oral use,104.90,GLAXOSMITHKLINE (GSK),Canada,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZOFRAN MELT 4MG ORAL LYOPHILISATE TABLET,ONDANSETRON,8-5773-23,2017,4 mg,Oral lyophilisate,Oral use,110.35,CATALENT,United Kingdom,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZOFRAN MELT 8MG ORAL LYOPHILISATE TABLET,ONDANSETRON,2706245453,2017,8 mg,Oral lyophilisate,Oral use,178.25,CATALENT,United Kingdom,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BRINTELLIX 10 mg film-coated tablet,VORTIOXETINE,0305233585,2016,10 mg,Film-coated tablet,Oral use,140.65,H. LUNDBECK,Denmark,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BRINTELLIX 20 mg film-coated tablet,VORTIOXETINE,1704233552,2016,20 mg,Film-coated tablet,Oral use,234.40,H. LUNDBECK,Denmark,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
INVOKANA 300 mg film-coated tablet,CANAGLIFLOZIN,2106222241,2016,300 mg,Film-coated tablet,Oral use,159,JANSSEN - ORTHO,Puerto Rico,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
HYCAMTIN 4MG I.V. VIAL,TOPOTECAN,3-5773-23,2016,4 mg,Powder for concentrate for solution for infusion,Intravenous use,489.85,GLAXO SMITHKLINE MANUFACTURING S.P.A.,Italy,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
PRISMASOL 2 mmol/l POTASSIUM SOLUTION FOR HAEMO/HAEMOFI,"LACTIC ACID, SODIUM HYDROGEN CARBONATE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, GLUCOSE, SODIUM CHLORIDE",0709222591,2016,"5.4,3.090,2.033,5.145,0.157,22,6.45 g/l",Solution for haemodialysis/haemofiltration,Intravenous use,128.8,Bieffe Medital S.p.A,Italy,BAXTER HOLDING B.V,Netherlands,Marketed,Prescription,store between (4°c – 30°c),Hospital,"Farouk, Maamoun Tamer & CO"
GLUCARE 1000 mg XR Tablet,METFORMIN HYDROCHLORIDE,0908222454,2016,1000 mg,Extended-release tablet,Oral use,56.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVONIC 250 mg film-coated tablet,LEVOFLOXACIN,0908222453,2016,250 mg,Film-coated tablet,Oral use,28.9,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVON 500 mg film-coated tablet,LEVOFLOXACIN,1108257998,2016,500 mg,Film-coated tablet,Oral use,40.4,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LEVON 750 mg film-coated tablet,LEVOFLOXACIN,1108258006,2016,750 mg,Film-coated tablet,Oral use,58.25,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
OLENZA 5 mg orally disintegrating tablet,OLANZAPINE,1508222493,2016,5 mg,"Tablet, orally disintegrating",Oral use,128.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
OLENZA 10 mg orally disintegrating tablet,OLANZAPINE,1508222494,2016,10 mg,"Tablet, orally disintegrating",Oral use,210.50,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
OLENZA 15 mg orally disintegrating tablet,OLANZAPINE,1508222490,2016,15 mg,"Tablet, orally disintegrating",Oral use,315.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,2305222050,2016,5 %,Solution for infusion,Intravenous use,224.15,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,0108222377,2016,5 %,Solution for infusion,Intravenous use,1120.70,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
LEVONIC 750 mg film-coated tablet,LEVOFLOXACIN,0408222402,2016,750 mg,Film-coated tablet,Oral use,64.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,0108222378,2016,5 %,Solution for infusion,Intravenous use,2241.40,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,0108222379,2016,5 %,Solution for infusion,Intravenous use,8965.60,INSTITUTO GRIFOLS,Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
0.3% POTASSIUM CHLORIDE in 5% DEXTROSE Injection USP,"DEXTROSE, POTASSIUM CHLORIDE",438-149-16,2016,"5,0.3 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.3% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",439-149-16,2016,"0.9,0.3 %",Solution for infusion,Intravenous use,8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.3% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",0109222574,2016,"0.9,0.3 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.075% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",443-149-16,2016,"0.9,0.075 %",Solution for infusion,Intravenous use,8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.075% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",444-149-16,2016,"0.9,0.075 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.22% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",445-149-16,2016,"0.9,0.22 %",Solution for infusion,Intravenous use,8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.22% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",446-149-16,2016,"0.9,0.22 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.15% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",447-149-16,2016,"0.9,0.15 %",Solution for infusion,Intravenous use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.15% POTASSIUM CHLORIDE in 0.9% SODIUM CHLORIDE Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",1210222709,2016,"0.9,0.15 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
0.075% POTASSIUM CHLORIDE in 5% DEXTROSE and 0.45% SODIUM CHLORIDE Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",449-149-16,2016,"5,0.45,0.075 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
ZOLEDRON 4 mg per 5 ml,ZOLEDRONIC ACID,2405233713,2016,0.8 mg/ml,Solution for injection,Intravenous use,713.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
FLEBOGAMMA 5% DIF SOLUTION FOR INFUSION,NORMAL HUMAN IMMUNOGLOBULIN,0108222376,2016,5 %,Solution for infusion,Intravenous use,4482.80,"Instituto Grifols, S.A.",Spain,INSTITUTO GRIFOLS,Spain,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
PRISMASOL 4 mmol/l POTASSIUM SOLUTION FOR HAEMO/HAEMOFI,"SODIUM CHLORIDE, CALCIUM CHLORIDE, LACTIC ACID, POTASSIUM CHLORIDE, SODIUM HYDROGEN CARBONATE, GLUCOSE, MAGNESIUM CHLORIDE",0709222592,2016,"6.45,5.145,5.4,0.314,3.090,22,2.033 g/l",Solution for haemodialysis/haemofiltration,Intravenous use,128.8,Bieffe Medital S.p.A,Italy,BAXTER HOLDING B.V,Netherlands,Marketed,Prescription,store between (4°c – 30°c),Hospital,"Farouk, Maamoun Tamer & CO"
ARPENIA 15 mg ORODISPERSIBLE TABLET,ARIPIPRAZOLE,2307233910,2016,15 mg,Orodispersible tablet,Oral use,248.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PRINCEOXIN 250 mg film-coated tablet,LEVOFLOXACIN,0908222439,2017,250 mg,Film-coated tablet,Oral use,17,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PREGA 50 MG CAPSULE,PREGABALIN,2907245689,2017,50 mg,"Capsule, hard",Oral use,45.1,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 75 MG CAPSULE,PREGABALIN,2907245674,2017,75 mg,"Capsule, hard",Oral use,42.8,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 75 MG CAPSULE,PREGABALIN,2907245677,2017,75 mg,"Capsule, hard",Oral use,64.2,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 150 MG CAPSULE,PREGABALIN,2907245684,2017,150 mg,"Capsule, hard",Oral use,82.9,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 150 MG CAPSULE,PREGABALIN,2907245688,2017,150 mg,"Capsule, hard",Oral use,165.8,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 300 MG CAPSULE,PREGABALIN,1208245757,2017,300 mg,"Capsule, hard",Oral use,116.4,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
PREGA 300 MG CAPSULE,PREGABALIN,1208245759,2017,300 mg,"Capsule, hard",Oral use,232.8,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
TAPCLOB 5MG/5ML ORAL SUSPENSION,CLOBAZAM,1602233255,2017,1 mg/ml,Suspension,Oral use,420.70,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MARTINDALE PHARMACEUTICALS LTD TRADING AS MARTINDALE PHARMA,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
TAPCLOB 10MG/5ML ORAL SUSPENSION,CLOBAZAM,1602233254,2017,2 mg/ml,Suspension,Oral use,447.20,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MARTINDALE PHARMACEUTICALS LTD TRADING AS MARTINDALE PHARMA,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
ESSERA 50 mg film-coated tablet,SILDENAFIL,1108258000,2016,50 mg,Film-coated tablet,Oral use,43.7,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
ESSERA 100 mg film-coated tablet,SILDENAFIL,1108257994,2016,100 mg,Film-coated tablet,Oral use,43.7,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
PRINCEOXIN 500 mg film-coated tablet,LEVOFLOXACIN,0908222438,2017,500 mg,Film-coated tablet,Oral use,34,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Risilud 0.05% NASAL SPRAY,MOMETASONE FUROATE,2807222361,2017,0.05 %,Spray,Nasal use,22.65,LEK PHARMACEUTICALS D.D.,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
LOCASONE S OINTMENT,"SALICYLIC ACID, MOMETASONE FUROATE",2907245675,2017,"5,0.1 %",Ointment,Topical,11.5,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LOCASONE S OINTMENT,"SALICYLIC ACID, MOMETASONE FUROATE",2907245687,2017,"5,0.1 %",Ointment,Topical,38.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
LOCASONE S OINTMENT,"SALICYLIC ACID, MOMETASONE FUROATE",2907245679,2017,"5,0.1 %",Ointment,Topical,76.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ESSENTIAL D-3 50000 IU CAPSULE,COLECALCIFEROL,0410222686,2017,50000 IU,Capsule,Oral use,38.45,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,Prescription,store below 30°c,Pharmacy,GULF NEOCARE
TREZOL 2.5 mg film-coated tablet,LETROZOLE,3010222835,2017,2.5 mg,Film-coated tablet,Oral use,165.20,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LAMIRA 25 mg TABLET,LAMOTRIGINE,2006233830,2017,25 mg,Tablet,Oral use,25.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LAMIRA 50 mg TABLET,LAMOTRIGINE,2006233831,2017,50 mg,Tablet,Oral use,41,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LAMIRA 100 mg TABLET,LAMOTRIGINE,0610222692,2017,100 mg,Tablet,Oral use,74.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LOCASONE S OINTMENT,"SALICYLIC ACID, MOMETASONE FUROATE",2508245820,2017,"5,0.1 %",Ointment,Topical,23,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ARPENIA 10 mg ORODISPERSIBLE TABLET,ARIPIPRAZOLE,1111246184,2016,10 mg,Orodispersible tablet,Oral use,200,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TRANDATE TAB 200 MG.,LABETALOL HYDROCHLORIDE,1806257577,2017,200 mg,Tablet,Oral use,63.6,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
SYNACTHEN DEPOT,TETRACOSACTIDE,6-5357-21,2017,1 mg/ml,Suspension for injection,Intramuscular use,1698,TAKEDA AUSTRIA GmbH,Austria,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,IDEAL PRESCIPITATION CO
LEVOZIN 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,1907222313,2016,5 mg,Film-coated tablet,Oral use,15.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RIDON 1 MG/ML ORAL SOLUTION,RISPERIDONE,0408222405,2016,1 mg/ml,Oral solution,Oral use,170.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MOXICAN 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,2405222057,2017,400 mg,Film-coated tablet,Oral use,58.6,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
NOVOEIGHT 250 IU Powder & Solvent For Solution For Injection,TUROCTOCOG ALFA,0906222166,2017,250 IU,Powder and solvent for solution for injection,Intravenous use,574.00,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOEIGHT 500 IU Powder & Solvent For Solution For Injection,TUROCTOCOG ALFA,0906222167,2017,500 IU,Powder and solvent for solution for injection,Intravenous use,1147.95,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
NOVOEIGHT 1000 IU Powder & Solvent For Solution For Injection,TUROCTOCOG ALFA,0906222168,2017,1000 IU,Powder and solvent for solution for injection,Intravenous use,2295.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
CUREAML 500 mg Capsules,HYDROXYCARBAMIDE,1406222189,2017,500 mg,Capsule,Oral use,52.55,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
DANOVAR,"TENOFOVIR DISOPROXIL, EMTRICITABINE",0706222145,2017,"300,200 mg",Film-coated tablet,Oral use,1464.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ELOXATIN 100MG VIAL,OXALIPLATIN,55-23-17,2017,100 mg,Concentrate for solution for infusion,Intravenous use,1835.65,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS DEUTSCHLAND GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
DIOSTAR PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2006222223,2017,"80,12.5 mg",Film-coated tablet,Oral use,22.40,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
DIOSTAR PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2006222221,2017,"160,25 mg",Film-coated tablet,Oral use,24.5,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
EMDITIL 500MG Film-coated TABLET,CEFUROXIME AXETIL,1506222215,2017,500 mg,Film-coated tablet,Oral use,49.3,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
KEYTRUDA 25 mg/ml Concentrate For Solution For Infusion,PEMBROLIZUMAB,2501233168,2017,25 mg/ml,Concentrate for solution for infusion,Intravenous use,14680.00,MSD INTERNATIONAL GMBH T/A MSD,Ireland,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
ELTROXIN 0.05MG TAB,LEVOTHYROXINE SODIUM,18-887-17,2017,0.05 mg,Tablet,Oral use,20,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ELTROXIN 0.1MG TAB,LEVOTHYROXINE SODIUM,1806257579,2017,0.1 mg,Tablet,Oral use,22.35,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
PURINETHOL 50MG TAB,MERCAPTOPURINE,2108258087,2017,50 mg,Tablet,Oral use,328.75,EXCELLA GmbH & Co.KG,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
TRANDATE INJ. 100 MG.-AMP.20ML,LABETALOL HYDROCHLORIDE,14-887-17,2017,100 mg,Solution for injection,Intravenous use,44.90,CENEXI,France,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
TRANDATE 100MG TABLET,LABETALOL HYDROCHLORIDE,1806257578,2017,100 mg,Film-coated tablet,Oral use,46.5,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
DIOSTAR PLUS,"VALSARTAN, HYDROCHLOROTHIAZIDE",2006222222,2017,"160,12.5 mg",Film-coated tablet,Oral use,24.5,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ATORLIP 20 mg film-coated tablet,ATORVASTATIN CALCIUM,1012258767,2015,20 mg,Film-coated tablet,Oral use,43.45,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
ATORLIP 40 mg film-coated tablet,ATORVASTATIN CALCIUM,1012258766,2015,40 mg,Film-coated tablet,Oral use,86.90,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
XELJANZ 5 mg film-coated tablet,TOFACITINIB,0409234121,2015,5 mg,Film-coated tablet,Oral use,3485.15,PFIZER,Germany,PFIZER,United States,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
ACUVAIL ophthalmic solution,KETOROLAC TROMETHAMINE,0505257333,2013,0.45 %,Ophthalmic solution,Ophthalmic use,35.45,ALLERGAN,United States,AbbVie Inc,United States,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OPDIVO 10 mg/ml solution for injection,NIVOLUMAB,2-960-15,2015,10 mg/ml,Solution for injection,Intravenous use,3385.15,BRISTOL-MYERS SQUIBB,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
OPDIVO 10 mg/ml solution for injection,NIVOLUMAB,3-960-15,2015,10 mg/ml,Solution for injection,Intravenous use,8462.95,BRISTOL-MYERS SQUIBB,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
OLIMEL N5E emulsion for infusion,"GLUCOSE, OLIVE OIL, SOYA OIL, ALANINE, SODIUM GLYCEROPHOSPHATE, ARGININE, LYSINE, GLYCINE, PHENYLALANINE, POTASSIUM CHLORIDE, VALINE, HISTIDINE, PROLINE, GLUTAMIC ACID, ISOLEUCINE5, METHIONINE, THREONINE, SODIUM ACETATE, SERINE, ASPARTIC ACID, MAGNESIUM CHLORIDE, TRYPTOPHAN, CALCIUM CHLORIDE, TYROSINE",6-483-15,2015,"230,80,80,9.52,7.34,6.45,5.18,4.56,4.56,4.47,4.21,3.93,3.93,3.29,3.29,3.29,3.29,2.99,2.60,1.90,1.62,1.10,1.03,0.17 g/l",Emulsion for infusion,Intravenous use,929.60,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
ADAZIO 25 mg film-coated tablet,QUETIAPINE,2001268955,2015,25 mg,Film-coated tablet,Oral use,22.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ADAZIO 100 mg film-coated tablet,QUETIAPINE,267-325-15,2015,100 mg,Film-coated tablet,Oral use,75.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ADAZIO 200 mg film-coated tablet,QUETIAPINE,2001268957,2015,200 mg,Film-coated tablet,Oral use,151.90,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ADAZIO 300 mg film-coated tablet,QUETIAPINE,2001268956,2015,300 mg,Film-coated tablet,Oral use,113.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
BRONCHOFAST 10 mg film-coated tablet,MONTELUKAST SODIUM,2001268953,2015,10 mg,Film-coated tablet,Oral use,71.45,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
AZERA 100 mg enteric-coated tablet,ACETYLSALICYLIC ACID,1906257582,2014,100 mg,Enteric-coated tablet,Oral use,6.35,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
SORTIVA H 100/12.5 mg film-coated tablet,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",215-212-15,2015,"100,12.5 mg",Film-coated tablet,Oral use,48.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
JURNISTA 8 mg prolonged-release tablet,HYDROMORPHONE HYDROCHLORIDE,5-626-15,2015,8 mg,Prolonged-release tablet,Oral use,155.3,Alza Corporation,United States,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
JURNISTA 16 mg prolonged-release tablet,HYDROMORPHONE HYDROCHLORIDE,6-626-15,2015,16 mg,Prolonged-release tablet,Oral use,245.4,Alza Corporation,United States,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
JURNISTA 32 mg prolonged-release tablet,HYDROMORPHONE HYDROCHLORIDE,7-626-15,2015,32 mg,Prolonged-release tablet,Oral use,453,Alza Corporation,United States,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
FENTANYL 50 mg mcg/ml solution for injection,FENTANYL,1810222752,2015,50 µ/ml,Solution for injection,Intravenous use,23.60,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
FENTANYL 50 mcg/ml solution for injection,FENTANYL,1810222750,2015,50 µ/ml,Solution for injection,Intravenous use,63.15,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
"VIVARO 100 IU/ml pre-filled pen, disposable",INSULIN GLARGINE,58-370-15,2015,100 IU/ml,Solution for injection,Subcutaneous use,216.60,sanofi-aventis,Germany,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
ATORLIP 10 mg film-coated tablet,ATORVASTATIN CALCIUM,1012258768,2015,10 mg,Film-coated tablet,Oral use,43.45,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
RENVELA 2.4 g powder for oral suspension,SEVELAMER CARBONATE,4-832-15,2015,2.4 g,Powder for oral suspension,Oral use,623.25,GENZYME IRELAND LIMITED,Ireland,GENZYME,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ENGERIX-B,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,2810258494,2015,10 µg,Suspension for injection,Intramuscular use,30.90,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SURVANTA INTRATRACHEAL SUSP.VIAL 8ML,BERACTANT,1-548-15,2015,25 mg/ml,"Endotracheopulmonary instillation, suspension",Intratracheal use,1742.4,Abbott Laboratories,United States,ABBVIE Inc.,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
SEVORANE INHAL.ANESTHESIA Plastic BOTTLE,SEVOFLURANE,2203233409,2015,100 %,"Inhalation vapour, liquid",Inhalation use,514.15,AESICA QUEENBOROUGH LIMITED,United Kingdom,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
SEVORANE INHAL.ANESTHESIA aluminum BOTTLE,SEVOFLURANE,5-920-15,2015,100 %,"Inhalation vapour, liquid",Inhalation use,734.5,AESICA QUEENBOROUGH LIMITED,United Kingdom,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
HUMIRA 40MG/0.4ML PRE- FILLED SYRINGE,ADALIMUMAB,3001233192,2015,40 mg,Solution for injection,Subcutaneous use,3477.40,VETTER PHARMA,Germany,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
SOLPADEINE CAPSULE,"PARACETAMOL, CAFFEINE CITRATE, CODEINE",0812258752,2015,"500,30,8 mg",Capsule,Oral use,13.15,"Haleon Alcala, S.A",Spain,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
GRACIAL TABLET,"DESOGESTREL, ETHINYLESTRADIOL",5-887-15,2015,"0.025,0.03 mg",Tablet,Oral use,19.6,"CYNDEA PHARMA , S.L",Spain,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ZELBORAF 240 mg film-coated tablet,VEMURAFENIB,0804257201,2015,240 mg,Film-coated tablet,Oral use,7210.00,"Delpharm Milano, S.r.l.",Italy,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
MORPHINE SULPHATE BP 10 mg/ml solution for injection,MORPHINE SULFATE,0106222122,2015,10 mg/ml,Solution for injection,Parenteral use,34.85,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
EPHEDRINE HYDROCHLORIDE 30 mg/ml solution for injction,Ephedrine hydrochloride,1810222751,2015,30 mg/ml,Solution for injection,Parenteral use,49.00,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
"DILUTE ADRENALINE (Epinephrine) 1:10, 000 solution for injection",ADRENALINE,0706222144,2015,100 µ/ml,Solution for injection,Parenteral use,243.00,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
METHADONE MARTINDALE PHARMA 2 mg/ml oral solution,METHADONE,1-468-15,2015,2 mg/ml,Oral solution,Oral use,765.5,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
METHADONE MARTINDALE PHARMA 2 mg/ml oral solution,METHADONE,2-468-15,2015,2 mg/ml,Oral solution,Oral use,174,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
FERINJECT,FERRIC CARBOXYMALTOSE,1-557-15,2015,50 mg/ml,Solution for injection/infusion,Intravenous use,356.35,SPIMACO,Saudi Arabia,VIFOR INTERNATIONAL,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ARAC HEALTHCARE
FERINJECT,FERRIC CARBOXYMALTOSE,2-557-15,2015,50 mg/ml,Solution for injection/infusion,Intravenous use,1781.85,SPIMACO,Saudi Arabia,VIFOR INTERNATIONAL,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ARAC HEALTHCARE
INVEGA SUSTENNA 150 mg,PALIPERIDONE,2411222926,2015,100 mg/ml,Prolonged-release suspension for injection,Intramuscular use,1059.00,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
INVEGA SUSTENNA 100 mg,PALIPERIDONE,0202233205,2015,100 mg/ml,Prolonged-release suspension for injection,Intramuscular use,910.50,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
INVEGA SUSTENNA 75 mg,PALIPERIDONE,2411222927,2015,100 mg/ml,Prolonged-release suspension for injection,Intramuscular use,630.05,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
INVEGA SUSTENNA 50 mg,PALIPERIDONE,2411222928,2015,100 mg/ml,Prolonged-release suspension for injection,Intramuscular use,484.80,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN-CILAG,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SUSTANON 250 AMP,"TESTOSTERONE DECANOATE, TESTOSTERONE ISOCAPROATE, TESTOSTERONE PHENYLPROPIONATE, TESTOSTERONE PROPIONATE",2907257884,2015,"100,60,60,30 mg",Solution for injection,Intramuscular use,21.65,EVER PHARMA JENA GMBH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ALNAGHI COMPANY
G-PRIDE 1 mg tablet,GLIMEPIRIDE,2411211357,2015,1 mg,Tablet,Oral use,8.35,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
G-PRIDE 2 mg tablet,GLIMEPIRIDE,2411211358,2015,2 mg,Tablet,Oral use,13.7,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
MENOPUR Multidose,MENOTROPHIN,0809222594,2014,600 IU,Powder and solvent for solution for injection,Subcutaneous use,501.5,FERRING,Germany,FERRING,Czech Republic,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
MENOPUR Multidose,MENOTROPHIN,2909222675,2014,1200 IU,Powder and solvent for solution for injection,Subcutaneous use,1002.95,FERRING,Germany,FERRING,Czech Republic,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
BIODAL 50000 iu tablet,COLECALCIFEROL,1811211339,2015,50000 IU,Film-coated tablet,Oral use,64.1,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,HAYAT PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SODIUM CHLORIDE 0.45% INFUSION,SODIUM CHLORIDE,433-149-16,2016,0.45 %,Intravenous infusion,Parenteral use,7.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
SODIUM CHLORIDE 0.45% INFUSION,SODIUM CHLORIDE,2107222339,2016,0.45 %,Intravenous infusion,Parenteral use,7.45,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Pharmaceutical Solution Industries (PSI)
AVOQUIN cream,HYDROQUINONE,1505257400,2015,1.9 %,Cream,Topical,15.6,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BLOCAL 5 mg capsule,AMLODIPINE BESILATE,2509305984,2016,5 mg,"Capsule, hard",Oral use,23.8,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
DEMENT 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,2710211242,2016,10 mg,Film-coated tablet,Oral use,103.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BRONCHOVENT 5mg/ml nebuliser solution,SALBUTAMOL,1108222472,2015,5 mg/ml,Nebuliser solution,Inhalation use,12.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
NATURAL E 400 softgel capsule,ALPHA TOCOFERIL,2102221751,2015,400 IU,Capsule,Oral use,36.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
IROVEL 150 mg film-coated tablet,IRBESARTAN,2507222347,2016,150 mg,Film-coated tablet,Oral use,48.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IROVEL 300 mg film-coated tablet,IRBESARTAN,0712211433,2016,300 mg,Film-coated tablet,Oral use,59.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MEDROLONE 40 mg lyophilisate for solution for injection,METHYLPREDNISOLONE SODIUM SUCCINATE,3011258680,2016,40 mg,Lyophilisate for solution for injection,Parenteral use,10.85,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MEDROLONE 500 mg lyophilisate for solution for injection,METHYLPREDNISOLONE SODIUM SUCCINATE,201-334-16,2016,500 mg,Lyophilisate for solution for injection,Parenteral use,65.50,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VIOTOPIC 0.03% ointment,TACROLIMUS,2610222813,2016,0.03 %,Ointment,Topical,79.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VIOTOPIC 0.1% ointment,TACROLIMUS,2610222811,2016,0.1 %,Ointment,Topical,88.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BALANCED ELECTROLYTES pH 7.4 solution for infusion,BALANCED ELECTROLYTES,420-149-16,2016,,Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 7.4 solution for infusion,BALANCED ELECTROLYTES,421-149-16,2016,,Solution,Intravenous use,11.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 7.4 solution for infusion,BALANCED ELECTROLYTES,422-149-16,2016,,Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
CoDICERAN 16/12.5 film-coated tablet,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",0311211255,2016,"16,12.5 mg",Tablet,Oral use,41.35,LEK PHARMACEUTICALS D.D.,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
HAVRIX,HEPATITIS A VIRUS,508257936,2015,1440 ELISA unit,Suspension for injection,Intramuscular use,90.79,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OLANA 10 mg orodispersible tablet,OLANZAPINE,1908258063,2015,10 mg,Tablet,Oral use,196.65,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ADCETRIS 50 mg powder for concentrate for solution for infusion,BRENTUXIMAB VEDOTIN,1-647-15,2015,50 mg,Powder for concentrate for solution for infusion,Intravenous use,13071.30,BSP PHARMACEUTICALS,Italy,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
BRONCAST 10 mg film-coated tablet,MONTELUKAST SODIUM,2301256739,2015,10 mg,Film-coated tablet,Oral use,71.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BRONCAST 5 mg chewable tablet,MONTELUKAST SODIUM,1505257402,2015,5 mg,Chewable tablet,Oral use,79.4,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
LEVOFLOXACIN Sandoz 500 mg film-coated tablet,LEVOFLOXACIN,96-116-15,2015,500 mg,Film-coated tablet,Oral use,31.55,Novartis Pharmaceutical Manufacturing LLC,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
CELEBREX 400 mg capsule,CELECOXIB,1-5702-22,2015,400 mg,"Capsule, hard",Oral use,55.45,VIATRIS PHARMACEUTICALS LLC,United States,PHARMACIA UPJOHN,United States,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
BROFIX 0.09% eye drops solution,BROMFENAC SODIUM,133-368-15,2015,0.09 %,"Eye drops, solution",Ophthalmic use,58.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
CIPRALEX 10 MG F.C. TABLETS,ESCITALOPRAM,1704233551,2015,10 mg,Film-coated tablet,Oral use,88.50,H. LUNDBECK,Denmark,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CIPRALEX 10 MG F.C. TABLETS,ESCITALOPRAM,3-972-15,2015,10 mg,Film-coated tablet,Oral use,384.35,H. LUNDBECK,Denmark,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CIPRALEX 20MG F.C. TABLETS,ESCITALOPRAM,4-972-15,2015,20 mg,Film-coated tablet,Oral use,129.23,H. LUNDBECK,Denmark,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CLARINASE TAB,"PSEUDOEPHEDRINE HYDROCHLORIDE, LORATADINE",4-949-16,2016,"120,5 mg",Tablet,Oral use,18.85,SAG Manufacturing SLU,Spain,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,Bayer Saudi Arabia
OLANA 5 mg orodispersible tablet,OLANZAPINE,1908258065,2015,5 mg,Tablet,Oral use,119.90,ACTAVIS,Malta,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
ARIXTRA 2.5MG-0.5ML PRE-FILLED SYRINGE,FONDAPARINUX SODIUM,2406257601,2016,5 mg/ml,Solution for injection,Subcutaneous use,218.85,ASPEN NOTRE DAM de BONDEVILLE,France,ASPEN PHARMACARE CANADA INC,Canada,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
DEFIROX 250 mg dispersible tablet,DEFERASIROX,1910211199,2015,250 mg,Dispersible tablet,Oral use,816.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DEFIROX 500 mg dispersible tablet,DEFERASIROX,1910211198,2015,500 mg,Dispersible tablet,Oral use,1622.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DIOSTAR 80 mg film-coated tablet,VALSARTAN,0102210484,2015,80 mg,Film-coated tablet,Oral use,22.4,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
DIOSTAR 160 mg film-coated tablet,VALSARTAN,0102210485,2015,160 mg,Film-coated tablet,Oral use,24.5,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
MOXIVE 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,326-212-15,2015,400 mg,Film-coated tablet,Oral use,54.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
MOXIVE 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,327-212-15,2015,400 mg,Film-coated tablet,Oral use,72.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
OCTAGAM 100 mg/ml solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2904210704,2015,100 mg/ml,Solution,Intravenous use,896.55,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTAGAM 100 mg/ml solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2904210703,2015,100 mg/ml,Solution,Intravenous use,2241.40,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTAGAM 100 mg/ml solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2904210705,2015,100 mg/ml,Solution,Intravenous use,4482.80,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OCTAGAM 100 mg/ml solution for infusion,NORMAL HUMAN IMMUNOGLOBULIN,2904210702,2015,100 mg/ml,Solution,Intravenous use,8965.60,OCTAPHARMA,Austria,OCTAPHARMA,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
TARGOPLANIN 200 mg injection,TEICOPLANIN,1901268949,2015,200 mg,Powder for injection,Intravenous use,68.45,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
DEFIROX 125 mg dispersible tablet,DEFERASIROX,1910211197,2015,125 mg,Dispersible tablet,Oral use,410.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ENGERIX B,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,1411258592,2015,20 µg,Suspension for injection,Intramuscular use,42.50,GLAXOSMITHKLINE (GSK),Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BOOSTRIX VACCINE,"DIPHTHERIA TOXOID, TETANUS TOXOID, Haemagglutinin, PERTACTIN, ACELLULAR PERTUSSIS",0311258538,2015,"2,20,8,2.5,8 IU, µg",Suspension for injection,Intramuscular use,63.10,GLAXOSMITHKLINE BIOLOGICALS,France,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ZYMAXID 0.5% eye drops solution,GATIFLOXACIN,1303257050,2013,0.5 %,Ophthalmic solution,Ophthalmic use,28.35,ALLERGAN,United States,AbbVie Inc,United States,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Elong 30 mg film-coated tablet,DAPOXETINE,1108257986,2015,30 mg,Film-coated tablet,Oral use,60.3,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
Elong 60 mg film-coated tablet,DAPOXETINE,5-968-15,2015,60 mg,Film-coated tablet,Oral use,60.3,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
OLIMEL N7E emulsion for infusion,"GLUCOSE, OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, LYSINE",2-483-15,2015,"140,40,40,6.41,4.34,1.28,2.21,3.07,2.64,2.21,3.07,2.21,3.07,2.64,1.75,2.21,0.74,0.11,2.83,1.50,3.67,2.24,0.81,0.52,3.48 g/l",Emulsion for infusion,Intravenous use,748.50,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
OLIMEL N7E emulsion for infusion,"OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, GLUCOSE, LYSINE",3-483-15,2015,"40,40,6.41,4.34,1.28,2.21,3.07,2.64,2.21,3.07,2.21,3.07,2.64,1.75,2.21,0.74,0.11,2.83,1.50,3.67,2.24,0.81,0.52,140,3.48 g/l",Emulsion for infusion,Intravenous use,665.20,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
OLIMEL N9E emulsion for infusion,"OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, GLUCOSE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE",4-483-15,2015,"40,40,8.24,5.58,1.65,2.84,3.95,3.40,2.84,3.95,4.48,2.84,3.95,3.40,2.25,2.84,0.95,0.15,3.64,110,1.50,3.67,2.24,0.81,0.52 g/l",Emulsion for infusion,Intravenous use,748.50,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
OLIMEL N9E emulsion for infusion,"OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, GLUCOSE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE",5-483-15,2015,"40,40,8.24,5.58,1.65,2.84,3.95,3.40,2.84,3.95,4.48,2.84,3.95,3.40,2.25,2.84,0.95,0.15,3.64,110,1.50,3.67,2.24,0.81,0.52 g/l",Emulsion for infusion,Intravenous use,665.20,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
PERIOLIMEL N4E emulsion for infusion,"OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, LYSINE, GLUCOSE",8-483-15,2015,"30,30,3.66,2.48,0.73,1.26,1.76,1.51,1.26,1.76,1.26,1.76,1.51,1.00,1.26,0.42,0.06,1.62,1.16,1.91,1.19,0.45,0.30,1.99,75 g/l",Emulsion for infusion,Intravenous use,748.40,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
PERIOLIMEL N4E emulsion for infusion,"OLIVE OIL, SOYA OIL, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, ISOLEUCINE5, LEUCINE, METHIONINE, PHENYLALANINE, PROLINE, SERINE, THREONINE, TRYPTOPHAN, TYROSINE, VALINE, SODIUM ACETATE, SODIUM GLYCEROPHOSPHATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, CALCIUM CHLORIDE, LYSINE, GLUCOSE",9-483-15,2015,"30,30,3.66,2.48,0.73,1.26,1.76,1.51,1.26,1.76,1.26,1.76,1.51,1.00,1.26,0.42,0.06,1.62,1.16,1.91,1.19,0.45,0.30,1.99,75 g/l",Emulsion for infusion,Intravenous use,997.80,Baxalta Belgium Manufacturing SA,Belgium,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
ULTIBRO Breezhaler,"GLYCOPYRRONIUM BROMIDE, (indacaterol (as acetate",97-9-15,2015,"50,110 µg",Capsule,Inhalation use,193.55,NOVARTIS,Switzerland,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VFEND 200MG TABLET,VORICONAZOLE,1310258409,2020,200 mg,Film-coated tablet,Oral use,2593.65,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ALFOSIN XR 10 mg prolonged-release tablet,ALFUZOSIN,24-249-15,2015,10 mg,Extended-release tablet,Oral use,70.75,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TABIXA 20 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,2201268985,2015,20 mg,Film-coated tablet,Oral use,205,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HALURAN inhalation solution,SEVOFLURANE,293-277-15,2015,,inhalation solution,Inhalation use,428.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LORETA 5mg film-coated tablet,DESLORATADINE,1108257974,2015,5 mg,Film-coated tablet,Oral use,18.85,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
LORA FM 10 mg tablet,LORATADINE,1108257980,2015,10 mg,Tablet,Oral use,15.9,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,DAMMAM PHARMA
QUETTA 25 mg film-coated tablet,QUETIAPINE,319-212-15,2015,25 mg,Film-coated tablet,Oral use,37.00,ACTAVIS,Malta,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
QUETTA 100 mg film-coated tablet,QUETIAPINE,320-212-15,2015,100 mg,Film-coated tablet,Oral use,42.20,ACTAVIS,Malta,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VFEND 50MG TABLET,VORICONAZOLE,1310258407,2015,50 mg,Film-coated tablet,Oral use,648.40,Pfizer Italia S.R.L,Italy,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
QUETTA 200 mg film-coated tablet,QUETIAPINE,321-212-15,2015,200 mg,Film-coated tablet,Oral use,84.40,ACTAVIS,Malta,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
BREVIBLOC Premixed 10 mg/ml solution for infusion,ESMOLOL,1000000223,2014,10 mg/ml,Solution,Intravenous use,387,BAXTER HEALTHCARE,Ireland,BAXTER HEALTHCARE,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
PREZISTA 400 mg film-coated tablet,DARUNAVIR,103-6-13,2013,400 mg,Film-coated tablet,Oral use,1157.75,JANSSEN-CILAG SPA,Italy,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PREZISTA 600 mg film-coated tablet,DARUNAVIR,104-6-13,2013,600 mg,Film-coated tablet,Oral use,1855.05,JANSSEN-CILAG SPA,Italy,JANSSEN PHARMACEUTICA N.V,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
INLYTA 1 mg film-coated tablet,AXITINIB,1910200225,2014,1 mg,Film-coated tablet,Oral use,3258.05,PFIZER,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Cigalah Group"
INLYTA 5 mg film-coated tablet,AXITINIB,1910200224,2014,5 mg,Film-coated tablet,Oral use,16085.70,PFIZER,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Cigalah Group"
GIOTRIF 30 mg film-coated tablet,AFATINIB,99-68-14,2014,30 mg,Film-coated tablet,Oral use,7381.00,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
GIOTRIF 40 mg film-coated tablet,AFATINIB,100-68-14,2014,40 mg,Film-coated tablet,Oral use,7381.00,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
CLOFAST-P 50 mg tablet,DICLOFENAC POTASSIUM,0709258172,2014,50 mg,Tablet,Oral use,9.1,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
NORMALIX SR 1.5 mg modified-release tablet,INDAPAMIDE,2710211241,2015,1.5 mg,modified-release tablet,Oral use,24.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PARACETAMOL B.Braun 10 mg/ml solution for infusion,PARACETAMOL,2602256939,2015,10 mg/ml,Solution for infusion,Intravenous use,14.35,B. BRAUN MEDICAL A.G,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
PARACETAMOL B.Braun 10 mg/ml solution for infusion,PARACETAMOL,2602256941,2015,10 mg/ml,Solution for infusion,Intravenous use,14.35,B. BRAUN MEDICAL A.G,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
BALANCED ELECTROLYTES pH 7.4 solution for infusion,BALANCED ELECTROLYTES,423-149-16,2016,,Solution,Intravenous use,30.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
QUETTA 300 mg film-coated tablet,QUETIAPINE,0703221818,2015,300 mg,Film-coated tablet,Oral use,126.60,ACTAVIS,Malta,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PANTOL 40 mg enteric-coated tablet,PANTOPRAZOLE,3005245384,2014,40 mg,Gastro-resistant coated tablet,Oral use,26.9,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
ALERSON 0.1 % Cream,MOMETASONE FUROATE,0908222444,2015,0.1 %,Cream,Topical,10.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ALERSON 0.1 % Ointment,MOMETASONE FUROATE,0908222445,2015,0.1 %,Ointment,Topical,10.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
IMBRUVICA 140 mg capsule,IBRUTINIB,106-6-15,2015,140 mg,Capsule,Oral use,32040,CATALENT,United States,JANSSEN-CILAG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
HEPAVIR 0.5 mg film-coated tablet,ENTECAVIR,323-212-15,2015,0.5 mg,Film-coated tablet,Oral use,1502.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
HEPAVIR 1 mg film-coated tablet,ENTECAVIR,324-212-15,2015,1 mg,Film-coated tablet,Oral use,1541.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
EVITAR 0.1% gel,TAZAROTENE,71-539-15,2015,0.1 %,Gel,Topical,54.5,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
EVITAR 0.1% gel,TAZAROTENE,72-539-15,2015,0.1 %,Gel,Topical,95,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
EVITAR 0.1% gel,TAZAROTENE,73-539-15,2015,0.1 %,Gel,Topical,139.95,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
EVITAR 0.1% gel,TAZAROTENE,74-539-15,2015,0.1 %,Gel,Topical,180,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DEEF MARKITING COMPANY
EYLEA 40 mg/ml solution for injection,AFLIBERCEPT,0402210498,2015,40 mg/ml,Solution for injection,Intravitreal use,2422.90,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
TARCEVA 150 mg film-coated tablet,ERLOTINIB,0304233462,2014,150 mg,Film-coated tablet,Oral use,4910.10,"Delpharm Milano, S.r.l.",Italy,ROCHE,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Import Company - BANAJA
KIVEXA film-coated tablet,"ABACAVIR, LAMIVUDINE",0509211009,2015,"600,300 mg",Film-coated tablet,Oral use,1676.8,Delpharm Poznań Spółka Akcyjna,Poland,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OLIMEL N9 emulsion for infusion,"GLUCOSE, OLIVE OIL, SOYA OIL, ALANINE, ARGININE, LYSINE, LEUCINE, PHENYLALANINE, GLYCINE, VALINE, PROLINE, GLUTAMIC ACID, THREONINE, ISOLEUCINE5, METHIONINE, SERINE, HISTIDINE, ASPARTIC ACID, TRYPTOPHAN, TYROSINE",7-483-15,2015,"110,40,40,8.24,5.58,4.48,3.95,3.95,3.95,3.64,3.40,2.84,2.84,2.84,2.84,2.25,3.40,1.65,0.95,0.15 g/l",Emulsion for infusion,Intravenous use,1195.50,Baxalta manufacturing Sarl,Switzerland,BAXTER,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
HEXAXIM vaccine,"DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, Haemagglutinin, INACTIVATED POLIO VIRUS (IPV) TYPE 1, INACTIVATED POLIO VIRUS (IPV) TYPE 2, INACTIVATED POLIO VIRUS (IPV) TYPE 3, HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN, HAEMOPHILUS INFLUENZAE TYPE B",25-191-15,2015,"20,40,25,25,40,8,32,10,12 IU, µg, DA",Suspension for injection,Intramuscular use,173.1,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
HEXAXIM vaccine,"TETANUS TOXOID, PERTUSSIS TOXOID, Haemagglutinin, INACTIVATED POLIO VIRUS (IPV) TYPE 1, INACTIVATED POLIO VIRUS (IPV) TYPE 2, INACTIVATED POLIO VIRUS (IPV) TYPE 3, HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN, HAEMOPHILUS INFLUENZAE TYPE B, DIPHTHERIA TOXOID",26-191-15,2015,"40,25,25,40,8,32,10,12,20 IU, µg, DA",Suspension for injection,Intramuscular use,1731,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
JALRA 50 mg tablet,VILDAGLIPTIN,2210258467,2015,50 mg,Tablet,Oral use,45.6,"Siegfried Barbera, S.L",Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JALRA 50 mg tablet,VILDAGLIPTIN,2210258468,2015,50 mg,Tablet,Oral use,91.2,"Siegfried Barbera, S.L",Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JALRA M,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",0710258346,2015,"850,50 mg",Film-coated tablet,Oral use,93.70,NOVARTIS Pharma Stein AG,Switzerland,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JALRA M,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",0710258345,2015,"1000,50 mg",Film-coated tablet,Oral use,98.70,NOVARTIS Pharma Stein AG,Switzerland,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
CITABOL 1000 mg powder for solution for infusion,GEMCITABINE,1211258579,2015,1000 mg,Powder for solution for infusion,Intravenous use,260.85,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
CITABOL 200 mg powder for solution for infusion,GEMCITABINE,1211258578,2015,200 mg,Powder for solution for infusion,Intravenous use,52.15,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
YERVOY 5 mg/ml intravenous infusion,IPILIMUMAB,22-21-15,2015,5 mg/ml,Intravenous infusion,Intravenous use,14866.60,BAXTER PHARMACEUTICAL SOLUTION LLC,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
PEMAR 10 mg prolonged-release tablet,DALFAMPRIDINE,296-277-15,2015,10 mg,Prolonged-release tablet,Oral use,1731,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PANTOL 20 mg enteric-coated tablet,PANTOPRAZOLE,0808222423,2014,20 mg,Gastro-resistant coated tablet,Oral use,18.8,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
ATROSOL 250 mcg/ml nebuliser solution,IPRATROPIUM BROMIDE,1108222473,2015,250 µ/ml,Nebuliser solution,Inhalation use,41.2,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
PANTOL 40 mg enteric-coated tablet,PANTOPRAZOLE,0808222422,2014,40 mg,Gastro-resistant coated tablet,Oral use,47.4,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
AZAR 50 mg film-coated tablet,LOSARTAN POTASSIUM,2109234234,2014,50 mg,Film-coated tablet,Oral use,40.80,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
AZAR 100 mg film-coated tablet,LOSARTAN POTASSIUM,2109234235,2014,100 mg,Film-coated tablet,Oral use,47.50,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
AZAR-D 50/12.5 mg film-coated tablet,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",0105245238,2014,"50,12.5 mg",Film-coated tablet,Oral use,41.90,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
AZAR-D 100/25 mg film-coated tablet,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE",11-809-14,2014,"50,12.5 mg",Film-coated tablet,Oral use,48.20,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LD-NOR 10 mg film-coated tablet,ATORVASTATIN CALCIUM,2405233718,2014,10 mg,Film-coated tablet,Oral use,43.45,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LD-NOR 20 mg film-coated tablet,ATORVASTATIN CALCIUM,2405233717,2014,20 mg,Film-coated tablet,Oral use,43.45,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
LD-NOR 40 mg film-coated tablet,ATORVASTATIN CALCIUM,2405233716,2014,40 mg,Film-coated tablet,Oral use,86.90,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
HARVONI 400/90 mg film-coated tablet,"SOFOSBUVIR, LEDIPASVIR",0112258698,2015,"400,90 mg",Film-coated tablet,Oral use,47139.30,GILEAD SCIENCES LIMITED (CORK),Ireland,GILEAD SCIENCES LIMITED,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
NovoThirteen (rFXIII) powder and solvent for solution for injection,CATRIDECACOG,0412258730,2015,2500 IU,Powder and solvent for solution for injection,Intravenous use,83063.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
HEPATAB 0.5 mg film-coated tablet,ENTECAVIR,294-277-15,2015,0.5 mg,Film-coated tablet,Oral use,1669.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
HEPATAB 1 mg film-coated tablet,ENTECAVIR,295-277-15,2015,1 mg,Film-coated tablet,Oral use,1712.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
BLES,BOVINE LIPID EXTRACT SURFACTANT,2-979-15,2015,"27 µ/ml, µg",Suspension,Intratracheal use,918.6,BLES Biochemicals,Canada,BLES Biochemicals,Canada,Marketed,Prescription,Store in freezer under – 10 c° for 36 months or Store in refrigerator from 2-8 c° for 10 months,Hospital,PharmaZone (Netaq Al Dawa) Pharmaceuticals
ZARZIO 30 mU/0.5 mL solution for injection,FILGRASTIM,92-116-15,2015,0.3 mg,Solution for injection/infusion,Intravenous use,455.30,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZARZIO 48 mU/0.5 mL solution for injection,FILGRASTIM,93-116-15,2015,0.48 mg,Solution for injection/infusion,Intravenous use,725.60,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ENTRESTO,"VALSARTAN, SACUBITRIL",0701210396,2015,"25.7,24.3 mg",Film-coated tablet,Oral use,200.80,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ENTRESTO,"VALSARTAN, SACUBITRIL",0701210397,2015,"51.4,48.6 mg",Film-coated tablet,Oral use,200.80,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ENTRESTO,"VALSARTAN, SACUBITRIL",0701210395,2015,"102.8,97.2 mg",Film-coated tablet,Oral use,401.60,NOVARTIS FARMA S.P.A,Italy,NOVARTIS,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
CLOGREL 75 mg film-coated tablet,CLOPIDOGREL,2707200128,2015,75 mg,Film-coated tablet,Oral use,118.15,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
QUETAL XR 200 mg film-coated tablet,QUETIAPINE,0908222451,2015,200 mg,Extended-release tablet,Oral use,136.6,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
QUETAL XR 150 mg film-coated tablet,QUETIAPINE,0908222456,2015,150 mg,Extended-release tablet,Oral use,102.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
QUETAL XR 300 mg film-coated tablet,QUETIAPINE,0908222448,2015,300 mg,Extended-release tablet,Oral use,180.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVANIX 500 mg film-coated tablet,LEVOFLOXACIN,14-584-17,2017,500 mg,Film-coated tablet,Oral use,56.55,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BALANCED ELECTROLYTES pH 5.5 solution for infusion,BALANCED ELECTROLYTES,424-149-16,2016,,Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 5.5 solution for infusion,BALANCED ELECTROLYTES,426-149-16,2016,,Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VALES 500 mg film-coated tablet,LEVETIRACETAM,0902221707,2016,500 mg,Film-coated tablet,Oral use,115.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VALES 500 mg film-coated tablet,LEVETIRACETAM,0902221708,2016,500 mg,Film-coated tablet,Oral use,383.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IMATOX 4 mg/2 ml solution for injection/infusion,ONDANSETRON,0512211422,2016,2 mg/ml,Solution,Intramuscular and intravenous use,102.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
IMATOX 4 mg/2 ml solution for injection/infusion,ONDANSETRON,0902221713,2016,2 mg/ml,Solution,Intramuscular and intravenous use,157.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ARTHOSAVE 200 mg tablet,HYDROXYCHLOROQUINE SULFATE,0311222867,2016,200 mg,Tablet,Oral use,127,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
SIRDALUD 2MG TAB,TIZANIDINE,1-5773-23,2016,2 mg,Tablet,Oral use,18.75,NOVARTIS,Turkey,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
SIRDALUD 4MG TAB,TIZANIDINE,2-5773-23,2016,4 mg,Tablet,Oral use,30.70,NOVARTIS,Turkey,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
TRILEPTAL 300MG F.C TAB,OXCARBAZEPINE,122-9-16,2016,300 mg,Film-coated tablet,Oral use,46.30,NOVARTIS,Italy,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
CATAFLAM 50MG TABLET,DICLOFENAC POTASSIUM,0207245466,2016,50 mg,Coated tablet,Oral use,31.7,NOVARTIS,Turkey,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
FAMVIR 125MGTAB,FAMCICLOVIR,5-5357-21,2016,125 mg,Film-coated tablet,Oral use,113.25,"Siegfried Barbera, S.L",Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FAMVIR 250MG TAB,FAMCICLOVIR,4-5357-21,2016,250 mg,Film-coated tablet,Oral use,414.75,"Siegfried Barbera, S.L",Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TRILEPTAL 600MG F.C TAB,OXCARBAZEPINE,121-9-16,2016,600 mg,Film-coated tablet,Oral use,84.85,NOVARTIS,Italy,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
TRILEPTAL 60MG\ML SUSPENTION,OXCARBAZEPINE,0309258151,2016,60 mg/ml,Oral suspension,Oral use,123.80,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
CATAFAST 50 MG SACHET,DICLOFENAC POTASSIUM,137-9-16,2016,50 mg,Powder for oral suspension,Oral use,18,MIPHARM,Italy,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
MOSEGOR SYRUP,PIZOTIFEN,0402210497,2016,50 µ/ml,Syrup,Oral use,20.05,Delpharm Orleans,France,ETHYX PHARMACEUTICALS,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SANDIMMUN CONC.FOR INFUSIN 250MG-5ML,CICLOSPORIN,109-9-16,2016,50 mg/ml,Concentrate for solution for infusion,Intravenous use,531.35,NOVARTIS,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
SANDIMMUN NEORAL DRINK 100MG-ML,CICLOSPORIN,108-9-16,2016,100 mg/ml,Oral solution,Oral use,706.85,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VOLTAREN 50 MG TAB,DICLOFENAC SODIUM,1401268912,2016,50 mg,Tablet,Oral use,19.80,NOVARTIS Saglik Gida ve Tarm,Turkey,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
LUCENTIS 10MG-ML INTRAVITREAL Injection,RANIBIZUMAB,141-9-16,2016,10 mg/ml,Solution for injection,Intravenous use,2353.90,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
VOLTAREN 100 MG,DICLOFENAC SODIUM,130-9-16,2016,100 mg,Suppository,Rectal use,18.2,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
VOLTAREN 75 MG AMP,DICLOFENAC SODIUM,129-9-16,2016,25 mg/ml,Solution for injection/infusion,Parenteral use,30.70,LEK PHARMACEUTICAL D.D,Slovenia,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
VALES 250 mg film-coated tablet,LEVETIRACETAM,0902221705,2016,250 mg,Film-coated tablet,Oral use,66.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VALES 1000 mg film-coated tablet,LEVETIRACETAM,0902221704,2016,1000 mg,Film-coated tablet,Oral use,188.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LAVOXIN 500 mg solution for infusion,LEVOFLOXACIN,2410211219,2016,5 mg/ml,Solution for infusion,Intravenous use,79.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
KADCYLA 160 mg powder for concentrate for solution for infusion,TRASTUZUMAB EMTANSINE,2804245222,2015,160 mg,Powder for concentrate for solution for infusion,Intravenous use,8761.65,Patheon Manufacturing Services LLC,United States,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
SANDIMMUN NEORAL 100MG CAPS,CICLOSPORIN,0803221830,2016,100 mg,Capsule,Oral use,646.20,CATALENT,Germany,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
SANDIMMUN NEORAL 50MG CAP,CICLOSPORIN,0803221828,2016,50 mg,Capsule,Oral use,290.90,CATALENT,Germany,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
MOSEGOR 0.5MG SUGAR COATED TABLETS,PIZOTIFEN,0402210496,2016,0.5 mg,Coated tablet,Oral use,17.7,Delpharm LAigle,France,ETHYX PHARMACEUTICALS,France,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SANDOSTATIN LAR 20MG VIAL,OCTREOTIDE ACETATE,113-9-16,2016,20 mg,Powder and solvent for suspension for injection,Intramuscular use,4316.75,Novartis Pharmaceutical Manufacturing GmbH,Austria,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
SIMULECT 20 MG I.V VIAL,BASILIXIMAB,116-9-16,2016,20 mg,Powder and solvent for solution for injection,Intravenous use,4922.75,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
PARLODEL 2.5 MG TAB,BROMOCRIPTINE,4-5773-23,2016,2.5 mg,Tablet,Oral use,54.10,NOVARTIS,Italy,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
SANDIMMUN 50MG-ML AMPULE,CICLOSPORIN,110-9-16,2016,50 mg/ml,Concentrate for solution for infusion,Intravenous use,124.70,NOVARTIS,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
VOLTAREN 25 MG TAB,DICLOFENAC SODIUM,125-9-16,2016,25 mg,Tablet,Oral use,14.85,NOVARTIS Saglik Gida ve Tarm,Turkey,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VOLTAREN 50 MG. SUPP.,DICLOFENAC SODIUM,127-9-16,2016,50 mg,Suppository,Rectal use,19.9,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VOLTAREN 75 Mg SR TABLET,DICLOFENAC SODIUM,128-9-16,2016,75 mg,Prolonged-release tablet,Oral use,20.95,NOVARTIS,Italy,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
SANDIMMUN NEORAL 25MG CAPS,CICLOSPORIN,0803221829,2016,25 mg,Capsule,Oral use,161.60,CATALENT,Germany,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
TEGRETOL CR 200MG SCORED TAB,CARBAMAZEPINE,1401268911,2016,200 mg,Prolonged-release tablet,Oral use,40.75,NOVARTIS,Italy,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
FEMARA 2.5 MG TABLET,LETROZOLE,132-9-16,2016,2.5 mg,Film-coated tablet,Oral use,183.55,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
GAVISCON DOUBLE ACTION ORAL SUSPENSION,"SODIUM ALGINATE, SODIUM BICARBONATE, CALCIUM CARBONATE",10-417-12,2014,"500,325,213 mg",Oral suspension,Oral use,12.55,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
PARACETOL 10 mg/ml intravenous infusion,PARACETAMOL,1509211057,2016,10 mg/ml,Solution for infusion,Intravenous use,346.00,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
GLYCOPYRRONIUM BROMIDE 200 mcg/ml solution for injection,GLYCOPYRRONIUM BROMIDE,0106222123,2016,200 µ/ml,Solution for injection,Intramuscular and intravenous use,29.95,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PETHIDINE PETHIDINE 50 mg/ml injection BP,PETHIDINE,0706222143,2016,50 mg/ml,Injection,Intramuscular and intravenous use,30.10,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PETHIDINE PETHIDINE 50 mg/ml injection BP,PETHIDINE,0706222141,2016,50 mg/ml,Injection,Intramuscular and intravenous use,30.10,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
KADCYLA 100 mg powder for concentrate for solution for infusion,TRASTUZUMAB EMTANSINE,2804245221,2015,100 mg,Powder for concentrate for solution for infusion,Intravenous use,5476.00,Patheon Manufacturing Services LLC,United States,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
LESCOL XL 80 MG FILM COATED TAB,FLUVASTATIN,0210258310,2016,80 mg,Prolonged-release tablet,Oral use,51.50,"Siegfried Barbera, S.L",Spain,ETHYX PHARMACEUTICALS,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VOLTAREN SUPP 12.5 MG.,DICLOFENAC SODIUM,124-9-16,2016,12.5 mg,Suppository,Rectal use,12.7,DELPHARM HUNINGUE S.A.S.,France,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ANAFRANIL TAB 10MG,CLOMIPRAMINE HYDROCHLORIDE,2406257598,2016,10 mg,Coated tablet,Oral use,17.9,NOVARTIS,Italy,TEOFARMA S.R.L,Italy,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ANAFRANIL TABLETS 25 MG,CLOMIPRAMINE HYDROCHLORIDE,2406257597,2016,25 mg,Coated tablet,Oral use,21.4,NOVARTIS,Italy,TEOFARMA S.R.L,Italy,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VIMPAT 100 mg film-coated tablet,LACOSAMIDE,1508210936,2015,100 mg,Film-coated tablet,Oral use,278.4,Aesica Pharmaceuticals GmbH.,Germany,U.C.B.,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VIMPAT 150 mg film-coated tablet,LACOSAMIDE,1508210937,2015,150 mg,Film-coated tablet,Oral use,417.6,Aesica Pharmaceuticals GmbH.,Germany,U.C.B.,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FLUTIFORM 50/5 mcg pressurised inhalation suspension,"FLUTICASONE PROPIONATE, FORMOTEROL FUMARATE",1511211320,2016,"0.05,0.005 mg","Pressurised inhalation, suspension",Inhalation use,105,Recipharm HC Limited,United Kingdom,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
FLUTIFORM 250/10 mcg pressurised inhalation suspension,"FLUTICASONE PROPIONATE, FORMOTEROL FUMARATE",1511211322,2016,"0.25,0.01 mg","Pressurised inhalation, suspension",Inhalation use,225,Recipharm HC Limited,United Kingdom,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
AMARYL 6 mg tablet,GLIMEPIRIDE,53-23-16,2016,6 mg,Tablet,Oral use,52.35,sanofi-aventis,Italy,sanofi-aventis,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Naselfast nasal spray suspension,TRIAMCINOLONE ACETONIDE,0610222694,2016,55 µg,Nasal spray,Nasal use,46.55,Recipharm HC Limited,United Kingdom,Opella Healthcare UK Limited,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Opella Arabia Limited Co
FLUTIFORM 125/5 mcg pressurised inhalation suspension,"FLUTICASONE PROPIONATE, FORMOTEROL FUMARATE",1511211321,2016,"0.125,0.005 mg","Pressurised inhalation, suspension",Inhalation use,130,Recipharm HC Limited,United Kingdom,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
VIRECTA 50 mg film-coated tablet,SILDENAFIL,26-437-16,2016,50 mg,Film-coated tablet,Oral use,43.7,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
OCUFENAC 1 mg/ml ophthalmic solution,DICLOFENAC SODIUM,3001244813,2016,0.1 %,Ophthalmic solution,Ophthalmic use,24.8,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
XTANDI 40 mg capsule,ENZALUTAMIDE,1412223014,2015,40 mg,"Capsule, soft",Oral use,9620.65,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
SOLIAN 100 MG TABLET,AMISULPRIDE,2111246320,2016,100 mg,Tablet,Oral use,71.20,Delpharm Dijon,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
SOLIAN 200MG TAB,AMISULPRIDE,4-883-16,2016,200 mg,Tablet,Oral use,140.65,Delpharm Dijon,France,sanofi-aventis,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
SOLIAN 400 MG FILM COATED TABLETS,AMISULPRIDE,5-883-16,2016,400 mg,Film-coated tablet,Oral use,220.6,Delpharm Dijon,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
XATRAL XL 10 MG,ALFUZOSIN,6-883-16,2016,10 mg,Prolonged-release tablet,Oral use,93.70,SANOFI WINTHROP INDUSTRIE,France,Sanofi Aventis France,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
CORDARONE 200MG TAB,AMIODARONE,1905222046,2016,200 mg,Tablet,Oral use,25.30,SANOFI WINTHROP INDUSTRIE,France,sanofi-aventis,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DEPAKINE 57.64MG-ML SYRUP,VALPROATE SODIUM,0503256985,2016,57.64 mg/ml,Syrup,Oral use,20.85,Unither Liquid Manufacturing,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
FLAGYL 250MG TAB,METRONIDAZOLE,8-883-16,2016,250 mg,Film-coated tablet,Oral use,10.05,"SANOFI-AVENTIS, S.A",Spain,sanofi-aventis,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
FLAGYL 500MG SCORED TABS,METRONIDAZOLE,9-883-16,2016,500 mg,Film-coated tablet,Oral use,19.15,sanofi-aventis,Spain,sanofi-aventis,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
10% DEXTROSE in 0.45% SODIUM CHLORIDE intravenous infusion,"DEXTROSE, SODIUM CHLORIDE",0109222576,2016,"10,0.45 %",Solution,Intravenous use,7.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
YAZ PLUS film-coated tablet,"DROSPINENONE, ETHINYLESTRADIOL, LEVOMEFOLATE CALCIUM",2709211083,2016,"3,0.02,0.451 mg",Film-coated tablet,Oral use,44.45,BAYER WEIMAR GmbH UND CO. KG,Germany,BAYER PHARMA AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
CELLCEPT 500 mg tablet,MYCOPHENOLATE MOFETIL,2404245204,2016,500 mg,Film-coated tablet,Oral use,251.15,Delpharm Milano S.r.l,Italy,ROCHE,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
AUBAGIO 14 mg film-coated tablet,TERIFLUNOMIDE,1709211065,2016,14 mg,Film-coated tablet,Oral use,2715.60,Opella Healthcare International,France,GENZYME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
ARIPEX 10 mg tablet,ARIPIPRAZOLE,2501221641,2016,10 mg,Tablet,Oral use,222.25,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ARIPEX 5 mg tablet,ARIPIPRAZOLE,2501221638,2016,5 mg,Tablet,Oral use,111.1,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ARIPEX 15 mg tablet,ARIPIPRAZOLE,2501221642,2016,15 mg,Tablet,Oral use,276.1,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SOFOCURE 400 mg film-coated tablet,SOFOSBUVIR,1205222018,2016,400 mg,Film-coated tablet,Oral use,5600,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
FUSIBACT 2% ointment,FUSIDIC ACID,2410234389,2016,2 %,Ointment,Topical,16.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
OLOPAT 0.1 % ophthalmic solution  - unit dose,OLOPATADINE,0912211441,2016,0.1 %,"Eye drops, solution",Ophthalmic use,58.7,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
VAROXA 10 mg film-coated tablet,RIVAROXABAN,0512211418,2016,10 mg,Film-coated tablet,Oral use,237.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VAROXA 15 mg film-coated tablet,RIVAROXABAN,0512211420,2016,15 mg,Film-coated tablet,Oral use,221.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VAROXA 20 mg film-coated tablet,RIVAROXABAN,0512211421,2016,20 mg,Film-coated tablet,Oral use,221.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
JEVTANA 60 mg concentrate and solvent for solution for infusion,CABAZITAXEL,2504221981,2015,60 mg,Concentrate and solvent for solution for infusion,Intravenous use,14702.10,AVENTIS PHARMA LIMITED,United Kingdom,sanofi-aventis,France,Marketed,Prescription,do not store above 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
TABIFLEX 75 mg solution for injection/infusion,DICLOFENAC SODIUM,0902221718,2016,25 mg/ml,Solution for injection/infusion,Intravenous use,26.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
GYNOCIN 10 IU/ml solution for injection,OXYTOCIN,1611211327,2016,10 IU/ml,Solution for injection,Parenteral use,23.8,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
GYNOCIN 10 IU/ml solution for injection,OXYTOCIN,0911211293,2016,10 IU/ml,Solution for injection,Parenteral use,11.9,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
VIRECTIL 100 mg tablet,SILDENAFIL,0901221580,2016,100 mg,Film-coated tablet,Oral use,39.35,LABORATORIES PHARMA 5,Morocco,LABORATORIES PHARMA 5,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIRECTIL 100 mg tablet,SILDENAFIL,0901221579,2016,100 mg,Film-coated tablet,Oral use,9.85,LABORATORIES PHARMA 5,Morocco,LABORATORIES PHARMA 5,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIRECTIL 50 mg tablet,SILDENAFIL,1901256678,2016,50 mg,Film-coated tablet,Oral use,39.35,LABORATORIES PHARMA 5,Morocco,LABORATORIES PHARMA 5,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIRECTIL 50 mg tablet,SILDENAFIL,1811246239,2016,50 mg,Film-coated tablet,Oral use,9.85,LABORATORIES PHARMA 5,Morocco,LABORATORIES PHARMA 5,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GLUCARE XR 500 mg tablet,METFORMIN HYDROCHLORIDE,2301221627,2016,500 mg,Extended-release tablet,Oral use,15.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCARE XR 500 mg tablet,METFORMIN HYDROCHLORIDE,2301221626,2016,500 mg,Extended-release tablet,Oral use,31.70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCARE XR 500 mg tablet,METFORMIN HYDROCHLORIDE,2301221630,2016,500 mg,Extended-release tablet,Oral use,47.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCARE XR 750 mg tablet,METFORMIN HYDROCHLORIDE,2301221628,2016,750 mg,Extended-release tablet,Oral use,23.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLUCARE XR 750 mg tablet,METFORMIN HYDROCHLORIDE,2301221629,2016,750 mg,Extended-release tablet,Oral use,47.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZOLINDA 10 mg tablet,ARIPIPRAZOLE,0302221674,2016,10 mg,Tablet,Oral use,274.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZOLINDA 5 mg tablet,ARIPIPRAZOLE,0302221676,2016,5 mg,Tablet,Oral use,137.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZOLINDA 15 mg tablet,ARIPIPRAZOLE,0302221675,2016,15 mg,Tablet,Oral use,340.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FABRAZYME 35 mg powder for concentrate for solution for infusion,AGALSIDASE BETA,6-832-16,2016,5 mg/ml,Powder for concentrate for solution for infusion,Intravenous use,14909.65,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
DUODOPA intestinal gel,"LEVODOPA, CARBIDOPA",6-920-15,2015,"20,5 mg",Gel,Inhalation use,5566.00,HP Halden Pharma AS,Norway,Abbvie Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
TILCOTIL TAB 20MG,TENOXICAM,4-864-16,2016,20 mg,Tablet,Oral use,56.1,ROCHE,Switzerland,MEDA PHARMA GmbH & Co KG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Viatris Arabia Limited, ZIMMO TRADING ESTABLISHMENT"
REMERON 30MG TAB,MIRTAZAPINE,1612200342,2016,30 mg,Film-coated tablet,Oral use,78.40,Organon Pharma (UK) Limited,United Kingdom,ORGANON,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
COAPROVEL 300-25MG F.C. TABLETS,"IRBESARTAN, HYDROCHLOROTHIAZIDE",1512223018,2016,"300,25 mg",Film-coated tablet,Oral use,77,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
INEGY,"SIMVASTATIN, EZETIMIBE",0104210660,2016,"20,10 mg",Tablet,Oral use,143.75,MSD International GmbH (Singapore Branch),Singapore,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
INEGY,"SIMVASTATIN, EZETIMIBE",0104210661,2016,"40,10 mg",Tablet,Oral use,167.75,MSD International GmbH (Singapore Branch),Singapore,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
EZETROL 10 mg tablet,EZETIMIBE,2403210641,2016,10 mg,Tablet,Oral use,159.80,MSD International GmbH (Singapore Branch),Singapore,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FABRAZYME 5 mg powder for concentrate for solution for infusion,AGALSIDASE BETA,5-832-16,2016,5 mg/ml,Powder for concentrate for solution for infusion,Intravenous use,2129.95,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
STERILE WATER for injection,WATER,1606222216,2016,,Solvent for parenteral use,Intravenous use,24.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
BALANCED ELECTROLYTES pH 5.5 solution for infusion,BALANCED ELECTROLYTES,427-149-16,2016,,Solution,Intravenous use,30.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 5 and 5% dextrose solution for infusion,"DEXTROSE, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",428-149-16,2016,"55,5.26,5.02,3.68,0.37,0.3 g",Solution,Intravenous use,11.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 5 and 5% dextrose solution for infusion,"DEXTROSE, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",429-149-16,2016,"55,5.26,5.02,3.68,0.37,0.3 g",Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 5 and 5% dextrose solution for infusion,"DEXTROSE, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",430-149-16,2016,"55,5.26,5.02,3.68,0.37,0.3 g",Solution,Intravenous use,30.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
BALANCED ELECTROLYTES pH 5 and 5% dextrose solution for infusion,"DEXTROSE, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE",431-149-16,2016,"55,5.26,5.02,3.68,0.37,0.3 g",Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
MULTILYTE pH 5.5 solution for infusion,"MAGNESIUM ACETATE, POTASSIUM ACETATE, SODIUM CHLORIDE",434-149-16,2016,"0.320,1.28,2.34 mg/ml",Solution,Intravenous use,16,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MULTILYTE pH 5.5 solution for infusion,"MAGNESIUM ACETATE, POTASSIUM ACETATE, SODIUM CHLORIDE",435-149-16,2016,"0.32,1.28,2.34 mg/ml",Solution,Intravenous use,10.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MULTILYTE pH 5.5 solution for infusion,"MAGNESIUM ACETATE, POTASSIUM ACETATE, SODIUM CHLORIDE",436-149-16,2016,"0.32,1.28,2.34 mg/ml",Solution,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
MULTILYTE pH 5.5 solution for infusion,"MAGNESIUM ACETATE, POTASSIUM ACETATE, SODIUM CHLORIDE",437-149-16,2016,"0.32,1.28,2.34 mg/ml",Solution,Intravenous use,27.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
ADENOCOR 6MG-2ML VIAL,ADENOSINE,1209234181,2016,3 mg/ml,Solution for injection,Intravenous use,153.45,FAMAR (SANOFI AVENTIS),Spain,AVENTIS PHARMA LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
MENOPUR 75 IU powder for solution for injection,MENOTROPHIN,27-367-16,2016,75 IU,Powder and solvent for solution for injection,"intramuscular, subcutaneous",313.45,FERRING,Germany,FERRING,Czech Republic,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
STERILE WATER for injection,WATER,2510211226,2016,,Solvent for parenteral use,Intravenous use,31.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ESOMEP 20 mg gastro-resistant tablet,ESOMEPRAZOLE,2904221997,2016,20 mg,Gastro-resistant tablet,Oral use,28.45,SALUTAS PHARMA GmbH,Germany,SANDOZ,Spain,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ESOMEP 40 mg gastro-resistant tablet,ESOMEPRAZOLE,2904222000,2016,40 mg,Gastro-resistant tablet,Oral use,38.80,SALUTAS PHARMA GmbH,Germany,SANDOZ,Spain,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ESOMEP 40 mg gastro-resistant tablet,ESOMEPRAZOLE,2904221998,2016,40 mg,Gastro-resistant tablet,Oral use,63.50,SALUTAS PHARMA GmbH,Germany,SANDOZ,Spain,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
KEMADRIN 5MG TABLET,PROCYCLIDINE,0704257190,2016,5 mg,Tablet,Oral use,26.95,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ALKERAN TABLETS 2 MG,MELPHALAN,8-887-16,2016,2 mg,Film-coated tablet,Oral use,347.1,EXCELLA GmbH & Co. KG,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
DICERAN 8 mg film-coated tablet,CANDESARTAN CILEXETIL,0311211254,2016,8 mg,Tablet,Oral use,23.45,Novartis Pharmaceutical Manufacturing LLC,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DICERAN 16 mg film-coated tablet,CANDESARTAN CILEXETIL,0311211256,2016,16 mg,Tablet,Oral use,28.3,Novartis Pharmaceutical Manufacturing LLC,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MEMENTA 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,1-666-16,2016,10 mg,Film-coated tablet,Oral use,94.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
QUINOX 200 mg solution for infusion,CIPROFLOXACIN,2608210986,2016,2 mg/ml,Solution,Intravenous use,64.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ILLUSOF 300 mg/ml solution for injection/infusion,IOHEXOL,2410211216,2016,300 mg/ml,Injection,Intravenous use,57.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ILLUSOF 300 mg/ml solution for injection/infusion,IOHEXOL,2410211218,2016,300 mg/ml,Injection,Intravenous use,113.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LIDOCAINE HYDROCHLORIDE 1% solution for injection,LIDOCAINE HYDROCHLORIDE,0512211423,2016,1 %,Solution for injection,Parenteral use,247.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ESOMEP 20 mg gastro-resistant tablet,ESOMEPRAZOLE,2904221999,2016,20 mg,Gastro-resistant tablet,Oral use,55.45,SALUTAS PHARMA GmbH,Germany,SANDOZ,Spain,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BALANCED ELECTROLYTES pH 5.5 solution for infusion,BALANCED ELECTROLYTES,425-149-16,2016,,Solution,Intravenous use,11.4,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
SINGULAIR,MONTELUKAST SODIUM,0803210591,2016,5 mg,Chewable tablet,Oral use,111.20,MERCK SHARP & DOHME,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SINGULAIR PAEDIATRIC 4 MG CHEWABLE TAB,MONTELUKAST SODIUM,0803210590,2016,4 mg,Chewable tablet,Oral use,111.20,MERCK SHARP & DOHME,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SERONORM 0.25 mg solution for IV injection,PALONOSETRON HYDROCHLORIDE,1503233374,2016,0.05 mg/ml,Solution for injection,Intravenous use,207.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
OSTADIL 4 mg concentrate for IV infusion,ZOLEDRONIC ACID,1109234173,2016,0.8 mg/ml,Concentrate for solution for infusion,Intravenous use,713.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
VIMPAT 50 mg film-coated tablet,LACOSAMIDE,2406210828,2015,50 mg,Film-coated tablet,Oral use,144.55,Aesica Pharmaceuticals GmbH.,Germany,U.C.B.,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
AMBAFEN 4 mg/ml solution for infusion,IBUPROFEN,0509234141,2016,4 mg/ml,Solution for infusion,Intravenous use,33,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
GOUTEX 80 mg film-coated tablet,FEBUXOSTAT,1303221842,2016,80 mg,Film-coated tablet,Oral use,95.40,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
GOUTEX 40 mg film-coated tablet,FEBUXOSTAT,1303221841,2016,40 mg,Film-coated tablet,Oral use,95.40,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
COSENTYX 150 mg/ml solution for injection in pre-filled pen,SECUKINUMAB,1201233090,2016,150 mg/ml,Solution for injection,Subcutaneous use,2114.55,NOVARTIS,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
TRESIBA FlexTouch 100 U/ml solution for injection,INSULIN DEGLUDEC,67-100-15,2015,100 IU/ml,Solution for injection,Subcutaneous use,359.95,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
SERONORM 0.075 mg solution for IV injection,PALONOSETRON HYDROCHLORIDE,0404221915,2016,0.05 mg/ml,Solution for injection,Intravenous use,69.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
1% CALCIUM GLUCONATE intravenous infusion BP,CALCIUM GLUCONATE,442-149-16,2016,1 %,Solution for infusion,Intravenous use,14.5,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
SOVIRA 400 mg film-coated tablet,SOFOSBUVIR,3110211250,2016,400 mg,Film-coated tablet,Oral use,5600,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GABEX 75 mg capsule,PREGABALIN,135-368-16,2016,75 mg,Capsule,Oral use,64.2,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
GABEX 150 mg capsule,PREGABALIN,136-368-16,2016,150 mg,Capsule,Oral use,82.9,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
GABEX 300 mg capsule,PREGABALIN,1506222194,2016,300 mg,Capsule,Oral use,129.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SPRYCEL 20MG F.C. TABLETS,DASATINIB,0212258710,2016,20 mg,Film-coated tablet,Oral use,6157.65,AstraZeneca Pharmaceuticals LP,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
SPRYCEL 50MG F.C. TABLETS,DASATINIB,0212258711,2016,50 mg,Film-coated tablet,Oral use,9747.25,AstraZeneca Pharmaceuticals LP,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
SPRYCEL 70MG F.C. TABLETS,DASATINIB,16-960-16,2016,70 mg,Film-coated tablet,Oral use,10048.70,AstraZeneca Pharmaceuticals LP,United States,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
VALES 100 mg/ml oral solutin,LEVETIRACETAM,2410211220,2016,100 mg/ml,Oral solution,Oral use,229.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LASTINEM 500 mg powder for solution for infusion,"CILASTATIN, IMIPENEM",5-796-15,2015,"500,500 mg",Powder for solution for infusion,Intravenous use,213.5,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
SINGULAIR,MONTELUKAST SODIUM,0803210592,2016,10 mg,Film-coated tablet,Oral use,111.20,MERCK SHARP & DOHME,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
LAVISTINA 24 mg tablet,BETAHISTINE DIHYDROCHLORIDE,2510211231,2016,24 mg,Tablet,Oral use,45.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LAVISTINA 8 mg tablet,BETAHISTINE DIHYDROCHLORIDE,2510211229,2016,8 mg,Tablet,Oral use,50.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SINGULAIR PEDIATRIC 4MG GRANULES,MONTELUKAST SODIUM,2311211354,2016,4 mg,Granules,Oral use,111.20,Patheon Manufacturing Services LLC,United States,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JANUVIA 100MG F.C. TABLETS,SITAGLIPTIN PHOSPHATE,1101210399,2016,100 mg,Film-coated tablet,Oral use,105.25,Organon Pharma (UK) Limited,United Kingdom,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PROSCAR,FINASTERIDE,1003210593,2016,5 mg,Film-coated tablet,Oral use,75.15,Organon Pharma (UK) Limited,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
JANUMET,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",2501210468,2016,"1000,50 mg",Tablet,Oral use,114.00,PATHEON INC,Puerto Rico,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JANUMET,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",2501210469,2016,"850,50 mg",Tablet,Oral use,110.00,PATHEON INC,Puerto Rico,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ZOCOR 10MG TAB,SIMVASTATIN,0302210492,2016,10 mg,Film-coated tablet,Oral use,66.95,Organon Pharma (UK) Limited,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ZOCOR 20MG TAB,SIMVASTATIN,0302210489,2016,20 mg,Film-coated tablet,Oral use,66.95,Organon Pharma (UK) Limited,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ZOCOR 40MG TAB,SIMVASTATIN,0302210490,2016,40 mg,Film-coated tablet,Oral use,66.95,Organon Pharma (UK) Limited,United Kingdom,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CANCIDAS 50 MG VIAL,CASPOFUNGIN,1509211051,2016,50 mg,Powder for concentrate for solution for infusion,Parenteral use,1161.95,FAREVA MIRABEL,France,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
CANCIDAS 70 MG VIAL,CASPOFUNGIN,0311222868,2016,70 mg,Powder for concentrate for solution for infusion,Parenteral use,1161.95,FAREVA MIRABEL,France,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
NASONEX 0.05% NASAL SPRAY,MOMETASONE FUROATE,2403210640,2016,0.05 µg,Nasal spray,Nasal use,47.55,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ATROVENT 250MCG-2ML UDV (SOLUTION FOR INHALATION),IPRATROPIUM BROMIDE,0110258288,2016,0.125 mg/ml,inhalation solution,Inhalation use,27.60,Laboratoire Unither,France,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
LAVISTINA 16 mg tablet,BETAHISTINE DIHYDROCHLORIDE,2510211230,2016,16 mg,Tablet,Oral use,34.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ATROVENT 500MCG-2ML UDV (SOLUTION FOR INHALATION),IPRATROPIUM BROMIDE,0110258287,2016,0.25 mg/ml,Nebuliser solution,Inhalation use,42.15,Laboratoire Unither,France,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
ADENURIC 80 mg film-coated tablet,FEBUXOSTAT,0510222690,2016,80 mg,Film-coated tablet,Oral use,78.35,Algorithm SAL,Lebanon,Algorithm SAL,Lebanon,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
VITAL E 400 mg capsule,ALPHA TOCOFERIL,134-368-15,2015,400 mg,Capsule,Oral use,36.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DELAXIN 30 mg delayed-release capsule,DULOXETINE,216-334-16,2016,30 mg,"Gastro-resistant capsule, hard",Oral use,47.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
DELAXIN 60 mg delayed-release capsule,DULOXETINE,217-334-16,2016,60 mg,"Gastro-resistant capsule, hard",Oral use,95.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
REMSIMA 100 mg powder for solution for infusion,INFLIXIMAB,198-334-15,2015,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1357.25,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
PRANZA ODT 5 mg,OLANZAPINE,2510222801,2016,5 mg,Orodispersible tablet,Oral use,107.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PRANZA ODT 10 mg,OLANZAPINE,2510222802,2016,10 mg,Orodispersible tablet,Oral use,177,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PRANZA 5 mg film-coated tablet,OLANZAPINE,0311222866,2016,5 mg,Film-coated tablet,Oral use,107.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PRANZA 10 mg film-coated tablet,OLANZAPINE,2610222818,2016,10 mg,Film-coated tablet,Oral use,177,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FYCOMPA 2 mg Film-Coated Tablet,PERAMPANEL,0105233569,2016,2 mg,Film-coated tablet,Oral use,64.2,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PRIMA D3 5000 IU softgel capsule,COLECALCIFEROL,2410234388,2018,5000 IU,"Capsule, soft",Oral use,33.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
PRIMA D3 10000 IU softgel capsule,COLECALCIFEROL,0709234152,2018,10000 IU,"Capsule, soft",Oral use,19.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
PRIMA D3 50000 IU softgel capsule,COLECALCIFEROL,2410234384,2018,50000 IU,"Capsule, soft",Oral use,96.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
NULEX 100 mg Capsule,GABAPENTIN,1209234189,2018,100 mg,Capsule,Oral use,12.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NULEX 300 mg Capsule,GABAPENTIN,1209234192,2018,300 mg,Capsule,Oral use,65.4,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NULEX 400 mg Capsule,GABAPENTIN,1209234190,2018,400 mg,Capsule,Oral use,76.9,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NULEX 600 mg Film Coated Tablet,GABAPENTIN,1209234188,2018,600 mg,Film-coated tablet,Oral use,69.2,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NULEX 800 mg Film Coated Tablet,GABAPENTIN,1209234193,2018,800 mg,Film-coated tablet,Oral use,92.3,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
SEQUIT 25 mg Film Coated Tablets,QUETIAPINE,0409234102,2018,25 mg,Film-coated tablet,Oral use,29.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SEQUIT 100 mg Film Coated Tablets,QUETIAPINE,0409234103,2018,100 mg,Film-coated tablet,Oral use,34.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SEQUIT 200 mg Film Coated Tablets,QUETIAPINE,1311234461,2018,200 mg,Film-coated tablet,Oral use,68.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SEQUIT 300 mg Film Coated Tablets,QUETIAPINE,1311234460,2018,300 mg,Film-coated tablet,Oral use,102.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
BRIDION 100 mg/ml Solution for Injection,SUGAMMADEX,2609234274,2017,100 mg/ml,Solution for injection,Intravenous use,2178.25,MERCK SHARP & DOHME B.V.,Netherlands,MERCK SHARP & DOHME LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
AKYNZEO 300 mg/0.5 mg hard capsules,"NETUPITANT, PALONOSETRON HYDROCHLORIDE",1303257068,2018,"300,0.5 mg","Capsule, hard",Oral use,306.70,Helsinn Birex Pharmaceuticals Ltd,Ireland,Helsinn Birex Pharmaceuticals Ltd,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LIXIANA 60 mg film coted tablet,EDOXABAN TOSILATE,1209234186,2018,60 mg,Film-coated tablet,Oral use,240,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LIXIANA 30 mg film coted tablet,EDOXABAN TOSILATE,1209234184,2018,30 mg,Film-coated tablet,Oral use,240,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LIXIANA 15 mg film coted tablet,EDOXABAN TOSILATE,1209234185,2018,15 mg,Film-coated tablet,Oral use,120,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
INVANZ 1 gm Powder for Concentrate for Solution for Infusion,ERTAPENEM SODIUM,2310234370,2018,1 g,Powder for concentrate for solution for infusion,Intravenous use,133.65,FAREVA MIRABEL,France,MERCK SHARP & DOHME LIMITED,United Kingdom,Marketed,Prescription,do not store above 25°c,Hospital,ALNAGHI COMPANY
VILDATIN 50 mg Tablet,VILDAGLIPTIN,1309234201,2018,50 mg,Tablet,Oral use,36.95,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
VILDATIN 50 mg Tablet,VILDAGLIPTIN,1309234202,2018,50 mg,Tablet,Oral use,79.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
TEGOZOL 20 mg Capsule,TEMOZOLOMIDE,1211234455,2018,20 mg,Capsule,Oral use,231.25,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PRIMA D3 5000 IU softgel capsule,COLECALCIFEROL,2410234386,2018,5000 IU,"Capsule, soft",Oral use,16.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
PRIMA D3 2000 IU softgel capsule,COLECALCIFEROL,2410234390,2018,2000 IU,"Capsule, soft",Oral use,33.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
PRIMA D3 2000 IU softgel capsule,COLECALCIFEROL,2410234385,2018,2000 IU,"Capsule, soft",Oral use,9.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
BETMIGA 25 mg Prolonged Release Film Coted Tablet,MIRABEGRON,2308234026,2018,25 mg,Prolonged-release film-coated tablet,Oral use,142.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BETMIGA 50 mg Prolonged Release Film Coted Tablet,MIRABEGRON,2308234027,2018,50 mg,Prolonged-release film-coated tablet,Oral use,183.9,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CLOMID 50MG TAB,CLOMIFENE,0309245855,2018,50 mg,Tablet,Oral use,22.5,PATHEON FRANCE,France,sanofi-aventis FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
XELJANZ XR 11 mg Extended Release Tablet,TOFACITINIB,2509234268,2018,11 mg,modified-release tablet,Oral use,3485.15,Pfizer Ireland Pharmaceuticals,Ireland,PFIZER,United States,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
THYROGEN 0.9 mg/ml powder for solution For injection,THYROTROPIN ALFA,2310246094,2017,0.9 mg/ml,powder for solution for injection,Intramuscular use,4584.70,HOSPIRA INC. MCPHERSON,United States,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Arabian Trade House, Sanofi Arabia Trading Co. Ltd"
LAGONA 20 mg  Hard capsule,TEMOZOLOMIDE,1601244748,2018,20 mg,"Capsule, hard",Oral use,214.55,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
TEGOZOL 100 mg Capsule,TEMOZOLOMIDE,1211234454,2018,100 mg,Capsule,Oral use,1096.70,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LAGONA 5 mg  Hard capsule,TEMOZOLOMIDE,1601244752,2018,5 mg,"Capsule, hard",Oral use,53.65,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LAGONA 100 mg  Hard capsule,TEMOZOLOMIDE,1601244750,2018,100 mg,"Capsule, hard",Oral use,1017.55,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LAGONA 100 mg  Hard capsule,TEMOZOLOMIDE,1601244751,2018,100 mg,"Capsule, hard",Oral use,4070.15,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LAGONA 5 mg  Hard capsule,TEMOZOLOMIDE,1601244749,2018,5 mg,"Capsule, hard",Oral use,214.55,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
TEGOZOL 250 mg Capsule,TEMOZOLOMIDE,1211234453,2018,250 mg,Capsule,Oral use,2970.25,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
FENSOLIN 5 mg Film Coated Tablet,SOLIFENACIN SUCCINATE,0612234572,2018,5 mg,Film-coated tablet,Oral use,84.7,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
FENSOLIN 10 mg Film Coated Tablet,SOLIFENACIN SUCCINATE,1610234338,2018,10 mg,Film-coated tablet,Oral use,108.9,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
DEPAKINE 500MG TABS,VALPROATE SODIUM,21-883-18,2018,500 mg,Gastro-resistant tablet,Oral use,32.20,"Sanofi-aventis, S.A.",Spain,sanofi-aventis FRANCE,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
MAVIRET 100 mg/40 mg Film Coated Tablet,"GLECAPREVIR, PIBRENTASVIR",2911234566,2018,"100,40 mg",Film-coated tablet,Oral use,39417.35,Abbott Laboratories Fournier (Laboratories) Ireland Ltd,Ireland,ABBVIE Inc.,United States,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
GLEMAX 1 mg Tablet,GLIMEPIRIDE,2201244780,2018,1 mg,Tablet,Oral use,8.35,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
GLEMAX 2 mg Tablet,GLIMEPIRIDE,2201244778,2018,2 mg,Tablet,Oral use,13.7,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
GLEMAX 3 mg Tablet,GLIMEPIRIDE,2201244781,2018,3 mg,Tablet,Oral use,21.25,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
GLEMAX 4 mg Tablet,GLIMEPIRIDE,2201244783,2018,4 mg,Tablet,Oral use,24.95,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
GLEMAX 6 mg Tablet,GLIMEPIRIDE,2201244779,2018,6 mg,Tablet,Oral use,37.4,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
CIPALIN 0.5 mg/ml Vial,CISPLATIN,288-334-18,2018,10 mg,Concentrate for solution for infusion,Intravenous use,21,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CIPALIN 0.5 mg/ml Vial,CISPLATIN,289-334-18,2018,10 mg,Concentrate for solution for infusion,Intravenous use,43.25,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CIPALIN 0.5 mg/ml Vial,CISPLATIN,290-334-18,2018,10 mg,Concentrate for solution for infusion,Intravenous use,60,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
PRICK TEST,ALLERGEN EXTRACT -SKIN PRICK TEST (FOOD),2403245074,2018,0 mg/ml,Solution,Topical,136.6,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
OCTAPLEX 500 IU,PROTHROMBIN,0603245027,2018,25 IU/ml,Powder and solvent for solution for injection,Intravenous use,1633.50,OCTAPHARMA,Austria,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,Jazeera Pharmaceutical Industries (JPI)
PRICK TEST,ALLERGEN EXTRACT - SKIN PRICK TEST (INDOOR),2403245076,2018,0 mg/ml,Solution,Topical,136.6,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
PRIC-TEK Sol. for Skin Prick Test (Mould),ALLERGEN EXTRACT -SKIN PRICK TEST (MOULD),9-5208-18,2018,0 mg/ml,Solution,Topical,136.6,"Inmunotek, S.L",Spain,ALLERGOTEK limited,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
Clustek,POLIMERIZED ALLERGEN EXTRACT,2403245072,2018,10000 TU/ml,Suspension for injection,Subcutaneous use,888.35,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Takhassusi Bio Medical
Oraltek 30.000 TU/ml Sol. for Sublingual Spray (Pollen),ALLERGEN EXTRACT,2403245075,2018,30000 TU/ml,Spray,Sublingual use,808.6,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
Clustek 10.000 TU/ml Susp. for Injection (Pollen),POLIMERIZED ALLERGEN EXTRACT,2403245073,2018,10000 TU/ml,Suspension for injection,Subcutaneous use,888.35,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Takhassusi Bio Medical
ALLERGOTEK Oraltek 30.000 TU/ml Sol. for Sublingual Spray (Indoor),ALLERGENIC EXTRACTS,2403245079,2018,30000 TU/ml,Spray,Sublingual use,808.6,"Inmunotek, S.L",Spain,ALLERGOTEK limited,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
Oraltek 30.000 TU/ml Sol. for Sublingual Spray (Mould),ALLERGEN EXTRACT,2403245078,2018,30000 TU/ml,Spray,Sublingual use,808.6,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
EMANERA 20mg Gastro-Resistant Capsule,ESOMEPRAZOLE,1410246038,2018,20 mg,Gastro-resistant capsule,Oral use,46.05,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
EMANERA 40mg Gastro-Resistant Capsule,ESOMEPRAZOLE,1410246039,2018,40 mg,Gastro-resistant capsule,Oral use,61.70,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
PULECTUS 100 mg Film Coated Tablet,ERLOTINIB,1604245165,2018,100 mg,Film-coated tablet,Oral use,3731.15,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
PULECTUS 150 mg Film Coated Tablet,ERLOTINIB,0705245255,2018,150 mg,Film-coated tablet,Oral use,4419.10,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
AZYN 500 mg Film Coated Tablet,AZITHROMYCIN,2301256738,2018,500 mg,Film-coated tablet,Oral use,26.4,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
CERUXIM 250 mg Film Coted Tablet,CEFUROXIME AXETIL,0201244653,2018,250 mg,Film-coated tablet,Oral use,33.7,MEDOCHEMIE LTD (FACTORY C),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PRICK TEST,ALLERGEN EXTRACT -SKIN PRICK TEST (POLLEN),2403245077,2018,0 mg/ml,Solution,Topical,136.6,"Inmunotek, S.L",Spain,Takhasussi Biomedical,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Takhassusi Bio Medical
ARBAVASC HCT 160/10/25 mg Film-coated Tablet,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0409234115,2018,"160,25,10 mg",Film-coated tablet,Oral use,66.85,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BUSCOPAN TABLETS 10MG,HYOSCINE BUTYLBROMIDE,1112246394,2018,10 mg,Tablet,Oral use,12.75,DELPHARM REIMS S.A.S,France,A. Nattermann and Cie Gmbh,Germany,Marketed,OTC,store below 25°c,Pharmacy,Opella Arabia Limited Co
KISQALI 200 mg Film-Coated Tablet,RIBOCICLIB,2308234033,2018,200 mg,Film-coated tablet,Oral use,8320.25,NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTE. LTD.,Singapore,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novartis Saudi Limited
VULTERA 200 mg Film Coated Tablet,VORICONAZOLE,1810234396,2018,200 mg,Film-coated tablet,Oral use,2334.30,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VULTERA 50 mg Film Coated Tablet,VORICONAZOLE,1810234356,2018,50 mg,Film-coated tablet,Oral use,583.55,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
YOCAIR 4 mg Chewable Tablets,MONTELUKAST SODIUM,2210234366,2018,4 mg,Chewable tablet,Oral use,64.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
YOCAIR 5 mg Chewable Tablets,MONTELUKAST SODIUM,0409234109,2018,5 mg,Chewable tablet,Oral use,64.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SNAFI 5 mg Film Coated Tablet,TADALAFIL,1209234183,2018,5 mg,Film-coated tablet,Oral use,136.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LORETA 2.5 mg/5 ml Syrup,DESLORATADINE,1108257995,2018,0.5 mg/ml mg/ml,Syrup,Oral use,14.3,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
LOVERA 10 mg Film Coated Tablet,TADALAFIL,1108258004,2018,10 mg,Film-coated tablet,Oral use,74.45,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SOMATULINE AUTOGEL 120 MG SOLUTION FOR INJECTION IN PRE-FILLE,LANREOTIDE ACETATE,0702244865,2017,120 mg,Solution for injection in pre-filled syringe,Subcutaneous use,4377.55,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
KISQALI 200 mg Film-Coated Tablet,RIBOCICLIB,2308234034,2018,200 mg,Film-coated tablet,Oral use,12471.15,NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTE. LTD.,Singapore,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novartis Saudi Limited
FUSIDERM 2% OINTMENT,FUSIDIC ACID,1209234182,2018,2 %,Ointment,Topical,16.3,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
TOSTAF 500 mg Vial,VANCOMYCIN,1709234220,2018,500 mg,Powder for solution for infusion,Intravenous use,18,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
XULTOPHY 100 U/ml + 3.6 mg/ml Solution for  Injection,"INSULIN DEGLUDEC, LIRAGLUTIDE",2510234393,2018,"100,3.6 mg/ml, U/m",Solution for injection,Subcutaneous use,821.30,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
EXXARA 8 mg film-coated tablets,LORNOXICAM,3108234069,2018,8 mg,Film-coated tablet,Oral use,17.5,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ZAVICEFTA 2 g/0.5 g Vial,"CEFTAZIDIME, AVIBACTAM",2204245188,2018,"2,0.5 g",Powder for concentrate for solution for infusion,Intravenous use,4537.50,ACS DOBFAR SPA,Italy,Pfizer Ireland Pharmaceuticals,Ireland,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
ONDA 2 mg/ml Solution for Injection,ONDANSETRON,1206233785,2018,2 mg/ml,Solution for injection,Intravenous use,22.45,VIANEX S.A (Plant A),Greece,VIANEX S.A,Greece,Marketed,Prescription,store below 30°c,Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
TRAMAL 50 MG-1 ML AMPOULE,TRAMADOL HYDROCHLORIDE,2612223042,2018,50 mg/ml,Solution for injection,Intravenous use,18.15,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
TRAMAL 50 MG-1 ML AMPOULE,TRAMADOL HYDROCHLORIDE,2609222646,2018,50 mg/ml,Solution for injection,Intravenous use,31.9,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
DIANE-35 TAB,"CYPROTERONE ACETATE, ETHINYLESTRADIOL",1502221726,2018,"2`,0.035 mg",Coated tablet,Oral use,21.9,BAYER WEIMAR GmbH UND CO. KG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
MUCOSOLVAN TAB 30MG,AMBROXOL HYDROCHLORIDE,2210258455,2018,30 mg,Tablet,Oral use,14.70,DELPHARM REIMS S.A.S,France,A. Nattermann and Cie Gmbh,Germany,Marketed,OTC,store below 25°c,Pharmacy,Opella Arabia Limited Co
KISQALI 200 mg Film-Coated Tablet,RIBOCICLIB,2308234032,2018,200 mg,Film-coated tablet,Oral use,4169.40,NOVARTIS SINGAPORE PHARMACEUTICAL MANUFACTURING PTE. LTD.,Singapore,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novartis Saudi Limited
ARBAVASC HCT 160/10/12.5 mg Film-coated Tablet,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0409234113,2018,"160,12.5,10 mg",Film-coated tablet,Oral use,66.85,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVASC HCT 160/5/25 mg Film-coated Tablet,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0409234114,2018,"160,25,5 mg",Film-coated tablet,Oral use,57.2,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARBAVASC HCT 160/5/12.5 mg Film-coated Tablet,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0409234116,2018,"160,12.5,5 mg",Film-coated tablet,Oral use,57.2,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
EPINOR 1 mg/ml Injection,NOREPINEPHRINE BITARTRATE,1309234200,2018,1 mg/ml,Injection,Intravenous use,43.15,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
NOREPIRIN 2 mg/ml Injection,NOREPINEPHRINE BITARTRATE,1303245047,2018,2 mg/ml,Injection,Intravenous use,86.35,"Huons Co., Ltd.",KOREA,"Huons Co., Ltd.",KOREA,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
ELEVIT PRONATAL,"RIBOFLAVIN (VITAMIN B2), THIAMINE, BIOTIN, MANGANESE, FOLIC ACID, PYRIDOXINE (VITAMIN B6), COPPER, CYANOCOBALAMIN, NICOTINAMIDE, CALCIUM PANTOTHENATE, COLECALCIFEROL (VITAMIN D3), ASCORBIC ACID, MAGNESIUM HYDROXIDE, PHOSPHATE, CALCIUM CHLORIDE, RETINOL, FERROUS FUMARATE, ZINC OXIDE, DL-ALPHA TOCOFERIL ACETATE",0709234155,2017,"1.8,1.6,0.2,1,0.8,2.6,1,4,19,10,12.5,100,100,125,125,3600,60,7.5,15 mg, IU, µg",Film-coated tablet,Oral use,39,Dragenopharm Apotheker Puschl GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
OLUMIANT 2 mg Film Coated Tablet,BARICITINIB,2503245091,2018,2 mg,Film-coated tablet,Oral use,3776.55,"LILLY DEL CARIBE, INC.",United States,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
OLUMIANT 4 mg Film Coated Tablet,BARICITINIB,2503245090,2018,4 mg,Film-coated tablet,Oral use,3776.55,"LILLY DEL CARIBE, INC.",United States,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
MOZOBIL 24mg/1.2ml solution for injection,PLERIXAFOR,2205257448,2018,20 mg/ml,Solution for injection,Subcutaneous use,15876.40,Genzyme Corporation,United States,Sanofi B.V,Netherlands,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
OLMEPRESS 40 mg film-coated tablet,OLMESARTAN MEDOXOMIL,1910234359,2018,40 mg,Film-coated tablet,Oral use,57.25,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MONOFER 100 mg/ml Solution For Injection/Infusion,IRON ISOMALTOSIDE 1000,2-574-18,2018,100 mg/ml,Solution for injection/infusion,Intravenous use,403.6,WASSERBURGER ARZNEIMITTELWEK GMBH,Germany,PHARMACOSMOS A/S,Denmark,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,"Farouk, Maamoun Tamer & CO"
MONOFER 100 mg/ml Solution For Injection/Infusion,IRON ISOMALTOSIDE 1000,3-574-18,2018,100 mg/ml,Solution for injection/infusion,Intravenous use,2018,WASSERBURGER ARZNEIMITTELWEK GMBH,Germany,PHARMACOSMOS A/S,Denmark,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,"Farouk, Maamoun Tamer & CO"
ADEMPAS 0.5 mg film-coated tablets,RIOCIGUAT,60-4-18,2018,0.5 mg,Film-coated tablet,Oral use,5020.50,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ADEMPAS 1 mg film-coated tablets,RIOCIGUAT,61-4-18,2018,1 mg,Film-coated tablet,Oral use,5020.50,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ADEMPAS 1.5 mg film-coated tablets,RIOCIGUAT,62-4-18,2018,1.5 mg,Film-coated tablet,Oral use,5020.50,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ADEMPAS 2 mg film-coated tablets,RIOCIGUAT,63-4-18,2018,2 mg,Film-coated tablet,Oral use,5020.50,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ADEMPAS 2.5 mg film-coated tablets,RIOCIGUAT,64-4-18,2018,2.5 mg,Film-coated tablet,Oral use,5020.50,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
ORGALUTRAN 0.25MG\0.5ML SYRINGE,GANIRELIX ACETATE,2905257494,2018,0.25 mg,Solution for injection,Subcutaneous use,142.15,VETTER PHARMA,Germany,ORGANON,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,"Farouk, Maamoun Tamer & CO"
PROVERA 5MG TAB,MEDROXYPROGESTERONE ACETATE,0410234297,2018,5 mg,Tablet,Oral use,34.65,Pfizer Italia S.R.L,Italy,PFIZER ITALY S.R.I,Italy,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
DEPAKINE 200MG TABS,VALPROATE SODIUM,18-883-18,2018,200 mg,Gastro-resistant tablet,Oral use,18.45,"SANOFI-AVENTIS, S.A",Spain,sanofi-aventis FRANCE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
OLMEPRESS 20 mg film-coated tablet,OLMESARTAN MEDOXOMIL,1910234360,2018,20 mg,Film-coated tablet,Oral use,43,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AMEP 10 mg Tablet,AMLODIPINE BESILATE,1611234490,2018,10 mg,Tablet,Oral use,27.2,COOPER PHARMA,Morocco,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ELONVA 150 mcg Solution For Injection,CORIFOLLITROPIN ALFA,2304245197,2018,150 µg,Solution for injection,Subcutaneous use,2168.40,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,N.V. Organon,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
TANDO 5 mg Film Coted Tablet,TADALAFIL,1106233780,2018,5 mg,Film-coated tablet,Oral use,136.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TANDO 20 mg Film Coted Tablet,TADALAFIL,1106233779,2018,20 mg,Film-coated tablet,Oral use,64.85,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
XIGDUO XR 10 mg/1000 mg Film Coted Tablet,"METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN",1309234198,2018,"1000,10 mg",Film-coated tablet,Oral use,124.40,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
KETOVA 100 mg Film Coated Tablets,IMATINIB MESILATE,1707233875,2018,100 mg,Film-coated tablet,Oral use,545.3,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
ORATANE 10 mg Soft Capsules,ISOTRETINOIN,1911234504,2017,10 mg,Capsule,Oral use,40.25,SWISS CAPS AG,Switzerland,DOUGLAS MANUFACTURING Ltd,New Zealand,Marketed,Prescription,store below 30°c,Pharmacy,Thimar Aljazirah Company
NOSTIFIX 0.5 mg TABLET,CABERGOLINE,0309234090,2018,0.5 mg,Tablet,Oral use,119.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NOSTIFIX 0.5 mg TABLET,CABERGOLINE,0309234091,2018,0.5 mg,Tablet,Oral use,37.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VEELBORE 3.5 mg Powder For Solution For Injection,BORTEZOMIB,1807233880,2018,3.5 mg,powder for solution for injection,Subcutaneous use,2692.85,PharmIdea SIA,Latvia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ZOLONIA 5 mg Film Coated Tablet,ZOLPIDEM,3108234079,2018,5 mg,Film-coated tablet,Oral use,18.40,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZOLONIA 10 mg Film Coated Tablet,ZOLPIDEM,2606233836,2018,10 mg,Film-coated tablet,Oral use,36.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
YASMIN TAB.,"DROSPINENONE, ETHINYLESTRADIOL",1310222733,2018,"3,0.03 mg",Film-coated tablet,Oral use,23.75,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
FLOMOXIN 400 mg Solution for Infusion,MOXIFLOXACIN HYDROCHLORIDE,2205233680,2018,1.6 mg/ml,Solution for infusion,Intravenous use,85.40,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
TEICO 200 mg Vial,TEICOPLANIN,1411234468,2018,200 mg,Powder and solvent for solution for injection/infusion,Intramuscular and intravenous use,55.4,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
TEICO 400 mg Vial,TEICOPLANIN,1411234470,2018,400 mg,Powder and solvent for solution for injection/infusion,Intramuscular and intravenous use,79.7,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
XIGDUO XR 10 mg/500 mg Film Coted Tablet,"METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN",1309234196,2018,"500,10 mg",Film-coated tablet,Oral use,122.45,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
XIGDUO XR 5 mg/1000 mg Film Coted Tablet,"METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN",1309234197,2018,"1000,5 mg",Film-coated tablet,Oral use,128.00,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ORATANE 20 mg Soft Capsules,ISOTRETINOIN,1911234503,2017,20 mg,Capsule,Oral use,61.6,SWISS CAPS AG,Switzerland,DOUGLAS MANUFACTURING Ltd,New Zealand,Marketed,Prescription,store below 30°c,Pharmacy,Thimar Aljazirah Company
CERUXIM 500 mg Film Coted Tablet,CEFUROXIME AXETIL,0201244654,2018,500 mg,Film-coated tablet,Oral use,56.55,MEDOCHEMIE LTD (FACTORY C),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VILTIN 50 mg Tablet,VILDAGLIPTIN,0310234289,2018,50 mg,Tablet,Oral use,31.05,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
EXTEMENT 25 mg Chewable Tablet,SILDENAFIL,2905245381,2018,25 mg,Chewable tablet,Oral use,36.3,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
LACTATED RINGERS INJECTION,LACTATED RINGER(S),1209234187,2018,,Solution for injection,Intravenous use,138.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
RINGERS INJECTION,RINGER(S) SOLUTION,1007233854,2018,,Solution for injection,Intravenous use,130.80,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
DOCETAXEL SPC 20 mg/ml Solution for Infusion,DOCETAXEL,2711234555,2018,20 mg/ml,Concentrate for solution for infusion,Intravenous use,801.80,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,SUDAIR PHARMA COMPANY
Imalar 100 mg Tablet,IMATINIB MESILATE,2602244991,2018,100 mg,Tablet,Oral use,981.55,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Imalar 400 mg Tablet,IMATINIB MESILATE,2602244990,2018,400 mg,Tablet,Oral use,2181.25,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
SOLIQUA SOLOSTAR (33 mcg/ml) /100 U Solution for Injection,"INSULIN GLARGINE, LIXISENATIDE",0701256537,2018,"100,0.33 µ/ml, IU/m",Solution for injection in pre-filled syringe,Subcutaneous use,748.75,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
SOLIQUA SOLOSTAR (33 mcg/ml) /100 U Solution for Injection,"INSULIN GLARGINE, LIXISENATIDE",0701256535,2018,"100,0.33 µ/ml, IU/m",Solution for injection in pre-filled syringe,Subcutaneous use,449.25,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
SOLIQUA SOLOSTAR 50 mcg/ml) /100 U Solution for Injection,"INSULIN GLARGINE, LIXISENATIDE",0701256536,2018,"100,0.5 µ/ml, IU/m",Solution for injection in pre-filled syringe,Subcutaneous use,898.4,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
SOLIQUA SOLOSTAR 50 mcg/ml) /100 U Solution for Injection,"INSULIN GLARGINE, LIXISENATIDE",0701256538,2018,"100,0.5 µ/ml, IU/m",Solution for injection in pre-filled syringe,Subcutaneous use,539.05,Sanofi aventis Deutschland GmbH,Germany,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
ARPENIA 1 mg/ml Oral Solution,ARIPIPRAZOLE,1611234487,2018,1 mg/ml,Oral solution,Oral use,219.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
INSTIGAR 30 mg Delayed-Release Capsule,DEXLANSOPRAZOLE,0308233951,2018,30 mg,Modified-release capsule,Oral use,30.55,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BORTEZOMIB SPC 3.5 mg Powder for Solution for Infusion,BORTEZOMIB,0810234311,2018,3.5 mg,powder for solution for injection,Subcutaneous use,3029.45,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
INSTIGAR 30 mg Delayed-Release Capsule,DEXLANSOPRAZOLE,0608233966,2018,30 mg,Modified-release capsule,Oral use,72.15,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EZEACT 40 mg Tablet,AZILSARTAN MEDOXOMIL,0111234414,2018,40 mg,Tablet,Oral use,65.2,TAKEDA PHARMACEUTICAL COMPANY LIMITED,Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
EZEACT 80 mg Tablet,AZILSARTAN MEDOXOMIL,1511234486,2018,80 mg,Tablet,Oral use,97.85,TAKEDA PHARMACEUTICAL COMPANY LIMITED,Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
OMIZ 40mg Powder For Solution For Infusion,OMEPRAZOLE,2410234392,2017,40 mg,Powder for solution for infusion,Intravenous use,112.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
NIVESTIM 600 mcg Solution for Injection/ Infusion,FILGRASTIM,0211234423,2018,600 µg,Solution for injection/infusion,Intravenous use,315.55,HOSPIRA ZAGREB D.O.O.,Croatia,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
NIVESTIM 600 mcg Solution for Injection/ Infusion,FILGRASTIM,0211234424,2018,600 µg,Solution for injection/infusion,Intravenous use,788.85,HOSPIRA ZAGREB D.O.O.,Croatia,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
NIVESTIM 960 mcg Solution for Injection/ Infusion,FILGRASTIM,0211234422,2018,960 µg,Solution for injection/infusion,Intravenous use,1262.15,HOSPIRA ZAGREB D.O.O.,Croatia,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
ARENA PLUS 150 mg/12.5 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0309234095,2017,"150,12.5 mg",Film-coated tablet,Oral use,45.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ARENA PLUS 300 mg/12.5 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0309234094,2017,"300,12.5 mg",Film-coated tablet,Oral use,55.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ARENA PLUS 300 mg/25 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0309234096,2017,"300,25 mg",Film-coated tablet,Oral use,55.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
INSTIGAR 60 mg Delayed-Release Capsule,DEXLANSOPRAZOLE,0308233950,2018,60 mg,Modified-release capsule,Oral use,98.95,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ACTODRYL Syrup,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE",0607233848,2018,"25,5,0.25 mg/ml",Syrup,Oral use,12.00,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PEMETREXED SPC 500 mg Powder for Solution for  Infusion,PEMETREXED,1907233889,2018,500 mg,Powder for solution for infusion,Intravenous use,3405.85,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
CAPECITABINE SPC 150 mg Film Coted Tablet,Capecitabine,1910234362,2018,150 mg,Film-coated tablet,Oral use,177.35,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
EXTEMENT 50 mg Chewable Tablet,SILDENAFIL,2805245357,2018,50 mg,Chewable tablet,Oral use,39.35,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
EXTEMENT 100 mg Chewable Tablet,SILDENAFIL,2905245380,2018,100 mg,Chewable tablet,Oral use,39.35,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
IRBEGEN 150 mg Film Coated Tablet,IRBESARTAN,0801244686,2017,150 mg,Film-coated tablet,Oral use,25.65,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
IRBEGEN 300 mg Film Coated Tablet,IRBESARTAN,0801244681,2017,300 mg,Film-coated tablet,Oral use,26.85,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SEROGEN 25 mg Film Coated Tablet,QUETIAPINE,0801244682,2018,25 mg,Film-coated tablet,Oral use,19.9,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SEROGEN 100 mg Film Coated Tablet,QUETIAPINE,0801244683,2018,100 mg,Film-coated tablet,Oral use,46.9,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SEROGEN 200 mg Film Coated Tablet,QUETIAPINE,0801244684,2018,200 mg,Film-coated tablet,Oral use,87,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SEROGEN 300 mg Film Coated Tablet,QUETIAPINE,0801244685,2018,300 mg,Film-coated tablet,Oral use,71.4,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
LAYAL Syrup,LEVOCETIRIZINE DIHYDROCHLORIDE,0409234098,2018,0.5 mg/ml,Syrup,Oral use,11.55,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
PARACETAMOL B.Braun 10 mg/ml solution for infusion,PARACETAMOL,2602256940,2018,10 mg/ml,Solution for infusion,Intravenous use,31.50,B. BRAUN MEDICAL S.A,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
LIPOPLUS 20 % Emulsion For Infusion,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL, OMEGA-3-ACID ETHYL ESTERS",1810234352,2017,"100,80,20 g",Emulsion for infusion,Intravenous use,29.60,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
LIPOPLUS 20 % Emulsion For Infusion,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL, OMEGA-3-ACID ETHYL ESTERS",1810234351,2017,"100,80,20 g",Emulsion for infusion,Intravenous use,49.80,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
CAPECITABINE SPC 500 mg Film Coted Tablet,Capecitabine,1910234363,2018,500 mg,Film-coated tablet,Oral use,1060.55,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
LIPOPLUS 20 % Emulsion For Infusion,"TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL, OMEGA-3-ACID ETHYL ESTERS",1810234353,2017,"100,80,20 g",Emulsion for infusion,Intravenous use,83.6,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
BASAGLAR 100 u/ml solution for injection in Pre-Filled pen,INSULIN GLARGINE,2711234554,2018,100 IU/ml,Solution for injection in pre-filled pen,Subcutaneous use,163.20,ELI LILLY,France,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
DELTACEF 1 gm Vial,CEFEPIME HYDROCHLORIDE,0409234126,2018,1 g,powder for solution for injection,Intramuscular and intravenous use,30.3,MEDOCHEMIE LTD (FACTORY C),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
DELTACEF 2 gm Vial,CEFEPIME HYDROCHLORIDE,0409234125,2018,2 g,powder for solution for injection,Intramuscular and intravenous use,52,MEDOCHEMIE LTD (FACTORY C),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
JADENU 90 mg Film-coated Tablet,DEFERASIROX,1611234497,2018,90 mg,Film-coated tablet,Oral use,618.2,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
JADENU 180 mg Film-coated Tablet,DEFERASIROX,1611234499,2018,180 mg,Film-coated tablet,Oral use,1228.25,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
JADENU 360 mg Film-coated Tablet,DEFERASIROX,1611234498,2018,360 mg,Film-coated tablet,Oral use,2440.3,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ROTUB 6 mg/ml Concentrate For Solution For Infusion,PACLITAXEL,1-5190-18,2018,6 mg/ml,Concentrate for solution for infusion,Intravenous use,197.9,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,VITANE PHARMA GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,HEALTH DRUG STORE
ROTUB 6 mg/ml Concentrate For Solution For Infusion,PACLITAXEL,2-5190-18,2018,6 mg/ml,Concentrate for solution for infusion,Intravenous use,727.8,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,VITANE PHARMA GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,HEALTH DRUG STORE
ROTUB 6 mg/ml Concentrate For Solution For Infusion,PACLITAXEL,3-5190-18,2018,6 mg/ml,Concentrate for solution for infusion,Intravenous use,846.3,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,VITANE PHARMA GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,HEALTH DRUG STORE
ROTUB 6 mg/ml Concentrate For Solution For Infusion,PACLITAXEL,4-5190-18,2018,6 mg/ml,Concentrate for solution for infusion,Intravenous use,2209.45,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,VITANE PHARMA GMBH,Germany,Marketed,Prescription,store below 30°c,Hospital,HEALTH DRUG STORE
AMBAFEN 4 mg/ml solution for infusion,IBUPROFEN,466-149-18,2018,4 mg/ml,Solution for infusion,Intravenous use,33,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
AMEP 5 mg Tablet,AMLODIPINE BESILATE,1611234491,2018,5 mg,Tablet,Oral use,13,COOPER PHARMA,Morocco,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DYNASTAT 40 mg Powder And solvent for Solution For injection,PARECOXIB,0111234413,2018,40 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,177.9,PHARMACIA UPJOHN,United States,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
BETOPTIC OPTHALMIC SOLUTION 0.5%,BETAXOLOL HYDROCHLORIDE,1510246054,2018,0.5 %,Ophthalmic solution,Ocular use,11.4,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
TOBRADEX EYE OINT,"TOBRAMYCIN, DEXAMETHASONE",1211246210,2018,"0.3,0.1 %",Eye ointment,Ocular use,20.4,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
OCUDINE 0.2%  OPHTHALMIC SOLUTION,BRIMONIDINE TARTRATE,3001244810,2018,2 mg/ml,Ophthalmic solution,Ophthalmic use,45.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
NOSTAM 0.4 MG PROLONGED RELEASE TABLET,TAMSULOSIN HYDROCHLORIDE,3007245701,2018,0.4 mg,Prolonged-release tablet,Oral use,28.3,Novartis Pharmaceutical Manufacturing LLC,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
RAMEP 20 MG GASTRO-RESISTANT TABLET,RABEPRAZOLE SODIUM,3007245702,2018,20 mg,Gastro-resistant tablet,Oral use,30.15,Novartis Pharmaceutical Manufacturing LLC,Slovenia,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
HEMLIBRA 150 MG/ML SOLUTION FOR INJECTION,EMICIZUMAB,0602256835,2018,150 mg/ml,Solution for injection,Subcutaneous use,44604.40,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
HEMLIBRA 150 MG/ML SOLUTION FOR INJECTION,EMICIZUMAB,0602256836,2018,150 mg/ml,Solution for injection,Subcutaneous use,31222.85,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
HEMLIBRA 150 MG/ML SOLUTION FOR INJECTION,EMICIZUMAB,0602256833,2018,150 mg/ml,Solution for injection,Subcutaneous use,17841.45,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
HEMLIBRA 30 MG/ML SOLUTION FOR INJECTION,EMICIZUMAB,0602256834,2018,30 mg/ml,Solution for injection,Subcutaneous use,8920.85,CHUGAI PHARMACEUTICAL CO LTD,Japan,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
ZOLAN 10 MG FILM-COATED  TABLET,OLANZAPINE,2204245184,2018,10 mg,Film-coated tablet,Oral use,217.6,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ZOLAN 5 MG FILM-COATED  TABLET,OLANZAPINE,2805245358,2018,5 mg,Film-coated tablet,Oral use,132.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
AQUAFLAM 50 MG SACHET,DICLOFENAC POTASSIUM,1902244942,2018,50 mg,Powder for oral solution,Oral use,24,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
BIOSOFT EYE DROP,SODIUM HYALURONATE,2-5210-18,2018,0.2 %,Eye drops,Ophthalmic use,31.1,Oy Finnsusp Ab,Finland,Oy Finnsusp Ab,Finland,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BIOSOFT PLUS EYE DROP,"TREHALOSE, SODIUM HYALURONATE",1-5210-18,2018,"2,0.25 %",Eye drops,Ophthalmic use,31.1,Oy Finnsusp Ab,Finland,Oy Finnsusp Ab,Finland,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
PARACONICA 10 MG/ML SOLUTION FOR INFUSION,PARACETAMOL,2602244983,2018,10 mg/ml,Solution for infusion,Intravenous use,143.45,S.M. Farmaceutici SRL,Italy,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
CHLORASEPTIC SORE THROAT LOZENGES (cherry),"MENTHOL, BENZOCAINE",2-5127-18,2018,"10,6 mg",Lozenge,Oral use,26.25,Bestco Inc.,United States,Prestige Brands Inc.,United States,Marketed,OTC,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
CHLORASEPTIC SORE THROAT LOZENGES (citrus),"MENTHOL, BENZOCAINE",3-5127-18,2018,"10,6 mg",Lozenge,Oral use,26.25,Bestco Inc.,United States,Prestige Brands Inc.,United States,Marketed,OTC,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
CHLORASEPTIC SORE THROAT LOZENGES ( Lemon),"MENTHOL, BENZOCAINE",1-5127-18,2018,"10,6 mg",Lozenge,Oral use,26.25,Bestco Inc.,United States,Prestige Brands Inc.,United States,Marketed,OTC,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
DYSPORT 500U VIAL,CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX,1006245399,2018,500 U,Powder for injection,"intramuscular, subcutaneous",947.1,Ipsen Biopharm Limited,United Kingdom,Ipsen Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
VERZENIO 200 MG FILM-COATED TABLET,ABEMACICLIB,0907245508,2018,200 mg,Film-coated tablet,Oral use,3117.80,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VERZENIO 150 MG FILM-COATED TABLET,ABEMACICLIB,0907245507,2018,150 mg,Film-coated tablet,Oral use,3117.80,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VERZENIO 100 MG FILM-COATED TABLET,ABEMACICLIB,0907245510,2018,100 mg,Film-coated tablet,Oral use,3117.80,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VERZENIO 50 MG FILM-COATED TABLET,ABEMACICLIB,0907245511,2018,50 mg,Film-coated tablet,Oral use,3117.80,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
AZI-ONCE 500MG F.C.TABLET,AZITHROMYCIN,1610234342,2018,500 mg,Film-coated tablet,Oral use,26.4,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
DIAPAM 10MG/2ML SOL. FOR INJ./INF,DIAZEPAM,0104245141,2018,5 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,23.85,Medochemie (Ampoule Injectable Facility),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CLEXANE 40MG\0.4ML PREFILLED SYRINGE,ENOXAPARIN SODIUM,23-883-19,2019,"40 mg, mg/ml",Solution for injection,Intravenous use,39.65,SANOFI WINTHROP INDUSTRIE,France,sanofi-aventis FRANCE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
KYPROLIS 60 mg Powder For Solution For Injection,CARFILZOMIB,2201233141,2019,60 mg,powder for solution for injection,Intravenous use,4235.30,Patheon Manufacturing Services LLC,United States,ONYX PHARMACEUTICALS INC.,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
M.M.R II 0.5ML VACCINE+ 0.7ML DILUENT,"MEASLES VIRUS (SCHWARZ) LIVE ATTENUATED, MUMPS VIRUS (JERYL LYNN, STRAIN RIT 4385) LIVE ATTENUATED, RUBELLA VIRUS (WISTAR RA 27/3) LIVE ATTENUATED",0208245719,2019,"1000,12.5,1000 CCID50",Powder and solvent for suspension for injection,Intramuscular use,51.9,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
ARCOXIA 60MG TAB,Etoricoxib,0502256831,2019,60 mg,Film-coated tablet,Oral use,70.70,Rovi Pharma Industrial Service,Spain,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARCOXIA 90MG TAB,Etoricoxib,0502256830,2019,90 mg,Film-coated tablet,Oral use,70.70,Rovi Pharma Industrial Service,Spain,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Z FILL DEEP 2 IMPLANT IN PRE-FILLED SYRINGE,SODIUM HYALURONATE,1-5199-18,2018,23 mg/ml,Implant in pre-filled syringe,Topical,320.95,Croma GmbH,Austria,Zimmer MedizinSysteme,Germany,Marketed,Prescription,,Pharmacy,Kalium Co for Scientific Equipment & Cosmetic Products w.l.l
CLEXANE 80MG\0.8ML PREFILLED SYRINGE,ENOXAPARIN SODIUM,2111246319,2019,80 mg,Solution for injection,Intravenous use,68.2,sanofi-aventis,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
DEXILANT 30 mg,DEXLANSOPRAZOLE,25-5083-20,2019,30 mg,Prolonged-release capsule,Oral use,72.15,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
SOOLANTRA 10MG/GM CREAM,IVERMECTIN,0307245473,2018,10 mg/g,Cream,Topical,82.85,Laboratories Galderma ZI Montdésir,France,GALDERMA,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
CARPAZIO 150 MG FILM COATED TABLET,OXCARBAZEPINE,1106245408,2018,150 mg,Film-coated tablet,Oral use,31.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CARPAZIO 300 MG FILM COATED TABLET,OXCARBAZEPINE,2902245009,2018,300 mg,Film-coated tablet,Oral use,45.4,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CARPAZIO 600 MG FILM COATED TABLET,OXCARBAZEPINE,0603256996,2018,600 mg,Film-coated tablet,Oral use,74.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VIBERZI 100 MG FILM COATED TABLETS,ELUXADOLINE,2-5179-18,2018,100 mg,Film-coated tablet,Oral use,238.35,Patheon Pharmaceuticals Inc.,United States,ALLERGAN PHARMACEUTICALS LTD,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIBERZI 75MG FILM COATED TABLETS,ELUXADOLINE,1-5179-18,2018,75 mg,Film-coated tablet,Oral use,238.35,Patheon Pharmaceuticals Inc.,United States,ALLERGAN PHARMACEUTICALS LTD,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VELPHORO 500 MG CHEWABLE TABLET,PA-21 FERRIC OXY-HYDROXIDE COMPONENT,0502244842,2018,500 mg,Chewable tablet,Oral use,603.50,CORDEN PHARMA FRIBOURG AG,Switzerland,VIFOR INTERNATIONAL,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
MABTHERA 120 MG/ML SOLUTION FOR SUBCUTANEOUS FOR INJECTION,RITUXIMAB,0311258534,2018,120 mg/ml,Concentrate and diluent for solution for infusion,Subcutaneous use,7032.6,F. Hoffmann-La Roche Ltd,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Roche Products Saudi Arabia
DEXILANT 30 mg,DEXLANSOPRAZOLE,24-5083-20,2019,30 mg,Prolonged-release capsule,Oral use,30.55,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
Z FILL CONTOUR 2 IMPLANT IN PRE-FILLED SYRINGE,SODIUM HYALURONATE,2-5199-18,2018,23 mg/ml,Implant in pre-filled syringe,Topical,320.95,Croma GmbH,Austria,Zimmer MedizinSysteme,Germany,Marketed,Prescription,,Pharmacy,Kalium Co for Scientific Equipment & Cosmetic Products w.l.l
Z FILL REFRESH 2 IMPLANT IN PRE-FILLED SYRINGE,SODIUM HYALURONATE,3-5199-18,2018,23 mg/ml,Implant in pre-filled syringe,Topical,251.15,Croma GmbH,Austria,Zimmer MedizinSysteme,Germany,Marketed,Prescription,,Pharmacy,Kalium Co for Scientific Equipment & Cosmetic Products w.l.l
BRIDION 100 MG/ML SOLUTION FOR INJECTION,SUGAMMADEX,1403245052,2017,100 mg/ml,Solution for injection,Intravenous use,5445.65,Patheon Manufacturing Services LLC,United States,MERCK SHARP & DOHME LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
SODIUM CHLORIDE 3% I.V. INJECTION,SODIUM CHLORIDE,25-430-19,2019,3 %,Solution for injection,Parenteral use,20,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
SODIUM CHLORIDE 3% I.V. INJECTION,SODIUM CHLORIDE,26-430-19,2019,3 %,Solution for injection,Parenteral use,10,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
SODIUM CHLORIDE 0.9% INJECTION,SODIUM CHLORIDE,27-430-19,2019,0.9 %,Solution for injection,Parenteral use,20,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
SODIUM CHLORIDE 0.9% INJECTION,SODIUM CHLORIDE,28-430-19,2019,0.9 %,Solution for injection,Parenteral use,10,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
ESCITALAX 20MG FILM COATED TABLET,ESCITALOPRAM,1009245896,2018,20 mg,Film-coated tablet,Oral use,65.40,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ESCITALAX 15MG FILM COATED TABLET,ESCITALOPRAM,1009245897,2018,15 mg,Film-coated tablet,Oral use,49.05,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ESCITALAX 10MG FILM COATED TABLET,ESCITALOPRAM,1009245898,2018,10 mg,Film-coated tablet,Oral use,32.65,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LIPIZET 10MG TABLET,EZETIMIBE,1211246207,2018,10 mg,Tablet,Oral use,110.6,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Arkator 60MG F.C.TABLET,Etoricoxib,1501256639,2019,60 mg,Film-coated tablet,Oral use,54.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Arkator 90MG F.C.TABLET,Etoricoxib,1501256655,2019,90 mg,Film-coated tablet,Oral use,54.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Arkator 120MG F.C.TABLET,Etoricoxib,1501256651,2019,120 mg,Film-coated tablet,Oral use,13.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MERISCAN 0.5MMOL/ML VIAL,GADODIAMIDE,1501256643,2019,0.5 mmol/ml,Solution for injection,Intravenous use,1028.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
STORVAS 40MG F.C.TABLET,ATORVASTATIN CALCIUM,1306245424,2019,40 mg,Film-coated tablet,Oral use,30.9,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
STORVAS 20MG F.C.TABLET,ATORVASTATIN CALCIUM,2305245344,2019,20 mg,Film-coated tablet,Oral use,22.65,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
STORVAS 10MG F.C.TABLET,ATORVASTATIN CALCIUM,2305245343,2019,10 mg,Film-coated tablet,Oral use,15.35,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
EPIXX 100MG/ML SYRUP,LEVETIRACETAM,1-5250-19,2019,100 mg/ml,Oral solution,Oral use,63.1,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MUCOSOLVAN LA 75MG CAPS,AMBROXOL HYDROCHLORIDE,0307245471,2018,75 mg,Capsule,Oral use,17.85,SANOFI WINTHROP INDUSTRIE,France,A. Nattermann and Cie Gmbh,Germany,Marketed,OTC,store below 30°c,Pharmacy,Opella Arabia Limited Co
UNISIA 8 MG/2.5 MG TABLET,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE",2207245626,2018,"8,2.5 mg",Tablet,Oral use,67,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
UNISIA 8 MG/5MG TABLET,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE",2207245627,2018,"8,5 mg",Tablet,Oral use,68.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ATOXIA 60 mg Film-coated Tablet,Etoricoxib,1-5286-19,2019,60 mg,Film-coated tablet,Oral use,14.65,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ATOXIA 90 mg Film-coated Tablet,Etoricoxib,2-5286-19,2019,90 mg,Film-coated tablet,Oral use,14.65,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MERISCAN 0.5MMOL/ML VIAL,GADODIAMIDE,1501256641,2019,0.5 mmol/ml,Solution for injection,Intravenous use,2045,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LAXILOSE SYRUP,LACTULOSE,2012234599,2018,67 %,Syrup,Oral use,18.45,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
ZOLEDRONIC ACID FRESENIUS KABI 4 MG/5 ML CONC. FOR SOLUTION FOR INFUSION,ZOLEDRONIC ACID,0905245266,2018,0.8 mg/ml,Concentrate for solution for infusion,Intravenous use,78.65,FRESENIUS KABI,Austria,FRESENIUS KABI,Austria,Marketed,Prescription,store below 30°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
MEPROSON 40MG POWDER FOR INJECTION,METHYLPREDNISOLONE,2612246496,2019,40 mg,powder for solution for injection,Intramuscular and intravenous use,7.85,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
ETOXA 60 MG FILM COATED TABLET,Etoricoxib,2102244963,2019,60 mg,Film-coated tablet,Oral use,48.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ETOXA 90 MG FILM COATED TABLET,Etoricoxib,2102244964,2019,90 mg,Film-coated tablet,Oral use,48.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ETOXA 120 MG FILM COATED TABLET,Etoricoxib,2102244962,2019,120 mg,Film-coated tablet,Oral use,12.25,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PLATEREL 5MG F.C.TABLET,PRASUGREL,1501256632,2018,5 mg,Film-coated tablet,Oral use,175,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PLATEREL 10MG F.C.TABLET,PRASUGREL,1501256628,2018,10 mg,Film-coated tablet,Oral use,175,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MEXAT 25 MG/ML SOLUTION FOR INJECTION,METHOTREXATE,4-5223-18,2018,25 mg/ml,Solution for injection,Intramuscular and intravenous use,301.55,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
MEXAT 25 MG/ML SOLUTION FOR INJECTION,METHOTREXATE,3-5223-18,2018,25 mg/ml,Solution for injection,Intramuscular and intravenous use,187.60,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
MEXAT 25 MG/ML SOLUTION FOR INJECTION,METHOTREXATE,2-5223-18,2018,25 mg/ml,Solution for injection,Intramuscular and intravenous use,29.35,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
CIPRO-SOL  200MG /100 ML bag,CIPROFLOXACIN,468-149-18,2018,2 mg/ml,Solution for infusion,Intravenous use,64.25,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
ULTIVA 1MG VIAL(LYOPHILIZED),REMIFENTANIL HYDROCHLORIDE,1004221931,2019,1 mg,Powder for concentrate for solution for infusion,Intravenous use,82.1,GLAXOSMITHKLINE (GSK),Italy,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
ULTIVA 2MG VIAL(LYOPHILIZED),REMIFENTANIL HYDROCHLORIDE,42-887-19,2019,2 mg,Powder for concentrate for solution for infusion,Intravenous use,155.50,GLAXOSMITHKLINE (GSK),United Kingdom,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
ULTIVA 5MG VIAL(LYOPHILIZED),REMIFENTANIL HYDROCHLORIDE,1004221930,2019,5 mg,Powder for concentrate for solution for infusion,Intravenous use,369.35,Aspen SA Operations (PTY) Ltd,South Africa,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
DIBASA 100000 I.U  AMPOULE,COLECALCIFEROL,1902244948,2018,100000 IU/ml,Solution,Intramuscular use,15.15,ABIOGEN PHARMA S.p.A.,Italy,ABIOGEN PHARMA S.p.A.,Italy,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
DIBASA 300000 I.U AMPOULE,COLECALCIFEROL,1902244947,2018,300000 IU/ml,Solution,Intramuscular use,13.3,ABIOGEN PHARMA S.p.A.,Italy,ABIOGEN PHARMA S.p.A.,Italy,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
MEPROSON 500 MG POWDER FOR INJECTION,METHYLPREDNISOLONE SODIUM SUCCINATE,2304257272,2019,500 mg,powder for solution for injection,Intramuscular and intravenous use,258.5,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
QATPEN XR 150MG TABLETS,QUETIAPINE,1108257999,2018,150 mg,Extended-release tablet,Oral use,73.25,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ZAHRA TABLET,"DROSPINENONE, ETHINYLESTRADIOL",0402256808,2018,"3,0.03 mg",Tablet,Oral use,18.15,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
LENALIDOMIDE SPC 25 mg Capsule,LENALIDOMIDE,2711234556,2018,25 mg,"Capsule, hard",Oral use,16804.35,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
PENTHROX 99.9 % liquid for inhalation,METHOXYFLURANE,2-600-18,2018,99.9 %,"Inhalation vapour, liquid",Inhalation use,1121.50,Medical Developments International Limited,Australia,Medical Developments International Limited,Australia,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
PENTHROX 99.9 % liquid for inhalation,METHOXYFLURANE,1302244914,2018,99.9 %,"Inhalation vapour, liquid",Inhalation use,125.00,Medical Developments International Limited,Australia,Medical Developments International Limited,Australia,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
PENTHROX 99.9 % liquid for inhalation,METHOXYFLURANE,4-600-18,2018,99.9 %,"Inhalation vapour, liquid",Inhalation use,800.00,Medical Developments International Limited,Australia,Medical Developments International Limited,Australia,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
MONTAS 4 mg Chewable Tablets,MONTELUKAST SODIUM,2001256685,2018,4 mg,Chewable tablet,Oral use,29.75,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
MONTAS 5 mg Chewable Tablets,MONTELUKAST SODIUM,1003257017,2018,5 mg,Chewable tablet,Oral use,35.7,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
CONVENTIN 300 mg Capsule,GABAPENTIN,2910234400,2018,300 mg,Capsule,Oral use,32.1,EVA PHARMA,Egypt,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CONVENTIN 400 mg Capsule,GABAPENTIN,2910234399,2018,400 mg,Capsule,Oral use,35.7,EVA PHARMA,Egypt,EVA PHARMA,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZYTERO 12.5 mg Film Coated Tablet,ALOGLIPTIN,0402256811,2018,12.5 mg,Film-coated tablet,Oral use,52.9,TAKEDA IRELAND LIMITED,Ireland,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
ZYTERO 25 mg Film Coated Tablet,ALOGLIPTIN,0402256810,2018,25 mg,Film-coated tablet,Oral use,105.85,TAKEDA IRELAND LIMITED,Ireland,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
LEVETAM 100 mg/ml Oral Solution,LEVETIRACETAM,0610258330,2017,100 mg/ml,Oral solution,Oral use,239.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LENALIDOMIDE SPC 10 mg Capsule,LENALIDOMIDE,2711234558,2018,10 mg,"Capsule, hard",Oral use,14505.9,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
APISAL 0.9% EYE-NOSE DROPS,SODIUM CHLORIDE,39-290-18,2018,0.9 %,"Ear/eye/nose drops, solution",Ophthalmic use,5.7,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 25°c,Pharmacy,Salehiya Trading Co.
ATROSOL 250 mcg/2 ml nebuliser solution,IPRATROPIUM BROMIDE,1810234350,2018,125 µ/ml,Nebuliser solution,Inhalation use,27.55,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VIBRAMYCIN 100MG TABLET,DOXYCYCLINE,1506257552,2018,100 mg,Tablet,Oral use,29.8,Fareva Amboise,France,PFIZER,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
MICROLUT 0.03MG-TAB COATED TAB.,LEVONORGESTREL,2208210963,2018,0.03 mg,Coated tablet,Oral use,14.55,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
XALKORI 250MG CAPSULE,CRIZOTINIB,3009245990,2018,250 mg,"Capsule, hard",Oral use,14478.75,PFIZER,Germany,PFIZER,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
XALKORI 200MG CAPSULE,CRIZOTINIB,3009245992,2018,200 mg,"Capsule, hard",Oral use,14478.75,PFIZER,Germany,PFIZER,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
ZYTIGA 500 Film-coated Tablet,ABIRATERONE ACETATE,2911234568,2018,500 mg,Film-coated tablet,Oral use,7522.10,PATHEON JALLIEU,France,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TOBREX OPTH.OINT. 0.3%,TOBRAMYCIN,2505233731,2018,0.3 %,Eye ointment,Ocular use,18.7,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
TOBREX OPTH.SOLUTION 0.3%,TOBRAMYCIN,2505233730,2018,0.3 %,Eye ointment,Ocular use,20,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
MAXITROL DROPS,"POLYMYXIN B, NEOMYCIN SULFATE, DEXAMETHASONE",1707245592,2018,"6000,3500,1 mg/ml, IU/","Eye drops, suspension",Ocular use,11.55,"Siegfried EI Masnou, S.A",Spain,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
VIGAMOX 0.5% OPHTHALMIC SOLUTION,MOXIFLOXACIN HYDROCHLORIDE,1707245591,2018,0.5 %,"Eye drops, solution",Ocular use,26.6,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
AZOPT 1%,BRINZOLAMIDE,2905245375,2018,1 %,"Eye drops, suspension",Ocular use,29.2,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ROXONE 1 gm Powder for Solution for Injection,CEFTRIAXONE,1710234345,2018,1 g,powder for solution for injection,Intramuscular and intravenous use,329.25,MEDOCHEMIE LTD (FACTORY C),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
DUOTRAV EYE DROPS,"TRAVOPROST, TIMOLOL MALEATE",1303245048,2018,"40,6.8 mg/ml, µg",Eye drops,Ocular use,52.85,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
LENALIDOMIDE SPC 5 mg Capsule,LENALIDOMIDE,2711234557,2018,5 mg,"Capsule, hard",Oral use,13834.9,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
NINLARO 3 mg Hard Capsule,IXAZOMIB CITRATE,1001244702,2018,3 mg,"Capsule, hard",Oral use,15269.3,HAUPT PHARMA AMAREG GmbH,Germany,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
EPNONE 50 mg Tablet,EPLERENONE,1012234584,2018,50 mg,Film-coated tablet,Oral use,61.25,MSN LABORATORIES PRIVATE LIMITED,India,MSN LABORATORIES PRIVATE LIMITED,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
VAROXA 10 mg Film Coated Tablet,RIVAROXABAN,2008245782,2018,10 mg,Film-coated tablet,Oral use,79.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FORTEO 20 MCG per 80MCL,TERIPARATIDE,0101244649,2018,"250 µ/ml, µg",Solution for injection,Subcutaneous use,1421.95,ELI LILLY,France,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
NEUROGAB 75 mg capsule,PREGABALIN,2501221639,2015,75 mg,Capsule,Oral use,64.2,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SIMBRINZA DROPS SUSP,"BRIMONIDINE TARTRATE, BRINZOLAMIDE",2505233729,2018,"2,10 mg/ml","Eye drops, suspension",Ocular use,64.6,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
NEVANAC EYE DROP,NEPAFENAC,1306233791,2018,1 mg/ml,"Eye drops, suspension",Ocular use,23.9,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
DEPAKINE 200MG-ML SOLU.,VALPROATE SODIUM,1410246041,2018,200 mg/ml,Oral solution,Oral use,16.35,Sanofi İlaç Sanayi ve Tic A.Ş,Turkey,sanofi-aventis FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
EXTRANEAL 7.5% w/v solution,PERITONEAL DIALYSIS SOLUTION,0811234440,2018,7.5 %,Solution for peritoneal dialysis,Intraperitoneal,70.55,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
EXTRANEAL 7.5% w/v solution,PERITONEAL DIALYSIS SOLUTION,0412258727,2018,7.5 %,Solution for peritoneal dialysis,Intraperitoneal,70.55,BAXTER,Ireland,Baxter Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
NINLARO 4 mg Hard Capsule,IXAZOMIB CITRATE,1001244703,2018,4 mg,"Capsule, hard",Oral use,19914.95,HAUPT PHARMA AMAREG GmbH,Germany,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
SEVITENSE 40/10 MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0802244879,2018,"40,10 mg",Film-coated tablet,Oral use,89.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE 20/10 MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0802244881,2018,"20,10 mg",Film-coated tablet,Oral use,78.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE 20/5 MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0802244882,2018,"20,5 mg",Film-coated tablet,Oral use,63.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE PLUS 40/10/12.5 MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0802244885,2018,"40,12.5,10 mg",Film-coated tablet,Oral use,105.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE PLUS 40/5/25 MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0802244887,2018,"40,25,5 mg",Film-coated tablet,Oral use,94.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE PLUS 40/10/25 MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0802244883,2018,"40,25,10 mg",Film-coated tablet,Oral use,105.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE PLUS 40/5/12.5 MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0802244886,2018,"40,12.5,5 mg",Film-coated tablet,Oral use,94.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEVITENSE PLUS 20/5/12.5 MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0802244884,2018,"20,12.5,5 mg",Film-coated tablet,Oral use,73.8,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DIVIDO 75MG DUAL RELEASE CAP,DICLOFENAC SODIUM,0810258366,2018,75 mg,"Modified-release capsule, hard",Oral use,45.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
COUFATEX 1 mg Tablet,WARFARIN SODIUM,0211234420,2018,1 mg,Tablet,Oral use,77.70,APOTEX INC. (GRAY RAY),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
COUFATEX 2 mg Tablet,WARFARIN SODIUM,0211234419,2018,2 mg,Tablet,Oral use,82.80,APOTEX INC. (GRAY RAY),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
COUFATEX 5 mg Tablet,WARFARIN SODIUM,0211234421,2018,5 mg,Tablet,Oral use,65.50,APOTEX INC. (GRAY RAY),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
NINLARO 2.3 mg Hard Capsule,IXAZOMIB CITRATE,1001244701,2018,2.3 mg,"Capsule, hard",Oral use,11947.4,HAUPT PHARMA AMAREG GmbH,Germany,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
SEVITENSE 40/5 MG FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0802244880,2018,"40,5 mg",Film-coated tablet,Oral use,83.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
AZARGA EYE DROPS,"TIMOLOL MALEATE, BRINZOLAMIDE",2905245376,2018,"5,10 mg/ml","Eye drops, suspension",Ocular use,51.35,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
HALAVEN,ERIBULIN MESILATE,1301268896,2018,0.44 mg/ml,Solution for injection,Intravenous use,1475.95,BSP PHARMACEUTICALS,Italy,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
EMCAST 5 MG CHEWABLE TABLET,MONTELUKAST SODIUM,0201244651,2018,5 mg,Chewable tablet,Oral use,64.30,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
EMCAST 4 MG CHEWABLE TABLET,MONTELUKAST SODIUM,0201244652,2018,4 mg,Chewable tablet,Oral use,64.30,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
EMCAST 10 MG,MONTELUKAST SODIUM,0201244650,2018,10 mg,Film-coated tablet,Oral use,71.45,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
PILOCIN,"TRIBENOSIDE, LIDOCAINE HYDROCHLORIDE",1610234339,2018,"50,20 mg/g",Cream,Rectal use,15.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
SYSTANE ULTRA UD LUBRICANT EYE DROPS,"POLYETHYLENE GLYCOL, PROPYLENE GLYCOL",64-115-18,2018,"0.4,0.3 %",Eye drops,Ophthalmic use,47.8,ALCON LABORATORIES,France,ALCON LABORATORIES,United States,Marketed,OTC,store below 30°c,Pharmacy,AL-KAMAL IMPORT OFFICE CO. LTD.
PHOXILIUM 1.2MMOL/I SOL. FOR HAEMODIAL./HAEMOFILT,"CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, DISODIUM PHOSPHATE, MAGNESIUM CHLORIDE",1802244939,2018,"3.68,0.314,6.44,0.225,2.44 g",Solution for haemodialysis/haemofiltration,Hemodialysis,128.8,Gambro Dasco S.p.A,Italy,BAXTER HOLDING B.V,Netherlands,Marketed,Prescription,"Store between +4°C - +30°C , Do not refrigerate or freeze",Hospital,"Farouk, Maamoun Tamer & CO"
PREGALEN 50 MG CAPSULE,PREGABALIN,18-430-18,2018,50 mg,"Capsule, hard",Oral use,34.1,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PREGALEN 50 MG CAPSULE,PREGABALIN,1712234588,2018,50 mg,"Capsule, hard",Oral use,68.2,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PREGALEN 150 MG CAPSULE,PREGABALIN,1712234590,2018,150 mg,"Capsule, hard",Oral use,143.9,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PREGALEN 150 MG CAPSULE,PREGABALIN,21-430-18,2018,150 mg,"Capsule, hard",Oral use,71.95,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
RENOMER 800 MG FILM-COATED TABLET,SEVELAMER CARBONATE,1112234586,2018,800 mg,Film-coated tablet,Oral use,529.75,Pharmaten Pharmaceutical Industry,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PREGALEN 75 MG CAPSULE,PREGABALIN,22-430-18,2018,75 mg,"Capsule, hard",Oral use,64.2,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
OXIRA 8MG F.C.TABLET,LORNOXICAM,2101256694,2018,8 mg,Film-coated tablet,Oral use,17.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VALDATIN 50MG TABLET,VILDAGLIPTIN,1007257741,2018,50 mg,Tablet,Oral use,33.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VALDATIN 50MG TABLET,VILDAGLIPTIN,1007257742,2018,50 mg,Tablet,Oral use,66.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
TAFINLAR 50MG CAPSULE(28),DABRAFENIB MESILATE,2905245377,2018,50 mg,"Capsule, hard",Oral use,2821.45,Glaxo Operations UK Limited,United Kingdom,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
TAFINLAR 75MG CAPSULE(28),DABRAFENIB MESILATE,2905245374,2018,75 mg,"Capsule, hard",Oral use,4142.1,Glaxo Operations UK Limited,United Kingdom,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
XEMETAN 25MG F.C.TABLET,EXEMESTANE,3112234645,2018,25 mg,Coated tablet,Oral use,88.85,OMAN PHARMACEUTICAL PRODUCTS,Oman,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
PREGALEN 75 MG CAPSULE,PREGABALIN,1712234589,2018,75 mg,"Capsule, hard",Oral use,128.4,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
ACTEMRA 162 mg/0.9 ml solution for injection in pre-filled syringe,TOCILIZUMAB,1007257725,2018,180 mg/ml,Solution for injection,Subcutaneous use,3613.10,VETTER PHARMA,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
EPITAM 500MG PROLONGED RELEASE TABLET,LEVETIRACETAM,268-334-17,2017,500 mg,Prolonged-release tablet,Oral use,82.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
PROXEN F.C. TAB 250MG,NAPROXEN,0310246011,2019,250 mg,Film-coated tablet,Oral use,26.35,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,OTC,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., STADA Arabia Limited Company, Salehiya Trading Co."
PROXEN F.C TAB 500MG,NAPROXEN,0310246010,2019,500 mg,Film-coated tablet,Oral use,35.30,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,OTC,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., STADA Arabia Limited Company, Salehiya Trading Co."
REGULON,"DESOGESTREL, ETHINYLESTRADIOL",0805245259,2019,"150,30 µg",Film-coated tablet,Oral use,10.2,GEDEON RICHTER,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VALIP 2 mg  film-coated tablets,PITAVASTATIN,2011234519,2018,2 mg,Film-coated tablet,Oral use,54.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
VALIP 4 mg  film-coated tablets,PITAVASTATIN,1601244737,2018,4 mg,Film-coated tablet,Oral use,64.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ROSUVAS 10 MG FILM COATED TABLET,ROSUVASTATIN,1408245765,2018,10 mg,Film-coated tablet,Oral use,45.5,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ROSUVAS 20 MG FILM COATED TABLET,ROSUVASTATIN,1408245766,2018,20 mg,Film-coated tablet,Oral use,70.65,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
EPITAM 750MG PROLONGED RELEASE TABLET,LEVETIRACETAM,2010211203,2017,750 mg,Prolonged-release tablet,Oral use,123.5,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
TREMFYA 100 MG/ML,GUSELKUMAB,2805245366,2018,100 mg/ml,Solution for injection,Subcutaneous use,9265.60,"Cilag AG, Schaffhausen, Switzerland",Switzerland,JANSSEN-CILAG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
ZONAM 2 MG FILM-COATED TABLET,ESZOPICLONE,1501244729,2018,2 mg,Film-coated tablet,Oral use,27.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZONAM 1 MG FILM-COATED TABLET,ESZOPICLONE,1501244730,2018,1 mg,Film-coated tablet,Oral use,13.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ESBRIET 267 MG FILM COATED TABLET,PIRFENIDONE,1808258041,2018,267 mg,Film-coated tablet,Oral use,2447.50,DELPHARM MILANO SRI,Italy,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ESBRIET 801 MG FILM COATED TABLET,PIRFENIDONE,1808258042,2018,801 mg,Film-coated tablet,Oral use,7342.55,DELPHARM MILANO SRI,Italy,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
LONSURF,"TRIFLURIDINE, TIPIRACIL",2803245127,2018,"15,6.14 mg",Film-coated tablet,Oral use,1944.90,TAIHO PHARMACEUTICAL CO LTD ( KITAJIMA PLANT ),Japan,LES LABORATORIES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
LONSURF,"TRIFLURIDINE, TIPIRACIL",2803245128,2018,"20,8.19 mg",Film-coated tablet,Oral use,2511.10,TAIHO PHARMACEUTICAL CO LTD ( KITAJIMA PLANT ),Japan,LES LABORATORIES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
OCREVUS 30 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION,OCRELIZUMAB,1208245754,2017,300 mg,Concentrate for solution for infusion,Intravenous use,20981.40,Roche Diagnostics GmbH,Germany,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
AFUNDAS-L 50 MG,CASPOFUNGIN,2503245096,2018,50 mg,Powder for concentrate for solution for infusion,Intravenous use,675.30,Gensenta İlaç Sanayi ve Ticaret A.Ş,Turkey,Sandoz IIac San,Turkey,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sandoz Limited Trading
AFUNDAS-L 70 MG,CASPOFUNGIN,2503245097,2018,70 mg,Powder for concentrate for solution for infusion,Intravenous use,819.55,Gensenta İlaç Sanayi ve Ticaret A.Ş,Turkey,Sandoz IIac San,Turkey,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sandoz Limited Trading
LEROXO 8 MG FILM COATED TABLET,LORNOXICAM,0401244678,2018,8 mg,Film-coated tablet,Oral use,17.5,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZONAM 3 MG FILM-COATED TABLET,ESZOPICLONE,1501244728,2018,3 mg,Film-coated tablet,Oral use,41.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
HUMALOG KWIK-PEN MIX 50,"INSULIN LISPRO, INSULIN PROTAMINE",0205245244,2018,"50,50 IU/ml",Suspension for injection,Subcutaneous use,161.30,ELI LILLY,France,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
NEXOL 40 mg Lyophilisate For Solution For Infusion,ESOMEPRAZOLE,3010222836,2017,40 mg,powder for solution for injection,Intravenous use,150.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
DOCETAXEL EBEWE 10 mg/ml concentration For Solution For Infusion,DOCETAXEL,1001244700,2017,10 mg/ml,Concentrate for solution for infusion,Intravenous use,199.05,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
OFEV 100 mg Soft Capsule,NINTEDANIB,2507233928,2017,100 mg,Capsule,Oral use,5370.35,CATALENT GERMANY EBERBACH GmbH,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
DESIRETT 75 mcg Film-Coated Tablets,DESOGESTREL,1610222737,2017,0.075 mg,Film-coated tablet,Oral use,13.05,"LABORATORIOS LEON FARMA, S.A.",Spain,EXELTIS GERMANY GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Resliva,PREDNISOLONE SODIUM PHOSPHATE,0801233059,2017,3 mg/ml,Syrup,Oral use,37.8,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Resliva 5 mg/5 ml syrup,PREDNISOLONE SODIUM PHOSPHATE,2310222777,2017,1 mg/ml,Syrup,Oral use,16.7,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
VITA-D 50000 IU Tablet,COLECALCIFEROL,0712222991,2017,50000 IU,Tablet,Oral use,48.05,QUEST VITAMINS MIDDLE EAST FZE,United Arab Emirates,SYNERGY PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CLOPACIN 75mg film-coated tablets,CLOPIDOGREL,0604233503,2017,75 mg,Film-coated tablet,Oral use,118.15,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
AROMAPLEX 25 mg Film-Coated Tablet,EXEMESTANE,2408234049,2017,25 mg,Film-coated tablet,Oral use,95.40,GENEPHARM S.A.,Greece,GENEPHARM S.A,Greece,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
LYSTEDA 650 mg Tablet,TRANEXAMIC ACID,0702244866,2017,650 mg,Tablet,Oral use,88.95,"MIKART, INC.",United States,Ferring Pharmaceuticals Inc./ USA,United States,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
MOVIPREP POWDER FOR ORAL SOLUTION,"ASCORBIC ACID, SODIUM ASCORBATE, SODIUM SULFATE, MACROGOL, POTASSIUM CHLORIDE, SODIUM CHLORIDE",1203245038,2017,"4.7,5.9,7.5,100,1.015,2.691 g",Powder for oral solution,Oral use,44.9,NORGINE LIMITED,United Kingdom,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
COAPROVEL 300-12.5 MG TABLET,"IRBESARTAN, HYDROCHLOROTHIAZIDE",1003221840,2018,"300,12.5 mg",Film-coated tablet,Oral use,77,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
RELPAX 20MG TABLET,ELETRIPTAN,65-892-17,2017,20 mg,Film-coated tablet,Oral use,58.20,Pfizer Italia S.R.L,Italy,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
RELPAX 20MG TABLET,ELETRIPTAN,66-892-17,2017,20 mg,Film-coated tablet,Oral use,113.85,Pfizer Italia S.R.L,Italy,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
RELPAX 40MG TABLET,ELETRIPTAN,2305233704,2017,40 mg,Film-coated tablet,Oral use,48.15,Pfizer Italia S.R.L,Italy,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
RELPAX 40MG TABLET,ELETRIPTAN,2305233705,2017,40 mg,Film-coated tablet,Oral use,84.83,Pfizer Italia S.R.L,Italy,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
TRUSOPT,DORZOLAMIDE,0712234579,2017,2 %,"Eye drops, solution",Ocular use,39.15,MERCK SHARP & DOHME,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
ALDACTONE TAB,SPIRONOLACTONE,1812246449,2017,100 mg,Tablet,Oral use,25.05,PIRAMAL HEALTHCARE UK LIMITED,United Kingdom,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ALDACTONE TAB,SPIRONOLACTONE,0105245234,1983,25 mg,Tablet,Oral use,18,PIRAMAL HEALTHCARE UK LIMITED,United Kingdom,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DOCETAXEL EBEWE 10 mg/ml concentration For Solution For Infusion,DOCETAXEL,1001244699,2017,10 mg/ml,Concentrate for solution for infusion,Intravenous use,758.65,Fareva Unterach GmbH,Austria,EBEWE PHARMA,Austria,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ZERSA 600 mg Film-coated Tablet,LINEZOLID,1902233260,2017,600 mg,Film-coated tablet,Oral use,1929.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ZEVTERA 500 mg Powder for concentration for Solution for Infusion,CEFTOBIPROLE MEDOCARIL SODIUM,1209234194,2017,500 mg,Powder for concentrate for solution for infusion,Intravenous use,1836.25,Nipro Pharma Corporation Ise Plant,Japan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
PEMITRA 500 mg Vial,PEMETREXED,2310222780,2017,500 mg,Powder for concentrate for solution for infusion,Intravenous use,3784.3,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
SEFARIX 300 mg Capsule,CEFDINIR,2512223037,2017,300 mg,Capsule,Oral use,57.8,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
LEUKERAN 2 MG. TAB.,CHLORAMBUCIL,24-887-17,2017,2 mg,Film-coated tablet,Oral use,297,EXCELLA GmbH & Co. KG,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
NIMENRIX,"TETANUS TOXOID, MENINGOCOCCAL GROUP A (NEISSERIA MENINGITIDIS) POLYSACCHARIDE VACCINE, MENINGOCOCCAL GROUP C (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP W (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP Y (NEISSERIA MENINGITIDIS) POLYSACCHARIDE",1808258046,2017,"44,5,5,5,5 µg",Powder and solvent for solution for injection,Intramuscular use,158.95,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Pfizer Saudi Trading
DIPROSONE CREAM 0.05%,BETAMETHASONE DIPROPIONATE,0905233616,2017,0.05 %,Cream,Topical,17.85,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
AMARYL M 2/500 mg film-coated tablet,"METFORMIN HYDROCHLORIDE, GLIMEPIRIDE",2610222819,2017,"500,2 mg",Film-coated tablet,Oral use,32,HANDOK PHARMACEUTICALS CO. LTD.,KOREA,Sanofi Arabia Trading Co. Ltd,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
SEVOFLURANE Inhalation Anesthetic,SEVOFLURANE,4-683-17,2017,250 ml,"Inhalation vapour, liquid",Inhalation use,477.55,BAXTER HEALTHCARE CORPORATION,Puerto Rico,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BISOLOL 2.5 mg Tablet,BISOPROLOL FUMARATE,2410222783,2017,2.5 mg,Tablet,Oral use,10.8,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
BISOLOL 5 mg Tablet,BISOPROLOL FUMARATE,2410222784,2017,5 mg,Tablet,Oral use,16.25,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
BISOLOL 10 mg Tablet,BISOPROLOL FUMARATE,2410222785,2017,10 mg,Tablet,Oral use,23.05,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
ALPROLIX 250 I.U Powder And Solvent For Solution For Injection,EFTRENONACOG ALFA,0105233576,2017,250 IU,Powder and solvent for solution for injection,Intravenous use,1549.05,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ALPROLIX 500 I.U Powder And Solvent For Solution For Injection,EFTRENONACOG ALFA,0105233575,2017,500 IU,Powder and solvent for solution for injection,Intravenous use,3098.10,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ALPROLIX 1000 I.U Powder And Solvent For Solution For Injection,EFTRENONACOG ALFA,0105233579,2017,1000 IU,Powder and solvent for solution for injection,Intravenous use,6196.20,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ALPROLIX 2000 I.U Powder And Solvent For Solution For Injection,EFTRENONACOG ALFA,0105233578,2017,2000 IU,Powder and solvent for solution for injection,Intravenous use,12392.40,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
ALPROLIX 3000 I.U Powder And Solvent For Solution For Injection,EFTRENONACOG ALFA,0105233577,2017,3000 IU,Powder and solvent for solution for injection,Intravenous use,18588.65,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
CEMIVIL 400 mg Film Coated Tablets,IMATINIB MESILATE,0711222877,2017,400 mg,Film-coated tablet,Oral use,2423.6,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CEMIVIL 100 mg Film Coated Tablets,IMATINIB MESILATE,0711222878,2017,100 mg,Film-coated tablet,Oral use,605.9,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
FLUCAZOL 50 mg Capsule,FLUCONAZOLE,1802244927,2017,50 mg,"Capsule, hard",Oral use,42.7,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
FLUCAZOL 150 mg Capsule,FLUCONAZOLE,1802244928,2017,150 mg,"Capsule, hard",Oral use,15.05,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
MONCAS 10 mg Film Coated Tablet,MONTELUKAST SODIUM,2102244958,2017,10 mg,Film-coated tablet,Oral use,64.85,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
MONCAS 4 mg Chewable Tablet,MONTELUKAST SODIUM,2102244957,2017,4 mg,Chewable tablet,Oral use,40.05,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
OFEV 150 mg Soft Capsule,NINTEDANIB,2507233927,2017,150 mg,Capsule,Oral use,10513.00,CATALENT GERMANY EBERBACH GmbH,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
RUMAFEN 1% gel,DICLOFENAC DIETHYLAMINE,2411222930,2017,1 %,Gel,Topical,24.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,"Store below 30°C , protect from Light",Pharmacy,RIYADH PHARMA
ZEGA 75 MG CAPSULE,PREGABALIN,0703233337,2017,75 mg,Capsule,Oral use,29.95,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ZEGA 150 MG CAPSULE,PREGABALIN,2601233184,2017,150 mg,Capsule,Oral use,82.55,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
DESLIN 2.5mg/5ml Oral Solution,DESLORATADINE,0612222982,2017,0.5 mg/ml,Oral solution,Oral use,15.9,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
TULIP 10 mg film-coated tablet,ATORVASTATIN CALCIUM,0905233605,2017,10 mg,Film-coated tablet,Oral use,15.35,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
TULIP 20 mg film-coated tablet,ATORVASTATIN CALCIUM,0905233604,2017,20 mg,Film-coated tablet,Oral use,22.65,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
TULIP 40 mg film-coated tablet,ATORVASTATIN CALCIUM,0905233607,2017,40 mg,Film-coated tablet,Oral use,31.9,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
TULIP 80 mg film-coated tablet,ATORVASTATIN CALCIUM,0905233608,2017,80 mg,Film-coated tablet,Oral use,48.7,LEK S.A,Poland,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
AMLOHOPE 10 mg/10 mg Capsule,"RAMIPRIL, AMLODIPINE BESILATE",0905233611,2017,"10,10 mg","Capsule, hard",Oral use,50.85,EGIS PHARMACEUTICALS PLC,Hungary,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
AMLOHOPE 10 mg/5 mg Capsule,"RAMIPRIL, AMLODIPINE BESILATE",0905233603,2017,"10,5 mg","Capsule, hard",Oral use,45.2,EGIS PHARMACEUTICALS PLC,Hungary,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
AMLOHOPE 5 mg/10 mg Capsule,"RAMIPRIL, AMLODIPINE BESILATE",0905233610,2017,"5,10 mg","Capsule, hard",Oral use,45.2,EGIS PHARMACEUTICALS PLC,Hungary,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
GENOTROPIN 16IU CARTRIDGE,SOMATROPIN,0504233484,2017,16 IU,Powder and solvent for solution for injection,Subcutaneous use,385.7,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
SEVIKAR HCT 20/5/12.5MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",1701233106,2016,"20,12.5,5 mg",Film-coated tablet,Oral use,86.85,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SEVIKAR HCT 40/5/12.5MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",1701233104,2016,"40,12.5,5 mg",Film-coated tablet,Oral use,110.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SEVIKAR HCT 40/5/25MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",1701233108,2016,"40,25,10 mg",Film-coated tablet,Oral use,110.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SEVIKAR HCT 40/10/12.5MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",1701233107,2016,"40,12.5,10 mg",Film-coated tablet,Oral use,124.2,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SEVIKAR HCT 40/10/25MG FILM COATED  TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",1701233105,2016,"40,25,10 mg",Film-coated tablet,Oral use,124.2,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RESOCAL 99.934% POWDER FOR USE IN DRINKING WATER,CALCIUM POLYSTYRENE SULFONATE,2907245673,2017,99.934 %,Powder for oral/rectal suspension,Oral use,197.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
RESOCAL 99.934% POWDER FOR USE IN DRINKING WATER,CALCIUM POLYSTYRENE SULFONATE,2907245681,2017,99.934 %,Powder for oral/rectal suspension,Oral use,197.35,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,DEEF MARKITING COMPANY
ROXONIN TAPE 50 mg Cutaneous Patch,LOXOPROFEN,1901233124,2017,50 mg,Cutaneous patch,Topical,34.50,"LEAD CHEMICAL CO., LTD.",Japan,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
IKOTREF 100 mg Solution For Injection,HYDROCORTISONE SODIUM SUCCINATE,2601233178,2017,100 mg,powder for solution for injection,Parenteral use,16.80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
IKOTREF 250 mg Solution For Injection,HYDROCORTISONE SODIUM SUCCINATE,2601233177,2017,250 mg,powder for solution for injection,Parenteral use,17.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
PRAXBIND 50 mg/ml Solution For Injection/Infusion,IDARUCIZUMAB,2702233301,2017,50 mg/ml,Solution for injection/infusion,Intravenous use,9115.10,"BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,BIBERACH",Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Boehringer Ingelheim Scientific Office, Cigalah Group"
RINA 0.5 mg/ml Syrup,DESLORATADINE,2211222922,2017,0.5 mg/ml,Syrup,Oral use,9.55,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
CANESTEN-1 VAG.TAB 500MG WITH APPLICATOR,CLOTRIMAZOLE,17-949-17,2017,500 mg,Vaginal tablet,Vaginal use,21.70,Haupt Pharma Wulfing GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Bayer Saudi Arabia
ZYLORIC 100MG TABLET,ALLOPURINOL,0303256969,2017,100 mg,Tablet,Oral use,22,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
DIFICLIR 200 mg Film Coated Tablet,FIDAXOMICIN,0305233586,2017,200 mg,Film-coated tablet,Oral use,5677.50,PATHEON INC,Canada,Tillotts Pharma GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
ALOXI 0.25 mg/ 5 ml Solution For Injection,PALONOSETRON HYDROCHLORIDE,1-5078-17,2017,0.05 mg/ml,Solution for injection,Intravenous use,139,FAREVA PAU 1,France,HELSINN BIREX PHARMACEUTICAL Ltd,Ireland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
FLEXBUMIN 200GM/L SOLUTION FOR INFUSION,ALBUMIN HUMAN,0504233486,2017,200 g/l,Solution for infusion,Intravenous use,156.55,"Baxalta US, Inc",United States,Takeda Manufacturing AG,Austria,Marketed,Prescription,do not store above 25°c,Hospital,ALNAGHI COMPANY
FLEXBUMIN 200GM/L SOLUTION FOR INFUSION,ALBUMIN HUMAN,0504233487,2017,200 g/l,Solution for infusion,Intravenous use,285.85,"Baxalta US, Inc",United States,Takeda Manufacturing AG,Austria,Marketed,Prescription,do not store above 25°c,Hospital,ALNAGHI COMPANY
ROXONIN TAPE 100 mg Cutaneous Patch,LOXOPROFEN,1901233125,2017,100 mg,Cutaneous patch,Topical,37.95,"LEAD CHEMICAL CO., LTD.",Japan,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
APROVEL 300MG TAB,IRBESARTAN,0112222958,2017,300 mg,Film-coated tablet,Oral use,77,SANOFI WINTHROP INDUSTRIE,France,Sanofi Clir SNC,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
APROVEL 150MG TAB,IRBESARTAN,2010222772,2017,150 mg,Tablet,Oral use,63,SANOFI WINTHROP INDUSTRIE,France,Sanofi Clir SNC,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ROLENIUM 500/50 mcg Elpenhaler,"FLUTICASONE PROPIONATE, SALMETEROL",1510246045,2017,"500,50 µg","Inhalation powder, pre-dispensed",Inhalation use,159.4,ELPEN PHARMACEUTICALS,Greece,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ALADIN 50 mg film-coated tablets,SILDENAFIL,2710246111,2017,50 mg,Film-coated tablet,Oral use,43.7,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
MIDIXIME 400 mg Capsules,CEFIXIME,2909222673,2017,400 mg,Capsule,Oral use,49.55,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
MIDIXIME 200 mg Capsules,CEFIXIME,2909222672,2017,200 mg,Capsule,Oral use,31.05,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
BLINCYTO,BLINATUMOMAB,0904233512,2017,35 µg,Powder for concentrate for solution for infusion,Intravenous use,9946.20,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,Amgen Inc.,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
DESLIN 5 mg film-coated tablet,DESLORATADINE,1608222495,2017,5 mg,Film-coated tablet,Oral use,28.25,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
IGAMAD 750 IU/ml Solution for Injection,HUMAN RHO(D) IMMUNE GLOBULIN,0510234307,2017,750 IU/ml,Solution for injection,Intramuscular use,251.15,INSTITUTO GRIFOLS,Spain,INSTITUTO GRIFOLS,Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
NUROFEN FOR CHILDREN STRAWBERRY ORAL SUSPENSION,IBUPROFEN,2101244774,2017,20 mg/ml,Suspension,Oral use,17.15,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
LEVOZAL 0.5 mg/ml Syrup,LEVOCETIRIZINE DIHYDROCHLORIDE,0412222974,2017,0.5 mg,Syrup,Oral use,14.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
BETAGEN 24 mg tablet,BETAHISTINE DIHYDROCHLORIDE,2709222655,2017,24 mg,Tablet,Oral use,65.50,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ALADIN 25 mg film-coated tablets,SILDENAFIL,2710246110,2017,25 mg,Film-coated tablet,Oral use,36.3,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
ASPIRIN ADULT TAB 300MG,ACETYLSALICYLIC ACID,9-949-17,2017,300 mg,Tablet,Oral use,3.5,Bayer Bitterfeld GmbH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, Cigalah Group"
CANDEUR 2 mg/ml Solution For Infusion,FLUCONAZOLE,0801233061,2017,2 mg/ml,Solution,Intravenous use,26.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ARVIDA 0.5 mg Tablet,ENTECAVIR,2501233169,2017,0.5 mg,Tablet,Oral use,1352.55,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
QATPEN XR 200 mg tablet,QUETIAPINE,1108257978,2017,200 mg,Extended-release tablet,Oral use,110.65,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
QATPEN XR 300 mg tablet,QUETIAPINE,1108258001,2017,300 mg,Extended-release tablet,Oral use,146.55,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
QATPEN XR 400 mg tablet,QUETIAPINE,1108257993,2017,400 mg,Extended-release tablet,Oral use,208.15,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LEVETAM 500 mg film-coated tablet,LEVETIRACETAM,2307257828,2017,500 mg,Film-coated tablet,Oral use,109.40,ACTAVIS,Iceland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FORMIT XR 750 MG TABLETS,METFORMIN HYDROCHLORIDE,1302233242,2017,750 mg,Extended-release tablet,Oral use,22.50,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FORMIT XR 750 MG TABLETS,METFORMIN HYDROCHLORIDE,0206222128,2017,750 mg,Extended-release tablet,Oral use,45.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
MEROZA 500 mg powder for Solution for Injection or Infusion,MEROPENEM,2505233733,2017,500 mg,Powder for solution for injection/infusion,Intravenous use,211.95,DEMO S.A,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
MEROZA 1 g powder for Solution for Injection or Infusion,MEROPENEM,2505233734,2017,1 g,Powder for solution for injection/infusion,Intravenous use,356.4,DEMO S.A,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
LEVONIC 5 mg/ml Infusion,LEVOFLOXACIN,2909222678,2017,5 mg/ml,Solution for infusion,Intravenous use,71.3,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CANDEUR 2 mg/ml Solution For Infusion,FLUCONAZOLE,2510222798,2017,2 mg/ml,Solution,Intravenous use,52.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
DEPOJOY 60 mg film-coated tablet,DAPOXETINE,0802233221,2017,60 mg,Film-coated tablet,Oral use,79,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
FYCOMPA 4 mg Film-Coated Tablet,PERAMPANEL,0105233571,2016,4 mg,Film-coated tablet,Oral use,428.00,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FYCOMPA 6 mg Film-Coated Tablet,PERAMPANEL,0105233567,2016,6 mg,Film-coated tablet,Oral use,428.00,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FYCOMPA 8 mg Film-Coated Tablet,PERAMPANEL,0105233570,2016,8 mg,Film-coated tablet,Oral use,498.10,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FYCOMPA 10 mg Film-Coated Tablet,PERAMPANEL,0105233568,2016,10 mg,Film-coated tablet,Oral use,527.70,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FYCOMPA 12 mg Film-Coated Tablet,PERAMPANEL,0205233581,2016,12 mg,Film-coated tablet,Oral use,527.70,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
TRULICITY 0.75 mg Solution for Injection in Prefilled Pen,DULAGLUTIDE,0512222978,2016,0.75 mg,Solution for injection,Subcutaneous use,362.40,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
TRULICITY 1.5 mg Solution for Injection in Prefilled Pen,DULAGLUTIDE,0512222980,2016,1.5 mg,Solution for injection,Subcutaneous use,362.40,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
TOUJEO 300 IU/ml Solution for Injection in Pre-filled Pen,INSULIN GLARGINE,56-23-17,2017,300 IU/ml,Solution for injection in pre-filled pen,Subcutaneous use,216.95,sanofi-aventis,Germany,sanofi-aventis,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
TOUJEO 300 IU/ml Solution for Injection in Pre-filled Pen,INSULIN GLARGINE,3005233745,2017,300 IU/ml,Solution for injection in pre-filled pen,Subcutaneous use,356.35,sanofi-aventis,Germany,sanofi-aventis,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Sanofi Arabia Trading Co. Ltd
DEPOJOY 30 mg film-coated tablet,DAPOXETINE,0802233222,2017,30 mg,Film-coated tablet,Oral use,79,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ANTIKAST 4 mg chewable tablet,MONTELUKAST SODIUM,0610222691,2017,4 mg,Chewable tablet,Oral use,40.05,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ANTIKAST 5 mg chewable tablet,MONTELUKAST SODIUM,3010222854,2017,5 mg,Chewable tablet,Oral use,40.05,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
TENORYL PLUS 5 mg/5 mg TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",3010222840,2016,"5,5 mg",Tablet,Oral use,55.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TENORYL PLUS 5 mg/10 mg TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",3010222842,2016,"10,5 mg",Tablet,Oral use,67.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TENORYL PLUS 10 mg/5 mg TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",3010222841,2016,"5,10 mg",Tablet,Oral use,83.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
TENORYL PLUS 10 mg/10 mg TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",3010222839,2016,"10,10 mg",Tablet,Oral use,95.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
MARLON 10 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,1108257990,2017,10 mg,Film-coated tablet,Oral use,91.1,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
MARLON 20 mg film-coated tablet,MEMANTINE HYDROCHLORIDE,2206257589,2017,20 mg,Film-coated tablet,Oral use,166.05,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
IMODIUM INSTANTS 2MG ORODESPERSIBLE TABLET,LOPERAMIDE,2112234622,2016,2 mg,Tablet,Oral use,12.4,CATALENT UK SWINDON ZYDIS LIMITED,United Kingdom,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
IMODIUM INSTANTS 2MG ORODESPERSIBLE TABLET,LOPERAMIDE,2112234621,2016,2 mg,Tablet,Oral use,22.35,CATALENT UK SWINDON ZYDIS LIMITED,United Kingdom,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
LAVIE 500 mg Film-Coated Tablets,LEVETIRACETAM,2809222658,2017,500 mg,Film-coated tablet,Oral use,83.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
LAVIE 1000 mg Film-Coated Tablets,LEVETIRACETAM,2609222638,2017,1000 mg,Film-coated tablet,Oral use,152.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ANTIKAST 10 mg film-coated tablet,MONTELUKAST SODIUM,2709222653,2017,10 mg,Film-coated tablet,Oral use,40.05,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
AMLOHOPE 5 mg/5 mg Capsule,"RAMIPRIL, AMLODIPINE BESILATE",0905233609,2017,"5,5 mg","Capsule, hard",Oral use,40.25,EGIS PHARMACEUTICALS PLC,Hungary,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
LODIPAM 5 mg Film-Coated Tablet,AMLODIPINE BESILATE,2109222630,2017,5 mg,Film-coated tablet,Oral use,23.8,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
CITOXAL 5 mg film-coated tablet,ESCITALOPRAM,2109222627,2017,5 mg,Film-coated tablet,Oral use,32.6,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
KEFLEX 250MG-5ML SUSPENTION,CEFALEXIN,20-809-17,2017,50 mg/ml,Powder for oral suspension,Oral use,23.75,ACS Dobfar S.P.A,Italy,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
KEFLEX 500MG TAB,CEPHALEXIN ANHYDROUS,21-809-17,2017,500 mg,Tablet,Oral use,40.1,ACS Dobfar S.P.A,Italy,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
METAZ LOTION 0.1%,MOMETASONE FUROATE,0103221777,2017,0.1 %,Lotion,Topical,31.50,Dallah Pharma Factory,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
METAZ 0.1% W-W OINTMENT,MOMETASONE FUROATE,16-809-17,2017,0.1 %,Ointment,Topical,9.95,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
METAZ 0.1% W-W OINTMENT,MOMETASONE FUROATE,2405233714,2017,0.1 %,Ointment,Topical,19.95,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
METAZ CREAM 0.1%,MOMETASONE FUROATE,2405233715,2017,0.1 %,Cream,Topical,19.95,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
TRACON 100MG CAPSULES,ITRACONAZOLE,23-809-17,2017,100 mg,Capsule,Oral use,101.2,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
TRACON 100MG CAPSULES,ITRACONAZOLE,24-809-17,2017,100 mg,Capsule,Oral use,31.1,SPIMACO,Saudi Arabia,COOPER PHARMA,Morocco,Marketed,Prescription,store below 25°c,Pharmacy,ARAC HEALTHCARE
CELEBREX 100MG CAPSULE,CELECOXIB,62-892-17,2017,100 mg,"Capsule, hard",Oral use,24.95,Pfizer Pharmaceutical LLC,United States,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
CELEBREX 200MG CAPSULE,CELECOXIB,0110245995,2017,200 mg,"Capsule, hard",Oral use,40.5,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
CELEBREX 200MG CAPSULE,CELECOXIB,11-5825-23,2017,200 mg,"Capsule, hard",Oral use,21.95,PFIZER SAUDI LIMITED,Saudi Arabia,Viatris Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
DIPROSONE OINTMENT 0.05%,BETAMETHASONE DIPROPIONATE,0905233617,2017,0.05 %,Ointment,Topical,17.85,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JAKAVI 20MG TABLET,RUXOLITINIB,19-665-17,2017,20 mg,Tablet,Oral use,13769.30,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
JAKAVI 5MG TABLET,RUXOLITINIB,17-665-17,2017,5 mg,Tablet,Oral use,6977.80,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
RESTASIS 0.05% Eye Drop Emulsion,CICLOSPORIN,0412222970,2011,0.05 %,"Eye drops, emulsion",Ophthalmic use,101.20,ALLERGAN,United States,AbbVie Inc,United States,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
IRINOTECAN JAZEERA 20 mg/ml concentrate for solution for infusion,IRINOTECAN,1810222748,2017,20 mg/ml,concentrate for solution for injection,Intravenous use,98.95,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
IRINOTECAN JAZEERA 20 mg/ml concentrate for solution for infusion,IRINOTECAN,1810222747,2017,20 mg/ml,concentrate for solution for injection,Intravenous use,247.4,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CEFAFOUR 1gm IV/IM Vial,CEFEPIME HYDROCHLORIDE,1210222720,2017,1 g,powder for solution for injection,Intravenous use,33.65,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CEFAFOUR 2 gm IV/IM Vial,CEFEPIME HYDROCHLORIDE,1210222719,2017,2 g,powder for solution for injection,Intravenous use,57.8,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
COSOPT EYE DROPS,"DORZOLAMIDE, TIMOLOL MALEATE",1302233235,2017,"2,0.5 %","Eye drops, solution",Ocular use,46.55,FAREVA MIRABEL,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ZEMPLAR 5 mcg/ml solution for injection,PARICALCITOL,0209258140,2017,5 µ/ml,Solution for injection,Intravenous use,266.40,Avara Liscate Pharmaceutical services S.p.A,Italy,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
ROLENIUM 250/50 mcg Elpenhaler,"FLUTICASONE PROPIONATE, SALMETEROL",1510246051,2017,"250,50 µg","Inhalation powder, pre-dispensed",Inhalation use,120.85,ELPEN PHARMACEUTICALS,Greece,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
JAKAVI 15MG TABLET,RUXOLITINIB,18-665-17,2017,15 mg,Tablet,Oral use,13769.30,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
LODIPAM 10 mg Film-Coated Tablet,AMLODIPINE BESILATE,2109222626,2017,10 mg,Film-coated tablet,Oral use,45.95,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
TRIOSOF 320MG/ML INJECTION,IODIXANOL,0801233060,2017,652 mg/ml,Solution for injection,Intravenous use,65.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
CITOXAL 10 mg film-coated tablet,ESCITALOPRAM,2109222625,2017,10 mg,Film-coated tablet,Oral use,46.6,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
CITOXAL 20 mg film-coated tablet,ESCITALOPRAM,2109222629,2017,20 mg,Film-coated tablet,Oral use,83.9,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
LODIPAM 2.5 mg Film-Coated Tablet,AMLODIPINE BESILATE,2109222628,2017,2.5 mg,Film-coated tablet,Oral use,22.25,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
FLOMOCIN 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,1511234473,2017,400 mg,Film-coated tablet,Oral use,41.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FLOMOCIN 400 mg film-coated tablet,MOXIFLOXACIN HYDROCHLORIDE,1511234474,2017,400 mg,Film-coated tablet,Oral use,58.6,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TAGRISSO 40 mg Film-Coated Tablet,OSIMERTINIB MESILATE,0803233344,2017,40 mg,Film-coated tablet,Oral use,28409.90,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
TAGRISSO 80 mg Film-Coated Tablet,OSIMERTINIB MESILATE,0803233343,2017,80 mg,Film-coated tablet,Oral use,28409.90,AstraZeneca,Sweden,AstraZeneca,Sweden,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
ZOLIX 0.5 mg/ml Oral Solution,LEVOCETIRIZINE DIHYDROCHLORIDE,1601244732,2017,0.5 mg/ml,Oral solution,Oral use,25.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
BUTAFYL 1% W/V SPRAY,BUTENAFINE,2709222654,2017,1 %,Spray,Topical,38.9,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
TRIOSOF 320MG/ML INJECTION,IODIXANOL,3010222843,2017,652 mg/ml,Solution for injection,Intravenous use,109.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
DEXTROSE 5% + 0.45% SODIUM CHLORIDE INJECTION,"DEXTROSE, SODIUM CHLORIDE",1302233236,2017,"5,0.45 %",Solution,Intravenous use,127.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
5 % w/v DEXTROSE Injection 500 ml,DEXTROSE,1302233238,2017,5 %,Solution for infusion,Intravenous use,162.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,1302233237,2017,0.9 %,Solution,Intravenous use,137.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
PIPERACILLIN - TAZOPACTAM SANDOZ 4.5GM VIAL,"PIPERACILLIN, Tazobactam",103-116-17,2017,"4,0.5 g",Powder for solution for infusion,Intravenous use,550.55,SANDOZ,Austria,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
PARALOK 40 mg for I.V. Infusion,PANTOPRAZOLE,2909222679,2017,40 mg,Powder for infusion,Intravenous use,25.45,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Jazeera Pharmaceutical Industries (JPI)
TECENTRIQ 60 mg/ml Concentrate For Solution For Infusion,ATEZOLIZUMAB,1709258231,2017,60 mg/ml,Injection,Intravenous use,29065.25,ROCHE DIAGNOSTICS,Germany,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Roche Products Saudi Arabia"
REBIF 22 MCG/0.5 ml Solution for injection in cartridge,INTERFERON BETA-1A,1501233101,2014,66 µg,Solution for injection,Subcutaneous use,1979.15,MERCK SERONO SPA,Italy,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
REBIF 44 MCG/0.5 ml Solution for injection in cartridge,INTERFERON BETA-1A,1501233102,2014,132 µg,Solution for injection,Subcutaneous use,3958.25,MERCK SERONO SPA,Italy,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Merck Limited"
WATER FOR INJECTION USP,WATER,1302233241,2017,,Solvent for parenteral use,Intravenous use,48.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
WATER FOR INJECTION USP,WATER,1302233240,2017,,Solvent for parenteral use,Intravenous use,90.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
EREVARD 10MG Film-Coated Tablet,VARDENAFIL,2401233160,2017,10 mg,Film-coated tablet,Oral use,59.95,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EREVARD 20MG Film-Coated Tablet,VARDENAFIL,2510222799,2017,20 mg,Film-coated tablet,Oral use,76.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DEXTROSE 5% + 0.9% SODIUM CHLORIDE INJECTION,"DEXTROSE, SODIUM CHLORIDE",1302233239,2017,"5,0.9 %",Solution,Intravenous use,137.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
IRBEGEN PLUS 150/12.5 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",5-5035-17,2017,"150,12.5 mg",Film-coated tablet,Oral use,36,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
IRBEGEN PLUS 300/25 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",7-5035-17,2017,"300,25 mg",Film-coated tablet,Oral use,47.70,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
CINAC 30 MG FILM COATED TABLET,CINACALCET,2305233694,2017,30 mg,Film-coated tablet,Oral use,268.05,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
CINAC 60 MG FILM COATED TABLET,CINACALCET,2305233690,2017,60 mg,Film-coated tablet,Oral use,498,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
SIMPONI 100 MG/ML SOLUTION FOR INJECTION IN PREFILLED PEN,GOLIMUMAB,4-842-17,2017,100 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,5170.65,BAXTER PHARMACEUTICAL SOLUTION LLC,United States,JANSSEN-BIOLOGICS B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
HEROX 20 mg film-coated tablet,TADALAFIL,2307233920,2018,20 mg,Film-coated tablet,Oral use,160.1,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SEDALERT 100 MCG -ML IV. VIAL,DEXMEDETOMIDINE,2307233913,2018,100 µ/ml,Concentrate for solution for infusion,Intravenous use,83.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LEUKAST 4 mg Granules,MONTELUKAST SODIUM,2401233154,2018,4 mg,Granules,Oral use,77.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NEVOLEEN 1 mg/ml Ampoule,NOREPINEPHRINE BITARTRATE,2305233702,2018,1 mg/ml,Concentrate for solution for infusion,Intravenous use,115.15,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
QUTENZA 179 mg Cutaneous Patch,CAPSAICIN,2611234547,2017,179 mg,Cutaneous patch,Topical,1117,LTS LOHMANN Therapie-Systeme,Germany,GRUNENTHAL,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
QUTENZA 179 mg Cutaneous Patch,CAPSAICIN,2611234548,2017,179 mg,Cutaneous patch,Topical,2234,LTS LOHMANN Therapie-Systeme,Germany,GRUNENTHAL,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LEVETAM 100 mg/ml Oral Solution,LEVETIRACETAM,0610258329,2017,100 mg/ml,Oral solution,Oral use,119.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
HYFRESH EYE GEL UD,SODIUM HYALURONATE,2604233562,2018,3 mg/ml,Gel,Ophthalmic use,46.1,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TEDO 20 mg film-coated tablet,TADALAFIL,2802233302,2018,20 mg,Film-coated tablet,Oral use,129.7,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
ALLERTEC 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,0105233574,2018,5 mg,Film-coated tablet,Oral use,23.1,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,OTC,store below 30°c,Pharmacy,DERMAZONE Est
FEGONA 0.5 MG CAPSULE,FINGOLIMOD HYDROCHLORIDE,1805233676,2018,0.5 mg,Capsule,Oral use,4806.25,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
EVOX 750MG FILM COATED TABLET,LEVOFLOXACIN,0407233845,2017,750 mg,Film-coated tablet,Oral use,60.8,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
EVOX 500MG FILM COATED TABLET,LEVOFLOXACIN,0407233844,2017,500 mg,Film-coated tablet,Oral use,35.25,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
EVOX 250MG FILM COATED TABLET,LEVOFLOXACIN,0407233842,2017,250 mg,Film-coated tablet,Oral use,23.8,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
CYRAMZA 10 mg/ml Injection,RAMUCIRUMAB,1307233868,2017,10 mg/ml,Injection,Intravenous use,11346.00,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ARTIZ 10 MG F.C TABLET,CETIRIZINE HYDROCHLORIDE,2401233162,2017,10 mg,Film-coated tablet,Oral use,29.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EPITAM 100 mg/ml I.V. Infusion,LEVETIRACETAM,2305233701,2017,100 mg/ml,Concentrate for solution for infusion,Intravenous use,69.45,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
RIFINAH,"RIFAMPICIN, ISONIAZID",0706233775,2018,"150,100 mg",Coated tablet,Oral use,35.65,Sanofi S.r.l.,Italy,SANOFI S.P.A.,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
RIFINAH,"RIFAMPICIN, ISONIAZID",0706233774,2018,"300,150 mg",Coated tablet,Oral use,64.45,Sanofi S.r.l.,Italy,SANOFI S.P.A.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
TRAVATAN EYE DROP,TRAVOPROST,3107245709,2018,0.004 µ/ml,Eye drops,Ocular use,46.30,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,Novartis Saudi Limited
ZEPILEN 1GM POWDER FOR SOLUTION FOR INJECTION/INFUSION,CEFAZOLIN,3005233752,2017,1 g,powder for solution for injection,Intramuscular and intravenous use,100.8,MEDOCHEMIE LTD,Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
BINOCRIT 2000 I.U/1.0 ml Solution For Injection,EPOETIN ALFA,2108234015,2017,2000 IU,Solution for injection in pre-filled syringe,Intravenous use,329.7,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
MIRVASO 3 MG/G GEL,BRIMONIDINE TARTRATE,0507233847,2017,3 mg/g,Gel,Topical,186.75,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Galderma Arabia"
DIPHERELINE 0.1 MG POWDER FOR SOLUTION FOR INJECTION / INFUSION,TRIPTORELIN,2108234017,2017,0.1 mg,powder for solution for injection,Subcutaneous use,122.8,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 25°c,Hospital,Salehiya Trading Co.
ESCITAM 10 mg film-coated tablet,ESCITALOPRAM,2305233691,2017,10 mg,Film-coated tablet,Oral use,46.60,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
NIZORTAN 40 mg Tablet,TELMISARTAN,2307233918,2018,40 mg,Tablet,Oral use,45.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NIZORTAN 80 mg Tablet,TELMISARTAN,2307233912,2018,80 mg,Tablet,Oral use,59.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ESCITAM 20 mg film-coated tablet,ESCITALOPRAM,2305233695,2017,20 mg,Film-coated tablet,Oral use,83.90,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
SOMATULINE AUTOGEL 60 MG SOLUTION FOR INJECTION IN PRE-FILLE,LANREOTIDE ACETATE,1810234355,2017,60 mg,Solution for injection in pre-filled syringe,Subcutaneous use,3433.6,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
SOMATULINE AUTOGEL 90 MG SOLUTION FOR INJECTION IN PRE-FILLE,LANREOTIDE ACETATE,1810234354,2017,90 mg,Solution for injection in pre-filled syringe,Subcutaneous use,4190.7,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
FUSIDERM 2% CREAM,FUSIDIC ACID,1306233795,2018,2 %,Cream,Topical,19.5,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
SOLFISAN 5 mg Film Coated Tablet,SOLIFENACIN SUCCINATE,2305233693,2018,5 mg,Film-coated tablet,Oral use,94.1,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
SOLFISAN 10 mg Film Coated Tablet,SOLIFENACIN SUCCINATE,2305233689,2018,10 mg,Film-coated tablet,Oral use,121,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
EPCLUSA 400 mg/100 mg Film-coated Tablet,"SOFOSBUVIR, VELPATASVIR",2405233723,2018,"400,100 mg",Film-coated tablet,Oral use,40067.95,GILEAD SCIENCES IRELAND UC,Ireland,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
TALTZ 80 mg/ml Injection,IXEKIZUMAB,2711234553,2018,80 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,4259.15,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ALLAIR 10 mg Film Coated Tablet,MONTELUKAST SODIUM,2205233683,2018,10 mg,Film-coated tablet,Oral use,71.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RIALOCAINE 2 % Gel,LIDOCAINE HYDROCHLORIDE,0309234089,2018,2 %,Gel,Topical,11,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
MOXICLAV 1 gm Film Coted Tablet,"AMOXICILLIN, CLAVULANIC ACID",0106233763,2018,"875,125 mg",Film-coated tablet,Oral use,44.6,MEDOCHEMIE LTD (FACTORY B),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TRAMAL RETARD 100MG F.C TAB,TRAMADOL HYDROCHLORIDE,2609222643,2018,100 mg,Film-coated tablet,Oral use,22.65,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
VENTAVIS 10 mcg/ml solution for inhalation,ILOPROST,58-4-18,2018,10 µ/ml,Nebuliser solution,Inhalation use,2624.15,Berlimed S.A.,Spain,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
POSTINOR-2,LEVONORGESTREL,2705245356,2018,0.75 mg,Tablet,Oral use,38.55,GEDEON RICHTER,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CARDEX,BISOPROLOL FUMARATE,1710222741,2018,2.5 mg,Film-coated tablet,Oral use,13.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
CARDEX 10 MG FILM COATED TABLET,BISOPROLOL FUMARATE,1710222739,2018,10 mg,Film-coated tablet,Oral use,28.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
CARDEX PLUS 10/25 mg F.C TABLETS,"HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE",1809234222,2018,"25,10 mg",Film-coated tablet,Oral use,38.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,ACINO PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
CARDEX PLUS 5/12.5 mg F.C TABLETS,"HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE",1809234221,2018,"12.5,5 mg",Film-coated tablet,Oral use,25.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,ACINO PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
TOBRADEX EYE DROPS,"TOBRAMYCIN, DEXAMETHASONE",0910234318,2018,"0.3,0.1 %","Eye drops, suspension",Ocular use,21,S.A. Alcon Couvreur N.V,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
MAXITROL,"POLYMYXIN B, NEOMYCIN SULFATE, DEXAMETHASONE",0901256573,2018,"6000,3500,1 mg/ml, IU/",Eye ointment,Ocular use,11.3,NOVARTIS MANUFACTURING NV,Belgium,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,Novartis Saudi Limited
ARPEK 250 mg film-coated tablet,LEVETIRACETAM,1104233523,2018,250 mg,Film-coated tablet,Oral use,83.45,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ARPEK 500 mg film-coated tablet,LEVETIRACETAM,1104233522,2018,500 mg,Film-coated tablet,Oral use,132.55,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SALAZOPYRIN-EN TAB 500MG,SULFASALAZINE,1703257080,2018,500 mg,Tablet,Oral use,28.35,Recipharm Uppsala AB,Sweden,Pfizer AB,Sweden,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
MERONEM 1GM VIAL I-V,MEROPENEM,0401268843,2018,1 g,powder for solution for injection,Intravenous use,890.60,ACS DOBFAR SPA,Italy,Pfizer Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
MERONEM 500MG VIAL I-V,MEROPENEM,0401268841,2018,500 mg,powder for solution for injection,Intravenous use,473.85,ACS DOBFAR SPA,Italy,Pfizer Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
CARDEX 5 MG FILM COATED TABLET,BISOPROLOL FUMARATE,1710222740,2018,5 mg,Film-coated tablet,Oral use,20.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
CYRAMZA 10 mg/ml Injection,RAMUCIRUMAB,1307233869,2017,10 mg/ml,Injection,Intravenous use,2402.60,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VOLCON 200 mg film-coated tablet,VORICONAZOLE,1009234159,2018,200 mg,Film-coated tablet,Oral use,2334.30,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ENTAVIR 0.5 mg Film Coated Tablet,ENTECAVIR,1108257982,2018,0.5 mg,Film-coated tablet,Oral use,1352.55,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ENTAVIR 1 mg Film Coated Tablet,ENTECAVIR,1108258003,2018,1 mg,Film-coated tablet,Oral use,1387.1,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LINID 2 MG/ML SOLUTION FOR INFUSION,LINEZOLID,2305233692,2018,2 mg/ml,Solution for infusion,Intravenous use,144.15,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
LOVERA 5 mg film-coated tablet,TADALAFIL,1108257987,2018,5 mg,Film-coated tablet,Oral use,151.3,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LOVERA 20 mg film-coated tablet,TADALAFIL,1108257985,2018,20 mg,Film-coated tablet,Oral use,97.25,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
LOVERA 20 mg film-coated tablet,TADALAFIL,1108257979,2018,20 mg,Film-coated tablet,Oral use,194.5,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
GANFORT EYE DROPS,"TIMOLOL MALEATE, BIMATOPROST",3005233753,2018,"5,0.3 mg/ml","Eye drops, solution",Ophthalmic use,72.30,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AMLOBEN 5 mg Tablet,AMLODIPINE BESILATE,1-837-18,2018,5 mg,Tablet,Oral use,13.95,BENTA S.A.L.,Lebanon,BENTA S.A.L.,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
REXULTI 0.25 mg Tablet,BREXPIPRAZOLE,24-972-18,2018,0.25 mg,Tablet,Oral use,86.20,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
REXULTI 0.5 mg Tablet,BREXPIPRAZOLE,25-972-18,2018,0.5 mg,Tablet,Oral use,141.40,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
REXULTI 2 mg Tablet,BREXPIPRAZOLE,0703245053,2018,2 mg,Tablet,Oral use,405.35,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
REXULTI 3 mg Tablet,BREXPIPRAZOLE,0703245036,2018,3 mg,Tablet,Oral use,405.35,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
REXULTI 4 mg Tablet,BREXPIPRAZOLE,0703245035,2018,4 mg,Tablet,Oral use,405.35,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
HERCEPTIN 120 mg/ml Solution For Injection,Trastuzumab,2804245220,2018,120 mg/ml,Solution for injection,Subcutaneous use,6252.00,F. Hoffmann-La Roche Ltd.,Switzerland,ROCHE,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
GLOZAL 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,0307233838,2017,5 mg,Film-coated tablet,Oral use,15.95,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
GLOZAL 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,0307233837,2017,5 mg,Film-coated tablet,Oral use,23.9,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
RIVETAL 1.5 mg Capsule,RIVASTIGMINE,2102244956,2018,1.5 mg,"Capsule, hard",Oral use,101.45,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
RIVETAL 3 mg Capsule,RIVASTIGMINE,2504245210,2018,3 mg,"Capsule, hard",Oral use,114.05,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
RIVETAL 4.5 mg Capsule,RIVASTIGMINE,2102244959,2018,4.5 mg,"Capsule, hard",Oral use,133.05,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
RIVETAL 6 mg Capsule,RIVASTIGMINE,2102244960,2018,6 mg,"Capsule, hard",Oral use,160.50,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
REXULTI 1 mg Tablet,BREXPIPRAZOLE,0703245037,2018,1 mg,Tablet,Oral use,405.35,"Otsuka Pharmaceutical Co., Ltd.",Japan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
MIXIF 400 mg Capsules,CEFIXIME,0502233212,2017,400 mg,Capsule,Oral use,41.3,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
SYNJARDY 5/850 mg Film-coated Tablet,"METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN",2903233442,2017,"850,5 mg",Film-coated tablet,Oral use,165.8,"BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,BIBERACH",Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SYNJARDY 5/1000 mg Film-coated Tablet,"METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN",2903233444,2017,"1000,5 mg",Film-coated tablet,Oral use,171.5,"BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,BIBERACH",Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SYNJARDY 12.5/850 mg Film-coated Tablet,"METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN",2903233443,2017,"850,12.5 mg",Film-coated tablet,Oral use,165.8,"BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,BIBERACH",Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SYNJARDY 12.5/1000 mg Film-coated Tablet,"METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN",2903233445,2017,"1000,12.5 mg",Film-coated tablet,Oral use,171.5,"BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,BIBERACH",Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
REPATHA 140 mg/ml Solution For Injection,EVOLOCUMAB,3004233565,2017,140 mg/ml,Solution for injection,Subcutaneous use,1758.45,AMGEN MANUFACTURING LIMITED,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Accofil 480 mcg/0.5 ml solution For injection/infusion,FILGRASTIM,0910234316,2017,480 µg,Solution for injection/infusion,Intramuscular and intravenous use,850.60,INTAS PHARMACEUTICALS LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
Accofil 300 mcg/0.5 ml solution For injection/infusion,FILGRASTIM,1610234343,2017,300 µg,Solution for injection/infusion,Intramuscular and intravenous use,554.75,INTAS PHARMACEUTICALS LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
LEVODIS 5 mg/ml Solution For Injection,LEVOFLOXACIN,2803233438,2017,5 mg/ml,Solution for infusion,Intravenous use,54.15,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
MYORA 500 MG FILM COATED TABLET,MYCOPHENOLATE MOFETIL,1707233877,2017,500 mg,Film-coated tablet,Oral use,194.55,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PRALUENT 150 mg Prefilled Pen,ALIROCUMAB,2105245333,2017,150 mg,Solution for injection in pre-filled pen,Subcutaneous use,1755.00,Sanofi aventis Deutschland GmbH,Germany,sanofi-aventis,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
KETOVA 400 mg Film Coated Tablets,IMATINIB MESILATE,2105233678,2017,400 mg,Film-coated tablet,Oral use,3231.5,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
TOPRAZOLE 40 mg Powder for solution for injection,PANTOPRAZOLE,2401233163,2017,40 mg,powder for solution for injection,Intravenous use,22.9,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ANNUVA 50 mg Tablet,DICLOFENAC SODIUM,1108257989,2017,50 mg,Tablet,Oral use,17.65,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SERCAND 25 mg film-coated tablet,QUETIAPINE,0504233489,2017,25 mg,Film-coated tablet,Oral use,11.65,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
NEUROBION ampoules,"THIAMINE, PYRIDOXINE, CYANOCOBALAMIN",1303233365,2017,"100,100,1000 mg, µg",Solution for injection,Intramuscular use,45.5,CENEXI,France,P&G Health GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
DESLORATADINE/GENEPHARM 5 mg film-coated tablet,DESLORATADINE,1907233885,2017,5 mg,Film-coated tablet,Oral use,16.75,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,OTC,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
MONCAS 5 mg Chewable Tablet,MONTELUKAST SODIUM,3110234409,2017,5 mg,Chewable tablet,Oral use,40.05,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SPIOLTO RESPIMATE,"TIOTROPIUM, OLODATEROL",1501244717,2017,"2.5,2.5 µg",inhalation solution,Inhalation use,200.05,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
PROPOFOL-LIPURO 0.5% EMULSION FOR Inj./Infusion,PROPOFOL,1707233874,2017,0.5 %,Emulsion for injection/infusion,Intravenous use,62.25,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 25°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
STELARA 130MG/26ML Concentrate for solution for infusion,USTEKINUMAB,2007233891,2017,130 mg,Solution for injection in pre-filled syringe,Intravenous use,10025.25,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
SPEDRA 50 mg Tablet,AVANAFIL,0404233469,2017,50 mg,Tablet,Oral use,54.50,SANOFI AVENTIS GROUP,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
PANLOCK 40 mg Enteric coated tablet,PANTOPRAZOLE,20-251-17,2017,40 mg,Coated tablet,Oral use,18.8,MEDICAL UNION PHARMACEUTICALS CO,Egypt,MEDICAL UNION PHARMACEUTICALS CO,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,"Annhdah Medical Company, Cigalah Group"
SPEDRA 100 mg Tablet,AVANAFIL,0404233468,2017,100 mg,Tablet,Oral use,59,SANOFI AVENTIS GROUP,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
PRALUENT 150 mg Prefilled Pen,ALIROCUMAB,10-540-17,2017,150 mg,Solution for injection in pre-filled pen,Subcutaneous use,936.55,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
PRALUENT 75 mg Prefilled Pen,ALIROCUMAB,8-540-17,2017,75 mg,Solution for injection in pre-filled pen,Subcutaneous use,936.55,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
LINDYNETTE 0.075/0.03 mg Film-coated Tablet,"ETHINYLESTRADIOL, GESTODENE",0801233067,2017,"0.03,0.075 mg",Coated tablet,Oral use,18.4,GEDEON RICHTER PLC.,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
GENVOYA Film-coated Tablet,"EMTRICITABINE, ELVITEGRAVIR, COBICISTAT, TENOFOVIR ALAFENAMIDE",2803233431,2017,"200,150,150,10 mg",Film-coated tablet,Oral use,3657.20,PATHEON INC,Canada,GILEAD SCIENCES LIMITED (CORK),Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
ROZLET 2.5 mg film-coated tablet,LETROZOLE,0709234153,2017,2.5 mg,Film-coated tablet,Oral use,165.20,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GEMCITABINE JAZEERA 40 mg/ml Lyophilisate For solution For infusion,GEMCITABINE,0712222985,2017,40 mg/ml,Powder for solution for infusion,Intravenous use,234.75,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
COLISTIN JPI Powder For Solution For Injection/Infusion,COLISTIMETHATE SODIUM,2201233140,2017,1000000 IU,Powder for solution for injection/infusion,Intravenous use,357.75,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ZIDRONIC 4 mg/5 ml Vial,ZOLEDRONIC ACID,0712222986,2017,0.8 mg/ml,Solution for infusion,Intravenous use,713.60,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
FEMAPLEX 2.5 mg film-coated tablet,LETROZOLE,2408234052,2017,2.5 mg,Film-coated tablet,Oral use,136.55,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, QOMEL MEDICAL DRUG STORE, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
ZERBAXA Powder For Injection Vial,"Tazobactam, CEFTOLOZANE",2501233167,2017,"0.5,1 g",Powder for injection,Intravenous use,3282.10,"STERI-PHARMA, LLC",United States,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
PRALUENT 75 mg Prefilled Pen,ALIROCUMAB,1605245315,2017,75 mg,Solution for injection in pre-filled pen,Subcutaneous use,1755.00,Sanofi aventis Deutschland GmbH,Germany,sanofi-aventis,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
ELOCOM 0.1% OINTMENT,MOMETASONE FUROATE,1701244757,2017,0.1 %,Ointment,Topical,19.95,Organon Heist bv,Belgium,N.V. Organon,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DIPROSALIC OINTMENT,"SALICYLIC ACID, BETAMETHASONE DIPROPIONATE",1010234324,2017,"30,0.5 mg/g",Ointment,Topical,15.2,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
GEMCITABINE JAZEERA 40 mg/ml Lyophilisate For solution For infusion,GEMCITABINE,0712222984,2017,40 mg/ml,Powder for solution for infusion,Intravenous use,46.95,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ACETYLCYSTEINE 200mg/ml Injection,ACETYLCYSTEINE,0804233505,2017,200 mg/ml,Injection,Intravenous use,99.05,DEMO S.A.,Greece,AURUM PHARMACEUTICALS LTD,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
OZURDEX 700 mcg Intravitreal Implant In Applicator,DEXAMETHASONE,0802233223,2017,700 µg,Intravitreal implant in applicator,Intravitreal use,3260.15,ALLERGAN PHARMACEUTICALS LTD,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
PRALUENT 75 mg Prefilled Syringe,ALIROCUMAB,4-540-17,2017,75 mg,Solution for injection in pre-filled syringe,Subcutaneous use,936.55,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
PRALUENT 75 mg Prefilled Syringe,ALIROCUMAB,5-540-17,2017,75 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1873.1,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
PRALUENT 150 mg Prefilled Syringe,ALIROCUMAB,6-540-17,2017,150 mg,Solution for injection in pre-filled syringe,Subcutaneous use,936.55,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
PRALUENT 150 mg Prefilled Syringe,ALIROCUMAB,7-540-17,2017,150 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1873.1,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
ELOCOM 0.1% CREAM,MOMETASONE FUROATE,1701244759,2017,0.1 %,Cream,Topical,19.95,ORGANON HEIST BV,Belgium,Organon Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
IRBEGEN PLUS 300/12.5 mg Film Coated Tablet,"IRBESARTAN, HYDROCHLOROTHIAZIDE",6-5035-17,2017,"300,12.5 mg",Film-coated tablet,Oral use,47.70,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
SPEDRA 200 mg Tablet,AVANAFIL,0404233470,2017,200 mg,Tablet,Oral use,59,SANOFI AVENTIS GROUP,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
PANREST 20 mg Enteric Coated Tablet,PANTOPRAZOLE,1701244754,2017,20 mg,Coated tablet,Oral use,18.4,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PANREST 40 mg Enteric Coated Tablet,PANTOPRAZOLE,1701244755,2017,40 mg,Coated tablet,Oral use,39.7,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BINOCRIT 1000 I.U/0.5 ml Solution For Injection,EPOETIN ALFA,2108234010,2017,1000 IU,Solution for injection in pre-filled syringe,Intravenous use,163.75,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BINOCRIT 4000 I.U/0.4 ml Solution For Injection,EPOETIN ALFA,2108234007,2017,4000 IU,Solution for injection in pre-filled syringe,Intravenous use,659.40,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BINOCRIT 10000 I.U/1.0 ml Solution For Injection,EPOETIN ALFA,2108234014,2017,10000 IU,Solution for injection in pre-filled syringe,Intravenous use,261.00,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BINOCRIT 30000 I.U/0.75 ml Solution For Injection,EPOETIN ALFA,2108234012,2017,30000 IU,Solution for injection in pre-filled syringe,Intravenous use,783.00,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
BINOCRIT 40000 I.U/1.0 ml Solution For Injection,EPOETIN ALFA,2108234009,2017,40000 IU,Solution for injection in pre-filled syringe,Intravenous use,1044.00,IDT Biologika GmbH,Germany,SANDOZ,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
DENACIF 300 mg Capsule,CEFDINIR,1704233557,2017,300 mg,Capsule,Oral use,57.8,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
DENACIF 125 mg/5 ml Suspension,CEFDINIR,1704233556,2017,25 mg/ml,Powder for oral suspension,Oral use,41.4,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DENACIF 125 mg/5 ml Suspension,CEFDINIR,1704233558,2017,25 mg/ml,Powder for oral suspension,Oral use,64.75,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
QUET 100 mg Film-coated Tablet,QUETIAPINE,2-976-17,2017,100 mg,Film-coated tablet,Oral use,23.45,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
QUET 200 mg Film-coated Tablet,QUETIAPINE,3-976-17,2017,200 mg,Film-coated tablet,Oral use,43.5,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
LUXAT 10mg Film Coated Tablet,MONTELUKAST SODIUM,4-976-17,2017,10 mg,Film-coated tablet,Oral use,36.2,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
ABILIFY MAINTENA 400 mg Powder And Solvent For Prolonged-Release,ARIPIPRAZOLE,1109234176,2017,400 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,1188.65,"OTSUKA PHARMACEUTICAL CO., LTD",Japan,H. LUNDBECK,Denmark,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PAFINUR 10 mg Tablet,RUPATADINE FUMARATE,1003233351,2017,10 mg,Tablet,Oral use,23.80,Nocour Health S.A,Spain,Nocour Health S.A,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Cigalah Group, STADA Arabia Limited Company"
STEROFUNDIN ISO Solution For Infusion,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, MALIC ACID",3005233751,2017,"6.799,0.2984,0.3675,0.2033,3.266,0.671 g",Solution for infusion,Intravenous use,8.65,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Medical Supplies And Services Co Ltd (Mediserv)
STEROFUNDIN ISO Solution For Infusion,"POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM ACETATE, MALIC ACID, MAGNESIUM CHLORIDE",3005233749,2017,"0.2984,6.799,0.3675,3.266,0.671,0.2033 g",Solution for infusion,Intravenous use,11.75,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Medical Supplies And Services Co Ltd (Mediserv)
SERCAND 200 mg film-coated tablet,QUETIAPINE,1105233630,2017,200 mg,Film-coated tablet,Oral use,136.70,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
XYRIO 20 mg Tablet,TADALAFIL,2105233677,2017,20 mg,Tablet,Oral use,63.3,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZORON 4 mg tablet,ONDANSETRON,1001233081,2017,4 mg,Film-coated tablet,Oral use,100.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ZORON 8 mg tablet,ONDANSETRON,1001233084,2017,8 mg,Film-coated tablet,Oral use,145.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ACYCLOVIR JPI 250 mg vial,ACYCLOVIR,1001233085,2017,250 mg,"Sterile, lyophilized, white powder",Intravenous use,96.75,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ACYCLOVIR JPI 500 mg vial,ACYCLOVIR,1001233086,2017,500 mg,"Sterile, lyophilized, white powder",Intravenous use,193.5,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
SERCAND 100 mg film-coated tablet,QUETIAPINE,1105233631,2017,100 mg,Film-coated tablet,Oral use,68.35,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SERCAND 300 mg film-coated tablet,QUETIAPINE,0504233485,2017,300 mg,Film-coated tablet,Oral use,102.55,APOTEX,Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SUPRANE LIQUID FOR INHALATION,DESFLURANE,2305233697,2016,100 %,"Inhalation vapour, liquid",Inhalation use,2148.90,BAXTER HEALTHCARE CORPORATION,Puerto Rico,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
MIDIANA 3 mg/ 0.3 mg F.C.tablet,"DROSPINENONE, ETHINYLESTRADIOL",0801233068,2017,"3,0.03 mg",Film-coated tablet,Oral use,20.2,GEDEON RICHTER PLC.,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
DAPO 60 MG FILM COATED TABLET,DAPOXETINE,1801233112,2017,60 mg,Film-coated tablet,Oral use,54.25,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,RIYADH PHARMA
XYRIO 5 mg Tablet,TADALAFIL,2105233679,2017,5 mg,Tablet,Oral use,151.3,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DIFLUCAN 200 mg capsule,FLUCONAZOLE,0401268842,2018,200 mg,Capsule,Oral use,340.60,Fareva Amboise,France,PFIZER HOLDING FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
DIFLUCAN 50 mg capsule,FLUCONAZOLE,0401268840,2018,50 mg,Capsule,Oral use,45.45,Fareva Amboise,France,PFIZER HOLDING FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
DALACIN C 300MG CAPS,CLINDAMYCIN HYDROCHLORIDE,1709234218,2018,300 mg,"Capsule, hard",Oral use,32.8,Pfizer Manufcaturing Belgium N. V.,Belgium,PFIZER HOLDING FRANCE,France,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DALACIN C 150 MG CAPS,CLINDAMYCIN HYDROCHLORIDE,1709234217,2018,150 mg,"Capsule, hard",Oral use,18.1,Pfizer Manufcaturing Belgium N. V.,Belgium,PFIZER HOLDING FRANCE,France,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CAMPTO 100MG-5ML VIAL FOR I.V INFUSION,IRINOTECAN,1303257044,2018,20 mg/ml,concentrate for solution for injection,Intravenous use,291.05,Zydus Hospira Oncology Private Limited ZHOPL,India,PFIZER PERTH PTY LIMITED,Australia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
CLAZ MR 30 mg tablet,GLICLAZIDE,65-249-18,2018,30 mg,modified-release tablet,Oral use,21.6,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MYOZYME 50mg Powder For Concentrate For Solution For Infusion,ALGLUCOSIDASE ALFA,1402244920,2017,5 mg/ml,Powder for concentrate for solution for infusion,Intravenous use,2606,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
ALECENSA 150 Mg Capsule,ALECTINIB HYDROCHLORIDE,0804257200,2017,150 mg,Capsule,Oral use,23760.05,EXCELLA GmbH & Co. KG,Germany,ROCHE,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Roche Products Saudi Arabia"
ELORES 1.5 g Powder For Solution For Injection/Infusion,"CEFTRIAXONE, SULBACTAM",2405233719,2017,"1000,500 mg",powder for solution for injection,Intramuscular and intravenous use,49.15,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
DIFLUCAN 150 mg capsule,FLUCONAZOLE,0401268839,2018,150 mg,Capsule,Oral use,19.45,Fareva Amboise,France,PFIZER HOLDING FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO"
LIVADOR 750MG F.C.TABLET,LEVOFLOXACIN,2702256961,2018,750 mg,Film-coated tablet,Oral use,43.4,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
PROLASTIN®-C,ALPHA.1-PROTEINASE INHIBITOR HUMAN,1403257070,2019,50 mg/ml,powder for solution for injection,Intravenous use,1468.05,GRIFOLS THERAPEUTICS LLC,United States,GRIFOLS THERAPEUTICS INC,United States,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
METOJECT 50 mg/ml solution for injection,METHOTREXATE,1511222901,2016,50 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,98.95,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NUMETA G16% E,"TRYPTOPHAN, ARGININE, PHENYLALANINE, REFINED OLIVE OIL (~80%) + REFINED SOYA OIL (~20%), METHIONINE, CALCIUM CHLORIDE DIHYDRATE, GLUTAMIC ACID, ASPARTIC ACID, TAURINE, SERINE, PROLINE, ISOLEUCINE5, HISTIDINE, CYSTEINE, POTASSIUM ACETATE, THREONINE, TYROSINE, ORNITHINE, GLYCINE, LYSINE, LEUCINE, SODIUM CHLORIDE, GLUCOSE, SODIUM GLYCEROPHOSPHATE HYDRATED, ALANINE, MAGNESIUM ACETATE TETRAHYDRATE, VALINE",1311246216,2018,"0.26,1.08,0.54,15.5,0.31,0.46,1.29,0.77,0.08,0.51,0.39,0.86,0.49,0.24,1.12,0.48,0.10,0.32,0.51,1.42,1.29,0.30,77.50,0.98,1.03,0.33,0.98 g",Emulsion for infusion,Intravenous use,2439.90,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Belgium Manufacturing SA,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
OXYNORM 20MG/2ML AMPOULE,OXYCODONE HYDROCHLORIDE,10-5010-19,2019,10 mg/ml,Solution for injection/infusion,"Intravenous, Subcutaneous",65.7,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmacuticals limited UK,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
SEIZET 100 mg Chewable/Dispersible Tablet,LAMOTRIGINE,1501256664,2019,100 mg,Chewable/dispersible tablet,Oral use,66.75,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MAVEC 100MG F.C. TABLET,IMATINIB MESILATE,1311246219,2019,100 mg,Film-coated tablet,Oral use,441.7,Natco Pharma Limited,India,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
VIAGRA 50 mg Orodispersible Tablet,SILDENAFIL,2803245126,2019,50 mg,Tablet,Oral use,66.35,Fareva Amboise,France,UPJOHN EESV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
MAVEC 400MG F.C. TABLET,IMATINIB MESILATE,1311246218,2019,400 mg,Film-coated tablet,Oral use,1963.1,Natco Pharma Limited,India,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Xelorni 8 mg F.C.TABLET,LORNOXICAM,3112246508,2019,8 mg,Film-coated tablet,Oral use,23.6,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
ENNLA 5% Cream,"LIDOCAINE HYDROCHLORIDE, PRILOCAINE",3007257895,2019,"25,25 mg/g",Cream,Topical,9.9,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,DEEF MARKITING COMPANY
ENNLA 5% Cream,"LIDOCAINE HYDROCHLORIDE, PRILOCAINE",2503257161,2019,"25,25 mg/g",Cream,Topical,29.7,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,DEEF MARKITING COMPANY
ENNLA 5% Cream,"LIDOCAINE HYDROCHLORIDE, PRILOCAINE",3007257894,2019,"25,25 mg/g",Cream,Topical,59.4,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,DEEF PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,DEEF MARKITING COMPANY
METOJECT 50 mg/ml solution for injection,METHOTREXATE,1511222902,2016,50 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,105.75,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
TARGINACT 10MG/5MG PR TABLET,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE",11-5010-19,2019,"10,5 mg",Film-coated tablet,Oral use,110.25,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,2905257493,2019,0.9 %,Solution for injection,Intravenous use,238.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
OBSOL 5 MG FILM COATED TABLET,BISOPROLOL FUMARATE,3112246512,2019,5 mg,Film-coated tablet,Oral use,16.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
"TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed","FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL",3001256785,2018,"100,62.5,25 µg","Inhalation powder, pre-dispensed",Inhalation use,236.8,Glaxo Operations UK Ltd,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
GAMCET 0.4MG PROLONGED RELEASE F.C.TABLET,TAMSULOSIN HYDROCHLORIDE,0402256821,2019,0.4 mg,Prolonged-release film-coated tablet,Oral use,50.3,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
VIAGRA 50 mg Orodispersible Tablet,SILDENAFIL,2803245125,2019,50 mg,Tablet,Oral use,132.75,Fareva Amboise,France,UPJOHN EESV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
QUREX XL 1000 mg film-coated tablet,CIPROFLOXACIN,1811246235,2019,1000 mg,Film-coated tablet,Oral use,53.75,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
LIVADOR 500 MG FILM COATED TABLET,LEVOFLOXACIN,0402256822,2019,500 mg,Film-coated tablet,Oral use,35.25,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ROLITAC 5 mg Capsule,TACROLIMUS,121-116-18,2018,5 mg,"Capsule, hard",Oral use,2350.808,Sandoz Private Limited,India,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ROLITAC 0.5 mg Capsule,TACROLIMUS,122-116-18,2018,0.5 mg,"Capsule, hard",Oral use,235.05,Sandoz Private Limited,India,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
ROLITAC 1 mg Capsule,TACROLIMUS,123-116-18,2018,1 mg,"Capsule, hard",Oral use,470.15,Sandoz Private Limited,India,SANDOZ,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Xevaneer 300 mg capsule,CEFDINIR,2411246331,2019,300 mg,Capsule,Oral use,52,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
METOJECT 50 mg/ml solution for injection,METHOTREXATE,1511222903,2016,50 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,109.25,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
TARGINACT 20MG/10MG PR TABLET,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE",12-5010-19,2019,"20,10 mg",Prolonged-release tablet,Oral use,220.55,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ANASTROZOLE 1MG F.C.TABLET,ANASTROZOLE,12-5015-18,2018,1 mg,Film-coated tablet,Oral use,156.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,1401244709,2019,0.9 %,Solution for injection,Intravenous use,75.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
ZYPREXA 5MG COATED TABLETS,OLANZAPINE,0705245254,2019,5 mg,Coated tablet,Oral use,174.20,Lilly S.A,Spain,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Saudi Advanced Renal Services Ltd (SRS)"
XEVANEER 125mg/5ml Powder For Oral Suspension,CEFDINIR,1703257078,2019,25 mg/ml,Powder for oral suspension,Oral use,29.8,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
OBSOL 10 MG FILM COATED TABLET,BISOPROLOL FUMARATE,3112246511,2019,10 mg,Film-coated tablet,Oral use,23.05,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
REVCOX 200MG CAPSULE,CELECOXIB,0909258197,2020,200 mg,"Capsule, hard",Oral use,21.8,Novartis Pharmaceutical Manufacturing LLC,Slovenia,Sandoz GmbH,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
FACTOR IX GRIFOLS,COAGULATION FACTOR IX RECOMBINANT HUMAN,1612258798,2019,40-62.5 IU/ml,Powder and solvent for solution for injection,Intravenous use,260.2,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
TARGINACT 40MG/20MG PR TABLET,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE",13-5010-19,2019,"40,20 mg",Prolonged-release tablet,Oral use,421.95,Bard Pharmaceuticals Limited,United Kingdom,Napp pharmaceuticals limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
ZYPREXA 10MG F.C.TAB,OLANZAPINE,1503233372,2019,10 mg,Coated tablet,Oral use,285.60,"LILLY DEL CARIBE, INC.",United States,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Saudi Advanced Renal Services Ltd (SRS)"
XALTIN 5MG/ML CONC. FOR SOLUTION FOR INFUSION (10ml),OXALIPLATIN,3009245973,2019,5 mg/ml,Concentrate for solution for infusion,Intravenous use,222.15,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
REMIFENTANIL MEDIS 1 MG VIAL,REMIFENTANIL HYDROCHLORIDE,1103257036,2019,1 mg,Powder for solution for injection/infusion,Intravenous use,79.2,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
ANORO ELLIPTA,"UMECLIDINIUM BROMIDE, VILANTEROL",0310211093,2019,"62.5,25 µg","Inhalation powder, pre-dispensed",Inhalation use,158.4,GLAXO OPERATION,United Kingdom,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IMIGRAN 20 MG NASAL SPRAY,SUMATRIPTAN,1309211040,2019,20 mg,Nasal spray,Nasal use,38.20,GLAXOSMITHKLINE (GSK),Italy,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
HUMAN ALBUMIN 20% SOLUTION FOR INFUSION,ALBUMIN HUMAN,1303257048,2019,20 %,Solution,Intravenous use,164.45,HUMAN BioPlazma LLC,Hungary,HUMAN BioPlazma LLC,Hungary,Marketed,Prescription,store below 30°c,Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET,BUPROPION HYDROCHLORIDE,0907257717,2019,300 mg,Prolonged-release film-coated tablet,Oral use,121.05,Bausch Health Companies Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
WELLBUTRIN XL 150 EXTENDED RELEASE F.C.TABLET,BUPROPION HYDROCHLORIDE,1004257228,2019,150 mg,Prolonged-release film-coated tablet,Oral use,65.00,Bausch Health Companies Inc,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VOLIBRIS 5 mg film-coated tablet,AMBRISENTAN,0506222133,2019,5 mg,Film-coated tablet,Oral use,3523.65,PATHEON INC,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VOLIBRIS 10 mg film-coated tablet,AMBRISENTAN,0506222132,2019,10 mg,Film-coated tablet,Oral use,3523.65,PATHEON INC,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
RELVAR ELLIPTA,"FLUTICASONE FUROATE, VILANTEROL",0310211095,2019,"100,25 µg",Inhalation powder,Inhalation use,158.4,GLAXO OPERATION,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FACTOR IX GRIFOLS,COAGULATION FACTOR IX RECOMBINANT HUMAN,1612258796,2019,40-62.5 IU/ml,Powder and solvent for solution for injection,Intravenous use,520.4,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,14-5023-19,2019,0.9 %,Solution for injection,Intravenous use,100.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
ALIMTA 500MG POWDER FOR SOLUTION FOR INFUSION,PEMETREXED,14-5117-19,2019,500 mg,Powder for concentrate for solution for infusion,Parenteral use,3861.45,ELI LILLY,United States,Eli Lilly and Company,Netherlands,Marketed,Prescription,do not store above 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
OXALIPLATIN 5MG/ML  (20ml),OXALIPLATIN,3009245972,2019,5 mg/ml,Concentrate for solution for infusion,Intravenous use,444.35,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
RELVAR ELLIPTA 200/25 mcg inhalation powder,"FLUTICASONE FUROATE, VILANTEROL",0310211094,2019,"200,25 µg",Inhalation powder,Inhalation use,158.4,GLAXO OPERATION,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
REMIFENTANIL MEDIS 5 MG VIAL,REMIFENTANIL HYDROCHLORIDE,1103257035,2019,5 mg,Powder for solution for injection/infusion,Intravenous use,306.05,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
VENTOLIN 0.5MG\ML INJ,SALBUTAMOL,1601256669,2020,0.5 mg/ml,Solution for injection,Intravenous use,17.45,GLAXOSMITHKLINE (GSK),Italy,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
MABRON,TRAMADOL HYDROCHLORIDE,2503257159,2019,50 mg/ml,Solution for injection/infusion,Intravenous use,17,Medochemie (Ampoule Injectable Facility),Cyprus,MEDOCHEMIE LTD PHARMACEUTICAL INDUSTRY,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
FUCITHALMIC VISCOUS EYE DROPS,FUSIDIC ACID,2409245938,2019,1 %,"Eye drops, suspension",Ocular use,15.75,Leo Laboratories Limited,Ireland,Amdipharm limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
WILATE 1000 IU Powder and Solvent for Solution for Injection,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",1004257225,2018,"1000,1000 IU",Powder and solvent for solution for injection,Intravenous use,2738.10,Octapharma Pharmazeutika Produktionsges.m.b.h,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
DESCOVY 200MG/25MG F.C.TABLET,"EMTRICITABINE, TENOFOVIR ALAFENAMIDE",2705257472,2018,"200,28 mg",Film-coated tablet,Oral use,1626.35,PATHEON INC,Canada,Gilead Sciences International Ltd,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
NUMETA G19% E,"ARGININE, LYSINE, ALANINE, ASPARTIC ACID, CYSTEINE, ISOLEUCINE5, GLUTAMIC ACID, THREONINE, GLYCINE, GLUCOSE, LEUCINE, SODIUM GLYCEROPHOSPHATE HYDRATED, CALCIUM CHLORIDE DIHYDRATE, SERINE, TAURINE, HISTIDINE, TRYPTOPHAN, TYROSINE, SODIUM CHLORIDE, ORNITHINE, PHENYLALANINE, METHIONINE, VALINE, REFINED OLIVE OIL (~80%) + REFINED SOYA OIL (~20%), POTASSIUM ACETATE, PROLINE, MAGNESIUM ACETATE TETRAHYDRATE",1311246215,2018,"1.92,2.51,1.83,1.37,0.43,1.53,2.29,0.85,0.91,191.50,2.29,2.21,0.56,0.91,0.14,0.87,0.46,0.18,1.79,0.57,0.96,0.55,1.74,28.1,3.14,0.69,0.55 g",Emulsion for infusion,Intravenous use,2439.90,Baxalta Belgium Manufacturing SA,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
RAFOL 1 mg Tablet,FOLIC ACID,2010246078,2019,1 mg,Tablet,Oral use,15.30,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DIOZAD,"VALSARTAN, HYDROCHLOROTHIAZIDE",1-5130-19,2019,"160,25 mg",Film-coated tablet,Oral use,24.5,Macleods Pharmaceuticals Limited,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Razy Al Madina Pharmaceutical
PYRIDOXIN TAB 40MG,PYRIDOXINE,1401244707,2019,40 mg,Tablet,Oral use,5.35,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ALZAMED 5MG F.C.TABLET,DONEPEZIL HYDROCHLORIDE,1-5149-19,2019,5 mg,Film-coated tablet,Oral use,47.45,World Medicine İlaç San. ve Tic. A.Ş.,Turkey,World Medicine İlaç San. ve Tic. A.Ş.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
KAPRON 500 mg/5ml Injection,TRANEXAMIC ACID,1612246427,2019,100 mg/ml,Solution for injection,Intravenous use,26.7,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Hospital,Thimar Aljazirah Company
CRESPINE GEL FOR INJECTION,HYALURONIC ACID,1-5192-18,2018,1 mg,Gel,Intraarticular use,463.15,Biopolymer GmbH & Co. Kg,Germany,Biopolymer GmbH & Co. Kg,Germany,Marketed,Prescription,store below 30°c,Hospital,"Blue Elaf Limited Company, ELAF MED LIMITED COMPANY"
HEXAXIM VACCINE,"TETANUS TOXOID, DIPHTHERIA TOXOID, PERTUSSIS TOXOID, Haemagglutinin, INACTIVATED POLIO VIRUS (IPV) TYPE 1, INACTIVATED POLIO VIRUS (IPV) TYPE 2, INACTIVATED POLIO VIRUS (IPV) TYPE 3, HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN, HAEMOPHILUS INFLUENZAE TYPE B",2204257268,2019,"40,20,25,25,25,8,32,10,12 IU, µg, DA",Suspension for injection,Intramuscular use,1579,SANOFI PASTEUR SA,France,SANOFI PASTEUR SA,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
ETHIONAMIDE 250 MG FCT,ETHIONAMIDE,1211246204,2019,250 mg,Film-coated tablet,Oral use,190,Macleods Pharmaceuticals Ltd.,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
MEDICURTAIN 10% GEL FOR INJECTION,"SODIUM HYALURONATE, HYDROXYETHYL STARCH",2711258668,2019,"10,5 mg/ml",Gel,Intraabdominal use,237.95,"Shin Poong Pharmaceutical co,Ltd",KOREA,"SHIN POONG PHARMACEUTICAL CO , Ltd.",KOREA,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALJAWAHER PHARMACEUTICAL MEDICAL COMPANY, YAHMAA MEDICAL COMPANY"
LATUDA 40 MG F.C.TABLET,LURASIDONE,112258690,2019,40 mg,Film-coated tablet,Oral use,243.1,Bushu Pharmaceuticals Ltd.,Japan,Medius AG,Switzerland,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Farouk, Maamoun Tamer & CO"
XEOMIN 50 U Vial,CLOSTRIDIUM BOTULINUM NEUROTOXIN A,1911246274,2019,50 U,powder for solution for injection,Intramuscular use,323.95,IDT Biologika GmbH,Germany,MERZ PHARMACEUTICALS GMBH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
CITAROX 200 mg VIAL,GEMCITABINE,1510246058,2019,40 mg/ml,Powder for solution for infusion,Intravenous use,29.55,S.C Sindan pharma SRL,Romania,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
LETRASAN 2.5MG F.C.TABLET,LETROZOLE,1-5260-19,2019,2.5 mg,Film-coated tablet,Oral use,68.45,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
TORLEN 5 MG FILM-COATED TABLET,TADALAFIL,1310258406,2019,5 mg,Film-coated tablet,Oral use,136.15,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
NEULASTIM 6MG-0.6ML PRE-FILLED SYRINGE,PEGFILGRASTIM,2012234611,2019,6 mg/ml,Solution for injection,Subcutaneous use,2568.25,AMGEN MANUFACTURING LIMITED,United States,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
NAVELA 1.5 MG TABLET,LEVONORGESTREL,1009245891,2019,1.5 mg,Tablet,Oral use,38.55,"LABORATORIOS LEON FARMA, S.A.",Spain,EXELTIS GERMANY GmbH,Germany,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BESPONSA 0.9 mg Vial,INOTUZUMAB OZOGAMICIN,1301256587,2019,0.9 mg,Powder for concentrate for solution for infusion,Intravenous use,38487.50,WYETH,United States,PFIZER INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
APROVASC 150MG/5MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",1-5307-19,2019,"150,5 mg",Tablet,Oral use,95.65,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
IBICAR 250 MCG INHALATION,BECLOMETHASONE DIPROPIONATE,1111246185,2019,250 µg,Pressurised inhalation,Inhalation use,24.05,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ANADEX 1MG F.C.TABLET,ANASTROZOLE,3-5685-23,2019,1 mg,Film-coated tablet,Oral use,120.00,GENEPHARM S.A.,Greece,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
LUPRON DEPOT 3.75MG-VIAL,LEUPRORELIN,2506245428,2019,3.75 mg,Powder and solvent for suspension for injection,Subcutaneous use,423.90,TAKEDA,Japan,Abbvie BV.,Netherlands,Marketed,Prescription,store below 25°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
RESINCALCIO POWDER FOR SUSPENSION,CALCIUM POLYSTYRENE SULFONATE,1-5318-19,2019,99.75 %,Powder for oral/rectal suspension,Oral use,156.5,Laboratorios Rubió; S.A.,Spain,Laboratorios Rubió; S.A.,Spain,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
CARBAGLU 200MG DISPERSIBLE TABLETS,CARGLUMIC ACID,1-5334-19,2019,200 mg,Dispersible tablet,Oral use,1539.70,Laboratoires BTT,France,Recordati Rare Diseases,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ZIMMO TRADING ESTABLISHMENT
NUTRYELT CONC. FOR SOLUTION FOR INFUSION,"CHROMIUM CHLORIDE HEXAHYDRATE, SODIUM SELENITE PENTAHYDRATE, POTASSIUM IODIDE, SODIUM FLUORIDE, MANGANESE GLUCONATE, COPPER GLUCONATE, ZINC GLUCONATE, SODIUM MOLYBDATE, FERROUS GLUCONATE",1311246217,2019,"30.45,153.32,170.06,2099.5,445.69,2142.4,69700,42.93,7988.2 µg",Concentrate for solution for infusion,Intravenous use,127.9,LABORATOIRE AGUETTANT,France,Baxter Healthcare SA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
SYNTOCINON 5 IU injection,OXYTOCIN,4-5480-20,2019,5 IU/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,11.65,Steriscience Sp. z.o.o,Poland,Mylan Pharma GmbH,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
SKINOREN 20% CREAM,AZELAIC ACID,82-19-21,2019,20 %,Cream,Topical,32.70,LEO Pharma Manufacturing Italy Srl,Italy,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Bayer Saudi Arabia, Cigalah Group"
KYTRIL 1MG TAB,GRANISETRON,2610234397,2019,1 mg,Tablet,Oral use,165.85,Delpharm Milano S.r.l,Italy,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
BEMFOLA 75IU/0.125ML INJECTION,FOLLITROPIN ALFA,2105257441,2019,75 IU,Solution for injection,Subcutaneous use,86.1,CP PHARMACEUTICAL LIMITED,United Kingdom,Finox Biotech AG,Liechtenstein,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
VPRIV 40 U POWDER FOR SOLUTION FOR INFUSION,VELAGLUCERASE ALFA,1005233624,2019,400 U,Powder for solution for infusion,Intravenous use,6118.55,Cangene BioPharma Inc. (CBI),United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
GEMZAR 200MG LYPH.VIAL 5ML,GEMCITABINE,1-5396-19,2019,40 mg/ml,Powder for solution for infusion,Intravenous use,142.6,Vianex S.A. – Plant C,Greece,LILLY FRANCE,France,Marketed,Prescription,store below 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
PLAQUENIL 200MG TAB,HYDROXYCHLOROQUINE SULFATE,1-5397-19,2019,200 mg,Film-coated tablet,Oral use,84.45,"Sanofi-aventis, S.A.",Spain,Sanofi-aventis Ireland Limited,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ESIDREX TAB. 25 MG,HYDROCHLOROTHIAZIDE,1009234160,2019,25 mg,Tablet,Oral use,17.25,"Siegfried Barbera, S.L",Spain,Laboratoires Juvisé Pharmaceuticals,France,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
NEUROBION tablet,"PYRIDOXINE, THIAMINE, CYANOCOBALAMIN",1906233826,2019,"200,100,200 mg, µg",Coated tablet,Oral use,15.85,P&G Health Austria GmbH & Co. OG,Austria,P&G Health GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
ROBITUSSIN CF SYRUP,"GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN",1-5412-19,2019,"100,30,10 mg",Syrup,Oral use,8.8,FEREVA RICHMOND,United States,PFIZER INC,United States,Marketed,Prescription,store below 25°c,Pharmacy,Annhdah Medical Company
ACARIZAX 12SQ-HDM ORALLY LYOPHILISATE,"DERMATOPHAGOIDES FARINAE EXTRACT, DERMATOPHAGOIDES PTERONYSSINUS EXTRACT",0708257955,2020,12 SQ-HDM,Oral lyophilisate,Sublingual use,323.30,Catalent UK Swindon Zydis Ltd,United Kingdom,ALK-Abello A/S,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
GEMCITABINE GLENMARK 200MG VIAL,GEMCITABINE,3012246506,2020,200 mg,Powder for injection,Intravenous use,42.25,GLENMARK GENERIC SA,Argentina,GLENMARK GENERIC SA,Argentina,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Salehiya Trading Co."
TISSEEL Lyo Powder And Solvent For Sealant,"HUMAN FIBRINOGEN, APROTININ, HUMAN THROMBIN, CALCIUM CHLORIDE",2503257158,2020,"72-110,2250-3750,400-625,36-44 IU, mg/ml",Powder and solvent for sealant,Epilesional use,485.70,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Baxter Medical Products GmbH,Austria,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
NOYADA 25MG/5ML ORAL SOLUTION,CAPTOPRIL,1806257574,2019,5 mg,Oral solution,Oral use,165,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
FACTOR IX GRIFOLS,COAGULATION FACTOR IX RECOMBINANT HUMAN,1612258797,2019,40-62.5 IU/ml,Powder and solvent for solution for injection,Intravenous use,1040.8,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
CIALIS 20MG TAB,TADALAFIL,53-972-22,2019,20 mg,Film-coated tablet,Oral use,109.50,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ONDANSETRON MEDIS 8MG F.C.TABLET,ONDANSETRON,2612246497,2019,8 mg,Film-coated tablet,Oral use,136.35,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
NEO-MERCAZOLE 5MG TAB,CARBIMAZOLE,1811246234,2019,5 mg,Tablet,Oral use,21.85,Amdipharm Limited,Ireland,AMDIPHARMA,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PATANOL 0.1% OPHTHALMIC SOLUTION,OLOPATADINE,0901256572,2019,0.1 %,"Eye drops, solution",Ocular use,22.05,ALCON LABORATORIES,United States,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
AMRI-K 10MG/1ML AMPOULES,PHYTOMENADIONE,1711246231,2019,10 mg/ml,Solution for injection,Intramuscular use,13.45,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES,Egypt,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
PATADAY 0.2% OPHTHALMIC SOLUTION,OLOPATADINE,0309258150,2019,0.2 %,"Eye drops, solution",Ocular use,37.9,ALCON LABORATORIES,United States,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
STERILE WATER FOR INJECTION,WATER,1911246276,2018,,Solvent for parenteral use,Intravenous use,4.95,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
NOYADA 5MG/5ML ORAL SOLUTION,CAPTOPRIL,1806257573,2019,1 mg,Oral solution,Oral use,140.4,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
FACTOR IX GRIFOLS,COAGULATION FACTOR IX RECOMBINANT HUMAN,1612258799,2019,40-62.5 IU/ml,Powder and solvent for solution for injection,Intravenous use,1561.2,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
CIALIS 20MG TAB,TADALAFIL,54-972-22,2019,20 mg,Film-coated tablet,Oral use,314.15,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
FLORYL 50MG/ML SOL. FOR INJ./INFUSION,FLUOROURACIL,2706245456,2019,50 mg/ml,Solution for injection/infusion,Intravenous use,31.45,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
SILOMES 400 mg Tablet,AMISULPRIDE,1501256663,2019,400 mg,Tablet,Oral use,178.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FLOXMED 500MG F.C.TABLET,LEVOFLOXACIN,16-631-19,2019,500 mg,Film-coated tablet,Oral use,56.55,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
STERILE WATER FOR INJECTION,WATER,2011246290,2018,,Solvent for parenteral use,Intravenous use,3.8,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
CAFFEINE CITRATE 10 mg/ml Solution For Injection,CAFFEINE CITRATE,3005233754,2019,10 mg/ml,Solution for injection,Intravenous use,415.00,MACARTHYS LABORATORIES LIMITED T\A MARTINDALE PHARMA,United Kingdom,Martindale Pharma,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,GULF NEOCARE
EVISTA 60 MG F-C TABLETS,RALOXIFENE,0705245253,2019,60 mg,Film-coated tablet,Oral use,88.55,"LILLY DEL CARIBE, INC.",United States,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
FLORYL 50MG/ML SOL. FOR INJ./INFUSION,FLUOROURACIL,2008245787,2019,50 mg/ml,Solution for injection/infusion,Intravenous use,29.85,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
LOXAMOX 250MG/50ML SOL. FOR IV INFUSION,LEVOFLOXACIN,0110246001,2019,5 mg/ml,Solution for infusion,Intravenous use,32.1,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
HEPARINOL 5000 IU/ML INJECTION,HEPARIN SODIUM,1610246064,2018,5000 IU/ml,Solution for injection,"Intravenous, Subcutaneous",317.4,AIN MEDICARE SDN. BHD.,Malaysia,AIN MEDICARE SDN. BHD.,Malaysia,Marketed,Prescription,store below 30°c,Hospital,AL EWAN MEDICAL COMPANY
Ondansetron Kabi 2 MG/ML SOL. FOR INJ,ONDANSETRON,1202256889,2019,2 mg/ml,Solution for injection,Intramuscular and intravenous use,56.1,"Labesfal Laboratorios Almiro S.A., Fresenius Kabi Group",Portugal,"Labesfal Laboratorios Almiro, S.A.",Portugal,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
VALES 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION,LEVETIRACETAM,1501256646,2019,500 mg,Concentrate for solution for infusion,Intravenous use,694.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
LOXAMOX 500MG/100ML SOL. FOR INFUSION,LEVOFLOXACIN,0110246000,2019,5 mg/ml,Solution for infusion,Intravenous use,35.2,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
AROX 0.5%  EYE DROPS,MOXIFLOXACIN HYDROCHLORIDE,2111246313,2019,0.5 %,Eye drops,Ophthalmic use,25.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
BEPANTHEN PLUS CREAM,"DEXPANTHENOL, Chlorhexidine",1312211471,2019,"50,5 mg",Cream,Topical,12.35,GP GRENZACH,Germany,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,"Bayer Saudi Arabia, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VONAL 10MG ML SOLUTION FOR INFUSION,PARACETAMOL,2705257469,2019,10 mg/ml,Solution for infusion,Intravenous use,17.30,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
AZELASTIN-COMOD 0.5 mg/ml EYE DROP,AZELASTINE,1610246065,2019,0.5 mg/ml,"Eye drops, solution",Ophthalmic use,37.25,URSAPHARM Arzneimittel GmbH,Germany,URSAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
DUPIXENT 200 mg Solution for Injection in Pre-filled syringe,DUPILUMAB,1902200013,2020,200 mg,Solution for injection,Subcutaneous use,4637.75,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
LAXATROL 50 MG/8.60 MG FILM COATED TABLET (100S),"DOCUSATE SODIUM, SENNOSIDES",2307245633,2019,"50,8.6 mg",Film-coated tablet,Oral use,42.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
TORICOX 120MG F.C.TABLET,Etoricoxib,0409245858,2019,120 mg,Film-coated tablet,Oral use,15.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SUMAREX 50 MG F.C.TABLET (2S),SUMATRIPTAN,0409245862,2019,50 mg,Film-coated tablet,Oral use,30.2,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
CYMBALTA 60MG HARD GASTRO-RESISTANT CAP,DULOXETINE,0512222979,2019,60 mg,Gastro-resistant capsule,Oral use,112.40,"Lilly Del Caribe, Inc.",Puerto Rico,ELI LILLY NEDERLAND B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
BETOLINA 5MG/ML INJECTION,BUPIVACAINE,1501256662,2019,5 mg/ml,Solution for injection,Topical,58.7,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SUMAREX 50 MG F.C.TABLET (6S),SUMATRIPTAN,0409245859,2019,50 mg,Film-coated tablet,Oral use,79.4,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SUMAREX 100 MG F.C.TABLET (2S),SUMATRIPTAN,0409245857,2019,100 mg,Film-coated tablet,Oral use,40.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
SUMAREX 100 MG F.C.TABLET (6S),SUMATRIPTAN,0409245860,2019,100 mg,Film-coated tablet,Oral use,104.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TORICOX 60 MG F.C.TABLET,Etoricoxib,0409245861,2019,60 mg,Film-coated tablet,Oral use,43.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TORICOX 90 MG F.C.TABLET,Etoricoxib,1612246424,2019,90 mg,Film-coated tablet,Oral use,43.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
INTIDROL 40 MG LYOPHILISATE FOR SOLUTION FOR INJECTION,METHYLPREDNISOLONE SODIUM SUCCINATE,2705257470,2019,40 mg,powder for solution for injection,Intramuscular and intravenous use,10.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
HENASEN 500MG F.C.TABLET,"DIOSMIN, HESPERIDIN",1612246423,2019,"450,50 mg",Film-coated tablet,Oral use,24.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
EYMID 1% EYE DROP,TROPICAMIDE,2411246321,2019,1 %,Eye drops,Ophthalmic use,39.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,JAMJOOM PHARMACEUTICALS CO. LTD.
SECLODYN 1% EYE DROPS,CYCLOPENTOLATE,0512246365,2019,1 %,"Eye drops, solution",Ophthalmic use,49.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
CO-ANGINET,"VALSARTAN, HYDROCHLOROTHIAZIDE",2702256959,2019,"80,12.5 mg",Film-coated tablet,Oral use,22.4,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OLSAR 20MG F.C.TABLET,OLMESARTAN MEDOXOMIL,0505257341,2019,20 mg,Film-coated tablet,Oral use,50.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
OLSAR 40MG F.C.TABLET,OLMESARTAN MEDOXOMIL,0505257340,2019,40 mg,Film-coated tablet,Oral use,67.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ALEVIO 25MG F.C.TABLET,TOPIRAMATE,0701256532,2019,25 mg,Film-coated tablet,Oral use,25.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ALEVIO 100MG F.C.TABLET,TOPIRAMATE,1912246457,2019,100 mg,Film-coated tablet,Oral use,93.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
LICAN 1% CREAM,LULICONAZOLE,1612246422,2019,10 mg/g,Cream,Topical,58.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
INTIDROL 125 MG LYOPHILISATE FOR SOLUTION FOR INJECTION,METHYLPREDNISOLONE SODIUM SUCCINATE,2705257471,2019,125 mg,powder for solution for injection,Intramuscular and intravenous use,25.80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
TAZMERON 15MG F.C.TABLET,MIRTAZAPINE,2201256735,2019,15 mg,Film-coated tablet,Oral use,39.20,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TAZMERON 30MG F.C.TABLET,MIRTAZAPINE,1702256906,2019,30 mg,Film-coated tablet,Oral use,78.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
TAZMERON 45MG F.C.TABLET,MIRTAZAPINE,1702256907,2019,45 mg,Film-coated tablet,Oral use,117.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
CARTINUM 150 MG/15 ML,CARBOPLATIN,0912246376,2019,10 mg/ml,Concentrate for solution for infusion,Intravenous use,127.25,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
CO-ANGINET,"VALSARTAN, HYDROCHLOROTHIAZIDE",2702256957,2019,"160,12.5 mg",Film-coated tablet,Oral use,24.5,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
INTIDROL 500 MG LYOPHILISATE FOR SOLUTION FOR INJECTION,METHYLPREDNISOLONE SODIUM SUCCINATE,2705257468,2019,500 mg,powder for solution for injection,Intramuscular and intravenous use,54,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
CARTINUM 10 MG/ML VIAL,CARBOPLATIN,0912246375,2019,10 mg/ml,Concentrate for solution for infusion,Intravenous use,242.20,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
CO-ANGINET,"VALSARTAN, HYDROCHLOROTHIAZIDE",2702256960,2019,"160,25 mg",Film-coated tablet,Oral use,24.5,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
NAUSIDOM 10 mg Tablet,DOMPERIDONE,22-584-19,2019,10 mg,Film-coated tablet,Oral use,11.2,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
INTIDROL 1GM LYOPHILISATE FOR SOLUTION FOR INJECTION,METHYLPREDNISOLONE SODIUM SUCCINATE,2705257467,2019,1000 mg,powder for solution for injection,Intramuscular and intravenous use,104.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
CIFOGRU 2MG/ML VIAL,CIPROFLOXACIN,3006245459,2019,2 mg/ml,Intravenous infusion,Intravenous use,53.1,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
KEVZARA 150MG SOL. FOR INJ. IN PRE-FILLED SYRINGE,SARILUMAB,23-540-18,2018,150 mg,Solution for injection,Subcutaneous use,3183.55,SANOFI WINTHROP INDUSTRIE,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
ODECON 150 mg Capsule,FLUCONAZOLE,23-584-19,2019,150 mg,Capsule,Oral use,15.05,NEOPHARMA,United Arab Emirates,NEOPHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
HUMAN ALBUMIN 20% SOLUTION FOR INFUSION,ALBUMIN HUMAN,1303257047,2019,20 %,Solution,Intravenous use,314.6,HUMAN BioPlazma LLC,Hungary,HUMAN BioPlazma LLC,Hungary,Marketed,Prescription,store below 30°c,Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
DOCINE 500 mg Vial,DAPTOMYCIN,2204257265,2019,500 mg,Powder for solution for injection/infusion,Intravenous use,392.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Tabuk Pharmaceutical Manufacturing Company
NPLATE 250 MCG POWDER FOR SOLUTION FOR INJECTION,ROMIPLOSTIM,1508245769,2018,250 µg,Powder and solvent for solution for injection,Subcutaneous use,2701.95,Patheon Italia S.P.A.,Italy,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
CIFOGRU 2MG/ML VIAL,CIPROFLOXACIN,3006245458,2019,2 mg/ml,Intravenous infusion,Intravenous use,26.55,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
KEVZARA 150MG SOL. FOR INJ. IN PRE - FILLED PEN,SARILUMAB,24-540-18,2018,150 mg,Solution for injection,Subcutaneous use,3183.55,SANOFI WINTHROP INDUSTRIE,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
LAZURE 200MG SOLUTION FOR INFUSION,LACOSAMIDE,1501256656,2019,10 mg/ml,Solution for infusion,Intravenous use,420.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ADRENALINE 0.1MG/ML INJECTION,ADRENALINE,2707257860,2019,0.1 mg/ml,Solution for injection,"Intrathecal, Intravenous, Intramuscular",50.45,Macarthys Laboratories Ltd,United Kingdom,Aurum Pharmaceuticals Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
WILATE 500 IU Powder and Solvent for Solution for Injection,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",1611258594,2018,"500,500 IU",Powder and solvent for solution for injection,Intravenous use,1369.05,Octapharma Pharmazeutika Produktionsges.m.b.h,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
DESCOVY 200MG/10MG F.C.TABLET,"EMTRICITABINE, TENOFOVIR ALAFENAMIDE",2705257473,2018,"200,11.2 mg",Film-coated tablet,Oral use,1626.35,PATHEON INC,Canada,Gilead Sciences International Ltd,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
RAFOL 5 mg Tablet,FOLIC ACID,2010246077,2019,5 mg,Tablet,Oral use,15.30,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DIOZAD,"VALSARTAN, HYDROCHLOROTHIAZIDE",2-5130-19,2019,"160,12.5 mg",Film-coated tablet,Oral use,24.5,Macleods Pharmaceuticals Limited,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Razy Al Madina Pharmaceutical
ALZAMED 5MG F.C.TABLET,DONEPEZIL HYDROCHLORIDE,2-5149-19,2019,5 mg,Film-coated tablet,Oral use,89.6,World Medicine İlaç San. ve Tic. A.Ş.,Turkey,World Medicine İlaç San. ve Tic. A.Ş.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ISONIAZID 300MG TABLET,ISONIAZID,1612246431,2019,300 mg,Tablet,Oral use,38.2,Macleods Pharmaceuticals Ltd.,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
LATUDA 80 MG F.C.TABLET,LURASIDONE,0112258692,2019,80 mg,Film-coated tablet,Oral use,243.1,Bushu Pharmaceuticals Ltd.,Japan,Medius AG,Switzerland,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Farouk, Maamoun Tamer & CO"
XEOMIN 100 U Vial,CLOSTRIDIUM BOTULINUM NEUROTOXIN A,1911246275,2019,100 U,powder for solution for injection,Intramuscular use,647.9,IDT Biologika GmbH,Germany,MERZ PHARMACEUTICALS GMBH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
DOCADEX 20 mg/ml Injection,DOCETAXEL,1505257395,2019,20 mg/ml,Concentrate for solution for infusion,Intravenous use,126.30,S.C Sindan pharma SRL,Romania,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
IMATIS 100MG F.C.TABLET,IMATINIB MESILATE,2-5260-19,2019,100 mg,Tablet,Oral use,1639.9,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Hospital,PharmaZone (Netaq Al Dawa) Pharmaceuticals
ROVASTA,ROSUVASTATIN,1109258208,2019,10 mg,Film-coated tablet,Oral use,31.1,Medochemie Ltd (Central Factory),Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TORLEN 20 MG FILM-COATED TABLET,TADALAFIL,1310258405,2019,20 mg,Film-coated tablet,Oral use,50.55,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BACLOFEN INTRATHECAL SINTETICA 0.05MG/ML INJECTION,BACLOFEN,2-5299-19,2019,0.05 mg/ml,Solution for injection,Intrathecal use,274.9,Sintetica SA,Switzerland,Sintetica SA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
CYBELLE FILM COATED TABLET,"DESOGESTREL, ETHINYLESTRADIOL",1302256899,2019,"30,150 µg",Film-coated tablet,Oral use,10.2,"LABORATORORIOS LEON PHARMA, S.A",Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
APROVASC 150MG/10MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",2-5307-19,2019,"150,10 mg",Tablet,Oral use,95.65,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
MOMATE NASAL SPRAY,MOMETASONE FUROATE,1510246052,2019,0.05 %,Spray,Nasal use,22.65,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
KYTRIL 1MG-ML AMP,GRANISETRON,0304233463,2019,1 mg/ml,Injection,Intravenous use,145.75,CENEXI,France,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
BEMFOLA 150IU/0.25ML INJECTION,FOLLITROPIN ALFA,2105257442,2019,150 IU,Solution for injection,Subcutaneous use,168.8,CP PHARMACEUTICAL LIMITED,United Kingdom,Finox Biotech AG,Liechtenstein,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PROZAC 20MG CAPSULES,FLUOXETINE,1611234496,2019,20 mg,"Capsule, hard",Oral use,92.05,PATHEON FRANCE,France,LILLY FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
NEUROBION tablet,"PYRIDOXINE, THIAMINE, CYANOCOBALAMIN",1906233827,2019,"200,100,200 mg, µg",Coated tablet,Oral use,23.30,P&G Health Austria GmbH & Co. OG,Austria,P&G Health GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
IMNOVID 1 mg capsule,POMALIDOMIDE,3107222371,2020,1 mg,Capsule,Oral use,27953.30,CELGENE INTERNATIONAL,Switzerland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
GEMCITABINE GLENMARK 1000MG VIAL,GEMCITABINE,3012246507,2020,1000 mg,Powder for injection,Intravenous use,94.35,GLENMARK GENERIC SA,Argentina,GLENMARK GENERIC SA,Argentina,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Salehiya Trading Co."
TISSEEL Lyo Powder And Solvent For Sealant,"HUMAN FIBRINOGEN, HUMAN THROMBIN, APROTININ, HUMAN THROMBIN, CALCIUM CHLORIDE",2310234375,2020,"72-110,2250-3750,400-625,36-44 mg/ml, IU/",Powder and solvent for sealant,Epilesional use,971.40,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Baxter Medical Products GmbH,Austria,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
PLAXOTRIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (20 ml),OXALIPLATIN,25-5035-19,2019,5 mg/ml,Concentrate for solution for infusion,Intravenous use,237.25,GENEPHARM S.A.,Greece,GENEPHARM S.A,Greece,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
ACCEPT 250MG CAPSULE,MYCOPHENOLATE MOFETIL,1303257046,2019,250 mg,"Capsule, hard",Oral use,225.65,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
D-Seul 5000 I.U SOFT GELATIN CAPSULE,COLECALCIFEROL,2609245960,2019,5000 IU,"Capsule, soft",Oral use,21.70,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
KEVZARA 200MG SOL. FOR INJ. IN PRE-FILLED SYRINGE,SARILUMAB,25-540-18,2018,200 mg,Solution for injection,Subcutaneous use,3577.75,SANOFI WINTHROP INDUSTRIE,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
SABRIL 500MG F.C.TAB,VIGABATRIN,1903257102,1994,500 mg,Film-coated tablet,Oral use,213.7,sanofi-aventis,France,Sanofi Aventis France,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
PLAXOTRIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (10ml),OXALIPLATIN,26-5035-19,2019,5 mg/ml,Concentrate for solution for infusion,Intravenous use,118.6,GENEPHARM S.A.,Greece,GENEPHARM S.A,Greece,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD"
DOCETAXEL ACCORD 20 mg/ml Vial,DOCETAXEL,0302256791,2019,20 mg/ml,Concentrate for solution for infusion,Intravenous use,111.1,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare S.L.U,Spain,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
D-Seul 2000 I.U SOFT GELATIN CAPSULE,COLECALCIFEROL,0509245866,2019,2000 IU,"Capsule, soft",Oral use,9.6,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
KEVZARA 200MG SOL. FOR INJ. IN PRE - FILLED PEN,SARILUMAB,26-540-18,2018,200 mg,Solution for injection,Subcutaneous use,3577.75,SANOFI WINTHROP INDUSTRIE,France,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
DORAVIT 1.25MG/ML I.V. INJECTION,DROPERIDOL,2207245625,2017,1.25 mg/ml,Solution for injection,Intravenous use,188.2,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
DEPAKINE CHRONO 500MG TABS,VALPROATE SODIUM,1311258585,2000,500 mg,Prolonged-release film-coated tablet,Oral use,51.85,sanofi-aventis,France,Sanofi Aventis France,France,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ELAPRASE 2 mg/ml concentrate for solution for infusion,IDURSULFASE,2810211248,2019,2 mg/ml,Concentrate for solution for infusion,Intravenous use,10363.65,Cangene BioPharma Inc. (CBI),United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Salehiya Trading Co."
Ozempic,SEMAGLUTIDE,2701200003,2020,1 mg,Solution for injection in pre-filled pen,Subcutaneous use,418.65,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Ozempic,SEMAGLUTIDE,2701200004,2020,0.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,418.65,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Ozempic,SEMAGLUTIDE,2701200005,2020,0.25 mg,Solution for injection in pre-filled pen,Subcutaneous use,418.65,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
DOCETAXEL ACCORD 20 mg/ml Vial,DOCETAXEL,0302256792,2019,20 mg/ml,Concentrate for solution for infusion,Intravenous use,444.4,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare S.L.U,Spain,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
D-Seul 2000 I.U ORAL SOLUTION DROPS,COLECALCIFEROL,0701256539,2019,2000 IU,"Oral drops, solution",Oral use,21.70,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Beta Cor 5mg Tablet,BISOPROLOL FUMARATE,0411246143,2019,5 mg,Film-coated tablet,Oral use,11.9,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
HEPARINOL 1000 IU/ML INJECTION,HEPARIN SODIUM,1609245914,2018,1000 IU/ml,Solution for injection,"Intravenous, Subcutaneous",165.6,AIN MEDICARE SDN. BHD.,Malaysia,AIN MEDICARE SDN. BHD.,Malaysia,Marketed,Prescription,store below 30°c,Hospital,AL EWAN MEDICAL COMPANY
Ondansetron Kabi 2 MG/ML SOL. FOR INJ,ONDANSETRON,1202256888,2019,2 mg/ml,Solution for injection,Intramuscular and intravenous use,112.25,"Labesfal Laboratorios Almiro S.A., Fresenius Kabi Group",Portugal,"Labesfal Laboratorios Almiro, S.A.",Portugal,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
DEVARIN 20 MG F.C.TABLET,VARDENAFIL,28-5015-19,2019,20 mg,Film-coated tablet,Oral use,68.7,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DOCETAXEL ACCORD 20 mg/ml Vial,DOCETAXEL,0302256793,2019,20 mg/ml,Concentrate for solution for infusion,Intravenous use,888.8,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare S.L.U,Spain,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
D-Seul 10000 SOFT GELATIN CAPSULE,COLECALCIFEROL,0509245867,2019,10000 IU,"Capsule, soft",Oral use,15.75,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CLEXANE 60MG\0.6ML PREFILLED SYRINGE,ENOXAPARIN SODIUM,28-883-19,2019,60 mg,Solution for injection,Intravenous use,55.3,SANOFI WINTHROP INDUSTRIE,France,sanofi-aventis,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
IMIPENEM-CILASTATIN LABATEC 500/500 VIAL,"CILASTATIN, IMIPENEM",1009245894,2019,"500,500 mg",Powder for solution for infusion,Intravenous use,313.35,ACS DOBFAR S.P.A,Italy,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, KHALED MOHAMMED ALTAYAR TRADING EST."
CARDURA 1 mg tablet,DOXAZOSIN,0905233614,2019,1 mg,Tablet,Oral use,30.75,Pfizer Manufacturing Deutschland GmbH,Germany,UPJOHN UK LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
DEVARIN 10 MG F.C.TABLET,VARDENAFIL,29-5015-19,2019,10 mg,Film-coated tablet,Oral use,53.95,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
D-Seul 50000 SOFT GELATIN CAPSULE,COLECALCIFEROL,0509245868,2019,50000 IU,"Capsule, soft",Oral use,25.65,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CRESEMBA 200MG VIAL,ISAVUCONAZONIUM SULFATE,1102256872,2019,200 mg,Powder for concentrate for solution for infusion,Intravenous use,1581.4,"Baxter Pharmaceutical Solutions, LLC",United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
CRESEMBA 100MG CAPSULE,ISAVUCONAZONIUM SULFATE,1102256873,2019,100 mg,"Capsule, hard",Oral use,2925.7,SwissCo Services AG,Switzerland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MABTHERA 119.4 MG SOLUTION FOR SUBCUTANEOUS INJECTION,RITUXIMAB,298-24-19,2019,119.4 mg,Concentrate and diluent for solution for infusion,Subcutaneous use,8037.25,F. Hoffmann-La Roche Ltd.,Switzerland,ROCHE,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Roche Products Saudi Arabia
GASTROZOLE PLUS 40/1100 MG CAPSULES,"OMEPRAZOLE, SODIUM BICARBONATE",1211246191,2019,"40,1100 mg",Capsule,Oral use,114.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
SCLERA 120 MG CAPSULE,Dimethyl Fumarate,0807245501,2019,120 mg,"Gastro-resistant capsule, hard",Oral use,462.95,Hikma Pharmaceuticals PLC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CLEXANE 20MG\0.2ML PREFILLED SYRINGE,ENOXAPARIN SODIUM,29-883-20,2020,20 mg,Solution for injection,Intravenous use,23.05,sanofi-aventis,France,Sanofi Aventis France,France,Marketed,Prescription,store below 25°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ESOMA 40 MG DELAYED RELEASE CAPSULES,ESOMEPRAZOLE MAGNESIUM,299-325-19,2019,40 mg,Delayed-release tablet,Oral use,40.85,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RENIS 12.5 MG CAPSULE,SUNITINIB,1107245546,2019,12.5 mg,"Capsule, hard",Oral use,3919.35,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
NEAUVIA Organic Intense,HYALURONIC ACID,3001200006,2020,28 mg/ml,Solution for injection in pre-filled syringe,Intradermal use,324.345,MATEX LAB Spa,Italy,MATEX LAB Spa,Italy,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,Shafi Advanced Trading Establishment
ESOMA 40 MG DELAYED RELEASE CAPSULES,ESOMEPRAZOLE MAGNESIUM,300-325-19,2019,40 mg,Delayed-release tablet,Oral use,72.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
RENIS 25 MG CAPSULE,SUNITINIB,1107245547,2019,25 mg,"Capsule, hard",Oral use,7838.7,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CARDURA 2 mg tablet,DOXAZOSIN,0905233613,2019,2 mg,Tablet,Oral use,30.75,Pfizer Manufacturing Deutschland GmbH,Germany,UPJOHN UK LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
ESOMA 20 MG DELAYED RELEASE CAPSULES,ESOMEPRAZOLE MAGNESIUM,301-325-19,2019,20 mg,Delayed-release tablet,Oral use,58.4,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
MENVEO VACCINE,"MENINGOCOCCAL GROUP A (NEISSERIA MENINGITIDIS) POLYSACCHARIDE VACCINE, MENINGOCOCCAL GROUP C (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP W (NEISSERIA MENINGITIDIS) POLYSACCHARIDE, MENINGOCOCCAL GROUP Y (NEISSERIA MENINGITIDIS) POLYSACCHARIDE",2609245959,2019,"10,5,5,5 µg",Powder and solution for solution for injection,Intramuscular use,207.10,GSK Vaccines Srl,Italy,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ESOMA 20 MG DELAYED RELEASE CAPSULES,ESOMEPRAZOLE MAGNESIUM,302-325-19,2019,20 mg,Delayed-release tablet,Oral use,29.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,RIYADH PHARMA
CELECT 100 MG CAPSULE,CELECOXIB,0807245503,2019,100 mg,"Capsule, hard",Oral use,19.1,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GASTROZOLE PLUS 20 MG/1100 MG CAPSULE,"OMEPRAZOLE, SODIUM BICARBONATE",1111246177,2019,"20,1100 mg",Capsule,Oral use,50.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
CELECT 200 MG CAPSULE,CELECOXIB,0807245499,2019,200 mg,"Capsule, hard",Oral use,30.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLACERA PLUS 15MG/500MG F.C.TABLET,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE",1802256911,2019,"500,15 mg",Film-coated tablet,Oral use,83.75,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
DOXENDA 60 MG F.C.TABLET,DAPOXETINE,1911246267,2019,60 mg,Film-coated tablet,Oral use,52.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
COXICEL 200 MG HARD CAPSULE,CELECOXIB,1301256595,2019,200 mg,"Capsule, hard",Oral use,13.9,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Cisplatin 1 mg/ml VIAL,CISPLATIN,1901256680,2019,1 mg/ml,Solution for infusion,Intravenous use,60,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
GLACERA PLUS 15MG/850MG F.C.TABLET,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE",1802256910,2019,"850,15 mg",Film-coated tablet,Oral use,83.75,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
DOXENDA 30 MG F.C.TABLET,DAPOXETINE,1911246272,2019,30 mg,Film-coated tablet,Oral use,52.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
LEVOBAT 500 MG FILM COATED TABLET,LEVOFLOXACIN,0402256809,2019,500 mg,Film-coated tablet,Oral use,40.4,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
TEDO 20 mg film-coated tablet,TADALAFIL,2403257141,2019,20 mg,Film-coated tablet,Oral use,16.2,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
SCLERA 240 MG CAPSULE,Dimethyl Fumarate,0807245500,2019,240 mg,"Gastro-resistant capsule, hard",Oral use,3703.5,Hikma Pharmaceuticals PLC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CORTIMENT MMX 9 MG PROLONGED RELEASE TABLET,BUDESONIDE,1208245745,2018,9 mg,Prolonged-release tablet,Oral use,327,Cosmo S.P.A,Italy,Ferring GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
COXICEL 200 MG HARD CAPSULE,CELECOXIB,1301256593,2019,200 mg,"Capsule, hard",Oral use,27.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DIVINUS 5 mg film-coated tablet,DAPAGLIFLOZIN,2511246336,2019,5 mg,Film-coated tablet,Oral use,151.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EZEACT PLUS 40MG/12.5MG TABLET,"AZILSARTAN MEDOXOMIL, CHLORTHALIDONE",2406257604,2019,"40,12.5 mg",Tablet,Oral use,71.45,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
DIVINUS 10 mg film-coated tablet,DAPAGLIFLOZIN,1911246258,2019,10 mg,Film-coated tablet,Oral use,151.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VIPDOMET 12.5 mg/1000 mg TABLETS,"METFORMIN HYDROCHLORIDE, ALOGLIPTIN",2201233133,2019,"1000,12.5 mg",Film-coated tablet,Oral use,117.45,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FLUARIX TETRA Suspension for Injection in Pre-filled Syringe,"MONOVALENT INACTIVATED SPILIT VIRION AH 1N1, MONOVALENT INACTIVATED SPILIT VIRION AH 3N2, MONOVALENT INACTIVATED SPILIT VIRION B STRAIN VICTORIA LINEAGE, MONOVALENT INACTIVATED SPILIT VIRION B STRAIN YAMAGATE LINEAGE",158-276-20,2018,"15,15,15,15 µg",Suspension for injection,Intramuscular use,54.35,GLAXOSMITHKLINE (GSK),Germany,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
BELARA 0.03MG/2MG F.C.TABLET,"CHLORMADINONE, ETHINYLESTRADIOL",2104257259,2018,"2,0.03 mg",Film-coated tablet,Oral use,65.7,GEDEON RICHTER PLC.,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VIPDOMET 12.5 mg/500 mg TABLETS,"METFORMIN HYDROCHLORIDE, ALOGLIPTIN",2201233131,2019,"500,12.5 mg",Film-coated tablet,Oral use,109.9,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
INCRESYNC 25/45 mg Tablet,"ALOGLIPTIN, PIOGLITAZONE",321-334-19,2019,"25,45 mg",Tablet,Oral use,175.75,TAKEDA PHARMACEUTICAL COMPANY LIMITED,Japan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
INCRESYNC 25/15 mg Tablet,"ALOGLIPTIN, PIOGLITAZONE",0603245026,2019,"25,15 mg",Tablet,Oral use,137.6,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
INCRESYNC 25/30 mg Tablet,"ALOGLIPTIN, PIOGLITAZONE",0603245025,2019,"25,30 mg",Tablet,Oral use,159.75,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PENTASA XTEND 2 GM SACHET,MESALAZINE,1506257554,2019,2 g,Oral powder,Oral use,299.75,FERRING,Switzerland,FERRING,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
COXICEL 200 MG HARD CAPSULE,CELECOXIB,1301256598,2019,200 mg,"Capsule, hard",Oral use,41.8,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ONDRON 2MG/ML AMPOULE,ONDANSETRON,32-5223-19,2019,2 mg/ml,Solution,Intramuscular and intravenous use,112.25,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
EZEACT PLUS 40MG/25MG TABLET,"AZILSARTAN MEDOXOMIL, CHLORTHALIDONE",2406257608,2019,"40,25 mg",Tablet,Oral use,71.45,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
SOTIRA 5MG CAPSULE,LENALIDOMIDE,1102256871,2020,5 mg,"Capsule, hard",Oral use,12451.4,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
SOTIRA 10MG CAPSULE,LENALIDOMIDE,1102256870,2020,10 mg,"Capsule, hard",Oral use,13055.3,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
SOTIRA 15MG CAPSULE,LENALIDOMIDE,1102256868,2020,15 mg,"Capsule, hard",Oral use,13773.35,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
BUFOMIX 160/4.5MCG EASYHALER,"BUDESONIDE, FORMTEROL",0403256975,2020,"160,4.5 µg",Inhalation powder,Inhalation use,158.00,"Orion Corporation, Orion Pharma",Finland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BUFOMIX 320/9MCG EASYHALER,"BUDESONIDE, FORMOTEROL FUMARATE",0403256973,2020,"320,9 µg",Inhalation powder,Inhalation use,84.2,"Orion Corporation, Orion Pharma",Finland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VIPIDIA 12.5 mg film-coated tablet,ALOGLIPTIN,2201233134,2020,12.5 mg,Film-coated tablet,Oral use,52.9,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
VIPIDIA 25 mg film-coated tablet,ALOGLIPTIN,2201233132,2020,25 mg,Film-coated tablet,Oral use,105.85,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
EDARBYCLOR 40 MG/12.5 MG TABLET,"AZILSARTAN MEDOXOMIL, CHLORTHALIDONE",0409234112,2020,"40,12.5 mg",Film-coated tablet,Oral use,71.45,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
CO-OLMEPRESS 40 mg/12.5 mg F.C. Tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1301256596,2019,"40,12.5 mg",Film-coated tablet,Oral use,66.15,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ONDRON 2MG/ML AMPOULE,ONDANSETRON,33-5223-19,2019,2 mg/ml,Solution,Intramuscular and intravenous use,56.1,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
EDARBYCLOR 40 MG/25 MG TABLET,"AZILSARTAN MEDOXOMIL, CHLORTHALIDONE",0409234111,2020,"40,25 mg",Film-coated tablet,Oral use,71.45,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
LAYAL 5 mg film-coated tablet,LEVOCETIRIZINE DIHYDROCHLORIDE,2011246286,2019,5 mg,Tablet,Oral use,7.95,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
CYERO 25/15 mg Tablet,"ALOGLIPTIN, PIOGLITAZONE",2705257465,2019,"25,15 mg",Film-coated tablet,Oral use,137.6,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
STRATTERA 10MG CAPSULES,ATOMOXETINE HYDROCHLORIDE,1612246436,2019,10 mg,"Capsule, hard",Oral use,224.55,"LILLY DEL CARIBE, INC.",United States,"Lilly,S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"ARAC HEALTHCARE, Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
EDARBI 40 mg tablet,AZILSARTAN MEDOXOMIL,0802221699,2020,40 mg,Tablet,Oral use,65.2,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
EDARBI 80 mg tablet,AZILSARTAN MEDOXOMIL,0802221694,2020,80 mg,Tablet,Oral use,97.85,Arab Pharmaceutical Manufacturing,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
PONIZEX 40MG VIAL,PANTOPRAZOLE,2703257173,2020,40 mg,powder for solution for injection,Intravenous use,130.7,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
CYERO 25/30 mg Tablet,"ALOGLIPTIN, PIOGLITAZONE",2705257466,2019,"25,30 mg",Film-coated tablet,Oral use,159.75,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
CIMZIA 200 mg Solution for Injection,CERTOLIZUMAB PEGOL,1512246418,2018,200 mg,Solution for injection,Subcutaneous use,2839.40,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,U.C.B.,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
HEMOSOL B0 SOLUTION FOR HAEMODIALYSIS,"CALCIUM CHLORIDE, SODIUM CHLORIDE, LACTIC ACID, SODIUM HYDROGEN CARBONATE, MAGNESIUM CHLORIDE",1311246214,2018,"5.145,6.45,5.4,3.09,2.033 g/l",Solution for haemodialysis/haemofiltration,Hemodialysis,128.8,Bieffe Medital S.p.A,Italy,BAXTER HOLDING B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
VEMLIDY 25MG F.C.TABLET,TENOFOVIR ALAFENAMIDE,2409245940,2018,25 mg,Film-coated tablet,Oral use,940.90,PATHEON INC,Canada,Gilead Sciences International Ltd,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
ROMACIN POWDER FOR ORAL/RECTAL Suspension,CALCIUM POLYSTYRENE SULFONATE,0912246379,2019,99.934 %,Powder for oral/rectal suspension,"Oral, Rectal",177.6,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DIOZAD,"VALSARTAN, HYDROCHLOROTHIAZIDE",3-5130-19,2019,"80,12.5 mg",Film-coated tablet,Oral use,22.4,Macleods Pharmaceuticals Limited,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Razy Al Madina Pharmaceutical
CORREX 90MG F.C.TABLET,Etoricoxib,1712246443,2019,90 mg,Film-coated tablet,Oral use,19.15,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ISONIAZID 100MG TABLET,ISONIAZID,1612246432,2019,100 mg,Tablet,Oral use,15.7,Macleods Pharmaceuticals Ltd.,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
LATUDA 20 MG F.C.TABLET,LURASIDONE,0112258691,2019,20 mg,Film-coated tablet,Oral use,243.1,Bushu Pharmaceuticals Ltd.,Japan,Medius AG,Switzerland,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"Farouk, Maamoun Tamer & CO"
XOROLA 2.5MG F.C.TABLET,LETROZOLE,0107257647,2019,2.5 mg,Film-coated tablet,Oral use,115.65,Sindan pharma SRL,Romania,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
CAVERTA 50 MG F.C.TABLET,SILDENAFIL,3-5252-18,2018,50 mg,Film-coated tablet,Oral use,6.3,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MONOCLOX 500 mg VIAL,CLOXACILLIN,0602256849,2019,500 mg,Powder for solution for injection/infusion,Intramuscular and intravenous use,66.35,MEDOCHEMIE LTD (FACTORY B),Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
LUTTAGEN 0.075MG/0.03MG TABLET,"ETHINYLESTRADIOL, GESTODENE",0502256826,2019,"0.03,0.075 mg",Tablet,Oral use,17.65,"LABORATORIOS LEON FARMA, S.A.",Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
APROVASC 300MG/5MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",3-5307-19,2019,"300,5 mg",Tablet,Oral use,135.95,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
CARBAGLU 200MG DISPERSIBLE TABLETS,CARGLUMIC ACID,3-5334-19,2019,200 mg,Dispersible tablet,Oral use,17563.05,Laboratoires BTT,France,Recordati Rare Diseases,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ZIMMO TRADING ESTABLISHMENT
Vislube GEL,SODIUM HYALURONATE,3-5336-19,2019,0.3 %,eye gel,Ophthalmic use,46.1,Holopack Verpackungstechnik GmbH,Germany,TRB CHEMEDICA INTERNATIONAL SA,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Cigalah Group"
TRAVOCORT CREAM,"DIFLUCORTOLONE VALERATE, ISOCONAZOLE NITRATE",81-19-21,2019,"0.1,0.1 %",Cream,Topical,16.50,LEO Pharma Manufacturing Italy Srl,Italy,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
BEMFOLA 225IU/0.375ML INJECTION,FOLLITROPIN ALFA,2105257440,2019,225 IU,Solution for injection,Subcutaneous use,258.85,CP PHARMACEUTICAL LIMITED,United Kingdom,Finox Biotech AG,Liechtenstein,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
MENOPUR 75 IU POWDER FOR SOLUTION FOR INJECTION,MENOTROPHIN,1601256673,2019,75 IU,Powder and solvent for solution for injection,Intramuscular use,608.4,Ferring GmbH,Germany,Ferring GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
IMNOVID 4 mg capsule,POMALIDOMIDE,3107222365,2020,4 mg,Capsule,Oral use,29031.45,CELGENE INTERNATIONAL,Switzerland,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
TISSEEL Lyo Powder And Solvent For Sealant,"HUMAN FIBRINOGEN, APROTININ, HUMAN THROMBIN, CALCIUM CHLORIDE",2310234374,2020,"72-110,2250-3750,400-625,36-44 mg/ml, IU/",Powder and solvent for sealant,Epilesional use,2428.50,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Baxter Medical Products GmbH,Austria,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
CO-OLMEPRESS 40 mg/25 mg F.C. Tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1301256597,2019,"40,25 mg",Film-coated tablet,Oral use,66.15,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ANGINET 160 MG FILM COATED TABLETS,VALSARTAN,0509234129,2020,160 mg,Film-coated tablet,Oral use,24.5,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TRIX 200 mg Capsule,FENOFIBRATE,2101256712,2019,200 mg,Capsule,Oral use,31.55,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ZYTERO PLUS 12.5 mg/ 500 mg Film Coated Tablet,"METFORMIN HYDROCHLORIDE, ALOGLIPTIN",2708258123,2019,"500,12.5 mg",Film-coated tablet,Oral use,109.9,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION,GADOTERIC ACID,409258161,2019,0.5 mmol/ml,Solution for injection in pre-filled syringe,Intravenous use,664.3,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
PENTASA 4GM PROLONGED RELEASE GRANULES IN SACHET,MESALAZINE,2503257162,2019,4 g,Granules in sachet,Oral use,292.55,FERRING,Switzerland,FERRING,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ANGINET 80 MG FILM COATED TABLETS,VALSARTAN,0509234128,2020,80 mg,Film-coated tablet,Oral use,22.4,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
QUZAL 25 mg Tablets,QUETIAPINE,2101256717,2019,25 mg,Tablet,Oral use,19.9,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ZYTERO PLUS 12.5 mg/ 1000 mg Film Coated Tablet,"METFORMIN HYDROCHLORIDE, ALOGLIPTIN",2708258124,2019,"1000,12.5 mg",Film-coated tablet,Oral use,117.45,"Takeda Pharmaceutical Company Limited, Osaka Plant",Japan,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
DIPROLENE 0.05% OINT,BETAMETHASONE DIPROPIONATE,1701244758,2017,0.05 %,Ointment,Topical,21,Organon Heist bv,Belgium,Organon Belgium,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION,GADOTERIC ACID,0409258163,2019,0.5 mmol/ml,Solution for injection in pre-filled syringe,Intravenous use,984.2,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
VELTASSA 25.2G SACHET,PATIROMER SORBITEX CALCIUM,3-756-19,2019,25.2 g,Powder for oral suspension,Oral use,1219.7,Patheon Inc.,Canada,OM Pharma S.A.,Portugal,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ARAC HEALTHCARE
CANDEZA 8 mg Tablet,CANDESARTAN CILEXETIL,1706257564,2018,8 mg,Tablet,Oral use,23.45,"Bluepharma - Industria Farmaceutica, S.A.",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CANDEZA 16 mg Tablet,CANDESARTAN CILEXETIL,1706257565,2018,16 mg,Tablet,Oral use,34.45,"Bluepharma - Industria Farmaceutica, S.A.",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
NIMBEX 2MG\ML SOLUTION FOR INJ,CISATRACURIUM,2-5974-24,2019,2 mg/ml,Solution for injection,Intravenous use,40.95,GLAXOSMITHKLINE (GSK),Italy,Aspen Pharmacare Australia Pty Ltd,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
CEBO 200 MG CAPSULE,CELECOXIB,0807245504,2019,200 mg,"Capsule, hard",Oral use,27.85,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CANDEZA 16/12.5 mg TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",1706257566,2018,"16,12.5 mg",Tablet,Oral use,34.45,"Bluepharma - Industria Farmaceutica, S.A.",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CANDEZA 8/12.5 mg TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",1706257568,2018,"16,12.5 mg",Tablet,Oral use,23.45,"Bluepharma - Industria Farmaceutica, S.A.",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CLARISCAN 0.5MMOL/ML SOL. FOR INJECTION,GADOTERIC ACID,409258162,2019,0.5 mmol/ml,Solution,Intravenous use,1265.05,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
QUZAL 100 mg Tablets,QUETIAPINE,2101256718,2019,100 mg,Tablet,Oral use,46.9,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
PADO 20MG FILM COATED TABLET,PAROXETINE,0602256840,2018,20 mg,Film-coated tablet,Oral use,31.4,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
COVATEL 40MG/10MG TABLET,"TELMISARTAN, AMLODIPINE BESILATE",1501256630,2019,"40,10 mg",Tablet,Oral use,45.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Rinvoq,UPADACITINIB,0403200025,2020,15 mg,Prolonged-release tablet,Oral use,4685.40,AbbVie Ireland,Ireland,AbbVie Inc,United States,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
COVATEL,"TELMISARTAN, AMLODIPINE BESILATE",1501256629,2019,"40,5 mg",Tablet,Oral use,45.7,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
QUZAL 200 mg Tablets,QUETIAPINE,2101256716,2019,200 mg,Tablet,Oral use,87,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
GAVILDA 50MG TABLET     28S,VILDAGLIPTIN,0810258361,2018,50 mg,Tablet,Oral use,33.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
GAVILDA 50MG TABLET      56S,VILDAGLIPTIN,0810258376,2018,50 mg,Tablet,Oral use,66.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
GLADOS MET 15/850 TABLETS,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE",1501256640,2019,"850,15 mg",Tablet,Oral use,93.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ALVANCO 500MG POW. FOR INFUSION,VANCOMYCIN,1208258010,2019,500 mg,Powder for concentrate for solution for infusion,Intravenous use,33.95,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
GLADOS MET 15/500 TABLETS,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE",1501256659,2019,"500,15 mg",Tablet,Oral use,93.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ALVANCO 1000MG POW. FOR INFUSION,VANCOMYCIN,1208258011,2019,1000 mg,Powder for concentrate for solution for infusion,Intravenous use,30.6,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Relif 100 mg Capsule,CELECOXIB,1501256638,2019,100 mg,Capsule,Oral use,21.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Relif 200 mg Capsule,CELECOXIB,1501256652,2019,200 mg,Capsule,Oral use,34.4,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IMATOX 4MG FILM COATED TABLETS,ONDANSETRON,2702256950,2019,4 mg,Film-coated tablet,Oral use,100.80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZORA 40 MG GASTRO-RESISTANT HARD CAPSULES (14S),ESOMEPRAZOLE SODIUM,1808245771,2019,40 mg,Gastro-resistant capsule,Oral use,36.75,TOWA PHARMACEUTICAL EUROPE S L,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
IMATOX 8MG FILM COATED TABLETS,ONDANSETRON,2702256951,2019,8 mg,Film-coated tablet,Oral use,136.35,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZORA 40 MG GASTRO-RESISTANT HARD CAPSULES (28S),ESOMEPRAZOLE SODIUM,1808245773,2019,40 mg,Gastro-resistant capsule,Oral use,65.65,TOWA PHARMACEUTICAL EUROPE S L,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
NIZORTAN PLUS,"TELMISARTAN, HYDROCHLOROTHIAZIDE",1501256625,2019,"40,12.5 mg",Tablet,Oral use,53.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZORA 20 MG GASTRO-RESISTANT HARD CAPSULES (14S),ESOMEPRAZOLE SODIUM,1808245772,2019,20 mg,Gastro-resistant capsule,Oral use,26.95,TOWA PHARMACEUTICAL EUROPE S L,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
NIZORTAN PLUS,"TELMISARTAN, HYDROCHLOROTHIAZIDE",1501256631,2019,"80,12.5 mg",Tablet,Oral use,53.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EZORA 20 MG GASTRO-RESISTANT HARD CAPSULES (28S),ESOMEPRAZOLE SODIUM,1808245774,2019,20 mg,Gastro-resistant capsule,Oral use,52.55,TOWA PHARMACEUTICAL EUROPE S L,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
NIZORTAN PLUS,"TELMISARTAN, HYDROCHLOROTHIAZIDE",1501256634,2019,"80,25 mg",Tablet,Oral use,53.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Imesta 500 mg/500 mg Powder For IV Infusion (10S),"CILASTATIN, IMIPENEM",0401268844,2019,"500,500 mg",Powder for solution for infusion,Intravenous use,348.15,ACS Dobfar S.p.A.,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
STERILE WATER FOR INJECTION,WATER,1302256897,2019,,Solvent for parenteral use,Intravenous use,19,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Imesta 500 mg/500 mg Powder For IV Infusion (1Vial),"CILASTATIN, IMIPENEM",0610258325,2019,"500,500 mg",Powder for solution for infusion,Intravenous use,34.8,ACS Dobfar S.p.A.,Italy,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
REDUVASC 150MG/5MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",0810258365,2019,"150,5 mg",Film-coated tablet,Oral use,81.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Pneumovax 23 Pneumococcal Vaccine Polyvalent,"PNEUMOCOCCAL (STREPTOCOCCUS PNEUMONIAE) POLYSACCHARIDE (SEROTYPE 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F)",2910246125,2019,50 µ/ml,Solution for injection,"Intravenous, Subcutaneous",135.5,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
IMUTIN 100 MG CAPSULE,IMATINIB MESILATE,2703257176,2019,100 mg,Capsule,Oral use,795.05,ADAMED Pharma S.A,Poland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
REDUVASC 150MG/10MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",0810258373,2019,"150,10 mg",Film-coated tablet,Oral use,81.3,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
IMUTIN 400 MG CAPSULE,IMATINIB MESILATE,2703257177,2019,400 mg,Capsule,Oral use,1766.8,ADAMED Pharma S.A,Poland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
REDUVASC 300MG/5MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",0810258358,2019,"300,5 mg",Film-coated tablet,Oral use,115.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FUNGISKA 50 mg Vial,CASPOFUNGIN,0112258694,2019,50 mg,Powder for concentrate for solution for infusion,Intravenous use,639.7,MEFAR ILAC SANAYII A.S.,Turkey,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
REDUVASC 300MG/10MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",0810258363,2019,"300,10 mg",Film-coated tablet,Oral use,115.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
FUNGISKA 70 mg Vial,CASPOFUNGIN,0112258695,2019,70 mg,Powder for concentrate for solution for infusion,Intravenous use,819.55,MEFAR ILAC SANAYII A.S.,Turkey,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
CELLONA 500 mg F.C.TAB,MYCOPHENOLATE MOFETIL,2101256692,2019,500 mg,Film-coated tablet,Oral use,583.65,Kocak Farma İlac Ve Kimya Sanayi A.S.,Turkey,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
EMIFLOC 500 mg Film-coated Tablet,LEVOFLOXACIN,1003257028,2019,500 mg,Film-coated tablet,Oral use,41.75,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
BANORIV 2.5 mg Film Coated Tablet,RIVAROXABAN,1908258057,2019,2.5 mg,Film-coated tablet,Oral use,31.7,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
BANORIV 10 mg Film Coated Tablet,RIVAROXABAN,1908258055,2019,10 mg,Film-coated tablet,Oral use,71.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
BANORIV 15MG F.C.TABLET,RIVAROXABAN,1908258058,2019,15 mg,Film-coated tablet,Oral use,186.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
BANORIV 20 mg Film Coated Tablet,RIVAROXABAN,1908258056,2019,20 mg,Film-coated tablet,Oral use,199.60,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ZANSOR 150MG F.C.TABLET,IRBESARTAN,42-968-19,2019,150 mg,Film-coated tablet,Oral use,40.5,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
PERTENSIO 125 mg Film-Coated Tablet,BOSENTAN,1803257095,2019,125 mg,Film-coated tablet,Oral use,6115.65,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
BENZAFLEX XR 15 mg Capsule,CYCLOBENZAPRINE HYDROCHLORIDE,0710258336,2019,15 mg,"Capsule, hard",Oral use,31.1,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
DEBROMU 40MG F.C.TABLET,OTILONIUM BROMIDE,0805257354,2019,40 mg,Film-coated tablet,Oral use,19.65,Berlin-Chemie AG,Germany,A.Menarini Industrie Farmaceutiche Riunite s.r.l,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BENZAFLEX XR 30 mg Capsule,CYCLOBENZAPRINE HYDROCHLORIDE,0610258326,2019,30 mg,"Capsule, hard",Oral use,62.2,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
OLFEN PATCHES,DICLOFENAC SODIUM,2110246081,2018,140 mg,Transdermal patch,Transdermal use,49.35,Teika Pharmaceutical Co Ltd,Japan,ACINO PHARMA AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
SNAFI 20MG TAB,TADALAFIL,2307257829,2019,20 mg,Film-coated tablet,Oral use,266.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
EZOLOC 25 MG TABLET,EXEMESTANE,3005245385,2019,25 mg,Film-coated tablet,Oral use,98.7,EirGen Pharma,Ireland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
EMIFLOC 500 mg Film-coated Tablet,LEVOFLOXACIN,1003257026,2019,500 mg,Film-coated tablet,Oral use,29.8,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
QUZAL 300 mg Tablets,QUETIAPINE,2101256715,2019,300 mg,Tablet,Oral use,142.8,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
STRATTERA 18MG CAPSULES,ATOMOXETINE HYDROCHLORIDE,1612246434,2019,18 mg,"Capsule, hard",Oral use,224.55,"LILLY DEL CARIBE, INC.",United States,"Lilly,S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ZANSOR 300MG F.C.TABLET,IRBESARTAN,43-968-19,2019,300 mg,Film-coated tablet,Oral use,49.7,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
GLOFEL 20 mg Film-coated Tablet,TADALAFIL,2603257169,2019,20 mg,Film-coated tablet,Oral use,32,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
QUZAL 400 mg Tablets,QUETIAPINE,2101256713,2019,400 mg,Tablet,Oral use,190.4,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
NIMBEX 5MG\ML INJ,CISATRACURIUM,44-887-19,2019,5 mg/ml,Solution for injection,Intravenous use,245.85,GLAXOSMITHKLINE (GSK),Italy,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
QATPEN 25MG F.C.TABLET,QUETIAPINE,1108258002,2019,25 mg,Film-coated tablet,Oral use,29.95,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
BRIVIACT 50MG F.C.TABLET,BRIVARACETAM,1505257392,2018,50 mg,Film-coated tablet,Oral use,286.55,UCB Pharma S.A.,Belgium,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SODANOR POWDER FOR ORAL/RECTAL SUSP.,SODIUM POLYSTYRENE SULFONATE,2010246076,2019,99.934 %,Powder for oral/rectal suspension,"Oral, Rectal",268.75,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DIOZAD,"VALSARTAN, HYDROCHLOROTHIAZIDE",4-5130-19,2019,"320,12.5 mg",Film-coated tablet,Oral use,30.1,Macleods Pharmaceuticals Limited,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Razy Al Madina Pharmaceutical
CORREX 120MG F.C.TABLET,Etoricoxib,1712246444,2019,120 mg,Film-coated tablet,Oral use,11,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ACIDOXAX 4MG VIAL,ZOLEDRONIC ACID,4-5251-19,2019,4 mg,Concentrate for solution for infusion,Intravenous use,57.95,Actavis Italy SpA,Italy,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
CAVERTA 100MG F.C.TABLET,SILDENAFIL,4-5252-18,2018,100 mg,Film-coated tablet,Oral use,13.1,Sun Pharmaceutical Industries Limited,India,Sun Pharmaceutical Industries Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DIAPHAGE 1 G SR TABLET,METFORMIN HYDROCHLORIDE,45-271-19,2019,1000 mg,Tablet,Oral use,23.8,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ravildo 3.125 mg F.C Tablets,CARVEDILOL,4-5286-19,2019,3.125 mg,Film-coated tablet,Oral use,6.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CISPLATIN 1MG-1ML VIAL,CISPLATIN,1010246028,2019,1 mg/ml,concentrate for solution for injection,Parenteral use,72.10,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,do not store above 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
APROVASC 300MG/10MG F.C.TABLET,"IRBESARTAN, AMLODIPINE BESILATE",4-5307-19,2019,"300,10 mg",Tablet,Oral use,135.95,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,"sanofi-aventis de Mexico, S.A. de C.V.",Mexico,Marketed,Prescription,store below 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
COMBIWAVE,"FLUTICASONE PROPIONATE, SALMETEROL",1202256881,2019,"50,25 µg",Pressurised inhalation,Inhalation use,36.75,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
ADVANTAN 0.1% SKIN OINTMENT,METHYLPREDNISOLONE,79-19-21,2019,0.1 %,Ointment,Topical,18.2,LEO Pharma Manufacturing Italy Srl,Italy,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
BEMFOLA 300IU/0.5ML INJECTION,FOLLITROPIN ALFA,2105257443,2019,300 IU,Solution for injection,Subcutaneous use,339.55,CP PHARMACEUTICAL LIMITED,United Kingdom,Finox Biotech AG,Liechtenstein,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
IMNOVID 3 mg capsule,POMALIDOMIDE,3107222366,2020,3 mg,Capsule,Oral use,29031.45,CELGENE INTERNATIONAL,Switzerland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
GLOFEL 20 mg Film-coated Tablet,TADALAFIL,2603257171,2019,20 mg,Film-coated tablet,Oral use,64,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
QUZAL 400 mg Tablets,QUETIAPINE,2101256714,2019,400 mg,Tablet,Oral use,95.2,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
QATPEN 100MG F.C.TABLET,QUETIAPINE,1108257981,2019,100 mg,Film-coated tablet,Oral use,34.15,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
RELEZIN 2 MG TABLET,TIZANIDINE,0110246003,2019,2 mg,Tablet,Oral use,14.75,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MOTILONE 10MG F.C.TABLET,DOMPERIDONE,0805257357,2019,10 mg,Coated tablet,Oral use,7.45,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
GLOFEL 20 mg Film-coated Tablet,TADALAFIL,2603257172,2019,20 mg,Film-coated tablet,Oral use,192,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
RESPAL ORAL SOLUTION,RISPERIDONE,1003257032,2019,1 mg/ml,Oral solution,Oral use,103.7,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
ARCOXIA 120MG TAB,Etoricoxib,0502256832,2003,120 mg,Film-coated tablet,Oral use,18.60,Rovi Pharma Industrial Service,Spain,N.V. Organon,Netherlands,Marketed,Prescription,store below 25°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
QATPEN 150MG F.C.TABLET,QUETIAPINE,1108257976,2019,150 mg,Film-coated tablet,Oral use,51.25,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
DUPHASTON 10 MG TAB,DYDROGESTERONE,46-972-19,2019,10 mg,Film-coated tablet,Oral use,52.9,ABBOTT BIOLOGICALS,Netherlands,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RELEZIN 4 MG TABLET,TIZANIDINE,0110245999,2019,4 mg,Tablet,Oral use,24.2,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
QATPEN 200MG F.C.TABLET,QUETIAPINE,1108258005,2019,200 mg,Film-coated tablet,Oral use,68.35,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
EDYST 20 MG F.C.TABLET,TADALAFIL,0106257507,2019,20 mg,Film-coated tablet,Oral use,50.55,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL COMPANY,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MOXIQUIN 400MG TABLET,MOXIFLOXACIN HYDROCHLORIDE,1112246395,2019,400 mg,Film-coated tablet,Oral use,58.6,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
ZYROSA 10MG F.C.TABLET,ROSUVASTATIN,2001256686,2019,10 mg,Tablet,Oral use,45.2,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
RUATINE 20MG CAPSULE,ISOTRETINOIN,1905257415,2019,20 mg,"Capsule, soft",Oral use,55.45,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL CO.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZYROSA 20MG F.C.TABLET,ROSUVASTATIN,2001256687,2019,20 mg,Tablet,Oral use,67.95,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
MOXIDAD CAPSULES 250MG,AMOXICILLIN,0912246372,1992,250 mg,Capsule,Oral use,7.3,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
VIVAZAC PLUS 300MG/25MG F.C.TABLET,"IRBESARTAN, HYDROCHLOROTHIAZIDE",51-271-19,2019,"300,25 mg",Film-coated tablet,Oral use,47.70,UNITED PHARMACEUTICAL COMPANY,Jordan,UNITED PHARMACEUTICAL COMPANY,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIVAZAC PLUS 300MG/12.5MG F.C.TABLET,"IRBESARTAN, HYDROCHLOROTHIAZIDE",52-271-19,2019,"300,12.5 mg",Film-coated tablet,Oral use,47.70,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
MARCAINE INJ 0.5%,BUPIVACAINE,52-887-19,2019,0.5 %,Solution for injection,Intravenous use,77.8,AstraZeneca AB,Sweden,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
VIVAZAC PLUS 150MG/12.5MG F.C.TABLET,"IRBESARTAN, HYDROCHLOROTHIAZIDE",53-271-19,2019,"150,12.5 mg",Film-coated tablet,Oral use,36,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
STRATTERA 25MG CAPSULES,ATOMOXETINE HYDROCHLORIDE,1612246435,2019,25 mg,"Capsule, hard",Oral use,224.55,"LILLY DEL CARIBE, INC.",United States,"Lilly,S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
VIVAZAC 300MG F.C.TABLET,IRBESARTAN,1501268923,2019,300 mg,Film-coated tablet,Oral use,26.85,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BRIVIACT 25MG F.C.TABLET,BRIVARACETAM,1505257393,2018,25 mg,Film-coated tablet,Oral use,286.55,UCB Pharma S.A.,Belgium,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SAFLUTAN 15MCG/ML EYE DROPS,TAFLUPROST,5-5091-18,2018,15 µg,"Eye drops, solution in single-dose container",Ophthalmic use,60.60,Laboratoire Unither,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
CARBOSET 600 mg film-coated tablet,CALCIUM CARBONATE,2010246075,2019,600 mg,Film-coated tablet,Oral use,25.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DIOZAD,"VALSARTAN, HYDROCHLOROTHIAZIDE",5-5130-19,2019,"320,25 mg",Film-coated tablet,Oral use,33.45,Macleods Pharmaceuticals Limited,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Razy Al Madina Pharmaceutical
GLEPTAL 50MG TABLET,VILDAGLIPTIN,1512246415,2020,50 mg,Tablet,Oral use,33.25,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DOXORUBICIN 2 MG/ML SOLUTION FOR INFUSION,DOXORUBICIN HYDROCHLORIDE,5-5223-18,2018,2 mg/ml,Concentrate for solution for infusion,"Intravenous, Intravesical",42.15,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
VIVAZAC 150MG F.C.TABLET,IRBESARTAN,75-5286-20,2019,150 mg,Film-coated tablet,Oral use,26.85,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ravildo 6. 25 mg F.C Tablets,CARVEDILOL,0509245870,2019,6.25 mg,Film-coated tablet,Oral use,12.9,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VINCRISTIN SULPH. 1MG-ML VIAL,VINCRISTINE,0510258324,2020,1 mg/ml,Solution for injection,Intravenous use,159.8,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
COMBIWAVE,"FLUTICASONE PROPIONATE, SALMETEROL",1202256883,2019,"125,25 µg",Pressurised inhalation,Inhalation use,44.5,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
ADVANTAN 0.1% SKIN CREAM,METHYLPREDNISOLONE,1301268898,2019,0.1 %,Cream,Topical,18.2,LEO Pharma Manufacturing Italy Srl,Italy,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
BEMFOLA 450IU/0.75ML INJECTION,FOLLITROPIN ALFA,2105257444,2019,450 IU,Solution for injection,Subcutaneous use,436.95,CP PHARMACEUTICAL LIMITED,United Kingdom,Finox Biotech AG,Liechtenstein,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
IMNOVID 2 mg capsule,POMALIDOMIDE,3107222370,2020,2 mg,Capsule,Oral use,27953.30,CELGENE INTERNATIONAL,Switzerland,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
AVIALIS 5 MG F.C.TABLET,TADALAFIL,0909245878,2019,5 mg,Film-coated tablet,Oral use,136.15,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVIALIS 20 MG F.C.TABLET,TADALAFIL,0909245879,2019,20 mg,Film-coated tablet,Oral use,64,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
AVIALIS 20 MG F.C.TABLET,TADALAFIL,0909245880,2019,20 mg,Film-coated tablet,Oral use,16,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
NAROPIN 10MG-ML AMP,ROPIVACAINE,57-887-19,2019,10 mg/ml,Solution for injection,Inhalation use,144.9,AstraZeneca,Sweden,Aspen Pharma Trading Limited,Ireland,Marketed,Prescription,store below 25°c,Pharmacy,
XIBAX 60MG F.C.TABLET,Etoricoxib,1501256665,2019,60 mg,Film-coated tablet,Oral use,41,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
XIBAX 90MG F.C.TABLET,Etoricoxib,1510246047,2019,90 mg,Film-coated tablet,Oral use,41,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
XIBAX 120MG F.C.TABLET,Etoricoxib,1510246050,2019,120 mg,Film-coated tablet,Oral use,11,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CORTRIEF NASAL SPRAY,BUDESONIDE,1510246046,2019,64 µg,"Nasal spray, suspension",Nasal use,45.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
MOXIDAD FORTE,AMOXICILLIN,0705245252,1992,500 mg,Capsule,Oral use,12.9,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ESCIPRA 10MG FILM COATED TABLET,ESCITALOPRAM,1002256858,2019,10 mg,Film-coated tablet,Oral use,43.50,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ZALDIAR,"TRAMADOL HYDROCHLORIDE, PARACETAMOL",0212258709,2019,"325,37.5 mg",Film-coated tablet,Oral use,27.1,FARMACEUTICI FORMENTI,Italy,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
ESCIPRA 20MG FILM COATED TABLET,ESCITALOPRAM,2509245950,2019,20 mg,Film-coated tablet,Oral use,78.30,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
STRATTERA 40MG CAPSULES,ATOMOXETINE HYDROCHLORIDE,1612246433,2019,40 mg,"Capsule, hard",Oral use,224.55,"LILLY DEL CARIBE, INC.",United States,"Lilly,S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
EVOKA 30 MG F.C.TABLET,DAPOXETINE,1510246049,2019,30 mg,Film-coated tablet,Oral use,49,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BRIVIACT 10MG F.C.TABLET,BRIVARACETAM,1505257390,2018,10 mg,Film-coated tablet,Oral use,74.90,UCB Pharma S.A.,Belgium,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DOXORUBICIN 2MG/ML SOLUTION FOR INFUSION,DOXORUBICIN HYDROCHLORIDE,6-5223-18,2018,2 mg/ml,Concentrate for solution for infusion,"Intravenous, Intravesical",175.05,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
Ravildo 12.5 mg F.C Tablets,CARVEDILOL,0509245871,2019,12.5 mg,Film-coated tablet,Oral use,17.6,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VINCRISTIN SULPH. 1MG-ML VIAL,VINCRISTINE,0610258327,2020,1 mg/ml,Solution for injection,Intravenous use,244.45,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
COMBIWAVE,"FLUTICASONE PROPIONATE, SALMETEROL",1202256882,2019,"250,25 µg",Pressurised inhalation,Inhalation use,64.4,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
EVOKA 60 MG F.C.TABLET,DAPOXETINE,1510246048,2019,60 mg,Film-coated tablet,Oral use,49,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
MUCOSOLVAN  30MG-5ML ORAL LIQUID,AMBROXOL HYDROCHLORIDE,0906245397,2019,6 mg/ml,Oral liquid,Oral use,34.9,DELPHARM REIMS S.A.S,France,A. Nattermann and Cie Gmbh,Germany,Marketed,OTC,do not store above 30°c,Pharmacy,Opella Arabia Limited Co
SPASMOLYT 20 MG COATED TABLETS,TROSPIUM,2209258258,2010,20 mg,Coated tablet,Oral use,22.05,Rottapharm|Madaus Group,Germany,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
XOFIGO 1100 kBq/ml Solution for Injection,RADIUM RA-223 DICHLORIDE,68-4-19,2019,1100 kBq/ml,Solution for injection,Intravenous use,22054.2,INSTITUTE FOR ENERGY TECHNOLOGY (IFE),Norway,BAYER AG,Germany,Marketed,Prescription,,Hospital,Abdulla Fouad Holding Co.
VOSEVI 400MG/100MG/100MG F.C.TABLET,"SOFOSBUVIR, VELPATASVIR, VOXILAPREVIR",0402256812,2019,"400,100,100 mg",Film-coated tablet,Oral use,35531.35,GILEAD SCIENCES IRELAND UC,Ireland,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
ENBREL 50MG PRE-FILLED PEN,ETANERCEPT,69-892-19,2019,50 mg,Solution for injection,Subcutaneous use,3368.45,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
LOCOID CREAM 0.1%,HYDROCORTISONE BUTYRATE,0806222156,2019,0.1 %,Cream,Topical,11.40,Temmler ltalia S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
TRAMAL 50 MG CAPSULE,TRAMADOL HYDROCHLORIDE,2204257269,2019,50 mg,Capsule,Oral use,34.95,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
STRATTERA 60MG CAPSULES,ATOMOXETINE HYDROCHLORIDE,1612246437,2019,60 mg,"Capsule, hard",Oral use,224.55,"LILLY DEL CARIBE, INC.",United States,"Lilly,S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
LOCOID LIPO CREAM 0.1%,HYDROCORTISONE BUTYRATE,0804257203,2019,0.1 %,Cream,Topical,11.40,Temmler ltalia S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BRIVIACT 10MG/ML ORAL SOLUTION,BRIVARACETAM,2307257808,2018,10 mg/ml,Oral solution,Oral use,409.35,Unither Manufacturing LLC,United States,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
TRIUM UD Eye Drops,"HYALURONIC ACID, GINKO BILOBA",6-427-22,2018,"0.15,0.05 g",Eye drops,Ophthalmic use,33.9,Sooft Italia SBA,Italy,Fidia Farmaceutici S.p.A.,Italy,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
LOCOID LOTION 0.1%,HYDROCORTISONE BUTYRATE,0804257202,2019,0.1 %,Cutaneous liquid,Topical,19.8,Temmler ltalia S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,OTC,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Aceda 500mg F.C.Tablet,Capecitabine,2008245790,2018,500 mg,Film-coated tablet,Oral use,658.4,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Ravildo 25 mg F.C Tablets,CARVEDILOL,0509245869,2019,25 mg,Film-coated tablet,Oral use,26.65,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CABOMETYX 60 mg F.C. Tablet,CABOZANTINIB,1711258605,2019,60 mg,Film-coated tablet,Oral use,14744.00,PATHEON INC,Canada,IPSEN PHARMA,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
CLAZ MR 60 mg tablet,GLICLAZIDE,2110246083,2019,60 mg,modified-release tablet,Oral use,21.6,APOTEX,Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AVORES 400 Film Coated Tablets,MOXIFLOXACIN HYDROCHLORIDE,0701256529,2019,400 mg,Film-coated tablet,Oral use,41.85,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
AVORES 400 Film Coated Tablets,MOXIFLOXACIN HYDROCHLORIDE,0701256533,2019,400 mg,Film-coated tablet,Oral use,58.6,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
TRAMAL 50 MG CAPSULE,TRAMADOL HYDROCHLORIDE,0410222688,2019,50 mg,Capsule,Oral use,15.55,GRUNENTHAL,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
METOJECT 50 mg/ml solution for injection,METHOTREXATE,1511222900,2016,50 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,75.2,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
BRIVIACT 10MG/ML VIAL,BRIVARACETAM,1505257391,2018,10 mg/ml,Solution for injection/infusion,Intravenous use,744.35,UCB Pharma S.A.,Belgium,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Aceda 150mg F.C.Tablet,Capecitabine,2008245791,2018,150 mg,Film-coated tablet,Oral use,122.9,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
FENTEX 50MG/ML SOLUTION FOR INJECTION,PHENYTOIN SODIUM,2905257491,2019,50 mg/ml,Solution for injection,Intramuscular and intravenous use,128.5,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ADVIL 200MG TAB,IBUPROFEN,1308258018,2019,200 mg,Tablet,Oral use,7.15,WYETH PHARMACEUTICAL COMPANY,United States,GLAXOSMITHKLINE (GSK),Canada,Marketed,OTC,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Haleon Arabia Limited"
LENVIMA 4 mg HARD CAPSULES,LENVATINIB,0904257215,2019,4 mg,"Capsule, hard",Oral use,5161.85,PATHEON INC,Canada,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CABOMETYX 40 mg F.C. Tablet,CABOZANTINIB,1711258604,2019,40 mg,Film-coated tablet,Oral use,14744.00,PATHEON INC,Canada,IPSEN PHARMA,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
SYNAGIS 100MG\ML I.M Solution for Injection,PALIVIZUMAB,0402256819,2018,100 mg/ml,Solution for injection,Intramuscular use,3679.9,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,AstraZeneca AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SKYRIZI 75 mg,RISANKIZUMAB,0902200010,2020,75 mg,Solution for injection in pre-filled syringe,Subcutaneous use,12733.30,AbbVie Deutschland GmbH & Co KG,Germany,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
PEYONA 20MG/ML SOL. FOR INF. AND ORAL Solution,CAFFEINE CITRATE,9-340-19,2019,20 mg/ml,Solution for infusion and oral solution,"Intravenous, Oral",699.00,ALFASIGMA S.p.A.,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
METOJECT 50 mg/ml solution for injection,METHOTREXATE,1106233784,2016,50 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,81.7,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
5%W/V DEXTROSE INJECTION 250ML,DEXTROSE,2912258827,2019,5 %,Solution for injection,Intravenous use,232.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
LAMUCON 500 mg F.C.TAB,MYCOPHENOLATE MOFETIL,0502256827,2018,500 mg,Film-coated tablet,Oral use,158.50,Sandoz Private Limited,India,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
TABIDEX 1 MG F. C. TABLET,ANASTROZOLE,9-5223-18,2018,1 mg,Film-coated tablet,Oral use,105.1,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SEIZET 25 mg Chewable/Dispersible Tablet,LAMOTRIGINE,2912246500,2019,25 mg,Chewable/dispersible tablet,Oral use,23.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LENVIMA 10 mg HARD CAPSULES,LENVATINIB,0904257216,2019,10 mg,"Capsule, hard",Oral use,5161.85,PATHEON INC,Canada,EISAI EUROPE LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CABOMETYX 20 mg F.C. Tablet,CABOZANTINIB,1711258603,2019,20 mg,Film-coated tablet,Oral use,14744.00,PATHEON INC,Canada,IPSEN PHARMA,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
VIAGRA 50 mg Orodispersible Tablet,SILDENAFIL,0409234117,2019,50 mg,Tablet,Oral use,33.15,Fareva Amboise,France,UPJOHN EESV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
Pluryal BOOSTER,"GLYCERIN, SODIUM HYALURONATE",0504200047,2020,"20,18 mg/ml",Injection,Intradermal use,286.832,MD SKIN Solutions,Luxembourg,MD SKIN SOLUTIONS,Luxembourg,Marketed,Prescription,store below 25°c,Pharmacy,Beauty Med
Pluryal VOLUME,SODIUM HYALURONATE,0504200048,2020,23 mg/ml,Injection,Intradermal use,352.25,MD SKIN Solutions,Luxembourg,MD SKIN SOLUTIONS,Luxembourg,Marketed,Prescription,store below 25°c,Pharmacy,Beauty Med
Pluryal CLASSIC,SODIUM HYALURONATE,0504200049,2020,23 mg/ml,Injection,Intradermal use,301.928,MD SKIN Solutions,Luxembourg,MD SKIN SOLUTIONS,Luxembourg,Marketed,Prescription,store below 25°c,Pharmacy,Beauty Med
Dolibz,CELECOXIB,0504200050,2020,200 mg,Capsule,Oral use,24.998,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Dolibz,CELECOXIB,0504200051,2020,100 mg,Capsule,Oral use,12.498,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
PROPOVEN 1% VIAL,PROPOFOL,10-174-20,2020,1 %,Emulsion for injection/infusion,Intravenous use,461.7,FRESENIUS KABI,Austria,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
LIDOVA 5 mg capsule,LENALIDOMIDE,111-370-20,2020,5 mg,"Capsule, hard",Oral use,11206.25,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
LIDOVA 10 mg capsule,LENALIDOMIDE,112-370-20,2020,10 mg,"Capsule, hard",Oral use,11749.75,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
LIDOVA 25 mg capsule,LENALIDOMIDE,113-370-20,2020,25 mg,"Capsule, hard",Oral use,13611.5,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
CIALIS ONCE-A-DAY 5MG TABLETS,TADALAFIL,1202233231,2019,5 mg,Film-coated tablet,Oral use,229.9,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
GAVISCON ADVANCE PEPPERMINT LIQUID SACHET,"SODIUM ALGINATE, POTASSIUM BICARBONATE",1901268948,2018,"500,100 mg",Oral suspension,Oral use,30.4,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Cigalah Group
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,13-5023-19,2019,0.9 %,Solution for injection,Intravenous use,160.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
SILOMES 50MG TABLET,AMISULPRIDE,1906257584,2019,50 mg,Tablet,Oral use,40.55,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GAVISCON ADVANCE PEPPERMINT LIQUID SACHET,"SODIUM ALGINATE, POTASSIUM BICARBONATE",1901268945,2018,"500,100 mg",Oral suspension,Oral use,15.2,RECKITT BENCKISER HEALTHCARE INTERNATIONAL,United Kingdom,RECKITT BENCKISER,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Cigalah Group
SILOMES 100 mg Tablet,AMISULPRIDE,1906257585,2019,100 mg,Tablet,Oral use,60.9,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
EPANUTIN SUSP 30MG-5ML,PHENYTOIN SODIUM,1401256613,2016,6 mg/ml,Oral suspension,Oral use,7.6,Delpharm Orleans,France,UPJOHN UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
FLECTOR EP GRANULES,DICLOFENAC EPOLAMINE,1-5186-18,2018,65 mg,Granules,Oral use,40.00,Fine Foods And Pharmaceuticals N.T.M S.p.A,Italy,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"---, Abdulrehman Algosaibi G.T.C."
HYADENT BARRIER GEL,"HYALURONIC ACID, HYALURONIC ACID CROSS-LINKED",1-5191-18,2018,"2,16 mg",Gel for injection,Dental use,329.4,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,Store between (2°C – 25°C),Hospital,Blue Elaf Limited Company
BIOQ ROPIVACAINE 2MG/ML SOL. FOR INFUSION,ROPIVACAINE,1-5289-19,2019,2 mg/ml,Solution for infusion,Intravenous use,639.75,Holopack Verpackungstechnik GmbH,Germany,BioQ Pharma Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
BACLOFEN INTRATHECAL SINTETICA 0.5MG/ML INJECTION,BACLOFEN,1-5299-19,2019,0.5 mg/ml,Solution for injection,Intrathecal use,1374.45,Sintetica SA,Switzerland,Sintetica SA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
TACROZ FORTE OINTMENT,TACROLIMUS,1-5345-20,2020,0.1 %,Ointment,Topical,29.40,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CANHERA 150MG VIAL,Trastuzumab,1-5366-19,2019,150 mg,Infusion,Intravenous use,1364.7,Biocon Limited,India,Biocon Biologics Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,EBRAHIM M. ALMANA & BROS. CO.
NITYR 2 mg Tablet,NITISINONE,1-5416-20,2020,2 mg,Tablet,Oral use,2413.55,Rivopharm SA,Switzerland,Cycle Pharmaceuticals LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Modern Quality Drug Warehouse
DILIZOLEN 600MG TABLET,LINEZOLID,1603257077,2020,600 mg,Tablet,Oral use,1404.45,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
NICOTINELL TTS-10,NICOTINE,0805233602,2020,17.5 mg,Transdermal patch,Topical,66.10,LTS LOHMANN Therapie-Systeme,Germany,Haleon Schweiz AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
ERLEADA 60 mg Film-coated Tablet,APALUTAMIDE,1808258040,2020,60 mg,Film-coated tablet,Oral use,11731.35,JANSSEN ORTHO LLC,United States,JANSSEN BIOTECH INC.,United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
LEPONEX 100MG TAB,CLOZAPINE,0812258750,2020,100 mg,Tablet,Oral use,145.15,Madaus GmbH,Germany,Viatris Pharma GmbH,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
SILOMES 200 mg Tablet,AMISULPRIDE,1906257583,2019,200 mg,Tablet,Oral use,114.3,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DERMALSTYLE forte Lidocaine,"SODIUM HYALURONATE, LIDOCAINE HYDROCHLORIDE",1603200038,2020,"23,0.3 mg/ml",Gel for injection,Subcutaneous use,342.352,CROMA PHARMA GMBH,Austria,CROMA PHARMA Gmbh,Austria,Marketed,Prescription,store below 25°c,Pharmacy,ELAGY ESTABLISHMENT FOR TRADING
DERMALSTYLE smile Lidocaine,"SODIUM HYALURONATE, LIDOCAINE HYDROCHLORIDE",1603200039,2020,"23,0.3 mg/ml",Gel for injection,Subcutaneous use,342.352,CROMA PHARMA GMBH,Austria,CROMA PHARMA Gmbh,Austria,Marketed,Prescription,store below 25°c,Pharmacy,ELAGY ESTABLISHMENT FOR TRADING
Luxturna,VORETIGENE NEPARVOVEC,1603200040,2020,5*10^12 vg/ml,Concentrate and solvent for solution for injection,Subretinal use,1342192.50,Nova Laboratories Ltd,United Kingdom,Novartis Europharm Limited,Ireland,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,Novartis Saudi Limited
Amgevita 40 mg per 0.8 ml syringe,ADALIMUMAB,1603200041,2020,"40 mg, mg/ml",Solution for injection,Subcutaneous use,2955.80,Amgen Manufacturing Ltd,United States,Amgen Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
Amgevita 40 mg per 0.8 ml Pen,ADALIMUMAB,1603200042,2020,"40 mg, mg/ml",Solution for injection,Subcutaneous use,2955.80,Amgen Manufacturing Ltd,United States,Amgen Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
ALDURAZYME 100 U/ML VIAL,LARONIDASE,16-832-19,2019,100 U,Concentrate for solution for infusion,Intravenous use,2972.65,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
ANGIRAM,RAMIPRIL,1804200053,2020,10 mg,Tablet,Oral use,41.849,Aurobindo Pharma Limited Unit XV,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
ANGIRAM,RAMIPRIL,1804200054,2020,5 mg,Tablet,Oral use,32.65,Aurobindo Pharma Limited Unit XV,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
CAL-C-VITA EFFERVESCENT,"ASCORBIC ACID, COLECALCIFEROL, CALCIUM CARBONATE, PYRIDOXINE (VITAMIN B6)",19-949-20,2020,"1000,300,250,15 mg, IU",Effervescent tablet,Oral use,20.85,DELPHARM GAILLARD,France,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,store below 25°c,Pharmacy,Bayer Saudi Arabia
VITRAKVI,LAROTRECTINIB,2004200055,2020,25 mg,Capsule,Oral use,19273.72,Penn Pharmaceutical Services Ltd,United Kingdom,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
JIVI powder and solvent for solution for injection,PEGYLATED B DOMAIN DELETED RECOMBINANT HUMAN COAGULATION FACTOR VIII DAMOCTOCOG ALFA PEGOL,2004200056,2020,500 IU,Powder and solvent for solution for injection,Intravenous use,1752.25,Bayer Healthcare LLC Biological Products Division,United States,BAYER HEALTHCARE LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
JIVI powder and solvent for solution for injection,PEGYLATED B DOMAIN DELETED RECOMBINANT HUMAN COAGULATION FACTOR VIII DAMOCTOCOG ALFA PEGOL,2004200057,2020,1000 IU,Powder and solvent for solution for injection,Intravenous use,3504.5,Bayer Healthcare LLC Biological Products Division,United States,BAYER HEALTHCARE LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
JIVI powder and solvent for solution for injection,PEGYLATED B DOMAIN DELETED RECOMBINANT HUMAN COAGULATION FACTOR VIII DAMOCTOCOG ALFA PEGOL,2004200058,2020,2000 IU,Powder and solvent for solution for injection,Intravenous use,7009.05,Bayer Healthcare LLC Biological Products Division,United States,BAYER HEALTHCARE LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
VITRAKVI,LAROTRECTINIB,2004200059,2020,20 mg/ml,Oral solution,Oral use,26100.26,Penn Pharmaceutical Services Ltd,United Kingdom,BAYER AG,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Bayer Saudi Arabia
VITRAKVI,LAROTRECTINIB,2004200060,2020,100 mg,Capsule,Oral use,77094.89,Penn Pharmaceutical Services Ltd,United Kingdom,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
MILORA HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0205200066,2020,"160,12.5,10 mg",Film-coated tablet,Oral use,60.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
MILORA HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0205200067,2020,"160,12.5,5 mg",Film-coated tablet,Oral use,51.5,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
MILORA HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0205200068,2020,"160,25,10 mg",Film-coated tablet,Oral use,60.15,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
VERTEX,ROSUVASTATIN,0205200070,2020,10 mg,Film-coated tablet,Oral use,51.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
VERTEX,ROSUVASTATIN,0205200071,2020,20 mg,Film-coated tablet,Oral use,87.249,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
YOCAIR 10MG F.C.TABLET,MONTELUKAST SODIUM,210-368-19,2019,5 mg,Film-coated tablet,Oral use,71.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DAPOX 30MG F.C.TABLET,DAPOXETINE,217-368-20,2020,30 mg,Film-coated tablet,Oral use,52.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DAPOX 60MG F.C.TABLET,DAPOXETINE,218-368-20,2020,60 mg,Film-coated tablet,Oral use,52.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
NEUPRO 2 mg/24 hrs Transdermal Patches,ROTIGOTINE,3009258279,2018,2 mg,Transdermal patch,Transdermal use,156.35,LTS LOHMANN Therapie-Systeme,Germany,UCB Pharma S.A,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
KOZAMOD 5% CREAM,IMIQUIMOD,2304257274,2020,5 %,Cream,Topical,140.5,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
BORTEZON 3.5 mg Powder For Solution For Injection,BORTEZOMIB,6-655-23,2020,3.5 mg,powder for solution for injection,Subcutaneous use,2177.05,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
TAMENIB 100 MG CAPSULE,IMATINIB MESILATE,1-5685-23,2020,100 mg,"Capsule, hard",Oral use,795.05,NOBILUS ENT,Poland,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Cigalah Group"
TACROZ 0.03% OINTMENT,TACROLIMUS,1205257379,2020,0.03 %,Ointment,Topical,26.50,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
NITYR 5 mg Tablet,NITISINONE,2-5416-20,2020,5 mg,Tablet,Oral use,5012.55,Rivopharm SA,Switzerland,Cycle Pharmaceuticals LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Modern Quality Drug Warehouse
NICOTINELL TTS-20,NICOTINE,0805233600,2020,35 mg,Transdermal patch,Topical,66.10,LTS LOHMANN Therapie-Systeme,Germany,Haleon Schweiz AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
LEPONEX 25MG TAB,CLOZAPINE,0812258751,2020,25 mg,Tablet,Oral use,47.10,Madaus GmbH,Germany,Viatris Pharma GmbH,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
OXIDOTE 1GM VIAL,PRALIDOXIME CHLORIDE,1501256645,2019,1 g,powder for solution for injection,Intramuscular and intravenous use,1694.75,Tabuk Pharmaceutical Manufacturing Co./ Dammam Plant,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
APRELEX 20MCG/ML INHALATION SOLUTION,ILOPROST,26-993-20,2020,20 µ/ml,inhalation solution,Inhalation use,2132.15,Tabuk Pharmaceutical Manufacturing Co./ Dammam Plant,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
ADANCOR 10 mg tablet,NICORANDIL,3003221899,2020,10 mg,Tablet,Oral use,32,MERCK HEALTHCARE KGAA,Germany,Merck Schweiz AG,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALHAYA MEDICAL CO, Salehiya Trading Co."
RENIS 50MG CAPSULE,SUNITINIB,1107245545,2019,50 mg,"Capsule, hard",Oral use,15677.45,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ISENTRESS 600MG F.C.TABLET,RALTEGRAVIR POTASSIUM,2108258088,2019,600 mg,Film-coated tablet,Oral use,1679.95,MSD International GmbH (Singapore Branch),Singapore,MERCK SHARP & DOHME LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
SOLIAN 50MG TAB,AMISULPRIDE,31-883-20,2020,50 mg,Tablet,Oral use,49.9,Delpharm Dijon,France,Sanofi Aventis France,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
ABREMIA 250MG TABLET,ABIRATERONE ACETATE,0311258539,2019,250 mg,Tablet,Oral use,5867.25,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
HERZUMA 150MG VIAL,Trastuzumab,2804257285,2020,150 mg,Powder for concentrate for solution for infusion,Intravenous use,1364.7,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
SOTIRA 25MG CAPSULE,LENALIDOMIDE,1102256869,2020,25 mg,"Capsule, hard",Oral use,15123.9,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MODZAL 15MG/3ML INJECTION,MIDAZOLAM,2207257790,2019,5 mg/ml,Solution for injection,Parenteral use,36.9,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ESOBLOC 10 mg/ml solution for infusion,ESMOLOL,2407257850,2020,10 mg/ml,Solution for infusion,Intravenous use,13.2,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
TRUXIMA,RITUXIMAB,2804257284,2020,500 mg,Concentrate for solution for infusion,Intravenous use,3701.40,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
CO-OLMEPRESS 20 mg/12.5 mg F.C. Tablet,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1301256594,2019,"20,12.5 mg",Film-coated tablet,Oral use,48.8,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
IMATIS 400MG F.C.TABLET,IMATINIB MESILATE,3-5260-19,2019,400 mg,Tablet,Oral use,1425.85,DEVA HOLDING A.S.,Turkey,DEVA HOLDING A.S.,Turkey,Marketed,Prescription,store below 30°c,Hospital,PharmaZone (Netaq Al Dawa) Pharmaceuticals
BACLOFEN INTRATHECAL SINTETICA 2MG/ML INJECTION,BACLOFEN,3-5299-19,2019,2 mg/ml,Solution for injection,Intrathecal use,2748.9,Sintetica SA,Switzerland,Sintetica SA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
FLUSORT 0.05% NASAL SPRAY,FLUTICASONE PROPIONATE,0704257196,2019,0.05 %,Nasal spray,Nasal use,18,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
TAMENIB 400 MG CAPSULE,IMATINIB MESILATE,2-5685-23,2020,400 mg,"Capsule, hard",Oral use,1766.8,NOBILUS ENT,Poland,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Cigalah Group"
NITYR 10 mg Tablet,NITISINONE,3-5416-20,2020,10 mg,Tablet,Oral use,9067.85,Rivopharm SA,Switzerland,Cycle Pharmaceuticals LTD,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Modern Quality Drug Warehouse
NICOTINELL TTS-30,NICOTINE,0805233601,2020,52.5 mg,Transdermal patch,Topical,66.10,LTS LOHMANN Therapie-Systeme,Germany,Haleon Schweiz AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"***************************, ALNAGHI COMPANY"
OLMIDIP 20/5 mg FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1004257220,2020,"20,5 mg",Film-coated tablet,Oral use,55.3,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OLMIDIP 40/5 mg FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2403257154,2020,"40,5 mg",Film-coated tablet,Oral use,68.65,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OLMIDIP 40/10 mg FILM COATED TABLET,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2403257152,2020,"40,10 mg",Film-coated tablet,Oral use,71.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SUTEXA 12.5MG CAPSULE,SUNITINIB,2804257295,2020,12.5 mg,"Capsule, hard",Oral use,3527.4,Combino Pharm (Malta) Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
DAMESTA 10MG F.C.TABLET,ESCITALOPRAM,40-968-19,2019,10 mg,Film-coated tablet,Oral use,46.6,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SUTEXA 25MG CAPSULE,SUNITINIB,2804257293,2020,25 mg,"Capsule, hard",Oral use,7054.85,Combino Pharm (Malta) Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
DAMESTA  20MG F.C.TABLET,ESCITALOPRAM,0909258189,2019,20 mg,Film-coated tablet,Oral use,83.9,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
SUTEXA 50MG CAPSULE,SUNITINIB,2804257291,2020,50 mg,"Capsule, hard",Oral use,14109.7,Combino Pharm (Malta) Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
LAZURE 50MG F.C.TABLET,LACOSAMIDE,2201256724,2020,50 mg,Film-coated tablet,Oral use,117.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LAZURE 100MG F.C.TABLET,LACOSAMIDE,2201256725,2020,100 mg,Film-coated tablet,Oral use,226.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LAZURE 200MG F.C.TABLET,LACOSAMIDE,2201256731,2020,200 mg,Film-coated tablet,Oral use,453.2,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
PIRAMYL-MET 2/500 mg Film-coated Tablet,"METFORMIN HYDROCHLORIDE, GLIMEPIRIDE",0810258371,2020,"500,2 mg",Film-coated tablet,Oral use,26,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
LIFANCE 5MG F.C.TABLET,SOLIFENACIN SUCCINATE,1706257562,2019,5 mg,Film-coated tablet,Oral use,84.7,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LIFANCE 10MG F.C.TABLET,SOLIFENACIN SUCCINATE,1706257561,2019,10 mg,Film-coated tablet,Oral use,108.9,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LEJAM 30MG FILM COATED TABLET,DAPOXETINE,2605257462,2020,30 mg,Film-coated tablet,Oral use,122.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
LEJAM 60MG FILM COATED TABLET,DAPOXETINE,2710258490,2020,60 mg,Film-coated tablet,Oral use,122.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
ABSTRAL 100MCG SUBLINGUAL TABLET,FENTANYL,2509258266,2018,100 µg,Sublingual tablet,Sublingual use,271.1,RECIPHARM PARETS,Spain,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
BACLOFEN INTRATHECAL SINTETICA 2MG/ML INJECTION,BACLOFEN,4-5299-19,2019,2 mg/ml,Solution for injection,Intrathecal use,1099.55,Sintetica SA,Switzerland,Sintetica SA,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ENEVOM 80 MG CAPSULE,APREPITANT,3004257315,2020,80 mg,"Capsule, hard",Oral use,79.05,"Rontis Hellas S.A., Medical and Pharmaceutical Products",Greece,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ENEVOM 125 MG CAPSULE,APREPITANT,3004257316,2020,125 mg,"Capsule, hard",Oral use,79.05,"Rontis Hellas S.A., Medical and Pharmaceutical Products",Greece,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
PAQUIX 2.5MG FILM COATED TABLET,APIXABAN,47-5286-20,2020,2.5 mg,Film-coated tablet,Oral use,118.2,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PAQUIX 2.5MG FILM COATED TABLET,APIXABAN,0106257506,2020,2.5 mg,Film-coated tablet,Oral use,224.15,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PAQUIX 5 MG FILM COATED TABLET,APIXABAN,0106257512,2020,5 mg,Film-coated tablet,Oral use,224.15,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BATIPAN 100 mg per 50 ml - VIAL,OXALIPLATIN,1008257970,2019,2 mg/ml,Powder for solution for infusion,Intravenous use,237.25,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
ABSTRAL 200MCG SUBLINGUAL TABLET,FENTANYL,2509258265,2018,200 µg,Sublingual tablet,Sublingual use,271.1,RECIPHARM PARETS,Spain,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LANOXIN 0.125MG TAB,DIGOXIN,2907257882,2020,0.125 mg,Tablet,Oral use,16.1,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
LANOXIN 0.25MG TAB,DIGOXIN,1806257576,2020,0.25 mg,Tablet,Oral use,11.7,ASPEN Bad Oldesloe GmbH,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
IMURAN,AZATHIOPRINE,0303256968,2020,50 mg,Tablet,Oral use,101.9,EXCELLA GMBH CO. KG,Germany,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
RECOMBIVAX HB,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,6-20-19,2019,,Suspension for injection,Intramuscular use,40.45,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
FOLOTYN 20MG/ML SOLUTION FOR INFUSION,PRALATREXATE,6-5115-18,2018,20 mg/ml,Solution for infusion,Intravenous use,15091.7,BAXTER ONCOLOGY GmbH,Germany,MUNDIPHARMA MEDICAL COMPANY,Switzerland,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
TECANA 20MG/ML VIAL,IRINOTECAN,6-5251-19,2019,20 mg/ml,Powder for solution for infusion,Intravenous use,118.35,Actavis Italy SpA,Italy,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
MAYZENT,SIPONIMOD,0705200074,2020,0.25 mg,Film-coated tablet,Oral use,826.95,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMACEUTICALS CORPORATION,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
MAYZENT,SIPONIMOD,0705200075,2020,2 mg,Film-coated tablet,Oral use,8264.9,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMACEUTICALS CORPORATION,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
MAYZENT,SIPONIMOD,0705200076,2020,0.25 mg,Film-coated tablet,Oral use,8264.9,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMACEUTICALS CORPORATION,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
RECOMBIVAX HB,HEPATITIS B VIRUS VACCINE,1807245600,2019,,Suspension for injection,Intramuscular use,46.7,MERCK SHARP AND DOHME LLC,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
LIPANTHYL 145MG F.C. TABLETS,FENOFIBRATE,3011222949,2020,145 mg,Film-coated tablet,Oral use,44.55,Abbott Laboratories Fournier (Laboratories) Ireland Ltd,Ireland,Abbott Laboratories GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LINDEC 600 mg Film-coated Tablet,LINEZOLID,82-249-20,2020,600 mg,Film-coated tablet,Oral use,1706.4,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PROPOVEN 1% VIAL,PROPOFOL,9-174-20,2020,1 %,Emulsion for injection/infusion,Intravenous use,102.9,FRESENIUS KABI,Austria,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,"ALHAYA MEDICAL CO, Faisal Musaed El Seif Saudi Pharmaceutical Co."
NIZORAL SHAMPOO,KETOCONAZOLE,1505257396,2020,2 %,Shampoo,Topical,30.55,JANSSEN PHARMACEUTICA N.V.,Belgium,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Cigalah Group, STADA Arabia Limited Company"
SPINRAZA 2.4 mg/ml Vial,NUSINERSEN,7-5547-22,2019,12 mg,Solution for injection,Intrathecal use,394762.5,Patheon Italia S.P.A.,Italy,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Biogen Arabia, Salehiya Trading Co."
Renee Touch,HYALURONIC ACID,0507200103,2020,24 mg/ml,Solution for injection in pre-filled syringe,Intradermal use,184.13,MATEX LAB SA,Germany,Qventis GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,mawj al samaa medical company
Renee Volume,HYALURONIC ACID,0507200104,2020,28 mg/ml,Solution for injection in pre-filled syringe,Intradermal use,194.653,MATEX LAB SA,Germany,Qventis GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,mawj al samaa medical company
Renee Smile,HYALURONIC ACID,0507200105,2020,22 mg/ml,Solution for injection in pre-filled syringe,Intradermal use,194.653,MATEX LAB SA,Germany,Qventis GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,mawj al samaa medical company
Cuprior,TRIENTINE TETRAHYDROCHLORIDE,0707200107,2020,150 mg,Film-coated tablet,Oral use,7303.80,DELPHARM EVREUX,France,Orphalan,France,Marketed,Prescription,store below 30°c,Pharmacy,"Arabian Trade House, Rowad Al Ilham Medical Warehouse"
NEUPRO 8 mg/24 hrs Transdermal Patches,ROTIGOTINE,1302244915,2020,8 mg,Transdermal patch,Transdermal use,364.00,LTS LOHMANN Therapie-Systeme,Germany,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
GASTROGRAFIN 76-ORAL AQUEOUS SOLN.,DIATRIZOATE MEGLUMINE,0505245248,1986,597.3 mg,Gastroenteral solution,Oral use,58.20,Berlimed S.A.,Spain,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
NEUPRO 6 mg/24 hrs Transdermal Patches,ROTIGOTINE,1302244916,2020,6 mg,Transdermal patch,Transdermal use,296.00,LTS LOHMANN Therapie-Systeme,Germany,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ACICLOVIR  250MG/10ML,ACYCLOVIR,0704257188,2020,25 mg/ml,Concentrate for solution for infusion,Intravenous use,119.55,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
VIRONTA,ROSUVASTATIN,1205200078,2020,40 mg,Film-coated tablet,Oral use,82.40,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIRONTA,ROSUVASTATIN,1205200081,2020,10 mg,Film-coated tablet,Oral use,31.10,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
VIRONTA,ROSUVASTATIN,1205200082,2020,20 mg,Film-coated tablet,Oral use,50.25,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PEDEXA,CELECOXIB,123-124-19,2019,200 mg,Capsule,Oral use,12.5,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
TYRA 5 mg film-coated tablet,TADALAFIL,2406257612,2019,5 mg,Film-coated tablet,Oral use,126.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
PREVENAR 13 PRE-FILLED SYRINGE VACCINE,PNEUMOCOCCAL POLYSACHARIDE,1303257045,2020,,Suspension for injection,Subcutaneous use,245.85,PFIZER,Ireland,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
CYTARABINE 100MG-1ML VIAL,CYTARABINE,13-5287-20,2020,100 mg/ml,Solution for injection,Intravenous use,121.4,Zydus Hospira Oncology Private Limited ZHOPL,India,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
PROSTIN E2 VAGINAL TAB. 3MG,DINOPROSTONE,0307257678,2020,3 mg,Vaginal tablet,Vaginal use,174.05,Sanico NV,Belgium,Pfizer S.A,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
PRAVAFEN 40/160 mg,"FENOFIBRATE, PRAVASTATIN",1405200083,2020,"160,40 mg","Capsule, hard",Oral use,65.35,SMB Technology SA,Belgium,Laboratories SMB SA,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Annhdah Medical Company
Kavira,ENTECAVIR,1407200108,2020,0.5 mg,Film-coated tablet,Oral use,402.449,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Kavira,ENTECAVIR,1407200109,2020,1 mg,Film-coated tablet,Oral use,462.4,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
CYTARABINE 100MG-1ML VIAL,CYTARABINE,14-5287-20,2020,100 mg/ml,Solution for injection,Intravenous use,302.85,Zydus Hospira Oncology Private Limited ZHOPL,India,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
VFEND 200MG POWDER FOR SOLU.FOR INFUSION,VORICONAZOLE,1310258408,2020,200 mg,Powder for solution for infusion,Parenteral use,327.80,PHARMACIA UPJOHN,United States,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
TAXOTERE 20 MG/ML SOLUTION FOR INFUSION,DOCETAXEL,1-5079-20,2020,20 mg/ml,Concentrate for solution for infusion,Intravenous use,461.7,Sanofi aventis Deutschland GmbH,Germany,Aventis Pharma S.A.,France,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
HYQVIA 100MG/ML SOLUTION FOR INFUSION,HUMAN NORMAL IMMUNOGLOBULIN,1-5356-19,2019,10 %,Solution for infusion,Subcutaneous use,1120.70,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,ALNAGHI COMPANY
DILATREND 25MG TABLET,CARVEDILOL,0803221824,2020,25 mg,Tablet,Oral use,47.25,Delpharm Milano S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
LEMTRADA 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION,ALEMTUZUMAB,0801268887,2020,12 mg,Concentrate for solution for infusion,Intravenous use,32921.25,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,Sanofi Belgium,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
LIPANTHYL 200MG MICRONISED CAPS,FENOFIBRATE,3105222110,2020,200 mg,"Capsule, hard",Oral use,44.55,Astrea Fontaine,France,Abbott Laboratories,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CYCLOGEST 200MG PESSARIES,PROGESTERONE,1112246392,2020,200 mg,Pessary,Vaginal use,66.20,Accord -UK Limited,United Kingdom,L.D Collins & CO Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PecFent 400 MCG NASAL SPRAY,FENTANYL,1-5499-20,2020,400 µg,"Nasal spray, solution",Nasal use,201.85,L. Molteni & C dei F. LLi Alitti Societa di Esercizio,Italy,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ATACAND PLUS TABLET,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",18-5444-25,2020,"16,12.5 mg",Tablet,Oral use,75.90,AstraZeneca,Sweden,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
NEXIUM 20MG TAB,ESOMEPRAZOLE,2803233432,2020,20 mg,Gastro-resistant tablet,Oral use,35.25,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
CARBOPLATIN 10MG-ML VIAL,CARBOPLATIN,0704257192,2020,10 mg/ml,Solution,Parenteral use,141.40,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,do not store above 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
RAPAMUNE 1 MG Coated tablet,SIROLIMUS,15-828-20,2020,1 mg,Coated tablet,Oral use,371.90,Pfizer Ireland Pharmaceuticals,Ireland,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 25°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
SIAX,CLOSTRIDIUM BOTULINUM NEUROTOXIN A COMPLEX,0712258743,2020,50 U,Powder for injection,Intramuscular use,251.7,Medytox Inc.,KOREA,Medytox Inc.,KOREA,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Al Amin Medical Instruments Co. Ltd.
TWINZOL EYE DROPS,"DORZOLAMIDE, TIMOLOL MALEATE",1806257580,2020,"2,0.5 %",Eye drops,Ophthalmic use,33.80,Orchidia Pharmaceutical Industries,Egypt,Orchidia Pharmaceutical Industries,Egypt,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
XIIDRA 50 MG/ML EYE DROPS,LIFITEGRAST,1-5639-24,2020,50 mg/ml,"Eye drops, solution",Ophthalmic use,361.5,The Ritedose Corporation,United States,"Bausch & Lomb, Incorporated",United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
CARBOPLATIN 10MG-ML VIAL,CARBOPLATIN,0704257193,2020,10 mg/ml,Solution,Parenteral use,336.65,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,do not store above 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
BOSENTOR 62.5 mg Film-Coated Tablet,BOSENTAN,3001233189,2020,62.5 mg,Tablet,Oral use,6115.65,Genvion Corporation,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
PEEVO,CLOPIDOGREL,1705200084,2020,75 mg,Film-coated tablet,Oral use,118.15,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
0.45% w/v Sodium Chloride Injection 500 ml,SODIUM CHLORIDE,1706200098,2020,0.45 %,Solution for infusion,Intravenous use,6.198,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
GLYCERYL TRINITRATE 50MG-10ML I-V AMP,GLYCERYL TRINITRATE,17-5287-20,2020,5 mg/ml,Solution for injection,Intravenous use,131.1,Seigfried Hameln GmbH,Germany,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
SUPLASYN 20MG/2ML INJECTION,SODIUM HYALURONATE,1-768-20,2020,10 mg/ml,Injection,Intraarticular use,144.65,Mylan Institutional,Ireland,Mylan Institutional,Ireland,Marketed,Prescription,store below 25°c,Hospital,Viatris Arabia Limited
VINBLASTINE SULPHATE 10MG-10ML VIAL,VINBLASTINE,0704257189,2020,1 mg/ml,Solution for injection,Intravenous use,504.55,HOSPIRA AUSTRALIA,Australia,HOSPIRA UK LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
NEURITAM,LEVETIRACETAM,1907200110,2020,100 mg/ml,Oral solution,Oral use,167.20,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
NEURITAM,LEVETIRACETAM,1907200111,2020,100 mg/ml,Oral solution,Oral use,83.6,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
MILORA HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0205200069,2020,"160,25,5 mg",Film-coated tablet,Oral use,51.5,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
Zolinda Oral Solution,ARIPIPRAZOLE,2206200099,2020,1 mg/ml,Oral solution,Oral use,197.299,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
LORBRENA,LORLATINIB,2207200112,2020,100 mg,Film-coated tablet,Oral use,22662.298,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Carglumic Acid Waymade,CARGLUMIC ACID,2207200113,2020,200 mg,Dispersible tablet,Oral use,943.049,Apothecon Pharmaceuticals PVT Limited,India,Waymade Plc UK,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Carglumic Acid Waymade,CARGLUMIC ACID,2207200114,2020,200 mg,Dispersible tablet,Oral use,11316.449,Apothecon Pharmaceuticals PVT Limited,India,Waymade Plc UK,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
LORBRENA,LORLATINIB,2207200116,2020,25 mg,Film-coated tablet,Oral use,7554.097,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Levetiracetam BOS,LEVETIRACETAM,2207200117,2020,100 mg/ml,Solution for infusion,Intravenous use,625.05,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Metolina,METOPROLOL TARTRATE,2207200118,2020,100 mg,Film-coated tablet,Oral use,23.199,Aurobindo Pharma Limited,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Aurobindo Pharma Saudi Arabia Limited
DEXILANT 60 mg,DEXLANSOPRAZOLE,23-5083-20,2019,60 mg,Prolonged-release capsule,Oral use,98.95,TAKEDA GMBH,Germany,ACINO PHARMA AG,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CELEZON,RUXOLITINIB,2307200122,2020,25 mg,Tablet,Oral use,14033.699,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CELEZON,RUXOLITINIB,2307200123,2020,20 mg,Tablet,Oral use,11226.949,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CELEZON,RUXOLITINIB,2307200124,2020,5 mg,Tablet,Oral use,5490.75,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CELEZON,RUXOLITINIB,2307200125,2020,15 mg,Tablet,Oral use,11226.949,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Engerix-B10,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,2307200126,2020,10 µg,Suspension for injection,Intramuscular use,42.45,GlaxoSmithKline Biologicals,Belgium,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Takhzyro,LANADELUMAB,2406200100,2020,300 mg,Solution for injection,Subcutaneous use,52774.45,Catalent Indiana LLC formerly Cook Pharmica LLC,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
COPSFIN 70MG VIAL,CASPOFUNGIN,2506200101,2020,70 mg,Powder for solution for injection/infusion,Parenteral use,663.849,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
TAXOTERE 20 MG/ML SOLUTION FOR INFUSION,DOCETAXEL,2-5079-20,2020,20 mg/ml,Concentrate for solution for infusion,Intravenous use,1846.8,Sanofi aventis Deutschland GmbH,Germany,Aventis Pharma S.A.,France,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
ADOL EXTRA CAPLETS,"PARACETAMOL, CAFFEINE CITRATE",0809258182,2020,"500,60 mg",Caplet,Oral use,6.40,ALPHA PHARMA INDUSTRY,Saudi Arabia,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
NEUPOGEN 30 MU,FILGRASTIM,1107245544,2019,0.6 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,176.40,AMGEN MANUFACTURING LIMITED,United States,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
HYQVIA 100MG/ML SOLUTION FOR INFUSION,HUMAN NORMAL IMMUNOGLOBULIN,2-5356-19,2019,10 %,Solution for infusion,Subcutaneous use,2241.40,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,ALNAGHI COMPANY
DILATREND 6.25 MG TABLET,CARVEDILOL,0803221825,2020,6.25 mg,Tablet,Oral use,27.80,Delpharm Milano S.r.l,Italy,CHEPLAPHARM Arzneimittel GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
KLACID 125MG-5ML SUSP,CLARITHROMYCIN,2004221964,2020,25 mg/ml,Granules for suspension,Oral use,27.95,ABBVIE SRL,Italy,Abbott Laboratories Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CYCLOGEST 400MG PESSARIES,PROGESTERONE,1112246393,2020,400 mg,Pessary,Vaginal use,87.65,Accord -UK Limited,United Kingdom,L.D Collins & CO Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
PecFent 400 MCG NASAL SPRAY,FENTANYL,2-5499-20,2020,400 µg,"Nasal spray, solution",Nasal use,772.4,L. Molteni & C dei F. LLi Alitti Societa di Esercizio,Italy,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NEXIUM 20MG TAB,ESOMEPRAZOLE,2303233415,2020,20 mg,Gastro-resistant tablet,Oral use,68.70,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SIAX,CLOSTRIDIUM BOTULINUM NEUROTOXIN A COMPLEX,0712258745,2020,100 U,Powder for injection,Intramuscular use,391.45,Medytox Inc.,KOREA,Medytox Inc.,KOREA,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Al Amin Medical Instruments Co. Ltd.
Hyalo4 Plus,"SULFADIAZINE SILVER, SODIUM HYALURONATE",2607200127,2020,"1,0.2 %",Cream,Topical,45.00,Fidia Farmaceutici SpA,Italy,Fidia Farmaceutici SPA,Italy,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
PARSABIV,ETELCALCETIDE,0705257349,2019,10 mg,Solution for injection,Intravenous use,1288.9,Patheon Manufacturing Services LLC,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
BOSENTOR 125 mg Film-Coated Tablet,BOSENTAN,3001233190,2020,125 mg,Tablet,Oral use,6115.65,Genvion Corporation,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
PARSABIV,ETELCALCETIDE,0705257347,2019,2.5 mg,Solution for injection,Intravenous use,322.2,Patheon Manufacturing Services LLC,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
SUPLASYN 1-SHOT INJECTION,SODIUM HYALURONATE,2-768-20,2020,10 mg/ml,Injection,Intraarticular use,478.05,Mylan Institutional,Ireland,Mylan Institutional,Ireland,Marketed,Prescription,store below 25°c,Hospital,Viatris Arabia Limited
PARSABIV,ETELCALCETIDE,0705257348,2019,5 mg,Solution for injection,Intravenous use,644.45,Patheon Manufacturing Services LLC,United States,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
INTRAROSA,PRASTERONE,3105200086,2020,6.5 mg,Pessary,Vaginal use,76.795,FEREVA RICHMOND,United States,MUNDIPHARMA MEDICAL COMPANY,Switzerland,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,ALNAGHI COMPANY
MODZAL 5MG/5ML INJECTION,MIDAZOLAM,1707257771,2019,1 mg/ml,Solution for injection,Parenteral use,26.2,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
SISACURE 2MG/ML AMPOULE,CISATRACURIUM,2407257851,2020,2 mg/ml,Solution for injection/infusion,Intravenous use,155.70,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
ZYTEDIN 100MG POWDER FOR INJECTION,AZACITIDINE,2805257488,2020,100 mg,Powder for suspension for injection,Subcutaneous use,1041.65,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VULGA 65 mg XR film-coated tablet,MINOCYCLINE,0408257921,2020,65 mg,Prolonged-release tablet,Oral use,80.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
TAXOTERE 20 MG/ML SOLUTION FOR INFUSION,DOCETAXEL,3-5079-20,2020,20 mg/ml,Concentrate for solution for infusion,Intravenous use,3693.6,Sanofi aventis Deutschland GmbH,Germany,Aventis Pharma S.A.,France,Marketed,Prescription,store below 25°c,Hospital,Sanofi Arabia Trading Co. Ltd
UNAIRA 3GM SACHET,FOSFOMYCIN,0408257920,2020,3 g,Granules for oral solution,Oral use,29.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
NEUPOGEN 30 MU,FILGRASTIM,1107245543,2019,0.3 mg/ml,Solution for injection,Intravenous use,843.70,AMGEN MANUFACTURING LIMITED,United States,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
HYQVIA 100MG/ML SOLUTION FOR INFUSION,HUMAN NORMAL IMMUNOGLOBULIN,3-5356-19,2019,10 %,Solution for infusion,Subcutaneous use,4482.80,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,ALNAGHI COMPANY
TOBI PODHALER 28MG,TOBRAMYCIN,3-5480-20,2020,28 mg,"Inhalation powder, hard capsule",Inhalation use,11890.7,NOVARTIS,United States,Mylan Pharma GmbH,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Viatris Arabia Limited"
PecFent 100 MCG NASAL SPRAY,FENTANYL,3-5499-20,2020,100 µg,"Nasal spray, solution",Nasal use,201.85,L. Molteni & C dei F. LLi Alitti Societa di Esercizio,Italy,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NEXIUM 40MG TAB,ESOMEPRAZOLE,2303233413,2020,40 mg,Gastro-resistant tablet,Oral use,48.05,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
SIAX,CLOSTRIDIUM BOTULINUM NEUROTOXIN A COMPLEX,0712258744,2020,200 U,Powder for injection,Intramuscular use,631.15,Medytox Inc.,KOREA,Medytox Inc.,KOREA,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Al Amin Medical Instruments Co. Ltd.
BUSULCAN 6 mg/ml Vial,BUSULFAN,2412246484,2020,6 mg/ml,Solution,Intravenous use,7359.00,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ADANCOR 20 mg tablet,NICORANDIL,3003221898,2016,20 mg,Tablet,Oral use,57.8,MERCK HEALTHCARE KGAA,Germany,Merck (Schweiz) AG,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALHAYA MEDICAL CO, Salehiya Trading Co."
VOSTRAN 2MG/ML SOLUTION FOR INJECTION,ONDANSETRON,0311258530,2020,2 mg/ml,Solution for injection,Intramuscular and intravenous use,112.25,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Debilur,LURASIDONE,423-277-20,2020,80 mg,Film-coated tablet,Oral use,206.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Debilur,LURASIDONE,424-277-20,2020,40 mg,Film-coated tablet,Oral use,206.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Debilur,LURASIDONE,425-277-20,2020,20 mg,Film-coated tablet,Oral use,206.6,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
CLERON 250MG F.C.TABLET,CLARITHROMYCIN,2407257846,2017,250 mg,Film-coated tablet,Oral use,22,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
RESEDRA 1MG/ML ORAL SOLUTION,RISPERIDONE,1906257586,2020,1 mg/ml,Oral solution,Oral use,170.75,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
FLOXAG 320MG F.C. TABLET,GEMIFLOXACIN MESILATE,2809258275,2020,320 mg,Film-coated tablet,Oral use,55.90,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
FLOXAG 320MG F.C. TABLET,GEMIFLOXACIN MESILATE,2809258276,2020,320 mg,Film-coated tablet,Oral use,74.50,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
SKINFILL GOLD PLUS INJECTION,HYALURONIC ACID,4-5165-18,2018,20 mg/ml,Injection,Intradermal use,558.15,Promoitalia Group Spa,Italy,Promoitalia Group Spa,Italy,Marketed,Prescription,,Hospital,Al-Arfaj Commercial and import Co.
HYQVIA 100MG/ML SOLUTION FOR INFUSION,HUMAN NORMAL IMMUNOGLOBULIN,4-5356-19,2019,10 %,Solution for infusion,Subcutaneous use,8965.60,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,ALNAGHI COMPANY
CLERON 500MG F.C.TABLET,CLARITHROMYCIN,2407257847,2017,500 mg,Film-coated tablet,Oral use,32.5,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
PecFent 100 MCG NASAL SPRAY,FENTANYL,4-5499-20,2020,100 µg,"Nasal spray, solution",Nasal use,772.4,L. Molteni & C dei F. LLi Alitti Societa di Esercizio,Italy,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
NEXIUM 40MG TAB,ESOMEPRAZOLE,2303233414,2020,40 mg,Gastro-resistant tablet,Oral use,77.25,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
KLENDAM,CLINDAMYCIN HYDROCHLORIDE,2207257787,2020,300 mg,Capsule,Oral use,27.9,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
DIPRIVAN VIAL 10MG-ML,PROPOFOL,49-887-19,2019,10 mg/ml,Emulsion for injection/infusion,Intravenous use,110.05,Corden Pharma S.P.A,Italy,ASPEN PHARMA TRADING LIMITED (APTL),Ireland,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
Kurenail,AMOROLFINE,49-972-20,2020,5 %,Solution,Topical,66.4,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
DEFRA 120MG DELAYED RELEASE CAPSULES,Dimethyl Fumarate,0308257913,2020,120 mg,Delayed-release capsule,Oral use,404.45,Macleods Pharmaceuticals Ltd.,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
FONTAX 20 mg film-coated tablet,TADALAFIL,1012258764,2020,20 mg,Film-coated tablet,Oral use,64.85,MEDOCHEMIE LTD,Cyprus,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
DEFRA 240MG DELAYED RELEASE CAPSULES,Dimethyl Fumarate,0308257912,2020,240 mg,Delayed-release capsule,Oral use,3235.9,Macleods Pharmaceuticals Ltd.,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
MOPIZALE 500MG/100ML SOLUTION FOR INFUSION,METRONIDAZOLE,52-5286-20,2020,5 mg/ml,Solution for infusion,Intravenous use,68,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
EXITINE,FLUMAZENIL,2703257174,2020,0.1 mg/ml,Solution for infusion,Intravenous use,219.9,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
GARDIA 16MG TABLETS,CANDESARTAN CILEXETIL,0110246002,2020,16 mg,Tablet,Oral use,34.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
SKINFILL SILVER PLUS INJECTION,HYALURONIC ACID,5-5165-18,2018,15 mg/ml,Injection,Intradermal use,418.6,Promoitalia Group Spa,Italy,Promoitalia Group Spa,Italy,Marketed,Prescription,,Hospital,Al-Arfaj Commercial and import Co.
HYQVIA 100MG/ML SOLUTION FOR INFUSION,HUMAN NORMAL IMMUNOGLOBULIN,5-5356-19,2019,10 %,Solution for infusion,Subcutaneous use,13448.40,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,ALNAGHI COMPANY
NEXIUM 40MG VIAL POWDER FOR IV. INFUSION,ESOMEPRAZOLE,2106222242,2020,40 mg,Powder for solution for injection/infusion,Intravenous use,204.05,ASTRAZENECA PHARMACEUTICAL LTD,China,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
IRIS 0.5 MG/ML SYRUP,DESLORATADINE,55-5286-20,2020,0.5 mg/ml,Syrup,Oral use,9.55,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
GARDIA PLUS 16/12.5MG TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",0709258167,2020,"16,12.5 mg",Tablet,Oral use,34.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
MESTINON 60MG TABLET,PYRIDOSTIGMINE,2005257424,2020,60 mg,Tablet,Oral use,22.25,ICN Polfa Rzeszow S.A.,Poland,MEDA Pharmaceuticals Switzerland GmbH,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
GARDIA PLUS 8/12.5MG TABLETS,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE",0709258170,2020,"16,12.5 mg",Tablet,Oral use,23.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
KALMO 8MG F.C.TABLET,LORNOXICAM,1203257039,2020,8 mg,Film-coated tablet,Oral use,15.75,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
TRIVACIN 9.5MG/24H TRANSDERMAL PATCHES,RIVASTIGMINE,2001268965,2020,18 mg,Transdermal patch,Transdermal use,166.95,Luye Pharma AG,Germany,Acino AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CUVITRU 200MG/ML INJECTION,HUMAN NORMAL IMMUNOGLOBULIN,6-5356-19,2019,200 mg/ml,Solution for injection,Subcutaneous use,448.30,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
AVOBAN 2% W-W OINTMENT,MUPIROCIN CALCIUM,2003257122,2020,2 %,Ointment,Topical,38.8,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
GADOVIST 1MMOL-ML PRE-FILLED SYRINGE,GADOBUTROL,69-4-20,2020,1 mmol/ml,Solution for injection,Intravenous use,386.1,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
COPSFIN 50MG VIAL,CASPOFUNGIN,0402256803,2020,50 mg,Powder for solution for injection/infusion,Parenteral use,518.15,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
TRIVACIN 4.6MG/24H TRANSDERMAL PATCHES,RIVASTIGMINE,2001268966,2020,9 mg,Transdermal patch,Transdermal use,166.95,Luye Pharma AG,Germany,Acino AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CUVITRU 200MG/ML INJECTION,HUMAN NORMAL IMMUNOGLOBULIN,7-5356-19,2019,200 mg/ml,Solution for injection,Subcutaneous use,896.55,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
CUVITRU 200MG/ML INJECTION,HUMAN NORMAL IMMUNOGLOBULIN,8-5356-19,2019,200 mg/ml,Solution for injection,Subcutaneous use,1793.10,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
NEUPRO 4 MG/24 HRS TRANSDERMAL PATCHES,ROTIGOTINE,0903257011,2020,4 mg,Transdermal patch,Transdermal use,219.00,LTS LOHMANN Therapie-Systeme,Germany,UCB Pharma S.A.,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
CUVITRU 200MG/ML INJECTION,HUMAN NORMAL IMMUNOGLOBULIN,9-5356-19,2019,200 mg/ml,Solution for injection,Subcutaneous use,3586.25,Baxalta Belgium Manufacturing SA,Belgium,Baxalta Innovations GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
TRAPRON,TRANEXAMIC ACID,0909245882,2019,100 mg/ml,Solution for injection,Intravenous use,52.80,PT. Novell Pharmaceutical Laboratories,Indonesia,PT. Novell Pharmaceutical Laboratories,Indonesia,Marketed,Prescription,store below 30°c,Hospital,Girgas pharmaceutical Co
DIAOPTIM MR,GLICLAZIDE,2308200132,2020,60 mg,modified-release tablet,Oral use,24.00,LES LABORATOIRES SERVIER INDUSTRIE,France,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Benlysta,BELIMUMAB,1808200129,2020,200 mg,Solution for injection,Subcutaneous use,3531.99,Glaxo Operations UK Ltd,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Dovato,"LAMIVUDINE, DOLUTEGRAVIR SODIUM",1005200077,2020,"300,52.6 mg",Film-coated tablet,Oral use,2885.15,GLAXOSMITHKLINE (GSK),United States,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
piqray,ALPELISIB,2207200115,2020,200 mg,Film-coated tablet,Oral use,17606.34,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Hospital,Novartis Saudi Limited
piqray,ALPELISIB,2207200120,2020,150 mg,Film-coated tablet,Oral use,17606.34,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Hospital,Novartis Saudi Limited
piqray 200 mg + 50 mg,ALPELISIB,2207200119,2020,250 mg,Film-coated tablet,Oral use,17606.34,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Hospital,Novartis Saudi Limited
OZERO,Etoricoxib,1705200085,2020,60 mg,Film-coated tablet,Oral use,40.999,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
OZERO,Etoricoxib,0405200072,2020,120 mg,Film-coated tablet,Oral use,10.999,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
OZERO,Etoricoxib,0405200073,2020,90 mg,Film-coated tablet,Oral use,40.999,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
ACRETIN C 1.2% + 0.025 % GEL,"CLINDAMYCIN PHOSPHATE, TRETINOIN",226-368-20,2020,"1.2,0.025 %",Gel,Topical,33.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
RIBOLISIN EYE DROPS,SODIUM HYALURONATE,5-427-22,2018,0.15 %,"Eye drops, solution",Ophthalmic use,33.9,Sooft Italia SBA,Italy,Fidia Farmaceutici S.p.A.,Italy,Marketed,Prescription,store below 25°c,Pharmacy,Dallah Health Care Company
NORMAL SALINE (0.9% W/V SODIUM CHLORIDE) INJECTION,SODIUM CHLORIDE,10-5023-19,2019,0.9 %,Solution for injection,Intravenous use,170.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Renee Lift,HYALURONIC ACID,0809200147,2020,26 mg/ml,Solution for injection/infusion in pre-filled syringe,Intradermal use,184.13,MATEX LAB SA,Germany,Qventis GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,mawj al samaa medical company
Bexsero,"RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA I, RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN, RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN I, RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN, RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN I, OUTER MEMBRANE VESICLES FROM N MENINGITIDIS SEROGROUP B STRAIN NZ98254",1908200131,2020,"50,50,50,50,50,50,50 µg",Suspension for injection in pre-filled syringe,Intramuscular use,347.9,GSK Vaccines Srl,Italy,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
VIRONTA,ROSUVASTATIN,2508200133,2020,5 mg,Film-coated tablet,Oral use,15.10,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Pevas,PRASUGREL,3008200140,2020,5 mg,Film-coated tablet,Oral use,157.5,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
Pevas,PRASUGREL,3008200141,2020,10 mg,Film-coated tablet,Oral use,157.5,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
Birato,ABIRATERONE ACETATE,0109200145,2020,250 mg,Tablet,Oral use,3696.00,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
OLICAN,FINGOLIMOD HYDROCHLORIDE,0909200148,2020,0.5 mg,Capsule,Oral use,3583.65,PHARMASCIENCE INC.,Canada,PHARMASCIENCE INC.,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Dotagraf 0.5 mmol/ml Solution for Injection,GADOTERIC ACID,1609200152,2020,0.5 mmol/ml,Solution for injection,Intravenous use,59.80,Headquarter Sanochemia Pharmazeutika AG,Austria,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
D-SEUL 50000 IU SOFT GELATIN CAPSULE,CHOLECALCIFEROL,0709258165,2020,50000 IU,"Capsule, soft",Oral use,38.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Cigalah Group
D-SEUL 50000 IU SOFT GELATIN CAPSULE,CHOLECALCIFEROL,0709258166,2020,50000 IU,"Capsule, soft",Oral use,64.10,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Cigalah Group
Trevicta 175 mg prolonged release suspension for injection,PALIPERIDONE,15-626-17,2017,175 mg,Prolonged-release suspension for injection,Intramuscular use,2077.30,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Trevicta 263 mg prolonged release suspension for injection,PALIPERIDONE,16-626-17,2017,263 mg,Prolonged-release suspension for injection,Intramuscular use,2561.30,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Trevicta 350 mg prolonged release suspension for injection,PALIPERIDONE,17-626-17,2017,350 mg,Prolonged-release suspension for injection,Intramuscular use,2894.90,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Trevicta 525 mg prolonged release suspension for injection,PALIPERIDONE,18-626-17,2017,525 mg,Prolonged-release suspension for injection,Intramuscular use,3559.80,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
BIOCAFFCIT,CAFFEINE CITRATE,1908258051,2020,10 mg/ml,Solution for injection,Intravenous use,398.95,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
BIOCAFFCIT,CAFFEINE CITRATE,1908258049,2020,10 mg/ml,Solution for injection,Intravenous use,797.90,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
BIOCAFFCIT,CAFFEINE CITRATE,3108258128,2020,20 mg,Solution for injection,Intravenous use,2393.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
BIOCAFFCIT,CAFFEINE CITRATE,1908258050,2020,20 mg/ml,Oral solution,Oral use,2393.65,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharmaceutical Solution Industries (PSI)
VOSTRAN 2MG/ML SOLUTION FOR INJECTION,ONDANSETRON,0311258531,2020,2 mg/ml,Solution for injection,Intramuscular and intravenous use,56.10,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
AMLOVAN-HCT 10/320/25MG F.C.TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2307257833,2020,"320,25,10 mg",Film-coated tablet,Oral use,89.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
GONISTA 125MG F.C TABLETS,BOSENTAN,0709258169,2020,125 mg,Film-coated tablet,Oral use,5504.10,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GONISTA 62.5MG F.C TABLETS,BOSENTAN,0709258168,2020,62.5 mg,Film-coated tablet,Oral use,5504.10,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
QATPEN 300MG F.C.TABLET,QUETIAPINE,1108257997,2019,300 mg,Film-coated tablet,Oral use,102.55,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
DEVARIN 10MG ORODISPERSIBLE TABLET,VARDENAFIL,0112258699,2020,10 mg,Orodispersible tablet,Ocular use,53.95,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DOCADEX 80MG/4ML,DOCETAXEL,1505257394,2020,20 mg/ml,Concentrate for solution for infusion,Intravenous use,505.10,S.C.SINDAN PHARMA S.R.L,Romania,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
BATIPAN 50MG INJECTION,OXALIPLATIN,1008257971,2020,5 mg,Powder for solution for infusion,Intravenous use,118.60,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
AUGE CARE EYE DROPS,"HYDRAFLEX, DEXPANTHENOL",2-5348-19,2019,"0.5,2 %",Eye drops,Ophthalmic use,33.90,Ote Pharma Sol B.V,Netherlands,Ote Pharma Sol B.V,Netherlands,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Pharmacy,Bonn Health Care Co
BANORIV 2.5MG F.C.TABLET,RIVAROXABAN,1908258059,2020,2.5 mg,Film-coated tablet,Oral use,190.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
HYE MONO EYE DROPS,HYALURONIC ACID,1-5455-20,2020,0.4 %,"Eye drops, solution",Ocular use,25.60,Farmigea S.p.A,Italy,Farmigea S.p.A,Italy,Marketed,OTC,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
HYE MULTI EYE DROPS,HYALURONIC ACID,2-5455-20,2020,0.4 %,"Eye drops, solution",Ocular use,14.10,Farmigea S.p.A,Italy,Farmigea S.p.A,Italy,Marketed,OTC,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
XILOIAL MONO EYE DROPS,"HYALURONIC ACID, TS-POLYSACCHARIDE",3-5455-20,2020,"2,2 g/ml","Eye drops, solution",Ocular use,29.85,Farmigea S.p.A,Italy,Farmigea S.p.A,Italy,Marketed,OTC,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
XILOIAL EYE DROPS,"HYALURONIC ACID, TS-POLYSACCHARIDE",4-5455-20,2020,"2,2 g/ml","Eye drops, solution",Ocular use,29.85,Farmigea S.p.A,Italy,Farmigea S.p.A,Italy,Marketed,OTC,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
DUSPAMEN 200 mg prolonged release capsule,MEBEVERINE HYDROCHLORIDE,2608258112,2020,200 mg,modified-release tablet,Oral use,40.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
GLADIO,ACECLOFENAC,1505257405,2020,100 mg,Film-coated tablet,Oral use,17.30,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
BASALOG ONE,INSULIN GLARGINE,1-5291-20,2020,100 IU/ml,Solution for injection,Subcutaneous use,38.35,Biocon SDN. BHD,Malaysia,Biocon Limited,India,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,EBRAHIM M. ALMANA & BROS. CO.
BASALOG ONE,INSULIN GLARGINE,3-5291-20,2020,100 IU/ml,Solution for injection,Subcutaneous use,191.75,Biocon SDN. BHD,Malaysia,Biocon Limited,India,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,EBRAHIM M. ALMANA & BROS. CO.
BASALOG ONE,INSULIN GLARGINE,2-5291-20,2020,100 IU/ml,Solution for injection,Subcutaneous use,115.05,Biocon SDN. BHD,Malaysia,Biocon Limited,India,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,EBRAHIM M. ALMANA & BROS. CO.
ORNIBEL 0.120 mg / 0.015 mg per 24 Hours,"ETONOGESTREL, ETHINYLESTRADIOL",2-5089-20,2020,"11,3.474 mg",Implant,Vaginal use,31.55,"LABORATORIOS LEON FARMA, S.A.",Spain,EXELTIS GERMANY GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ARIGAL 250MG/2.5ML,ARGATROBAN,2407257849,2019,100 mg/ml,Solution for injection,Intravenous use,2686,"Exela Pharma Sciences, LLC",United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ARIGAL 50MG/50ML,ARGATROBAN,2407257848,2019,1 mg/ml,Solution for injection,Intravenous use,537.20,"Exela Pharma Sciences, LLC",United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
TRIPLEX B FILM COATED TABLET,"PYRIDOXINE, THIAMINE, CYANOCOBALAMIN",2307245634,2020,"200,100,200 mg, µg",Film-coated tablet,Oral use,19.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
KINZADO,LINEZOLID,2307257834,2020,600 mg,Film-coated tablet,Oral use,1447.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
MIXIF,CEFIXIME,2407257853,2020,20 mg/ml,Powder for oral suspension,Oral use,25.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
HY-LIGHT,HYALURONIC ACID,5-5455-20,2020,0.2 %,Eye drops,Ocular use,14.10,Farmigea S.p.A,Italy,Farmigea S.p.A,Italy,Marketed,OTC,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
COSYREL 5MG/5MG F.C.TABLET,"PERINDOPRIL ARGININE, BISOPROLOL FUMARATE",5-5193-19,2019,"5,5 mg",Film-coated tablet,Oral use,41.15,LES LABORATOIRES SERVIER INDUSTRIE,France,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
COSYREL 5MG/10MG F.C.TABLET,"PERINDOPRIL ARGININE, BISOPROLOL FUMARATE",6-5193-19,2019,"10,5 mg",Film-coated tablet,Oral use,54.40,LES LABORATOIRES SERVIER INDUSTRIE,France,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
OMISEC,OMEPRAZOLE,43-5286-20,2020,40 mg,Powder for solution for infusion,Intravenous use,22.50,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
APIEXEL,ARIPIPRAZOLE,1-5519-20,2020,5 mg,Tablet,Oral use,98,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,International Teriaqi for medicines ESt
APIEXEL,ARIPIPRAZOLE,0112258702,2020,10 mg,Tablet,Oral use,178.90,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,International Teriaqi for medicines ESt
APIEXEL,ARIPIPRAZOLE,0112258685,2020,15 mg,Tablet,Oral use,222,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,International Teriaqi for medicines ESt
ADYNOVATE,"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT",6-5888-25,2020,1000 IU,Powder and solvent for solution for injection,Intravenous use,3009.55,Baxalta manufacturing Sarl,Switzerland,"TAKEDA PHARMACEUTICALS USA, INC.",United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
ADYNOVATE,"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT",5-5888-25,2020,500 IU,Powder and solvent for solution for injection,Intravenous use,1504.75,Baxalta manufacturing Sarl,Switzerland,"TAKEDA PHARMACEUTICALS USA, INC.",United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
ADYNOVATE,"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT",4-5888-25,2020,250 IU,Powder and solvent for solution for injection,Intravenous use,752.35,Baxalta manufacturing Sarl,Switzerland,"TAKEDA PHARMACEUTICALS USA, INC.",United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
DYMISTA,"AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE",2-5927-24,2020,"1000,365 µg","Nasal spray, suspension",Inhalation use,77.20,Cipla Limited,India,Viatris Healthcare GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
ILARIS,CANAKINUMAB,1-5309-24,2019,150 mg/ml,Solution for injection,Subcutaneous use,43890.42,NOVARTIS Pharma Stein AG,Switzerland,Novartis Europharm Limited,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Novartis Saudi Limited
SMOFLIPID,"SOYA OIL, TRIGLYCERIDES MEDIUM CHAIN, OLIVE OIL, FISH OIL",1011258562,2020,"60,60,50,30 mg/ml",Emulsion for infusion,Intravenous use,667.80,FRESENIUS KABI,Austria,FRESENIUS KABI AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SMOFLIPID,"SOYA OIL, TRIGLYCERIDES MEDIUM CHAIN, OLIVE OIL, FISH OIL",1011258561,2020,"60,60,50,30 mg/ml",Emulsion for infusion,Intravenous use,494.85,FRESENIUS KABI,Austria,FRESENIUS KABI,Sweden,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
LISONORM 20 -10,"LISINOPRIL, AMLODIPINE BESILATE",2110258446,2019,"20,10 mg",Tablet,Oral use,54.40,GEDEON RICHTER PLC.,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
LISONORM 10 - 5,"LISINOPRIL, AMLODIPINE BESILATE",2110258445,2019,"10,5 mg",Tablet,Oral use,38.75,GEDEON RICHTER PLC.,Hungary,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VOLOPEM,BOSUTINIB,1908258054,2020,500 mg,Film-coated tablet,Oral use,9030.40,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VOLOPEM,BOSUTINIB,1908258053,2020,100 mg,Film-coated tablet,Oral use,2635.55,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CITAROX 1000MG VIAL,GEMCITABINE,10-5251-20,2020,1000 mg,Powder for solution for infusion,Intravenous use,147.85,S.C Sindan pharma SRL,Romania,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
FANVIL,VARDENAFIL,2109258245,2020,10 mg,Orodispersible tablet,Oral use,41.95,CHANELLE MEDICAL,Ireland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
REOVAIR,MONTELUKAST SODIUM,2109258242,2020,5 mg,Chewable tablet,Oral use,60.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
CERDELGA,ELIGLUSTAT,15-832-18,2018,84 mg,"Capsule, hard",Oral use,95189.65,GENZYME IRELAND LIMITED,Ireland,GENZYME EUROPE B.V.,Netherlands,Marketed,Prescription,store below 30°c,Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
TOPFEROL,CHOLECALCIFEROL,2001268967,2019,50000 IU,Film-coated tablet,Oral use,17.85,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ESPADA 10MG F.C TABLETS,MEMANTINE HYDROCHLORIDE,62-5286-20,2020,10 mg,Film-coated tablet,Oral use,83.15,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ESPADA 20MG F.C TABLETS,MEMANTINE HYDROCHLORIDE,63-5286-20,2020,20 mg,Film-coated tablet,Oral use,151.60,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PROLUTEX,PROGESTERONE,1-5976-24,2019,25 mg,Solution for injection,"intramuscular, subcutaneous",213,IBSA Institut Biochimique SA,Switzerland,IBSA Istitut Biochimique SA,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
Vislube EYD DROPS,SODIUM HYALURONATE,2-5336-19,2019,0.18 %,"Ear/eye drops, solution",Ophthalmic use,28.40,Holopack Verpackungstechnik GmbH,Germany,TRB CHEMEDICA INTERNATIONAL SA,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Cigalah Group"
Olimestra,OLMESARTAN MEDOXOMIL,0410200178,2020,20 mg,Film-coated tablet,Oral use,36.926,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Olimestra,OLMESARTAN MEDOXOMIL,0410200177,2020,40 mg,Film-coated tablet,Oral use,51.965,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Eralyce,PERMETHRIN,1509200150,2020,1 %,Cream,Topical,42.9,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Eralyce,PERMETHRIN,1509200149,2020,5 %,Cream,Topical,42.9,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Betavert,BETAHISTINE DIHYDROCHLORIDE,1709200157,2020,8 mg,Tablet,Oral use,13.599,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Betavert,BETAHISTINE DIHYDROCHLORIDE,1709200154,2020,16 mg,Tablet,Oral use,23,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Betavert,BETAHISTINE DIHYDROCHLORIDE,1709200156,2020,24 mg,Tablet,Oral use,24.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Dusta,DUTASTERIDE,2009200160,2020,0.5 mg,"Capsule, soft",Oral use,90.90,"LABORATORIOS LEON FARMA, S.A.",Spain,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
BITENS,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3009200170,2020,"20,5 mg",Film-coated tablet,Oral use,49.75,GENEPHARM S.A.,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
BITENS,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3009200171,2020,"40,5 mg",Film-coated tablet,Oral use,61.8,GENEPHARM S.A.,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
BITENS,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3009200168,2020,"40,10 mg",Film-coated tablet,Oral use,64.549,GENEPHARM S.A.,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Etoxib,Etoricoxib,2209200162,2020,120 mg,Film-coated tablet,Oral use,11,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Etoxib,Etoricoxib,2209200161,2020,90 mg,Film-coated tablet,Oral use,41,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Etoxib,Etoricoxib,2209200163,2020,60 mg,Film-coated tablet,Oral use,41,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Isolone,PREDNISOLONE,3009200174,2020,5 mg,Effervescent tablet,Oral use,11.695,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group"
Isolone,PREDNISOLONE,3009200173,2020,20 mg,Effervescent tablet,Oral use,26.447,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group"
Lenova,LEVOFLOXACIN,2909200167,2020,500 mg,Tablet,Oral use,24.787,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Thimar Aljazirah Company
Cablivi,CAPLACIZUMAB,0510200185,2020,10 mg,Powder and solvent for solution for injection,"Intravenous, Subcutaneous",16906.902,Patheon Italia S.P.A.,Italy,Ablynx NV,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Sanofi Arabia Trading Co. Ltd"
Ferasiro 90,DEFERASIROX,2210200239,2020,90 mg,Film-coated tablet,Oral use,525.45,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Ferasiro 180,DEFERASIROX,2210200238,2020,180 mg,Film-coated tablet,Oral use,1044.00,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Ferasiro 360,DEFERASIROX,2110200237,2020,360 mg,Film-coated tablet,Oral use,2074.20,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Kymriah,TISAGENLECLEUCEL,2110200234,2020,6 cells,Dispersion for infusion,Intravenous use,1633500,NOVARTIS,United States,Novartis Europharm Limited,Ireland,Marketed,Prescription,Store at temperatures below -140°C in the vapour phase of liquid nitrogen,Hospital,Novartis Saudi Limited
DERMALAX PLUS INJECTION,HYALURONIC ACID,1-5349-19,2019,20 mg/ml,Injection,Intradermal use,224.55,"Across Co., Ltd",KOREA,"Across Co., Ltd",KOREA,Marketed,Prescription,Store between (2°C – 25°C),Hospital,Panorama Gulf Company
SENERGY PLUS (10/160/25)MG F.C TABLETS,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",67-5286-20,2020,"160,25,10 mg",Film-coated tablet,Oral use,54.15,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SENERGY PLUS (10/160/12.5)MG F.C TABLETS,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",66-5286-20,2020,"160,12.5,10 mg",Film-coated tablet,Oral use,54.15,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SENERGY PLUS (5/160/25)MG F.C TABLETS,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",65-5286-20,2020,"160,25,5 mg",Film-coated tablet,Oral use,46.35,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SENERGY PLUS (5/160/12.5)MG F.C TABLETS,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",64-5286-20,2020,"160,12.5,5 mg",Film-coated tablet,Oral use,46.35,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SCOLTA 10MG F.C TABLETS,ROSUVASTATIN,1501268921,2020,10 mg,Film-coated tablet,Oral use,31.10,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SCOLTA 20MG F.C TABLETS,ROSUVASTATIN,1501268924,2020,20 mg,Film-coated tablet,Oral use,50.25,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SCOLTA 40MG F.C TABLETS,ROSUVASTATIN,1501268922,2020,40 mg,Film-coated tablet,Oral use,82.40,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CROTAL 1MG CAPSULE,TACROLIMUS,2307257825,2020,1 mg,Capsule,Oral use,423.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CROTAL 5MG CAPSULE,TACROLIMUS,2307257830,2020,5 mg,Capsule,Oral use,2115.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
JANUMET XR,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",1-5061-18,2020,"500,50 mg",Extended-release tablet,Oral use,168.65,MSD International GmbH Las Piedras,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JANUMET XR,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",2-5061-18,2020,"1000,50 mg",Extended-release tablet,Oral use,168.65,MSD International GmbH Las Piedras,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JANUMET XR,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",3-5061-18,2020,"1000,100 mg",Extended-release tablet,Oral use,168.65,MSD International GmbH Las Piedras,United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RIVAXEL 4.6MG/24HRS TRANSDERMAL PATCHES,RIVASTIGMINE,0412258738,2020,9 mg,Transdermal patch,Transdermal use,185.50,"SK Chemicals Co., Ltd",KOREA,SK CHEMICALS CO . LTD,KOREA,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RIVAXEL 9.5MG/24HRS TRANSDERMAL PATCHES,RIVASTIGMINE,0412258736,2020,18 mg,Transdermal patch,Transdermal use,185.50,"SK Chemicals Co., Ltd",KOREA,SK CHEMICALS CO . LTD,KOREA,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
RIVAXEL 13.3MG/24HRS TRANSDERMAL PATCHES,RIVASTIGMINE,0412258739,2020,27 mg,Transdermal patch,Transdermal use,185.50,"SK Chemicals Co., Ltd",KOREA,SK CHEMICALS CO . LTD,KOREA,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
GEBTIN,GEMCITABINE,73-5286-20,2020,200 mg,Powder for injection,Intravenous use,42.25,Jiangsu Hansoh Pharmaceutical Group Co,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
GEBTIN,GEMCITABINE,72-5286-20,2020,1 g,Powder for injection,Intravenous use,211.25,Jiangsu Hengrui Pharmaceuticals Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
GLATIJECT,GLATIRAMER,1310258416,2020,20 mg/ml,Solution for injection,Subcutaneous use,4110.40,Gland Pharma Limited,India,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
GLATIJECT,GLATIRAMER,1310258417,2020,40 mg/ml,Solution for injection,Subcutaneous use,4293.55,Gland Pharma Limited,India,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
DECOZAL 0.05% METERED DOSE NASAL SPRAY,XYLOMETAZOLINE HYDROCHLORIDE,41-290-20,2020,0.05 %,Nasal spray,Nasal use,5.50,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
Demexa,DEXMEDETOMIDINE,2810200249,2020,100 µ/ml,Solution for injection,Intravenous use,498.40,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
MALAUST,"ATOVAQUONE, PROGUANIL HYDROCHLORIDE",2510200241,2020,"250,100 mg",Film-coated tablet,Oral use,44.25,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Hyrimoz,ADALIMUMAB,0110200176,2020,40 mg,Solution for injection,Subcutaneous use,2098.638,SANDOZ,Austria,Sandoz GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Hyrimoz,ADALIMUMAB,0110200175,2020,40 mg,Solution for injection,Subcutaneous use,2098.638,Novartis Pharmaceutical Manufacturing GmbH,Austria,Sandoz GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Bortezomib BOS,BORTEZOMIB,0410200180,2020,3.5 mg,powder for solution for injection,"Intravenous, Subcutaneous",1523.95,Boston Oncology Arabia,Saudi Arabia,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Exopex,ESCITALOPRAM,0410200181,2020,10 mg,Film-coated tablet,Oral use,23.2,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Exopex,ESCITALOPRAM,0410200182,2020,20 mg,Film-coated tablet,Oral use,23.2,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Pemitax,PEMETREXED,0410200179,2020,500 mg,Powder for concentrate for solution for infusion,Intravenous use,1816.60,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Esperoct,TUROCTOCOG ALFA PEGOL,0610200190,2020,500 IU,Powder and solvent for solution for injection,Intravenous use,1504.749,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
Esperoct,TUROCTOCOG ALFA PEGOL,0610200188,2020,1000 IU,Powder and solvent for solution for injection,Intravenous use,3009.549,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
RAFLOX,LEVOFLOXACIN,9-5129-20,2020,250 mg,Film-coated tablet,Oral use,26.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
RAFLOX,LEVOFLOXACIN,0412258735,2020,500 mg,Film-coated tablet,Oral use,40.40,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
RAFLOX,LEVOFLOXACIN,0412258734,2020,750 mg,Film-coated tablet,Oral use,47.15,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ALBUNORM,PLASMA PROTEIN-L WITH HUMAN ALBUMIN,12-5098-20,2020,50 mg/ml,Solution for infusion,Intravenous use,187.05,OCTAPHARMA,Sweden,OCTAPHARMA AG,Switzerland,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
%ALBUNORM 20,PLASMA PROTEIN-L WITH HUMAN ALBUMIN,4-5098-20,2020,200 mg/ml,Solution for infusion,Intravenous use,213.85,OCTAPHARMA,Sweden,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
ALBUNORM 20%,PLASMA PROTEIN-L WITH HUMAN ALBUMIN,3-5098-20,2020,200 mg/ml,Solution for infusion,Intravenous use,146.40,OCTAPHARMA,Sweden,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
L-CET,LEVOCETIRIZINE DIHYDROCHLORIDE,51-498-20,2020,0.5 mg/ml,Oral solution,Oral use,11.55,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,OTC,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Lenalidomide SPC,LENALIDOMIDE,0810200199,2020,15 mg,"Capsule, hard",Oral use,14505.899,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Lenalidomide SPC,LENALIDOMIDE,0810200193,2020,20 mg,"Capsule, hard",Oral use,14505.899,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Cabazitaxel SPC 60mg/1.5ml,CABAZITAXEL,0810200206,2020,60 mg,Concentrate and solvent for solution for infusion,Intravenous use,12496.8,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Colistimethate SPC,COLISTIMETHATE SODIUM,0810200195,2020,"1,000,000 IU",Powder for solution for injection/infusion,Intravenous use,321.949,XELLIA PHARMACEUTICAL APS,Denmark,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200202,2020,1 mg,"Capsule, hard",Oral use,22712.049,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200203,2020,2 mg,"Capsule, hard",Oral use,22712.049,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200207,2020,3 mg,"Capsule, hard",Oral use,23588.049,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200197,2020,4 mg,"Capsule, hard",Oral use,23588.049,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200192,2020,1 mg,"Capsule, hard",Oral use,22712.049,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200204,2020,2 mg,"Capsule, hard",Oral use,22712.049,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200198,2020,3 mg,"Capsule, hard",Oral use,23588.049,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Pomalidomide SPC,POMALIDOMIDE,0810200205,2020,4 mg,"Capsule, hard",Oral use,23588.049,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
CALMAR,ZINC OXIDE,2307257822,2020,10 %,Cream,Topical,20.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
Paracetamol Kabi,PARACETAMOL,11-174-20,2020,10 mg/ml,Solution for infusion,Intravenous use,123.50,FRESENIUS KABI,Germany,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Imipenem/Cilastatin Kabi 500MG/500MG VIAL,CILASTATIN,14-174-20,2020,500 mg,Powder for solution for infusion,Intravenous use,313.35,ACS Dobfar S.P.A,Italy,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
OZAPIN,OLANZAPINE,50-968-20,2020,15 mg,Orodispersible tablet,Oral use,265.50,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
OZAPIN,OLANZAPINE,49-968-20,2020,20 mg,Orodispersible tablet,Oral use,290.30,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
Hyalax Light,SODIUM HYALURONATE,1-5254-19,2019,23 mg/ml,Solution for injection in pre-filled syringe,Intradermal use,320.95,Croma GmbH,Austria,CITC Cosmetology International Trade Company GmbH,Germany,Marketed,Prescription,Store between (2°C – 25°C),Hospital,DERMAZONE Est
FEIBA 50U POWDER&SOLVENT,FACTOR VIII INHIBITOR BYPASSING FRACTION,16-5603-22,2020,50 U/ml,Powder and solvent for solution for infusion,Intravenous use,1645.30,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing AG,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Eligon,FINGOLIMOD HYDROCHLORIDE,0810200201,2020,0.5 mg,"Capsule, hard",Oral use,3225.299,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Pixar,APIXABAN,0810200200,2020,2.5 mg,Film-coated tablet,Oral use,250.25,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Pixar,APIXABAN,0810200196,2020,5 mg,Film-coated tablet,Oral use,250.25,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Olsar Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1510200211,2020,"40,25 mg",Film-coated tablet,Oral use,70.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Olsar Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1510200209,2020,"40,12.5 mg",Film-coated tablet,Oral use,70.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Olsar Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",1510200208,2020,"20,12.5 mg",Film-coated tablet,Oral use,53.30,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Triolite,"FLUOCINOLONE ACETONIDE, TRETINOIN, HYDROQUINONE",1510200210,2020,"0.1,0.5,40 mg",Cream,Topical,63.099,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Ixifi,INFLIXIMAB,0610200191,2020,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1527.20,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Japan inc,Japan,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
Arixtra 7.5mg-0.6ml Pre-filled syringe,FONDAPARINUX SODIUM,2108258084,2020,12.5 mg/ml,Solution for injection,Subcutaneous use,675.25,ASPEN NOTRE DAM de BONDEVILLE,France,ASPEN PHARMACARE CANADA INC,Canada,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
Inhixa,ENOXAPARIN SODIUM,1810200221,2020,150 mg,Solution for injection,"Intravenous, Subcutaneous",106.20,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200220,2020,120 mg,Solution for injection,"Intravenous, Subcutaneous",93.50,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200219,2020,"100 mg, mg/ml",Solution for injection,"Intravenous, Subcutaneous",66.10,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200222,2020,80 mg,Solution for injection,"Intravenous, Subcutaneous",53.15,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200217,2020,60 mg,Solution for injection,"Intravenous, Subcutaneous",44.60,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200218,2020,40 mg,Solution for injection,"Intravenous, Subcutaneous",34.65,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Inhixa,ENOXAPARIN SODIUM,1810200223,2020,20 mg,Solution for injection,"Intravenous, Subcutaneous",17.85,Shenzhen Techdow Pharmaceutical Co Ltd,China,Techdow Pharma Netherlands B.V,Netherlands,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
DANDAXA,TADALAFIL,302-186-20,2020,20 mg,Film-coated tablet,Oral use,192,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
DANDAXA,TADALAFIL,301-186-20,2020,20 mg,Film-coated tablet,Oral use,64,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
REVARDIA,ADENOSINE,28-993-20,2020,3 mg/ml,Solution for injection,Intravenous use,156.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Tabuk Pharmaceutical Manufacturing Company
CO-ZANSOR 150/12.5MG F.C TABLETS,"IRBESARTAN, HYDROCHLOROTHIAZIDE",1108257992,2020,"150,12.5 mg",Film-coated tablet,Oral use,39.05,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-ZANSOR 300/12.5MG F.C. TABLETS,"IRBESARTAN, HYDROCHLOROTHIAZIDE",1108257988,2020,"300,12.5 mg",Film-coated tablet,Oral use,47.70,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
CO-ZANSOR 300/25MG F.C. TABLETS,"IRBESARTAN, HYDROCHLOROTHIAZIDE",1108257975,2020,"300,25 mg",Film-coated tablet,Oral use,47.70,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
TETRAXIM,"DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, FILAMENTOUS HAEMAGGLUTININ, INACTIVATED POLIOMYELITIS VIRUS TYPE 1 (MAHONEY STRAIN), INACTIVATED POLIOMYELITIS VIRUS TYPE 2 (MEF-1 STRAIN), INACTIVATED POLIOMYELITIS VIRUS TYPE 3 (SAUKETT STRAIN)",2-5219-19,2019,"30,40,25,25,40,8,32 IU, DAgU",Suspension for injection in pre-filled syringe,Intramuscular use,63.85,SANOFI PASTEUR SA,France,SANOFI PASTEUR SA,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
LEZAL,LEVOCETIRIZINE DIHYDROCHLORIDE,1808258047,2020,0.5 mg/ml,Oral solution,Oral use,17.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
CIS-TAC,CISATRACURIUM,13-174-20,2020,2 mg/ml,Solution for injection/infusion,Intravenous use,73.75,Fresenius Kabi manufacturing SA (Pty) Ltd,South Africa,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
AMLOVAN-HCT 10/160/25MG F.C.TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",443-212-20,2020,"160,25,10 mg",Film-coated tablet,Oral use,54.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AMLOVAN-HCT 10/160/12.5MG F.C.TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",440-212-20,2020,"160,12.5,10 mg",Film-coated tablet,Oral use,54.15,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AMLOVAN-HCT 5/160//25MG F.C.TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",441-212-20,2020,"160,25,5 mg",Film-coated tablet,Oral use,46.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
AMLOVAN-HCT 5/160/12.5MG F.C.TABLET,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",442-212-20,2020,"160,12.5,5 mg",Film-coated tablet,Oral use,46.35,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
VILTIN 50 MG TABLET,VILDAGLIPTIN,69-399-20,2020,50 mg,Tablet,Oral use,66.50,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
ARIPEX 2MG TABLET,ARIPIPRAZOLE,57-968-20,2020,2 mg,Tablet,Oral use,44.45,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
XIFAXAN 200MG F.C.TABLET,RIFAXIMIN,1-5327-19,2020,200 mg,Film-coated tablet,Oral use,83.90,Alfasigma S.p.A,Italy,Alfasigma S.p.A,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
FLAMEX 400MG CAPSULE,CELECOXIB,1301256601,2019,400 mg,"Capsule, hard",Oral use,22.65,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,AL-DAWAA MEDICAL SERVICES CO. LTD
FLAMEX 200 MG CAPSULE,CELECOXIB,2410246107,2019,200 mg,"Capsule, hard",Oral use,12.50,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,AL-DAWAA MEDICAL SERVICES CO. LTD
Sildenafil OHRE Pharma,SILDENAFIL,0411200251,2020,20 mg,Film-coated tablet,Oral use,1327.499,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,STRAGEN FRANCE,France,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
BOSULIF,BOSUTINIB,0911200258,2020,100 mg,Film-coated tablet,Oral use,2635.55,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Otipax,"PHENAZONE, LIDOCAINE HYDROCHLORIDE",0411200253,2020,"4,1 g","Ear drops, solution",Auricular use,8.558,Biocodex,France,Biocodex,France,Marketed,Prescription,store below 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
ATOX,Etoricoxib,0511200255,2020,120 mg,Film-coated tablet,Oral use,10.999,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ATOX,Etoricoxib,0511200256,2020,90 mg,Film-coated tablet,Oral use,40.999,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
ATOX,Etoricoxib,0511200254,2020,60 mg,Film-coated tablet,Oral use,40.999,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
Tedo 5 film-coated tablet,TADALAFIL,0411200252,2020,5 mg,Film-coated tablet,Oral use,136.15,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
FOLICRON SR CAPSULE,"FERROUS SULFATE, FOLIC ACID",303-186-20,2020,"150,0.5 mg",Sustained-release tablet,Oral use,7.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
FROXA,DEFEROXAMINE,79-5286-20,2020,500 mg,Powder for injection,Subcutaneous use,90.15,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
AMKANT,AMIKACIN,71-5286-20,2020,250 mg/ml,Solution for injection,Intramuscular and intravenous use,97.85,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
OGIVRI,Trastuzumab,1-5909-24,2020,420 mg,Lyophilisate for solution for infusion,Intravenous use,3821.15,Biocon Biologics Limited,India,Biosimilar Collaborations Ireland Limited (BCIL),Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Viatris Arabia Limited"
ROST,ROSUVASTATIN,8-5362-20,2020,10 mg,Tablet,Oral use,55.15,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ROST,ROSUVASTATIN,9-5362-20,2020,20 mg,Tablet,Oral use,93.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ROST,ROSUVASTATIN,10-5362-20,2020,40 mg,Tablet,Oral use,183,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Durotine,DULOXETINE,4-5362-20,2020,30 mg,"Gastro-resistant capsule, hard",Oral use,36.10,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Durotine,DULOXETINE,5-5362-20,2020,60 mg,"Gastro-resistant capsule, hard",Oral use,72.20,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Otrasa,DASATINIB,1111200262,2020,20 mg,Film-coated tablet,Oral use,5003.10,Synthon Hispania SL,Spain,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Otrasa,DASATINIB,1111200260,2020,50 mg,Film-coated tablet,Oral use,8285.15,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Otrasa,DASATINIB,1111200259,2020,70 mg,Film-coated tablet,Oral use,8541.40,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Otrasa,DASATINIB,1111200264,2020,80 mg,Film-coated tablet,Oral use,4270.70,Synthon Hispania SL,Spain,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Otrasa,DASATINIB,1111200263,2020,100 mg,Film-coated tablet,Oral use,8285.15,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Otrasa,DASATINIB,1111200261,2020,140 mg,Film-coated tablet,Oral use,8541.40,Synthon Hispania SL,Spain,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Kanjinti,Trastuzumab,2211200282,2020,150 mg,Powder for concentrate for solution for infusion,Intravenous use,1364.70,AMGEN TECHNOLOGY,Ireland,Amgen Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Kanjinti,Trastuzumab,2211200281,2020,420 mg,Powder for concentrate for solution for infusion,Intravenous use,3821.15,AMGEN TECHNOLOGY,Ireland,AMGEN EUROPE B.V.,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Galtipex,GLATIRAMER,2511200292,2020,40 mg/ml,Solution for injection,Subcutaneous use,3864.2,Aspen Healthcare,Malta,Aspen Healthcare,Malta,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Reagila,Cariprazine hydrochloride,1611200270,2020,1.5 mg,"Capsule, hard",Oral use,225.7,GEDEON RICHTER PLC.,Hungary,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Reagila,Cariprazine hydrochloride,1611200272,2020,3 mg,"Capsule, hard",Oral use,225.7,GEDEON RICHTER PLC.,Hungary,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Reagila,Cariprazine hydrochloride,1611200271,2020,4.5 mg,"Capsule, hard",Oral use,225.7,GEDEON RICHTER PLC.,Hungary,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Reagila,Cariprazine hydrochloride,1611200273,2020,6 mg,"Capsule, hard",Oral use,225.7,GEDEON RICHTER PLC.,Hungary,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Crotal,TACROLIMUS,2211200278,2020,0.5 mg,Capsule,Oral use,211.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lamsev 800,SEVELAMER CARBONATE,2111200277,2020,800 mg,Film-coated tablet,Oral use,476.749,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
IVNEM,"CILASTATIN, IMIPENEM",1611200269,2020,"500,500 mg",Powder for solution for infusion,Intravenous use,313.35,ACS DOBFAR SPA,Italy,Hikma FARMACEUTICA Portugal SA,Portugal,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Tredia,Dimethyl Fumarate,1811200275,2020,240 mg,"Capsule, hard",Oral use,2912.3,Shilpa Medicare Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Tredia,Dimethyl Fumarate,1811200274,2020,120 mg,"Capsule, hard",Oral use,363.999,Shilpa Medicare Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
NEURITAM,LEVETIRACETAM,2211200280,2020,500 mg,Film-coated tablet,Oral use,82.35,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
NEURITAM,LEVETIRACETAM,2211200279,2020,250 mg,Film-coated tablet,Oral use,50.50,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Beovu,Brolucizumab,2311200287,2020,120 mg/ml,Solution for injection,Intravitreal use,2754.151,NOVARTIS MANUFACTURING NV,Belgium,Novartis Europharm Limited,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Novartis Saudi Limited
Ocaliva,Obeticholic Acid,2311200285,2020,5 mg,Film-coated tablet,Oral use,9837.80,PIRAMAL HEALTHCARE UK LIMITED,United Kingdom,ADVANZ PHARMA EUROPE LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Ocaliva,Obeticholic Acid,2311200284,2020,10 mg,Film-coated tablet,Oral use,9837.80,PIRAMAL HEALTHCARE UK LIMITED,United Kingdom,ADVANZ PHARMA EUROPE LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Etimicol 10,EZETIMIBE,3011200299,2020,10 mg,Tablet,Oral use,118.5,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Trientine dihydrochloride,TRIENTINE DIHYDROCHLORIDE,2311200283,2020,250 mg,"Capsule, hard",Oral use,8450.10,Apothecon Pharmaceuticals PVT Limited,India,Navinta LLC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,QOMEL MEDICAL DRUG STORE
Zirabev,Bevacizumab,2411200290,2020,25 mg/ml,Concentrate for solution for infusion,Intravenous use,780.699,PFIZER,Ireland,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
Zirabev,Bevacizumab,2411200291,2020,25 mg/ml,Concentrate for solution for infusion,Intravenous use,2973.099,PHARMACIA UPJOHN,United States,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
Xoria,ADENOSINE,0212200305,2020,3 mg/ml,Solution for injection,Intravenous use,110,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Pitacro,Capecitabine,2611200293,2020,150 mg,Tablet,Oral use,257.699,MSN LABORATORIES PRIVATE LIMITED,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Pitacro,Capecitabine,2611200294,2020,500 mg,Tablet,Oral use,859.047,MSN LABORATORIES PRIVATE LIMITED,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Tyrox,ERLOTINIB,2611200297,2020,25 mg,Film-coated tablet,Oral use,930.3,REMEDICA,Cyprus,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Tyrox,ERLOTINIB,2611200296,2020,100 mg,Film-coated tablet,Oral use,3721.15,REMEDICA,Cyprus,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Rivaroxaban SPC,RIVAROXABAN,3011200303,2020,10 mg,Film-coated tablet,Oral use,64.15,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Rivaroxaban SPC,RIVAROXABAN,3011200302,2020,15 mg,Film-coated tablet,Oral use,251.60,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Rivaroxaban SPC,RIVAROXABAN,3011200301,2020,20 mg,Film-coated tablet,Oral use,179.60,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Montas,MONTELUKAST SODIUM,2911200298,2020,10 mg,Film-coated tablet,Oral use,38.1,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Bosentan OHRE Pharma,BOSENTAN,3011200300,2020,62.5 mg,Film-coated tablet,Oral use,5504.1,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,OHRE Pharma,France,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Dimethyl Fumarate SPC,Dimethyl Fumarate,1312200328,2020,120 mg,"Prolonged-release capsule, hard",Oral use,780,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Dimethyl Fumarate SPC,Dimethyl Fumarate,0612200307,2020,120 mg,"Prolonged-release capsule, hard",Oral use,260,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Dimethyl Fumarate SPC,Dimethyl Fumarate,0612200309,2020,240 mg,"Prolonged-release capsule, hard",Oral use,1560.149,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Dimethyl Fumarate SPC,Dimethyl Fumarate,0612200308,2020,240 mg,"Prolonged-release capsule, hard",Oral use,520.049,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Hyacorp Face,"HYALURONIC ACID, HYALURONIC ACID CROSS-LINKED",0712200316,2020,"2,20 mg",Gel,Intradermal use,934.441,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Hyacorp Face,"HYALURONIC ACID, HYALURONIC ACID CROSS-LINKED",0712200314,2020,"2,20 mg/ml",Gel,Intradermal use,233.601,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
HYAcorp MLF1 - HYAcorp MLF2,"HYALURONIC ACID, HYALURONIC ACID CROSS-LINKED",0712200315,2020,"2,20 mg",Gel,Intradermal use,966.664,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Hyacorp Fine,SODIUM HYALURONATE,0712200310,2020,14 mg,Gel,Intradermal use,273.888,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Hyacorp Lips,"HYALURONIC ACID, HYALURONIC ACID CROSS-LINKED",0712200311,2020,"2,16 mg",Gel,Intradermal use,254.748,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Hyaprof Soft,HYALURONIC ACID,0712200313,2020,20 mg/ml,Gel,Intradermal use,424.752,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Hyaprof Balance,HYALURONIC ACID,0712200312,2020,22 mg/ml,Gel,Intradermal use,467.22,Bioscience GmbH,Germany,Bioscience GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Vitateck Medical Company
Ascenta,TADALAFIL,1212200323,2020,20 mg,Film-coated tablet,Oral use,64.84,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Ascenta,TADALAFIL,1512200340,2020,5 mg,Film-coated tablet,Oral use,136.149,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Vdia,VILDAGLIPTIN,1212200324,2020,50 mg,Tablet,Oral use,33.25,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Vdia,VILDAGLIPTIN,1212200325,2020,50 mg,Tablet,Oral use,66.5,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Dermafill Volume Ultra,HYALURONIC ACID,0812200317,2020,20 mg/ml,Gel,Intradermal use,241.697,Bohus BioTech AB,Sweden,SBS MED INFINITY COSMETICS SAS,France,Marketed,Prescription,store below 25°c,Hospital,RIDA ALMOTAHIDA EST
Metrosol,METRONIDAZOLE,1312200326,2020,5 mg/ml,Solution for infusion,Intravenous use,10.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Jalor,HYALURONIC ACID,1012200322,2020,23 mg/ml,Gel,Subcutaneous use,342.352,CROMA PHARMA GMBH,Austria,CROMA PHARMA Gmbh,Austria,Marketed,Prescription,store below 25°c,Hospital,Health Experts Trading Est
Diva,"DROSPINENONE, ETHINYLESTRADIOL",1012200319,2020,"3,0.03 mg",Film-coated tablet,Oral use,16.35,"LABORATORIOS LEON FARMA, S.A.",Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Slinda,Drospirenone,1012200318,2020,4 mg,Film-coated tablet,Oral use,43.55,"LABORATORIOS LEON FARMA, S.A.",Spain,Exeltis USA Inc,United States,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Ruxaar,METHOTREXATE,1012200320,2020,2.5 mg,Tablet,Oral use,107.50,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Nucala,MEPOLIZUMAB,1312200329,2020,100 mg/ml,Solution for injection,Subcutaneous use,4709.35,Glaxo Operations UK Ltd,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Nucala,MEPOLIZUMAB,1312200330,2020,100 mg/ml,Solution for injection,Subcutaneous use,4709.35,Glaxo Operations UK Ltd,United Kingdom,Glaxo Saudi Arabia Ltd,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Trazimera,Trastuzumab,2012200344,2020,150 mg,Powder for concentrate for solution for infusion,Intravenous use,1029.399,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
TYKODAS,DASATINIB,2712200368,2020,50 mg,Film-coated tablet,Oral use,5219.65,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
TYKODAS,DASATINIB,2712200367,2020,70 mg,Film-coated tablet,Oral use,5381.05,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
CIPROCARE,Ciprofloxacine,2712200364,2020,200 mg,Solution for infusion,Intravenous use,57.1,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
IMBRUVICA,IBRUTINIB,2312200353,2020,140 mg,Film-coated tablet,Oral use,8010,JANSSEN-CILAG,Switzerland,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Exitor,Etoricoxib,2112200347,2020,120 mg,Film-coated tablet,Oral use,47.15,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Exitor,Etoricoxib,2112200346,2020,90 mg,Film-coated tablet,Oral use,41,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Exitor,Etoricoxib,2112200351,2020,60 mg,Film-coated tablet,Oral use,41,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tadil,TADALAFIL,2112200348,2020,20 mg,Film-coated tablet,Oral use,160,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tadil,TADALAFIL,2112200345,2020,5 mg,Film-coated tablet,Oral use,136.15,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tadil,TADALAFIL,2112200350,2020,2.5 mg,Film-coated tablet,Oral use,68.05,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Farouk, Maamoun Tamer & CO, Saudi Amarox"
Virtra,"LOPINAVIR, RITONAVIR",2112200349,2020,"200,50 mg",Film-coated tablet,Oral use,1040.9,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Borvix,BORTEZOMIB,2412200362,2020,3.5 mg,powder for solution for injection,Intravenous use,2177.05,Qilu Pharmaceutical Hainan Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Bonteo 20 mcg per 80 mcl,TERIPARATIDE,2412200363,2020,250 µ/ml,Solution for injection,Subcutaneous use,1155.35,Rechon Life Science AB,Sweden,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
ARGENTA,Etoricoxib,1101210406,2021,120 mg,Film-coated tablet,Oral use,11,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
ARGENTA,Etoricoxib,1101210405,2021,90 mg,Film-coated tablet,Oral use,41,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
ARGENTA,Etoricoxib,1101210407,2021,60 mg,Film-coated tablet,Oral use,41,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Carfilzomib SPC,CARFILZOMIB,3112200377,2020,60 mg,Powder for injection,Intravenous use,3441.2,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,SUDAIR PHARMA COMPANY
SOLYO,LIDOCAINE HYDROCHLORIDE,3112200376,2020,10 mg/ml,Solution for injection,Intravenous use,7,Medochemie (Ampoule Injectable Facility),Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Zorta,ARIPIPRAZOLE,0401210378,2021,15 mg,Tablet,Oral use,248.5,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Zorta,ARIPIPRAZOLE,0401210379,2021,10 mg,Tablet,Oral use,200,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Rexofil,TADALAFIL,0601210382,2021,5 mg,Film-coated tablet,Oral use,136.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Rexofil,TADALAFIL,0601210381,2021,20 mg,Film-coated tablet,Oral use,64.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Penetro,VARDENAFIL,0601210383,2021,10 mg,Orodispersible tablet,Oral use,53.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Levonic,LEVOFLOXACIN,1301210411,2021,5 mg/ml,Solution for infusion,Intravenous use,106.95,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Meropa,MEROPENEM,0601210386,2021,1000 mg,Powder for solution for injection/infusion,Intravenous use,356.40,ACS DOBFAR S.P.A,Italy,Hikma FARMACEUTICA Portugal SA,Portugal,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Abdulrehman Algosaibi G.T.C.
Meropa,MEROPENEM,0601210385,2021,500 mg,Powder for solution for injection/infusion,Intravenous use,211.95,ACS Dobfar S.p.A.,Italy,Hikma FARMACEUTICA Portugal SA,Portugal,Marketed,Prescription,store below 30°c don't freeze,Hospital,Abdulrehman Algosaibi G.T.C.
Blum-D,CHOLECALCIFEROL,1601210418,2021,50000 IU,Film-coated tablet,Oral use,64.1,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Parinso,LACOSAMIDE,1101210403,2021,50 mg,Film-coated tablet,Oral use,52.85,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Parinso,LACOSAMIDE,1101210400,2021,100 mg,Film-coated tablet,Oral use,101.8,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Parinso,LACOSAMIDE,1101210401,2021,150 mg,Film-coated tablet,Oral use,152.7,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Parinso,LACOSAMIDE,1101210402,2021,200 mg,Film-coated tablet,Oral use,203.95,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Ondex,ONDANSETRON,1201210409,2021,2 mg/ml,Solution for injection,Intramuscular and intravenous use,127.45,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Ondex,ONDANSETRON,1201210410,2021,2 mg/ml,Solution for injection,Intramuscular and intravenous use,63.7,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
FEXOFIN,FEXOFENADINE HYDROCHLORIDE,1-5362-19,2019,180 mg,Film-coated tablet,Oral use,32.50,IND-SWIFT LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Refixia,NONACOG BETA PEGOL,2101210449,2021,500 IU,Powder and solvent for solution for injection,Intravenous use,3052.55,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
Refixia,NONACOG BETA PEGOL,2101210448,2021,1000 IU,Powder and solvent for solution for injection,Intravenous use,6105.70,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
Refixia,NONACOG BETA PEGOL,2101210450,2021,2000 IU,Powder and solvent for solution for injection,Intravenous use,12211.95,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Novo nordisk Saudi trading, Salehiya Trading Co."
Exdure,DAPOXETINE,2001210442,2021,60 mg,Film-coated tablet,Oral use,78.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Exdure,DAPOXETINE,2001210434,2021,30 mg,Film-coated tablet,Oral use,78.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Dextrose 5% and Lactated Ringer's Injection,"DEXTROSE, SODIUM LACTATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE",1910200226,2020,"50,6.2,6,0.3,0.2 g",Injection,Intravenous use,5.8,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Erastapecs Trio,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2001210438,2021,"40,25,10 mg",Tablet,Oral use,95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Erastapecs Trio,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2001210437,2021,"40,12.5,5 mg",Tablet,Oral use,84.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Erastapecs Trio,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2001210439,2021,"20,12.5,5 mg",Tablet,Oral use,66.4,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Illusof,IOHEXOL,2001210430,2021,350 mg/ml,Solution for injection,Intravenous use,140.65,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Tabuk Pharmaceutical Manufacturing Company
Illusof,IOHEXOL,2001210431,2021,350 mg/ml,Solution for injection,Intravenous use,65.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Tabuk Pharmaceutical Manufacturing Company
XEVANEER 125mg/5ml Powder For Oral Suspension,CEFDINIR,2401210456,2021,25 mg/ml,Powder for oral suspension,Oral use,59.60,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Xivar,RIVAROXABAN,2401210453,2021,10 mg,Film-coated tablet,Oral use,173.2,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Xivar,RIVAROXABAN,2401210455,2021,15 mg,Film-coated tablet,Oral use,226.40,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Xivar,RIVAROXABAN,2401210454,2021,20 mg,Film-coated tablet,Oral use,161.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
CANHERA,Trastuzumab,2-5366-20,2020,440 mg,Powder and solvent for solution for injection,Intravenous use,4003.10,Biocon Limited,India,Biocon Biologics Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,EBRAHIM M. ALMANA & BROS. CO.
CEPHADAR,CEFALEXIN,129-124-20,2020,250 mg,"Capsule, hard",Oral use,214.70,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
CLARISCAN,GADOTERIC ACID,40-261-19,2020,0.5 mmol/ml,Solution for injection,Intravenous use,1058,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
CLARISCAN,GADOTERIC ACID,39-261-19,2020,0.5 mmol/ml,Solution for injection,Intravenous use,714.10,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
CLARISCAN,GADOTERIC ACID,41-261-19,2020,0.5 mmol/ml,Solution for injection,Intravenous use,1265.05,GE Healthcare AS,Norway,GE Healthcare AS,Norway,Marketed,Prescription,store below 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
SOPORIDEX,DEXMEDETOMIDINE,3-5424-19,2020,100 µ/ml,Concentrate for solution for infusion,Intravenous use,680.55,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
SOPORIDEX,DEXMEDETOMIDINE,2-5424-19,2020,100 µ/ml,Concentrate for solution for infusion,Intravenous use,395.70,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
SOPORIDEX,DEXMEDETOMIDINE,1-5424-19,2020,100 µ/ml,Concentrate for solution for infusion,Intravenous use,1592.30,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
CLAMUDEX,Bicalutamide,84-5286-21,2020,50 mg,Film-coated tablet,Oral use,230,Kocak Farma İlac Ve Kimya Sanayi A.S.,Turkey,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Emcap,Capecitabine,1510200212,2020,500 mg,Tablet,Oral use,556.80,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
CLASGEN,CICLOSPORIN,40-290-20,2020,0.5 mg/ml,Eye drops,Ophthalmic use,117.50,"Huons Co., Ltd.",KOREA,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ZAVEDOS 1MG/ML VIAL,IDARUBICIN HYDROCHLORIDE,3-5669-21,2021,1 mg/ml,Solution for injection,Intravenous use,366.80,Zydus Hospira Oncology Private Limited ZHOPL,India,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ZAVEDOS 1MG/ML VIAL,IDARUBICIN HYDROCHLORIDE,2-5669-21,2021,1 mg/ml,Solution for injection,Intravenous use,183.40,Zydus Hospira Oncology Private Limited ZHOPL,India,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
EPILYRE,LEVETIRACETAM,0401268846,2021,1000 mg,Film-coated tablet,Oral use,137.20,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
EPILYRE,LEVETIRACETAM,0401268845,2021,500 mg,Film-coated tablet,Oral use,83.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
EXAMIDE,TORSEMIDE,1301268910,2021,5 mg,Film-coated tablet,Oral use,23.45,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
EXAMIDE,TORSEMIDE,1301268908,2021,10 mg,Film-coated tablet,Oral use,39.75,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
EXAMIDE,TORSEMIDE,1301268909,2021,20 mg,Film-coated tablet,Oral use,66.10,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
ONDANION,ONDANSETRON,2307257839,2021,2 mg/ml,Solution for injection/infusion,Intravenous use,56.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
ONDANION,ONDANSETRON,458-212-20,2021,2 mg/ml,Solution for injection/infusion,Intravenous use,112.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
BICNU,CARMUSTINE,4-5197-20,2021,100 mg,Powder and solvent for solution for infusion,Intravenous use,3743.45,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Health Care Co.
CONTRAVE,"BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE",17-313-22,2021,"90,8 mg",Prolonged-release tablet,Oral use,358.45,PATHEON INC,Canada,Algorithm SAL,Lebanon,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
GARDIA,DESETHYL CANDESARTAN CILEXETIL,78-5286-20,2021,8 mg,Tablet,Oral use,23.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FOLICUM,FOLIC ACID,305-186-21,2021,5 mg,Tablet,Oral use,27.60,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,"Store below 30°C , Protect from light and moisture",Pharmacy,Cigalah Group
FOLICUM,FOLIC ACID,304-186-21,2021,1 mg,Tablet,Oral use,24.85,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 25°c,Pharmacy,Cigalah Group
MAVENCLAD,CLADRIBINE,2101210447,2021,10 mg,Tablet,Oral use,7485.10,NerPharMa SRL,Italy,Merck Europe BV,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Merck Limited"
LEVOACT,LEVOFLOXACIN,20-5015-18,2021,500 mg,Film-coated tablet,Oral use,29.80,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
AVIZOR LACRIFRESH OCU DRY 0.3%,SODIUM HYALURONATE,1-5488-20,2021,0.3 %,Eye drops,Ophthalmic use,46.10,AVIZOR International S.L,Spain,AVIZOR International S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Gulf Care Trading Est
Tiplex,THIOTEPA,344-334-20,2021,15 mg,Lyophilisate for solution for injection,"Intravenous, Intravesical",1205.05,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Erlotinib SPC,ERLOTINIB,2701210477,2021,100 mg,Film-coated tablet,Oral use,3358.05,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Erlotinib SPC,ERLOTINIB,2801210481,2021,150 mg,Film-coated tablet,Oral use,4419.10,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Fosaprepitant SPC,FOSAPREPITANT DIMEGLUMINE,0902210504,2021,150 mg,powder for solution for injection,Intravenous use,200,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Vyndamax,TAFAMIDIS,1602210522,2021,61 mg,"Capsule, soft",Oral use,39840.55,CATALENT PHARMA SOLUTIONS,United States,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Minims Povidone Iodine 5%,POVIDONE-IODINE,1-5341-19,2021,5 %,Eye drops,Ophthalmic use,82.15,Laboratoire Chauvin SAS,France,CHAUVIN BAUSCH & LOMB,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
LEVOACT,LEVOFLOXACIN,19-5015-18,2021,500 mg,Film-coated tablet,Oral use,41.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
NORACTONE,SPIRONOLACTONE,82-171-20,2021,25 mg,Tablet,Oral use,207.90,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Merional HG,MENOTROPHIN,2-5976-24,2021,75 IU,Powder and solvent for solution for injection,"intramuscular, subcutaneous",69.00,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
MERIONAL HG,MENOTROPHIN,3-5976-24,2021,150 IU,Powder and solvent for solution for injection,"intramuscular, subcutaneous",138.00,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"ALNAGHI COMPANY, ZIMMO TRADING ESTABLISHMENT"
ABILIRAZOLE,ARIPIPRAZOLE,6-5362-20,2020,10 mg,Tablet,Oral use,200,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ABILIRAZOLE,ARIPIPRAZOLE,7-5362-20,2020,15 mg,Tablet,Oral use,248.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
TECABEN,ENTECAVIR,3-5362-19,2020,1 mg,Film-coated tablet,Oral use,1387.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
TECABEN,ENTECAVIR,2-5362-19,2020,0.5 mg,Film-coated tablet,Oral use,1352.55,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
OLMAZIDE 20/12.5MG F.C.TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",13-5362-20,2020,"20,12.5 mg",Film-coated tablet,Oral use,47.95,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
OLMAZIDE 40/12.5MG,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",14-5362-20,2020,"40,12.5 mg",Film-coated tablet,Oral use,63.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
OLMAZIDE 40/25MG,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",15-5362-20,2020,"40,25 mg",Film-coated tablet,Oral use,63.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,11-5362-20,2020,40 mg,Lyophilisate for solution for injection,Oral use,13.55,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,12-5362-20,2020,40 mg,Lyophilisate for solution for injection,Oral use,135.65,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
DARINE,DESLORATADINE,15-631-19,2021,5 mg,Tablet,Oral use,28.25,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
OXIRA RAPID,LORNOXICAM,454-212-20,2021,8 mg,Film-coated tablet,Oral use,19.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SPIMACO
ALMETRA,PEMETREXED,80-5286-20,2021,500 mg,Powder for concentrate for solution for infusion,Intravenous use,2595.15,Jiangsu Hansoh Pharmaceutical Group Co,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
LEVOACT,LEVOFLOXACIN,18-5015-18,2021,500 mg,Film-coated tablet,Oral use,59.65,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Hyalfid Gel,"AMINO ACIDS, SODIUM HYALURONATE",8-427-22,2021,0.3 %,"Eye drops, solution",Ophthalmic use,42,Sooft Italia SBA,Italy,Fidia Farmaceutici S.p.A.,Italy,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
Hyalfid,"AMINO ACIDS, SODIUM HYALURONATE",7-427-22,2021,0.15 %,"Eye drops, solution",Ophthalmic use,42,Sooft Italia SBA,Italy,Fidia Farmaceutici S.p.A.,Italy,Marketed,OTC,store below 25°c,Pharmacy,Dallah Health Care Company
CARELIO,METOPROLOL SUCCINATE,19-5083-20,2021,25 mg,Tablet,Oral use,14.25,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CARELIO,METOPROLOL SUCCINATE,20-5083-20,2021,50 mg,Tablet,Oral use,23.40,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CARELIO,METOPROLOL SUCCINATE,21-5083-20,2021,100 mg,Tablet,Oral use,36.40,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
CARELIO,METOPROLOL SUCCINATE,22-5083-20,2021,200 mg,Tablet,Oral use,42.25,ACINO PHARMA AG,Switzerland,ACINO PHARMA AG,Switzerland,Marketed,Prescription,store below 25°c,Pharmacy,"Acino Arabia for trading LLC, Cigalah Group"
SPIOLTO RESPIMAT,"TIOTROPIUM, OLODATEROL",120-68-20,2021,"2.5,2.5 µg",inhalation solution,Inhalation use,178.70,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
HEMADID,FERROUS SULFATE,211-368-19,2020,200 mg,Film-coated tablet,Oral use,63.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
DABITRAN,DABIGATRAN ETEXILATE,17-5362-20,2021,75 mg,"Capsule, hard",Oral use,250.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
DABITRAN,DABIGATRAN ETEXILATE,16-5362-20,2021,75 mg,"Capsule, hard",Oral use,125.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
DABITRAN,DABIGATRAN ETEXILATE,19-5362-20,2021,150 mg,"Capsule, hard",Oral use,250.25,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
DABITRAN,DABIGATRAN ETEXILATE,18-5362-20,2021,150 mg,"Capsule, hard",Oral use,125.10,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
TRUXIMA,RITUXIMAB,339-334-20,2021,100 mg,Concentrate for solution for infusion,Intravenous use,1555.70,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
KETESSE,DEXKETOPROFEN TROMETHAMINE,3-5500-20,2021,25 mg/ml,Concentrate and solvent for solution for infusion,Intramuscular and intravenous use,97.95,A.Menarini Manufacturing Logistics And Services SRL,Italy,Menarini International O. L. S.A,Luxembourg,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
KETESSE,DEXKETOPROFEN TROMETHAMINE,2-5500-20,2021,25 mg/ml,Concentrate and solvent for solution for infusion,Intramuscular and intravenous use,24.50,A.Menarini Manufacturing Logistics And Services SRL,Italy,Menarini International O. L. S.A,Luxembourg,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
BIKTARVY,"EMTRICITABINE, BICTEGRAVIR, TENOFOVIR ALAFENAMIDE",7-861-20,2020,"200,52.45,25 mg",Film-coated tablet,Oral use,2881.95,GILEAD SCIENCES LIMITED (CORK),Ireland,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
Lamotrine,LAMOTRIGINE,2001210440,2021,25 mg,Tablet,Oral use,23.25,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Lamotrine,LAMOTRIGINE,2001210441,2021,100 mg,Tablet,Oral use,66.75,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Lamotrine,LAMOTRIGINE,0102210483,2021,50 mg,Tablet,Oral use,33.35,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
ALUNBRIG,BRIGATINIB,2801210480,2021,180 mg,Film-coated tablet,Oral use,19586.1,Penn Pharmaceutical Services Ltd,United Kingdom,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ALUNBRIG,BRIGATINIB,2801210479,2021,90 mg,Film-coated tablet,Oral use,14842.7,Penn Pharmaceutical Services Ltd,United Kingdom,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
ALUNBRIG,BRIGATINIB,2801210478,2021,30 mg,Film-coated tablet,Oral use,4947.55,Penn Pharmaceutical Services Ltd,United Kingdom,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Eylea 40 mg/ml Solution for injection in pre-filled syringe,AFLIBERCEPT,0102210486,2021,40 mg/ml,Solution for injection in pre-filled syringe,Intravitreal use,3028.60,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Bayer Saudi Arabia"
FONTAX,TADALAFIL,1502210513,2021,5 mg,Film-coated tablet,Oral use,136.15,MEDOCHEMIE LTD.,Cyprus,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VIZIMPRO,DACOMITINIB,0402210493,2021,45 mg,Film-coated tablet,Oral use,8836.2,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Pfizer Saudi Trading"
VIZIMPRO,DACOMITINIB,0402210495,2021,30 mg,Film-coated tablet,Oral use,8836.2,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Pfizer Saudi Trading"
VIZIMPRO,DACOMITINIB,0402210494,2021,15 mg,Film-coated tablet,Oral use,8836.2,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, Pfizer Saudi Trading"
Baxdela,DELAFLOXACIN MEGLUMINE,0802210501,2021,300 mg,Powder for concentrate for solution for infusion,Intravenous use,3219,Patheon Italia S.P.A.,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Baxdela,DELAFLOXACIN MEGLUMINE,0802210500,2021,450 mg,Tablet,Oral use,4537.5,AustarPharma LLC,United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Fuxran,FULVESTRANT,0902210503,2021,50 mg/ml,Solution for injection,Intramuscular use,1361.25,Fareva Unterach GmbH,Austria,Sandoz Pharmaceuticals,Switzerland,Marketed,Prescription,do not store above 25°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Loradin,DESLORATADINE,1002210505,2021,5 mg,Film-coated tablet,Oral use,26.40,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Herptrex,VALACICLOVIR,1002210508,2021,500 mg,Film-coated tablet,Oral use,381,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Herptrex,VALACICLOVIR,1002210507,2021,500 mg,Film-coated tablet,Oral use,73.4,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Bivoneb,NEBIVOLOL HYDROCHLORIDE,1002210509,2021,5 mg,Tablet,Oral use,25.95,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lynparza,OLAPARIB,1402210511,2021,100 mg,Film-coated tablet,Oral use,15657.10,AbbVie Limited,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Lynparza,OLAPARIB,1402210512,2021,150 mg,Film-coated tablet,Oral use,15657.10,AbbVie Limited,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Vittoria,"VALSARTAN, AMLODIPINE BESILATE",1502210519,2021,"320,10 mg",Film-coated tablet,Oral use,83.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vittoria,"VALSARTAN, AMLODIPINE BESILATE",1502210518,2021,"160,10 mg",Film-coated tablet,Oral use,62.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vittoria,"VALSARTAN, AMLODIPINE BESILATE",1502210514,2021,"320,5 mg",Film-coated tablet,Oral use,71.95,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vittoria,"VALSARTAN, AMLODIPINE BESILATE",1502210517,2021,"160,5 mg",Film-coated tablet,Oral use,56.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vildus,VILDAGLIPTIN,1502210515,2021,50 mg,Tablet,Oral use,33.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vildus,VILDAGLIPTIN,1502210516,2021,50 mg,Tablet,Oral use,66.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Keta,KETOTIFEN,1502210521,2021,0.025 %,Eye drops,Ophthalmic use,21.5,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
Etvab,ENTECAVIR,1602210523,2021,0.5 mg,Film-coated tablet,Oral use,1541.40,COHANCE LIFESCIENCES LIMITED,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Etvab,ENTECAVIR,1602210524,2021,1 mg,Film-coated tablet,Oral use,1580.80,COHANCE LIFESCIENCES LIMITED,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
TALZENNA,TALAZOPARIB TOSYLATE,1702210526,2021,0.25 mg,"Capsule, hard",Oral use,5810.60,EXCELLA GMBH CO. KG,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
TALZENNA,TALAZOPARIB TOSYLATE,1702210525,2021,1 mg,"Capsule, hard",Oral use,17431.90,EXCELLA GMBH CO. KG,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Enoxaparin BOS,ENOXAPARIN SODIUM,1802210528,2021,20 mg,Solution for injection,Intravenous use,41.10,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,1802210527,2021,40 mg,Solution for injection,Intravenous use,70.75,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,1802210529,2021,60 mg,Solution for injection,Intravenous use,98.70,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,1802210530,2021,80 mg,Solution for injection,Intravenous use,121.75,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Boston Oncology Arabia
PROTON IV,PANTOPRAZOLE,2102210534,2021,40 mg,powder for solution for injection,Intravenous use,130.70,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
Ribex,IRBESARTAN,0303210581,2021,150 mg,Film-coated tablet,Oral use,21.30,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Ribex,IRBESARTAN,0303210580,2021,300 mg,Film-coated tablet,Oral use,26.65,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
CO-Ribex,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0303210584,2021,"150,12.5 mg",Film-coated tablet,Oral use,24.55,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
CO-Ribex,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0303210583,2021,"300,12.5 mg",Film-coated tablet,Oral use,28.90,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
CO-Ribex,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0303210582,2021,"300,25 mg",Film-coated tablet,Oral use,29.85,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Xaliptine,OXALIPLATIN,0703210585,2021,5 mg/ml,Concentrate for solution for infusion,Intravenous use,234.75,Fareva Unterach GmbH,Austria,HEXAL AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Xaliptine,OXALIPLATIN,0703210586,2021,5 mg/ml,Concentrate for solution for infusion,Intravenous use,114.90,Fareva Unterach GmbH,Austria,HEXAL AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Lectra,ANIDULAFUNGIN,0803210589,2021,100 mg,Powder for solution for infusion,Intravenous use,571.70,LABORATORIOS ALCALA FARMA,Spain,Med City Pharma,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Med city, ZIMMO TRADING ESTABLISHMENT"
Milrinone BOS,MILRINONE,1103210598,2021,1 mg/ml,Solution for injection,Intravenous use,786.5,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Ketorolac BOS,KETOROLAC TROMETHAMINE,1103210599,2021,30 mg/ml,Injection,Intramuscular and intravenous use,313.25,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Dextrose 4.3 % in 0.18 % Sodium Chloride,"DEXTROSE, SODIUM CHLORIDE",1503210603,2021,"4.3,1.8 %",Solution for infusion,Intravenous use,9.15,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Water for Injection,WATER,1503210604,2021,1000 ml,Solution for infusion,Parenteral use,8.60,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Rotavex Solution,"ANTHRAQUINONE GLYCOSIDE, SALICYLIC ACID",1503210606,2021,"0.5,1 %",Solution,Oromucosal use,12.60,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
BALVERSA,ERDAFITINIB,1703210609,2021,3 mg,Film-coated tablet,Oral use,37903.3,JANSSEN-CILAG SPA,Italy,JANSSEN BIOTECH INC.,United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
BALVERSA,ERDAFITINIB,1703210608,2021,4 mg,Film-coated tablet,Oral use,50537.75,JANSSEN-CILAG SPA,Italy,JANSSEN BIOTECH INC.,United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
BALVERSA,ERDAFITINIB,1703210610,2021,5 mg,Film-coated tablet,Oral use,31586.1,JANSSEN-CILAG SPA,Italy,JANSSEN BIOTECH INC.,United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
BALVERSA,ERDAFITINIB,1703210611,2021,3 mg,Film-coated tablet,Oral use,56854.95,JANSSEN-CILAG SPA,Italy,JANSSEN BIOTECH INC.,United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
PHENYLEPHRINE,PHENYLEPHRINE HYDROCHLORIDE,1803210612,2021,50 µ/ml,Solution for injection in pre-filled syringe,Intravenous use,453.75,LABORATOIRE AGUETTANT,France,AGUETTANT LABORATORIES,France,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
Oramorph,MORPHINE SULFATE,2203210613,2021,20 mg/ml,Oral solution,Oral use,30.35,L. Molteni & C dei F. LLi Alitti Societa di Esercizio,Italy,L Molteni and C dei F lli Alitti Societa di Esercizio SpA,Italy,Marketed,Prescription,do not store above 30°c,Hospital,YAHMAA MEDICAL COMPANY
"Carmustine for Injection, USP",CARMUSTINE,2303210622,2021,100 mg,Powder and solvent for solution for infusion,Intravenous use,3267,Piramal Pharma Solutions Inc,United States,Navinta LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,QOMEL MEDICAL DRUG STORE
Resincalcio,CALCIUM POLYSTYRENE SULFONATE,2403210638,2021,99.75 %,Powder for oral suspension,Oral use,106,Laboratorios Rubió; S.A.,Spain,Laboratorios Rubió; S.A.,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Sarclisa,ISATUXIMAB,2403210642,2021,20 mg/ml,Concentrate for solution for infusion,Intravenous use,2327.05,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Sarclisa,ISATUXIMAB,2403210643,2021,20 mg/ml,Concentrate for solution for infusion,Intravenous use,10284.7,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Duserex,DUTASTERIDE,2703210644,2021,0.5 mg,"Capsule, soft",Oral use,81.8,OLIVE HEALTHCARE,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Glevate,CLOBETASOL PROPIONATE,10-5314-20,2020,0.05 %,Cutaneous liquid,Topical,60.55,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
Ravixa,CLOPIDOGREL,3103210659,2021,75 mg,Film-coated tablet,Oral use,158.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Basaglar Tempo Pen,INSULIN GLARGINE,3003210650,2021,100 IU/ml,Solution for injection in pre-filled pen,Subcutaneous use,191.75,LILLY FRANCE,France,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Noradrenalin Sintetica 4mg/4ml without disulphite,NOREPINEPHRINE BITARTRATE,3003210649,2021,1 mg/ml,Concentrate for solution for infusion,Intravenous use,36.30,Sintetica SA,Switzerland,Sintetica SA,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
ABODEX,ABIRATERONE ACETATE,2010200233,2020,250 mg,Tablet,Oral use,5280.5,MSN LABORATORIES PRIVATE LIMITED,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Ticopex,TEICOPLANIN,77-5286-20,2020,200 mg,powder for solution for injection,Intravenous use,61.60,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Addaven,"CHROMIC CHLORIDE, COPPER CHLORIDE, FERRIC CHLORIDE, MANGANESE CHLORIDE TETRAHYDRATE, POTASSIUM IODIDE, SODIUM FLUORIDE, SODIUM MOLYBDATE, SODIUM SELENITE ANHYDROUS, ZINC CHLORIDE",2402210542,2021,"5.33,0.10,0.54,19.8,16.6,0.21,4.85,17.3,17.3 µ/ml, µg",Concentrate for solution for infusion,Intravenous use,298.95,HP Halden Pharma AS,Norway,Fresenius Kabi Norge AS,Norway,Marketed,Prescription,do not store above 30°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
EUVAX B 20MCG VIAL,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,7-800-21,2021,20 µg,Suspension for injection,Intramuscular use,582.40,"LG CHEM , OSONG PLANT",KOREA,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
EUVAX B 10MCG VIAL,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,6-800-21,2021,10 µg,Suspension for injection,Intramuscular use,374.35,"LG CHEM , OSONG PLANT",KOREA,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
FANCATA 100MG TABLET,CILOSTAZOL,456-212-20,2021,100 mg,Tablet,Oral use,67.40,ADAMED Pharma S.A,Poland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
FANCATA 50MG TABLET,CILOSTAZOL,457-212-20,2021,50 mg,Tablet,Oral use,52.95,ADAMED Pharma S.A,Poland,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
DACI,DAPTOMYCIN,81-5286-21,2021,500 mg,Powder for solution for injection/infusion,Intravenous use,372.40,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
KEPAM,LEVETIRACETAM,74-5286-20,2021,100 mg/ml,Solution for injection,Intravenous use,562.55,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
MOBIXEN,GLUCOSAMINE SULFATE,1-5382-19,2021,750 mg,Film-coated tablet,Oral use,92.10,"WALMARK, a.s",Czech Republic,"WALMARK, a.s",Czech Republic,Marketed,OTC,store below 25°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Cigalah Group, hash est"
BRIMOCOM,"TIMOLOL MALEATE, BRIMONIDINE TARTRATE",224-368-20,2021,"5,2 mg/ml",Eye drops,Ocular use,38.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
NOXAFIL,POSACONAZOLE,2-5760-22,2021,100 mg,Gastro-resistant tablet,Oral use,2491.45,N.V. Organon,Netherlands,MERCK SHARP & DOHME,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Irma-HCT 150 mg / 12.5 mg,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0812258757,2021,"150,12.5 mg",Film-coated tablet,Oral use,36,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
IRMA-HCT 300 mg / 12.5 mg,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0812258758,2021,"300,12.5 mg",Film-coated tablet,Oral use,47.75,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
ADOL,PARACETAMOL,308-186-21,2021,500 mg,Suppository,Rectal use,74.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ADOL,PARACETAMOL,307-186-21,2021,250 mg,Suppository,Rectal use,61.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ADOL,PARACETAMOL,306-186-21,2021,125 mg,Suppository,Rectal use,49.00,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
VIDONORM 5MG/4MG TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",42-972-19,2021,"5,4 mg",Tablet,Oral use,52.80,GEDEON RICHTER POLSKA Sp. z o.o,Poland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VIDONORM 5MG/8MG TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",43-972-19,2021,"5,8 mg",Tablet,Oral use,63.90,GEDEON RICHTER POLSKA Sp. z o.o,Poland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VIDONORM 10MG/4MG TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",44-972-19,2021,"10,4 mg",Tablet,Oral use,79.30,GEDEON RICHTER POLSKA Sp. z o.o,Poland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
VIDONORM 10MG/8MG TABLET,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",45-972-19,2021,"10,8 mg",Tablet,Oral use,90.40,GEDEON RICHTER POLSKA Sp. z o.o,Poland,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
LORINASE-D,"PSEUDOEPHEDRINE HYDROCHLORIDE, DESLORATADINE",2610200242,2021,"120,2.5 mg",Tablet,Oral use,24.60,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
Metolina,METOPROLOL TARTRATE,2111200276,2020,50 mg,Film-coated tablet,Oral use,13.45,Aurobindo Pharma Limited,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Trimbow,"BECLOMETHASONE DIPROPIONATE, GLYCOPYRRONIUM BROMIDE, FORMOTEROL FUMARATE",0612200306,2020,"87,9,5 µg","Pressurised inhalation, solution",Inhalation use,236.80,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ZIMMO TRADING ESTABLISHMENT
Palipra,PALIPERIDONE,2610200244,2020,6 mg,Prolonged-release tablet,Oral use,259.85,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Palipra,PALIPERIDONE,2610200245,2020,3 mg,Prolonged-release tablet,Oral use,259.85,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Aryzalera,ARIPIPRAZOLE,2502210555,2021,15 mg,Tablet,Oral use,126.65,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Aryzalera,ARIPIPRAZOLE,2502210556,2021,10 mg,Tablet,Oral use,126.65,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Olcontro,OLMESARTAN MEDOXOMIL,0202210487,2021,40 mg,Film-coated tablet,Oral use,67.10,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Olcontro,OLMESARTAN MEDOXOMIL,0202210488,2021,20 mg,Film-coated tablet,Oral use,50.35,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Attencare,ATOMOXETINE HYDROCHLORIDE,2001210435,2021,10 mg,"Capsule, hard",Oral use,190.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Attencare,ATOMOXETINE HYDROCHLORIDE,2001210436,2021,18 mg,"Capsule, hard",Oral use,190.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Attencare,ATOMOXETINE HYDROCHLORIDE,2001210443,2021,25 mg,"Capsule, hard",Oral use,190.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Attencare,ATOMOXETINE HYDROCHLORIDE,2001210433,2021,40 mg,"Capsule, hard",Oral use,190.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Attencare,ATOMOXETINE HYDROCHLORIDE,2001210432,2021,60 mg,"Capsule, hard",Oral use,190.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Iphen,PHENYLEPHRINE HYDROCHLORIDE,2402210553,2021,10 %,"Eye drops, solution",Ocular use,49.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 25°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
IMBRUVICA,IBRUTINIB,0103210571,2021,420 mg,Film-coated tablet,Oral use,24030,JANSSEN-CILAG,Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
VALGAN,Valganciclovir,2112200352,2020,450 mg,Film-coated tablet,Oral use,2499.85,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Xelobine,Capecitabine,2202210536,2020,500 mg,Film-coated tablet,Oral use,853.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Xelobine,Capecitabine,2202210537,2021,150 mg,Film-coated tablet,Oral use,149.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Vantra,AVANAFIL,2401210466,2021,100 mg,Tablet,Oral use,55.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Vantra,AVANAFIL,2401210462,2021,200 mg,Tablet,Oral use,55.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Zillion,LINEZOLID,2202210538,2021,600 mg,Film-coated tablet,Oral use,1447.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
MVASI,Bevacizumab,2402210547,2021,25 mg/ml,Concentrate for solution for infusion,Intravenous use,1173.75,AMGEN MANUFACTURING LIMITED,United States,Amgen Technology Ireland,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
MVASI,Bevacizumab,2402210550,2021,25 mg/ml,Concentrate for solution for infusion,Intravenous use,4057.85,AMGEN MANUFACTURING LIMITED,United States,Amgen Technology Ireland,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Ziextenzo,PEGFILGRASTIM,2502210557,2021,6 mg,Solution for injection in pre-filled syringe,Subcutaneous use,2095.70,SANDOZ,Austria,Sandoz GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
XCELENS extra 4,HYALURONIC ACID,1012200321,2020,23 mg,Gel for injection,Subcutaneous use,280.35,Croma GmbH,Austria,Xcelens International SAGL,Switzerland,Marketed,Prescription,store below 25°c,Hospital,Health Experts Trading Est
Rozitta,ROSUVASTATIN,2402210548,2021,20 mg,Film-coated tablet,Oral use,59.45,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Rozitta,ROSUVASTATIN,2402210549,2021,10 mg,Film-coated tablet,Oral use,44.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
KROMAFINA,ONDANSETRON,2402210540,2021,8 mg,Film-coated tablet,Oral use,136.35,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
KROMAFINA,ONDANSETRON,2402210541,2021,4 mg,Film-coated tablet,Oral use,99.10,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Cardesine 6mg/2ml Solution for Injection,ADENOSINE,2207257794,2020,3 mg/ml,Solution for injection,Intravenous use,122.20,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Pantrox,PANTOPRAZOLE,3103210658,2021,40 mg,powder for solution for injection,Intravenous use,22.90,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Sphingolin,FINGOLIMOD HYDROCHLORIDE,3103210655,2021,0.5 mg,"Capsule, hard",Oral use,4450.40,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Olmevasc,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3103210657,2021,"40,10 mg",Film-coated tablet,Oral use,66,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Olmevasc,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3103210653,2021,"40,5 mg",Film-coated tablet,Oral use,61.55,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Olmevasc,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3103210656,2021,"20,10 mg",Film-coated tablet,Oral use,57.95,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Olmevasc,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",3103210654,2021,"20,5 mg",Film-coated tablet,Oral use,47.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Pentaxim,"DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, FILAMENTOUS HAEMAGGLUTININ, INACTIVATED POLIOMYELITIS VIRUS TYPE 1 (MAHONEY STRAIN), INACTIVATED POLIOMYELITIS VIRUS TYPE 2 (MEF-1 STRAIN), INACTIVATED POLIOMYELITIS VIRUS TYPE 3 (SAUKETT STRAIN), HAEMOPHILUS INFLUENZAE TYPE B",0804210673,2021,"30,40,25,25,40,8,32,10 IU, µg, DA",Powder for suspension for injection,Intramuscular use,110.80,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
0.6% w/v Potassium Chloride in 0.9% w/v Sodium Chloride Injection USP,"SODIUM CHLORIDE, POTASSIUM CHLORIDE",1404210682,2021,"0.9,0.6 %",Solution for infusion,Intravenous use,18,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Cartimov,DIACEREIN,0804210671,2021,50 mg,"Capsule, hard",Oral use,37.3,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Lipofirate,FENOFIBRATE,1104210674,2021,145 mg,Film-coated tablet,Oral use,37.85,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Telfocus,TELMISARTAN,0505210717,2021,80 mg,Tablet,Oral use,47.35,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Telfocus,TELMISARTAN,0505210718,2021,40 mg,Tablet,Oral use,36.60,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Zapnex,CLOZAPINE,0505210715,2021,100 mg,Tablet,Oral use,109.25,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Zapnex,CLOZAPINE,0505210716,2021,25 mg,Tablet,Oral use,35.45,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
KLACID 125MG-5ML SUSP,CLARITHROMYCIN,3-5484-20,2021,25 mg/ml,Oral suspension,Oral use,46.60,ABBVIE SRL,Italy,Abbott Laboratories Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Farouk, Maamoun Tamer & CO"
DICLOGESIC RETARD,DICLOFENAC SODIUM,130-124-21,2021,100 mg,Coated tablet,Oral use,345.20,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
FUSIBACT-B CREAM,"FUSIDIC ACID, BETAMETHASONE VALERATE",2005257423,2021,"2,0.1 %",Cream,Topical,25.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
ELPIDA,DASATINIB,355-334-21,2021,20 mg,Film-coated tablet,Oral use,4752.95,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ENFORZA,"DAPAGLIFLOZIN, SAXAGLIPTIN",353-334-20,2021,"10,5 mg",Film-coated tablet,Oral use,214.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ELPIDA,DASATINIB,358-334-21,2021,140 mg,Film-coated tablet,Oral use,7302.90,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ARTELAC COMPLETE MDO EYE LUBRICANT,"SODIUM HYALURONATE, CARBOMER, TRIGLYCERIDES MEDIUM CHAIN",3-323-19,2021,"2.4,0.625,0.10 mg/g","Eye drops, solution",Ocular use,48.40,DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH,Germany,Dr. Gerhard Mann Chem. - Pharma. Fabrik GmbH,Germany,Marketed,OTC,store below 25°c,Pharmacy,ALNAGHI COMPANY
OROTIX 120MG F.C.TABLET,Etoricoxib,72-399-21,2021,120 mg,Film-coated tablet,Oral use,15.70,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
SMOFLIPID,"SOYA OIL, TRIGLYCERIDES MEDIUM CHAIN, OLIVE OIL, FISH OIL",7-734-21,2021,"60,60,50,30 mg/ml",Emulsion for infusion,Intravenous use,296.90,FRESENIUS KABI,Austria,FRESENIUS KABI AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
OCTAPLAS LG 45-70MG/ML,PLASMA PROTEIN FRACTION,5-5098-20,2021,45-70 mg/ml,Solution for infusion,Intravenous use,614.10,OCTAPHARMA,Sweden,OCTAPHARMA AG,Switzerland,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Vittoria-HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2004210689,2021,"160,12.5,5 mg",Film-coated tablet,Oral use,46.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vittoria-HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2004210687,2021,"160,25,5 mg",Film-coated tablet,Oral use,46.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Vittoria-HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2004210688,2021,"160,25,10 mg",Film-coated tablet,Oral use,54.15,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Xermelo,TELOTRISTAT ETHYL,1304210675,2021,250 mg,Film-coated tablet,Oral use,43775.00,CATALENT,France,IPSEN PHARMA,France,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Lovista,CABERGOLINE,1304210676,2021,0.5 mg,Tablet,Oral use,36.15,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Lovista,CABERGOLINE,1304210677,2021,0.5 mg,Tablet,Oral use,117.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Vimpat,LACOSAMIDE,2104210690,2021,200 mg,Film-coated tablet,Oral use,481.65,AESICA PHARMACEUTICALS GmbH,Germany,UCB Pharma S.A,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Tacidine,AZACITIDINE,1304210681,2021,100 mg,Powder for suspension for injection,Subcutaneous use,899.55,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Adijet,ADRENALINE,1304210679,2021,1 mg/ml,Solution for injection,Intramuscular and intravenous use,80,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Vedoxin,LEVOFLOXACIN,1304210680,2021,500 mg,Film-coated tablet,Oral use,44.90,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Vedoxin,LEVOFLOXACIN,1304210678,2021,250 mg,Film-coated tablet,Oral use,26,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Minoxil,MINOXIDIL,1404210683,2021,2 %,Solution,Topical,47.75,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Dallah Health Care Company
Vaxcel Heparin Sodium Injection,HEPARIN SODIUM,1504210684,2021,5000 IU/ml,Solution for injection,"Intravenous, Subcutaneous",213.45,Kotra Pharma M Sdn Bhd,Malaysia,Kotra pharma M Sdn Bhd,Malaysia,Marketed,Prescription,store below 30°c,Hospital,Al-Safa Warehouse For Pharmaceuticals Ltd
Dona,GLUCOSAMINE SULFATE,2904210701,2021,1500 mg,Powder for oral solution,Oral use,62.25,Rottapharm Ltd,Ireland,MEDA Pharma GmbH & Co. KG,Germany,Marketed,OTC,store below 30°c,Pharmacy,Viatris Arabia Limited
Lokelma,SODIUM ZIRCONIUM CYCLOSILICATE,0405210713,2021,5 g,Powder for oral suspension,Oral use,1057.40,AstraZeneca AB,Sweden,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Lokelma,SODIUM ZIRCONIUM CYCLOSILICATE,0405210712,2021,10 g,Powder for oral suspension,Oral use,1667.65,AstraZeneca AB,Sweden,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Rybelsus,SEMAGLUTIDE,0305210707,2021,14 mg,Tablet,Oral use,456.70,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Rybelsus,SEMAGLUTIDE,0305210711,2021,7 mg,Tablet,Oral use,456.70,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Rybelsus,SEMAGLUTIDE,0305210710,2021,3 mg,Tablet,Oral use,456.70,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Bosfit,BOSENTAN,1905210737,2021,125 mg,Film-coated tablet,Oral use,4874.80,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Emgality,GALCANEZUMAB,0605210720,2021,120 mg/ml,Solution for injection,Subcutaneous use,1343.05,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
ESOPOLE,ESOMEPRAZOLE,20-5362-21,2021,40 mg,Modified-release capsule,Oral use,36.75,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,22-5362-21,2021,40 mg,Modified-release capsule,Oral use,131.30,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,21-5362-21,2021,40 mg,Modified-release capsule,Oral use,65.65,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,24-5362-21,2021,20 mg,Modified-release capsule,Oral use,52.55,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,25-5362-21,2021,20 mg,Modified-release capsule,Oral use,105.10,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ESOPOLE,ESOMEPRAZOLE,23-5362-21,2021,20 mg,Modified-release capsule,Oral use,26.95,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ICLUSIG,PONATINIB,1-5888-24,2021,15 mg,Film-coated tablet,Oral use,9126.05,TAKEDA IRELAND LIMITED,Ireland,"TAKEDA PHARMACEUTICALS USA, INC.",United States,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
ICLUSIG,PONATINIB,2-5888-24,2021,45 mg,Film-coated tablet,Oral use,18252.15,TAKEDA IRELAND LIMITED,Ireland,"TAKEDA PHARMACEUTICALS USA, INC.",United States,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Rocuronium Bromide BOS,ROCURONIUM BROMIDE,0905210723,2021,10 mg/ml,Solution for injection,Intravenous use,127.95,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
TESTAVAN,TESTOSTERONE,1005210726,2021,20 mg/g,Gel,Transdermal use,213.00,ORION PHARMA,Finland,Ferring GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Erastapecs Co,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1005210728,2021,"40,10 mg",Film-coated tablet,Oral use,66,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Erastapecs Co,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1005210729,2021,"40,5 mg",Film-coated tablet,Oral use,61.55,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Erastapecs Co,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1005210727,2021,"20,5 mg",Film-coated tablet,Oral use,47.05,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Ilumya,TILDRAKIZUMAB,1705210730,2021,100 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,10664.50,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Jazeera Pharmaceutical Industries (JPI)
TEBARAT,AZELASTINE,1-5355-19,2021,0.5 mg/ml,Eye drops,Ocular use,38.70,"Laboratories SALVAT, S.A",Spain,"Laboratories SALVAT, S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Atropine Sulfate Aguettant,ATROPINE SULFATE,1805210731,2021,0.1 mg/ml,Solution for injection in pre-filled syringe,Intramuscular and intravenous use,306.60,LABORATOIRE AGUETTANT,France,AGUETTANT LABORATORIES,France,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
Allbloc,CLOFARABINE,1805210732,2021,1 mg/ml,Concentrate for solution for infusion,Intravenous use,4011.70,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Coxinix,CELECOXIB,1805210734,2021,200 mg,"Capsule, hard",Oral use,25.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Saizen,SOMATROPIN,1905210736,2021,6 mg,Solution for injection in cartridge,Subcutaneous use,512.85,MERCK SERONO SPA,Italy,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Cigalah Group, Merck Limited"
Saizen,SOMATROPIN,1905210735,2021,12 mg,Solution for injection in cartridge,Subcutaneous use,1025.70,MERCK SERONO SPA,Italy,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Cigalah Group, Merck Limited"
Poliza,DONEPEZIL HYDROCHLORIDE,2005210740,2021,5 mg,Dispersible tablet,Oral use,120.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Poliza,DONEPEZIL HYDROCHLORIDE,2005210738,2021,10 mg,Dispersible tablet,Oral use,197.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Fenajet,KETOPROFEN,2305210741,2021,100 mg,Solution for injection,Intramuscular use,34.15,Tabuk Pharmaceutical Manufacturing Co./ Dammam Plant,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Abrilada,ADALIMUMAB,2305210745,2021,40 mg,Solution for injection,Subcutaneous use,2955.80,CATALENT,United States,PFIZER,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
Abrilada,ADALIMUMAB,2305210746,2021,40 mg,Solution for injection,Subcutaneous use,2955.80,CATALENT,United States,PFIZER,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"ALNAGHI COMPANY, Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
POTELIGEO,MOGAMULIZUMAB,2405210747,2021,4 mg/ml,Concentrate for solution for infusion,Intravenous use,5905.30,Patheon Italia S.P.A.,Italy,Kyowa Kirin Holdings B.V.,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Lamzede,VELMANASE ALFA,2605210755,2021,10 mg,Powder for solution for infusion,Intravenous use,4352.35,CHIESI FARMACEUTICIS,Italy,CHIESI FARMACEUTICIS,Italy,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Golimara,FINGOLIMOD HYDROCHLORIDE,2605210756,2021,0.5 mg,"Capsule, hard",Oral use,4436.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
Gizlan,IRBESARTAN,0206210760,2021,150 mg,Film-coated tablet,Oral use,29.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Gizlan,IRBESARTAN,0206210759,2021,300 mg,Film-coated tablet,Oral use,29.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Tadoxel,DOCETAXEL,0206210761,2021,20 mg/ml,Concentrate for solution for infusion,Intravenous use,111.1,Jiangsu Hengrui Pharmaceuticals Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Tadoxel 80 mg/4 ml,DOCETAXEL,0206210762,2021,20 mg/ml,Concentrate for solution for infusion,Intravenous use,444.4,Jiangsu Hengrui Pharmaceuticals Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Divinusmet,"METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN",0206210763,2021,"1000,5 mg",Film-coated tablet,Oral use,119.40,Hikma Pharmaceuticals PLC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Divinusmet,"METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN",0206210764,2021,"1000,10 mg",Film-coated tablet,Oral use,116.10,Hikma Pharmaceuticals PLC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VORIC,VORICONAZOLE,0606210765,2021,200 mg,Powder for solution for infusion,Intravenous use,295,ELPEN PHARMACEUTICALS,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Catabina,Capecitabine,0706210768,2021,500 mg,Film-coated tablet,Oral use,978.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
7.5% Sodium Chloride Intravenous Infusion,SODIUM CHLORIDE,0806210769,2021,7.5 %,Solution for infusion,Intravenous use,34.50,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Olcontro HCT,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",0806210771,2021,"20,12.5 mg",Film-coated tablet,Oral use,47.95,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Olcontro HCT,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",0806210770,2021,"40,12.5 mg",Film-coated tablet,Oral use,63.80,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
PREVYMIS,LETERMOVIR,0906210772,2021,240 mg,Film-coated tablet,Oral use,20693.5,MSD INTERNATIONAL GMBH T/A MSD,Ireland,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Deriva BPO,"BENZOYL PEROXIDE, ADAPALENE",1006210773,2021,"25,1 mg",Gel,Topical,40.30,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
Evenity,ROMOSOZUMAB,0106210758,2021,105 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1809,AMGEN MANUFACTURING LIMITED,United States,Amgen Inc.,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Kromafina solution 4 mg/5 ml,ONDANSETRON,0605210722,2021,0.8 mg/ml,Oral solution,Oral use,90.95,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
TERROSA,TERIPARATIDE,1904210686,2021,250 µ/ml,Solution for injection,Subcutaneous use,1003.05,GEDEON RICHTER PLC.,Hungary,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Broncast Pediatric Chewable Tablet,MONTELUKAST SODIUM,2104210691,2021,4 mg,Chewable tablet,Oral use,60.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
CRYSVITA,BUROSUMAB,2504210694,2021,10 mg/ml,Solution for injection,Subcutaneous use,14779.20,Kyowa Kirin Co Ltd Takasaki Plant,Japan,Kyowa Kirin Inc,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
CRYSVITA,BUROSUMAB,2504210692,2021,20 mg/ml,Solution for injection,Subcutaneous use,29558.40,Kyowa Kirin Co Ltd Takasaki Plant,Japan,Kyowa Kirin Inc,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Salehiya Trading Co.
CRYSVITA,BUROSUMAB,2504210693,2021,30 mg/ml,Solution for injection,Subcutaneous use,44337.55,Kyowa Kirin Co Ltd Takasaki Plant,Japan,Kyowa Kirin Inc,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
LINZESS,LINACLOTIDE,35-93-20,2020,290 µg,Capsule,Oral use,204.10,Forest Laboratories Ireland Limited,Ireland,Allergan Inc,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
VIAGACIN,MOXIFLOXACIN HYDROCHLORIDE,1306210780,2021,400 mg,Film-coated tablet,Oral use,58.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
VIAGACIN,MOXIFLOXACIN HYDROCHLORIDE,1306210779,2021,400 mg,Film-coated tablet,Oral use,41.85,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
BAVENCIO,AVELUMAB,1506210790,2021,20 mg/ml,Solution for infusion,Intravenous use,4121.10,MERCK SERONO,Switzerland,Merck Europe BV,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Cigalah Group, Merck Limited"
ABRAXANE,PACLITAXEL,9-5550-22,2020,5 mg/ml,Powder for suspension,Intravenous use,1157.05,"Abraxis BioScience, LLC",United States,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
DULCOLAX 5MG ENTERIC COATED TABLET,BISACODYL,2807245667,2019,5 mg,Coated tablet,Oral use,11.20,DELPHARM REIMS S.A.S,France,A. Nattermann and Cie Gmbh,Germany,Marketed,OTC,store below 30°c,Pharmacy,Opella Arabia Limited Co
LINZESS,LINACLOTIDE,36-93-20,2020,145 µg,Capsule,Oral use,204.10,Forest Laboratories Ireland Limited,Ireland,Allergan Inc,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
VIBATIV,TELAVANCIN HYDROCHLORIDE,30-993-24,2021,750 mg,Lyophilisate for solution for infusion,Intravenous use,511.20,Samsung Biologics,South Korea,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Tabuk Pharmaceutical Manufacturing Company
VIBATIV (10 vials),TELAVANCIN HYDROCHLORIDE,29-993-24,2021,750 mg,Lyophilisate for solution for infusion,Intravenous use,5111.90,Samsung Biologics,South Korea,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Tabuk Pharmaceutical Manufacturing Company
VANCOLON 0.5 GM/Vial,VANCOMYCIN,309-186-21,2021,50 mg/ml,Powder for solution for injection/infusion,Intravenous use,363,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,do not store above 25°c,Hospital,Cigalah Group
PRILIGY,DAPOXETINE,2-184-19,2021,60 mg,Film-coated tablet,Oral use,50.40,Menarini - Von Heyden GmbH,Germany,Berlin Chemie AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LAYAL,LEVOCETIRIZINE DIHYDROCHLORIDE,2011246287,2021,5 mg,Tablet,Oral use,23.90,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
HIDRASEC,RACECADOTRIL,10-666-20,2021,100 mg,"Capsule, hard",Oral use,21.19,Laboratoires SOPHARTEX,France,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
HIDRASEC,RACECADOTRIL,9-666-20,2021,30 mg,Granules for oral suspension,Oral use,31.24,Laboratoires SOPHARTEX,France,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
HIDRASEC,RACECADOTRIL,8-666-20,2021,10 mg,Granules for oral suspension,Oral use,32.10,Laboratoires SOPHARTEX,France,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
HERZUMA,Trastuzumab,0810258352,2020,440 mg,Powder for concentrate for solution for infusion,Intravenous use,4003.10,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
FONDAPARINUX SPC 2.5MG/0.5ML INJECTION,FONDAPARINUX SODIUM,15-5171-20,2021,5 mg/ml,Injection,Subcutaneous use,37.20,Gland Pharma Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
PROTOPIC 0.1% OINTMENT,TACROLIMUS,76-19-21,2021,0.1 %,Ointment,Topical,188.80,Leo Laboratories Limited,Ireland,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALNAGHI COMPANY, Salehiya Trading Co."
PROTOPIC 0.03% OINTMENT,TACROLIMUS,77-19-21,2021,0.03 %,Ointment,Topical,176.60,Leo Laboratories Limited,Ireland,LEO Pharma A/S Denmark,Denmark,Marketed,Prescription,do not store above 25°c,Pharmacy,"ALNAGHI COMPANY, Salehiya Trading Co."
Dextrose 10% w/v in 0.225% w/v Sodium Chloride,"DEXTROSE, SODIUM CHLORIDE",1506210792,2021,"110,2.25 g/l",Solution for infusion,Intravenous use,6.40,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Capillo,"DIOSMIN, HESPERIDIN",2106210810,2021,"450,50 mg",Film-coated tablet,Oral use,31.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Eradocin,LEVOFLOXACIN,2106210812,2021,750 mg,Film-coated tablet,Oral use,47.20,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
ERADOCIN,LEVOFLOXACIN,2106210813,2021,500 mg,Film-coated tablet,Oral use,40.40,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Novfol,PROPOFOL,2206210818,2021,10 mg,Emulsion for infusion,Intravenous use,85.10,PT. Novell Pharmaceutical Laboratories,Indonesia,PT. Novell Pharmaceutical Laboratories,Indonesia,Marketed,Prescription,store below 30°c,Hospital,Girgas pharmaceutical Co
Bendy,"COLECALCIFEROL (VITAMIN D3), GLUCOSAMINE SULFATE, CHONDROITIN, HYALURONIC ACID, METHYL SULFONYL METHANE",2206210819,2021,"1000,600,250,3.3,50 mg, IU",Film-coated tablet,Oral use,54.60,TISHCON CORPORATION,United States,DILIGENCE PHARMA CORPORATION,United States,Marketed,OTC,store below 30°c,Pharmacy,Arabian Tihour Trading Establishment
Ondans,ONDANSETRON,2406210827,2021,8 mg,Film-coated tablet,Oral use,136.35,PHARMATHEN INTERNATIONAL,Greece,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Ondans,ONDANSETRON,2406210829,2021,4 mg,Film-coated tablet,Oral use,100.80,PHARMATHEN INTERNATIONAL,Greece,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Turbo,SILDENAFIL,1307210862,2021,50 mg,Orodispersible tablet,Oromucosal use,87.40,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Turbo,SILDENAFIL,1307210863,2021,50 mg,Orodispersible tablet,Oromucosal use,43.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
VaxigripTetra,"INFLUENZA A VIRUS A/INDONESIA/5/2005 (H5N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",1406210789,2021,15 µg,Suspension for injection in pre-filled syringe,Intramuscular use,54.35,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Aimovig,ERENUMAB,2406210832,2021,70 mg,Solution for injection in pre-filled pen,Subcutaneous use,1343.05,Amgen Manufacturing Ltd,United States,Novartis Europharm Limited,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novartis Saudi Limited
PROTON IV,PANTOPRAZOLE,1407210865,2021,40 mg,powder for solution for injection,Intravenous use,17.05,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
Resepta,MYCOPHENOLATE SODIUM,2406210831,2021,360 mg,Gastro-resistant tablet,Oral use,786.70,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Resepta,MYCOPHENOLATE SODIUM,2406210830,2021,180 mg,Gastro-resistant tablet,Oral use,393.35,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
DAVLEX,DESVENLAFAXINE SUCCINATE,3006210838,2021,50 mg,Film-coated tablet,Oral use,74.55,UNITED INTERNATIONAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Stablix 0.5 ml Ampules,TETANUS TOXOID,0107210839,2021,0.5 ml,Solution for injection,Intramuscular use,131.90,PT Bio Farma ( Persero ),Indonesia,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
LEUKAIR,MONTELUKAST SODIUM,1207210859,2021,5 mg,Chewable tablet,Oral use,35.70,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
LEUKAIR,MONTELUKAST SODIUM,1207210858,2021,4 mg,Chewable tablet,Oral use,29.75,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Dergit,SOLIFENACIN SUCCINATE,1608210938,2021,10 mg,Film-coated tablet,Oral use,108.90,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Dergit,SOLIFENACIN SUCCINATE,1207210860,2021,5 mg,Film-coated tablet,Oral use,84.70,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Avoban,MUPIROCIN CALCIUM,1207210861,2021,2 %,Cream,Topical,38.80,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Valtroza,BORTEZOMIB,1407210866,2021,3.5 mg/ml,powder for solution for injection,"Intravenous, Subcutaneous",2699.70,Shilpa Medicare Ltd,India,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Vorican,VORICONAZOLE,1407210867,2021,200 mg,Powder for solution for infusion,Intravenous use,283.10,Gland Pharma Limited,India,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
RENAPAT,SEVELAMER CARBONATE,1407210868,2021,800 mg,Film-coated tablet,Oral use,679.35,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Phreno XR,QUETIAPINE,1407210877,2021,400 mg,Prolonged-release tablet,Oral use,127,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210874,2021,400 mg,Prolonged-release tablet,Oral use,254,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210873,2021,300 mg,Prolonged-release tablet,Oral use,80.25,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210875,2021,300 mg,Prolonged-release tablet,Oral use,160.50,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210876,2021,200 mg,Prolonged-release tablet,Oral use,48.35,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210870,2021,200 mg,Prolonged-release tablet,Oral use,96.70,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210869,2021,50 mg,Prolonged-release tablet,Oral use,18.85,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Phreno XR,QUETIAPINE,1407210872,2021,50 mg,Prolonged-release tablet,Oral use,37.70,PHARMATHEN INTERNATIONAL,Greece,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Spravato,ESKETAMINE HYDROCHLORIDE,1507210879,2021,28 mg,Nasal spray,Nasal use,952.90,Renaissance Lakewood LLC,United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SPRAVATO,ESKETAMINE HYDROCHLORIDE,1507210878,2021,28 mg,Nasal spray,Nasal use,1905.75,Renaissance Lakewood LLC,United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
SPRAVATO,ESKETAMINE HYDROCHLORIDE,1507210880,2021,28 mg,Nasal spray,Nasal use,2858.65,Renaissance Lakewood LLC,United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Idacio,ADALIMUMAB,1507210881,2021,40 mg,Solution for injection,Subcutaneous use,2035.35,MERCK SERONO SPA,Italy,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Idacio,ADALIMUMAB,1507210882,2021,40 mg,Solution for injection,Subcutaneous use,2035.35,MERCK SERONO SPA,Italy,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Coufatex,WARFARIN SODIUM,2807210887,2021,2.5 mg,Tablet,Oral use,68.85,Apotex Inc. (Garyray),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Coufatex,WARFARIN SODIUM,1606210795,2021,3 mg,Tablet,Oral use,97.40,Apotex Inc. (Garyray),Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Coufatex,WARFARIN SODIUM,1606210797,2021,4 mg,Tablet,Oral use,97.40,Apotex Inc. (Garyray),Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Coufatex,WARFARIN SODIUM,1606210796,2021,10 mg,Tablet,Oral use,113.05,Apotex Inc. (Garyray),Canada,APOTEX,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Divido Combo,"DICLOFENAC SODIUM, OMEPRAZOLE",0208210900,2021,"75,20 mg","Capsule, hard",Oral use,101.10,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Olneda,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0408210902,2021,"20,5 mg",Film-coated tablet,Oral use,54.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Olneda,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0408210904,2021,"20,10 mg",Film-coated tablet,Oral use,67.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Olneda,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0408210901,2021,"40,5 mg",Film-coated tablet,Oral use,71.75,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Olneda,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",0408210903,2021,"40,10 mg",Film-coated tablet,Oral use,77,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Amovac Enema,"MONOSODIUM PHOSPHATE, DISODIUM PHOSPHATE",0508210905,2021,"160,60 mg/ml",Enema,Rectal use,8.55,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,OTC,store below 30°c,Pharmacy,Thimar Aljazirah Company
REYVOW,LASMIDITAN,0808210909,2021,50 mg,Film-coated tablet,Oral use,172.40,"LILLY DEL CARIBE, INC.",United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
REYVOW,LASMIDITAN,0808210910,2021,100 mg,Film-coated tablet,Oral use,344.90,"LILLY DEL CARIBE, INC.",United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Multifidera,Dimethyl Fumarate,1008210919,2021,240 mg,"Capsule, hard",Oral use,2912.30,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Multifidera,Dimethyl Fumarate,1008210917,2021,120 mg,"Capsule, hard",Oral use,518.70,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lipofirate,FENOFIBRATE,3008210999,2021,48 mg,Film-coated tablet,Oral use,12.50,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
LEQVIO,INCLISIRAN,2908210992,2021,284 mg,Solution for injection/infusion in pre-filled syringe,Subcutaneous use,9954.50,Corden Pharma S.P.A,Italy,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c don't freeze,Hospital,Novartis Saudi Limited
Plasiv,APIXABAN,1808210950,2021,5 mg,Film-coated tablet,Oral use,222.45,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Plasiv,APIXABAN,1808210951,2021,5 mg,Film-coated tablet,Oral use,106.40,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Plasiv,APIXABAN,1808210948,2021,2.5 mg,Film-coated tablet,Oral use,222.45,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Plasiv,APIXABAN,1808210949,2021,2.5 mg,Film-coated tablet,Oral use,106.40,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Lenamid,LENALIDOMIDE,1008210921,2021,25 mg,"Capsule, hard",Oral use,13611.50,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Darzalex 1800 mg per 15 ml,DARATUMUMAB,1208210930,2021,1800 mg,Solution for injection,Subcutaneous use,22518.90,JANSSEN-CILAG,Switzerland,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Lenamid,LENALIDOMIDE,1008210920,2021,10 mg,"Capsule, hard",Oral use,11749.75,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lenamid,LENALIDOMIDE,1008210918,2021,5 mg,"Capsule, hard",Oral use,11206.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
TERODA,POTASSIUM IODIDE,1108210925,2021,130 mg,Tablet,Oral use,17.10,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
TERODA,POTASSIUM IODIDE,1108210926,2021,65 mg,Tablet,Oral use,8.55,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
TERODA,POTASSIUM IODIDE,1108210923,2021,65 mg,Tablet,Oral use,85.5,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
TERODA,POTASSIUM IODIDE,1108210924,2021,130 mg,Tablet,Oral use,171,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Megmento,MICAFUNGIN,1208210931,2021,100 mg,Powder for solution for infusion,Intravenous use,714,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Megmento,MICAFUNGIN,1208210932,2021,50 mg,Powder for solution for infusion,Intravenous use,357,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Decryst,FEBUXOSTAT,1608210941,2021,80 mg,Film-coated tablet,Oral use,90.10,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Decryst,FEBUXOSTAT,1608210939,2021,40 mg,Film-coated tablet,Oral use,90.10,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
EPITAM 1000MG F.C.TAB,LEVETIRACETAM,1608210940,2021,1000 mg,Film-coated tablet,Oral use,137.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
VIRGAN,GANCICLOVIR,1708210942,2021,1.5 mg/g,eye gel,Ocular use,50.90,Farmila Thea Farmaceuticispa,Italy,LABORATORIES THEA S.I.S,France,Marketed,Prescription,do not store above 25°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
Trexon,CEFTRIAXONE,1808210943,2021,1 g,Powder and solvent for solution for injection,Intramuscular use,15.50,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Trexon,CEFTRIAXONE,1808210945,2021,500 mg,Powder and solvent for solution for injection,Intramuscular use,10.35,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Trexon,CEFTRIAXONE,1808210946,2021,1 g,Powder and solvent for solution for injection,Intravenous use,15.50,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Trexon,CEFTRIAXONE,1808210944,2021,500 mg,Powder and solvent for solution for injection,Intravenous use,10.35,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Doptelet,AVATROMBOPAG,0709211015,2021,20 mg,Film-coated tablet,Oral use,2979.95,"Kawashima Plant, Eisai Co., Ltd",Japan,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,Arabian Trade House
Doptelet,AVATROMBOPAG,0709211017,2021,20 mg,Film-coated tablet,Oral use,4470.25,"Kawashima Plant, Eisai Co., Ltd",Japan,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,Arabian Trade House
Doptelet,AVATROMBOPAG,0709211016,2021,20 mg,Film-coated tablet,Oral use,8941.10,"Kawashima Plant, Eisai Co., Ltd",Japan,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,Arabian Trade House
Bysimin,BUTYLSCOPOLAMINE BROMIDE,2308210975,2021,20 mg/ml,Solution for injection,"intramuscular, subcutaneous",16.90,MEDOCHEMIE LTD.,Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Vapress,VALSARTAN,0209211006,2021,80 mg,Film-coated tablet,Oral use,20.90,MEDOCHEMIE LTD.,Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Farouk, Maamoun Tamer & CO"
Vapress,VALSARTAN,0509211010,2021,160 mg,Film-coated tablet,Oral use,22.85,MEDOCHEMIE LTD,Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,"Store below 30°C , Protect from light and moisture",Pharmacy,"Farouk, Maamoun Tamer & CO"
Averaz,AZACITIDINE,1506210791,2021,100 mg,Powder for suspension for injection,"Intravenous, Subcutaneous",1041.65,MSN LABORATORIES PRIVATE LIMITED,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Axyla,TERIFLUNOMIDE,2608210985,2021,14 mg,Film-coated tablet,Oral use,2534.55,Shilpa Medicare Ltd,India,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
OROTIX 60MG F.C.TABLET,Etoricoxib,70-399-21,2021,60 mg,Film-coated tablet,Oral use,43.95,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
OROTIX 90MG F.C.TABLET,Etoricoxib,71-399-21,2021,90 mg,Film-coated tablet,Oral use,43.95,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
JUNYELT,"MANGANESE GLUCONATE, COPPER GLUCONATE, ZINC GLUCONATE, SODIUM SELENITE PENTAHYDRATE, POTASSIUM IODIDE",2-5338-20,2021,"40.52,1428,6970,43.81,13.08 µg",Concentrate for solution for infusion,Intravenous use,249.80,LABORATOIRE AGUETTANT,France,Baxter Healthcare SA,Switzerland,Marketed,Prescription,do not store above 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
ABELCET 5MG/ML IV VIAL,AMPHOTERICIN B,1-5621-21,2021,100 mg,Intravenous infusion,Intravenous use,720.75,"Exelead, Inc",United States,Acino France SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Acino Arabia for trading LLC, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Rixathon,RITUXIMAB,2908210991,2021,10 mg/ml,Concentrate for solution for infusion,Intravenous use,1912.05,LEK PHARMACEUTICALS D.D.,Slovenia,Sandoz GmbH,Austria,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), Protect from light and heat",Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Rixathon,RITUXIMAB,2908210990,2021,10 mg/ml,Concentrate for solution for infusion,Intravenous use,6373.55,LEK PHARMACEUTICALS D.D.,Slovenia,SANDOZ GMBH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
AROX UD 0.5% EYE DROPS,MOXIFLOXACIN HYDROCHLORIDE,227-368-20,2021,5 %,Eye drops,Ocular use,33.35,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection,TRIPTORELIN,1-686-17,2021,3 mg,Powder and solvent for suspension for injection,Intramuscular use,458.35,IPSEN PHARMA BIOTECH,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
KLACID 500MG IV POWDER FOR INJECTION,CLARITHROMYCIN,4-5484-21,2021,500 mg,Powder for injection,Intravenous use,54.90,DELPHARM REIMS S.A.S,France,Abbott Laboratories Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
MOXIDAD CAPSULES 250 MG,AMOXICILLIN,131-124-21,2021,250 mg,"Capsule, hard",Oral use,168.20,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
ZINOLE 5MG TABLET (28 tablets),ARIPIPRAZOLE,43-5015-21,2021,5 mg,Tablet,Oral use,86.95,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZINOLE 10MG TABLET (28 tablets),ARIPIPRAZOLE,44-5015-21,2021,10 mg,Tablet,Oral use,173.90,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
ZINOLE 15MG TABLET (28tablets),ARIPIPRAZOLE,45-5015-21,2021,15 mg,Tablet,Oral use,231.95,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Laroza,LURASIDONE,1808210955,2021,120 mg,Film-coated tablet,Oral use,196.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Laroza,LURASIDONE,1808210954,2021,80 mg,Film-coated tablet,Oral use,196.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Laroza,LURASIDONE,1808210953,2021,40 mg,Film-coated tablet,Oral use,196.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Laroza,LURASIDONE,1808210952,2021,20 mg,Film-coated tablet,Oral use,196.25,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Celer,DESLORATADINE,1908210956,2021,5 mg,Film-coated tablet,Oral use,16.7,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Celer,DESLORATADINE,1908210957,2021,0.5 mg,Syrup,Oral use,14.30,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
PREVYMIS,LETERMOVIR,2108210958,2021,20 mg/ml,Concentrate for solution for infusion,Intravenous use,884.95,MSD INTERNATIONAL GMBH,Ireland,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ALNAGHI COMPANY
Zylone,PREDNISOLONE SODIUM PHOSPHATE,2108210959,2021,0.3 %,Syrup,Oral use,34,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Zylone,PREDNISOLONE SODIUM PHOSPHATE,2108210960,2021,0.1 %,Syrup,Oral use,15,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Vanin,VANCOMYCIN,2408210982,2021,1000 mg,Injection,Intravenous use,306,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Vanin,VANCOMYCIN,2408210983,2021,500 mg,Injection,Intravenous use,306,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Sayen,TADALAFIL,0809211019,2021,20 mg,Orodispersible tablet,Oral use,194.50,E - PHARMA TRENTO - SPA,Italy,Safety Science Medical Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Life Pulse Medical Company
Sayen,TADALAFIL,0809211018,2021,5 mg,Orodispersible tablet,Oral use,127.05,E - PHARMA TRENTO - SPA,Italy,Safety Science Medical Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Life Pulse Medical Company
Nosco,MOMETASONE FUROATE,0809211020,2021,50 µg,Nasal spray,Nasal use,37.45,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
NOREPINEPHRINE,NOREPINEPHRINE BITARTRATE,0807210854,2021,1 mg/ml,Concentrate for solution for infusion,Intravenous use,77.70,LABORATOIRE AGUETTANT,France,AGUETTANT LABORATORIES,France,Marketed,Prescription,do not store above 25°c,Hospital,Arabian Health Care Co.
ADRENALINE 0.1mg/mL,ADRENALINE,2908210994,2021,1 µ/ml,Solution for injection in pre-filled syringe,Intravenous use,504.50,AGUETTANT LABORATORIES,France,AGUETTANT LABORATORIES,France,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
Bortada,BORTEZOMIB,0707210852,2021,2.5 mg,Solution for injection,"Intravenous, Subcutaneous",2164.65,THYMOORGAN PHARMAZIE GMBH,Germany,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Cigalah Group, STADA Arabia Limited Company"
Potassium Chloride in Dextrose and Sodium Chloride Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",0809211023,2021,"5,0.45,0.3 %",Intravenous infusion,Intravenous use,18,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Potassium Chloride in Dextrose and Sodium Chloride Injection USP,"DEXTROSE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",0809211021,2021,"5,0.45,0.15 %",Intravenous infusion,Intravenous use,18,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
POTASSIUM CHLORIDE,POTASSIUM CHLORIDE,0809211022,2021,15 %,Intravenous infusion,Intravenous use,1.10,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Apriva,APREMILAST,2609211078,2021,30 mg,Film-coated tablet,Oral use,1998.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Apriva 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 20 tablets,APREMILAST,2609211079,2021,10-20-30 mg,Film-coated tablet,Oral use,932.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Zencin,AZITHROMYCIN,0909211032,2021,500 mg,Film-coated tablet,Oral use,32.30,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Zencin,AZITHROMYCIN,0909211031,2021,250 mg,Film-coated tablet,Oral use,29.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Zersa,LINEZOLID,2009211071,2021,20 mg/ml,Oral suspension,Oral use,630,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Mizotra,METHOTREXATE,1509211053,2021,25 mg/ml,Solution for injection,Intramuscular and intravenous use,293.50,THYMOORGAN PHARMAZIE GMBH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Rosalus 20mg Film coated Tablets,ROSUVASTATIN,0607210851,2021,20 mg,Film-coated tablet,Oral use,87.25,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Rosalus 10 mg Film Coated Tablets,ROSUVASTATIN,0607210850,2021,10 mg,Film-coated tablet,Oral use,51.45,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Rosalus 5 mg Film Coated Tablets,ROSUVASTATIN,0310211092,2021,5 mg,Film-coated tablet,Oral use,25.70,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Olcontro Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1509211055,2021,"20,5 mg",Film-coated tablet,Oral use,43.90,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Olcontro Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",1509211056,2021,"40,5 mg",Film-coated tablet,Oral use,57.45,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Norphed,NOREPINEPHRINE BITARTRATE,2209211073,2021,1 mg/ml,Concentrate for solution for infusion,Intravenous use,77.67,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Ragilin,RASAGILINE,1306210777,2021,1 mg,Tablet,Oral use,324.45,Ferrer Internacional S.A,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Marixino,MEMANTINE HYDROCHLORIDE,3009211091,2021,10 mg,Film-coated tablet,Oral use,28.73,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Feromenta Folic,"IRON POLYMALTOSE, FOLIC ACID",1306210776,2021,"100,0.35 mg",Chewable tablet,Oral use,15.70,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
Feromenta,IRON POLYMALTOSE,1306210774,2021,10 mg/ml,Oral solution,Oral use,10.45,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
Engerix B 20,HEPATITIS B VIRUS HBSAG SURFACE ANTIGEN,0507210849,2021,20 µg,Suspension for injection,Intramuscular use,66.90,GlaxoSmithKline Biologicals,Belgium,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Trazimera,Trastuzumab,1306210785,2021,440 mg,Powder for concentrate for solution for infusion,Intravenous use,3019.60,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Kovaltry,HUMAN COAGULATION FACTOR VIII,1609211060,2021,250 IU,Powder and solvent for solution for injection,Intravenous use,455.15,BAYER HEALTHCARE,United States,BAYER AG,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
Kovaltry,HUMAN COAGULATION FACTOR VIII,1609211061,2021,500 IU,Powder and solvent for solution for injection,Intravenous use,876.40,BAYER HEALTHCARE,United States,BAYER AG,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
Kovaltry,HUMAN COAGULATION FACTOR VIII,1609211062,2021,1000 IU,Powder and solvent for solution for injection,Intravenous use,1779.40,BAYER HEALTHCARE,United States,BAYER AG,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Bayer Saudi Arabia
Emgality,GALCANEZUMAB,2608210988,2021,100 mg/ml,Solution for injection,Subcutaneous use,3357.65,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Dotagraf 0.5 mmol/ml Solution for Injection,GADOTERIC ACID,2709211084,2021,0.5 mmol/ml,Solution for injection,Intravenous use,109.60,Headquarter Sanochemia Pharmazeutika AG,Austria,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
Quetal 400mg XR Tablets,QUETIAPINE,0407210842,2021,400 mg,Extended-release tablet,Oral use,208.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Ceftriaxone Amarox,CEFTRIAXONE,0109211005,2021,1 g,Powder and solvent for solution for injection,Intramuscular and intravenous use,21,Jodas Expoim Pvt Ltd,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Deltapharma International Co, Farouk, Maamoun Tamer & CO"
Ceftriaxone Venus,CEFTRIAXONE,1209211036,2021,1 g,Powder for solution for injection/infusion,Intramuscular and intravenous use,19.15,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
TiboFem,TIBOLONE,2809211086,2021,2.5 mg,Tablet,Oral use,60.30,CENEXI,France,Mithra Pharmaceuticals S A,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Omnicef 250mg/5ml Suspension,CEFDINIR,2709211085,2021,50 mg/ml,Oral suspension,Oral use,101.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Batlor,DESLORATADINE,0707210853,2021,0.5 mg/ml,Syrup,Oral use,11.45,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
TALYNTA,DAPOXETINE,1609211064,2021,60 mg,Film-coated tablet,Oral use,49,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
TALYNTA,DAPOXETINE,1609211063,2021,30 mg,Film-coated tablet,Oral use,49,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Lorius,DESLORATADINE,3009211090,2021,5 mg,Film-coated tablet,Oral use,16.75,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Lorius,DESLORATADINE,3009211089,2021,5 mg,Film-coated tablet,Oral use,5.60,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Zoxta,FEBUXOSTAT,1609211058,2021,80 mg,Film-coated tablet,Oral use,63.60,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Zoxta,FEBUXOSTAT,1609211059,2021,40 mg,Film-coated tablet,Oral use,63.60,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Kanvasiv,CASPOFUNGIN ACETATE,1509211054,2021,50 mg,Powder for concentrate for solution for infusion,Intravenous use,518.15,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Kanvasiv,CASPOFUNGIN ACETATE,1509211052,2021,70 mg,Powder for concentrate for solution for infusion,Intravenous use,663.85,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Prof,IBUPROFEN,1410211175,2021,400 mg,Solution for infusion,Intravenous use,33,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
REVANESSE CONTOUR,HYALURONIC ACID,5-5326-20,2021,25 mg/ml,Injection,Cutaneous use,680.65,Prollenium Medical Technologies,Canada,Prollenium Medical Technologies Inc,Canada,Marketed,Prescription,store below 25°c,Hospital,Roken Almothmir Est
REVANESSE KISS,HYALURONIC ACID,4-5326-20,2021,25 mg/ml,Injection,Cutaneous use,653.40,Prollenium Medical Technologies,Canada,Prollenium Medical Technologies Inc,Canada,Marketed,Prescription,store below 25°c,Hospital,Roken Almothmir Est
REVANESSE ULTRA,HYALURONIC ACID,3-5326-20,2021,25 mg/ml,Injection,Cutaneous use,653.40,Prollenium Medical Technologies,Canada,Prollenium Medical Technologies Inc,Canada,Marketed,Prescription,store below 25°c,Hospital,Roken Almothmir Est
REVANESSE,HYALURONIC ACID,2-5326-20,2021,25 mg/ml,Injection,Cutaneous use,585.35,Prollenium Medical Technologies,Canada,Prollenium Medical Technologies Inc,Canada,Marketed,Prescription,store below 25°c,Hospital,Roken Almothmir Est
Dandaxa,TADALAFIL,310-186-21,2021,20 mg,Film-coated tablet,Oral use,15.85,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
NEGAZOLE,METRONIDAZOLE,311-186-21,2021,250 mg,Film-coated tablet,Oral use,26,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CLARIDAR XL 500 mg Tablet,CLARITHROMYCIN,132-124-21,2021,500 mg,Prolonged-release tablet,Oral use,57.15,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
REVANESSE PURE,HYALURONIC ACID,1-5326-20,2021,14 mg/ml,Injection,Cutaneous use,530.60,Prollenium Medical Technologies,Canada,Prollenium Medical Technologies Inc,Canada,Marketed,Prescription,store below 25°c,Hospital,Roken Almothmir Est
Glucophage XR,METFORMIN HYDROCHLORIDE,1010211109,2021,1000 mg,Prolonged-release tablet,Oral use,33.35,MERCK HEALTHCARE KGAA,Germany,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Merck Limited, Salehiya Trading Co."
Carbimazole Macleods,CARBIMAZOLE,0609211011,2021,5 mg,Tablet,Oral use,20.75,Macleods Pharmaceuticals Limited,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Veklury,REMDESIVIR,0109211000,2021,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1769.65,GILEAD SCIENCES LIMITED (CORK),Ireland,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Gilead Sciences Arabia Ltd"
Keroz,FINGOLIMOD HYDROCHLORIDE,1606210794,2021,0.5 mg,"Capsule, hard",Oral use,3225.30,Shilpa Medicare Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Neulasta Onpro,PEGFILGRASTIM,2908210993,2021,6 mg,Solution for injection in pre-filled syringe,Subcutaneous use,3531.35,AMGEN MANUFACTURING LIMITED,United States,KYOWA KIRIN LIMITED,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Cigalah Group
Proteomib,BORTEZOMIB,1710211184,2021,3.5 mg,powder for solution for injection,"Intravenous, Subcutaneous",2177.05,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Salehiya Trading Co.
TRUMENBA,"MENINGOCOCCAL GROUP A (NEISSERIA MENINGITIDIS) POLYSACCHARIDE VACCINE, MENINGOCOCCAL GROUP B (NEISSERIA MENINGITIDIS) (STRAIN NZ98/254)",0510211105,2021,"60,60 µg",Suspension for injection in pre-filled syringe,Intramuscular use,313.7,PFIZER,Ireland,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Pfizer Saudi Trading
Enzastik,ENZALUTAMIDE,2009211067,2021,40 mg,"Capsule, soft",Oral use,8979.30,Eugia Pharma Specialties Limited,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Reblozyl,LUSPATERCEPT,0109211003,2021,75 mg,powder for solution for injection,Subcutaneous use,21912.20,Patheon Italia S.P.A.,Italy,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Reblozyl,LUSPATERCEPT,0109211004,2021,25 mg,powder for solution for injection,Subcutaneous use,7303.00,Patheon Italia S.P.A.,Italy,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Feromenta,IRON POLYMALTOSE,1306210775,2021,100 mg,Chewable tablet,Oral use,15.60,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
Tedalix,"TETANUS TOXOID, DIPHTHERIA TOXOID",1309211039,2021,"7.5,2 LfU",Suspension for injection,Intramuscular use,80.05,PT Bio Farma ( Persero ),Indonesia,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
Water for injection,WATER,2608210989,2021,500 ml,Intravenous infusion,Intravenous use,5.25,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Gizlan HCT,"IRBESARTAN, HYDROCHLOROTHIAZIDE",0410211104,2021,"150,12.5 mg",Film-coated tablet,Oral use,29.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Kesimpta,OFATUMUMAB,3009211088,2021,20 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,4344.95,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA SCHWEIZ AG,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Novartis Saudi Limited
Virad,TENOFOVIR DISOPROXIL,1110211122,2021,300 mg,Film-coated tablet,Oral use,843.90,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Trivira,"EFAVIRENZ, TENOFOVIR DISOPROXIL, EMTRICITABINE",1110211117,2021,"600,300,200 mg",Film-coated tablet,Oral use,2404.55,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Fulvestrant SPC,FULVESTRANT,1310211164,2021,50 mg/ml,Solution for injection,Intramuscular use,1322.7,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Nefalgic,NEFOPAM HYDROCHLORIDE,1310211174,2021,10 mg/ml,Solution for injection,Intramuscular and intravenous use,17.65,DELPHARM LILLE S.A.S.,France,Biocodex,France,Marketed,Prescription,store below 30°c,Hospital,Al-Safa Warehouse For Pharmaceuticals Ltd
Skyrizi 150 mg,RISANKIZUMAB,1410211182,2021,150 mg,Solution for injection,Subcutaneous use,12733.30,AbbVie Deutschland GmbH & Co KG,Germany,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Oselow,OSELTAMIVIR,1710211185,2021,75 mg,Capsule,Oral use,71.85,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Bosfit,BOSENTAN,1110211124,2021,62.5 mg,Film-coated tablet,Oral use,4874.80,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Vitram Film-Coated Tablet,LEVETIRACETAM,2510211232,2021,500 mg,Film-coated tablet,Oral use,83.95,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Brukinsa,ZANUBRUTINIB,0811211272,2021,80 mg,Capsule,Oral use,26739.45,CATALENT,United States,BEONE MEDICINES,United States,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
Quetta XR,QUETIAPINE,1210211138,2021,50 mg,Prolonged-release capsule,Oral use,33.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
IROREST FCT,DEFERASIROX,1310211163,2021,90 mg,Film-coated tablet,Oral use,525.45,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
IROREST FCT,DEFERASIROX,1310211166,2021,180 mg,Film-coated tablet,Oral use,1044,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
STRENSIQ,ASFOTASE ALFA,0711211268,2021,40 mg/ml,Solution for injection,Subcutaneous use,93298.50,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
STRENSIQ,ASFOTASE ALFA,0711211270,2021,40 mg/ml,Solution for injection,Subcutaneous use,59977.20,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
STRENSIQ,ASFOTASE ALFA,0711211269,2021,40 mg/ml,Solution for injection,Subcutaneous use,133285.10,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
STRENSIQ,ASFOTASE ALFA,0711211267,2021,100 mg/ml,Solution for injection,Subcutaneous use,266570.10,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Finate,FENOFIBRATE,1110211116,2021,200 mg,"Capsule, hard",Oral use,37.85,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Cincet,CINACALCET,1110211125,2021,60 mg,Film-coated tablet,Oral use,451.85,Aurobindo Pharma Limited Unit XV,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Cincet,CINACALCET,1110211126,2021,30 mg,Film-coated tablet,Oral use,221.20,Aurobindo Pharma Limited Unit XV,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Veval,DAPOXETINE,0710211107,2021,60 mg,Film-coated tablet,Oral use,36.75,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Veval,DAPOXETINE,0710211108,2021,30 mg,Film-coated tablet,Oral use,36.75,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
OCRAN,OCTREOTIDE ACETATE,1110211134,2021,500 µ/ml,Solution for injection,"Intravenous, Subcutaneous",665,GP PHARM SA,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,MS Pharma Saudi (MSPS)
OCRAN,OCTREOTIDE ACETATE,1110211135,2021,100 µ/ml,Solution for injection,"Intravenous, Subcutaneous",133,GP PHARM SA,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,MS Pharma Saudi (MSPS)
Urago,FEBUXOSTAT,1110211128,2021,40 mg,Film-coated tablet,Oral use,90.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Urago,FEBUXOSTAT,1110211127,2021,80 mg,Film-coated tablet,Oral use,90.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Tyronib,IMATINIB MESILATE,1110211118,2021,400 mg,Film-coated tablet,Oral use,1766.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tyronib,IMATINIB MESILATE,1110211119,2021,100 mg,Film-coated tablet,Oral use,795.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lindacil,CLINDAMYCIN HYDROCHLORIDE,1210211145,2021,300 mg,Capsule,Oral use,27.90,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Lindacil,CLINDAMYCIN HYDROCHLORIDE,1210211146,2021,150 mg,Capsule,Oral use,17.10,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Iylus,VILDAGLIPTIN,2510211233,2021,50 mg,Tablet,Oral use,33.25,Savvy Pharma,Jordan,Savvy Pharma,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Zersa,LINEZOLID,1810211196,2021,2 mg/ml,Solution for infusion,Intravenous use,136.90,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Zostivr,FAMCICLOVIR,1110211121,2021,500 mg,Film-coated tablet,Oral use,1100.00,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Divira,"TENOFOVIR DISOPROXIL, EMTRICITABINE",1110211120,2021,"300,200 mg",Tablet,Oral use,1366.40,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Squadaion,BENDAMUSTINE HYDROCHLORIDE,0411211258,2021,25 mg,Lyophilisate for solution for injection,Intravenous use,242.50,Mylan Laboratories Limited,India,Mylan Laboratories Limited,India,Marketed,Prescription,store below 30°c,Hospital,Viatris Arabia Limited
Squadaion,BENDAMUSTINE HYDROCHLORIDE,0411211259,2021,100 mg,Lyophilisate for solution for injection,Intravenous use,970.10,Mylan Laboratories Limited,India,Mylan Laboratories Limited,India,Marketed,Prescription,store below 30°c,Hospital,Viatris Arabia Limited
Mavilor,NEBIVOLOL HYDROCHLORIDE,0311211253,2021,5 mg,Tablet,Oral use,25.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
FLORATIL,SACCHAROMYCES BOULARDII,1-5434-21,2021,100 mg,Powder for oral suspension,Oral use,26.25,Biocodex,France,Biocodex,France,Marketed,Prescription,store below 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
FLORATIL,SACCHAROMYCES BOULARDII,2-5434-21,2021,200 mg,"Capsule, hard",Oral use,59.90,Biocodex,France,Biocodex,France,Marketed,Prescription,store below 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
NEURODERM,"LIDOCAINE HYDROCHLORIDE, TETRACAINE HYDROCHLORIDE",27-993-20,2021,"70,70 mg/g",Cream,Topical,39.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
NERVAX 75MG CAPSULES 60 capsule,PREGABALIN,2008245778,2021,75 mg,Capsule,Oral use,135.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DENGVAXIA,"CYD DENGUE VIRUS SEROTYPE (1, 2, 3 & 4)",3-5219-20,2021,5 log10 CCID,Powder and solvent for suspension for injection,Subcutaneous use,303.60,SANOFI PASTEUR,France,SANOFI PASTEUR SA,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
BRILINTA 60 MG FILM COATED TABLET,TICAGRELOR,100-15-17,2021,60 mg,Film-coated tablet,Oral use,153.50,AstraZeneca AB,Sweden,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Pergoveris,"FOLLITROPIN ALFA, LUTROPIN ALFA",1411211310,2021,"300,150 IU",Solution for injection in pre-filled pen,Subcutaneous use,607.80,MERCK SERONO,Italy,Merck Europe BV,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Cigalah Group, Merck Limited"
Pergoveris,"FOLLITROPIN ALFA, LUTROPIN ALFA",1411211311,2021,"450,225 IU",Solution for injection in pre-filled pen,Subcutaneous use,911.65,MERCK SERONO,Italy,Merck Europe BV,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Cigalah Group, Merck Limited"
Levozal,LEVOCETIRIZINE DIHYDROCHLORIDE,1610258428,2020,0.5 mg/ml,Syrup,Oral use,28.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
PXIDONE 1MG F.C.TABLET,"3-(2-(4-(6-FLUORO-1, 2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6, 7, 8, 9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1, 2-A)PYRIMIDIN-4-ONE",6-5492-21,2021,1 mg,Film-coated tablet,Oral use,47.40,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
PXIDONE 2MG F.C.TABLET,"3-(2-(4-(6-FLUORO-1, 2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6, 7, 8, 9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1, 2-A)PYRIMIDIN-4-ONE",7-5492-21,2021,2 mg,Film-coated tablet,Oral use,60.55,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
PXIDONE 3MG F.C.TABLET,"3-(2-(4-(6-FLUORO-1, 2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6, 7, 8, 9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1, 2-A)PYRIMIDIN-4-ONE",8-5492-21,2021,3 mg,Film-coated tablet,Oral use,116.80,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
PXIDONE 4MG F.C.TABLET,"3-(2-(4-(6-FLUORO-1, 2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6, 7, 8, 9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1, 2-A)PYRIMIDIN-4-ONE",9-5492-21,2021,4 mg,Film-coated tablet,Oral use,148.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Erastapecs Plus 20/12.5MG F.C.TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",10-5492-21,2021,"20,12.5 mg",Film-coated tablet,Oral use,47.95,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Erastapecs Plus 40/12.5MG F.C.TABLET,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",11-5492-21,2021,"40,12.5 mg",Film-coated tablet,Oral use,63.80,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
MST Continus 10 mg,MORPHINE SULFATE,1811211343,2021,10 mg,Prolonged-release tablet,Oral use,47.05,Bard Pharmaceuticals Limited,United Kingdom,MUNDIPHARMA MEDICAL COMPANY,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
MST Continus 30 mg,MORPHINE SULFATE,1811211344,2021,30 mg,Prolonged-release tablet,Oral use,116.20,Bard Pharmaceuticals Limited,United Kingdom,MUNDIPHARMA MEDICAL COMPANY,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
MST Continus 60 mg,MORPHINE SULFATE,1811211342,2021,60 mg,Prolonged-release tablet,Oral use,218.90,Bard Pharmaceuticals Limited,United Kingdom,MUNDIPHARMA MEDICAL COMPANY,Switzerland,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
Concor Amlo,"BISOPROLOL FUMARATE, AMLODIPINE BESILATE",0812211438,2021,"5,5 mg",Tablet,Oral use,41.10,EGIS PHARMACEUTICALS PLC,Hungary,Merck KFT,Hungary,Marketed,Prescription,store below 30°c,Pharmacy,"Merck Limited, Salehiya Trading Co."
Concor Amlo,"BISOPROLOL FUMARATE, AMLODIPINE BESILATE",0812211437,2021,"5,10 mg",Tablet,Oral use,55.55,EGIS PHARMACEUTICALS PLC,Hungary,Merck KFT,Hungary,Marketed,Prescription,store below 30°c,Pharmacy,"Merck Limited, Salehiya Trading Co."
IMFINZI 120 mg / 2.4 ml,DURVALUMAB,0911211289,2021,50 mg/ml,Solution for infusion,Intravenous use,2787.50,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
IMFINZI 500 mg / 10 ml,DURVALUMAB,0911211288,2021,50 mg/ml,Solution for infusion,Intravenous use,11614.50,Catalent Indiana LLC formerly Cook Pharmica LLC,United States,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Polivy,POLATUZUMAB VEDOTIN,2511211369,2021,140 mg,Powder for concentrate for solution for infusion,Intravenous use,45516.85,BSP PHARMACEUTICALS S.r.l.,Italy,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
Levozyrt,LEVOCETIRIZINE DIHYDROCHLORIDE,1811211337,2021,5 mg,Film-coated tablet,Oral use,23.90,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Erloz,ERLOTINIB,1111211299,2021,150 mg,Film-coated tablet,Oral use,4419.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Erloz,ERLOTINIB,1111211298,2021,100 mg,Film-coated tablet,Oral use,3358.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Trioltan,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0911211290,2021,"40,12.5,10 mg",Film-coated tablet,Oral use,79.80,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Trioltan,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",0911211291,2021,"40,12.5,5 mg",Film-coated tablet,Oral use,71.25,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
KETOTHROM,KETOROLAC TROMETHAMINE,1811211338,2021,30 mg/ml,Solution for injection,Intravenous use,35.20,PT. Novell Pharmaceutical Laboratories,Indonesia,PT. Novell Pharmaceutical Laboratories,Indonesia,Marketed,Prescription,store below 30°c,Hospital,Girgas pharmaceutical Co
Fulphila,PEGFILGRASTIM,0912211454,2021,10 mg/ml,Solution for injection,Subcutaneous use,1886.10,Biocon Limited,India,Biosimilar Collaborations Ireland Limited (BCIL),Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Cigalah Group, Viatris Arabia Limited"
Tigecycline BOS,TIGECYCLINE,0911211287,2021,50 mg,Powder for solution for infusion,Intravenous use,119.95,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Traxia,CISATRACURIUM,3011211401,2021,2 mg/ml,Solution for injection,Intravenous use,65.05,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Veltero,BORTEZOMIB,1111211297,2021,3.5 mg,Solution for injection,Intravenous use,2177.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Tranexamic acid BOS,TRANEXAMIC ACID,0612211429,2021,100 mg/ml,Solution for injection,Intravenous use,12.40,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
PRENA 15MG/5ML SYRUP,PREDNISOLONE,1411211316,2021,3 mg/ml,Syrup,Oral use,34,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Firazyr 30 mg per 3 ml,ICATIBANT,0212211410,2021,10 mg/ml,Solution for injection,Subcutaneous use,4781.10,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
Zostivr,FAMCICLOVIR,2811211384,2021,250 mg,Film-coated tablet,Oral use,550.00,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ANTINAL  200 MG CAPSULE,NIFUROXAZIDE,2411211363,2021,200 mg,Capsule,Oral use,13.85,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Thimar Aljazirah Company
Pedovex,CLOPIDOGREL,1411211315,2021,75 mg,Film-coated tablet,Oral use,173.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
DAPTOMYCIN BOS,DAPTOMYCIN,1611211329,2021,350 mg,Powder for solution for injection/infusion,Intravenous use,173.35,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Qualcox,CELECOXIB,0912211461,2021,200 mg,Capsule,Oral use,25.05,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Darista,DARUNAVIR,0112211405,2021,600 mg,Film-coated tablet,Oral use,1721.40,APL Health Care Limited,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Darista,DARUNAVIR,0112211406,2021,400 mg,Film-coated tablet,Oral use,1080.60,APL Health Care Limited,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
IBRANCE,PALBOCICLIB,1111211304,2021,75 mg,Film-coated tablet,Oral use,8551.00,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
IBRANCE,PALBOCICLIB,1111211305,2021,100 mg,Film-coated tablet,Oral use,8551.00,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
IBRANCE,PALBOCICLIB,1111211309,2021,125 mg,Film-coated tablet,Oral use,8551.00,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Kalmo,LORNOXICAM,0912211453,2021,8 mg,Film-coated tablet,Oral use,23.60,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Pexapan,APIXABAN,1111211303,2021,5 mg,Film-coated tablet,Oral use,231.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Pexapan,APIXABAN,1111211301,2021,2.5 mg,Film-coated tablet,Oral use,231.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Pexapan,APIXABAN,1111211300,2021,2.5 mg,Film-coated tablet,Oral use,77.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Xospata,GILTERITINIB,3011211402,2021,40 mg,Film-coated tablet,Oral use,72743.35,Astellas Pharma Inc,Japan,Astellas Pharma Europe B.V.,Netherlands,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Voricet,VORICONAZOLE,2311211352,2021,200 mg,Powder for solution for infusion,Parenteral use,289.05,LEK PHARMACEUTICALS D.D.,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Megval 50 mg per 10 ml,MELPHALAN,0512211427,2021,5 mg/ml,Powder and solvent for solution for infusion,Intravenous use,416.5,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
Relexib,CELECOXIB,0712211430,2021,200 mg,"Capsule, hard",Oral use,25,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Relexib,CELECOXIB,0712211431,2021,100 mg,"Capsule, hard",Oral use,12.50,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Migrotan,ELETRIPTAN,0512211417,2021,40 mg,Film-coated tablet,Oral use,59.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Migrotan,ELETRIPTAN,0512211419,2021,40 mg,Film-coated tablet,Oral use,131.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Resilia,FEBUXOSTAT,1611211331,2021,80 mg,Film-coated tablet,Oral use,87.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Resilia,FEBUXOSTAT,1611211330,2021,40 mg,Film-coated tablet,Oral use,87.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Alpha Pharma Industry, Cigalah Group"
Hivera,TENOFOVIR DISOPROXIL,2811211378,2021,300 mg,Film-coated tablet,Oral use,783.65,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Bexenta,CISATRACURIUM,1511211323,2021,2 mg/ml,Solution for injection,Intravenous use,69.85,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
Alix,PEMETREXED,1612211484,2021,500 mg,Lyophilisate for solution for injection,Intravenous use,2595.15,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
VFEND 40MG/ML POWDER FOR SUSPENSION,VORICONAZOLE,20-828-22,2021,40 mg/ml,Powder for oral suspension,Oral use,1470.25,Fareva Amboise,France,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"ALNAGHI COMPANY, Pfizer Saudi Trading"
Panamol,PARACETAMOL,2012211486,2021,10 mg/ml,Intravenous infusion,Intravenous use,17.30,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,AL RAZI PHARMA INDUSTRIES
Empaveli 1080 mg per 20 ml,PEGCETACOPLAN,2212211495,2021,54 mg/ml,Solution for infusion,Subcutaneous use,18371.60,Bora Pharmaceuticals Injectables Inc.,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Empaveli 1080 mg per 20 ml 8 vials,PEGCETACOPLAN,2212211496,2021,54 mg/ml,Solution for infusion,Subcutaneous use,146972.80,Bora Pharmaceuticals Injectables Inc.,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Starkoprex,TADALAFIL,3012211532,2021,20 mg,Film-coated tablet,Oral use,64.85,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
FENTANYL MEDIS 10 ml Ampoule,FENTANYL,1512211479,2021,50 µ/ml,Solution for injection,Intravenous use,63.80,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
FENTANYL MEDIS 2 ml Ampoule,FENTANYL,1512211480,2021,50 µ/ml,Solution for injection,Intravenous use,25.85,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
ARTELAC COMPLETE SDU EYE DROP,"SODIUM HYALURONATE, TRIGLYCERIDES MEDIUM CHAIN, CARBOMER",4-323-20,2022,"2.4,2,0.625 mg/g","Eye drops, solution",Ophthalmic use,53.60,DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH,Germany,Dr. Gerhard Mann Chem. - Pharma. Fabrik GmbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
Rozlytrek,ENTRECTINIB,0301221550,2022,100 mg,"Capsule, hard",Oral use,3444.35,Mayne Pharma Inc,United States,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Roche Products Saudi Arabia
Rozlytrek,ENTRECTINIB,0301221552,2022,200 mg,"Capsule, hard",Oral use,20653.45,Mayne Pharma Inc,United States,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Roche Products Saudi Arabia
Evrysdi 60 mg/80ml,RISDIPLAM,0301221551,2022,0.75 mg/ml,Powder for oral solution,Oral use,40090.20,F. Hoffmann-La Roche Ltd.,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store below 25°c,Hospital,Roche Products Saudi Arabia
Gemcitabine BOS,GEMCITABINE,0301221548,2021,1000 mg,Concentrate for solution for infusion,Intravenous use,169.75,Shilpa Medicare Ltd,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Lojuxta,LOMITAPIDE MESYLATE,1412211475,2021,5 mg,"Capsule, hard",Oral use,91051.30,CATALENT,United States,Amryt Pharmaceuticals DAC,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Lojuxta,LOMITAPIDE MESYLATE,1412211474,2021,10 mg,"Capsule, hard",Oral use,91051.30,CATALENT,United States,Amryt Pharmaceuticals DAC,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Lojuxta,LOMITAPIDE MESYLATE,1412211476,2021,20 mg,"Capsule, hard",Oral use,91051.30,CATALENT,United States,Amryt Pharmaceuticals DAC,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Kepavie,LEVETIRACETAM,1312211472,2022,500 mg,Film-coated tablet,Oral use,58.45,Taha Pharma,Tunisia,Taha Pharma,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
Cefepime Amarox,CEFEPIME HYDROCHLORIDE,1312211467,2021,1000 mg,Powder for solution for injection/infusion,Intravenous use,29,Jodas Expoim Pvt Ltd,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Deltapharma International Co, Farouk, Maamoun Tamer & CO"
Artelac Ectoin SDU,ECTOINE,1912211485,2021,20 mg,Eye drops,Ocular use,36.85,DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH,Germany,Dr. Gerhard Mann Chem. - Pharma. Fabrik GmbH,Germany,Marketed,OTC,store below 30°c,Pharmacy,ALNAGHI COMPANY
Zorta,ARIPIPRAZOLE,2612211584,2021,1 mg/ml,Oral solution,Oral use,157.85,UNITED INTERNATIONAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Dicynone,ETAMSYLATE,2012211491,2021,500 mg,Capsule,Oral use,50.60,Corden Pharma Lisbon S.A,Portugal,OM Pharma SA,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
Crinone,PROGESTERONE,1901221616,2022,8 %,Vaginal gel,Vaginal use,185.05,Dendron Brands Limited,United Kingdom,MERCK SERONO EUROPE LTD,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Merck Limited"
Starkoprex,TADALAFIL,1001221581,2022,5 mg,Film-coated tablet,Oral use,136.15,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Dusta plus,"DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE",1512211478,2022,"0.5,0.4 mg","Capsule, hard",Oral use,90.45,"LABORATORIOS LEON FARMA, S.A.",Spain,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
RELIPAN,DICLOFENAC SODIUM,0201221544,2022,25 mg/ml,Solution for injection,Intravenous use,20.75,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Pretava,PRALIDOXIME CHLORIDE,1201221585,2022,1 g,Powder for solution for injection/infusion,Intravenous use,1581.75,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Clavodar ES Suspension,"AMOXICILLIN, CLAVULANIC ACID",2812211516,2022,"600,62.9 mg",Powder for oral suspension,Oral use,29.40,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Fedlora,"PSEUDOEPHEDRINE HYDROCHLORIDE, LORATADINE",3112211533,2021,"12,1 mg/ml",Syrup,Oral use,17.35,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Midathetic,MIDAZOLAM,2012211490,2022,5 mg/ml,Solution for injection,Intravenous use,14.25,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Hospital,Thimar Aljazirah Company
Fasturtec,RASBURICASE,1301221587,2022,1.5 mg,Powder and solvent for solution for infusion,Intravenous use,979.75,sanofi S.R.L,Italy,Sanofi Aventis France,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
Fasturtec,RASBURICASE,1301221588,2022,7.5 mg,Powder and solvent for solution for infusion,Intravenous use,1632.90,sanofi S.R.L,Italy,Sanofi Aventis France,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
MONTEK 4 mg,MONTELUKAST SODIUM,2912211523,2021,4 mg,Chewable tablet,Oral use,64.30,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
MONTEK 5 mg,MONTELUKAST SODIUM,2912211522,2021,5 mg,Chewable tablet,Oral use,64.30,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
MONTEK 10 mg,MONTELUKAST SODIUM,2912211521,2021,10 mg,Film-coated tablet,Oral use,71.45,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
REMOSTA,SUNITINIB,0501221568,2022,50 mg,"Capsule, hard",Oral use,12446.00,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
REMOSTA,SUNITINIB,0501221569,2022,25 mg,"Capsule, hard",Oral use,6223.00,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
REMOSTA,SUNITINIB,0501221567,2022,12.5 mg,"Capsule, hard",Oral use,3111.50,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Erbitux 100 mg per 20 ml,CETUXIMAB,2301221621,2022,5 mg/ml,Solution for infusion,Intravenous use,1089.00,MERCK HEALTHCARE KGAA,Germany,Merck Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Merck Limited, Salehiya Trading Co."
KANUMA,SEBELIPASE ALFA,1101221583,2022,2 mg/ml,Concentrate for solution for infusion,Intravenous use,32606.95,Patheon Italia S.P.A.,Italy,Alexion Europe SAS,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Axepta,ATOMOXETINE HYDROCHLORIDE,2612211509,2021,10 mg,"Capsule, hard",Oral use,181.30,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
LOTEMAX 0.5% GEL,LOTEPREDNOL ETABONATE,2-5174-19,2022,0.5 %,eye gel,Ophthalmic use,64.10,"Bausch & Lomb, Incorporated",United States,"Bausch & Lomb, Incorporated",United States,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
Axepta,ATOMOXETINE HYDROCHLORIDE,2612211506,2021,18 mg,"Capsule, hard",Oral use,181.30,UNITED INTERNATIONAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
Axepta,ATOMOXETINE HYDROCHLORIDE,2612211508,2021,25 mg,"Capsule, hard",Oral use,181.30,UNITED INTERNATIONAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
Axepta,ATOMOXETINE HYDROCHLORIDE,2612211505,2021,40 mg,"Capsule, hard",Oral use,181.30,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
Axepta,ATOMOXETINE HYDROCHLORIDE,2612211507,2021,60 mg,"Capsule, hard",Oral use,181.30,UNITED INTERNATIONAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
HEMABO 24MG/1.2ML,PLERIXAFOR,0401221553,2022,20 mg/ml,Solution for injection,Subcutaneous use,11847.95,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Gizlan HCT,"IRBESARTAN, HYDROCHLOROTHIAZIDE",2812211517,2021,"300,12.5 mg",Film-coated tablet,Oral use,29.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Gizlan HCT,"IRBESARTAN, HYDROCHLOROTHIAZIDE",2812211515,2021,"300,25 mg",Film-coated tablet,Oral use,29.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Amstar,"VALSARTAN, AMLODIPINE BESILATE",3012211531,2022,"160,10 mg",Film-coated tablet,Oral use,42.20,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Amstar,"VALSARTAN, AMLODIPINE BESILATE",0201221547,2022,"160,5 mg",Film-coated tablet,Oral use,42.20,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Influvac Tetra,"A/Brisbane/02/2018 (H1N1), A/Kansas/14/2017 (H3N2), B/Colorado/06/2017, B/Phuket/3073/2013",0702221686,2022,"15,15,15,15 µg",Suspension for injection in pre-filled syringe,"intramuscular, subcutaneous",54.35,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Enstilar,"BETAMETHASONE DIPROPIONATE, Calcipotriol",0702221683,2022,"500,50 µg",Cutaneous foam,Cutaneous use,170.70,Leo Laboratories Limited,Ireland,Leo Pharma,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,ALNAGHI COMPANY
JEXT,ADRENALINE,1801221610,2022,150 µg,Solution for injection,Intramuscular use,363.00,ALK-Abelló S.A,Spain,ALK-Abello A/S,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
JEXT,ADRENALINE,1801221611,2022,300 µg,Solution for injection,Intramuscular use,363.00,ALK-Abelló S.A,Spain,ALK-Abello A/S,Denmark,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ELPIDA 50MG FILM COATED TABLET,DASATINIB,356-334-21,2021,50 mg,Film-coated tablet,Oral use,7083.80,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ELPIDA 70MG FILM COATED TABLET,DASATINIB,357-334-21,2021,70 mg,Film-coated tablet,Oral use,7302.90,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
VelExel,VENLAFAXINE HYDROCHLORIDE,2501221634,2022,150 mg,Prolonged-release tablet,Oral use,121.90,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,"Arabian Trade House, International Teriaqi for medicines ESt"
VelExel,VENLAFAXINE HYDROCHLORIDE,2501221635,2022,75 mg,Prolonged-release tablet,Oral use,60.95,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,"Arabian Trade House, International Teriaqi for medicines ESt"
NEUCYTE,PEGFILGRASTIM,0802221689,2022,10 mg/ml,Solution for injection,Subcutaneous use,1765.65,Biocon Limited,India,Biocon Biologics Limited,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., Mohamed Youssef Mohamed Salah Jamjoom Medical Company"
ENDOSA 2000IU PRE-FILLED SYRINGE,ENOXAPARIN SODIUM,1801221605,2022,20 mg,Solution for injection,Subcutaneous use,19.6,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,SPIMACO
ENDOSA 4000IU PRE-FILLED SYRINGE,ENOXAPARIN SODIUM,1801221609,2022,40 mg,Solution for injection,Subcutaneous use,33.8,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,SPIMACO
ENDOSA 6000IU PRE-FILLED SYRINGE,ENOXAPARIN SODIUM,1801221607,2022,60 mg,Solution for injection,Subcutaneous use,47,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,SPIMACO
ENDOSA 8000IU PRE-FILLED SYRINGE,ENOXAPARIN SODIUM,1801221608,2022,80 mg,Solution for injection,Subcutaneous use,58,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,SPIMACO
Penetro,VARDENAFIL,2302221761,2022,20 mg,Tablet,Oral use,68.70,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Aronep,ADRENALINE,2301221625,2022,1 mg/ml,Solution for injection,Intramuscular use,80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
HADLIMA 40MG/0.8ML INJECTION IN PFP,ADALIMUMAB,3101221656,2022,40 mg,Solution for injection,Subcutaneous use,1889.10,Catalent Belgium SA,Belgium,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO"
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING,ADALIMUMAB,3101221655,2022,40 mg,Solution for injection,Subcutaneous use,1889.10,Catalent Belgium SA,Belgium,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO"
TYKODAS,DASATINIB,2102221755,2022,100 mg,Film-coated tablet,Oral use,10439.30,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Avotrene Emulgel,DICLOFENAC SODIUM,3001221645,2022,1 %,Gel,Topical,14.40,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Lepica,PREGABALIN,2001221619,2022,150 mg,"Capsule, hard",Oral use,71.95,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Lepica,PREGABALIN,2001221620,2022,75 mg,"Capsule, hard",Oral use,51.40,Laboratorios Liconsa S.A,Spain,Medical Valley Invest AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ENTYVIO,VEDOLIZUMAB,3001221647,2022,108 mg,Solution for injection,Subcutaneous use,4079.15,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Abdulrehman Algosaibi G.T.C.
ENTYVIO,VEDOLIZUMAB,3001221646,2022,108 mg,Solution for injection,Subcutaneous use,4079.15,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Abdulrehman Algosaibi G.T.C.
Ezokamine,MICAFUNGIN,1901221617,2022,50 mg,Powder for solution for infusion,Intravenous use,331.50,"Sagent Pharmaceuticals, Inc",United States,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,"Farouk, Maamoun Tamer & CO"
Maxique 400 mg / 250 ml Solution For Intravenous Infusion,MOXIFLOXACIN HYDROCHLORIDE,0802221688,2022,1.6 mg/ml,Solution for infusion,Intravenous use,81,Pharmaceutical Solution Industries (PSI),Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Zavoxa,EZETIMIBE,1901221614,2022,10 mg,Tablet,Oral use,118.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
ATIQUIX,APIXABAN,2002221737,2022,5 mg,Film-coated tablet,Oral use,231.00,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
ATIQUIX,APIXABAN,2002221738,2022,2.5 mg,Film-coated tablet,Oral use,231.00,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Amaglime-Met,"METFORMIN HYDROCHLORIDE, GLIMEPIRIDE",0202221671,2022,"500,2 mg",Tablet,Oral use,19.40,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Trepadio,LACOSAMIDE,2102221756,2022,100 mg,Film-coated tablet,Oral use,193.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Trepadio,LACOSAMIDE,2102221757,2022,200 mg,Film-coated tablet,Oral use,387.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Trepadio,LACOSAMIDE,2102221758,2022,150 mg,Film-coated tablet,Oral use,290.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Kerendia,FINERENONE,1003221837,2022,10 mg,Film-coated tablet,Oral use,381.15,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Bayer Saudi Arabia
Enerzair Breezhaler,"MOMETASONE FUROATE, (indacaterol (as acetate, GLYCOPYRRONIUM BROMIDE",0903221834,2022,"160,150,50 µg","Inhalation powder, hard capsule",Inhalation use,236.80,NOVARTIS Pharma Stein AG,Switzerland,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
SHINGRIX,VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ADJUVANTED WITH AS01B,0703221823,2022,50 µg,Powder for suspension for injection,Intramuscular use,774.90,GlaxoSmithKline Biologicals,Belgium,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Sulmetic,AMISULPRIDE,1702221730,2022,400 mg,Film-coated tablet,Oral use,147.20,Aurobindo Pharma Limited Unit III,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Sulmetic,AMISULPRIDE,1702221731,2022,200 mg,Film-coated tablet,Oral use,94.30,Aurobindo Pharma Limited Unit III,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Emopack,OMEPRAZOLE,0102221665,2022,40 mg,Powder for solution for injection/infusion,Intravenous use,22.50,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Pulmirema 0.25 mg,BUDESONIDE,2301221624,2022,0.125 mg/ml,Nebuliser suspension,Inhalation use,134.50,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Pulmirema 0.5 mg,BUDESONIDE,2301221623,2022,0.25 mg/ml,Nebuliser suspension,Inhalation use,134.50,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Pulmirema 1 mg,BUDESONIDE,2301221622,2022,0.5 mg/ml,Nebuliser suspension,Inhalation use,191.30,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Sermitor,TOREMIFENE CITRATE,2102221747,2022,60 mg,Tablet,Oral use,155.05,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Anidulafungin BOS,ANIDULAFUNGIN,2102221754,2022,100 mg,Powder for concentrate for solution for infusion,Intravenous use,406.80,Actavis Italy SpA,Italy,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Floristil 250 mg per 5 ml,FULVESTRANT,2001221618,2022,50 mg/ml,Solution for injection,Intravenous use,1256.55,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd (CTTQ)",China,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
VITAROS 3MG/GM CREAM,ALPROSTADIL,1-5330-19,2022,3 mg/g,Cream,Topical,300.00,GROUPE PARIMA INC,Canada,ELIS PHARMACEUTICAL LTD,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALHAYA MEDICAL CO
VASCEPA 1GM CAPSULE,ICOSAPENT ETHYL,1-5828-23,2022,1 g,"Capsule, soft",Oral use,668.05,Patheon Soft Gels BV,Netherlands,Amarin Pharmaceuticals Ireland Ltd,United States,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Dorius,DESLORATADINE,2401221632,2022,5 mg,Film-coated tablet,Oral use,18.85,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Increlex 40 mg per 4 ml,MECASERMIN,1003221839,2022,10 mg/ml,Solution for injection,Subcutaneous use,2518.40,BAXTER ONCOLOGY GmbH,Germany,IPSEN PHARMA,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Salehiya Trading Co.
Iohexol PPI,IOHEXOL,2402221765,2022,300 mg/ml,Solution for injection,Intravenous use,530.90,Jodas Expoim Pvt Ltd,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Traxia,CISATRACURIUM,0703221820,2022,2 mg/ml,Solution for injection/infusion,Intravenous use,50,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Decitabine SPC 50mg for Injection,DECITABINE,1603221851,2022,50 mg,Powder for solution for infusion,Intravitreal use,4126,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
RYALTRIS,"OLOPATADINE, MOMETASONE FUROATE",1603221850,2022,"600,25 µg",Nasal spray,Nasal use,73.50,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Specialty S A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
PREMOSAN 10MG,METOCLOPRAMIDE HYDROCHLORIDE,312-186-22,2022,10 mg,Tablet,Oral use,64.15,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Platica,TICAGRELOR,2003221857,2022,90 mg,Film-coated tablet,Oral use,182.55,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Nicorette,NICOTINE,0603221810,2022,25 mg,Transdermal patch,Transdermal use,60.10,LTS LOHMANN Therapie-Systeme,Germany,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Nicorette,NICOTINE,0603221811,2022,15 mg,Transdermal patch,Transdermal use,60.10,LTS LOHMANN Therapie-Systeme,Germany,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Nicorette,NICOTINE,0603221812,2022,10 mg,Transdermal patch,Transdermal use,60.10,LTS LOHMANN Therapie-Systeme,Germany,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Trepadio,LACOSAMIDE,2003221858,2022,10 mg/ml,Syrup,Oral use,67.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Trepadio,LACOSAMIDE,2103221859,2022,50 mg,Film-coated tablet,Oral use,23.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Helt,TADALAFIL,1303221843,2022,5 mg,Film-coated tablet,Oral use,136.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
VITRAM Oral Solution,LEVETIRACETAM,0903221832,2022,100 mg/ml,Oral solution,Oral use,167.2,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
CANDAN,CANDESARTAN CILEXETIL,1302221724,2022,8 mg,Tablet,Oral use,23.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Vaprena,TOLVAPTAN,0103221787,2022,30 mg,Tablet,Oral use,3834.20,Jiangsu Hengrui Pharmaceuticals Co Ltd,China,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Vaprena,TOLVAPTAN,0103221785,2022,15 mg,Tablet,Oral use,3834.20,Jiangsu Hengrui Pharmaceuticals Co Ltd,China,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lodiab XR,METFORMIN HYDROCHLORIDE,0603221813,2022,1000 mg,Prolonged-release tablet,Oral use,28.35,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Lodiab XR,METFORMIN HYDROCHLORIDE,0603221817,2022,750 mg,Prolonged-release tablet,Oral use,21.25,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Lodiab XR,METFORMIN HYDROCHLORIDE,0603221814,2022,1000 mg,Prolonged-release tablet,Oral use,56.70,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Lodiab XR,METFORMIN HYDROCHLORIDE,0603221815,2022,1000 mg,Prolonged-release tablet,Oral use,85.05,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Lodiab XR,METFORMIN HYDROCHLORIDE,0603221816,2022,750 mg,Prolonged-release tablet,Oral use,42.50,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Lodiab XR,METFORMIN HYDROCHLORIDE,1503221849,2022,750 mg,Prolonged-release tablet,Oral use,63.75,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Baclon,BACLOFEN,2702221770,2022,10 mg,Tablet,Oral use,31.40,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Baclon,BACLOFEN,2702221771,2022,25 mg,Tablet,Oral use,63.45,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Sodium Chloride 0.9 % Injection USP,SODIUM CHLORIDE,2402221764,2022,0.9 %,concentrate for solution for injection,Intravenous use,4.15,ADVANCED PHARMACEUTICAL FACTORY (APF),Saudi Arabia,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,ADVANCED PHARMACEUTICAL FACTORY (APF)
Sogroya 10 mg / 1.5 ml,SOMAPACITAN,0903221831,2022,6.7 mg/ml,Solution for injection,Subcutaneous use,2048.00,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
GLYXAMBI,"EMPAGLIFLOZIN, LINAGLIPTIN",118-68-18,2022,"25,5 mg",Film-coated tablet,Oral use,226.05,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,BOEHRINGER INGELHEIM,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
GLYXAMBI,"EMPAGLIFLOZIN, LINAGLIPTIN",117-68-18,2022,"10,5 mg",Film-coated tablet,Oral use,226.05,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,BOEHRINGER INGELHEIM,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
FEMIC,TRANEXAMIC ACID,2103221861,2022,500 mg,Film-coated tablet,Oral use,127.70,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Serova,ROSUVASTATIN,2303221880,2022,10 mg,Film-coated tablet,Oral use,51.45,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Serova,ROSUVASTATIN,2303221879,2022,20 mg,Film-coated tablet,Oral use,87.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Serova,ROSUVASTATIN,2303221881,2022,40 mg,Film-coated tablet,Oral use,174.50,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Emedan 4 mg / 2 ml,ONDANSETRON,2303221883,2022,2 mg/ml,Solution for injection,Intravenous use,56.10,PHARMATHEN INTERNATIONAL,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Emedan 8 mg / 4 ml,ONDANSETRON,2303221882,2022,2 mg/ml,Solution for injection,Intravenous use,112.25,PHARMATHEN INTERNATIONAL,Greece,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Defitelio 200 mg per 2.5,DEFIBROTIDE,2303221875,2022,80 mg/ml,Concentrate for solution for infusion,Intravenous use,22191.65,Patheon Italia S.P.A.,Italy,Jazz Pharmaceutical Ireland Ltd,Ireland,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
Verquvo,VERICIGUAT,2403221885,2022,2.5 mg,Film-coated tablet,Oral use,220.80,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Bayer Saudi Arabia
Verquvo,VERICIGUAT,2403221884,2022,5 mg,Film-coated tablet,Oral use,220.80,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Bayer Saudi Arabia
Verquvo,VERICIGUAT,2403221886,2022,10 mg,Film-coated tablet,Oral use,422.45,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Bayer Saudi Arabia
ADRIBLASTINA 50MG/25ML VIAL,DOXORUBICIN HYDROCHLORIDE,7-5669-22,2022,2 mg/ml,Solution for injection,Intravenous use,116.90,Zydus Hospira Oncology Private Limited ZHOPL,India,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
ADRIBLASTINA 10MG/5ML VIAL,DOXORUBICIN HYDROCHLORIDE,6-5669-22,2022,2 mg/ml,Solution for injection,Intravenous use,51.75,Zydus Hospira Oncology Private Limited ZHOPL,India,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
FARMARUBICIN 10MG/5ML INJECTION,EPIRUBICIN HYDROCHLORIDE,1-5381-19,2022,2 mg/ml,Solution for injection,Intravenous use,86.80,PFIZER PERTH PTY LIMITED,Australia,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
FARMARUBICIN 50MG/25ML VIAL,EPIRUBICIN HYDROCHLORIDE,2-5381-19,2022,2 mg/ml,Solution for injection,Intravenous use,166.05,PFIZER PERTH PTY LIMITED,Australia,Pfizer Australia Pty LTD,Australia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
Salocan,CISATRACURIUM,0404221912,2022,2 mg/ml,Solution for injection,Intravenous use,139.30,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Tabuk Pharmaceutical Manufacturing Company
Salocan,CISATRACURIUM,0404221913,2022,2 mg/ml,Solution for injection,Intravenous use,68.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Tabuk Pharmaceutical Manufacturing Company
Praluent 300 mg per 2 ml,ALIROCUMAB,0404221909,2022,150 mg/ml,Solution for injection,Subcutaneous use,1873.10,Sanofi aventis Deutschland GmbH,Germany,Sanofi Clir SNC,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Voriole,VORICONAZOLE,0304221905,2022,200 mg,Powder for solution for infusion,Intravenous use,198.15,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Formit XR,METFORMIN HYDROCHLORIDE,1004221932,2022,500 mg,Extended-release tablet,Oral use,12.50,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Gizamlo,"IRBESARTAN, AMLODIPINE BESILATE",0604221921,2022,"300,10 mg",Film-coated tablet,Oral use,61.10,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Gizamlo,"IRBESARTAN, AMLODIPINE BESILATE",0604221922,2022,"300,5 mg",Film-coated tablet,Oral use,61.10,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Gizamlo,"IRBESARTAN, AMLODIPINE BESILATE",0604221923,2022,"150,5 mg",Film-coated tablet,Oral use,61.10,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Ultranem,MEROPENEM,0504221916,2022,1000 mg,Powder for solution for infusion,Intravenous use,356.40,ACS Dobfar S.P.A,Italy,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Ultranem,MEROPENEM,0504221917,2022,500 mg,Powder for solution for infusion,Intravenous use,211.95,ACS Dobfar S.P.A,Italy,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
LYPFEN,FENOFIBRATE,1304221942,2022,200 mg,"Capsule, hard",Oral use,35.95,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Formit XR,METFORMIN HYDROCHLORIDE,1104221936,2022,500 mg,Extended-release tablet,Oral use,25.00,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Bilaxten,BILASTINE,1304221939,2022,2.5 mg/ml,Oral solution,Oral use,26.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Bilaxten,BILASTINE,1304221940,2022,10 mg,Orodispersible tablet,Oral use,26.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Jylamvo,METHOTREXATE,1104221933,2022,2 mg/ml,Oral solution,Oral use,619.30,Quay Pharmaceuticals Limited,United Kingdom,Therakind (Europe) Limited,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,QOMEL MEDICAL DRUG STORE
WinRho SDF Liquid,ANTI-D [RHO] IMMUNOGLOBULIN,1104221934,2022,600 IU,Solution for injection,Intravenous use,142.55,Emergent BioSolutions Canada Inc,Canada,KI BIOPHARMA LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
WinRho SDF Liquid,ANTI-D [RHO] IMMUNOGLOBULIN,1104221935,2022,1500 IU,Solution for injection,Intravenous use,228.75,Emergent BioSolutions Canada Inc,Canada,KI BIOPHARMA LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
KAPRON,TRANEXAMIC ACID,1404221943,2022,500 mg,Tablet,Oral use,23.30,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Thimar Aljazirah Company
ANXETIN 20MG CAPSULES,FLUOXETINE,133-124-22,2022,20 mg,Capsule,Oral use,529.65,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
TRANSLARNA,ATALUREN,1-5481-20,2022,125 mg,Granules for oral suspension,Oral use,11894.60,Pharmaceutical Manufacturing Research Services Inc. PMRS,United States,PTC Therapeutics International Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TRANSLARNA,ATALUREN,2-5481-20,2022,250 mg,Granules for oral suspension,Oral use,23789.20,Pharmaceutical Manufacturing Research Services Inc. PMRS,United States,PTC Therapeutics International Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
TRANSLARNA,ATALUREN,3-5481-20,2022,1000 mg,Granules for oral suspension,Oral use,95156.85,Pharmaceutical Manufacturing Research Services Inc. PMRS,United States,PTC Therapeutics International Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,6-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,448.30,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,7-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,1120.70,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,8-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,2241.40,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,11-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,13448.40,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,10-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,8965.60,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
PANZYGA,HUMAN IMMUNOGLOBULIN PROTEINS,9-5098-20,2022,100 mg/ml,Solution for infusion,Intravenous use,4482.80,OCTAPHARMA,Austria,OCTAPHARMA AG,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Cartiflex,"GLUCOSAMINE SULFATE, GINKGO BILOBA",1804221947,2022,"500,50 mg","Capsule, hard",Oral use,26.0,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Exetora 20 mg/4 ml,TORASEMIDE,2704221992,2022,5 mg/ml,Solution for injection,Intravenous use,84.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Sodium Chloride 0.9%,SODIUM CHLORIDE,2504221974,2022,0.9 %,Solution for infusion,Intravenous use,5.00,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Sodium Chloride 0.9%,SODIUM CHLORIDE,2504221975,2022,0.9 %,Solution for infusion,Intravenous use,8.85,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Sodium Chloride 0.9%,SODIUM CHLORIDE,2504221976,2022,0.9 %,Solution for infusion,Intravenous use,15.55,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Epnone,EPLERENONE,2504221978,2022,25 mg,Film-coated tablet,Oral use,35.00,MSN LABORATORIES PRIVATE LIMITED,India,MSN LABORATORIES PRIVATE LIMITED,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Adrixa,DEXAMETHASONE,0805222002,2022,4 mg/ml,Solution for injection,Intravenous use,27.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Rastor,ROSUVASTATIN,2604221986,2022,40 mg,Film-coated tablet,Oral use,174.50,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Rastor,ROSUVASTATIN,2604221984,2022,20 mg,Film-coated tablet,Oral use,87.25,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Rastor,ROSUVASTATIN,2604221985,2022,10 mg,Film-coated tablet,Oral use,51.45,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Rastor,ROSUVASTATIN,2604221987,2022,5 mg,Film-coated tablet,Oral use,25.70,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Correx,Etoricoxib,1404221944,2022,90 mg,Film-coated tablet,Oral use,41.00,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
"ATECTURA 150/160MCG INHALATION POWDER, HARD CAPSULE","MOMETASONE FUROATE, (indacaterol (as acetate",2104221968,2022,"160,150 µg","Inhalation powder, hard capsule",Oral use,108.10,Siegfried Barbera S.L,Spain,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ATECTURA,"MOMETASONE FUROATE, (indacaterol (as acetate",2104221969,2022,"320,150 µg","Inhalation powder, hard capsule",Oral use,108.10,Siegfried Barbera S.L,Spain,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
ATECTURA,"MOMETASONE FUROATE, (indacaterol (as acetate",2104221967,2022,"80,150 µg","Inhalation powder, hard capsule",Oral use,108.10,Siegfried Barbera S.L,Spain,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
EMLOP 1MG/ML AMPOULE,GRANISETRON,2604221988,2022,1 mg/ml,Solution for injection/infusion,Intravenous use,31.05,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 25°c,Hospital,Thimar Aljazirah Company
AVOCOM 0.1% OINTMENT 50 g,MOMETASONE FUROATE,71-437-22,2022,0.1 %,Ointment,Topical,23.90,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
MONOZIDE 25MG TAB,HYDROCHLOROTHIAZIDE,83-171-21,2021,25 mg,Tablet,Oral use,327.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
ELIVE,ENTECAVIR,2704221994,2022,0.5 mg,Film-coated tablet,Oral use,1352.55,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
ELIVE,ENTECAVIR,2704221993,2022,1 mg,Film-coated tablet,Oral use,1387.10,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Tadafect,TADALAFIL,1704221945,2022,20 mg,Film-coated tablet,Oral use,116.90,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
GLOFEL 5 mg Film-coated Tablet,TADALAFIL,2604221982,2022,5 mg,Film-coated tablet,Oral use,120.00,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, MANAYER NAJD TRADING MEDICAL NEEDS CO."
Kerendia,FINERENONE,0805222001,2022,20 mg,Film-coated tablet,Oral use,381.15,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Bayer Saudi Arabia
Moxidad forte,AMOXICILLIN,2804221996,2022,500 mg,"Capsule, hard",Oral use,256.40,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Opsumit,MACITENTAN,1505222025,2022,10 mg,Film-coated tablet,Oral use,6720.50,EXCELLA GmbH & Co. KG,Germany,ACTELTION PHARMACEUTICALS LTD,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ceftazidime Venus,CEFTAZIDIME,3005222084,2022,1 g,Powder for solution for injection/infusion,Intramuscular and intravenous use,41.65,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Xenor,CEFTRIAXONE,1605222027,2022,1000 mg,powder for solution for injection,Intramuscular and intravenous use,155.00,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Ponizex,PANTOPRAZOLE,2305222051,2022,40 mg,powder for solution for injection,Intravenous use,16,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,MS Pharma Saudi (MSPS)
DIBASA,CHOLECALCIFEROL,2605222076,2022,10000 IU/ml,"Oral drops, solution",Oral use,18.45,ABIOGEN PHARMA S.p.A.,Italy,ABIOGEN PHARMA S.p.A.,Italy,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO"
Ultranem,MEROPENEM,1505222023,2022,2000 mg,Powder for solution for infusion,Intravenous use,840.00,ACS Dobfar S.P.A,Italy,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Utrogestan,PROGESTERONE,0106222116,2022,100 mg,"Capsule, soft","Oral use , Vaginal use",67.60,"CYNDEA PHARMA , S.L",Spain,Laboratoires Besins International,France,Marketed,Prescription,store below 30°c,Pharmacy,SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD
Utrogestan,PROGESTERONE,0106222117,2022,200 mg,"Capsule, soft","Oral use , Vaginal use",67.60,"CYNDEA PHARMA , S.L",Spain,Laboratoires Besins International,France,Marketed,Prescription,store below 30°c,Pharmacy,SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD
Afstyla,LONOCTOCOG ALFA,2505222064,2022,250 IU,Powder and solvent for solution for injection,Intravenous use,628.75,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Afstyla,LONOCTOCOG ALFA,2505222065,2022,500 IU,Powder and solvent for solution for injection,Intravenous use,1257.55,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Afstyla,LONOCTOCOG ALFA,2505222066,2022,1000 IU,Powder and solvent for solution for injection,Intravenous use,2515.00,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Afstyla,LONOCTOCOG ALFA,2505222067,2022,2000 IU,Powder and solvent for solution for injection,Intravenous use,5030.10,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Afstyla,LONOCTOCOG ALFA,2505222063,2022,3000 IU,Powder and solvent for solution for injection,Intravenous use,7545.00,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Fenido,PIRFENIDONE,2905222079,2022,267 mg,Film-coated tablet,Oral use,2170.35,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Fenido,PIRFENIDONE,2905222080,2022,801 mg,Film-coated tablet,Oral use,6285.70,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Breztri Aerosphere,"FORMOTEROL FUMARATE, GLYCOPYRRONIUM BROMIDE, BUDESONIDE",1705222041,2022,"5,7.2,160 TU/ml, µg","Pressurised inhalation, suspension",Inhalation use,236.80,AstraZeneca Dunkerque Production (AZDP),France,AstraZeneca,Austria,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Foscarnet BOS,FOSCARNET,1605222028,2022,24 mg/ml,Solution for infusion,Intravenous use,821.30,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Tysabri,NATALIZUMAB,1905222045,2022,150 mg,Solution for injection in pre-filled syringe,Subcutaneous use,5558.25,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Biogen Arabia, Salehiya Trading Co."
TAMFREX,TAMSULOSIN HYDROCHLORIDE,3105222113,2022,0.4 mg,Prolonged-release capsule,Oral use,63.00,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
SOCLAV,"AMOXICILLIN, CLAVULANIC ACID",3105222114,2022,"1000,125 mg",Powder for oral suspension,Oral use,39.75,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group"
SOCLAV,"AMOXICILLIN, CLAVULANIC ACID",3105222115,2022,"500,62.5 mg",Powder for oral suspension,Oral use,24.95,SOTHEMA,Morocco,Laboratories SOTHEMA,Morocco,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group"
ATORVA 80MG F.C. TABLETS,ATORVASTATIN CALCIUM,364-334-22,2022,80 mg,Film-coated tablet,Oral use,1448.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ATORVA 20MG F.C. TABLETS,ATORVASTATIN CALCIUM,362-334-22,2022,20 mg,Film-coated tablet,Oral use,724.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ATORVA 40MG F.C. TABLETS,ATORVASTATIN CALCIUM,363-334-22,2022,40 mg,Film-coated tablet,Oral use,1448.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ATORVA 10MG F.C. TABLETS,ATORVASTATIN CALCIUM,361-334-22,2022,10 mg,Film-coated tablet,Oral use,724.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Dacarbazine medac,DACARBAZINE,1401256608,2022,100 mg,Powder for solution for infusion,Intravenous use,506.70,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Dacarbazine medac,DACARBAZINE,1401256609,2022,200 mg,Powder for solution for injection/infusion,Intravenous use,1013.40,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Dacarbazine medac,DACARBAZINE,2904257308,2022,500 mg,Powder for solution for injection/infusion,Intravenous use,244.50,MEDAC,Germany,MEDAC,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
ASACOL,MESALAZINE,2806222271,2022,1600 mg,modified-release tablet,Oral use,295.55,Haupt Pharma Wulfing GmbH,Germany,Tillotts Pharma GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
Kerasal,SALICYLIC ACID,2806222272,2022,5 %,Ointment,Topical,14.80,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Factory,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Dallah Health Care Company
Retevmo,SELPERCATINIB,2806222274,2022,40 mg,Capsule,Oral use,11768.60,Quotient Sciences Philadelphia LLC,United States,Eli Lilly and Company,United States,Marketed,Prescription,do not store above 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Retevmo,SELPERCATINIB,2806222276,2022,80 mg,Capsule,Oral use,23537.15,Quotient Sciences Philadelphia LLC,United States,Eli Lilly and Company,United States,Marketed,Prescription,do not store above 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Truvelog,INSULIN ASPART,2306222250,2022,100 IU/ml,Solution for injection,Subcutaneous use,141.75,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Sanofi Arabia Trading Co. Ltd
Suxamethonium Chloride Martindale,SUXAMETHONIUM CHLORIDE,0706222142,2022,50 mg/ml,Solution for injection,Intravenous use,75.95,MACARTHYS LABORATORIES LIMITED T\A MARTINDALE PHARMA,United Kingdom,MARTINDALE PHARMACEUTICALS LTD TRADING AS MARTINDALE PHARMA,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Dapazin,DAPAGLIFLOZIN,0806222159,2022,5 mg,Film-coated tablet,Oral use,153.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Dapazin,DAPAGLIFLOZIN,0806222160,2022,10 mg,Film-coated tablet,Oral use,153.10,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
AKLIEF,TRIFAROTENE,0906222164,2022,50 µg/g,Cream,Topical,139.80,GALDERMA,France,GALDERMA,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Farouk, Maamoun Tamer & CO, Galderma Arabia"
Hizentra 2 g per  10 ml PFS,HUMAN NORMAL IMMUNOGLOBULIN,1306222181,2022,200 mg/ml,Solution for injection,Subcutaneous use,888.85,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Hizentra 1 g per 5 ml PFS,HUMAN NORMAL IMMUNOGLOBULIN,1306222182,2022,200 mg/ml,Solution for injection,Subcutaneous use,444.40,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Hizentra 4 g per 20 ml PFS,HUMAN NORMAL IMMUNOGLOBULIN,1306222183,2022,200 mg/ml,Solution for injection,Subcutaneous use,1777.65,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Rosacil,TADALAFIL,1306222185,2022,20 mg,Film-coated tablet,Oral use,64.85,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Rosacil,TADALAFIL,1306222184,2022,5 mg,Film-coated tablet,Oral use,136.15,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Tadalo,TADALAFIL,1306222186,2022,20 mg,Film-coated tablet,Oral use,64.85,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
BCG CULTURE AJV,live attenuated bacteria of the type Mycobacterium bovis BCG (Bacillus Calmette-Guerin),2706222262,2022,30 mg,Powder for bladder irrigation,"Intravenous, Intravesical",1361.65,AJ VACCINES A/S,Denmark,AJ VACCINES A/S,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
ENOXA,ENOXAPARIN SODIUM,2906222278,2022,20 mg,Solution for injection,Subcutaneous use,18.20,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ENOXA,ENOXAPARIN SODIUM,2906222279,2022,80 mg,Solution for injection,Subcutaneous use,49.30,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ENOXA,ENOXAPARIN SODIUM,2906222280,2022,60 mg,Solution for injection,Subcutaneous use,39.70,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
ENOXA,ENOXAPARIN SODIUM,2906222281,2022,40 mg,Solution for injection,Subcutaneous use,28.20,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Dapxiga,DAPAGLIFLOZIN,2906222285,2022,5 mg,Film-coated tablet,Oral use,135.95,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Dapxiga,DAPAGLIFLOZIN,2906222287,2022,10 mg,Film-coated tablet,Oral use,135.95,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Bivoneb,NEBIVOLOL HYDROCHLORIDE,2906222286,2022,5 mg,Tablet,Oral use,51.90,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Glucovance,"GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE",3006222290,2022,"5,1000 mg",Film-coated tablet,Oral use,25.50,MERCK SANTE,France,MERCK SANTE,France,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Cigalah Group, Merck Limited"
Valgiver,Valganciclovir,0207222295,2022,450 mg,Film-coated tablet,Oral use,2499.85,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Staquis,Crisaborole,0307222298,2022,2 %,Ointment,Topical,340.30,PHARMACIA UPJOHN,United States,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
Xcard,APIXABAN,0307222299,2022,2.5 mg,Tablet,Oral use,231.00,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Xcard,APIXABAN,0307222300,2022,5 mg,Tablet,Oral use,222.45,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Xcard,APIXABAN,0307222301,2022,2.5 mg,Tablet,Oral use,74.15,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Xcard,APIXABAN,0407222302,2022,5 mg,Tablet,Oral use,74.15,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tofibra,TOBRAMYCIN,0507222303,2022,300 mg,Nebuliser solution,Inhalation use,9762.30,Holopack (Laufen),Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Dopamine Fresenius 200 mg/5 ml,DOPAMINE HYDROCHLORIDE,2007222317,2022,40 mg/ml,Concentrate for solution for infusion,Intravenous use,163.40,Fresenius Kabi Austria GmbH,Austria,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
"Ephedrine 3 mg/ml, solution for injection in pre-filled syringe",Ephedrine hydrochloride,2407222343,2022,3 mg/ml,Solution for injection in pre-filled syringe,Intravenous use,273.05,LABORATOIRE AGUETTANT,France,AGUETTANT LABORATORIES,France,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
DIVAD 5000 I.U CAPSULE,CHOLECALCIFEROL,110-124-18,2022,5000 IU/U,"Capsule, hard",Oral use,9.60,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
VaxigripTetra,INFLUENZA VIRUS INACTIVATED SPLIT,1108222460,2022,15 µg,Suspension for injection,"intramuscular, subcutaneous",463.75,SANOFI PASTEUR,France,SANOFI PASTEUR,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Abdulrehman Algosaibi G.T.C.
Rydapt 25mg Soft Capsules,Midostaurin,2408222548,2022,25 mg,"Capsule, soft",Oral use,58587.25,CATALENT GERMANY EBERBACH GmbH,Germany,Novartis Europharm Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,Novartis Saudi Limited
Orziban,RIZATRIPTAN BENZOATE,0408222401,2022,10 mg,Orodispersible tablet,Oral use,150.70,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,MS Pharma Saudi (MSPS)
Thyritol,PARICALCITOL,3107222373,2022,5 µ/ml,Solution for injection,Intravenous use,248.65,Refarm Laboratories Ltd,Greece,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Salehiya Trading Co."
Dullarma,IBRUTINIB,1708222501,2022,140 mg,"Capsule, hard",Oral use,24785.00,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
CALCIUM CHLORIDE 10% I.V INFUSION,CALCIUM CHLORIDE,3-5077-20,2020,10 %,Intravenous infusion,Intravenous use,45.45,MARTINDALE PHARMACEUTICALS LIMITED,United Kingdom,Aurum Pharmaceuticals Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Vesuv,SILDENAFIL,1808222520,2022,50 mg,Film-coated tablet,Oral use,39.35,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Vesuv,SILDENAFIL,1808222521,2022,100 mg,Film-coated tablet,Oral use,39.35,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Lenvatinib BOS,LENVATINIB,1208222479,2022,10 mg,"Capsule, hard",Oral use,4817.75,Shilpa Medicare Ltd,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Sitagen,SITAGLIPTIN PHOSPHATE,1406222188,2022,50 mg,Film-coated tablet,Oral use,74.40,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Sitagen,SITAGLIPTIN PHOSPHATE,1406222187,2022,100 mg,Film-coated tablet,Oral use,90.20,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Zenix,LINEZOLID,0708222418,2022,600 mg,Film-coated tablet,Oral use,1137.60,Hemofarm AD Vrsac,Serbia,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., STADA Arabia Limited Company, Salehiya Trading Co."
Tigebax,TIGECYCLINE,0806222158,2022,50 mg,Powder for infusion,Intravenous use,111.40,Gland Pharma Limited,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Salehiya Trading Co."
PREMABAN,ATOSIBAN,3107222363,2022,7.5 mg/ml,Solution for injection,Intravenous use,45.05,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
PREMABAN,ATOSIBAN,3107222364,2022,7.5 mg/ml,Solution for injection,Intravenous use,250.35,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Buvidal,BUPRENORPHINE,0808222428,2022,8 mg,Solution for injection,Subcutaneous use,333.85,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,0808222427,2022,16 mg,Solution for injection,Subcutaneous use,333.85,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,0808222426,2022,24 mg,Solution for injection,Subcutaneous use,333.85,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,0808222430,2022,32 mg,Solution for injection,Subcutaneous use,333.85,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,0808222429,2022,64 mg,Solution for injection,Subcutaneous use,1460.50,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,2908222557,2022,96 mg,Solution for injection,Subcutaneous use,1460.50,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Buvidal,BUPRENORPHINE,0808222431,2022,128 mg,Solution for injection,Subcutaneous use,1460.50,Rechon Life Science AB,Sweden,Camurus AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Lovera,TADALAFIL,1808222522,2022,20 mg,Film-coated tablet,Oral use,32.40,DAMMAM PHARMA,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
Posacore,POSACONAZOLE,2308222535,2022,100 mg,Gastro-resistant tablet,Oral use,2325.35,Haimen pharma Inc,China,innovative healthcare solutions Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,innovative healthcare solutions
Orladeyo,Berotralstat,1608222499,2022,150 mg,"Capsule, hard",Oral use,41530.50,CATALENT,United States,"BioCryst Pharmaceuticals, Inc",United States,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
BIMZELX,BIMEKIZUMAB,3107222375,2022,160 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,8873.50,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,UCB Pharma S.A.,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO"
Helt,TADALAFIL,2909222671,2022,20 mg,Film-coated tablet,Oral use,63.45,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
YUPELRI 175 mcg / 3 ml,REVEFENACIN,0908222440,2022,175 µg,inhalation solution,Inhalation use,71.50,The Ritedose Corporation,United States,Mylan Ireland Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Viatris Arabia Limited
YUPELRI 175 mcg / 3 ml,REVEFENACIN,0908222443,2022,175 µg,inhalation solution,Inhalation use,306.50,The Ritedose Corporation,United States,Mylan Ireland Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Viatris Arabia Limited"
Adazio,QUETIAPINE,0408222412,2022,25 mg,Film-coated tablet,Oral use,33.30,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Zolgensma,ONASEMNOGENE ABEPARVOVEC,0510222689,2022,2000000000000 vg/ml,Suspension for injection,Intravenous use,7984675.90,"Novartis Gene Therapies, Inc",United States,Novartis Europharm Limited,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Novartis Saudi Limited
Xenor,CEFTRIAXONE,0509222586,2022,500 mg,powder for solution for injection,Intramuscular and intravenous use,77.50,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Betaquil,BETAHISTINE DIHYDROCHLORIDE,2909222668,2022,8 mg,Tablet,Oral use,13.60,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Betaquil,BETAHISTINE DIHYDROCHLORIDE,2909222666,2022,16 mg,Tablet,Oral use,23.00,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Betaquil,BETAHISTINE DIHYDROCHLORIDE,2909222667,2022,24 mg,Tablet,Oral use,24.30,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Helt,TADALAFIL,2909222669,2022,10 mg,Film-coated tablet,Oral use,28.45,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Helt,TADALAFIL,2909222670,2022,20 mg,Film-coated tablet,Oral use,15.85,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Helt,TADALAFIL,2909222674,2022,10 mg,Film-coated tablet,Oral use,7.25,Pharma International Co.,Jordan,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
NABOTA,CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX,2509222631,2022,100 IU,powder for solution for injection,Intramuscular use,391.45,DAEWOONG PHARMACEUTICAL CO LTD,South Korea,DAEWOONG PHARMACEUTICAL CO LTD,South Korea,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,AME compant for Medical Supplies
Gleptal,VILDAGLIPTIN,2509222633,2022,50 mg,Tablet,Oral use,66.50,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Xivar,RIVAROXABAN,3107222374,2022,15 mg,Film-coated tablet,Oral use,150.65,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Vyepti,EPTINEZUMAB,1708222503,2022,100 mg/ml,Concentrate for solution for infusion,Intravenous use,4029.15,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,H. LUNDBECK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Decanta,DECITABINE,1708222502,2022,50 mg,Powder for solution for infusion,Intravenous use,3919.70,Shilpa Medicare Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Iksaront,APIXABAN,0409222583,2022,5 mg,Film-coated tablet,Oral use,115.50,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Iksaront,APIXABAN,0409222582,2022,2.5 mg,Film-coated tablet,Oral use,115.50,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Neutra,LEVETIRACETAM,2108222527,2022,500 mg,Film-coated tablet,Oral use,58.45,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
Progecta,VASOPRESSIN,2308222532,2022,20 IU/ml,Solution for injection,"Intrathecal, Intravenous, Intramuscular",1489.05,JSC Farmak,Ukraine,JSC FARMAK,Ukraine,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Sorafenib BOS,SORAFENIB,2408222547,2022,200 mg,Film-coated tablet,Oral use,5138.60,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Varlin,VARENICLINE,2408222544,2022,1 mg,Film-coated tablet,Oral use,209.60,APL Health Care Limited,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Varlin  0.5 mg 11 tablets + 1 mg 14 tablets,VARENICLINE,2408222545,2022,0.5 mg,Film-coated tablet,Oral use,124.50,APL Health Care Limited,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Wetzo,APREMILAST,3008222562,2022,30 mg,Film-coated tablet,Oral use,1732.05,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Wetzo 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 20 tablets,APREMILAST,3008222561,2022,10-20-30 mg,Film-coated tablet,Oral use,866.00,Macleods Pharmaceuticals Limited,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
FOVEPTA,HUMAN HEPATITIS B IMMUNOGLOBULIN,3008222560,2022,200 IU,concentrate for solution for injection,"intramuscular, subcutaneous",983.20,VETTER PHARMA,Germany,BIOTEST,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Aimovig,ERENUMAB,1210222726,2022,140 mg,Solution for injection in pre-filled pen,Subcutaneous use,1343.05,Amgen Manufacturing Ltd,United States,Novartis Europharm Limited,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Novartis Saudi Limited
Phesgo,"PERTUZUMAB, Trastuzumab",2308222531,2022,"80,40 mg/ml",Solution for injection,Subcutaneous use,25814.85,F. Hoffmann-La Roche Ltd.,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
Phesgo,"PERTUZUMAB, Trastuzumab",2408222551,2022,"60,60 mg, µ/ml",Solution for injection,Subcutaneous use,15636.80,F. Hoffmann-La Roche Ltd.,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
Rivax,RIVAROXABAN,2609222640,2022,20 mg,Film-coated tablet,Oral use,192.45,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Rivax,RIVAROXABAN,2609222642,2022,15 mg,Film-coated tablet,Oral use,179.70,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Rivax,RIVAROXABAN,2609222639,2022,10 mg,Film-coated tablet,Oral use,64.15,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Rivax,RIVAROXABAN,2609222641,2022,2.5 mg,Film-coated tablet,Oral use,190.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Rivax,RIVAROXABAN,2609222647,2022,15 mg,Film-coated tablet,Oral use,299.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Nevotic,LEVOFLOXACIN,0610222695,2022,750 mg,Film-coated tablet,Oral use,43.40,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Zolomid,TEMOZOLOMIDE,1910222759,2022,20 mg,"Capsule, hard",Oral use,226.50,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,Eva Pharma for Pharmaceuticals & Medical Appliances,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Zolomid,TEMOZOLOMIDE,1910222760,2022,100 mg,"Capsule, hard",Oral use,1074.05,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,Eva Pharma for Pharmaceuticals & Medical Appliances,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
SIMLANDI 40MG/0.4ML SOLUTION FOR INJECTION PFS,ADALIMUMAB,1910222761,2022,"40 mg, mg/ml",Solution for injection,Subcutaneous use,1889.10,Alvotech hf,Iceland,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SIMLANDI 40MG/0.4ML SOLUTION FOR INJECTION PFS,ADALIMUMAB,1910222762,2022,40 mg,Solution for injection,Subcutaneous use,1889.10,Alvotech hf,Iceland,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Tabuk Pharmaceutical Manufacturing Company
SIMLANDI 80MG/0.4ML SOLUTION FOR INJECTION PFS,ADALIMUMAB,1910222763,2022,80 mg,Solution for injection,Subcutaneous use,1889.10,Alvotech hf,Iceland,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Roneza,"ROSUVASTATIN, EZETIMIBE",1309222602,2022,"5,10 mg",Film-coated tablet,Oral use,184.10,ELPEN PHARMACEUTICALS,Greece,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Roneza,"ROSUVASTATIN, EZETIMIBE",1309222601,2022,"10,10 mg",Film-coated tablet,Oral use,221.95,ELPEN PHARMACEUTICALS,Greece,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Roneza,"ROSUVASTATIN, EZETIMIBE",1309222600,2022,"20,10 mg",Film-coated tablet,Oral use,274.60,ELPEN PHARMACEUTICALS,Greece,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Roneza,"ROSUVASTATIN, EZETIMIBE",1309222603,2022,"40,10 mg",Film-coated tablet,Oral use,356.70,ELPEN PHARMACEUTICALS,Greece,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
EpiPen 300 mcg per 0.3 ml,ADRENALINE,2009222619,2022,"300 µg, mg/ml",Solution for injection,Intramuscular use,363.00,Meridian Medical Technologies Inc,United States,Alphapharm Pty Ltd Mylan Australia,Australia,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, Viatris Arabia Limited"
Koselugo,SELUMETINIB,1810222758,2022,10 mg,"Capsule, hard",Oral use,19792.55,Patheon Pharmaceuticals Inc.,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Koselugo,SELUMETINIB,1810222757,2022,25 mg,"Capsule, hard",Oral use,49481.45,Patheon Pharmaceuticals Inc.,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
EpiPen 150 mcg per  0.3 ml,ADRENALINE,2009222618,2022,150 µg,Solution for injection,Intramuscular use,363.00,Meridian Medical Technologies Inc,United States,Alphapharm Pty Ltd Mylan Australia,Australia,Marketed,Prescription,store below 25°c,Pharmacy,"Cigalah Group, Viatris Arabia Limited"
RYALTRIS,"OLOPATADINE, MOMETASONE FUROATE",2109222623,2022,"600,25 µg",Nasal spray,Nasal use,36.75,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Specialty S A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
RYALTRIS,"OLOPATADINE, MOMETASONE FUROATE",2109222624,2022,"600,25 µg",Nasal spray,Nasal use,17.15,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Specialty S A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Salehiya Trading Co."
Lipofirate,FENOFIBRATE,1309222605,2022,145 mg,Film-coated tablet,Oral use,75.70,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Lipofirate,FENOFIBRATE,1309222604,2022,48 mg,Film-coated tablet,Oral use,25.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Rigorixa,CELECOXIB,1409222607,2022,200 mg,"Capsule, hard",Oral use,25.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Seroflo 25/125 inhaler,"FLUTICASONE PROPIONATE, SALMETEROL",1210222723,2022,"125,25 µg",Inhalation powder,Inhalation use,99.55,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Seroflo 25/250 inhaler,"FLUTICASONE PROPIONATE, SALMETEROL",1210222722,2022,"250,25 µg",Inhalation powder,Inhalation use,131.35,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Hi-Alfa SR,ALFUZOSIN,1209222598,2022,10 mg,Prolonged-release tablet,Oral use,79.65,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Tumeeze Oral Emulsion,SIMETHICONE,2009222621,2022,40 mg/ml,Emulsion,Oral use,6.85,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
Dacepton,APOMORPHINE,1509222612,2022,5 mg/ml,Solution for infusion,Subcutaneous use,890.20,EVER PHARMA JENA GMBH,Germany,EVER Neuro Pharma GmbH,Austria,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,Cigalah Group
Vominore,"MECLOZINE, PYRIDOXINE (VITAMIN B6)",1509222611,2022,"25,50 mg",Tablet,Oral use,377.65,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Setral,SERTRALINE,1509222610,2022,50 mg,Film-coated tablet,Oral use,1056.50,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Olopat,OLOPATADINE,2909222660,2022,0.2 %,"Eye drops, solution",Ocular use,37.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
COSOPT PRESERVATIVE FREE EYE DROP,"DORZOLAMIDE, TIMOLOL MALEATE",7-5091-20,2022,"20,5 mg","Eye drops, solution",Ocular use,134.05,FAREVA MIRABEL,France,MUNDIPHARMA PTY LTD,Australia,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Ubrelvy,UBROGEPANT,2509222635,2022,100 mg,Tablet,Oral use,632.30,Forest Laboratories Ireland Limited,Ireland,ABBVIE Inc.,United States,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
Cardutrex,DOBUTAMINE,2111222914,2022,12.5 mg/ml,Concentrate for solution for infusion,Intravenous use,157.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
SPERO,RISPERIDONE,2011222911,2022,1 mg/ml,Oral solution,Oral use,192.75,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Sulmetic,AMISULPRIDE,2011222909,2022,100 mg,Tablet,Oral use,54.80,Aurobindo Pharma Limited Unit III,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Septolete total lemon and honey,"BENZYDAMINE HYDROCHLORIDE, CETYLPYRIDINIUM CHLORIDE",2011222908,2022,"3,1 mg",Lozenge,Oral use,30.35,KRKA dd Novo mesto,Slovenia,"KRKA D.D., NOVO MESTO",Slovenia,Marketed,OTC,store below 30°c,Pharmacy,DERMAZONE Est
Voconza,VORICONAZOLE,1711222907,2022,200 mg,Injection,Intravenous use,2831.00,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
VOCONZA 40MG/ML ORAL SUSPENSION,VORICONAZOLE,2310222779,2022,40 mg/ml,Oral suspension,Oral use,1396.75,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO"
VALGAN 50MG/ML POWDER FOR ORAL SOLUTION,Valganciclovir,2111222919,2022,50 mg/ml,Powder for oral solution,Oral use,1270.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Binoven XL,VENLAFAXINE HYDROCHLORIDE,2011222910,2022,150 mg,Prolonged-release capsule,Oral use,91.65,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Grasustek 6 mg per 0.6 ml,PEGFILGRASTIM,1511222904,2022,10 mg/ml,Solution for injection,Subcutaneous use,1765.65,USV Private Limited Daman,India,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Xenor,CEFTRIAXONE,0911222895,2022,1000 mg,powder for solution for injection,Intramuscular use,15.50,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Oleovit D3 Oral drops,COLECALCIFEROL (VITAMIN D3),2310222778,2022,14400 IU/ml,"Oral drops, solution",Oral use,29.25,Fresenius Kabi Austria GmbH,Austria,FRESENIUS KABI,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co"
Setral,SERTRALINE,2711222942,2022,100 mg,Film-coated tablet,Oral use,2191.05,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
Zercepac,Trastuzumab,2211222921,2022,150 mg,Powder for concentrate for solution for infusion,Intravenous use,720.60,Shanghai Henlius Biopharmaceutical Co Ltd,China,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
Feromental 100 mg / 5 ml,IRON SUCROSE,2411222929,2022,20 mg/ml,Solution for injection,Intravenous use,68.55,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,DAMMAM PHARMA
Pemetrexed EPC,PEMETREXED,2711222935,2022,500 mg,Powder for solution for infusion,Intravenous use,2595.15,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Eastern Pharma Co (EPC)
Pemetrexed EPC,PEMETREXED,2711222934,2022,100 mg,Powder for solution for infusion,Intravenous use,519.05,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Eastern Pharma Co (EPC)
Bonlevo,LEVOFLOXACIN,2811222945,2022,5 mg/ml,Intravenous infusion,Intravenous use,71.30,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Remsima SC,INFLIXIMAB,2711222940,2022,120 mg/ml,Solution for injection,Subcutaneous use,2963.60,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Remsima SC with Needle Guard,INFLIXIMAB,2711222936,2022,120 mg/ml,Solution for injection,Subcutaneous use,2963.60,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Remsima SC Auto injector Pre-filled pen,INFLIXIMAB,2711222938,2022,120 mg/ml,Solution for injection,Subcutaneous use,2963.60,VETTER PHARMA-FERTIGUNG GMBH & CO. KG,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Jazeera Pharmaceutical Industries (JPI)
MAACY,MACITENTAN,0911222893,2022,10 mg,Film-coated tablet,Oral use,6272.45,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Hizentra 1 g per 5 ml vial,HUMAN NORMAL IMMUNOGLOBULIN,0111222860,2022,200 mg/ml,Solution for injection,Subcutaneous use,444.40,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Hizentra 2 g per 10 ml Vial,HUMAN NORMAL IMMUNOGLOBULIN,0111222858,2022,200 mg/ml,Solution for injection,Subcutaneous use,888.85,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Hizentra 4 g per 20 ml Vial,HUMAN NORMAL IMMUNOGLOBULIN,0111222861,2022,200 mg/ml,Solution for injection,Subcutaneous use,1777.65,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Hizentra 10 g per 50 ml vial,HUMAN NORMAL IMMUNOGLOBULIN,0111222859,2022,200 mg/ml,Solution for injection,Subcutaneous use,4444.25,CSL BEHRING,Switzerland,CSL BEHRING,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Avialis,TADALAFIL,2709222651,2022,20 mg,Film-coated tablet,Oral use,32.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Taxporin,CEFTRIAXONE,2609222637,2022,1000 mg,Powder for solution for injection/infusion,Intramuscular and intravenous use,210.00,ACS Dobfar S.P.A,Italy,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Cefuzime,CEFUROXIME SODIUM,1809222615,2022,500 mg,Film-coated tablet,Oral use,85.85,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Gemorya,FINGOLIMOD HYDROCHLORIDE,1210222727,2022,0.5 mg,Capsule,Oral use,3010.30,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Gemorya,FINGOLIMOD HYDROCHLORIDE,1210222728,2022,0.25 mg,Capsule,Oral use,1505.15,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Takhzyro,LANADELUMAB,2710222830,2022,300 mg,Solution for injection,Subcutaneous use,52771.15,VETTER PHARMA,Germany,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
Rinvoq,UPADACITINIB,0812223001,2022,30 mg,Prolonged-release tablet,Oral use,5655.50,AbbVie Ireland,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Kineret,ANAKINRA,0611222874,2022,150 mg/ml,Solution for injection,Subcutaneous use,996.30,Patheon Italia S.P.A.,Italy,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Arabian Trade House
Syngro,OCTREOTIDE ACETATE,3010222846,2022,10 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,1510.30,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Syngro,OCTREOTIDE ACETATE,3010222847,2022,20 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,3020.45,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Syngro,OCTREOTIDE ACETATE,3010222848,2022,30 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,4530.65,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Dextrose,DEXTROSE,1710222746,2022,5 %,Intravenous infusion,Intravenous use,3.40,ADVANCED PHARMACEUTICAL FACTORY (APF),Saudi Arabia,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,ADVANCED PHARMACEUTICAL FACTORY (APF)
Dextrose,DEXTROSE,1710222745,2022,5 %,Intravenous infusion,Intravenous use,4.85,ADVANCED PHARMACEUTICAL FACTORY (APF),Saudi Arabia,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,ADVANCED PHARMACEUTICAL FACTORY (APF)
TENOVAS,TENOFOVIR DISOPROXIL,0111222857,2022,245 mg,Film-coated tablet,Oral use,744.45,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Tenovas,TENOFOVIR DISOPROXIL,0111222856,2022,245 mg,Film-coated tablet,Oral use,744.45,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Phenylephrine PSI,PHENYLEPHRINE HYDROCHLORIDE,1210222716,2022,10 mg/ml,Solution for injection,Intramuscular use,255.30,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Apixaban BOS,APIXABAN,0811222884,2022,2.5 mg,Film-coated tablet,Oral use,80.85,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Apixaban BOS,APIXABAN,0811222885,2022,5 mg,Film-coated tablet,Oral use,80.85,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
PIANKA 50 MG/ 5 ML SYRUP,IRON POLYMALTOSE,2310222776,2022,10 mg/ml,Syrup,Oral use,12.55,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
Cefuroxime-Venus,CEFUROXIME SODIUM,2010222771,2022,750 mg,Powder for solution for injection/infusion,Intramuscular and intravenous use,6.70,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Fermata,DEFERASIROX,0111222863,2022,500 mg,Dispersible tablet,Oral use,1713.90,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
IROREST FCT,DEFERASIROX,2610222807,2022,360 mg,Film-coated tablet,Oral use,2074.20,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Lotrell,LOTEPREDNOL ETABONATE,0911222892,2022,0.5 %,"Eye drops, suspension",Ocular use,44.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Palot,DAPOXETINE,0412222966,2022,30 mg,Film-coated tablet,Oral use,73.50,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Palot,DAPOXETINE,0412222964,2022,60 mg,Film-coated tablet,Oral use,73.50,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Palot,DAPOXETINE,0412222965,2022,30 mg,Film-coated tablet,Oral use,98.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Palot,DAPOXETINE,0412222963,2022,60 mg,Film-coated tablet,Oral use,98.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Meliglptin,SITAGLIPTIN HYDROCHLORIDE,0412222969,2022,100 mg,Film-coated tablet,Oral use,91.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Meliglptin,SITAGLIPTIN HYDROCHLORIDE,0412222967,2022,50 mg,Film-coated tablet,Oral use,45.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Surlex 500 mg / 5 ml,SUGAMMADEX,3010222845,2022,100 mg/ml,Solution for injection,Intravenous use,5082.65,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Surlex 200 mg  / 2 ml,SUGAMMADEX,3010222844,2022,100 mg/ml,Solution for injection,Intravenous use,2033.05,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SUDAIR PHARMA COMPANY
Meligamet 50 m / 1000 mg,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN HYDROCHLORIDE",0612222983,2022,"1000,50 mg",Tablet,Oral use,98.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Meligamet 50 mg / 850 mg,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN HYDROCHLORIDE",0412222968,2022,"850,50 mg",Tablet,Oral use,95.35,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Suva,ROSUVASTATIN,0712222989,2022,40 mg,Film-coated tablet,Oral use,171.45,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Suva,ROSUVASTATIN,0712222987,2022,20 mg,Film-coated tablet,Oral use,85.70,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Suva,ROSUVASTATIN,0712222988,2022,10 mg,Film-coated tablet,Oral use,50.55,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Suva,ROSUVASTATIN,0712222992,2022,5 mg,Film-coated tablet,Oral use,25.25,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Apeto,THIOTEPA,0412222962,2022,15 mg,powder for solution for injection,"Intravenous, Intravesical",843.55,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Apeto,THIOTEPA,0412222961,2022,100 mg,powder for solution for injection,"Intravenous, Intravesical",5623.65,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Rosgan,ROSUVASTATIN,0812222995,2022,40 mg,Film-coated tablet,Oral use,174.50,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Rosgan,ROSUVASTATIN,0812222997,2022,20 mg,Film-coated tablet,Oral use,87.25,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Prila,"LIDOCAINE HYDROCHLORIDE, PRILOCAINE",0412222973,2022,"2.5,2.5 %",Cream,Topical,66.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Taxporin,CEFTRIAXONE,0512222981,2022,500 mg,Powder for solution for injection/infusion,Intramuscular and intravenous use,148.50,ACS Dobfar S.P.A,Italy,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Binoven XL,VENLAFAXINE HYDROCHLORIDE,0812222996,2022,75 mg,Prolonged-release capsule,Oral use,54.10,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Carbatol,CARBAMAZEPINE,0412222972,2022,200 mg,Film-coated tablet,Oral use,145.00,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
Delstrigo,"DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL",1612223019,2022,"100,300,245 mg",Film-coated tablet,Oral use,2413.85,MSD INTERNATIONAL GMBH,Ireland,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
Nolpaza,PANTOPRAZOLE,2012223029,2022,20 mg,Gastro-resistant tablet,Oral use,18.40,KRKA dd Novo mesto,Slovenia,"KRKA D.D., NOVO MESTO",Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Nolpaza,PANTOPRAZOLE,2012223030,2022,40 mg,Gastro-resistant tablet,Oral use,39.70,KRKA dd Novo mesto,Slovenia,"KRKA D.D., NOVO MESTO",Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
XROMI,HYDROXYCARBAMIDE,0512222977,2022,100 mg/ml,Oral solution,Oral use,1393.30,Nova Laboratories Ltd,United Kingdom,Nova Laboratories Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,QOMEL MEDICAL DRUG STORE
Geuvid,VILDAGLIPTIN,1912223024,2022,50 mg,Tablet,Oral use,66.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Geuvid,VILDAGLIPTIN,1912223025,2022,50 mg,Tablet,Oral use,33.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Teriflunomide BOS,TERIFLUNOMIDE,1312223013,2022,14 mg,Film-coated tablet,Oral use,1765.10,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Olmetrol,OLMESARTAN MEDOXOMIL,1412223016,2022,40 mg,Film-coated tablet,Oral use,51.50,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Olmetrol,OLMESARTAN MEDOXOMIL,2112223031,2022,20 mg,Film-coated tablet,Oral use,38.70,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
SODIUM PHENYLACETATE AND SODIUM BENZOATE INJECTION,"SODIUM PHENYLACETATE, SODIUM BENZOATE",1312223006,2022,"10,10 %",Injection,Intravenous use,11070.70,University of Iowa Pharmaceuticals,United States,Navinta LLC,United States,Marketed,Prescription,store below 25°c,Hospital,QOMEL MEDICAL DRUG STORE
VEGA,SILDENAFIL,0401233054,2022,100 mg,Film-coated tablet,Oral use,10.90,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
VEGA,SILDENAFIL,0401233055,2023,50 mg,Film-coated tablet,Oral use,10.90,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
COSENTYX 75 mg/0.5 ml Solution for injection in pre-filled syringe,SECUKINUMAB,1201233092,2023,75 mg,Solution for injection,Subcutaneous use,1008.35,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Novartis Saudi Limited
Cosentyx 300 mg per 2 ml Solution for injection in pre-filled pen,SECUKINUMAB,1201233088,2023,300 mg,Solution for injection,Subcutaneous use,4033.45,NOVARTIS Pharma Stein AG,Switzerland,NOVARTIS PHARMA AG,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Novartis Saudi Limited
Demsone 10 mg per 5 ml,DEXAMETHASONE,2812223046,2022,2 mg/ml,Oral solution,Oral use,392.45,Rosemont Pharmaceuticals Ltd,United Kingdom,Rosemont Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,YAHMAA MEDICAL COMPANY
Mundell,ONDANSETRON,0501233057,2023,4 mg,Orodispersible tablet,Oral use,79.65,Biolab Sanus Farmaceutica Ltda,Brazil,Biolab Sanus Farmaceutica Ltda,Brazil,Marketed,Prescription,do not store above 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Mundell,ONDANSETRON,0501233058,2023,8 mg,Orodispersible tablet,Oral use,100.75,Biolab Sanus Farmaceutica Ltda,Brazil,Biolab Sanus Farmaceutica Ltda,Brazil,Marketed,Prescription,do not store above 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Flumazenil PSI,FLUMAZENIL,0901233071,2023,0.1 mg/ml,Solution for injection/infusion,Intravenous use,208.90,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
FASENRA Pen,BENRALIZUMAB,0212222960,2022,30 mg/ml,Solution for injection,Subcutaneous use,9386.85,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
PANTOLOC,PANTOPRAZOLE,2612223043,2022,40 mg,Tablet,Oral use,57.00,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Sertidep,SERTRALINE,1201233087,2023,100 mg,Film-coated tablet,Oral use,180.55,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Dopaxol PR,PRAMIPEXOLE,1501233095,2023,0.375 mg,Prolonged-release tablet,Oral use,107.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Dopaxol PR,PRAMIPEXOLE,1501233096,2023,0.75 mg,Prolonged-release tablet,Oral use,161.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Dopaxol PR,PRAMIPEXOLE,1501233103,2023,1.5 mg,Prolonged-release tablet,Oral use,264.25,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Dopaxol PR,PRAMIPEXOLE,1501233097,2023,3 mg,Prolonged-release tablet,Oral use,528.55,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Haemate P,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",2112223032,2022,"250,600 IU",Powder and solvent for solution for injection/infusion,Intravenous use,918.85,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Haemate P,"HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR",2112223033,2022,"500,1200 IU",Powder and solvent for solution for injection/infusion,Intravenous use,1837.70,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Difen,DICLOFENAC POTASSIUM,2512223038,2022,50 mg,Film-coated tablet,Oral use,21.45,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Osart,LOSARTAN POTASSIUM,2512223040,2022,100 mg,Film-coated tablet,Oral use,47.50,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Osart,LOSARTAN POTASSIUM,2512223039,2022,50 mg,Film-coated tablet,Oral use,40.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Incell,IBRUTINIB,2212223034,2022,140 mg,"Capsule, hard",Oral use,22427.35,Natco Pharma Limited,India,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Takidet,ESMOLOL,1501233098,2022,10 mg/ml,Solution for injection,Intravenous use,125.75,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Zodric 5 mg per 100 ml,ZOLEDRONIC ACID,1701233109,2023,0.05 mg/ml,Solution for infusion,Intravenous use,1189.60,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Zillion,LINEZOLID,3012223047,2022,20 mg/ml,Oral suspension,Oral use,598.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Aprizla,APREMILAST,0301233052,2023,30 mg,Film-coated tablet,Oral use,1598.80,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Tranexamic Acid PSI 500 mg per 5 ml,TRANEXAMIC ACID,0901233069,2023,100 mg/ml,Solution for injection,Intravenous use,31.00,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233175,2023,20 mg,"Capsule, hard",Oral use,317.65,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233171,2023,30 mg,"Capsule, hard",Oral use,340.30,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233170,2023,40 mg,"Capsule, hard",Oral use,363.00,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233173,2023,50 mg,"Capsule, hard",Oral use,383.40,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233174,2023,60 mg,"Capsule, hard",Oral use,399.30,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Vyvanse,LISDEXAMFETAMINE DIMESILATE,2501233172,2023,70 mg,"Capsule, hard",Oral use,408.40,Patheon Pharmaceuticals Inc.,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Morphine HCL Kabi,MORPHINE HYDROCHLORIDE,2501233166,2023,10 mg/ml,Solution for injection,Intravenous use,197.50,LABESFAL,Portugal,"Labesfal Laboratorios Almiro, S.A.",Portugal,Marketed,Prescription,store below 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Trodelvy,SACITUZUMAB GOVITECAN,2601233183,2023,180 mg,Powder for concentrate for solution for infusion,Intravenous use,4836.95,BSP PHARMACEUTICALS,Italy,GILEAD SCIENCES LIMITED (CORK),Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, Gilead Sciences Arabia Ltd"
PROVINDA,PERINDOPRIL ARGININE,1801233115,2023,10 mg,Film-coated tablet,Oral use,38.85,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
PROVINDA,PERINDOPRIL ARGININE,1801233117,2023,5 mg,Film-coated tablet,Oral use,29.55,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Valgaset,Valganciclovir,1901233119,2023,450 mg,Tablet,Oral use,2499.85,Aurobindo Pharma Limited Unit VII,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Ruxience 100 mg per 10 ml,RITUXIMAB,2401233165,2023,10 mg/ml,Concentrate for solution for infusion,Intravenous use,455.60,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Ruxience 500 mg per 50 ml,RITUXIMAB,2401233164,2023,10 mg/ml,Concentrate for solution for infusion,Intravenous use,2276.10,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Thymoglobuline,RABBIT ANTI HUMAN THYMOCYTE IMMUNOGLOBULIN,2501233176,2023,5 mg/ml,Powder for solution for infusion,Intravenous use,1001.00,GENZYME POLYCLONALS S.A.S,France,Sanofi B.V,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Pifeltro,DORAVIRINE,3001233195,2023,100 mg,Film-coated tablet,Oral use,1361.80,MSD INTERNATIONAL GMBH,Ireland,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
Xenor,CEFTRIAXONE,1801233114,2023,500 mg,powder for solution for injection,Intramuscular use,10.35,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Xofax,DEFERASIROX,2601233181,2023,90 mg,Film-coated tablet,Oral use,525.45,PHARMATHEN INTERNATIONAL,Greece,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Xofax,DEFERASIROX,2601233179,2023,180 mg,Film-coated tablet,Oral use,1044.00,PHARMATHEN INTERNATIONAL,Greece,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Xofax,DEFERASIROX,2601233180,2023,360 mg,Film-coated tablet,Oral use,2074.20,PHARMATHEN INTERNATIONAL,Greece,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
PEDEA 5MG/ML SOLUTION FOR INJECTION,IBUPROFEN,4-5334-22,2023,5 mg/ml,Solution for injection,Intravenous use,1169.05,RECORDATI,Italy,Recordati Rare Diseases,France,Marketed,Prescription,store below 25°c,Hospital,Al Osool Medical Trading Company
Oxaliplatin AqVida 50 mg per 10 ml,OXALIPLATIN,1901233129,2023,5 mg/ml,Concentrate for solution for infusion,Intravenous use,114.90,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Cigalah Group
Oxaliplatin AqVida 100 mg per 20 ml,OXALIPLATIN,1901233128,2023,5 mg/ml,Concentrate for solution for infusion,Intravenous use,234.75,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Cigalah Group
Oxaliplatin AqVida 200 mg per 40 ml,OXALIPLATIN,1901233127,2023,5 mg/ml,Concentrate for solution for infusion,Intravenous use,449.30,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Cigalah Group
Licarb,LITHIUM CARBONATE,1302233246,2023,300 mg,Capsule,Oral use,100.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Enhertu,Trastuzumab,1202233232,2023,100 mg,Powder for concentrate for solution for infusion,Intravenous use,7859.50,BAXTER ONCOLOGY GmbH,Germany,AstraZeneca,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
Bortezomib EPC,BORTEZOMIB,2401233151,2023,3.5 mg,powder for solution for injection,"Intravenous, Subcutaneous",2177.05,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Eastern Pharma Co (EPC)
Tadil,TADALAFIL,2301233144,2023,20 mg,Film-coated tablet,Oral use,32.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Tadil,TADALAFIL,2301233146,2023,20 mg,Film-coated tablet,Oral use,16.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
LIBSA,RIVAROXABAN,2301233147,2023,20 mg,Film-coated tablet,Oral use,179.70,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Libsa,RIVAROXABAN,2301233149,2023,15 mg,Film-coated tablet,Oral use,179.70,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Libsa,RIVAROXABAN,2301233148,2023,10 mg,Film-coated tablet,Oral use,192.45,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Libsa,RIVAROXABAN,2301233150,2023,10 mg,Film-coated tablet,Oral use,64.15,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Uxorate,FEBUXOSTAT,2301233143,2023,120 mg,Film-coated tablet,Oral use,84.10,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ABILIRAZOLE,ARIPIPRAZOLE,2301233145,2023,5 mg,Tablet,Oral use,110.00,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Domassel,TICAGRELOR,0911222894,2022,90 mg,Film-coated tablet,Oral use,167.65,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Mounjaro,TIRZEPATIDE,2002233271,2023,5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro,TIRZEPATIDE,2002233273,2023,7.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro,TIRZEPATIDE,2002233274,2023,10 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United States,Eli Lilly and Company,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro,TIRZEPATIDE,2002233272,2023,12.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro,TIRZEPATIDE,2002233275,2023,15 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Rinvoq,UPADACITINIB,2102233279,2023,45 mg,Prolonged-release tablet,Oral use,7538.00,ABBVIE IRELAND NL B.V.,Ireland,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
LIPOCOMB,"ROSUVASTATIN, EZETIMIBE",2102233277,2023,"10,10 mg","Capsule, hard",Oral use,80.45,EGIS PHARMACEUTICALS PLC,Hungary,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
LIPOCOMB,"ROSUVASTATIN, EZETIMIBE",2102233276,2023,"20,10 mg","Capsule, hard",Oral use,97.65,EGIS PHARMACEUTICALS PLC,Hungary,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Servier Saudi Arabia Trading LLC"
Vigolev,LEVOFLOXACIN,2602233290,2023,250 mg,Film-coated tablet,Oral use,26.90,MEDOCHEMIE LTD,Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Vigolev,LEVOFLOXACIN,2602233289,2023,500 mg,Film-coated tablet,Oral use,42.70,MEDOCHEMIE LTD,Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Ornivoda,ORNIDAZOLE,0102233197,2023,500 mg,Film-coated tablet,Oral use,54.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Proveblue,METHYLTHIONINIUM CHLORIDE,0102233201,2023,5 mg/ml,Solution for injection,Intravenous use,374.05,CENEXI,France,Provepharm SAS,France,Marketed,Prescription,do not store above 30°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Proveblue,METHYLTHIONINIUM CHLORIDE,0102233202,2023,5 mg/ml,Solution for injection,Intravenous use,289.25,CENEXI,France,Provepharm SAS,France,Marketed,Prescription,do not store above 30°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Xatiza 60 mg  / 1.5 ml,CABAZITAXEL,0702233217,2023,40 mg/ml,Concentrate and solvent for solution for injection,Intravenous use,8310.35,MSN LABORATORIES PRIVATE LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Boston Oncology Arabia
Mounjaro,TIRZEPATIDE,1303233363,2023,2.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,ELI LILLY,United Kingdom,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Oneclapz,CLOPIDOGREL,1901233118,2023,75 mg,Film-coated tablet,Oral use,118.15,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Lenalidomide BOS,LENALIDOMIDE,0603233329,2023,5 mg,Capsule,Oral use,7844.35,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Lenalidomide BOS,LENALIDOMIDE,0603233328,2023,10 mg,Capsule,Oral use,8224.85,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Lenalidomide BOS,LENALIDOMIDE,0603233331,2023,15 mg,Capsule,Oral use,8224.85,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Lenalidomide BOS,LENALIDOMIDE,0603233330,2023,25 mg,Capsule,Oral use,9528.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
MORPHINE HCl,MORPHINE HYDROCHLORIDE,1402233249,2023,10 mg/ml,Solution for injection,"Intrathecal, Intravenous, Intramuscular",197.50,LABORATOIRES STEROP NV,Belgium,LABORATOIRES STEROP NV,Belgium,Marketed,Prescription,store below 25°c,Hospital,YAHMAA MEDICAL COMPANY
Eralyce,PERMETHRIN,0203233316,2023,1 %,Cream,Topical,85.80,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Etorigen,Etoricoxib,1402233252,2023,120 mg,Film-coated tablet,Oral use,22.05,Atlantic Pharma,Portugal,Farmoz Sociedade Tecnico Medicinal S.A,Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Etorigen,Etoricoxib,1402233251,2023,90 mg,Film-coated tablet,Oral use,41.00,Atlantic Pharma,Portugal,Farmoz Sociedade Tecnico Medicinal S.A,Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Etorigen,Etoricoxib,1402233250,2023,60 mg,Film-coated tablet,Oral use,41.00,Atlantic Pharma,Portugal,Farmoz Sociedade Tecnico Medicinal S.A,Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
NORMOSANG,HUMAN HEMIN,0103233308,2023,25 mg/ml,Concentrate for solution for infusion,Intravenous use,12109.70,EVER PHARMA JENA GMBH,Germany,Recordati Rare Diseases,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ADCO trading establishment
Xolair,OMALIZUMAB,1603233379,2023,150 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1796.85,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Novartis Europharm Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
Xolair,OMALIZUMAB,1603233378,2023,75 mg,Solution for injection in pre-filled syringe,Subcutaneous use,898.40,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Novartis Europharm Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novartis Saudi Limited
Tadil,TADALAFIL,2802233304,2023,10 mg,Film-coated tablet,Oral use,14.90,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Tadil,TADALAFIL,2802233305,2023,10 mg,Film-coated tablet,Oral use,74.45,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Etoruma,Etoricoxib,0603233334,2023,120 mg,Film-coated tablet,Oral use,11.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Etoruma,Etoricoxib,0703233336,2023,90 mg,Film-coated tablet,Oral use,41.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Etoruma,Etoricoxib,0603233333,2023,60 mg,Film-coated tablet,Oral use,41.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Sodium Chloride 0.45% w/v bag,SODIUM CHLORIDE,0503233323,2023,4.5 mg/ml,Solution for infusion,Intravenous use,7.45,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Trijan,TOFACITINIB,0703233338,2023,10 mg,Film-coated tablet,Oral use,3716.05,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Trijan,TOFACITINIB,0703233339,2023,5 mg,Film-coated tablet,Oral use,3252.85,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Sertidep,SERTRALINE,0603233332,2023,50 mg,Film-coated tablet,Oral use,95.70,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Azithromycin BOS,AZITHROMYCIN,0203233314,2023,500 mg,powder for solution for injection,Intravenous use,421.75,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
MONTELAIR ORAL GRANULES,MONTELUKAST SODIUM,0203233319,2023,4 mg,Granules in sachet,Oral use,77.10,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL CO,Egypt,Marketed,Prescription,do not store above 30°c,Pharmacy,AL JEDAANI STORE
Xolamol,"DORZOLAMIDE, TIMOLOL MALEATE",0803233349,2023,"20,5 mg/ml","Eye drops, solution",Ocular use,63.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Plerix,PLERIXAFOR,1302233248,2023,20 mg/ml,Solution for injection,Subcutaneous use,15716.65,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Bivocard,NEBIVOLOL HYDROCHLORIDE,0803233342,2023,5 mg,Tablet,Oral use,25.95,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Xaluprine,MERCAPTOPURINE,0803233341,2023,20 mg/ml,Oral suspension,Oral use,1573,Nova Laboratories Ltd,United Kingdom,Nova Laboratories Limited,United Kingdom,Marketed,Prescription,do not store above 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Zympass,"ROSUVASTATIN, EZETIMIBE",0902233225,2023,"10,10 mg",Film-coated tablet,Oral use,80.45,Sanofi İlaç Sanayi ve Tic A.Ş,Turkey,Sanofi-aventis Ireland Limited,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
Zympass,"ROSUVASTATIN, EZETIMIBE",0902233227,2023,"20,10 mg",Film-coated tablet,Oral use,97.65,Sanofi İlaç Sanayi ve Tic A.Ş,Turkey,Sanofi-aventis Ireland Limited,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
Zympass,"ROSUVASTATIN, EZETIMIBE",0902233226,2023,"40,10 mg",Film-coated tablet,Oral use,101.25,Sanofi İlaç Sanayi ve Tic A.Ş,Turkey,Sanofi-aventis Ireland Limited,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
Muxava,MOXIFLOXACIN HYDROCHLORIDE,1801233111,2023,400 mg,Film-coated tablet,Oral use,41.85,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Muxava,MOXIFLOXACIN HYDROCHLORIDE,1801233110,2023,400 mg,Film-coated tablet,Oral use,58.60,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Cefodox,CEFPODOXIME,1801233113,2023,200 mg,Film-coated tablet,Oral use,98.50,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Celenax,CELECOXIB,0503233324,2023,200 mg,"Capsule, hard",Oral use,25.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Bistonal,BISOPROLOL FUMARATE,1202233229,2023,10 mg,Film-coated tablet,Oral use,21.50,Aurobindo Pharma Limited Unit XV,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Bistonal,BISOPROLOL FUMARATE,1202233230,2023,5 mg,Film-coated tablet,Oral use,15.15,Aurobindo Pharma Limited Unit XV,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Bistonal,BISOPROLOL FUMARATE,1502233253,2023,2.5 mg,Film-coated tablet,Oral use,10.10,Aurobindo Pharma Limited Unit III,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Evrenzo,ROXADUSTAT,2102233286,2023,50 mg,Film-coated tablet,Oral use,715.20,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Evrenzo,ROXADUSTAT,2102233285,2023,100 mg,Film-coated tablet,Oral use,1347.75,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Evrenzo,ROXADUSTAT,2102233284,2023,150 mg,Film-coated tablet,Oral use,2021.60,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Avrolem,EVEROLIMUS,0803233350,2023,10 mg,Tablet,Oral use,19247.40,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Avrolem,EVEROLIMUS,0803233348,2023,5 mg,Tablet,Oral use,9623.70,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Avrolem,EVEROLIMUS,0803233345,2023,2.5 mg,Tablet,Oral use,4811.85,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Aminglu,CARGLUMIC ACID,2102233288,2023,200 mg,Dispersible tablet,Oral use,11540.75,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Naplax,DEXMEDETOMIDINE,2002233267,2023,4 µl/ml,Solution for infusion,Intravenous use,85.45,S.M. Farmaceutici SRL,Italy,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Med city, ZIMMO TRADING ESTABLISHMENT"
Sutixib,SUNITINIB,1303233361,2023,50 mg,"Capsule, hard",Oral use,12446.00,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Sutixib,SUNITINIB,1303233362,2023,25 mg,"Capsule, hard",Oral use,6223.00,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Sutixib,SUNITINIB,1303233360,2023,12.5 mg,"Capsule, hard",Oral use,3111.50,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Eletrivaz,ELETRIPTAN,0802233219,2023,40 mg,Tablet,Oral use,73.50,APL Health Care Limited,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Ponvory  (Initiation pack),PONESIMOD,2102233281,2023,"2,3,4,5,6,7,8,9,10 mg",Film-coated tablet,Oral use,1628.70,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Ponvory (maintenance pack),PONESIMOD,2102233280,2023,20 mg,Film-coated tablet,Oral use,3257.45,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Orbactiv,ORITAVANCIN,2102233287,2023,400 mg,Powder for concentrate for solution for infusion,Intravenous use,7344.75,Patheon Italia S.P.A.,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
DABITRAN,DABIGATRAN ETEXILATE,1302233245,2023,110 mg,Capsule,Oral use,125.10,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
DABITRAN,DABIGATRAN ETEXILATE,1302233244,2023,110 mg,Capsule,Oral use,250.25,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Ojox,MOXIFLOXACIN HYDROCHLORIDE,3101233196,2023,0.5 %,Eye drops,Ocular use,21.45,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Devasc,CLOPIDOGREL,1302233247,2023,75 mg,Tablet,Oral use,118.15,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
LUNIA,"EZETIMIBE, SIMVASTATIN",0203233317,2023,"10,40 mg",Tablet,Oral use,156.55,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
LUNIA,"EZETIMIBE, SIMVASTATIN",0203233315,2023,"10,20 mg",Tablet,Oral use,134.20,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Glycophos,SODIUM GLYCEROPHOSPHATE HYDRATED,2002233270,2023,216 mg/ml,Concentrate for solution for infusion,Intravenous use,382.90,HP Halden Pharma AS,Norway,FRESENIUS KABI AB,Sweden,Marketed,Prescription,do not store above 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Erlotinib EPC,ERLOTINIB,0703233340,2023,150 mg,Film-coated tablet,Oral use,4419.10,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Eastern Pharma Co (EPC)
Tekam,KETAMINE,1403233370,2023,10 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,104.20,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Moxiwar,MOXIFLOXACIN HYDROCHLORIDE,1503233371,2023,400 mg,Film-coated tablet,Oral use,58.60,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Bendokey,BENDAMUSTINE HYDROCHLORIDE,1503233373,2023,100 mg,Powder for concentrate for solution for infusion,Intravenous use,900.80,Eugia Pharma Specialties Limited,India,Eugia Pharma Specialities Limited,India,Marketed,Prescription,store below 30°c,Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Seroflo 50/100 Ciphaler,"FLUTICASONE PROPIONATE, SALMETEROL",1403233369,2023,"100,50 µg",Inhalation powder,Inhalation use,85.10,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Seroflo 50/250 Ciphaler,"FLUTICASONE PROPIONATE, SALMETEROL",1403233368,2023,"250,50 µg",Inhalation powder,Inhalation use,113.80,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Fylibix,DASATINIB,2203233408,2023,20 mg,Film-coated tablet,Oral use,2984.75,REMEDICA,Cyprus,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Fylibix,DASATINIB,2203233407,2023,50 mg,Film-coated tablet,Oral use,5968.05,REMEDICA,Cyprus,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Fylibix,DASATINIB,2203233406,2023,70 mg,Film-coated tablet,Oral use,5968.05,REMEDICA,Cyprus,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Retebin,CLOFARABINE,1603233375,2023,1 mg/ml,Concentrate for solution for infusion,Intravenous use,3811.10,Shilpa Medicare Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Ryxidal,RISPERIDONE,2103233397,2023,25 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,234.90,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Ryxidal,RISPERIDONE,2103233399,2023,37.5 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,327.00,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Ryxidal,RISPERIDONE,2103233398,2023,50 mg,Powder and solvent for prolonged-release suspension for injection,Intramuscular use,390.55,PHARMATHEN INTERNATIONAL,Greece,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Lanacet,CINACALCET,2203233412,2023,90 mg,Film-coated tablet,Oral use,1510.05,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Lanacet,CINACALCET,2203233410,2023,60 mg,Film-coated tablet,Oral use,1019.20,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Lanacet,CINACALCET,2203233411,2023,30 mg,Film-coated tablet,Oral use,526.65,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Loradeel,DESLORATADINE,2203233402,2023,5 mg,Film-coated tablet,Oral use,18.85,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Rosgan,ROSUVASTATIN,2203233401,2023,10 mg,Film-coated tablet,Oral use,55.15,Aurobindo Pharma Limited Unit VII,India,Aurobindo Pharma Saudi Arabia Limited,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aurobindo Pharma Saudi Arabia Limited
Lotac,TICAGRELOR,2503233416,2023,90 mg,Film-coated tablet,Oral use,167.65,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Lotac,TICAGRELOR,2503233417,2023,60 mg,Film-coated tablet,Oral use,153.50,Macleods Pharmaceuticals Limited,India,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Seroflo 50/500 ciphaler,"FLUTICASONE PROPIONATE, SALMETEROL",2603233418,2023,"500,50 µg",Inhalation powder,Inhalation use,158.40,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Extaq,RIVAROXABAN,2703233427,2023,10 mg,Film-coated tablet,Oral use,39.75,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Extaq,RIVAROXABAN,2703233426,2023,10 mg,Film-coated tablet,Oral use,103.10,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Extaq,RIVAROXABAN,2703233428,2023,15 mg,Film-coated tablet,Oral use,142.75,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Extaq,RIVAROXABAN,2703233424,2023,20 mg,Film-coated tablet,Oral use,142.75,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SmofKabiven extra Nitrogen,"SODIUM GLYCEROPHOSPHATE HYDRATED, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, SODIUM ACETATE, ALANINE, GLUCOSE, TAURINE, SOYA OIL, CALCIUM CHLORIDE, ZINC SULPHATE, VALINE, LEUCINE, TRYPTOPHAN, THREONINE, TRIGLYCERIDES MEDIUM CHAIN, SERINE, GLYCINE, PROLINE, LYSINE, FISH OIL, ARGININE, OLIVE OIL, HISTIDINE, METHIONINE, PHENYLALANINE, TYROSINE, ISOLEUCINE5",2703233429,2023,"2.3,0.62,2.3,1.6,9.3,86,0.66,8.8,0.29,0.006,4.1,4.9,1.3,2.9,8.8,4.3,7.3,7.4,4.4,4.4,7.9,7.3,2,2.8,3.4,0.26,3.3 g",Emulsion for infusion,Intravenous use,1657.85,FRESENIUS KABI,Sweden,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SmofKabiven extra Nitrogen,"PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, ARGININE, GLYCINE, THREONINE, FISH OIL, PROLINE, HISTIDINE, SERINE, ALANINE, TRYPTOPHAN, OLIVE OIL, TYROSINE, VALINE, CALCIUM CHLORIDE, SODIUM GLYCEROPHOSPHATE HYDRATED, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, SODIUM ACETATE, ZINC SULPHATE, GLUCOSE, SOYA OIL, TAURINE, TRIGLYCERIDES MEDIUM CHAIN",2703233423,2023,"3.4,2.8,4.4,4.9,3.3,7.9,7.3,2.9,4.4,7.4,2,4.3,9.3,1.3,7.3,0.26,4.1,0.29,2.3,0.62,2.3,1.6,0.006,86,8.8,0.66,8.8 g",Emulsion for infusion,Intravenous use,1768.35,FRESENIUS KABI,Sweden,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
SmofKabiven extra Nitrogen,"ALANINE, TRIGLYCERIDES MEDIUM CHAIN, SOYA OIL, GLUCOSE, ZINC SULPHATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM GLYCEROPHOSPHATE HYDRATED, CALCIUM CHLORIDE, VALINE, TYROSINE, OLIVE OIL, TRYPTOPHAN, TAURINE, SERINE, PROLINE, PHENYLALANINE, METHIONINE, LYSINE, LEUCINE, ISOLEUCINE5, HISTIDINE, GLYCINE, ARGININE, THREONINE, FISH OIL",2703233430,2023,"9.3,8.8,8.8,86,0.006,1.6,2.3,0.62,2.3,0.29,4.1,0.26,7.3,1.3,0.66,4.3,7.4,3.4,2.8,4.4,4.9,3.3,2,7.3,7.9,2.9,4.4 g",Emulsion for infusion,Intravenous use,1967.30,FRESENIUS KABI,Sweden,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
DROLINA,FUROSEMIDE,2703233422,2023,1 mg/ml,Oral solution,Oral use,19.40,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Apdx,APIXABAN,2703233425,2023,5 mg,Film-coated tablet,Oral use,115.50,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Apdx,APIXABAN,2803233435,2023,2.5 mg,Film-coated tablet,Oral use,115.50,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Vostifaz,VORICONAZOLE,2903233439,2023,200 mg,Film-coated tablet,Oral use,2334.30,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Carcivor 250 mg per 5 ml,FULVESTRANT,0404233476,2023,50 mg/ml,Solution for injection,Intramuscular use,1237.10,Laboratories Farmalan SA,Spain,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
Vetam,LEVETIRACETAM,2803233434,2023,500 mg,Film-coated tablet,Oral use,83.95,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Vetam,LEVETIRACETAM,2803233437,2023,1000 mg,Film-coated tablet,Oral use,137.20,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Omezyn Plus,"OMEPRAZOLE, SODIUM BICARBONATE",2903233441,2023,"40,1100 mg","Capsule, hard",Oral use,92.65,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
REZMYG,RIZATRIPTAN BENZOATE,3003233448,2023,10 mg,Orodispersible tablet,Oral use,80.65,Panacea Biotec Pharma Ltd,India,Panacea Biotec Pharma Ltd,India,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
REZMYG,RIZATRIPTAN BENZOATE,3103233454,2023,5 mg,Orodispersible tablet,Oral use,78.25,Panacea Biotec Pharma Ltd,India,Panacea Biotec Pharma Ltd,India,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Cinryze,HUMAN C1-ESTERASE INHIBITOR,0404233465,2023,500 IU,Powder and solvent for solution for injection,Intravenous use,5043.00,TAKEDA MANUFACTURING AUSTRIA AG,Austria,Takeda Manufacturing Austria AG,Austria,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Panda Advance,PARACETAMOL,0404233466,2023,500 mg,Tablet,Oral use,5.30,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
Prasido,TICAGRELOR,2803233436,2023,90 mg,Film-coated tablet,Oral use,156.50,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Papillio,PALBOCICLIB,0404233475,2023,75 mg,"Capsule, hard",Oral use,11361.40,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Papillio,PALBOCICLIB,0404233474,2023,100 mg,"Capsule, hard",Oral use,11361.40,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Papillio,PALBOCICLIB,0404233473,2023,125 mg,"Capsule, hard",Oral use,11361.40,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Cholib 145/20,"FENOFIBRATE, SIMVASTATIN",0404233477,2023,"145,20 mg",Film-coated tablet,Oral use,60.40,FOURNIER LABORATORIES IRELAND LIMITED,Ireland,Abbott Laboratories Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Cholib 145/40,"FENOFIBRATE, SIMVASTATIN",0404233482,2023,"145,40 mg",Film-coated tablet,Oral use,64.85,FOURNIER LABORATORIES IRELAND LIMITED,Ireland,Abbott Laboratories Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Bortezomib EPC,BORTEZOMIB,1004233513,2023,1 mg,powder for solution for injection,Intravenous use,565.468,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Eastern Pharma Co (EPC)
Regaine Foam for Men 5%,MINOXIDIL,0604233498,2023,5 %,Cutaneous foam,Cutaneous use,95.00,ASM Aerosol-Service AG,Switzerland,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Fusizone-F,SODIUM FUSIDATE,0604233497,2023,2 %,Ointment,Topical,8.15,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Uptravi 200 mcg titration pack,SELEXIPAG,1204233533,2023,200 µg,Film-coated tablet,Oral use,25496.80,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Uptravi 600 mcg,SELEXIPAG,1204233530,2023,600 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Uptravi 1000 mcg,SELEXIPAG,1204233531,2023,1000 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Uptravi 1200 mcg,SELEXIPAG,1204233532,2023,1200 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
JANUVIA 25 mg,SITAGLIPTIN PHOSPHATE,1304233539,2023,25 mg,Film-coated tablet,Oral use,44.65,Organon Pharma (UK) Limited,United Kingdom,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JANUVIA 50 mg,SITAGLIPTIN PHOSPHATE,1304233541,2023,50 mg,Film-coated tablet,Oral use,81.70,Organon Pharma (UK) Limited,United Kingdom,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Recarbrio,"IMIPENEM, CILASTATIN, RELEBACTAM",1304233540,2023,"500,500,250 mg",Powder for solution for infusion,Intravenous use,15509.40,MERCK SHARP AND DOHME LLC,United States,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ALNAGHI COMPANY
Pantrox,PANTOPRAZOLE,1704233559,2023,20 mg,Gastro-resistant tablet,Oral use,39.40,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Tigaron,ABIRATERONE ACETATE,0604233504,2023,250 mg,Film-coated tablet,Oral use,5280.5,ADAMED Pharma S.A,Poland,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Paxlovid,"RITONAVIR, PF-07321332 NIRMATRELVIR",1004233515,2023,"150,100 mg",Film-coated tablet,Oral use,4287.95,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
NovoRapid,INSULIN ASPART,0405233591,2023,100 U/ml,Solution for injection,"Intravenous, Subcutaneous",81.65,Novo Nordisk Produao Pharmaceutical Industry,United States,NOVO NORDISK,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,"Novo nordisk Saudi trading, Salehiya Trading Co."
Maxeva,MOXIFLOXACIN HYDROCHLORIDE,0105233566,2023,400 mg,Film-coated tablet,Oral use,59.50,EVA PHARMA,Egypt,Eva Pharma for Pharmaceuticals & Medical Appliances,Egypt,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Tukysa,TUCATINIB,0405233589,2023,50 mg,Film-coated tablet,Oral use,9638.40,Corden Pharma GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
Tukysa,TUCATINIB,0405233590,2023,150 mg,Film-coated tablet,Oral use,27600.90,Corden Pharma GmbH,Germany,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
NUBEQA,DAROLUTAMIDE,0305233584,2023,300 mg,Film-coated tablet,Oral use,10502.00,"Orion Corporation, Orion Pharma",Finland,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Bayer Saudi Arabia
Prodein Plus,"PARACETAMOL, CODEINE, CAFFEINE",1505233640,2023,"500,8,30 mg",Soluble tablet,Oral use,10.50,OMAN PHARMACEUTICAL PRODUCTS,Oman,OMAN PHARMACEUTICAL PRODUCTS,Oman,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO), Salehiya Trading Co."
Rolitac XL,TACROLIMUS,1205233635,2023,0.5 mg,"Prolonged-release capsule, hard",Oral use,253.30,Novartis Pharmaceutical Manufacturing LLC,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Rolitac XL,TACROLIMUS,1205233636,2023,1 mg,"Prolonged-release capsule, hard",Oral use,509.45,Novartis Pharmaceutical Manufacturing LLC,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Rolitac XL,TACROLIMUS,1205233638,2023,3 mg,"Prolonged-release capsule, hard",Oral use,1324.05,Novartis Pharmaceutical Manufacturing LLC,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Rolitac XL,TACROLIMUS,1205233637,2023,5 mg,"Prolonged-release capsule, hard",Oral use,2147.30,Novartis Pharmaceutical Manufacturing LLC,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
SAPHNELO 300 mg per 2 ml,ANIFROLUMAB,0905233612,2023,150 mg/ml,Concentrate for solution for infusion,Intravenous use,3653.00,AstraZeneca Nijmegen B.V,Netherlands,AstraZeneca AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
Inment,ESCITALOPRAM,1405233639,2023,20 mg,Film-coated tablet,Oral use,78.30,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Uptravi 1400 mcg,SELEXIPAG,1105233634,2023,1400 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Uptravi 1600 mcg,SELEXIPAG,1105233633,2023,1600 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GMBH CO. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Voricet,VORICONAZOLE,0905233606,2023,200 mg,Film-coated tablet,Oral use,1858.85,Sandoz Private Limited,India,Sandoz GmbH,Austria,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Adtralza,TRALOKINUMAB,1005233625,2023,150 mg,Solution for injection,Subcutaneous use,4413.45,Catalent Indiana LLC formerly Cook Pharmica LLC,United States,Pharmaceutical Products,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
BRAFTOVI,ENCORAFENIB,0705233598,2023,50 mg,"Capsule, hard",Oral use,2252.15,CATALENT PHARMA SOLUTIONS,United States,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
BRAFTOVI,ENCORAFENIB,0705233596,2023,75 mg,"Capsule, hard",Oral use,5067.30,CATALENT PHARMA SOLUTIONS,United States,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
MEKTOVI,BINIMETINIB,0705233595,2023,15 mg,Film-coated tablet,Oral use,10134.65,Almac Pharma Services Limited,United Kingdom,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
lidocaine Hydrochloride 2% w/v,LIDOCAINE HYDROCHLORIDE,0905233615,2023,2 %,Solution for injection,"intramuscular, subcutaneous",5.40,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
NGENLA,SOMATROGON,1005233627,2023,24 mg,Solution for injection,Subcutaneous use,795.00,Pfizer Manufcaturing Belgium N. V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
NGENLA,SOMATROGON,1005233626,2023,60 mg,Solution for injection,Subcutaneous use,1987.45,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"ALNAGHI COMPANY, Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Omnicef,CEFDINIR,1005233629,2023,600 mg,Film-coated tablet,Oral use,129.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Ticagrelor SPC F.C. Tablets,TICAGRELOR,2205233681,2023,90 mg,Film-coated tablet,Oral use,83.80,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
TEPADINA,THIOTEPA,1505233645,2023,15 mg,Powder for concentrate for solution for infusion,Intravenous use,748.30,BSP PHARMACEUTICALS,Italy,ADIENNE SA,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,QOMEL MEDICAL DRUG STORE
TEPADINA,THIOTEPA,1505233644,2023,100 mg,Powder for concentrate for solution for infusion,Intravenous use,4538.20,BSP PHARMACEUTICALS,Italy,ADIENNE SA,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,QOMEL MEDICAL DRUG STORE
Ventra,ESOMEPRAZOLE MAGNESIUM,1505233642,2023,20 mg,"Gastro-resistant capsule, hard",Oral use,54.50,ETHYPHARM,France,Macarthys Laboratories Ltd t/a Martindale Pharma,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Ventra,ESOMEPRAZOLE MAGNESIUM,1505233643,2023,40 mg,"Gastro-resistant capsule, hard",Oral use,67.80,ETHYPHARM,France,Macarthys Laboratories Ltd t/a Martindale Pharma,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Panpotin,EPOETIN ALFA,1805233674,2023,2000 IU,Solution for injection in pre-filled syringe,Intravenous use,222.60,PanGen Biotech Inc,South Korea,Saudi Vax,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Saudi Vax"
Panpotin,EPOETIN ALFA,1805233673,2023,4000 IU,Solution for injection in pre-filled syringe,Intravenous use,425.95,PanGen Biotech Inc,South Korea,Saudi Vax,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Saudi Vax"
Deroxi Liposomal 50 mg per 25 ml,DOXORUBICIN HYDROCHLORIDE,1505233641,2023,2 mg/ml,Solution for injection,Intravenous use,3733.95,Natco Pharma Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Docetaxel Venus (1 ml),DOCETAXEL,2405233720,2023,20 mg/ml,Concentrate for solution for infusion,Intravenous use,111.10,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
Docetaxel Venus (4 ml),DOCETAXEL,2405233721,2023,20 mg/ml,Solution for infusion,Intravenous use,444.40,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 25°c,Hospital,Salehiya Trading Co.
Pantrox,PANTOPRAZOLE,2805233743,2023,20 mg,Gastro-resistant tablet,Oral use,78.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
VeraSeal,"HUMAN FIBRINOGEN, HUMAN THROMBIN",2505233738,2023,"80,500 mg/ml, IU/",Sealant matrix,Epilesional use,465.20,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a freezer,Hospital,Abdulrehman Algosaibi G.T.C.
VeraSeal,"HUMAN FIBRINOGEN, HUMAN THROMBIN",2505233735,2023,"80,500 mg/ml, IU/",Sealant matrix,Epilesional use,845.45,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a freezer,Hospital,Abdulrehman Algosaibi G.T.C.
VeraSeal,"HUMAN FIBRINOGEN, HUMAN THROMBIN",2505233737,2023,"80,500 mg/ml, IU/",Sealant matrix,Epilesional use,1395.55,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a freezer,Hospital,Abdulrehman Algosaibi G.T.C.
VeraSeal,"HUMAN FIBRINOGEN, HUMAN THROMBIN",2505233736,2023,"80,500 mg/ml, IU/",Sealant matrix,Epilesional use,1909.05,"Instituto Grifols, S.A.",Spain,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store in a freezer,Hospital,Abdulrehman Algosaibi G.T.C.
FARINOX 20MG/0.2ML SOLUTION FOR INJECTION,ENOXAPARIN SODIUM,85-5286-22,2023,"20 mg, mg/ml",Solution for injection,"Intravenous, Subcutaneous",19.60,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Cigalah Group
FARINOX 40MG/0.4ML SOLUTION FOR INJECTION,ENOXAPARIN SODIUM,86-5286-22,2023,"40 mg, mg/ml",Solution for injection,"Intravenous, Subcutaneous",33.80,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Cigalah Group
FARINOX 60MG/0.6ML SOLUTION FOR INJECTION,ENOXAPARIN SODIUM,87-5286-22,2023,"60 mg, mg/ml",Solution for injection,"Intravenous, Subcutaneous",47.00,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c don't freeze,Pharmacy,Cigalah Group
FARINOX 80MG/0.8ML SOLUTION FOR INJECTION,ENOXAPARIN SODIUM,88-5286-22,2023,"80 mg, mg/ml",Solution for injection,"Intravenous, Subcutaneous",58.00,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Cigalah Group
Oncaspar,PEGASPARGASE,1505233646,2023,750 IU/ml,Powder for solution for injection/infusion,Intramuscular and intravenous use,8368.30,LES LABORATOIRES SERVIER INDUSTRIE,France,LES LABORATOIRES SERVIER,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Servier Saudi Arabia Trading LLC
BORTEZOMIB NEAPOLIS,BORTEZOMIB,1206233786,2023,3.5 mg,powder for solution for injection,"Intravenous, Subcutaneous",2177.05,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,do not store above 30°c,Hospital,"Mile Medical Company, Salehiya Trading Co."
Vapir,FAVIPIRAVIR,0606233767,2023,200 mg,Film-coated tablet,Oral use,925.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Scemblix,ASCIMINIB,1306233789,2023,40 mg,Film-coated tablet,Oral use,19832.70,NOVARTIS Pharma Stein AG,Switzerland,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
Scemblix,ASCIMINIB,1306233790,2023,20 mg,Film-coated tablet,Oral use,19832.70,NOVARTIS Pharma Stein AG,Switzerland,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Novartis Saudi Limited
Orabloc,"ARTICAINE HYDROCHLORIDE, ADRENALINE TARTRATE",1506233809,2023,"40,18.2 mg/ml",Solution for injection in cartridge,Dental use,99.40,PIERREL,Italy,PIERREL PHARMA S.R.L.,Italy,Marketed,Prescription,store below 25°c,Hospital,MEDICAL & PHARMACEUTICAL SERVICES CO.
Orabloc,"ARTICAINE HYDROCHLORIDE, ADRENALINE TARTRATE",1506233810,2023,"40,9.1 mg/ml",Solution for injection in cartridge,Dental use,99.40,PIERREL,Italy,PIERREL PHARMA S.R.L.,Italy,Marketed,Prescription,store below 25°c,Hospital,MEDICAL & PHARMACEUTICAL SERVICES CO.
Votellaz,SODIUM VALPROATE,0806233777,2023,500 mg,Prolonged-release tablet,Oral use,46.65,Aurobindo Pharma Limited Unit XV,India,Aurobindo Pharma Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Eztyd,AZACITIDINE,2106233834,2023,100 mg,Powder for suspension for injection,Subcutaneous use,884.80,Panacea Biotec Pharma Ltd,India,Panacea Biotec Pharma Ltd,India,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Intuniv XR,GUANFACINE HYDROCHLORIDE,2505233726,2023,1 mg,Prolonged-release tablet,Oral use,282.25,Patheon Manufacturing Services LLC,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Intuniv XR,GUANFACINE HYDROCHLORIDE,2505233728,2023,2 mg,Prolonged-release tablet,Oral use,294.50,Patheon Manufacturing Services LLC,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Intuniv XR,GUANFACINE HYDROCHLORIDE,2505233725,2023,3 mg,Prolonged-release tablet,Oral use,329.85,Patheon Manufacturing Services LLC,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Intuniv XR,GUANFACINE HYDROCHLORIDE,2505233727,2023,4 mg,Prolonged-release tablet,Oral use,383.40,Patheon Manufacturing Services LLC,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Sicfrex,DEFERASIROX,3105233756,2023,90 mg,Film-coated tablet,Oral use,525.45,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Paracetamol Medis,PARACETAMOL,1206233787,2023,10 mg/ml,Solution for infusion,Intravenous use,105.95,LES LABORATOIRES MEDIS,Tunisia,LES LABORATOIRES MEDIS,Tunisia,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
Bivocard,NEBIVOLOL HYDROCHLORIDE,2006233829,2023,2.5 mg,Tablet,Oral use,15.30,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Somavert,PEGVISOMANT,0106233761,2023,10 mg,Powder and solvent for solution for injection,Subcutaneous use,7391.65,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Somavert,PEGVISOMANT,0106233760,2023,15 mg,Powder and solvent for solution for injection,Subcutaneous use,11087.45,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Somavert,PEGVISOMANT,0106233762,2023,20 mg,Powder and solvent for solution for injection,Subcutaneous use,14783.30,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Klavox ES-600,"AMOXICILLIN TRIHYDRATE, Potassium Clavulanate",1306233793,2023,"600,42.9 mg",Powder for oral suspension,Oral use,29.40,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Propoven,PROPOFOL,0706233771,2023,20 mg/ml,Emulsion for injection/infusion,Intravenous use,760.45,Fresenius Kabi Austria GmbH,Austria,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,"ALHAYA MEDICAL CO, Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Aprolin,HYDRALAZINE,1106233783,2023,25 mg,Tablet,Oral use,50.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
ARNALTEM,TACROLIMUS,1906233825,2023,0.5 mg,"Capsule, hard",Oral use,200.95,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Macimit,MACITENTAN,1506233811,2023,10 mg,Film-coated tablet,Oral use,5824.40,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Amlovan,"VALSARTAN, AMLODIPINE BESILATE",1306233794,2023,"160,10 mg",Film-coated tablet,Oral use,62.90,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Imla,"PRILOCAINE, LIDOCAINE HYDROCHLORIDE",2106233832,2023,"2.50,2.50 % (W/W)",Cream,Topical,47.00,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Sogroya 5 mg / 1.5ml,SOMAPACITAN,1806233821,2023,3.3 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,1024.00,Novo Nordisk Bagsvaerd,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Novo nordisk Saudi trading
Flopadex,SILODOSIN,0706233776,2023,8 mg,"Capsule, hard",Oral use,64.05,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Sicfrex,DEFERASIROX,3105233757,2023,180 mg,Film-coated tablet,Oral use,1044.00,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Sicfrex,DEFERASIROX,3105233758,2023,360 mg,Film-coated tablet,Oral use,2074.20,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Amlovan,"VALSARTAN, AMLODIPINE BESILATE",1306233798,2023,"160,5 mg",Film-coated tablet,Oral use,56.85,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Ricavo,SUGAMMADEX,1506233819,2023,100 mg/ml,Solution for injection,Intravenous use,1887.80,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Skyrizi 600 mg per 10 ml,RISANKIZUMAB,2106233833,2023,60 mg/ml,Solution for infusion,Intravenous use,11103.25,AbbVie Limited,United States,AbbVie Inc,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Bosentan OHRE Pharma,BOSENTAN,1007233851,2023,125 mg,Film-coated tablet,Oral use,5504.1,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,OHRE Pharma,France,Marketed,Prescription,do not store above 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
HepaGam B,HUMAN HEPATITIS B IMMUNOGLOBULIN,1907233887,2023,312 IU/ml,Solution for injection,Intramuscular and intravenous use,576.85,Emergent BioSolutions Canada Inc,Canada,KI BIOPHARMA LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
HepaGam B,HUMAN HEPATITIS B IMMUNOGLOBULIN,1907233886,2023,1560 IU/ml,Solution for injection,Intramuscular and intravenous use,2877.70,Emergent BioSolutions Canada Inc,Canada,KI BIOPHARMA LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
Nurtec,RIMEGEPANT,3007233939,2023,75 mg,"Tablet, orally disintegrating",Oral use,607.00,CATALENT UK SWINDON ZYDIS LIMITED,United Kingdom,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Flexall Ultra,"GLUCOSAMINE HYDROCHLORIDE, METHYLSULFONYLMETHANE, CALCIUM FRUCTOBORATE, CHONDROITIN, SODIUM HYALURONATE",0806233778,2023,"500,500,72,66.7,1.1 mg",Film-coated tablet,Oral use,109.20,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Imodium Plus Caplets,"SIMETHICONE, LOPERAMIDE",1907233888,2023,"125,2 mg",Tablet,Oral use,25.70,Janssen Cilag - France,France,MCNEIL PRODUCTS LIMITED,United Kingdom,Marketed,OTC,do not store above 30°c,Pharmacy,Cigalah Group
BioVitin,BIOTIN,2007233902,2023,10 mg,Tablet,Oral use,61.05,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,OTC,do not store above 30°c,Pharmacy,GULF NEOCARE
AJOVY,FREMANEZUMAB,1707233878,2023,150 mg/ml,Solution for injection,Subcutaneous use,1343.05,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,Teva Gmbh,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Cigalah Group
Lumakras,SOTORASIB,2707233934,2023,120 mg,Tablet,Oral use,37902.60,Patheon Inc.,Canada,Amgen Inc.,United States,Marketed,Prescription,do not store above 25°c,Hospital,Salehiya Trading Co.
Coxido,CELECOXIB,2707233935,2023,200 mg,"Capsule, hard",Oral use,25.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Ivonsan,ONDANSETRON,2007233895,2023,2 mg/mg,Solution for injection,Intramuscular and intravenous use,56.10,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Vertella,POSACONAZOLE,2007233894,2023,100 mg,Gastro-resistant tablet,Oral use,2159.25,AET Laboratories Pvt. Ltd.,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Vardenafil Eva,VARDENAFIL,2007233896,2023,20 mg,Film-coated tablet,Oral use,68.70,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Ivonsan,ONDANSETRON,2007233897,2023,2 mg/ml,Solution for injection,Intramuscular and intravenous use,112.25,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
ClariSpray Original,OXYMETAZOLINE,1307233870,2023,0.5 mg/ml,Nasal spray,Nasal use,25.85,Delpharm Montréal Inc,Canada,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,Bayer Saudi Arabia
ClariSpray Menthol,OXYMETAZOLINE,1307233871,2023,0.5 mg/ml,Nasal spray,Nasal use,25.85,Delpharm Montréal Inc,Canada,BAYER CONSUMER CARE AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,Bayer Saudi Arabia
Sensityn,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",1107233858,2023,"1000,50 mg",Film-coated tablet,Oral use,91.65,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Sensityn,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",1107233857,2023,"850,50 mg",Film-coated tablet,Oral use,87.05,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Kolitarda,ROSUVASTATIN,2307233908,2023,20 mg,Film-coated tablet,Oral use,87.25,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Kolitarda,ROSUVASTATIN,2307233909,2023,10 mg,Film-coated tablet,Oral use,51.45,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Evrenzo,ROXADUSTAT,2507233929,2023,20 mg,Film-coated tablet,Oral use,290.05,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ARNALTEM,TACROLIMUS,2607233930,2023,5 mg,"Capsule, hard",Oral use,2009.90,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
ARNALTEM,TACROLIMUS,2607233931,2023,1 mg,"Capsule, hard",Oral use,402.00,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Fumadi,Dimethyl Fumarate,2007233900,2023,240 mg,Prolonged-release capsule,Oral use,2912.30,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Fumadi,Dimethyl Fumarate,2007233901,2023,120 mg,Prolonged-release capsule,Oral use,518.70,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Levar,LEVOCETIRIZINE DIHYDROCHLORIDE,2707233933,2023,5 mg,Film-coated tablet,Oral use,22.80,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Levar,LEVOCETIRIZINE DIHYDROCHLORIDE,2707233932,2023,5 mg,Film-coated tablet,Oral use,7.60,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Furosemide PSI 250 mg per 25 ml,FUROSEMIDE,2407233926,2023,10 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,18.20,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solution Industries (PSI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Vabysmo 6 mg per 0.05 ml,FARICIMAB,1207233862,2023,120 mg/ml,Solution for injection,Intravitreal use,3720.75,F. Hoffmann-La Roche Ltd.,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
Yescarta,AXICABTAGENE CILOLEUCEL,3107233942,2023,2000000 cells,Suspension for injection,Intravenous use,1638037.50,"Kite Pharma, Inc",United States,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,As provided in the Drug Summary Bulletin,Hospital,Cigalah Group
Glycelax,GLYCERIN,2007233893,2023,700 mg,Suppository,Rectal use,62.10,Unicare Pharma,Saudi Arabia,Unicare Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Unicare Pharma
Skyrizi 360 mg  per 2.4 ml,RISANKIZUMAB,3007233938,2023,"150 mg, mg/ml",Solution for injection in cartridge,Subcutaneous use,13323.90,Patheon Italia S.P.A.,Italy,AbbVie Inc,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Tezspire 210 mg per 1.9 ml Pre-filled syringe,TEZEPELUMAB,1207233867,2023,110 mg/ml,Solution for injection,Subcutaneous use,5804.95,AMGEN MANUFACTURING LIMITED,United States,AstraZeneca AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
Colistin JPI,COLISTIMETHATE SODIUM,2407233924,2023,2000000 IU,Powder for nebuliser solution/solution for injection/infusion,Intravenous and Inhalation Use,715.50,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Prograf,TACROLIMUS,0808233969,2023,0.5 mg,"Capsule, hard",Oral use,442.10,Astellas Pharma,Ireland,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Dezeroga,DAPAGLIFLOZIN,0108233947,2023,10 mg,Film-coated tablet,Oral use,135.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
CARVYKTI,CILTACABTAGENE AUTOLEUCEL,0908233977,2023,"100000000 TU/ml, cel",Intravenous infusion,Intravenous use,2409034.95,"Janssen Pharmaceuticals, Inc",United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store in a freezer,Hospital,"Cigalah Group, Farouk, Maamoun Tamer & CO"
Pratima Trio,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE, INDAPAMIDE",0108233944,2023,"10,10,2.5 mg",Film-coated tablet,Oral use,150.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Trio,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0108233943,2023,"10,2.5,5 mg",Film-coated tablet,Oral use,138.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Trio,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0108233946,2023,"5,1.25,5 mg",Film-coated tablet,Oral use,83.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Trio,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0108233945,2023,"5,1.25,10 mg",Film-coated tablet,Oral use,94.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Trepadio 200 mg per 20 ml,LACOSAMIDE,0608233965,2023,10 mg/ml,Solution for infusion,Intravenous use,399.55,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Quenfil,HYDROXYCHLOROQUINE SULFATE,0708233967,2023,200 mg,Film-coated tablet,Oral use,65.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Mixif,CEFIXIME,0908233976,2023,400 mg,"Capsule, hard",Oral use,75.50,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Lusam,LACOSAMIDE,1608233986,2023,150 mg,Film-coated tablet,Oral use,270.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lusam,LACOSAMIDE,1608233982,2023,100 mg,Film-coated tablet,Oral use,180.50,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lusam,LACOSAMIDE,1608233983,2023,50 mg,Film-coated tablet,Oral use,93.80,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lusam,LACOSAMIDE,1608233985,2023,10 mg/ml,Syrup,Oral use,83.90,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lusam,LACOSAMIDE,1608233984,2023,200 mg,Film-coated tablet,Oral use,361.65,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Glycelax,GLYCERIN,1608233989,2023,1400 mg,Suppository,Rectal use,69.55,Unicare Pharma,Saudi Arabia,Unicare Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Unicare Pharma
JNESTY,FUSIDIC ACID,2408234038,2023,2 %,Cream,Topical,4.05,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,JEDCO INTERNATIONAL PHARMACEUTICAL,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,AL JEDAANI STORE
Coguperin 20 mg per  0.2 ml,ENOXAPARIN SODIUM,2008234001,2023,"20 mg, mg/ml",Solution for injection,Subcutaneous use,18.20,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Coguperin 40 mg per 0.4 ml,ENOXAPARIN SODIUM,2008234000,2023,"40 mg, mg/ml",Solution for injection,Subcutaneous use,28.20,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Coguperin 60 mg per 0.6 ml,ENOXAPARIN SODIUM,2008234003,2023,"60 mg, mg/ml",Solution for injection,Subcutaneous use,39.70,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Coguperin 80 mg per 0.8 ml,ENOXAPARIN SODIUM,2008234002,2023,"80 mg, mg/ml",Solution for injection,Subcutaneous use,49.30,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Salehiya Trading Co.
Erlotinib EPC,ERLOTINIB,3008234066,2023,100 mg,Film-coated tablet,Oral use,3358.05,Reliance Life Sciences Pvt. Ltd,India,Eastern Pharma Co (EPC),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Eastern Pharma Co (EPC)
Effyren,CYCLOSPORIN,2408234035,2023,25 mg,"Capsule, hard",Oral use,72.95,Panacea Biotec Pharma Ltd,India,Panacea Biotec Pharma Ltd,India,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Amlohope Plus,"RAMIPRIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2108234013,2023,"10,10,25 mg","Capsule, hard",Oral use,62.80,LEK PHARMACEUTICALS D.D.,Slovenia,HEXAL AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Amlohope Plus,"RAMIPRIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2108234011,2023,"10,5,25 mg","Capsule, hard",Oral use,55.15,ADAMED Pharma S.A,Poland,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Amlohope Plus,"RAMIPRIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2108234008,2023,"5,5,12.5 mg","Capsule, hard",Oral use,45.55,ADAMED Pharma S.A,Poland,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Glycelax,GLYCERIN,1708233995,2023,2800 mg,Suppository,Rectal use,94.85,Unicare Pharma,Saudi Arabia,Unicare Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Unicare Pharma
Uxorate,FEBUXOSTAT,1708233997,2023,80 mg,Film-coated tablet,Oral use,84.10,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Uxorate,FEBUXOSTAT,1708233993,2023,40 mg,Film-coated tablet,Oral use,90.10,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Labirol 100 mg per 20 ml,LABETALOL HYDROCHLORIDE,2908234064,2023,5 mg/ml,Solution for injection,Intravenous use,44.90,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
ALUNBRIG,BRIGATINIB,2208234022,2023,90 mg,Film-coated tablet,Oral use,3710.65,Penn Pharmaceutical Services Ltd,United Kingdom,TAKEDA PHARMA A/S,Denmark,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Milorizast,APREMILAST,2208234019,2023,30 mg,Film-coated tablet,Oral use,1598.80,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Vaxneuvance,"Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)",2208234020,2023,64 µ/ml,Suspension for injection in pre-filled syringe,Intramuscular use,270.45,MSD INTERNATIONAL GMBH,Ireland,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Byannli,PALIPERIDONE,2108234016,2023,700 mg,Prolonged-release suspension for injection,Intramuscular use,6947.75,JANSSEN PHARMACEUTICA N.V.,Belgium,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Byannli,PALIPERIDONE,2108234018,2023,1000 mg,Prolonged-release suspension for injection,Intramuscular use,8543.50,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Capecitabine NEAPOLIS,Capecitabine,2808234063,2023,500 mg,Film-coated tablet,Oral use,577.85,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,store below 30°c,Hospital,"Mile Medical Company, PharmaZone (Netaq Al Dawa) Pharmaceuticals"
Doxydar,DOXYCYCLINE,2008234004,2023,100 mg,"Capsule, hard",Oral use,412.80,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
Novus,LURASIDONE,2408234051,2023,40 mg,Film-coated tablet,Oral use,186.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Novus,LURASIDONE,2408234050,2023,80 mg,Film-coated tablet,Oral use,186.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Topferol,CHOLECALCIFEROL,2708234055,2023,50000 IU,Film-coated tablet,Oral use,44.60,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
SoiCarby,"OMEPRAZOLE, SODIUM BICARBONATE",2308234025,2023,"40,1100 mg","Capsule, hard",Oral use,87.50,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Debrex,BREXPIPRAZOLE,3108234075,2023,2 mg,Film-coated tablet,Oral use,320.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Debrex,BREXPIPRAZOLE,3108234205,2023,0.5 mg,Film-coated tablet,Oral use,47.15,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Debrex,BREXPIPRAZOLE,3108234076,2023,1 mg,Film-coated tablet,Oral use,320.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Debrex,BREXPIPRAZOLE,3108234078,2023,4 mg,Film-coated tablet,Oral use,320.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Erbitux 500 mg per 100 ml,CETUXIMAB,3108234081,2023,5 mg/ml,Solution for infusion,Intravenous use,5445.00,MERCK HEALTHCARE KGAA,Germany,Merck Europe BV,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
CIBINQO,ABROCITINIB,3108234072,2023,50 mg,Film-coated tablet,Oral use,3901.20,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
CIBINQO,ABROCITINIB,3108234073,2023,100 mg,Film-coated tablet,Oral use,3901.20,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
CIBINQO,ABROCITINIB,3108234074,2023,200 mg,Film-coated tablet,Oral use,3901.20,Pfizer Manufacturing Deutschland GmbH,Germany,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Fenofibrate Ethypharm,FENOFIBRATE,3108234082,2023,145 mg,Tablet,Oral use,37.85,ETHYPHARM,France,Macarthys Laboratories Ltd t/a Martindale Pharma,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Lenvatinib BOS,LENVATINIB,3108234080,2023,4 mg,"Capsule, hard",Oral use,4817.75,Shilpa Medicare Ltd,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Hulio,ADALIMUMAB,0309234093,2023,40 mg,Solution for injection,Subcutaneous use,1889.10,Terumo Yamaguchi Corporation,Japan,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ZIMMO TRADING ESTABLISHMENT
Hulio,ADALIMUMAB,0309234092,2023,40 mg,Solution for injection,Subcutaneous use,1889.10,Terumo Yamaguchi Corporation,Japan,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ZIMMO TRADING ESTABLISHMENT
Nicorette Freshmint Gum,NICOTINE,0409234119,2023,4 mg,Medicated chewing-gum,Oral use,36.45,McNeil AB,Sweden,McNeil Sweden AB,Sweden,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Nicorette Freshmint Gum,NICOTINE,0409234120,2023,2 mg,Medicated chewing-gum,Oral use,28.30,McNeil AB,Sweden,McNeil Sweden AB,Sweden,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
Adacter,ENTECAVIR,0609234144,2023,0.5 mg,Film-coated tablet,Oral use,374.75,Novartis Pharmaceutical Manufacturing LLC,Slovenia,HEXAL AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Debrex,BREXPIPRAZOLE,3108234077,2023,3 mg,Film-coated tablet,Oral use,320.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Inogara,DAPOXETINE,1109234168,2023,60 mg,Film-coated tablet,Oral use,49.00,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Acalabrutinib BOS,Acalabrutinib,1109234174,2023,100 mg,"Capsule, hard",Oral use,13972.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Apilipx,ARIPIPRAZOLE,1209234180,2023,10 mg,Tablet,Oral use,200.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Apilipx,ARIPIPRAZOLE,1209234179,2023,5 mg,Tablet,Oral use,110.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Apilipx,ARIPIPRAZOLE,1209234178,2023,15 mg,Tablet,Oral use,248.50,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Apilipx,ARIPIPRAZOLE,1209234177,2023,30 mg,Tablet,Oral use,497.00,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Clodipan 8 mg and 5mg,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE",1309234203,2023,"8,5 mg","Capsule, hard",Oral use,58.80,ADAMED Pharma S.A,Poland,Aspen Healthcare,Malta,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
Clodipan 16 mg and 5 mg,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE",1309234204,2023,"16,5 mg","Capsule, hard",Oral use,64.65,ADAMED Pharma S.A,Poland,Aspen Healthcare,Malta,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
AMLOCARD 10 mg tablets,AMLODIPINE BESILATE,1309234209,2023,10 mg,Tablet,Oral use,43.35,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Rybrevant 350 mg per 7 ml,AMIVANTAMAB,1809234223,2023,50 mg/ml,Concentrate for solution for infusion,Intravenous use,5962.70,"Cilag AG, Schaffhausen, Switzerland",Switzerland,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
Elfonis 400 mg per 250 ml,MOXIFLOXACIN HYDROCHLORIDE,0802233224,2023,1.6 mg/ml,Solution for infusion,Intravenous use,76.95,Hemomont,Serbia,Hemofarm AD Vrsac,Serbia,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Salehiya Trading Co."
Cekea,HYDROXYCARBAMIDE,1709234219,2023,200 mg,"Capsule, hard",Oral use,27.60,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Lumify,BRIMONIDINE TARTRATE,2009234230,2023,0.25 mg/ml,"Eye drops, solution",Ophthalmic use,38.50,"Bausch & Lomb, Incorporated",United States,"Bausch & Lomb, Incorporated",United States,Marketed,OTC,store below 30°c,Pharmacy,ALNAGHI COMPANY
Welireg,BELZUTIFAN,2009234229,2023,40 mg,Film-coated tablet,Oral use,68062.50,MSD INTERNATIONAL GMBH,Ireland,MERCK SHARP & DOHME LIMITED,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Evoltra,CLOFARABINE,2109234258,2023,1 mg/ml,Concentrate for solution for infusion,Intravenous use,4011.70,PHARMACHEMIE,Netherlands,GENZYME EUROPE B.V.,Netherlands,Marketed,Prescription,store below 30°c,Hospital,Sanofi Arabia Trading Co. Ltd
ZOLECIN,CEFAZOLIN,2309234264,2023,1000 mg,Powder for injection,Intravenous use,80.05,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Lomipat,LACOSAMIDE,2109234256,2023,200 mg,Tablet,Oral use,193.75,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lomipat,LACOSAMIDE,2109234255,2023,150 mg,Tablet,Oral use,145.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lomipat,LACOSAMIDE,2109234254,2023,100 mg,Tablet,Oral use,96.70,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lomipat,LACOSAMIDE,2109234257,2023,50 mg,Tablet,Oral use,50.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Docetaxel AqVida 20 mg per 1 ml,DOCETAXEL,2509234270,2023,20 mg/ml,Solution for infusion,Intravenous use,111.10,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,Cigalah Group
Docetaxel AqVida 80 mg per 4 ml,DOCETAXEL,2509234269,2023,20 mg/ml,Solution for infusion,Intravenous use,444.40,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,Cigalah Group
Docetaxel AqVida 160 mg per 8 ml,DOCETAXEL,2509234271,2023,20 mg/ml,Solution for infusion,Intravenous use,888.80,AqVida GmbH Dassow,Germany,AqVida GmbH,Germany,Marketed,Prescription,do not store above 25°c,Hospital,Cigalah Group
Ursofalk,URSODEOXYCHOLIC ACID,2609234272,2023,500 mg,Film-coated tablet,Oral use,135.00,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Movicol Paediatric Plain,"MACROGOL, SODIUM CHLORIDE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE",2809234282,2023,"6.563,0.1754,0.0893,0.0251 g",Powder for oral solution,Oral use,35.30,NORGINE LIMITED,United Kingdom,ACINO PHARMA AG,Switzerland,Marketed,OTC,do not store above 30°c,Pharmacy,"Acino Arabia for trading LLC, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Sulbus 60 mg per 10 ml,BUSULFAN,2609234275,2023,6 mg/ml,Concentrate for solution for infusion,Intravenous use,6868.40,INTAS PHARMACEUTICALS LIMITED,India,Accord Healthcare Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
Pelgraz 6 mg in 0.6 ml,PEGFILGRASTIM,2609234273,2023,10 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,1765.65,INTAS PHARMACEUTICALS LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ZIMMO TRADING ESTABLISHMENT
Fetazim,CEFTAZIDIME,0310234290,2023,1 g,powder for solution for injection,Intramuscular and intravenous use,21.35,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Fetazim,CEFTAZIDIME,0310234287,2023,2 g,powder for solution for injection,Intravenous use,42.60,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Hospital,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Pantrox,PANTOPRAZOLE,0410234293,2023,40 mg,Gastro-resistant tablet,Oral use,37.65,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Pantrox,PANTOPRAZOLE,0410234291,2023,20 mg,Gastro-resistant tablet,Oral use,26.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Pantrox,PANTOPRAZOLE,0410234292,2023,40 mg,Gastro-resistant tablet,Oral use,112.90,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Triplixam,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0510234308,2023,"5,1.25,5 mg",Film-coated tablet,Oral use,83.20,SERVIER,Ireland,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,Servier Saudi Arabia Trading LLC
Triplixam,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0510234309,2023,"10,2.5,5 mg",Film-coated tablet,Oral use,133.30,SERVIER,Ireland,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,Servier Saudi Arabia Trading LLC
Triplixam,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0510234305,2023,"5,1.25,10 mg",Film-coated tablet,Oral use,94.95,SERVIER,Ireland,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,Servier Saudi Arabia Trading LLC
Triplixam,"PERINDOPRIL ARGININE, INDAPAMIDE, AMLODIPINE BESILATE",0510234306,2023,"10,2.5,10 mg",Film-coated tablet,Oral use,133.30,SERVIER,Ireland,LES LABORATOIRES SERVIER,France,Marketed,Prescription,store below 30°c,Pharmacy,Servier Saudi Arabia Trading LLC
Tadalafil EVA,TADALAFIL,0510234303,2023,20 mg,Film-coated tablet,Oral use,63.45,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Nevotic,LEVOFLOXACIN,0310234288,2023,500 mg,Film-coated tablet,Oral use,68.00,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Cytotec,MISOPROSTOL,0410234298,2023,200 µg,Tablet,Oral use,40.35,PIRAMAL HEALTHCARE UK LIMITED,United Kingdom,Pfizer Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Pfizer Saudi Trading"
Vabomere,"VABORBACTAM, MEROPENEM",0410234295,2023,"1,1 g",Powder for concentrate for solution for infusion,Intravenous use,1881.30,ACS Dobfar S.P.A,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Nexium 10 mg,ESOMEPRAZOLE,0910234320,2023,10 mg,Oral suspension,Oral use,85.40,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Albumin SK,ALBUMIN HUMAN,1010234322,2023,20 %,Solution for injection,Intravenous use,164.45,SK Plasma Co. Ltd,South Korea,SK Plasma Co. Ltd,South Korea,Marketed,Prescription,store below 30°c,Hospital,AL-DAWAA MEDICAL SERVICES CO. LTD
Albumin SK,ALBUMIN HUMAN,1010234323,2023,20 %,Solution for injection,Intravenous use,314.60,SK Plasma Co. Ltd,South Korea,SK Plasma Co. Ltd,South Korea,Marketed,Prescription,store below 30°c,Hospital,AL-DAWAA MEDICAL SERVICES CO. LTD
Tezspire 210 mg per 1.9 ml pen,TEZEPELUMAB,1210234328,2023,110 mg/ml,Solution for injection,Subcutaneous use,5804.95,AMGEN MANUFACTURING LIMITED,United States,AstraZeneca AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ALNAGHI COMPANY
Tiomist,TIOTROPIUM,1110234325,2023,10 µg,"Inhalation powder, hard capsule",Inhalation use,132.70,Laboratorios Liconsa S.A,Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Paxas,APIXABAN,1610234336,2023,5 mg,Film-coated tablet,Oral use,231.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Paxas,APIXABAN,1610234337,2023,2.5 mg,Film-coated tablet,Oral use,231.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Paxas,APIXABAN,1610234335,2023,2.5 mg,Film-coated tablet,Oral use,77.00,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Polmycol,COLISTIMETHATE SODIUM,1210234329,2023,1 million IU,Powder for solution for injection/infusion,Intravenous use,305.85,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Sumadix 500 per 5 ml Vials,SUGAMMADEX,1710234347,2023,100 mg/ml,Solution for injection,Intravenous use,4356.55,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Sumadix 200 per 2 ml Vials,SUGAMMADEX,1710234348,2023,100 mg/ml,Solution for injection,Intravenous use,1742.60,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Paduca 20 mg per 2 ml Vials,IBUPROFEN,1910234358,2023,10 mg/ml,Solution for injection,Intravenous use,1636.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Ontruzant,Trastuzumab,1910234365,2023,150 mg,Powder for concentrate for solution for infusion,Intravenous use,1029.40,Patheon Italia S.P.A.,Italy,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Ontruzant,Trastuzumab,1910234364,2023,420 mg,Powder for concentrate for solution for infusion,Intravenous use,2882.35,FAREVA PAU,France,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Daroxime,CEFUROXIME AXETIL,2210234368,2023,500 mg,Film-coated tablet,Oral use,46.05,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Enoxaparin BOS,ENOXAPARIN SODIUM,2410234391,2023,20 mg,Solution for injection,Intravenous use,13.70,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,2310234376,2023,40 mg,Solution for injection,Intravenous use,23.60,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,2310234377,2023,60 mg,Solution for injection,Intravenous use,32.90,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Enoxaparin BOS,ENOXAPARIN SODIUM,2310234378,2023,80 mg,Solution for injection,Intravenous use,40.55,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Bleoez,BLEOMYCIN SULFATE,2410234383,2023,15 IU,powder for solution for injection,"Intravenous, Intramuscular, Subcutaneous",67.90,Korea United Pharm. Inc,South Korea,Korea United Pharm. Inc,South Korea,Marketed,Prescription,store below 30°c,Hospital,YAHMAA MEDICAL COMPANY
Sineo,DIMETHINDENE MALEATE,2910234402,2023,1 mg/ml,Oral drops,Oral use,9.05,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Alpha Pharma Industry
Celezon,RUXOLITINIB,3010234405,2023,10 mg,Tablet,Oral use,9004.85,The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Antopaz,PANTOPRAZOLE,3010234406,2023,40 mg,powder for solution for injection,Intravenous use,22.90,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Advanced Pharmaceutical Industries
CIDOCOMB,"FUSIDIC ACID, BETAMETHASONE VALERATE",2910234401,2023,"20,1 mg/g",Cream,Topical,23.10,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Onstera,MONTELUKAST SODIUM,0111234415,2023,10 mg,Film-coated tablet,Oral use,65.40,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Verotec,BETAHISTINE DIHYDROCHLORIDE,0111234412,2023,8 mg,Tablet,Oral use,27.20,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
Verotec,BETAHISTINE DIHYDROCHLORIDE,0111234411,2023,16 mg,Tablet,Oral use,38.35,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
Verotec,BETAHISTINE DIHYDROCHLORIDE,0111234410,2023,24 mg,Tablet,Oral use,40.50,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Dallah Health Care Company
Glibil,GLIBENCLAMIDE,0211234418,2023,5 mg,Tablet,Oral use,173.20,Hikma Pharmaceuticals PLC,Jordan,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Ranexa,RANOLAZINE,0211234427,2023,375 mg,Prolonged-release tablet,Oral use,114.20,Menarini - Von Heyden GmbH,Germany,Menarini International O. L. S.A,Luxembourg,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ranexa,RANOLAZINE,0211234425,2023,500 mg,Prolonged-release tablet,Oral use,114.20,Menarini - Von Heyden GmbH,Germany,Menarini International O. L. S.A,Luxembourg,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ranexa,RANOLAZINE,0211234426,2023,750 mg,Prolonged-release tablet,Oral use,114.20,Menarini - Von Heyden GmbH,Germany,Menarini International O. L. S.A,Luxembourg,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Acyclovir - Vaxcel,ACYCLOVIR,0611234434,2023,250 mg,Powder for infusion,Intravenous use,193.50,Kotra Pharma M Sdn Bhd,Malaysia,Kotra pharma M Sdn Bhd,Malaysia,Marketed,Prescription,store below 30°c,Hospital,Al-Safa Warehouse For Pharmaceuticals Ltd
NUMETA G13% E,"CALCIUM CHLORIDE DIHYDRATE, REFINED OLIVE OIL (~80%) + REFINED SOYA OIL (~20%), ARGININE, PHENYLALANINE, ISOLEUCINE5, HISTIDINE, GLUCOSE, GLUTAMIC ACID, LEUCINE, CYSTEINE, ASPARTIC ACID, TRYPTOPHAN, ALANINE, ORNITHINE, PROLINE, GLYCINE, SERINE, SODIUM CHLORIDE, TAURINE, SODIUM GLYCEROPHOSPHATE HYDRATED, METHIONINE, POTASSIUM ACETATE, MAGNESIUM ACETATE TETRAHYDRATE, VALINE, THREONINE, LYSINE, TYROSINE",0811234441,2023,"0.55,7.5,0.78,0.39,0.62,0.35,40,0.93,0.93,0.18,0.56,0.19,0.75,0.23,0.28,0.37,0.37,0,0.06,0.98,0.22,0.61,0.10,0.71,0.35,1.03,0.07 g",Emulsion for infusion,Intravenous use,4066.50,BAXTER,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Arabian Health Care Co., ZIMMO TRADING ESTABLISHMENT"
Amleka 100 mg,AZACITIDINE,0811234445,2023,"100 mg, mg/ml",Powder for suspension for injection,Subcutaneous use,884.80,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Diafor XR,METFORMIN HYDROCHLORIDE,2011234518,2023,1000 mg,Prolonged-release tablet,Oral use,52.85,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Diafor XR,METFORMIN HYDROCHLORIDE,2011234510,2023,750 mg,Prolonged-release tablet,Oral use,39.65,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Diafor XR,METFORMIN HYDROCHLORIDE,2011234508,2023,500 mg,Prolonged-release tablet,Oral use,26.45,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Diafor XR,METFORMIN HYDROCHLORIDE,2011234517,2023,1000 mg,Prolonged-release tablet,Oral use,26.45,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Diafor XR,METFORMIN HYDROCHLORIDE,2011234511,2023,750 mg,Prolonged-release tablet,Oral use,19.85,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Diafor XR,METFORMIN HYDROCHLORIDE,2011234507,2023,500 mg,Prolonged-release tablet,Oral use,13.20,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Allocar,FINASTERIDE,2011234515,2023,1 mg,Film-coated tablet,Oral use,90.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Allocar,FINASTERIDE,2011234516,2023,5 mg,Film-coated tablet,Oral use,68.45,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lertiv,LERCANIDIPINE HYDROCHLORIDE,2011234509,2023,20 mg,Film-coated tablet,Oral use,132.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lertiv,LERCANIDIPINE HYDROCHLORIDE,2011234514,2023,10 mg,Film-coated tablet,Oral use,82.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lertiv,LERCANIDIPINE HYDROCHLORIDE,2011234512,2023,20 mg,Film-coated tablet,Oral use,66.40,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Lertiv,LERCANIDIPINE HYDROCHLORIDE,2011234513,2023,10 mg,Film-coated tablet,Oral use,41.40,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
GONAL-f 150 IU per 0.25 ml,FOLLITROPIN ALFA,3004233564,2023,600 IU/ml,Solution for injection,Subcutaneous use,189.75,MERCK SERONO SPA,Italy,Merck Europe BV,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Cigalah Group
Pantrox,PANTOPRAZOLE,2211234531,2023,40 mg,Gastro-resistant tablet,Oral use,56.45,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Gencebok,CAFFEINE CITRATE,2211234529,2023,10 mg/ml,Solution for infusion,"Intravenous, Oral",374.65,CENEXI,France,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Pafazin,DAPAGLIFLOZIN,2211234530,2023,10 mg,Film-coated tablet,Oral use,93.30,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Pafazin,DAPAGLIFLOZIN,2211234528,2023,5 mg,Film-coated tablet,Oral use,93.30,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Zodinex,LINEZOLID,2711234560,2023,600 mg,Film-coated tablet,Oral use,1251.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Azebat,AZELAIC ACID,2211234526,2023,20 % (W/W),Cream,Topical,24.50,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Spevigo 450 mg per 7.5 ml,SPESOLIMAB,2311234542,2023,"60 g/l, mg/ml",Solution for infusion,Intravenous use,84631.20,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,Boehringer Ingelheim Pharma GmbH and Co KG,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boehringer Ingelheim Scientific Office
Pliaglis 15 gram Cream,"LIDOCAINE HYDROCHLORIDE, TETRACAINE HYDROCHLORIDE",2311234539,2023,"7,7 %",Cream,Topical,76.90,INDUSTRIAL FARMACEUTICA CANTABRIA S.A,Spain,"Crescita Therapeutics, Inc",Canada,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Salehiya Trading Co.
Pliaglis 30 gram Cream,"LIDOCAINE HYDROCHLORIDE, TETRACAINE HYDROCHLORIDE",2311234540,2023,"7,7 %",Cream,Topical,139.15,INDUSTRIAL FARMACEUTICA CANTABRIA S.A,Spain,"Crescita Therapeutics, Inc",Canada,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Salehiya Trading Co.
Cekea,HYDROXYCARBAMIDE,2711234559,2023,500 mg,"Capsule, hard",Oral use,63.35,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Donifoxate,FEBUXOSTAT,2611234550,2023,80 mg,Film-coated tablet,Oral use,63.30,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
LERHASA,SALBUTAMOL,2711234551,2023,100 µg,"Pressurised inhalation, suspension",Inhalation use,14.50,Glenmark Pharmaceuticals Limited - Aurangabad,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Bleomycin Venus,BLEOMYCIN SULFATE,3011234569,2023,15 USP Units,Powder for solution for injection/infusion,Intramuscular and intravenous use,63.05,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Nexviazyme,AVALGLUCOSIDASE ALFA,0512234571,2023,100 mg,Powder for infusion,Intravenous use,5212.00,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
Zeposia,OZANIMOD,0612234574,2023,0.92 mg,"Capsule, hard",Oral use,4457.75,CELGENE INTERNATIONAL,Switzerland,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg,OZANIMOD,0612234573,2023,0.23+0.46 mg,"Capsule, hard",Oral use,1114.20,CELGENE INTERNATIONAL,Switzerland,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Esqua,TADALAFIL,0912234582,2023,5 mg,Film-coated tablet,Oral use,131.55,Atlantic Pharma,Portugal,Galenicum Health S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Tigaron,ABIRATERONE ACETATE,1812234595,2023,500 mg,Film-coated tablet,Oral use,5280.50,ADAMED Pharma S.A,Poland,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
Finjuve,FINASTERIDE,2012234612,2023,2.275 mg/ml,"Cutaneous spray, solution",Cutaneous use,237.20,Almirall Hermal GmbH,Germany,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pankaine 20 mg per 4 ml,BUPIVACAINE,2412234628,2023,5 mg/ml,Solution for injection,Intrathecal use,66.00,PANPHARMA,Germany,Panpharma,France,Marketed,Prescription,store below 30°c,Hospital,UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD.
Xonvea,"DOXYLAMINE SUCCINATE, PYRIDOXINE (VITAMIN B6)",2412234626,2023,"10,10 mg",Gastro-resistant tablet,Oral use,109.10,Duchesnay Inc,Canada,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Aztolyp,ATORVASTATIN CALCIUM,2012234603,2023,40 mg,Film-coated tablet,Oral use,86.90,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Aztolyp,ATORVASTATIN CALCIUM,2012234602,2023,20 mg,Film-coated tablet,Oral use,43.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Aztolyp,ATORVASTATIN CALCIUM,2012234600,2023,10 mg,Film-coated tablet,Oral use,43.45,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Wekasurg 200 mg per 2 ml,SUGAMMADEX,2012234601,2023,100 mg/ml,Solution for injection,Intravenous use,1742.60,WASSERBURGER ARZNEIMITTELWERK GMBH,Germany,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Figoya,FINGOLIMOD HYDROCHLORIDE,2012234606,2023,0.5 mg,"Capsule, hard",Oral use,3010.30,Dr. Reddy’s Laboratories Ltd. Formulation Unit VII,India,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Inment,ESCITALOPRAM,2012234607,2023,10 mg,Film-coated tablet,Oral use,43.50,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Xenpozyme,OLIPUDASE ALFA,2512234631,2023,20 mg,Powder for concentrate for solution for infusion,Intravenous use,17896.60,GENZYME IRELAND LIMITED,Ireland,Sanofi B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
Lintra,LINAGLIPTIN,0901244693,2024,5 mg,Film-coated tablet,Oral use,94.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Grateziano,SOFOSBUVIR,2712234636,2023,400 mg,Film-coated tablet,Oral use,2024.35,EUROPEAN EGYPTIAN PHARMACEUTICAL IND. CO,Egypt,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharco International pharmaceutical company
Balanced Salt Solution 500ml,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, SODIUM CITRATE",2712234635,2023,"0.64,0.075,0.048,0.030,0.39,0.17 g",Irrigation solution,IRRIGATION USE ONLY,55.95,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Renflexis,INFLIXIMAB,2612234632,2023,100 mg,Powder for concentrate for solution for infusion,Intravenous use,1089.00,Samsung Biologics,South Korea,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
Acloran Plus,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2812234637,2023,"16,5,12.5 mg","Capsule, hard",Oral use,46.35,ADAMED Pharma S.A,Poland,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Acloran Plus,"CANDESARTAN CILEXETIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2812234638,2023,"16,10,12.5 mg","Capsule, hard",Oral use,54.15,ADAMED Pharma S.A,Poland,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Stronyx,CABERGOLINE,0201244655,2024,0.5 mg,Tablet,Oral use,111.20,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Stronyx,CABERGOLINE,0201244656,2024,0.5 mg,Tablet,Oral use,34.35,EMIC UNITED PHARMACEUTICALS,Egypt,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
PREVENAR 20,"POLYSACCHARIDE FOR SEROTYPES 1, 3, 4, 5, 6A, 7F, 8, 9V, 10, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F, POLYSACCHARIDE FOR SEROTYPES 6B, CRM197 protein",0301244664,2024,"2.2,4.4,51 µg",Suspension for injection,Intramuscular use,270.45,PFIZER,Belgium,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
PREVENAR 20,"POLYSACCHARIDE FOR SEROTYPES 1, 3, 4, 5, 6A, 7F, 8, 9V, 10, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F, POLYSACCHARIDE FOR SEROTYPES 6B, CRM197 protein",0301244663,2023,"2.2,4.4,51 µg",Suspension for injection,Intramuscular use,2704.50,PFIZER,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Androgel,TESTOSTERONE,0801244680,2024,16.2 mg/g,Gel,Transdermal use,205.15,Laboratoires Besins International,France,Laboratoires Besins International,France,Marketed,Prescription,do not store above 30°c,Pharmacy,SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD
Korsuva,DIFELIKEFALIN,0901244691,2024,50 µ/ml,Solution for injection,Intravenous use,487.70,Siegfried Hameln GmbH,Germany,Vifor Fresenius Medical Care Renal Pharma,France,Marketed,Prescription,do not store above 30°c,Hospital,ARAC HEALTHCARE
Korsuva,DIFELIKEFALIN,0901244690,2024,50 µ/ml,Solution for injection,Intravenous use,1950.85,Siegfried Hameln GmbH,Germany,Vifor Fresenius Medical Care Renal Pharma,France,Marketed,Prescription,do not store above 30°c,Hospital,ARAC HEALTHCARE
Ircan 100 mg per 5 ml,IRINOTECAN,0901244688,2024,20 mg/ml,Lyophilisate for solution for injection,Intravenous use,169.05,Shilpa Medicare Ltd,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Dazaspect,AZACITIDINE,0901244689,2024,100 mg,Lyophilisate for solution for injection,"Intravenous, Subcutaneous",880.00,Shilpa Medicare Ltd,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Tavneos,AVACOPAN,0901244692,2024,10 mg,"Capsule, hard",Oral use,28159.35,Patheon Pharmaceuticals Inc.,United States,Vifor Fresenius Medical Care Renal Pharma,France,Marketed,Prescription,"Store below 30°C , protect from Light",Pharmacy,ARAC HEALTHCARE
Evrenzo,ROXADUSTAT,0901244695,2024,70 mg,Film-coated tablet,Oral use,1015.30,CATALENT PHARMA SOLUTIONS,United States,ASTELLAS PHARMA,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Xeerun,TERBINAFINE,0901244694,2024,1 %,"Cutaneous spray, solution",Topical,28.55,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Tadalo,TADALAFIL,1401244708,2024,5 mg,Film-coated tablet,Oral use,127.05,AL RAZI PHARMA INDUSTRIES FACTORY LTD,Saudi Arabia,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Vyxeos,"DAUNORUBICIN, CYTARABINE",1501244725,2024,"2.2,5 mg/ml",Powder for concentrate for solution for infusion,Intravenous use,23892.40,BAXTER ONCOLOGY GmbH,Germany,Jazz Pharmaceutical Ireland Ltd,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Clofarabine Ratiopharm,CLOFARABINE,1701244756,2024,1 mg/ml,Concentrate for solution for infusion,Intravenous use,1737.10,S.C.SINDAN PHARMA S.R.L,Romania,Ratiopharm GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
DROLINA,FUROSEMIDE,2101244771,2024,40 mg,Tablet,Oral use,60.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
DROLINA,FUROSEMIDE,2101244770,2024,20 mg,Tablet,Oral use,30.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Vasrasti,HYDROXYCHLOROQUINE SULFATE,2101244769,2024,200 mg,Film-coated tablet,Oral use,76.05,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Everolimus BOS,EVEROLIMUS,2101244772,2024,5 mg,Tablet,Oral use,9142.50,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Everolimus BOS,EVEROLIMUS,2101244773,2024,10 mg,Tablet,Oral use,17823.50,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Rocaltrol,CALCITRIOL,2201244776,2024,0.25 µg,"Capsule, soft",Oral use,136.20,CATALENT GERMANY EBERBACH GmbH,Germany,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 25°c,Pharmacy,ALNAGHI COMPANY
Ticagard,TICAGRELOR,2301244792,2024,90 mg,Film-coated tablet,Oral use,83.80,MSN LABORATORIES PRIVATE LIMITED,India,Razy Al Madina Pharmaceutical,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Razy Al Madina Pharmaceutical
Flohale,FLUTICASONE PROPIONATE,2301244784,2024,125 µg,Pressurised inhalation,Inhalation use,79.75,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Flohale,FLUTICASONE PROPIONATE,2301244785,2024,250 µg,Pressurised inhalation,Inhalation use,117.25,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Deroxi Liposomal,DOXORUBICIN HYDROCHLORIDE,2301244786,2024,2 mg/ml,Concentrate for solution for infusion,Intravenous use,1493.05,Natco Pharma Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Valencin,DAPTOMYCIN,2301244790,2024,500 mg,Powder for solution for injection/infusion,Intravenous use,346.75,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Bronchovent,SALBUTAMOL,2301244791,2024,5 mg/ml,inhalation solution,Inhalation use,548.15,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solutions Industry Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Unique Treatment L.L.C
Rivaroxaban MCP,RIVAROXABAN,2401244802,2024,20 mg,Film-coated tablet,Oral use,167.70,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
LIPRO SPRAY 10%,LIDOCAINE,2401244801,2024,100 mg/g,Solution for spray,Topical,22.30,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
LIVTENCITY,Maribavir,2401244793,2024,200 mg,Film-coated tablet,Oral use,52742.45,CATALENT,United States,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
AZACITIDINE NEAPOLIS,AZACITIDINE,0102244825,2024,100 mg,Lyophilisate for solution for injection,Subcutaneous use,884.80,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,do not store above 30°c,Hospital,"Mile Medical Company, Salehiya Trading Co."
Berinert,HUMAN C1-ESTERASE INHIBITOR,0602244851,2024,500 IU,Powder and solvent for solution for injection/infusion,Intravenous use,2624.95,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Anavalin,CABAZITAXEL,0102244830,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,11278.35,EVER PHARMA JENA GMBH,Germany,EVER Neuro Pharma GmbH,Austria,Marketed,Prescription,do not store above 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Voriconazole MCP,VORICONAZOLE,0102244820,2024,200 mg,Film-coated tablet,Oral use,2334.30,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Aquipta,Atogepant,0102244824,2024,60 mg,Tablet,Oral use,1343.05,Forest Laboratories Ireland Limited,Ireland,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
Aquipta,Atogepant,0102244823,2024,10 mg,Tablet,Oral use,1343.05,Forest Laboratories Ireland Limited,Ireland,Abbvie Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Cigalah Group"
Cabitac,TIGECYCLINE,3101244817,2024,50 mg,Powder for solution for infusion,Intravenous use,1028.45,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Suprax,CEFIXIME,3101244816,2024,40 mg/ml,Powder for oral suspension,Oral use,74.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Vantag,TIGECYCLINE,0402244840,2024,50 mg,Powder for solution for infusion,Intramuscular and intravenous use,1028.45,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Advanced Pharmaceutical Industries
BICAPROS,Bicalutamide,0502244847,2024,50 mg,Film-coated tablet,Oral use,218.20,"Atlas Pharm, S.A",Morocco,Eva Pharma for Pharmaceuticals & Medical Appliances,Egypt,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Gardasil 9,"HUMAN PAPILLOMAVIRUS TYPE 6 L1, HUMAN PAPILLOMAVIRUS TYPE 11 L1, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, Human Papillomavirus Type 31 L1 protein, Human Papillomavirus Type 33 L1 protein, Human Papillomavirus Type 45 L1 protein, Human Papillomavirus Type 52 L1 protein, Human Papillomavirus Type 58 L1 protein",2901244808,2024,"30,40,60,40,20,20,20,20,20 µg",Suspension for injection,Intramuscular use,605,"Baxter Pharmaceutical Solutions, LLC",United States,MERCK SHARP AND DOHME LLC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Olmetrol Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",0502244844,2024,"40,12.5 mg",Film-coated tablet,Oral use,63.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
Olmetrol Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",0502244843,2024,"20,12.50 mg",Film-coated tablet,Oral use,47.95,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
Olmetrol Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE",0502244845,2024,"40,25 mg",Film-coated tablet,Oral use,63.80,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ALHAYA MEDICAL CO
Eylea,AFLIBERCEPT,0602244856,2024,114.3 mg/ml,Solution for injection,Intravitreal use,3028.60,CATALENT,United States,BAYER AG,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Bayer Saudi Arabia
Novalir,BIVALIRUDIN,0602244853,2024,250 mg,Powder for solution for injection/infusion,Intravenous use,11094.50,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Cenoril,PERINDOPRIL ARGININE,0702244867,2024,10 mg,Film-coated tablet,Oral use,36.90,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Haemokion,PHYTOMENADIONE,0802244889,2024,10 mg,Solution for injection/infusion,Intravenous use,7.75,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 25°c,Hospital,Thimar Aljazirah Company
Diacerein,DIACEREIN,0602244852,2024,50 mg,"Capsule, hard",Oral use,53.15,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
ROSA,ROSUVASTATIN,0802244890,2024,20 mg,Film-coated tablet,Oral use,70.00,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Axelus,TESTOSTERONE,0802244891,2024,200 mg/ml,Solution for injection,Intramuscular use,26.25,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Lavinda,LINAGLIPTIN,0802244888,2024,5 mg,Film-coated tablet,Oral use,73.70,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Unique Treatment L.L.C
Decozal,XYLOMETAZOLINE HYDROCHLORIDE,0802244871,2024,0.05 %,"Nasal spray, solution",Nasal use,8.25,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Loanta,BACLOFEN,0802244868,2024,10 mg,Tablet,Oral use,29.20,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Tecvayli,TECLISTAMAB,0802244869,2024,90 mg/ml,Solution for injection,Subcutaneous use,22818.30,Patheon Manufacturing Services LLC,United States,Janssen-Cilag International NV,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Tecvayli,TECLISTAMAB,0802244870,2024,10 mg/ml,Solution for injection,Subcutaneous use,4474.25,Patheon Manufacturing Services LLC,United States,Janssen-Cilag International NV,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Liptyn,LINAGLIPTIN,1002244892,2024,5 mg,Tablet,Oral use,68.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
ROSA,ROSUVASTATIN,1102244897,2024,10 mg,Film-coated tablet,Oral use,45,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Meva SR,MEBEVERINE HYDROCHLORIDE,1102244894,2024,200 mg,"Modified-release capsule, hard",Oral use,40.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Abdullatif Mohammed Salah Jamjoom & Bros Co, JAMJOOM PHARMACEUTICALS CO. LTD."
Endura,DAPOXETINE,1202244902,2024,30 mg,Film-coated tablet,Oral use,36.75,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Endura,DAPOXETINE,1202244903,2024,60 mg,Film-coated tablet,Oral use,36.75,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Cenoril,PERINDOPRIL ARGININE,1202244904,2024,5 mg,Film-coated tablet,Oral use,28.05,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Beyfortus 100 mg per 1 ml,NIRSEVIMAB,1302244911,2024,100 mg/ml,Solution for injection,Intramuscular use,3781.75,Patheon Manufacturing Services LLC,United States,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Beyfortus,NIRSEVIMAB,1302244910,2024,"50 mg, mg/ml",Solution for injection,Intramuscular use,3781.75,Patheon Manufacturing Services LLC,United States,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Solfarin,WARFARIN SODIUM,1302244913,2024,1 mg/ml,Oral suspension,Oral use,815.00,Rosemont Pharmaceuticals Ltd,United Kingdom,Rosemont Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Bivalirudin,BIVALIRUDIN,1302244912,2024,250 mg,Powder for injection,Intravenous use,10539.75,Hainan Shuangcheng Pharmaceuticals Co. Ltd,China,Hainan Shuangcheng Pharmaceuticals Co. Ltd,China,Marketed,Prescription,do not store above 30°c,Hospital,YAHMAA MEDICAL COMPANY
Apdx,APIXABAN,1402244919,2024,2.5 mg,Film-coated tablet,Oral use,231.00,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Apdx,APIXABAN,1802244937,2024,5 mg,Film-coated tablet,Oral use,231.00,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Labetalol PSI 100 mg per 20 ml,LABETALOL HYDROCHLORIDE,1402244918,2024,5 mg/ml,Solution for injection/infusion,Intravenous use,8.40,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solutions Industry Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Glandacet,CINACALCET,1502244922,2024,90 mg,Film-coated tablet,Oral use,734.00,Piramal Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Glandacet,CINACALCET,1502244923,2024,60 mg,Film-coated tablet,Oral use,498.00,Piramal Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Glandacet,CINACALCET,1502244921,2024,30 mg,Film-coated tablet,Oral use,268.00,Piramal Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Omol,PARACETAMOL,1802244931,2024,500 mg,Tablet,Oral use,103.85,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Omacip,CIPROFLOXACIN,1802244929,2024,500 mg,Tablet,Oral use,2340.00,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Omcet,CETIRIZINE HYDROCHLORIDE,1802244930,2024,10 mg,Film-coated tablet,Oral use,512,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 25°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
semglee,INSULIN GLARGINE,1802244936,2024,100 IU/ml,Solution for injection,Subcutaneous use,163.05,Biocon SDN. BHD,Malaysia,Biosimilar Collaborations Ireland Limited (BCIL),Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Al Rajhi Pharma, Cigalah Group"
Myteb,TERIFLUNOMIDE,1802244938,2024,14 mg,Film-coated tablet,Oral use,2172.50,Aizant Drug Research Solutions Pvt.Ltd,India,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Ravegza 2.3 mg per 0.23 ml,RANIBIZUMAB,1802244932,2024,10 mg/ml,Solution for injection,Intravitreal use,2206.80,AJINOMOTO ALTHEA INCORPORATED,United States,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Amgevita 20 mg per 0.4 ml,ADALIMUMAB,2102244966,2024,"20 mg, mg/ml",Solution for injection,Subcutaneous use,884.50,AMGEN MANUFACTURING LIMITED,United States,Amgen Europe BV,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Salehiya Trading Co.
Tyenne 80 me per 4 ml,TOCILIZUMAB,1902244943,2024,20 mg/ml,Solution for infusion,Intravenous use,554.70,Fresenius Kabi Austria GmbH,Austria,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Tyenne 162 mg per 0.9 ml,TOCILIZUMAB,1902244946,2024,180 mg/ml,Solution for injection,Subcutaneous use,3345.45,Fresenius Kabi Austria GmbH,Austria,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Boston Oncology Arabia
Tyenne 200 mg per 10 ml,TOCILIZUMAB,1902244944,2024,20 mg/ml,Solution for infusion,Intravenous use,1366.80,Fresenius Kabi Austria GmbH,Austria,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Boston Oncology Arabia
Tyenne 400 mg per 20 ml,TOCILIZUMAB,1902244945,2024,20 mg/ml,Solution for infusion,Intravenous use,2703.60,Fresenius Kabi Austria GmbH,Austria,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
iPAT,OLOPATADINE,1902244950,2024,0.1 %,"Eye drops, solution",Ophthalmic use,19.90,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Decozal menthol,XYLOMETAZOLINE HYDROCHLORIDE,1902244949,2024,0.1 %,"Nasal spray, solution",Nasal use,13.10,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Adzoy,"ADAPALENE, BENZOYL PEROXIDE",1902244952,2024,"0.3,2.5 %",Gel,Topical,76.80,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Avysk,VALSARTAN,2002244953,2024,160 mg,Film-coated tablet,Oral use,24.50,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Avysk,VALSARTAN,2002244954,2024,80 mg,Film-coated tablet,Oral use,22.40,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
MASTROCIN,CLARITHROMYCIN,2102244961,2024,500 mg,Powder for solution for infusion,Intravenous use,34.50,ANFARM HELLAS S.A,Greece,ANFARM HELLAS S.A.,Greece,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Nepexto,ETANERCEPT,2602244982,2024,50 mg,Solution for injection in pre-filled pen,Subcutaneous use,2738.30,Lupin Limited Biotech division,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,ZIMMO TRADING ESTABLISHMENT
Acumen,ATOMOXETINE HYDROCHLORIDE,2602244985,2024,10 mg,"Capsule, hard",Oral use,160.75,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Acumen,ATOMOXETINE HYDROCHLORIDE,2602244984,2024,18 mg,"Capsule, hard",Oral use,160.75,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Acumen,ATOMOXETINE HYDROCHLORIDE,2602244986,2024,25 mg,"Capsule, hard",Oral use,160.75,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Acumen,ATOMOXETINE HYDROCHLORIDE,2602244987,2024,40 mg,"Capsule, hard",Oral use,160.75,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Acumen,ATOMOXETINE HYDROCHLORIDE,2602244988,2024,60 mg,"Capsule, hard",Oral use,160.75,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Arexvy,Recombinant respiratory syncytial virus prefusion F protein adjuvanted with AS01E,2802245004,2024,120 µg,Powder and suspension for suspension for injection,Intramuscular use,925.65,GlaxoSmithKline Biologicals,Belgium,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Paricalcitol Spectro,PARICALCITOL,2802245003,2024,5 µ/ml,Solution for injection,Intravenous use,461.05,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Andexxa,Andexanet alfa,2902245008,2024,200 mg,Powder for solution for infusion,Intravenous use,46282.50,"Baxter Pharmaceutical Solutions, LLC",United States,AstraZeneca AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,ALNAGHI COMPANY
Tepezza,Teprotumumab,2802245000,2024,500 mg,Intravenous infusion,Intravenous use,63245.05,Catalent Indiana LLC formerly Cook Pharmica LLC,United States,Horizon Therapeutics DAC,Ireland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Norepinephrine Kalceks,Noradrenaline,2802245005,2024,1 mg/ml,Concentrate for solution for infusion,Intravenous use,75.15,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,do not store above 30°c,Hospital,AL JEDAANI STORE
DUCRESSA,"DEXAMETHASONE, LEVOFLOXACIN",2902245007,2024,"1,5 mg/ml","Eye drops, solution",Ocular use,35.60,Tubilux Pharma S.p.A,Italy,Santen Oy,Finland,Marketed,Prescription,do not store above 30°c,Pharmacy,Al Hamaed medical company
RECOTHROM,Thrombin alfa,2902245010,2024,5000 IU,Powder,Topical,354.75,Patheon Italia S.P.A.,Italy,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,Store between (2°C – 25°C),Hospital,Arabian Health Care Co.
Ecinq,ULIPRISTAL ACETATE,0503245018,2024,30 mg,Film-coated tablet,Oral use,51.15,Haupt Pharma Münster GmbH,Germany,Aspen Healthcare,Malta,Marketed,OTC,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
Eulax,POLYETHYLENE GLYCOL,0503245019,2024,17 g,Powder for oral solution,Oral use,52.95,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Rina Extra,"DESLORATADINE, PSEUDOEPHEDRINE",0603245033,2024,"2.5,120 mg",modified-release tablet,Oral use,35.00,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Roxban,RIVAROXABAN,0603245020,2024,10 mg,Film-coated tablet,Oral use,179.70,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Roxban,RIVAROXABAN,0603245021,2024,15 mg,Film-coated tablet,Oral use,179.70,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Roxban,RIVAROXABAN,0603245022,2024,20 mg,Film-coated tablet,Oral use,179.70,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Abiraterone SPC,ABIRATERONE ACETATE,0703245034,2024,500 mg,Film-coated tablet,Oral use,5280.50,Aizant Drug Research Solutions Pvt.Ltd,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Vizarsin,SILDENAFIL,1703245057,2024,50 mg,Orodispersible tablet,Oral use,36.00,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,do not store above 30°c,Pharmacy,DERMAZONE Est
Linajent,LINAGLIPTIN,1703245056,2024,5 mg,Film-coated tablet,Oral use,68.05,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Daptomycin Amarox,DAPTOMYCIN,1803245058,2024,500 mg,Powder for solution for injection/infusion,Intravenous use,346.75,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Daptomycin Amarox,DAPTOMYCIN,1803245059,2024,350 mg,Powder for solution for injection/infusion,Intravenous use,242.70,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Famotidine Amarox,FAMOTIDINE,1803245062,2024,40 mg,Tablet,Oral use,77.25,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Famotidine Amarox,FAMOTIDINE,1803245063,2024,20 mg,Tablet,Oral use,38.60,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Famotidine Amarox,FAMOTIDINE,1803245061,2024,10 mg,Tablet,Oral use,19.30,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Opsutin,MACITENTAN,1803245060,2024,10 mg,Film-coated tablet,Oral use,5376.40,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Nepexto,ETANERCEPT,2103245068,2024,50 mg,Solution for injection in pre-filled syringe,Subcutaneous use,2738.30,Lupin Limited Biotech division,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Boston Oncology Arabia
Nepexto,ETANERCEPT,2103245067,2024,25 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1354.15,Lupin Limited Biotech division,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Boston Oncology Arabia
Diaglipt,VILDAGLIPTIN,2403245069,2024,50 mg,Tablet,Oral use,62.05,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Diphereline P.R.,TRIPTORELIN,2503245095,2024,22.5 mg,Powder and solvent for suspension for injection,Intramuscular use,2350.20,Debiopharm Research & Manufacturing S.A.,Switzerland,IPSEN PHARMA,France,Marketed,Prescription,do not store above 25°c,Hospital,Salehiya Trading Co.
abroten,ABIRATERONE ACETATE,2403245071,2024,500 mg,Film-coated tablet,Oral use,5280.50,Jodas Expoim Pvt Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
abroten,ABIRATERONE ACETATE,2403245070,2024,250 mg,Film-coated tablet,Oral use,5280.50,Jodas Expoim Pvt Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Novanza,TAFLUPROST,2403245080,2024,0.015 mg/ml,"Eye drops, solution in single-dose container",Ophthalmic use,56.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Tqmint,SILDENAFIL,2503245081,2024,25 mg,Chewable tablet,Oral use,59.60,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Tqmint,SILDENAFIL,2503245082,2024,50 mg,Chewable tablet,Oral use,14.90,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Tqmint,SILDENAFIL,2503245083,2024,100 mg,Chewable tablet,Oral use,19.05,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Ralzyo,RASAGILINE,2603245099,2024,1 mg,Tablet,Oral use,308.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Ralzyo,RASAGILINE,2603245098,2024,0.5 mg,Tablet,Oral use,308.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Fomepizole BOS,FOMEPIZOLE,2603245102,2024,1 g/ml,Solution for injection/infusion,Intravenous use,6655,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Cebatix,CELECOXIB,2603245104,2024,200 mg,"Capsule, hard",Oral use,37.50,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Bimatoprost BOS,BIMATOPROST,2603245101,2024,0.1 mg/ml,"Eye drops, solution",Ophthalmic use,31.15,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Busulfan BOS,BUSULFAN,2603245103,2024,6 mg/ml,Concentrate for solution for infusion,Intravenous use,6377.80,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Triova,TIOTROPIUM,2103245066,2024,13 µg,"Inhalation powder, hard capsule",Inhalation use,123.20,Laboratorios Liconsa S.A,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Mohammed Zaid Al Ashban and His Sons company for medical services
Uroleph,SOLIFENACIN SUCCINATE,2703245110,2024,10 mg,Film-coated tablet,Oral use,101.65,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Uroleph,SOLIFENACIN SUCCINATE,2703245109,2024,5 mg,Film-coated tablet,Oral use,79.05,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
ABRYSVO,"RSV SUBGROUP A STABILISED PREFUSION F, RSV SUBGROUP B STABILISED PREFUSION F",2803245123,2024,"60,60 µg",Powder and solvent for solution for injection,Intramuscular use,816.20,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
ABRYSVO,"RSV SUBGROUP A STABILISED PREFUSION F, RSV SUBGROUP B STABILISED PREFUSION F",2803245124,2024,"60,60 µg",Powder and solvent for solution for injection,Intramuscular use,8161.80,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Eptop,TOPIRAMATE,2803245116,2024,25 mg,Film-coated tablet,Oral use,25.30,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Eptop,TOPIRAMATE,2803245117,2024,50 mg,Film-coated tablet,Oral use,50.60,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Eptop,TOPIRAMATE,2803245118,2024,100 mg,Film-coated tablet,Oral use,87.25,PHARMATHEN INTERNATIONAL,Greece,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
RECOTHROM,Thrombin alfa,3103245136,2024,20000 IU,Powder,Topical,1419.00,Patheon Italia S.P.A.,Italy,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Arabian Health Care Co.
Uptravi 800 mcg,SELEXIPAG,0304245149,2024,800 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GmbH & Co. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Uptravi 400 mcg,SELEXIPAG,0304245150,2024,400 µg,Film-coated tablet,Oral use,10927.20,EXCELLA GmbH & Co. KG,Germany,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Lunginib,GEFITINIB,1504245162,2024,250 mg,Film-coated tablet,Oral use,4141.85,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,Eva Pharma for Pharmaceuticals & Medical Appliances,Egypt,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Adzoy,"ADAPALENE, BENZOYL PEROXIDE",1404245161,2024,"0.1,2.5 %",Gel,Topical,25.55,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Tiotropium Eva,TIOTROPIUM,1404245160,2024,18 µg,"Inhalation powder, hard capsule",Inhalation use,113.75,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Nyvepria,PEGFILGRASTIM,0404245151,2024,10 mg/ml,Solution for injection,Subcutaneous use,1765.65,HOSPIRA ZAGREB D.O.O.,Croatia,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Orfadin,NITISINONE,0404245152,2024,4 mg/ml,Oral suspension,Oral use,9220.80,APOTEK PRODUKTION & LABORATORIER AB,Sweden,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Arabian Trade House
Morphine sulfate 10 mg per 5 ml,MORPHINE SULFATE,0404245157,2024,2 mg/ml,Oral solution,Oral use,28.65,MACARTHYS LABORATORIES LIMITED T\A MARTINDALE PHARMA,United Kingdom,Martindale Pharma,United Kingdom,Marketed,Prescription,do not store above 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Retalex 50 mg per 5 ml,ATRACURIUM BESILATE,0404245153,2024,10 mg/ml,Solution for injection,Intravenous use,46.90,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Sotyktu,DEUCRAVACITINIB,1604245168,2024,6 mg,Film-coated tablet,Oral use,3777.35,Patheon Inc.,Canada,BRISTOL-MYERS SQUIBB,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Mucoplexil,OXOMEMAZINE,1604245163,2024,0.33 mg/ml,Syrup,Oral use,26.25,A. NATTERMANN & CIE GmbH,Germany,Sanofi Aventis France,France,Marketed,OTC,do not store above 25°c,Pharmacy,Opella Arabia Limited Co
Trientine dihydrochloride Tillomed,TRIENTINE DIHYDROCHLORIDE,1604245166,2024,250 mg,"Capsule, hard",Oral use,7662.35,Emcure Pharmaceuticals Ltd.,India,Tillomed Laboratories Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Minjuvi,TAFASITAMAB,1704245172,2024,200 mg,Powder for concentrate for solution for infusion,Intravenous use,3501.40,Boehringer Ingelheim Pharma GmbH & Co. KG,Germany,Incyte Biosciences International Sarl,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Sudex 500 mg per 5 ml,SUGAMMADEX,1804245175,2024,100 mg/ml,Solution for injection,Intravenous use,435.65,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Sudex 200 mg per 2 ml,SUGAMMADEX,1804245174,2024,100 mg/ml,Solution for injection,Intravenous use,174.25,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Fibrosta,TIROFIBAN,1804245173,2024,250 µ/ml,Concentrate for solution for infusion,Intravenous use,753.20,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Jazeera Pharmaceutical Industries (JPI)
Juleen,SITAGLIPTIN HYDROCHLORIDE,2104245177,2024,25 mg,Film-coated tablet,Oral use,40.65,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Juleen,SITAGLIPTIN HYDROCHLORIDE,2104245179,2024,50 mg,Film-coated tablet,Oral use,74.40,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Juleen,SITAGLIPTIN HYDROCHLORIDE,2104245178,2024,100 mg,Film-coated tablet,Oral use,90.20,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Arify,ARIPIPRAZOLE,2104245182,2024,10 mg,Tablet,Oral use,200.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Arify,ARIPIPRAZOLE,2104245181,2024,15 mg,Tablet,Oral use,248.50,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Jaypirca,PIRTOBRUTINIB,0604245159,2024,100 mg,Tablet,Oral use,20872.50,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Jaypirca,PIRTOBRUTINIB,0604245158,2024,50 mg,Tablet,Oral use,10436.25,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Jaypirca,PIRTOBRUTINIB,0604245208,2024,100 mg,Tablet,Oral use,41745.00,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Hospital,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Lammalid,LENALIDOMIDE,0404245156,2024,5 mg,"Capsule, hard",Oral use,11206.25,Synthon Chile LTDA,Chile,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Lammalid,LENALIDOMIDE,0404245154,2024,10 mg,"Capsule, hard",Oral use,11749.75,Synthon Chile LTDA,Chile,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Lammalid,LENALIDOMIDE,0404245209,2024,15 mg,"Capsule, hard",Oral use,11749.75,Synthon Chile LTDA,Chile,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Lammalid,LENALIDOMIDE,0404245155,2024,25 mg,"Capsule, hard",Oral use,13611.50,Synthon Chile LTDA,Chile,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
PROSTIN E2 2MG VAGINAL GEL IN APPLICATOR,DINOPROSTONE,2411222933,1999,2 mg,Vaginal gel,Vaginal use,83.00,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SA,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Farouk, Maamoun Tamer & CO"
Ravopro,TRAVOPROST,2204245183,2024,0.04 mg/ml,Eye drops,Ocular use,43.05,RAFARM S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Advanced Pharmaceutical Industries
Warfarin Macleods,WARFARIN SODIUM,2404245203,2024,5 mg,Tablet,Oral use,62.20,Macleods Pharmaceuticals Ltd.,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Propylthiouracil MACLEODS,PROPYLTHIOURACIL,2404245202,2024,50 mg,Tablet,Oral use,57.35,Macleods Pharmaceuticals Ltd.,India,Macleods Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Tenival,"AMLODIPINE BESILATE, VALSARTAN",2504245212,2024,"10,160 mg",Film-coated tablet,Oral use,62.90,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Tenival,"AMLODIPINE BESILATE, VALSARTAN",2504245211,2024,"5,160 mg",Film-coated tablet,Oral use,56.85,Macleods Pharmaceuticals Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Sedafol,PROPOFOL,2904245226,2024,10 mg/ml,Emulsion for infusion,Intravenous use,17.00,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Trumavar,"TRIFLURIDINE, TIPIRACIL",2904245224,2024,"15,6.14 mg",Film-coated tablet,Oral use,1815.25,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Trumavar,"TRIFLURIDINE, TIPIRACIL",2904245225,2024,"20,8.19 mg",Film-coated tablet,Oral use,2343.70,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
VERKAZIA,CICLOSPORIN,2804245219,2024,1 mg/ml,"Eye drops, emulsion",Ocular use,1324.95,Excelvision,France,Santen Oy,Finland,Marketed,Prescription,Store below 30°C Don't Freez,Pharmacy,Al Hamaed medical company
ARIKAYCE,AMIKACIN,3004245229,2024,590 mg,Nebuliser suspension,Inhalation use,53873.70,Resilience Biotechnologies Inc,Canada,Insmed Netherlands B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Haegarda,HUMAN C1-ESTERASE INHIBITOR,3004245227,2024,2000 IU,Powder and solvent for solution for injection,Subcutaneous use,10499.80,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Cigalah Group
Haegarda,HUMAN C1-ESTERASE INHIBITOR,3004245228,2024,3000 IU,Powder and solvent for solution for injection,Subcutaneous use,15749.70,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Cigalah Group
Rivaroxaban MCP,RIVAROXABAN,0105245232,2024,10 mg,Film-coated tablet,Oral use,64.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Rivaroxaban MCP,RIVAROXABAN,0105245233,2024,15 mg,Film-coated tablet,Oral use,167.70,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Lornoxicam- GPI,LORNOXICAM,0205245246,2024,8 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,13.70,Global Pharmaceutical Industries,Egypt,Global Pharmaceutical Industries,Egypt,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Ataben,ATAZANAVIR,0705245250,2024,150 mg,"Capsule, hard",Oral use,1771.15,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Ataben,ATAZANAVIR,0705245249,2024,200 mg,"Capsule, hard",Oral use,1771.15,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Camzyos,MAVACAMTEN,0905245268,2024,5 mg,"Capsule, hard",Oral use,6100.75,Patheon Inc.,Canada,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Camzyos,MAVACAMTEN,0905245269,2024,10 mg,"Capsule, hard",Oral use,6100.75,PATHEON INC,Canada,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Camzyos,MAVACAMTEN,0905245267,2024,15 mg,"Capsule, hard",Oral use,6100.75,PATHEON INC,Canada,Bristol-Myers Squibb / Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Camzyos,MAVACAMTEN,0905245270,2024,2.5 mg,"Capsule, hard",Oral use,6100.75,PATHEON INC,Canada,Bristol Myers Squibb Pharma EEIG,Ireland,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Jemperli,DOSTARLIMAB,0905245273,2024,50 mg/ml,Concentrate for solution for infusion,Intravenous use,27974.20,AJINOMOTO ALTHEA INCORPORATED,United States,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"GLAXO SAUDI ARABIA, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
KRABEVA 100 per 4 ml,Bevacizumab,0905245272,2024,25 mg/ml,Concentrate for solution for infusion,Intravenous use,698.45,Biocon Limited,India,Biocon Biologics Limited,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Mohamed Youssef Mohamed Salah Jamjoom Medical Company
KRABEVA 400 mg per 16 ml,Bevacizumab,0905245271,2024,25 mg/ml,Concentrate for solution for infusion,Intravenous use,2666.35,Biocon Limited,India,Biocon Biologics Limited,United Kingdom,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Mohamed Youssef Mohamed Salah Jamjoom Medical Company
Idelvion,ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN),0905245262,2024,250 IU,Powder and solvent for solution for injection,Intravenous use,2323.55,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Idelvion,ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN),0905245264,2024,500 IU,Powder and solvent for solution for injection,Intravenous use,4647.10,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Idelvion,ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN),0905245263,2024,1000 IU,Powder and solvent for solution for injection,Intravenous use,9294.30,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Idelvion,ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN),0905245261,2024,2000 IU,Powder and solvent for solution for injection,Intravenous use,18588.60,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Idelvion,ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN),0905245260,2024,3500 IU,Powder and solvent for solution for injection,Intravenous use,35978.05,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Etalon 0.25 mg per 5 ml,PALONOSETRON HYDROCHLORIDE,1205245276,2024,0.05 mg/ml,Solution for injection,Intravenous use,139.00,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Propofol - Lipuro 1000 mg per 50 ml,PROPOFOL,1205245277,2024,20 mg/ml,Emulsion for injection/infusion,Intravenous use,629.60,B. BRAUN MELSUNGEN AG,Germany,B. BRAUN,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Calquence,Acalabrutinib,1905245320,2024,100 mg,Film-coated tablet,Oral use,21385.85,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Pharmacy,"ALNAGHI COMPANY, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Bylvay,ODEVIXIBAT,1305245281,2024,200 µg,"Capsule, hard",Oral use,15768.60,PATHEON FRANCE,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Bylvay,ODEVIXIBAT,1305245282,2024,400 µg,"Capsule, hard",Oral use,31537.30,PATHEON FRANCE,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Bylvay,ODEVIXIBAT,1305245279,2024,600 µg,"Capsule, hard",Oral use,47305.90,PATHEON FRANCE,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Bylvay,ODEVIXIBAT,1305245280,2024,1200 µg,"Capsule, hard",Oral use,94620.35,PATHEON FRANCE,France,IPSEN PHARMA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Dupixent 300 mg Solution for injection in pre-filled pen,DUPILUMAB,1405245289,2024,"300 mg, mg/ml",Solution for injection,Subcutaneous use,5408.60,Sanofi aventis Deutschland GmbH,Germany,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Dupixent 200 mg Solution for injection in pre-filled pen,DUPILUMAB,1405245288,2024,200 mg,Solution for injection,Subcutaneous use,5408.60,SANOFI WINTHROP INDUSTRIE,France,SANOFI AVENTIS GROUPE,France,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Bastix,BACLOFEN,1405245291,2024,10 mg,Tablet,Oral use,26.95,Labatec Farmaceutica S.A,Portugal,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, medi sense"
Bastix,BACLOFEN,1405245290,2024,25 mg,Tablet,Oral use,54.40,Labatec Farmaceutica S.A,Portugal,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, medi sense"
Zelyssa 18 mg per 3 ml,LIRAGLUTIDE,1405245295,2024,6 mg/ml,Solution for injection,Subcutaneous use,665.55,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Evonanz 18 mg per 3 ml,LIRAGLUTIDE,1405245294,2024,6 mg/ml,Solution for injection,Subcutaneous use,297.75,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Milorizast 10 mg  - 20 mg - 30 mg starter pack,APREMILAST,1405245299,2024,10-20-30 mg,Film-coated tablet,Oral use,770.85,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Ambiful 250 mg per 5 ml,FULVESTRANT,1505245313,2024,50 mg/ml,Solution for injection,Intramuscular use,855.55,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Germany,Marketed,Prescription,store below 25°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Avysk HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE",2005245325,2024,"160,12.5 mg",Film-coated tablet,Oral use,30.30,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Avysk HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE",2005245324,2024,"160,25 mg",Film-coated tablet,Oral use,30.30,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Avysk HCT,"VALSARTAN, HYDROCHLOROTHIAZIDE",2005245323,2024,"80,12.5 mg",Film-coated tablet,Oral use,27.80,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SUNLENCA,LENACAPAVIR,2105245331,2024,300 mg,Film-coated tablet,Oral use,12201.60,ROTTENDORF PHARMA GMBH,Germany,"Gilead Sciences, Inc",United States,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
SUNLENCA,LENACAPAVIR,2105245330,2024,300 mg,Film-coated tablet,Oral use,15252.00,ROTTENDORF PHARMA GMBH,Germany,"Gilead Sciences, Inc",United States,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Gilead Sciences Arabia Ltd"
SUNLENCA 463.5 mg per 1.5 ml,LENACAPAVIR,2105245329,2024,"309 mg, mg/ml",Solution for injection,Subcutaneous use,90250.85,Patheon Italia S.P.A.,Italy,"Gilead Sciences, Inc",United States,Marketed,Prescription,store below 30°c,Hospital,"Cigalah Group, Gilead Sciences Arabia Ltd"
Racitam,LEVETIRACETAM,2205245335,2024,100 mg/ml,Oral solution,Oral use,83.60,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Cymbatex,DULOXETINE,2105245328,2024,30 mg,"Gastro-resistant capsule, hard",Oral use,36.10,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Cymbatex,DULOXETINE,2105245327,2024,60 mg,"Gastro-resistant capsule, hard",Oral use,72.20,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Olmy,OLMESARTAN MEDOXOMIL,2205245336,2024,20 mg,Film-coated tablet,Oral use,38.70,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Olmy,OLMESARTAN MEDOXOMIL,2205245334,2024,40 mg,Film-coated tablet,Oral use,51.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Vasopressin BOS,VASOPRESSIN,2205245337,2024,20 U/ml,Solution for infusion,Intravenous use,1389.80,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Cryptario,PALBOCICLIB,2305245341,2024,100 mg,Film-coated tablet,Oral use,7980.95,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Cryptario,PALBOCICLIB,2305245339,2024,75 mg,Film-coated tablet,Oral use,7980.95,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Cryptario,PALBOCICLIB,2305245340,2024,125 mg,Film-coated tablet,Oral use,7980.95,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
PORENZA,PAZOPANIB HYDROCHLORIDE,2805245359,2024,200 mg,Film-coated tablet,Oral use,1183.40,Pharmacare Premium Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
PORENZA,PAZOPANIB HYDROCHLORIDE,2805245360,2024,400 mg,Film-coated tablet,Oral use,2716.80,Pharmacare Premium Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Hydroxychloroquine SAJA,HYDROXYCHLOROQUINE SULFATE,2805245371,2024,200 mg,Film-coated tablet,Oral use,71.80,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Pabrolib,PALBOCICLIB,2805245361,2024,100 mg,"Capsule, hard",Oral use,10549.90,Aizant Drug Research Solutions Pvt.Ltd,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Pabrolib,PALBOCICLIB,2805245362,2024,75 mg,"Capsule, hard",Oral use,10549.90,Aizant Drug Research Solutions Pvt.Ltd,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Sesmo,ESOMEPRAZOLE MAGNESIUM,2805245372,2024,20 mg,"Capsule, hard",Oral use,26.95,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Sesmo,ESOMEPRAZOLE MAGNESIUM,2805245370,2024,20 mg,"Capsule, hard",Oral use,52.55,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Sesmo,ESOMEPRAZOLE MAGNESIUM,2805245373,2024,40 mg,"Capsule, hard",Oral use,36.75,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Sesmo,ESOMEPRAZOLE MAGNESIUM,2805245369,2024,40 mg,"Capsule, hard",Oral use,65.65,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Redunix 100 mg per 20 ml,TREPROSTINIL,3005245382,2024,5 mg/ml,Solution for infusion,"Intravenous, Subcutaneous",22876.55,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Redunix 50 mg per 20 ml,TREPROSTINIL,3005245383,2024,2.5 mg/ml,Solution for infusion,"Intravenous, Subcutaneous",14111.50,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Simvagen Plus,"EZETIMIBE, SIMVASTATIN",0606245394,2024,"10,20 mg",Tablet,Oral use,133.50,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Simvagen Plus,"EZETIMIBE, SIMVASTATIN",0606245395,2024,"10,40 mg",Tablet,Oral use,155.75,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Specrodoce,DOCETAXEL,0606245393,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,434.20,Shilpa Medicare Ltd,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Nervamine,METHYLCOBALAMIN,0606245396,2024,500 µg,Film-coated tablet,Oral use,20.80,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Jusprin,ACETYLSALICYLIC ACID,1306245423,2024,81 mg,Enteric-coated tablet,Oral use,22.50,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Floxmed,LEVOFLOXACIN,2506245429,2024,750 mg,Film-coated tablet,Oral use,66.10,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Vizarsin,SILDENAFIL,1106245410,2024,100 mg,Orodispersible tablet,Oral use,38.35,KRKA dd Novo mesto,Slovenia,"KRKA D.D., NOVO MESTO",Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Sogroya 15 mg / 1.5 ml,SOMAPACITAN,2606245436,2024,10 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,3072,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,Novo nordisk Saudi trading
trolac,KETOROLAC TROMETHAMINE,1206245413,2024,10 mg/ml,Solution for injection,Intramuscular and intravenous use,19.70,steril gene life sciences LTD,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
trolac,KETOROLAC TROMETHAMINE,1206245412,2024,30 mg/ml,Solution for injection,Intramuscular and intravenous use,21.70,steril gene life sciences LTD,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Famotidine for oral suspension,FAMOTIDINE,1006245404,2024,40-5 mg/ml,Oral suspension,Oral use,1649.85,Apothecon Pharmaceuticals PVT Limited,India,Navinta LLC,United States,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Pharmacy,QOMEL MEDICAL DRUG STORE
Famotidine Amarox,FAMOTIDINE,1206245421,2024,8 mg/ml,Oral suspension,Oral use,1270.50,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Akeega,"NIRAPARIB, ABIRATERONE",1206245415,,"50,500 mg",Film-coated tablet,Oral use,23027.20,PATHEON,France,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Akeega,"NIRAPARIB, ABIRATERONE",1206245414,2024,"100,500 mg",Film-coated tablet,Oral use,23027.20,PATHEON,France,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Cuprtin,TRIENTINE HYDROCHLORIDE,1206245422,2024,250 mg,"Capsule, hard",Oral use,7323.40,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Saudi Amarox
Locain,Lidocaine Base,1206245411,2024,10 %,Spray,Topical,35.00,Unicare Pharma,Saudi Arabia,Unicare Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Unicare Pharma
Stamagen,ABIRATERONE ACETATE,2506245430,2024,500 mg,Film-coated tablet,Oral use,4928.45,DELPHARM LILLE S.A.S.,France,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Pomalidomide BOS,POMALIDOMIDE,2606245437,2024,4 mg,Capsule,Oral use,15686.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Pomalidomide BOS,POMALIDOMIDE,2606245440,2024,3 mg,Capsule,Oral use,15686.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Pomalidomide BOS,POMALIDOMIDE,2606245439,2024,2 mg,Capsule,Oral use,12482.23,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Pomalidomide BOS,POMALIDOMIDE,2606245438,2024,1 mg,Capsule,Oral use,15103.50,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Ensutine,BENDAMUSTINE HYDROCHLORIDE,2706245446,2024,45 mg/ml,Solution for injection,Intravenous use,1796.05,DR. REDDY,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Teralas,TERIFLUNOMIDE,2706245443,2024,14 mg,Film-coated tablet,Oral use,2172.50,Pharmacare Premium Ltd,Malta,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Sildenafil,SILDENAFIL,0107245460,2024,10 mg/ml,Powder for oral suspension,Oral use,1315.2,Novitium Pharma LLC,United States,Novitium pharma LLC,United States,Marketed,Prescription,do not store above 30°c,Pharmacy,International Pioneers
CEVENFACTA,Eptacog beta,2706245449,2024,1 mg,Powder and solvent for solution for injection,Intravenous use,3168,sanofi S.R.L,Italy,Laboratoire français du Fractionnement et des Biotechnologies,France,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,"Farouk, Maamoun Tamer & CO"
CEVENFACTA,Eptacog beta,2706245447,2024,2 mg,Powder and solvent for solution for injection,Intravenous use,6348.5,sanofi S.R.L,Italy,Laboratoire français du Fractionnement et des Biotechnologies,France,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,"Farouk, Maamoun Tamer & CO"
CEVENFACTA,Eptacog beta,2706245448,2024,5 mg,Powder and solvent for solution for injection,Intravenous use,15842.65,sanofi S.R.L,Italy,Laboratoire français du Fractionnement et des Biotechnologies,France,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,"Farouk, Maamoun Tamer & CO"
Cabozantinib BOS,CABOZANTINIB,2706245451,2024,20 mg,Tablet,Oral use,13761.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Cabozantinib BOS,CABOZANTINIB,2706245450,2024,40 mg,Film-coated tablet,Oral use,13761.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Cabozantinib BOS,CABOZANTINIB,2706245452,2024,60 mg,Tablet,Oral use,13761.05,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Tepkinly,Epcoritamab,0107245461,2024,4 mg/ml,concentrate for solution for injection,Subcutaneous use,2789.95,VETTER PHARMA,Germany,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Tepkinly,Epcoritamab,0107245462,2024,48 mg/ml,Solution for injection,Subcutaneous use,33479.35,VETTER PHARMA,Germany,ABBVIE Deutschland GmbH,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Daglozin,DAPAGLIFLOZIN,2706245445,2024,5 mg,Film-coated tablet,Oral use,144.80,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Daglozin,DAPAGLIFLOZIN,2706245444,2024,10 mg,Film-coated tablet,Oral use,144.80,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Epiduo Forte,"BENZOYL PEROXIDE, ADAPALENE",0307245472,2024,"2.5,0.3 %",Gel,Topical,76.80,LABORATOIRES GALDERMA,France,GALDERMA,France,Marketed,Prescription,do not store above 30°c,Pharmacy,ALHAYA MEDICAL CO
Influvac Tetra,"A Brisbane 02 2018 H1N1, A Kansas 14 2017 H3N2, B Colorado 06 2017, B Phuket 3073 2013",0907245518,2024,15.15.15.15 µg,Solution for injection in pre-filled syringe,Intramuscular and intravenous use,543.45,ABBOTT BIOLOGICALS,Netherlands,ABBOTT BIOLOGICALS,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Essential D-3,CHOLECALCIFEROL,1307245553,2024,5000 IU,Capsule,Oral use,55.00,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,Prescription,store below 30°c,Pharmacy,GULF NEOCARE
Essential D-3,CHOLECALCIFEROL,1307245554,2024,10000 IU,Capsule,Oral use,64.10,ARNET PHARMACEUTICAL CORP,United States,ARNET PHARMACEUTICAL CORP,United States,Marketed,Prescription,store below 30°c,Pharmacy,GULF NEOCARE
Vizoden,VILAZODONE,1107245550,2024,20 mg,Film-coated tablet,Oral use,69.20,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Vizoden,VILAZODONE,1107245548,2024,40 mg,Film-coated tablet,Oral use,138.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Vizoden,VILAZODONE,1107245549,2024,10 mg,Film-coated tablet,Oral use,34.60,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
NERLYNX,NERATINIB,1007245533,2024,40 mg,Film-coated tablet,Oral use,17522.95,Pierre Fabre Medicament Production,France,PIERRE FABRE MEDICAMENT,France,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Avogesic,DIETHYLAMINE SALICYLATE,0407245481,2024,10 %,Cream,Topical,13.85,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Ultavan,VANCOMYCIN,1107245540,2024,5 mg/ml,Intravenous infusion,Intravenous use,1107.35,Inforlife S A,Swaziland,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Levogand,LEVOTHYROXINE SODIUM,1107245538,2024,50 µg,Tablet,Oral use,20,Acme Generics LLP,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Levogand,LEVOTHYROXINE SODIUM,1107245539,2024,25 µg,Tablet,Oral use,15.35,Acme Generics LLP,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
JARDIANCE 10 mg film-coated tablet,EMPAGLIFLOZIN,2810211247,2016,10 mg,Film-coated tablet,Oral use,159.00,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
JARDIANCE 25 mg film-coated tablet,EMPAGLIFLOZIN,2810211246,2016,25 mg,Film-coated tablet,Oral use,159.00,BOEHRINGER INGELHEIM,Germany,BOEHRINGER INGELHEIM,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Boehringer Ingelheim Scientific Office, Cigalah Group"
Docrosa,ROSUVASTATIN,0407245475,2024,10 mg,Film-coated tablet,Oral use,50.55,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Docrosa,ROSUVASTATIN,0407245476,2024,20 mg,Film-coated tablet,Oral use,85.70,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Docrosa,ROSUVASTATIN,0407245477,2024,40 mg,Film-coated tablet,Oral use,171.45,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Docrosa,ROSUVASTATIN,0407245478,2024,5 mg,Film-coated tablet,Oral use,25.25,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Azafor,PLERIXAFOR,1407245568,2024,20 mg/ml,Solution for injection,Subcutaneous use,14507.70,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Penmat,PEMETREXED,0907245512,2024,500 mg,Lyophilisate for solution for infusion,Intravenous use,2595.15,Shilpa Medicare Ltd,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Omeprex Plus,"OMEPRAZOLE, SODIUM BICARBONATE",1407245570,2024,"40,1100 mg",Capsule,Oral use,93.75,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Elbag,ELTROMBOPAG OLAMINE,1407245569,2024,50 mg,Film-coated tablet,Oral use,4610.35,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Elbag,ELTROMBOPAG OLAMINE,1407245571,2024,25 mg,Film-coated tablet,Oral use,2305.15,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
PANTOL,PANTOPRAZOLE,1707245599,2024,20 mg,Gastro-resistant coated tablet,Oral use,37.60,SPIMACO,Saudi Arabia,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ARAC HEALTHCARE
Aprolin,HYDRALAZINE,1607245585,2024,50 mg,Tablet,Oral use,100,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Aprolin,HYDRALAZINE,1607245584,2024,10 mg,Tablet,Oral use,20,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Methotrexate Venus,METHOTREXATE,1507245580,2024,100 mg/ml,Solution for injection,Intramuscular and intravenous use,71.15,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Methotrexate Venus,METHOTREXATE,1507245579,2024,25 mg/ml,Solution for injection,Intramuscular and intravenous use,20.70,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Rezurock,BELUMOSUDIL MESYLATE,1507245577,2024,200 mg,Film-coated tablet,Oral use,34581.50,UPM Pharmaceuticals,United States,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
Ultasil,SILDENAFIL,1707245597,2024,100 mg,Orodispersible film,Oral use,43.70,ALTERGON ITALIA S.r.l,Italy,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Ultasil,SILDENAFIL,1707245598,2024,50 mg,Orodispersible film,Oral use,43.70,ALTERGON ITALIA S.r.l,Italy,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Ultasil,SILDENAFIL,1707245596,2024,25 mg,Orodispersible film,Oral use,43.70,ALTERGON ITALIA S.r.l,Italy,IBSA INSTITUTE BIOCHIMIQUE S.A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Nuvessa,METRONIDAZOLE,1807245602,2024,1.3 %,Gel,Vaginal use,75.90,Laboratories Liconsa SA,Spain,Exeltis USA Inc,United States,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Concentia,METHYLPHENIDATE,1807245603,2024,18 mg,Prolonged-release tablet,Oral use,78.15,Laboratorios Liconsa S.A,Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Concentia,METHYLPHENIDATE,1807245604,2024,36 mg,Prolonged-release tablet,Oral use,108.55,Laboratorios Liconsa S.A,Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Mictonorm XL,PROPIVERINE HYDROCHLORIDE,2207245620,2024,30 mg,"Modified-release capsule, hard",Oral use,150.40,LOSAN PHARMA GMBH,Germany,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, medi sense"
Trovapt,TERIFLUNOMIDE,2207245623,2024,14 mg,Tablet,Oral use,2172.50,APOTEX INC. (SIGNET SITE),Canada,Apotex Inc,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Trisuva,TREPROSTINIL,2207245628,2024,5 mg/ml,Infusion,"Intravenous, Subcutaneous",12537.65,Lyocontract GmbH,Germany,AOP Orphan Pharmaceuticals GmbH,Austria,Marketed,Prescription,do not store above 30°c,Hospital,Thimar Aljazirah Company
Trisuva,TREPROSTINIL,2207245629,2024,10 mg/ml,Infusion,"Intravenous, Subcutaneous",21732.70,Lyocontract GmbH,Germany,AOP Orphan Pharmaceuticals GmbH,Austria,Marketed,Prescription,do not store above 30°c,Hospital,Thimar Aljazirah Company
Levogand,LEVOTHYROXINE SODIUM,0408245720,2024,100 µg,Tablet,Oral use,22.35,Acme Generics LLP,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Lidapro,"LIDOCAINE, PRILOCAINE",0508245724,2024,"2.5,2.5 % (W/W)",Cream,Topical,47.00,Dallah Pharma Factory,Saudi Arabia,Dallah Pharma Company,Saudi Arabia,Marketed,Prescription,Store below 30°C Don't Freez,Hospital,Dallah Health Care Company
Sita,Sitagliptin Phosphate Monohydrate,0408245723,2024,100 mg,Film-coated tablet,Oral use,90.20,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Sita,Sitagliptin Phosphate Monohydrate,0408245722,2024,50 mg,Film-coated tablet,Oral use,66.85,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alrai Pharmaceutical industry Co. (L.L.C)
Hyponal,HYOSCINE BUTYLBROMIDE,0408245721,2024,20 mg/ml,Solution for injection,Intramuscular and intravenous use,8.45,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
PROVINDA PLUS,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",3107245711,2024,"10,10 mg",Tablet,Oral use,85.90,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROVINDA PLUS,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",3107245713,2024,"10,5 mg",Tablet,Oral use,75.35,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROVINDA PLUS,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",3107245714,2024,"5,10 mg",Tablet,Oral use,60.70,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
PROVINDA PLUS,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",3107245712,2024,"5,5 mg",Tablet,Oral use,50.15,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
ELZONRIS,TAGRAXOFUSP,2907245672,2024,1000 µ/ml,Injection,Intravenous use,105008.35,Alcami Carolinas Corporation,United States,"Stemline Therapeutics, Inc",United States,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Hospital,Cigalah Group
Malaquon,"ATOVAQUONE, PROGUNAIL",2807245668,2024,"250,100 mg",Tablet,Oral use,93.05,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Malaquon,"ATOVAQUONE, PROGUNAIL",2807245669,2024,"62.5,25 mg",Tablet,Oral use,23.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
TACROZ Forte,TACROLIMUS,2407245649,2024,0.1 %,Ointment,Topical,70.70,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Tacroz,TACROLIMUS,2407245650,2024,0.03 %,Ointment,Topical,64.15,Glenmark Pharmaceuticals Limited - Baddi,India,Glenmark Pharmaceuticals Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Ligra,LIRAGLUTIDE,2407245648,2024,6 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,258.05,NOVOCOL,Canada,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Foscavir,FOSCARNET,2807245662,2024,24 mg/ml,Solution for infusion,Intravenous use,821.30,FRESENIUS KABI,Austria,Clinigen Healthcare Ltd,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,QOMEL MEDICAL DRUG STORE
Tulepsy,TOPIRAMATE,0608245728,2024,50 mg,Film-coated tablet,Oral use,50.60,PHARMATHEN INTERNATIONAL,Greece,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
SITAVIA,SITAGLIPTIN PHOSPHATE,0708245735,2024,50 mg,Film-coated tablet,Oral use,74.40,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
SITAVIA,SITAGLIPTIN PHOSPHATE,0708245736,2024,100 mg,Film-coated tablet,Oral use,90.20,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Tymlos,ABALOPARATIDE,0708245739,2024,2 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,1564.15,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
Mounjaro KwikPen,TIRZEPATIDE,1208245748,2024,10 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro KwikPen,TIRZEPATIDE,1208245747,2024,2.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro KwikPen,TIRZEPATIDE,1208245749,2024,12.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro KwikPen,TIRZEPATIDE,1208245750,2024,7.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro KwikPen,TIRZEPATIDE,1208245752,2024,5 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Mounjaro KwikPen,TIRZEPATIDE,1208245751,2024,15 mg,Solution for injection in pre-filled pen,Subcutaneous use,1261.40,Eli Lilly Italia SpA,Italy,Eli Lilly Nederland B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
PLUVICTO,LUTETIUM 177LU VIPIVOTIDE TETRAXETAN,1208245753,2024,1000 MBq/ml,Solution for injection/infusion,Intravenous use,100266.50,Advanced Accelerator Applications,Italy,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
Femic,TRANEXAMIC ACID,1308245762,2024,100 mg/ml,Solution for injection/infusion,Intravenous use,62.00,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Empagliflozin SPC,EMPAGLIFLOZIN,1308245763,2024,25 mg,Film-coated tablet,Oral use,135.15,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Empagliflozin SPC,EMPAGLIFLOZIN,1308245764,2024,10 mg,Film-coated tablet,Oral use,135.15,Sudair Pharma Company,Saudi Arabia,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Fludarabine Phosphate Neapolis,FLUDARABINE PHOSPHATE,1408245767,2024,25 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,161.05,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Mile Medical Company, PharmaZone (Netaq Al Dawa) Pharmaceuticals"
Pabrolib,PALBOCICLIB,2506245431,,125 mg,"Capsule, hard",Oral use,10549.90,Aizant Drug Research Solutions Pvt.Ltd,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Fomepizole Injection,FOMEPIZOLE,2807245663,2024,1 g/ml,Concentrate for solution for infusion,Intravenous use,2767.85,Immacule Lifesciences Private Limited,India,Navinta LLC,United States,Marketed,Prescription,store below 25°c,Hospital,QOMEL MEDICAL DRUG STORE
BLUM D,COLECALCIFEROL (VITAMIN D3),1808245770,2024,3000 IU,Oral drops,Oral use,8.30,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Dextrose and Sodium Chloride Injection USP,"DEXTROSE, SODIUM CHLORIDE",1808245776,2024,"5,0.9 % (W/V)",Intravenous infusion,Intravenous use,6.35,ADVANCED PHARMACEUTICAL FACTORY (APF),Saudi Arabia,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,ADVANCED PHARMACEUTICAL FACTORY (APF)
Dextrose and Sodium Chloride Injection USP,"DEXTROSE, SODIUM CHLORIDE",1808245777,2024,"10,0.225 % (W/V)",Intravenous infusion,Intravenous use,6.40,ADVANCED PHARMACEUTICAL FACTORY (APF),Saudi Arabia,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,ADVANCED PHARMACEUTICAL FACTORY (APF)
Rosol,MESALAZINE,2008245789,2024,1 g,Film-coated tablet,Oral use,191.50,"FAES FARMA, S.A.",Spain,"FAES FARMA, S.A.",Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Specrodoce,DOCETAXEL,2108245796,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,108.55,Shilpa Medicare Ltd,India,ALTAIF PHARMACEUTICALS COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Tralix,LINAGLIPTIN,2108245797,2024,5 mg,Film-coated tablet,Oral use,68.05,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Sprynat,DASATINIB,2108245798,2024,140 mg,Tablet,Oral use,2556.40,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Sprynat,DASATINIB,2108245799,2024,70 mg,Tablet,Oral use,5112.75,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Tugatev,TIGECYCLINE,2108245801,2024,50 mg,Powder for solution for infusion,Intravenous use,102.85,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Med city, ZIMMO TRADING ESTABLISHMENT"
Sprynat,DASATINIB,2108245800,2024,50 mg,Tablet,Oral use,4959.40,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
UNITUM,BENZYDAMINE HYDROCHLORIDE,2208245803,2024,5 %,Gel,Topical,76.00,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Atorva,ATORVASTATIN CALCIUM,2208245804,2024,10 mg,Film-coated tablet,Oral use,172.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Atorva,ATORVASTATIN CALCIUM,2208245805,2024,40 mg,Film-coated tablet,Oral use,304.80,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
ANAZOL,METRONIDAZOLE,2208245806,2024,500 mg,Film-coated tablet,Oral use,88.55,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Atorva,ATORVASTATIN CALCIUM,2208245807,2024,20 mg,Film-coated tablet,Oral use,172.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Onivyde pegylated liposomal,IRINOTECAN,2208245808,2024,4.3 mg/ml,Dispersion for infusion,Intravenous use,4171.55,LES LABORATOIRES SERVIER INDUSTRIE,France,LES LABORATORIES SERVIER,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Servier Saudi Arabia Trading LLC
Aripro,ARIPIPRAZOLE,2208245811,2024,10 mg,Tablet,Oral use,186.65,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Vresq,VORICONAZOLE,2308245817,2024,200 mg,powder for solution for injection,Intravenous use,283.10,Immacule Lifesciences Private Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"AL-KAMAL IMPORT OFFICE CO. LTD., Adel Ahmed Alshaeir Pharmaceutical Company"
Brimo-P,BRIMONIDINE TARTRATE,2508245818,2024,1.5 mg/ml,"Eye drops, solution",Ophthalmic use,34.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Ortyka,LAPATINIB,2508245822,2024,250 mg,Film-coated tablet,Oral use,3149.80,REMEDICA,Cyprus,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
sirolimus,SIROLIMUS,2508245823,2024,1 mg/ml,Oral solution,Oral use,1020.95,Novitium Pharma LLC,United States,"VistaPharma,Inc",United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,International Pioneers
Aladin,SILDENAFIL,2907245693,2024,50 mg,Tablet,Oral use,3713.35,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Aladin,SILDENAFIL,2907245692,2024,25 mg,Tablet,Oral use,3084.15,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Lohist,LORATADINE,2907245696,2024,10 mg,Tablet,Oral use,910.00,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Peditrace,"ZINC CHLORIDE, SODIUM FLUORIDE, COPPER CHLORIDE, MANGANESE CHLORIDE, POTASSIUM IODIDE, SODIUM SELENITE ANHYDROUS",2207245630,2024,"521,126,53.70,3.60,1.31,6.66 µ/ml",Concentrate for solution for infusion,Intravenous use,250.30,FRESENIUS KABI NORGE AS,Norway,FRESENIUS KABI AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
CANGIN,CASPOFUNGIN ACETATE,2608245826,2024,70 mg,Powder for concentrate for solution for infusion,Intravenous use,663.85,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
CANGIN,CASPOFUNGIN ACETATE,2608245827,2024,50 mg,Powder for concentrate for solution for infusion,Intravenous use,518.15,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Gavomeg,GANCICLOVIR,2608245828,2024,500 mg,Powder for concentrate for solution for infusion,Intravenous use,166.45,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ORS,"ANHYDROUS DEXTROSE, TRISODIUM CITRATE ANHYDROUS, POTASSIUM CHLORIDE, SODIUM CHLORIDE",2907245697,2024,"20,2.9,1.5,3.5 g",Oral powder,Oral use,20.15,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,OTC,store below 25°c,Pharmacy,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Pratima Duo,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",2708245829,2024,"5,10 mg",Tablet,Oral use,60.70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Duo,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",2708245830,2024,"10,10 mg",Tablet,Oral use,85.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Duo,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",2708245831,2024,"10,5 mg",Tablet,Oral use,75.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Pratima Duo,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",2708245832,2024,"5,5 mg",Tablet,Oral use,50.15,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Potassium Chloride Extended-Release Tablets USP,POTASSIUM CHLORIDE,2708245835,2024,600 mg,Modified-release film-coated tablet,Oral use,52.80,Granules Pharmaceuticals Inc,United States,Granules Pharmaceuticals Inc,United States,Marketed,Prescription,store below 25°c,Pharmacy,International Pioneers
Posazox,POSACONAZOLE,2808245842,2024,100 mg,Gastro-resistant tablet,Oral use,2491.45,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, Saudi Amarox"
Uridisitol,TOLTERODINE TARTRATE,2908245847,2024,2 mg,Film-coated tablet,Oral use,52.85,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Mofecon-DR,MYCOPHENOLATE SODIUM,0307245468,2024,180 mg,Prolonged-release tablet,Oral use,306.40,Concord Biotech LTD,India,Enmaeyat Pharmaceutical Industries Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Enmaeyat Pharmaceutical Industries Co
Mofecon-DR,MYCOPHENOLATE SODIUM,0307245469,2024,360 mg,Prolonged-release tablet,Oral use,536.20,Concord Biotech LTD,India,Enmaeyat Pharmaceutical Industries Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Enmaeyat Pharmaceutical Industries Co
"Dopamine Hydrochloride in 5% Dextrose, 1600 mcg/ml",DOPAMINE HYDROCHLORIDE,0309245856,2024,1600 µ/ml,Solution for injection/infusion,Intravenous use,687.10,BAXTER HEALTHCARE CORPORATION,Puerto Rico,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
"Dopamine Hydrochloride in 5% Dextrose, 3200 mcg/ml",DOPAMINE HYDROCHLORIDE,0509245863,2024,3200 µ/ml,Solution for injection/infusion,Intravenous use,1374.20,BAXTER HEALTHCARE CORPORATION,Puerto Rico,BAXTER HEALTHCARE CORPORATION,United States,Marketed,Prescription,store below 25°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Prestoprix Plus,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",0509245864,2024,"5,5 mg",Tablet,Oral use,50.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Prestoprix Plus,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",0509245865,2024,"5,10 mg",Tablet,Oral use,75.35,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Normoten,ATENOLOL,0809245874,2024,50 mg,Film-coated tablet,Oral use,139.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Normoten,ATENOLOL,0809245875,2024,100 mg,Film-coated tablet,Oral use,125.10,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ROCLANDA,"LATANOPROST, NETARSUDIL MESYLATE",0909245884,2024,"50,200 µ/ml","Eye drops, solution",Ocular use,48,Aerie Pharmaceuticals Ireland Limited,Ireland,Santen Oy,Finland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Al Hamaed medical company
Siromune,SIROLIMUS,1209245907,2024,1 mg/ml,Oral solution,Oral use,1199.65,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Saudi Amarox
Taycan,VANCOMYCIN,1509245911,2024,500 mg,Powder for concentrate for solution for infusion,Intravenous use,30.60,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Avores,MOXIFLOXACIN HYDROCHLORIDE,1709245918,2024,400 mg,Film-coated tablet,Oral use,2233.45,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
MEGAMOX,"AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID",1809245933,2024,"875,125 mg",Tablet,Oral use,210.30,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
MEGAMOX,"AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID",1609245912,2024,"500,125 mg",Tablet,Oral use,190.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Paraxon,"PARACETAMOL, CHLORZOXAZONE",1609245913,2024,"300,250 mg",Capsule,Oral use,42.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Cytomag,GANCICLOVIR,1609245915,2024,500 mg,Powder for concentrate for solution for infusion,Intravenous use,158.10,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,store below 30°c,Hospital,ARABIAN OASIS
Conestal,PRUCALOPRIDE,1709245922,2024,1 mg,Film-coated tablet,Oral use,85.30,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Conestal,PRUCALOPRIDE,1709245923,2024,2 mg,Film-coated tablet,Oral use,140.20,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Sapropterin Amarox,SAPROPTERIN,1709245927,2024,100 mg,Tablet,Oral use,13068,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Sapropterin Amarox,SAPROPTERIN,1709245926,2024,500 mg,Powder for oral solution,Oral use,16335,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Sapropterin Amarox,SAPROPTERIN,1709245925,2024,100 mg,Powder for oral solution,Oral use,3267,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Rufzel,RUFINAMIDE,1709245928,2024,40 mg/ml,Oral suspension,Oral use,665.50,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO, Saudi Amarox"
Gliptus,VILDAGLIPTIN,1909245935,2024,50 mg,Tablet,Oral use,66.50,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Docetaxel BOS,DOCETAXEL,2009245936,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,111.10,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Docetaxel BOS,DOCETAXEL,2009245937,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,444.40,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Boston Oncology Arabia
Erelzi,ETANERCEPT,1809245930,2024,50 mg,Solution for injection in pre-filled pen,Subcutaneous use,1742.45,SANDOZ,Austria,SANDOZ GMBH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Erelzi,ETANERCEPT,1809245929,2024,50 mg,concentrate for solution for injection,Subcutaneous use,1742.45,SANDOZ,Austria,Sandoz GmbH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Erelzi,ETANERCEPT,1809245931,2024,25 mg,Solution for injection in pre-filled syringe,Subcutaneous use,871.40,SANDOZ,Austria,SANDOZ GMBH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"Farouk, Maamoun Tamer & CO, Sandoz Limited Trading"
Abiraterone Acetate Neapolis,ABIRATERONE ACETATE,2409245939,2024,250 mg,Tablet,Oral use,3996.35,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
Redex,TADALAFIL,2609245961,2024,10 mg,Film-coated tablet,Oral use,32.35,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Prestoprix Plus,"AMLODIPINE BESILATE, PERINDOPRIL ARGININE",2509305982,2024,"10,10 mg",Tablet,Oral use,85.90,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Mictonorm XL,PROPIVERINE HYDROCHLORIDE,2609245956,2024,45 mg,"Modified-release capsule, soft",Oral use,165.45,LOSAN PHARMA GMBH,Germany,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, medi sense"
Ondavell,ONDANSETRON,2609245962,2024,2 mg/ml,Solution for injection,Intramuscular and intravenous use,50.65,PT. Novell Pharmaceutical Laboratories,Indonesia,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Ondavell,ONDANSETRON,2609245963,2024,2 mg/ml,Solution for injection,Intramuscular and intravenous use,91.95,PT. Novell Pharmaceutical Laboratories,Indonesia,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Gripdi,DAPAGLIFLOZIN,2909245968,2024,10 mg,Film-coated tablet,Oral use,93.30,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Gripdi,DAPAGLIFLOZIN,3009245976,2024,5 mg,Film-coated tablet,Oral use,93.30,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Litfulo,RITLECITINIB,3009245991,2024,50 mg,"Capsule, hard",Oral use,3605.85,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,store below 30°c,Pharmacy,"ALNAGHI COMPANY, Pfizer Saudi Trading"
Atomibe,"ATORVASTATIN CALCIUM, EZETIMIBE",0110245996,2024,"10,10 mg",Film-coated tablet,Oral use,116.25,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Atomibe,"ATORVASTATIN CALCIUM, EZETIMIBE",0110245997,2024,"20,10 mg",Film-coated tablet,Oral use,120.60,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Atomibe,"ATORVASTATIN CALCIUM, EZETIMIBE",0110245998,2024,"40,10 mg",Film-coated tablet,Oral use,126.10,Ind Swift Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
DASATINIB NEAPOLIS,DASATINIB,2509245944,2024,140 mg,Film-coated tablet,Oral use,2984.10,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
ZINOPRIL,LISINOPRIL,0310246007,2024,5 mg,Tablet,Oral use,134.30,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ZINOPRIL,LISINOPRIL,0310246008,2024,10 mg,Tablet,Oral use,221.00,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
ZINOPRIL,LISINOPRIL,0310246009,2024,20 mg,Tablet,Oral use,376.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
BEKEMV,ECULIZUMAB,0610246012,2024,10 mg/ml,Concentrate for solution for infusion,Intravenous use,13357.50,AMGEN TECHNOLOGY,Ireland,Amgen Technology Ireland,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Matroda,METOPROLOL TARTRATE,0710246014,2024,50 mg,Film-coated tablet,Oral use,17.05,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Matroda,METOPROLOL TARTRATE,0710246013,2024,100 mg,Film-coated tablet,Oral use,29.40,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Sitavic,"SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE",0810246016,2024,"50,1000 mg",Film-coated tablet,Oral use,91.20,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Sitavic,"SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE",0810246015,2024,"50,850 mg",Film-coated tablet,Oral use,88,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Panadrex,PARACETAMOL,0810246018,2024,500 mg,Tablet,Oral use,172.75,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,store below 30°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Revestive,TEDUGLUTIDE,0810246019,2024,5 mg,Powder and solvent for solution for injection,Subcutaneous use,77665.85,Patheon Italia S.P.A.,Italy,Takeda Pharmaceuticals International AG,Ireland,Marketed,Prescription,store below 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
Haemocomplettan P,HUMAN FIBRINOGEN,0910246026,2024,1 g,Powder for solution for injection/infusion,Intravenous use,2034.20,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Haemocomplettan P,HUMAN FIBRINOGEN,0910246025,2024,2 g,Powder for solution for injection/infusion,Intravenous use,4068.55,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Cigalah Group
Bilvardi,BIVALIRUDIN,0910246027,2024,250 mg,Powder for solution for injection/infusion,Intravenous use,10012.75,"Hainan Poly Pharm. Co., Ltd.",China,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Muscodex,SUGAMMADEX,1010246029,2024,100 mg/ml,Solution for injection,Intravenous use,1742.60,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Tabuk Pharmaceutical Manufacturing Company
Penovar,PENCICLOVIR,1010246032,2024,1 % (W/W),Cream,Topical,25.35,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Tavlesse,FOSTAMATINIB DISODIUM HEXAHYDRATE,1010246031,2024,100 mg,Film-coated tablet,Oral use,7477.75,PATHEON INC,Canada,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Tavlesse,FOSTAMATINIB DISODIUM HEXAHYDRATE,1010246030,2024,150 mg,Film-coated tablet,Oral use,11217.00,PATHEON INC,Canada,"Instituto Grifols, S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Saventi,"SACUBITRIL, VALSARTAN",1310246033,2024,"24,26 mg",Film-coated tablet,Oral use,401.60,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Saventi,"SACUBITRIL, VALSARTAN",1310246035,2024,"49,51 mg",Film-coated tablet,Oral use,401.60,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Saventi,"SACUBITRIL, VALSARTAN",1310246034,2024,"97,103 mg",Film-coated tablet,Oral use,401.60,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Cetraxal plus,"CIPROFLOXACIN, FLUOCINOLONE ACETONIDE",1410246040,2024,"3,0.25 mg/ml","Ear drops, solution",Auricular use,41.30,"Laboratories SALVAT, S.A",Spain,"Laboratories SALVAT, S.A",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Prestoprix,PERINDOPRIL ARGININE,1410246037,2024,10 mg,Film-coated tablet,Oral use,36.90,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Prestoprix,PERINDOPRIL ARGININE,1410246036,2024,5 mg,Film-coated tablet,Oral use,28.05,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Remox,AMOXICILLIN,1510246043,2024,250 mg,"Capsule, hard",Oral use,54.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Dormidex,DEXMEDETOMIDINE,1510246056,2024,100 µg/ml,Concentrate for solution for infusion,Intravenous use,302.05,B. BRAUN MEDICAL S.A,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Dormidex,DEXMEDETOMIDINE,1510246057,2024,100 µg/ml,Concentrate for solution for infusion,Intravenous use,605.85,B. BRAUN MEDICAL S.A,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Dormidex,DEXMEDETOMIDINE,1510246055,2024,100 µg/ml,Concentrate for solution for infusion,Intravenous use,1514.60,B. BRAUN MEDICAL S.A,Spain,B. BRAUN,Germany,Marketed,Prescription,store below 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Tonall,Nalbuphine,1710246072,2024,20 mg/ml,Solution for injection/infusion,"Intravenous, Intramuscular, Subcutaneous",31.05,Amoun Pharmaceutical Company,Egypt,Amoun Pharmaceutical Company,Egypt,Marketed,Prescription,store below 30°c,Hospital,Thimar Aljazirah Company
Cimuquit,VARENICLINE,1710246070,2024,0.5 & 1 mg,Film-coated tablet,Oral use,115.60,Lee Pharma,India,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Cimuquit,VARENICLINE,1710246069,2024,0.5 mg,Film-coated tablet,Oral use,120,Lee Pharma,India,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Cimuquit,VARENICLINE,1710246071,2024,1 mg,Film-coated tablet,Oral use,194.60,Lee Pharma,India,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Flamex,CELECOXIB,2110246085,2024,200 mg,Capsule,Oral use,37.50,Jordan Sweden Medical and Sterilization Co.,Jordan,JORDAN SWEEDEN COMPANY,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
Flamex,CELECOXIB,2110246084,2024,400 mg,Capsule,Oral use,67.95,Jordan Sweden Medical and Sterilization Co.,Jordan,JORDAN SWEEDEN COMPANY,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
VECANZOL,VORICONAZOLE,2410246098,2024,200 mg,Powder for solution for infusion,Intravenous use,283.10,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Monofer,FERRIC DERISOMALTOSE,2710246120,2024,100 mg/ml,Solution for injection/concentrate for solution for infusion,Intravenous use,403.60,Wasserburger arzneimittel werk GmbH,Germany,PHARMACOSMOS A/S,Denmark,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Timard,TOFACITINIB,2710246108,2024,5 mg,Film-coated tablet,Oral use,3090.20,Granules India Limited Unit V,India,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Timard,TOFACITINIB,2710246109,2024,10 mg,Film-coated tablet,Oral use,3782.40,Granules India Limited Unit V,India,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AJA PHARMACEUTICAL INDUSTRIES
Arthfre,LEFLUNOMIDE,2810246121,2024,20 mg,Film-coated tablet,Oral use,144.55,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Spasmopan,HYOSCINE BUTYLBROMIDE,2910246126,2024,10 mg,Coated tablet,Oral use,158.80,The Arab Pharmaceutical Manufacturing PSC Sult,Jordan,THE ARAB PHARMACEUTICAL MANUFACTURING COMPANY,Jordan,Marketed,OTC,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Baqsimi,GLUCAGON,H0000004831,2020,3 mg,Nasal spray,Nasal use,139.50,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
ROVASTIN,ROSUVASTATIN,H0000003060,2020,5 mg,Film-coated tablet,Oral use,21.45,Atlantic Pharma,Portugal,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
ROVASTIN,ROSUVASTATIN,H0000003064,2020,10 mg,Film-coated tablet,Oral use,26.10,Atlantic Pharma,Portugal,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
ROVASTIN,ROSUVASTATIN,H0000003067,2020,20 mg,Film-coated tablet,Oral use,39.45,Atlantic Pharma,Portugal,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
TEOSYAL ULTRA DEEP,HYALURONIC ACID,H0000006642,2021,25 mg/ml,Gel for injection,Subcutaneous use,725.05,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
TEOSYAL ULTIMATE,HYALURONIC ACID,H0000006641,2021,22 mg/ml,Gel for injection,Subcutaneous use,797.55,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
Evanthia,HYALURONIC ACID,H0000004846,2020,25 mg/ml,Gel for injection,Subcutaneous use,447.70,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
Evanthia,HYALURONIC ACID,H0000004844,2020,20 mg/ml,Gel for injection,Subcutaneous use,375.10,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
Evanthia,HYALURONIC ACID,H0000004668,2020,15 mg/ml,Gel for injection,Subcutaneous use,247.10,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
Auralya,HYALURONIC ACID,H0000004572,2020,30 mg/ml,Gel for injection,Subcutaneous use,359.35,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
Auralya,HYALURONIC ACID,H0000004571,2020,25 mg/ml,Gel for injection,Subcutaneous use,329.10,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
Auralya,HYALURONIC ACID,H0000004570,2020,20 mg/ml,Gel for injection,Subcutaneous use,298.85,IRAIstitutoRicerche Applicate SpA,Italy,IRA Instituto Ricerche Applicate SpA,Italy,Marketed,Prescription,store below 25°c,Hospital,-----
TEOSYAL KISS,HYALURONIC ACID,H0000006244,2021,25 mg/ml,Gel for injection,Intradermal use,707.85,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
Teosyal PureSense KISS,"HYALURONIC ACID, LIDOCAINE",H0000006281,2021,"25,0.3 %, mg/ml",Gel for injection,Intradermal use,707.85,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
TEOSYAL PureSense ULTIMATE,"HYALURONIC ACID, LIDOCAINE",H0000006622,2021,"22,0.3 %, mg/ml",Gel for injection,Subcutaneous use,531.70,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
TEOSYAL PureSence ULTRA DEEP,"HYALURONIC ACID, LIDOCAINE",H0000006644,2021,"25,0.3 %, mg/ml",Gel for injection,Subcutaneous use,725.05,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
TEOSYAL PureSense REDENSITY 2,"HYALURONIC ACID, LIDOCAINE",H0000006421,2021,"15,0.3 %, mg/ml",Gel for injection,Intradermal use,418.60,TeoxaneSA,Swaziland,TeoxaneSA,Swaziland,Marketed,Prescription,store below 25°c,Hospital,AME compant for Medical Supplies
Pemetrexed EVER Pharma,PEMETREXED,0511246145,2024,25 mg/ml,Concentrate for solution for infusion,Intravenous use,2235.45,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Austria,Marketed,Prescription,store below 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Pemetrexed EVER Pharma,PEMETREXED,0511246144,2024,25 mg/ml,Concentrate for solution for infusion,Intravenous use,4470.90,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Austria,Marketed,Prescription,store below 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Restomap,ESOMEPRAZOLE MAGNESIUM,0511246148,2024,40 mg,Gastro-resistant tablet,Oral use,52.55,Lee Pharma,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Oseltamivir PPI,OSELTAMIVIR,0511246149,2024,75 mg,Capsule,Oral use,28.90,Natco Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Oseltamivir PPI,OSELTAMIVIR,0511246146,2024,45 mg,Capsule,Oral use,16.15,Natco Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Oseltamivir PPI,OSELTAMIVIR,0511246147,2024,30 mg,Capsule,Oral use,15.60,Natco Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Aripro,ARIPIPRAZOLE,0511246153,2024,15 mg,Tablet,Oral use,231.95,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Provecta,BRIVARACETAM,0511246151,2024,50 mg,Film-coated tablet,Oral use,268.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Provecta,BRIVARACETAM,0511246152,2024,25 mg,Film-coated tablet,Oral use,268.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Provecta,BRIVARACETAM,0511246150,2024,10 mg,Film-coated tablet,Oral use,70.85,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Glitamomet,"PIOGLITAZONE, METFORMIN HYDROCHLORIDE",H0000001838,2021,"15,850 mg",Film-coated tablet,Oral use,78.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Catabina,Capecitabine,H0000001803,,150 mg,Film-coated tablet,Oral use,163.70,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
PROTON IV,PANTOPRAZOLE,H0000000074,2021,40 mg,powder for solution for injection,Intravenous use,17.05,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Emopack,OMEPRAZOLE,H0000013825,2022,40 mg,Powder for solution for injection/infusion,Intravenous use,225.00,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Levox,LEVOFLOXACIN,H0000004780,2022,5 mg/ml,Solution for infusion,Intravenous use,35.20,PHARMATHEN INTERNATIONAL,Greece,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
CALIVERA,ERLOTINIB,H0000004996,2022,25 mg,Film-coated tablet,Oral use,823.30,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
CALIVERA,ERLOTINIB,H0000004997,2022,100 mg,Film-coated tablet,Oral use,3293.15,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
CALIVERA,ERLOTINIB,H0000004998,2022,150 mg,Film-coated tablet,Oral use,4400.65,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
BOSULIF TABLETS,BOSUTINIB,H0000001917,2022,400 mg,Film-coated tablet,Oral use,7224.30,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pfizer Saudi Trading
BOSULIF TABLETS,BOSUTINIB,H0000001918,2022,500 mg,Film-coated tablet,Oral use,9030.40,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pfizer Saudi Trading
Perinam,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",H0000018659,2022,"3.5,2.5 mg",Tablet,Oral use,40.25,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Perinam,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",H0000018707,2022,"7,5 mg",Tablet,Oral use,66.40,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Perinam,"PERINDOPRIL ARGININE, AMLODIPINE BESILATE",H0000018708,2022,"14,10 mg",Tablet,Oral use,88.40,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Trulicity,DULAGLUTIDE,H0000023912,2022,4.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,362.40,ELI LILLY,Spain,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Trulicity,DULAGLUTIDE,H0000023902,2022,3 mg,Solution for injection in pre-filled pen,Subcutaneous use,362.40,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Soliris,ECULIZUMAB,1-5347-19,2024,300 mg,Concentrate for solution for infusion,Intravenous use,15227.15,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Flamotal 600 mg,IBUPROFEN,H0000005313,2024,600 mg,Film-coated tablet,Oral use,8.25,Future Pharmaceutical Indistries,Egypt,Future Pharmaceutical Industries,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
Altan,PRUCALOPRIDE,2107257777,2022,1 mg,Film-coated tablet,Oral use,98.40,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Altan,PRUCALOPRIDE,H0000006911,2022,2 mg,Film-coated tablet,Oral use,161.75,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
daroxime,CEFUROXIME AXETIL,H0000030255,2022,250 mg,Film-coated tablet,Oral use,36.20,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Duvalsa,"SACUBITRIL, VALSARTAN",1411246228,2024,"24,26 mg",Film-coated tablet,Oral use,186.45,Synthon Chile LTDA,Chile,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Duvalsa,"SACUBITRIL, VALSARTAN",1411246229,2024,"49,51 mg",Film-coated tablet,Oral use,186.45,Synthon Chile LTDA,Chile,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Duvalsa,"SACUBITRIL, VALSARTAN",1411246230,2024,"97,103 mg",Film-coated tablet,Oral use,372.95,Synthon Chile LTDA,Chile,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Arabian Japanese Pharmaceutical Co. Ltd.
Famodine,FAMOTIDINE,1111246168,2024,10 mg/ml,concentrate for solution for injection,Intravenous use,64.25,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Mictonorm,PROPIVERINE HYDROCHLORIDE,1211246206,2024,5 mg,Film-coated tablet,Oral use,36.05,ROTTENDORF PHARMA GMBH,Germany,Labatec- Pharma S.A,Switzerland,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, medi sense"
Lotemax,LOTEPREDNOL ETABONATE,1211246211,2024,0.5 %,"Eye drops, suspension",Ophthalmic use,44,"Bausch & Lomb, Incorporated",United States,"Bausch & Lomb, Incorporated",United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Vtreat,VILDAGLIPTIN,2111246314,2024,50 mg,Tablet,Oral use,62.05,PHARMATHEN INTERNATIONAL,Greece,Spectro Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Salitav,TOLVAPTAN,1911246263,2024,15 mg,Tablet,Oral use,3642.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Salitav,TOLVAPTAN,1911246261,2024,30 mg,Tablet,Oral use,3642.50,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Prokitav,TOLVAPTAN,1911246262,2024,45+15 mg,Tablet,Oral use,20397.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Prokitav,TOLVAPTAN,1911246268,2024,30 + 60 mg,Tablet,Oral use,20397.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Prokitav,TOLVAPTAN,1911246259,2024,30 + 90 mg,Tablet,Oral use,20397.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Treprostinil Tillomed,TREPROSTINIL,1811246241,2024,50 mg,Solution for infusion,Intravenous use,12700.35,Emcure Pharmaceuticals Ltd.,India,Tillomed Laboratories Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Treprostinil Tillomed,TREPROSTINIL,1811246240,2024,200 mg,Solution for infusion,Intravenous use,41177.80,Emcure Pharmaceuticals Ltd.,India,Tillomed Laboratories Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Treprostinil Tillomed,TREPROSTINIL,1811246238,2024,100 mg,Solution for infusion,Intravenous use,20588.90,Emcure Pharmaceuticals Ltd.,India,Tillomed Laboratories Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,Cigalah Group
Vtreat,VILDAGLIPTIN,2111246315,2024,50 mg,Tablet,Oral use,31.05,PHARMATHEN INTERNATIONAL,Greece,Spectro Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Fluzone High Dose Quadrivalent,INACTIVATED SPLIT INFLUENZA VIRUS,2111246316,2024,240 µg,Suspension for injection in pre-filled pen,Intramuscular use,168.00,SANOFI PASTEUR,United States,SANOFI PASTEUR,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Sanofi Arabia Trading Co. Ltd
Anastrozole Pharmacare,ANASTROZOLE,0411246138,2024,1 mg,Film-coated tablet,Oral use,128.25,Pharmacare Premium Ltd,Malta,Pharmacare Premium Ltd,Malta,Marketed,Prescription,store below 30°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
Warfarin ZYD,WARFARIN SODIUM,1811246247,2024,1 mg,Tablet,Oral use,73.80,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Warfarin ZYD,WARFARIN SODIUM,1811246246,2024,2 mg,Tablet,Oral use,78.65,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Warfarin ZYD,WARFARIN SODIUM,1811246242,2024,2.5 mg,Tablet,Oral use,65.40,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Warfarin ZYD,WARFARIN SODIUM,1811246244,2024,3 mg,Tablet,Oral use,92.55,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Warfarin ZYD,WARFARIN SODIUM,1811246243,2024,5 mg,Tablet,Oral use,62.20,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Warfarin ZYD,WARFARIN SODIUM,1811246245,2024,10 mg,Tablet,Oral use,107.40,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Padcev,ENFORTUMAB,1811246255,2024,20 mg,Powder for concentrate for solution for infusion,Intravenous use,2880.50,BAXTER ONCOLOGY GmbH,Germany,Astellas Pharma Europe B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Padcev,ENFORTUMAB,1811246254,2024,30 mg,Powder for concentrate for solution for infusion,Intravenous use,4320.75,BAXTER ONCOLOGY GmbH,Germany,Astellas Pharma Europe B.V.,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Sondelbay,TERIPARATIDE,1911246278,2024,250 µg/ml,Solution for injection,Subcutaneous use,952.90,INTAS PHARMACEUTICALS LIMITED,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Enrylaze,RECOMBINANT CRISANTASPASE,1911246279,2024,10 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,11250.30,Patheon Manufacturing Services LLC,United States,Jazz Pharmaceutical Ireland Ltd,Ireland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Funzol,FLUCONAZOLE,2011246304,2024,150 mg,Capsule,Oral use,2528.40,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Lorinex,DESLORATADINE,2111246310,2024,5 mg,Film-coated tablet,Oral use,177.35,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Retalex,ATRACURIUM BESILATE,2011246288,2024,10 mg/ml,Solution for injection,Intravenous use,26.95,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Posenox,POSACONAZOLE,2011246297,2024,18 mg/ml,Concentrate for solution for infusion,Intravenous use,1096.70,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Tabuk Pharmaceutical Manufacturing Company
Cefuroxime-Kotra,CEFUROXIME SODIUM,2011246308,2024,750 mg,Powder for injection,Intramuscular and intravenous use,67.00,Kotra Pharma M Sdn Bhd,Malaysia,Kotra pharma M Sdn Bhd,Malaysia,Marketed,Prescription,store below 30°c,Hospital,Al-Safa Warehouse For Pharmaceuticals Ltd
Racad,RACECADOTRIL,2011246300,2024,30 mg,Granules for oral suspension,Oral use,29.15,Athena Drug Delivery Solutions Pvt. Ltd,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Racad,RACECADOTRIL,2011246295,2024,10 mg,Granules for oral suspension,Oral use,29.95,Athena Drug Delivery Solutions Pvt. Ltd,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
VIRLAIO,TENOFOVIR DISOPROXIL,2011246307,2024,245 mg,Film-coated tablet,Oral use,723.25,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Relavers,SUGAMMADEX,2111246311,2024,100 mg/ml,Solution for injection,Intravenous bolus use,1476.40,Immacule Lifesciences Private Limited,India,AL RAZI PHARMA INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Eranza,ERTAPENEM SODIUM,2111246312,2024,1000 mg,Powder for concentrate for solution for infusion,Intravenous use,1191.85,ACS Dobfar S.P.A,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Voydeya,DANICOPAN,2711246346,2024,100 mg,Film-coated tablet,Oral use,26593.45,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Voydeya,DANICOPAN,2711246345,2024,50 + 100 mg,Film-coated tablet,Oral use,19945.05,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Europe SAS,France,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Rovanzy,"EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL",H0000013456,2023,"600,200,300 mg",Film-coated tablet,Oral use,2284.30,Macleods Pharmaceuticals Limited,India,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lyumjev Tempo Pen,INSULIN LISPRO,H0000034199,2023,100 IU/ml,Solution for injection in pre-filled pen,Subcutaneous use,167.95,ELI LILLY,United States,Eli Lilly and Company,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Parlotin,PAROXETINE,H0000003219,2023,20 mg,Film-coated tablet,Oral use,15.20,"BLUEPHARMA INDUSTRIA FARMACEUTICA, S.A",Portugal,"BLUEPHARMA GENERICOS,COMERCIO DE MEDICAMENTOS , S.A.",Portugal,Marketed,Prescription,store below 30°c,Pharmacy,YAHMAA MEDICAL COMPANY
Adzoy,"ADAPALENE, Hydrous Benzoyl Peroxide",2212246461,2024,"0.3,2.5 %",Gel,Topical,153.60,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Adzoy,"ADAPALENE, Hydrous Benzoyl Peroxide",2212246460,2024,"0.1,2.5 %",Gel,Topical,51.05,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Laperto,"LOPINAVIR, RITONAVIR",H0000034394,2023,"200,50 mg",Film-coated tablet,Oral use,988.85,Macleods Pharmaceuticals Limited,India,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Glipza,SAXAGLIPTIN,H0000032763,2023,5 mg,Film-coated tablet,Oral use,98.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Lotinil,"LOTEPREDNOL ETABONATE, TOBRAMYCIN",0412246364,2024,"0.5,0.3 %","Eye drops, solution",Ophthalmic use,64,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Sayen,TADALAFIL,H0000034308,2023,10 mg,Orodispersible tablet,Oral use,28.45,E-Pharma Trento SpA,Italy,Safety Science Medical Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Safety Science Medical Company
AMOCLAN,"CLAVULANIC ACID, AMOXICILLIN",H0000037134,2024,"200,1000 mg",Powder for injection,Parenteral use,88.25,LABORATORIO REIG JOFRE,Spain,Hikma Pharmaceuticals PLC,Jordan,Marketed,Prescription,store below 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
CRONOXAM PLUS,"SITAGLIPTIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE",2611246338,2024,"50,850 mg",Film-coated tablet,Oral use,88,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
CRONOXAM PLUS,"SITAGLIPTIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE",2611246339,2024,"50,1000 mg",Film-coated tablet,Oral use,91.20,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Sola D3,CHOLECALCIFEROL,2611246343,2024,10000 IU,Tablet,Oral use,19.25,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Gemcitabine Neapolis,GEMCITABINE,2711246344,2024,1000 mg,Powder for solution for infusion,Intravenous use,179.70,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,LES LABORATORIES NEAPOLIS PHARMA,Tunisia,Marketed,Prescription,store below 30°c,Hospital,PharmaZone (Netaq Al Dawa) Pharmaceuticals
Bicalutamide Pharmacare,Bicalutamide,2811246356,2024,50 mg,Film-coated tablet,Oral use,142.25,Pharmacare Premium Ltd,Malta,Pharmacare Premium Ltd,Malta,Marketed,Prescription,store below 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Selenium Aguettant,SODIUM SELENITE ANHYDROUS,2811246355,2024,10 µg/ml,Concentrate for solution for infusion,Intravenous use,340.20,LABORATOIRE AGUETTANT,France,Laboratoire Aguettant,France,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
ADOL 500 MG CAPLET,PARACETAMOL,0512246368,2024,500 mg,Tablet,Oral use,10.10,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Pharmacy,Cigalah Group
ADOL 500 MG CAPLET,PARACETAMOL,0512246367,2024,500 mg,Tablet,Oral use,20.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,OTC,store below 30°c,Hospital,Cigalah Group
Sodium Nitroprusside,SODIUM NITROPRUSSIDE,0412246363,2024,25 mg/ml,Solution for injection,Intravenous use,230.40,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,store below 30°c,Hospital,ARABIAN OASIS
Casgevy,Exagamglogene Autotemcel,1606257560,2025,4-13 * 106 cells/ml,Suspension for infusion,Intravenous use,9301875,Charles River Laboratories Inc,United States,Vertex Pharmaceuticals (Europe) Limited,United Kingdom,Marketed,Prescription,Store at temperatures below -140°C in the vapour phase of liquid nitrogen,Hospital,Cigalah Group
Capitan,ISOTRETINOIN,1012246386,2024,20 mg,"Capsule, soft",Oral use,61.6,GAP SA PHARMACEUTICAL,Greece,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Capitan,ISOTRETINOIN,1012246385,2024,10 mg,"Capsule, soft",Oral use,40.25,GAP SA PHARMACEUTICAL,Greece,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Dexorolin,CABERGOLINE,1112246401,2024,0.5 mg,Tablet,Oral use,35.20,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Dexorolin,CABERGOLINE,1112246402,2024,0.5 mg,Tablet,Oral use,112.90,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Caffate,CAFFEINE CITRATE,0912246380,2024,20 mg/ml,Solution for infusion and oral solution,"Intravenous, Oral",2247.90,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Apixaban JPI,APIXABAN,1612246429,2024,5 mg,Film-coated tablet,Oral use,231,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Apixaban JPI,APIXABAN,1612246430,2024,2.5 mg,Film-coated tablet,Oral use,231,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Apixaban JPI,APIXABAN,1612246428,2024,2.5 mg,Film-coated tablet,Oral use,77,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Octreotide BOS,OCTREOTIDE ACETATE,1712246439,2024,100 µg/ml,concentrate for solution for injection,"Intravenous, Subcutaneous",252.70,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Fibryga,HUMAN FIBRINOGEN,1712246446,2024,1 g,Powder for solution for injection/infusion,Intravenous use,1878.95,Octapharma Pharmazeutika Produktionsges.m.b.h,Austria,OCTAPHARMA,Austria,Marketed,Prescription,"Store below 25°C Don't Freez, Protect From Light",Hospital,Faisal Musaed El Seif Saudi Pharmaceutical Co.
Ondex,ONDANSETRON,1812246447,2024,0.8 mg/ml,Oral solution,Oral use,90.95,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Evox,LEVOFLOXACIN,1912246456,2024,500 mg,Film-coated tablet,Oral use,64.25,Jordan Sweden Medical and Sterilization Co.,Jordan,Jordan Sweden Medical and Sterilization Co.,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"AL-DAWAA MEDICAL SERVICES CO. LTD, SAUDI ARABIAN DRUG STORE COMPANY"
Pentix,GABAPENTIN,2012246458,2024,300 mg,Capsule,Oral use,39.25,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Pentix,GABAPENTIN,2012246459,2024,400 mg,Capsule,Oral use,46.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Xadago,SAFINAMIDE,1912246454,2024,50 mg,Tablet,Oral use,352.70,Zambon SpA,Italy,Zambon SpA,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Avocin,CLINDAMYCIN HYDROCHLORIDE,2212246465,2024,300 mg,"Capsule, hard",Oral use,34.85,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Avocin,CLINDAMYCIN HYDROCHLORIDE,2212246466,2024,150 mg,"Capsule, hard",Oral use,19.25,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
VYZULTA,LATANOPROSTENE BUNOD,2312246473,2024,0.024 %,"Eye drops, solution",Ophthalmic use,92.05,"Bausch & Lomb, Incorporated",United States,"Bausch & Lomb, Incorporated",United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,ALNAGHI COMPANY
0.9% w/v Sodium Chloride,SODIUM CHLORIDE,2412246482,2024,0.9 % (V/W),Solution for infusion,Intravenous use,26.65,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solutions Industry Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Ambracy,AMBRISENTAN,2412246478,2024,10 mg,Film-coated tablet,Oral use,3288.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Enzular,ENZALUTAMIDE,2412246479,2024,40 mg,Capsule,Oral use,8933.45,Cipla Limited,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Byraza Plus,"OMEPRAZOLE, SODIUM BICARBONATE",2412246481,2024,"40,1100 mg",Capsule,Oral use,87.50,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Lignox,"LIDOCAINE, PRILOCAINE",2512246494,2024,"2.5,2.5 % (W/W)",Cream,Topical,56.40,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Lignox,"LIDOCAINE, PRILOCAINE",2512246492,2025,"2.5,2.5 % (W/W)",Cream,Topical,47,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Lignox,"LIDOCAINE, PRILOCAINE",2512246493,2024,"2.5,2.5 % (W/W)",Cream,Topical,9.40,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Ambracy,AMBRISENTAN,2412246480,2024,5 mg,Film-coated tablet,Oral use,3288.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Avotrene Emulgel,DICLOFENAC DIETHYLAMINE,0601256516,2025,1 %,Gel,Topical,7.20,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Antagra,LEVETIRACETAM,2912246501,2024,500 mg,Film-coated tablet,Oral use,58.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Antagra,LEVETIRACETAM,2912246499,2024,1000 mg,Film-coated tablet,Oral use,116.90,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ravac,Rabies Vaccine Inactivated,0101256513,2025,2.5 IU,Lyophilisate for solution for injection,Intradermal use,306.30,Serum Institute,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Remox,AMOXICILLIN,0801256551,2025,500 mg,Capsule,Oral use,99.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Sugmastad,SUGAMMADEX,0901256568,2025,100 mg/ml,Solution for injection,Intravenous bolus use,1742.50,Hemofarm AD Vrsac,Serbia,Hemofarm AD Vrsac,Serbia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Sugmastad,SUGAMMADEX,0901256569,2025,100 mg/ml,Solution for injection,Intravenous bolus use,4356.50,Hemofarm AD Vrsac,Serbia,Hemofarm AD Vrsac,Serbia,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Domassel,TICAGRELOR,1301256592,2025,60 mg,Film-coated tablet,Oral use,131.55,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Tadalo,TADALAFIL,1401256616,2025,20 mg,Film-coated tablet,Oral use,16.20,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Comirnaty JN.1,BNT162b2 Omicron XBB.1.5 mRNA,1401256614,2025,30 µg,Concentrate for dispersion for injection,Intramuscular use,3552.50,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,Store at ≤-60°C,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Comirnaty JN.1,BNT162b2 Omicron XBB.1.5 mRNA,1401256615,2025,10 µg,Concentrate for dispersion for injection,Intramuscular use,3552.50,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER SAUDI LIMITED,Saudi Arabia,Marketed,Prescription,Store at ≤-60°C,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Irinotecan BOS,IRINOTECAN,1501256666,2025,20 mg/ml,Concentrate for solution for infusion,Intravenous use,169.05,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Restomap,ESOMEPRAZOLE,2412246483,2024,20 mg,Gastro-resistant tablet,Oral use,50.85,Lee Pharma,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Fenobat,KETOTIFEN,1601256671,2025,0.2 mg/ml,Syrup,Oral use,24.40,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
XIFAXAN,RIFAXIMIN,1601256672,2025,550 mg,Film-coated tablet,Oral use,1106.60,Alfasigma S.p.A,Italy,Alfasigma S.p.A,Italy,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
ETOPOSIDE-VENUS,ETOPOSIDE,1601256668,2025,20 mg/ml,Solution for injection,Intravenous use,40.20,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Wegovy,SEMAGLUTIDE,2101256697,2025,2.4 mg,Solution for injection in pre-filled pen,Subcutaneous use,1155.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Wegovy,SEMAGLUTIDE,2101256700,2025,1.7 mg,Solution for injection in pre-filled pen,Subcutaneous use,818.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Wegovy,SEMAGLUTIDE,2101256699,2025,1 mg,Solution for injection in pre-filled pen,Subcutaneous use,481.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Wegovy,SEMAGLUTIDE,2101256698,2025,0.5 mg,Solution for injection in pre-filled pen,Subcutaneous use,481.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Wegovy,SEMAGLUTIDE,2101256701,2025,0.25 mg,Solution for injection in pre-filled pen,Subcutaneous use,481.45,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
SACVALY,"SACUBITRIL, VALSARTAN",2001256684,2025,"97,103 mg",Film-coated tablet,Oral use,344.25,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-DAWAA MEDICAL SERVICES CO. LTD
SACVALY,"SACUBITRIL, VALSARTAN",2001256683,2025,"49,51 mg",Film-coated tablet,Oral use,344.25,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-DAWAA MEDICAL SERVICES CO. LTD
SACVALY,"SACUBITRIL, VALSARTAN",2001256682,2025,"24,26 mg",Film-coated tablet,Oral use,344.25,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL-DAWAA MEDICAL SERVICES CO. LTD
Flamotal 600 mg,IBUPROFEN,2101256707,2025,600 mg,Film-coated tablet,Oral use,8.25,Future Pharmaceutical Indistries,Egypt,Future Pharmaceutical Industries,Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
DAYVIGO,LEMBOREXANT,2101256710,2025,5 mg,Film-coated tablet,Oral use,219.60,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI,United States,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
DAYVIGO,LEMBOREXANT,2101256711,2025,10 mg,Film-coated tablet,Oral use,219.60,EISAI MANUFACTURING LIMITED,United Kingdom,EISAI,United States,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Broncast,MONTELUKAST SODIUM,3001256781,2025,10 mg,Film-coated tablet,Oral use,1285.20,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Ryzodeg FlexPen,"INSULIN ASPART, INSULIN DEGLUDEC",3001256783,2025,100 U/ml,Solution for injection in pre-filled pen,Subcutaneous use,378.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Norditropin FlexPro,SOMATROPIN,2701256761,2025,3.3 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,489.60,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novo Nordisk
Norditropin FlexPro,SOMATROPIN,2701256762,2025,6.7 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,975.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novo Nordisk
Norditropin FlexPro,SOMATROPIN,2701256763,2025,10 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,1463.90,NOVO NORDISK,Denmark,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Novo Nordisk
Tresiba FlexPen,INSULIN DEGLUDEC,3001256784,2025,100 U/ml,Solution for injection in pre-filled pen,Subcutaneous use,359.95,NOVO NORDISK PRODUCTION S.A.S,France,NOVO NORDISK,Denmark,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Novo Nordisk
Byraza Plus,"OMEPRAZOLE, SODIUM BICARBONATE",0502256823,2025,"20,1100 mg","Capsule, hard",Oral use,43.75,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Movapo,APOMORPHINE,0502256825,2025,10 mg/ml,Solution for injection,Subcutaneous use,764.55,CP PHARMACEUTICAL LIMITED,United Kingdom,Britannia Pharmaceuticals Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Salehiya Trading Co.
Lyrgaba,PREGABALIN,1002256856,2025,75 mg,"Capsule, hard",Oral use,1070.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Meteospasmyl,"ALVERINE CITRATE, SIMETICONE",0902256854,2025,"60,300 mg","Capsule, soft",Oral use,35.60,LABORATOIRES GALÉNIQUE VERNIN,France,Laboratoires Mayoly Spindler,France,Marketed,Prescription,store below 30°c,Pharmacy,Rezaik Abdullah Saeed Al-Gedrawy Al-Thabaiti and Partners
Trelegy Ellipta,"FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE",1102256864,2025,"200,62.5,25 µg","Inhalation powder, pre-dispensed",Inhalation use,236.80,Glaxo Operations UK Limited,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Acetazolamide,ACETAZOLAMIDE,1202256891,2025,250 mg,Tablet,Oral use,17.05,REMEDICA,Cyprus,REMEDICA,Cyprus,Marketed,Prescription,store below 30°c,Pharmacy,International Teriaqi for medicines ESt
Varoxa,RIVAROXABAN,2502256928,2025,2.5 mg,Film-coated tablet,Oral use,190.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
skyclarys,OMAVELOXOLONE,1602256903,2025,50 mg,"Capsule, hard",Oral use,127050,Patheon Pharmaceuticals Inc.,United States,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store below 30°c,Hospital,"Biogen Arabia, Salehiya Trading Co."
Ticagrelor,TICAGRELOR,0902256853,2025,90 mg,Film-coated tablet,Oral use,83.80,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Zextro,LINEZOLID,0203256966,2025,600 mg,Film-coated tablet,Oral use,2894.40,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
jodaxed,PEMETREXED,1602256902,2025,500 mg,Powder for concentrate for solution for infusion,Intravenous use,1833.75,Jodas Expoim Pvt Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Aubomide,TERIFLUNOMIDE,1602256901,2025,14 mg,Film-coated tablet,Oral use,1258.20,AET Laboratories Pvt. Ltd.,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Capgin,CASPOFUNGIN ACETATE,2702256949,2025,70 mg,Powder for concentrate for solution for infusion,Intravenous use,648.80,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Capgin,CASPOFUNGIN ACETATE,2702256948,2025,50 mg,Powder for concentrate for solution for infusion,Intravenous use,506.40,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Oxintel,TAMSULOSIN HYDROCHLORIDE,1902256916,2025,0.4 mg,Capsule,Oral use,63,Macleods Pharmaceuticals Limited,India,Doctors Pharmaceutical manufacturer,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, Doctors Pharmaceutical manufacturer"
Cronoxam,SITAGLIPTIN HYDROCHLORIDE,1902256915,2025,100 mg,Film-coated tablet,Oral use,81.95,PHARMACEUTICAL WORKS POLPHARMA S.A.,Poland,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Tofaci,TOFACITINIB,2002256921,2025,10 mg,Tablet,Oral use,3593.25,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Tofaci,TOFACITINIB,2002256923,2025,5 mg,Tablet,Oral use,2935.50,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
DICLOMAX,DICLOFENAC SODIUM,2602256946,2025,50 mg,Tablet,Oral use,141.20,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Sitamend,Sitagliptin Phosphate Monohydrate,2602256942,2025,50 mg,Film-coated tablet,Oral use,63.5,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Acumig,LASMIDITAN,2502256935,2025,50 mg,Film-coated tablet,Oral use,80.45,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Acumig,LASMIDITAN,2502256932,2025,100 mg,Film-coated tablet,Oral use,321.90,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Sitamend,Sitagliptin Phosphate Monohydrate,2502256929,2025,100 mg,Film-coated tablet,Oral use,84.20,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Lexipia,SELEXIPAG,0302256802,2025,400 µg,Film-coated tablet,Oral use,7649.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Lexipia,SELEXIPAG,0302256801,2025,600 µg,Film-coated tablet,Oral use,7649.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
baclocan,BACLOFEN,0602256842,2025,10 mg,Tablet,Oral use,53.90,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Nilo,NILOTINIB,2002256924,2025,200 mg,Capsule,Oral use,2673.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Nilo,NILOTINIB,2002256922,2025,150 mg,Capsule,Oral use,2108.95,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Plasma-Lyte 148 (pH 7.4) and Glucose 5% w/v,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM ACETATE TRIHYDRATE, SODIUM GLUCONATE, GLUCOSE MONOHYDRATE",0302256794,2025,"5.26,0.37,0.30,3.68,5.02,55 g/l",Solution for infusion,Intravenous use,176.95,Bieffe Medital S.A,Spain,Baxter Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Polygynax,"NEOMYCIN SULFATE, POLYMYXIN B, NYSTATIN",1702256908,2025,"35000,35000,10000 IU",Vaginal capsule,Vaginal use,23.35,CATALENT,France,LABORATOIRE INNOTECH INTERNATIONAL,France,Marketed,Prescription,store below 30°c,Pharmacy,Al-Safa Warehouse For Pharmaceuticals Ltd
Cotrax,CARBETOCIN,2801256764,2025,100 µg/ml,Solution for injection,Intravenous use,234.40,PharmIdea SIA,Latvia,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,"Cigalah Group, PharmaZone (Netaq Al Dawa) Pharmaceuticals"
Alatript,AMITRIPTYLINE HYDROCHLORIDE,1202256886,2025,75 mg,Film-coated tablet,Oral use,65.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Alatript,AMITRIPTYLINE HYDROCHLORIDE,1202256885,2025,50 mg,Film-coated tablet,Oral use,43.50,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Alatript,AMITRIPTYLINE HYDROCHLORIDE,1202256884,2025,25 mg,Film-coated tablet,Oral use,21.75,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Lexipia,SELEXIPAG,0302256800,2025,800 µg,Film-coated tablet,Oral use,7649.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Brevie,BRIVARACETAM,0202256788,2025,25 mg,Film-coated tablet,Oral use,266.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Brevie,BRIVARACETAM,0202256789,2025,50 mg,Film-coated tablet,Oral use,266.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Speranta,NERATINIB,1202256890,2025,40 mg,Film-coated tablet,Oral use,11389.90,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Acumig,LASMIDITAN,2502256931,2025,50 mg,Film-coated tablet,Oral use,160.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Acumig,LASMIDITAN,2502256933,2025,100 mg,Film-coated tablet,Oral use,160.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazz Pharmaceutical Ireland Ltd,Ireland,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Vumerity,Diroximel fumarate,0302256796,2025,231 mg,"Modified-release capsule, hard",Oral use,4556.80,CORDEN PHARMA FRIBOURG AG,Switzerland,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Elrexfio,Elranatamab,1102256876,2025,44 mg,Solution for injection,Intravenous use,9907.90,PHARMACIA UPJOHN,United States,PFIZER INC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Elrexfio,Elranatamab,1102256875,2025,76 mg,Solution for injection,Intravenous use,17113.70,PHARMACIA UPJOHN,United States,PFIZER INC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Bloka,OMEPRAZOLE,1302256898,2025,40 mg,Powder and solvent for solution for infusion,Intravenous use,22.40,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Dimex,Dimetindene Maleate,1002256859,2025,0.1 %,Gel,Topical,12.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,OTC,store below 25°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Abilify Asimtufii,ARIPIPRAZOLE,0602256837,2025,960 mg,Prolonged-release suspension for injection,Intramuscular use,2377.25,"OTSUKA PHARMACEUTICAL CO., LTD",Japan,H. LUNDBECK,Denmark,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Paricalcitol Spectro,PARICALCITOL,2002256919,2025,5 µg/ml,Solution for injection,Intravenous use,230.90,PHARMATHEN INTERNATIONAL,Greece,Spectro Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Filozad,CARFILZOMIB,0402256806,2025,60 mg,powder for solution for injection,Intravenous use,3441.20,Eugia Pharma Specialties Limited,India,Eugia Pharma Specialities Limited,India,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Rezzayo,Rezafungin acetate,2601256749,2025,200 mg,Powder for concentrate for solution for infusion,Intravenous use,8947.00,Patheon Italia S.P.A.,Italy,Mundipharma GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
Hemgenix,Etranacogene dezaparvovec,3101256786,2025,1*10^13 GC,Concentrate for solution for infusion,Intravenous use,13236137.05,UniQure,United States,CSL,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Broncast Pediatric,MONTELUKAST SODIUM,1303257053,2025,5 mg,Chewable tablet,Oral use,1429.20,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Lyrgaba,PREGABALIN,1303257052,2025,150 mg,"Capsule, hard",Oral use,1380.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Salofalk,MESALAZINE,1003257020,2025,500 mg,Prolonged-release granules,Oral use,152.30,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Salofalk,MESALAZINE,1003257022,2025,1000 mg,Prolonged-release granules,Oral use,152.30,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Salofalk,MESALAZINE,1003257018,2025,1500 mg,Prolonged-release granules,Oral use,238.15,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Salofalk,MESALAZINE,1003257019,2025,3000 mg,Prolonged-release granules,Oral use,416.35,LOSAN PHARMA GMBH,Germany,DR. FALK PHARMA,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Diclopid,DICLOFENAC POTASSIUM,1303257064,2025,50 mg,Tablet,Oral use,386.55,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Omace,LISINOPRIL,1303257057,2025,20 mg,Tablet,Oral use,1279.60,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Omace,LISINOPRIL,1303257059,2025,10 mg,Tablet,Oral use,779.75,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Omace,LISINOPRIL,1303257061,2025,5 mg,Tablet,Oral use,474.00,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Mycophenolate Mofetil Marcan,MYCOPHENOLATE MOFETIL,0603256992,2025,200 mg/ml,Powder for oral suspension,Oral use,886.05,Emcure Pharmaceuticals Ltd.,India,Marcan Pharmaceuticals Inc,Canada,Marketed,Prescription,store below 25°c,Pharmacy,Cigalah Group
Soluvit N,"BIOTIN, CYANOCOBALAMIN, FOLIC ACID, NICOTINAMIDE, PYRIDOXINE (VITAMIN B6), RIBOFLAVIN, SODIUM ASCORBATE, SODIUM PANTOTHENATE, THIAMINE",0603257008,2025,"60,5,0.4,40,4.9,4.9,113,16.5,3.1 mg, µg",Powder for solution for infusion,Intravenous use,189.75,Fresenius Kabi SSPC,China,FRESENIUS KABI AB,Sweden,Marketed,Prescription,store below 25°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Motilone,DOMPERIDONE,1303257062,2025,10 mg,Coated tablet,Oral use,244.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Paclitaxel Kabi,PACLITAXEL,0603257006,2025,6 mg/ml,Solution for injection,Intravenous use,162.80,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Paclitaxel Kabi,PACLITAXEL,0603257004,2025,6 mg/ml,Solution for injection,Intravenous use,510.90,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Paclitaxel Kabi,PACLITAXEL,0603257003,2025,6 mg/ml,Solution for injection,Intravenous use,778.45,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Paclitaxel Kabi,PACLITAXEL,0603257001,2025,6 mg/ml,Solution for injection,Intravenous use,1354.15,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Paclitaxel Kabi,PACLITAXEL,0603257002,2025,6 mg/ml,Solution for injection,Intravenous use,1560.10,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,store below 30°c,Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Imjudo,TREMELIMUMAB,1303257049,2025,20 mg/ml,Concentrate for solution for infusion,Intravenous use,80366.80,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,AstraZeneca AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Yuflyma,ADALIMUMAB,1003257029,2025,40 mg,Solution for injection in pre-filled pen,Subcutaneous use,1889.10,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Taycan,VANCOMYCIN,1003257025,2025,1000 mg,Powder for concentrate for solution for infusion,Intravenous use,36.05,ANFARM HELLAS S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Advanced Pharmaceutical Industries
Plasma-Lyte 148 (pH 7.4) and Glucose 5% w/v,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM ACETATE TRIHYDRATE, SODIUM GLUCONATE, GLUCOSE MONOHYDRATE",0302256795,2025,"5.26,0.37,0.30,3.68,5.02,55 g/l",Solution for infusion,Intravenous use,110.90,Bieffe Medital S.A,Spain,Baxter Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Dexrofex,DEFERASIROX,1003257014,2025,90 mg,Film-coated tablet,Oral use,525.45,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Dexrofex,DEFERASIROX,1003257013,2025,180 mg,Film-coated tablet,Oral use,1044.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Dexrofex,DEFERASIROX,1003257015,2025,360 mg,Film-coated tablet,Oral use,2074.20,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
MOVAPO,APOMORPHINE,0502256824,2025,5 mg/ml,Solution for infusion in cartridge,Subcutaneous use,876.95,Hemofarm AD Vrsac,Serbia,Britannia Pharmaceuticals Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
Clodreb,CLADRIBINE,0403256974,2025,10 mg,Tablet,Oral use,40050.10,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Clodreb,CLADRIBINE,0403256977,2025,10 mg,Tablet,Oral use,26700.05,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Clodreb,CLADRIBINE,0403256976,2025,10 mg,Tablet,Oral use,6675.00,THE ARAB PHARMACEUTICAL MANUFACTURING PSC,Jordan,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Olaparib BOS,OLAPARIB,0403256982,2025,100 mg,Film-coated tablet,Oral use,3914.25,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Sitfort,"SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE",1003257024,2025,"50,1000 mg",Film-coated tablet,Oral use,91.20,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Sitfort,"SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE",1003257023,2025,"50,850 mg",Film-coated tablet,Oral use,88.00,RIYADH PHARMA,Saudi Arabia,RIYADH PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,RIYADH PHARMA
Fluxetyl,FLUOXETINE,1003257021,2025,4 mg/ml,Oral solution,Oral use,22.15,SyriMed,United Kingdom,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,Prescription,store below 30°c,Pharmacy,"Cigalah Group, PharmaZone (Netaq Al Dawa) Pharmaceuticals"
Provecta,BRIVARACETAM,1003257030,2025,100 mg,Film-coated tablet,Oral use,268.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Provecta,BRIVARACETAM,1003257031,2025,75 mg,Film-coated tablet,Oral use,268.60,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Omacillin,AMOXICILLIN,1303257055,2025,250 mg,Capsule,Oral use,277.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,"EBRAHIM M. ALMANA & BROS. CO., ZIMMO TRADING ESTABLISHMENT"
Dunarez,DARUNAVIR,1303257051,2025,400 mg,Film-coated tablet,Oral use,501.70,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Dunarez,DARUNAVIR,1203257040,2025,600 mg,Film-coated tablet,Oral use,803.85,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Sugammadex Kabi,SUGAMMADEX,0603257007,2025,100 mg/ml,Solution for injection,Intravenous use,1742.6,"Labesfal Laboratorios Almiro S.A., Fresenius Kabi Group",Portugal,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,"Store below 30°C, do not freeze, keep in the package to protect from light.",Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Sugammadex Kabi,SUGAMMADEX,0603257005,2025,100 mg/ml,Solution for injection,Intravenous use,4356.6,"Labesfal Laboratorios Almiro S.A., Fresenius Kabi Group",Portugal,Fresenius Kabi Deutschland GmbH,Germany,Marketed,Prescription,"Store below 30°C, do not freeze, keep in the package to protect from light.",Hospital,"Abdullatif Mohammed Salah Jamjoom & Bros Co, Faisal Musaed El Seif Saudi Pharmaceutical Co."
Gupisone,PREDNISOLONE,1703257090,2025,20 mg,Tablet,Oral use,28.20,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Xadago,SAFINAMIDE,1703257089,2025,100 mg,Film-coated tablet,Oral use,352.70,Zambon SpA,Italy,Zambon SpA,Italy,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Plasma-Lyte 148 (pH 7.4),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM ACETATE TRIHYDRATE, SODIUM GLUCONATE",1703257087,2025,"5.26,0.37,0.30,3.68,5.02 g/l",Solution for infusion,Intravenous use,176.95,Bieffe Medital S.A,Spain,Baxter Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Plasma-Lyte 148 (pH 7.4),"SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE HEXAHYDRATE, SODIUM ACETATE TRIHYDRATE, SODIUM GLUCONATE",1703257086,2025,"5.26,0.37,0.30,3.68,5.02 g/l",Solution for infusion,Intravenous use,110.90,Bieffe Medital S.A,Spain,Baxter Healthcare Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Gabanet,GABAPENTIN,1903257104,2025,300 mg,Capsule,Oral use,735.45,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Dallah Health Care Company
Gabanet,GABAPENTIN,1903257103,2025,400 mg,Capsule,Oral use,639.55,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Dallah Health Care Company
DUSPAMEN,MEBEVERINE HYDROCHLORIDE,2003257124,2025,135 mg,Tablet,Oral use,80.40,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Oxytocin EVER Pharma,OXYTOCIN,2203257126,2025,10 IU/ml,Solution for injection,Intravenous use,19.80,EVER PHARMA JENA GMBH,Germany,EVER Neuro Pharma GmbH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Donfer,PIRFENIDONE,2003257120,2025,801 mg,Film-coated tablet,Oral use,5717.25,Recipharm Pharma Services Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Donfer,PIRFENIDONE,2003257121,2025,267 mg,Film-coated tablet,Oral use,3984.85,Recipharm Pharma Services Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Sitaglu,SITAGLIPTIN HYDROCHLORIDE,2003257118,2025,100 mg,Film-coated tablet,Oral use,84.20,DR. REDDY,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Sitaglu,SITAGLIPTIN HYDROCHLORIDE,2003257117,2025,50 mg,Film-coated tablet,Oral use,45,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Sitaglu,SITAGLIPTIN HYDROCHLORIDE,2003257119,2025,25 mg,Film-coated tablet,Oral use,37.95,DR. REDDY,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Quillivant XR,METHYLPHENIDATE,2303257136,2025,40 mg,Film-coated tablet,Oral use,517,"Tris Pharma, Inc",United States,SPIMACO,Saudi Arabia,Marketed,Prescription,(Store at (20°C-25°C,Pharmacy,SPIMACO
Quillivant XR,METHYLPHENIDATE,2303257134,2025,30 mg,Film-coated tablet,Oral use,517,"Tris Pharma, Inc",United States,SPIMACO,Saudi Arabia,Marketed,Prescription,(Store at (20°C-25°C,Pharmacy,SPIMACO
Quillivant XR,METHYLPHENIDATE,2303257135,2025,20 mg,Film-coated tablet,Oral use,372.15,"Tris Pharma, Inc",United States,SPIMACO,Saudi Arabia,Marketed,Prescription,(Store at (20°C-25°C,Pharmacy,SPIMACO
Bindolent,BENDAMUSTINE HYDROCHLORIDE,2303257130,2025,100 mg,Powder for concentrate for solution for infusion,Intravenous use,831.50,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Bindolent,BENDAMUSTINE HYDROCHLORIDE,2303257128,2025,25 mg,Powder for concentrate for solution for infusion,Intravenous use,1039.40,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Cialis,TADALAFIL,1603257071,2025,20 mg,Film-coated tablet,Oral use,27.40,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Senso,LIDOCAINE,2403257139,2025,5 %,Transdermal patch,Transdermal use,326.15,Teh Seng Pharmaceutical Mfg. Co,China,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Epirelefan,TRIAMCINOLONE ACETONIDE,2303257131,2025,40 mg/ml,Suspension for injection,"Intravenous, Intramuscular, Subcutaneous",17.90,EIPICO,Egypt,EIPICO,Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Hydralazine Sciegen,HYDRALAZINE,2303257127,2025,50 mg,Tablet,Oral use,30.00,"ScieGen Pharmaceuticals, Inc",United States,"ScieGen Pharmaceuticals, Inc",United States,Marketed,Prescription,store below 30°c,Pharmacy,ARABIAN OASIS
Hydralazine Sciegen,HYDRALAZINE,2303257129,2025,25 mg,Tablet,Oral use,15.00,"ScieGen Pharmaceuticals, Inc",United States,"ScieGen Pharmaceuticals, Inc",United States,Marketed,Prescription,store below 30°c,Pharmacy,ARABIAN OASIS
Cisatracurium BOS,CISATRACURIUM,2703257178,2025,2 mg/ml,Solution for injection/infusion,Intravenous use,27.85,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
TEGECEN,TIGECYCLINE,2703257175,2025,50 mg,Powder for solution for infusion,Intravenous use,870.55,MS Pharma Saudi,Saudi Arabia,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Do not store above 30°C,Protect from direct sunlight",Hospital,Cigalah Group
Amilian,AMISULPRIDE,2403257147,2025,400 mg,Tablet,Oral use,178.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Amilian,AMISULPRIDE,2403257145,2025,200 mg,Tablet,Oral use,114.30,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Amilian,AMISULPRIDE,2403257146,2025,100 mg,Tablet,Oral use,60.90,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Tzield,Teplizumab,2603257168,2025,1 mg/ml,Solution for injection,Intravenous use,50275.50,AJINOMOTO ALTHEA INCORPORATED,United States,SANOFI WINTHROP INDUSTRIE,France,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Ebglyss,Lebrikizumab,2503257166,2025,250 mg,Solution for injection,Subcutaneous use,4413.45,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Pharmacy,"Eli Lilly Saudi Arabia Limited, SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)"
Amvuttra,Vutrisiran,2003257116,2025,25 mg,Solution for injection,Subcutaneous use,326996.55,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,Alnylam Netherlands B.V,Netherlands,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Imjudo,TREMELIMUMAB,0604257179,2025,25 mg/ml,Concentrate for solution for infusion,Intravenous use,6697.25,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,AstraZeneca,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Ocuotan Plus,"LATANOPROST, TIMOLOL",1004257226,2025,"0.05,5 mg/ml","Eye drops, solution",Ocular use,30.05,RAFARM S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Advanced Pharmaceutical Industries
Sefarix,CEFDINIR,0904257214,2025,300 mg,Capsule,Oral use,104,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Erleada,APALUTAMIDE,1004257221,2025,240 mg,Film-coated tablet,Oral use,10522.15,JANSSEN PHARMACEUTICA N.V.,Belgium,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Metoject,METHOTREXATE,0604257180,2025,"50 mg, mg/ml",Solution for injection in pre-filled syringe,Subcutaneous use,74.85,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Metoject,METHOTREXATE,0604257181,2025,50 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,78.25,ONCOTEC PHARMA PRODUCTION GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
LAXIRA,ROCURONIUM BROMIDE,1004257222,2025,10 mg/ml,Solution for injection,Intravenous use,182.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SPIMACO
Arsenic Trioxide,ARSENIC TRIOXIDE,1404257230,2025,1 mg/ml,concentrate for solution for injection,Intravenous use,8711.90,HAUPT PHARMA WOLFRATSHAUSEN GMBH,Germany,International pioneers,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,International Pioneers
Restain,METHYLCOBALAMIN,1004257223,2025,500 µg,Film-coated tablet,Oral use,22.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,SPIMACO
Sola D3,CHOLECALCIFEROL,1604257234,2025,5000 IU,Film-coated tablet,Oral use,16.50,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Sola D3,CHOLECALCIFEROL,1604257233,2025,50000 IU,Film-coated tablet,Oral use,64.10,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Falofil,TADALAFIL,0704257198,2025,20 mg,Film-coated tablet,Oral use,63.45,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Imuldosa,USTEKINUMAB,1004257219,2025,90 mg/ml,Solution for injection,Subcutaneous use,8327.45,"STgen Bio Co., Ltd.",South Korea,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Boston Oncology Arabia
Imuldosa,USTEKINUMAB,1004257218,2025,90 mg/ml,Solution for injection,Subcutaneous use,8327.45,"STgen Bio Co., Ltd.",South Korea,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Boston Oncology Arabia
Columvi,Glofitamab,0904257211,2025,"1 mg, mg/ml",Concentrate for solution for infusion,Intravenous use,3630,"Genentech, Inc",United States,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Roche Products Saudi Arabia
Columvi,Glofitamab,0904257212,2025,1 mg/ml,Concentrate for solution for infusion,Intravenous use,14520,"Genentech, Inc",United States,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Roche Products Saudi Arabia
Tremfya,GUSELKUMAB,0804257210,2025,10 mg/ml,Concentrate for solution for infusion,Intravenous use,12030.30,"Cilag AG, Schaffhausen, Switzerland",Switzerland,Janssen Cilag AG,Switzerland,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Cigalah Group
Tremfya,GUSELKUMAB,0804257209,2025,100 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,11118.70,"Cilag AG, Schaffhausen, Switzerland",Switzerland,Janssen Cilag AG,Switzerland,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Pharmacy,Cigalah Group
Spikevax XBB,ANDUSOMERAN,0711234438,2023,50 µg,Injection,Intramuscular use,3818.30,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a freezer,Hospital,Tabuk Pharmaceutical Manufacturing Company
Spikevax XBB,ANDUSOMERAN,0711234439,2023,0.1 mg/ml,Injection,Intramuscular use,19079.30,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a freezer,Hospital,Tabuk Pharmaceutical Manufacturing Company
Spikevax JN1 50 Micrograms dispersion for injection in pre filled syringe,ANDUSOMERAN,0711234437,2023,50 µg,Solution for injection in pre-filled syringe,Intramuscular use,3827.85,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a freezer,Hospital,Tabuk Pharmaceutical Manufacturing Company
Verotec,BETAHISTINE DIHYDROCHLORIDE,2104257255,2025,8 mg,Tablet,Oral use,570.10,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Verotec,BETAHISTINE DIHYDROCHLORIDE,2104257256,2025,16 mg,Tablet,Oral use,530.70,Jordanian pharmaceutical manufacturing company,Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Veggie Vitamin D3,CHOLECALCIFEROL,2004257242,2025,2000 IU,"Capsule, soft",Oral use,33.00,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Taqnyet Addawa Pharma Co.
ANAZOL,METRONIDAZOLE,2304257275,2025,250 mg,Film-coated tablet,Oral use,41.95,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Volcardy Plus,"VALSARTAN, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2004257241,2025,"160,5,12.5 mg",Film-coated tablet,Oral use,46.35,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Volcardy Plus,"VALSARTAN, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2004257239,2025,"160,5,25 mg",Film-coated tablet,Oral use,46.35,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Volcardy Plus,"VALSARTAN, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2004257240,2025,"160,10,12.5 mg",Film-coated tablet,Oral use,54.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Volcardy Plus,"VALSARTAN, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2004257243,2025,"160,10,25 mg",Film-coated tablet,Oral use,54.15,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Talvey,TALQUETAMAB,2004257251,2025,2 mg/ml,Solution for injection,Subcutaneous use,1831.30,Patheon Manufacturing Services LLC,United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Talvey,TALQUETAMAB,2004257252,2025,40 mg/ml,Solution for injection,Subcutaneous use,24417.20,Patheon Manufacturing Services LLC,United States,JANSSEN PHARMACEUTICA N.V,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Winrevair,SOTATERCEPT,2104257258,2025,45 mg,Powder and solvent for solution for injection,Subcutaneous use,36247.20,Patheon Italia S.P.A.,Italy,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Winrevair,SOTATERCEPT,2104257257,2025,45 mg,Powder and solvent for solution for injection,Subcutaneous use,72494.40,Patheon Italia S.P.A.,Italy,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Truqap,Capivasertib,2904257307,2025,200 mg,Film-coated tablet,Oral use,28902.65,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
Truqap,Capivasertib,2904257306,2025,160 mg,Film-coated tablet,Oral use,28902.65,AstraZeneca AB,Sweden,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
Promazi,Chlorpromazine Hydrochloride,2804257298,2025,100 mg,Tablet,Oral use,291.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zercepac,Trastuzumab,0705257350,2025,420 mg,Powder for concentrate for solution for infusion,Intravenous use,2342.1,Shanghai Henlius Biopharmaceutical Co Ltd,China,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Nucala,MEPOLIZUMAB,0505257342,2025,40-0.4 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,1883.75,Glaxo Operations UK Ltd,United Kingdom,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Acura,Bevacizumab,0505257339,2025,25 mg/ml,Concentrate for solution for infusion,Intravenous use,1050.20,UNIVERSAL FARMA SL,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Acura,Bevacizumab,0505257338,2025,25 mg/ml,Concentrate for solution for infusion,Intravenous use,3630.35,UNIVERSAL FARMA SL,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Docetere,DOCETAXEL,2804257300,2025,20 mg/ml,Solution for infusion,Intravenous use,444.4,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Hospital,Saudi Amarox
Docetere,DOCETAXEL,2804257296,2025,20 mg/ml,Solution for infusion,Intravenous use,888.8,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Hospital,Saudi Amarox
Betaten,ATENOLOL,0805257356,2025,100 mg,Film-coated tablet,Oral use,485.60,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
Betaten,ATENOLOL,0805257355,2025,50 mg,Film-coated tablet,Oral use,242.80,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
Pafinur,RUPATADINE FUMARATE,2704257283,2025,1 mg/ml,Oral solution,Oral use,31.25,ITALFARMACO SA,Spain,NOCOUR HEALTH S.A,Spain,Marketed,Prescription,store below 30°c,Pharmacy,"Abdulrehman Algosaibi G.T.C., Cigalah Group, STADA Arabia Limited Company"
Endura,DAPOXETINE,0105257322,2025,30 mg,Film-coated tablet,Oral use,110,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Endura,DAPOXETINE,0105257323,2025,60 mg,Film-coated tablet,Oral use,110,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Risek Plus,"OMEPRAZOLE, SODIUM BICARBONATE",0605257346,2025,"40,1100 mg",Capsule,Oral use,89.20,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Rufzel,RUFINAMIDE,2804257301,2025,400 mg,Tablet,Oral use,1732.80,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Rufzel,RUFINAMIDE,0105257328,2025,200 mg,Tablet,Oral use,866,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Pinolanz,OLANZAPINE,2804257297,2025,10 mg,Powder for injection,Intramuscular use,126.50,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Amarox
Amiroic,AMINOCAPROIC ACID,2804257299,2025,0.25 g/ml,Oral solution,Oral use,3943.25,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Promazi,Chlorpromazine Hydrochloride,2804257304,2025,25 mg,Tablet,Oral use,72.75,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Itranox,ITRACONAZOLE,2804257302,2025,10 mg/ml,Oral solution,Oral use,484.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Sildenafil Amarox,SILDENAFIL,0105257327,2025,10 mg/ml,Powder for oral suspension,Oral use,1315.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Tadalafil SPI,TADALAFIL,2704257279,2025,20 mg,Film-coated tablet,Oral use,63.45,Jubilant Generics Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Tadalafil SPI,TADALAFIL,2704257280,2025,5 mg,Film-coated tablet,Oral use,127.05,Jubilant Generics Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Toxefro,DEFERASIROX,2804257290,2025,500 mg,Dispersible tablet,Oral use,1622.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Toxefro,DEFERASIROX,2804257294,2025,250 mg,Dispersible tablet,Oral use,816.50,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Promazi,Chlorpromazine Hydrochloride,2804257303,2025,25 mg/ml,Solution for injection,Intramuscular use,41.05,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Tagbro,TICAGRELOR,2804257292,2025,90 mg,Film-coated tablet,Oral use,167.65,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Tyruko,NATALIZUMAB,2904257312,2025,20 mg/ml,Concentrate for solution for infusion,Intravenous use,4004.50,Patheon Italia S.P.A.,Italy,SANDOZ GMBH,Austria,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Carfilzomib BOS,CARFILZOMIB,0105257325,2025,10 mg,Powder for solution for injection/infusion,Intravenous use,529.40,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Carfilzomib BOS,CARFILZOMIB,0105257326,2025,30 mg,Powder for solution for injection/infusion,Intravenous use,1588.25,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Carfilzomib BOS,CARFILZOMIB,0105257324,2025,60 mg,Powder for solution for injection/infusion,Intravenous use,3176.50,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Boston Oncology Arabia
Varenya,DESVENLAFAXINE SUCCINATE,0405257332,2025,50 mg,Extended-release tablet,Oral use,51.05,Zydus Lifesciences Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Varenya,DESVENLAFAXINE SUCCINATE,0405257331,2025,100 mg,Extended-release tablet,Oral use,75.40,Zydus Lifesciences Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Inveris,PALIPERIDONE,0805257353,2025,150 mg,Suspension for injection in pre-filled syringe,Intramuscular use,988.30,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Inveris,PALIPERIDONE,0805257352,2025,100 mg,Suspension for injection in pre-filled syringe,Intramuscular use,849.45,PHARMASCIENCE INC.,Canada,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Pemetrexed Seacross,PEMETREXED,1205257377,2025,500 mg,Powder for concentrate for solution for infusion,Intravenous use,1873.40,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Pemetrexed Seacross,PEMETREXED,1205257378,2025,100 mg,Powder for concentrate for solution for infusion,Intravenous use,498.25,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Zylinamet,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",1305257381,2025,"2.5,1000 mg",Film-coated tablet,Oral use,142.90,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Zylinamet,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",1305257382,2025,"2.5,850 mg",Film-coated tablet,Oral use,134.60,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Zylinamet,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",1305257383,2025,"2.5,500 mg",Film-coated tablet,Oral use,124.35,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Closa,"CLOPIDOGREL, ACETYLSALICYLIC ACID",1205257376,2025,"75,100 mg",Film-coated tablet,Oral use,120.60,ACTAVIS,Malta,CALIFORNIA GREENS CORPORATION FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Mahd Alseha Medical Co
ORSERDU,Elacestrant Dihydrochloride,1505257409,2025,345 mg,Film-coated tablet,Oral use,44126.90,CATALENT,United States,"Stemline Therapeutics, Inc",United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
ORSERDU,Elacestrant Dihydrochloride,1505257410,2025,86 mg,Film-coated tablet,Oral use,10999.75,CATALENT,United States,"Stemline Therapeutics, Inc",United States,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Tecartus,Brexucabtagene autoleucel,1505257388,2025,1 * 10^6 + 1 * 10^8 cells,Cell suspension for infusion,Intravenous use,1694937.75,Kite Pharma,United States,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,Stored frozen at ≤ −150 °C in vapor phase of liquid nitrogen,Hospital,Cigalah Group
Tecartus,Brexucabtagene autoleucel,1505257389,2025,2 * 10^6 + 2 * 10^8 cells,Cell suspension for infusion,Intravenous use,1694937.75,Kite Pharma,United States,Gilead Sciences Ireland UC,Ireland,Marketed,Prescription,Stored frozen at ≤ −150 °C in vapor phase of liquid nitrogen,Hospital,Cigalah Group
Filsuvez gel,Triterpene extract,1805257412,2025,100 mg/ml,Gel,Cutaneous use,41514.55,Lichtenheldt GmbH,Germany,Amryt pharmaceuticals DAC,Ireland,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
MenQuadfi,"MENINGOCOCCAL (SEROGROUP A) POLYSACCHARIDE, MENINGOCOCCAL (SEROGROUP C) POLYSACCHARIDE, MENINGOCOCCAL (SEROGROUP Y) POLYSACCHARIDE, MENINGOCOCCAL (SEROGROUP W135) POLYSACCHARIDE, TETANUS TOXOID",1405257385,2025,"10,10,10,10,55 µg",Solution for injection,Intramuscular use,191.00,SANOFI PASTEUR,United States,SANOFI PASTEUR,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Sanofi Arabia Trading Co. Ltd
Ticaglob,TICAGRELOR,1505257387,2025,90 mg,Film-coated tablet,Oral use,77.15,Global NAPI Pharmaceuticals (GNP),Egypt,Global NAPI Pharmaceuticals (GNP),Egypt,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
BAGENTA,GENTAMICIN,1505257408,2025,40 mg/ml,Solution for injection,Intramuscular and intravenous use,60.90,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,BATTERJEE PHARMACEUTICAL FACTORY
NIMENRIX,"MENINGOCOCCAL GROUP A, C, W135, Y, TETANUS TOXOID",1905257413,2025,"5,5,5,5,44 µg",Powder and solvent for solution for injection,Intramuscular use,1444.10,Pfizer Manufacturing Belgium N.V.,Belgium,Pfizer Europe MA EEIG,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Pfizer Saudi Trading
Bucaine Spinal,BUPIVACAINE,1905257414,2025,5 mg/ml,Solution for injection,Intrathecal use,29.70,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Marvi,VARENICLINE,2005257428,2025,0.5 mg,Film-coated tablet,Oral use,30.00,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Marvi,VARENICLINE,2005257433,2025,1 mg,Film-coated tablet,Oral use,123.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Briglor,TICAGRELOR,2405257449,2025,90 mg,Film-coated tablet,Oral use,167.65,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,"Do not store above 30°C, do not freeze",Pharmacy,Saudi Amarox
Briglor,TICAGRELOR,2405257451,2025,60 mg,Film-coated tablet,Oral use,142.50,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,"Do not store above 30°C, do not freeze",Pharmacy,Saudi Amarox
Olmexa Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2005257427,2025,"40,10,25 mg",Film-coated tablet,Oral use,85.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2005257426,2025,"40,5,25 mg",Film-coated tablet,Oral use,80.20,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2005257432,2025,"20,5,12.5 mg",Film-coated tablet,Oral use,59.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa Plus,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",2005257436,2025,"40,10,12.5 mg",Film-coated tablet,Oral use,79.70,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa Plus,"OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE",2005257437,2025,"40,12.5,5 mg",Film-coated tablet,Oral use,74.80,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Monovira,EFAVIRENZ,2405257450,2025,600 mg,Film-coated tablet,Oral use,1575.20,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Olmexa,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2005257435,2025,"40,10 mg",Film-coated tablet,Oral use,71.85,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2005257438,2025,"40,5 mg",Film-coated tablet,Oral use,66.95,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2005257429,2025,"20,10 mg",Film-coated tablet,Oral use,63.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Olmexa,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE",2005257425,2025,"20,5 mg",Film-coated tablet,Oral use,51.25,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Solitract Plus,"SOLIFENACIN SUCCINATE, TAMSULOSIN HYDROCHLORIDE",2805257477,2025,"6,0.4 mg",Modified-release film-coated tablet,Oral use,146.35,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Eva pharma for Industry
PREVYMIS,LETERMOVIR,3005257500,2025,480 mg,Concentrate for solution for infusion,Intravenous use,1452,MSD INTERNATIONAL GMBH,Ireland,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,store below 30°c,Hospital,ALNAGHI COMPANY
Lacosamide QO,LACOSAMIDE,2905257490,2025,10 mg/ml,Oral solution,Oral use,75.70,LM Manufacturing Limited,United Kingdom,Qomel Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Fentanyl Kalceks,FENTANYL,2805257478,2025,0.05 mg/ml,Solution for injection,Intramuscular and intravenous use,23.60,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 30°c,Hospital,AL JEDAANI STORE
Fentanyl Kalceks,FENTANYL,2805257480,2025,0.05 mg/ml,Solution for injection,Intramuscular and intravenous use,63.15,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 30°c,Hospital,AL JEDAANI STORE
Epixx,LEVETIRACETAM,2805257485,2025,250 mg,Film-coated tablet,Oral use,69.55,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Epixx,LEVETIRACETAM,2805257486,2025,500 mg,Film-coated tablet,Oral use,94.85,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Epixx,LEVETIRACETAM,2805257487,2025,1000 mg,Film-coated tablet,Oral use,194.85,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Empamac Met,"EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE",2805257482,2025,"12.5,1000 mg",Tablet,Oral use,60.5,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Xitamet,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN HYDROCHLORIDE",0306257537,2025,"850,50 mg",Film-coated tablet,Oral use,88,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Xitamet,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN HYDROCHLORIDE",0306257538,2025,"1000,50 mg",Film-coated tablet,Oral use,91.20,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,AJA PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AJA PHARMACEUTICAL INDUSTRIES
Ultavan,VANCOMYCIN,0306257539,2025,5 mg/ml,Intravenous infusion,Intravenous use,650.15,Inforlife S A,Swaziland,Branch of jazeera pharmaceutical industries company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Toycin,"TOBRAMYCIN, DEXAMETHASONE",0206257523,2025,"3,1 mg","Eye drops, suspension",Ocular use,18.90,RAFARM S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Advanced Pharmaceutical Industries
Tasylev,SEMAGLUTIDE,0206257517,2025,1.34 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,397.70,Stelis Biopharma Private Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Tasylev,SEMAGLUTIDE,0206257518,2025,1.34 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,397.70,Stelis Biopharma Private Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Stenar,CARMUSTINE,0406257545,2025,100 mg,Powder and solvent for solution for infusion,Intravenous use,3058.60,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SUDAIR PHARMA COMPANY
Oxlumo,LUMASIRAN,0306257534,2025,94.5/0.5 mg/ml,Solution for injection,Subcutaneous use,264372.20,"VETTER PHARMA-FERTIGUNG, GMBH & CO. KG",Germany,Alnylam Netherlands B.V,Netherlands,Marketed,Prescription,do not store above 30°c,Hospital,Salehiya Trading Co.
Medrolone,METHYLPREDNISOLONE,0306257542,2025,500 mg,Lyophilisate for solution for injection,Parenteral use,655,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Malsy,SUGAMMADEX,1706257569,2025,100 mg/ml,Solution for injection,Intravenous use,1742.60,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
Locovab,LACOSAMIDE,0106257508,2025,150 mg,Film-coated tablet,Oral use,270.75,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Locovab,LACOSAMIDE,0106257509,2025,100 mg,Film-coated tablet,Oral use,180.5,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Locovab,LACOSAMIDE,0106257510,2025,50 mg,Film-coated tablet,Oral use,93.8,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Locovab,LACOSAMIDE,0106257511,2025,200 mg,Film-coated tablet,Oral use,361.65,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Klare,CLARITHROMYCIN,0106257501,2025,500 mg,Film-coated tablet,Oral use,1657.80,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Jakenz,TOFACITINIB,0206257521,2025,10 mg,Film-coated tablet,Oral use,1676.85,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Jakenz,TOFACITINIB,0206257522,2025,5 mg,Film-coated tablet,Oral use,1369.90,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
IMCIVREE,SETMELANOTIDE,1606257556,2025,10 mg/ml,Solution for injection,Subcutaneous use,12967.85,RECIPHARMA,France,Rhythm Pharmaceuticals Netherlands,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Gynocin,OXYTOCIN,1606257557,2025,5 IU/ml,Solution for injection,Parenteral use,49.60,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Cardioprol,BISOPROLOL FUMARATE,0306257535,2025,10 mg,Film-coated tablet,Oral use,666.50,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Dallah Health Care Company
Cardioprol,BISOPROLOL FUMARATE,0306257536,2025,5 mg,Film-coated tablet,Oral use,488.30,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Hospital,"Dallah Health Care Company, Dallah Pharma Factory"
FINALLERG,CETIRIZINE HYDROCHLORIDE,206257520,2025,10 mg,Film-coated tablet,Oral use,22.35,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,OTC,store below 30°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
Fomicyt,FOSFOMYCIN,1206257551,2025,40 mg/ml,Powder for solution for infusion,Intravenous use,1356.65,Fisiopharma S.r.L,Italy,Infectopharm Arzneimittel und Consilium GmbH,Germany,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Fomicyt,FOSFOMYCIN,1206257550,2025,40 mg/ml,Powder for solution for infusion,Intravenous use,2713.35,Fisiopharma S.r.L,Italy,Infectopharm Arzneimittel und Consilium GmbH,Germany,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Fomicyt,FOSFOMYCIN,1206257549,2025,40 mg/ml,Powder for solution for infusion,Intravenous use,678.30,Fisiopharma S.r.L,Italy,Infectopharm Arzneimittel und Consilium GmbH,Germany,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,ZIMMO TRADING ESTABLISHMENT
Glycimille,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN",1506257555,2025,850/50 mg,Film-coated tablet,Oral use,90.60,Macleods Pharmaceuticals Limited,India,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharco International pharmaceutical company
Gynocin,OXYTOCIN,1606257559,2025,10 IU/ml,Solution for injection,Parenteral use,99.15,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Jazeera Pharmaceutical Industries (JPI)
Polmena,BUDESONIDE,2506257620,2025,0.5 mg/ml,Nebuliser suspension,Inhalation use,120.80,"CF PharmTech, Inc.",China,Med City Pharma,Saudi Arabia,Marketed,Prescription,"Do not store above 30°C, do not freeze",Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Batlor,DESLORATADINE,2406257607,2025,5 mg,Film-coated tablet,Oral use,28.25,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
FINALLERG,CETIRIZINE DIHYDROCHLORIDE,0206257520,2025,10 mg,Film-coated tablet,Oral use,22.35,Pharma International Co.,Jordan,PHARMA INTERNATIONAL CO,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
LABETALOL SALF,LABETALOL HYDROCHLORIDE,2406257596,2025,5 mg/ml,Solution for injection/infusion,Intravenous use,44.90,S.A.L.F. S.p.A. Laboratorio Farmacologico,Italy,S.A.L.F. S.p.A. Laboratorio Farmacologico,Italy,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI ARABIAN DRUG STORE COMPANY
Barolex,HYDRALAZINE,0306257543,2025,50 mg,Tablet,Oral use,30.00,Cadila Pharmaceutical LTD,India,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Medical and Pharmaceutical Services Company
Barolex,HYDRALAZINE,0306257544,2025,25 mg,Tablet,Oral use,15.00,Cadila Pharmaceutical LTD,India,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Medical and Pharmaceutical Services Company
Lenzal,LINEZOLID,2306257595,2025,600 mg,Film-coated tablet,Oral use,1877.10,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Catafenac,DICLOFENAC POTASSIUM,0206257532,2025,50 mg,Powder for oral solution,Oral use,40.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Catafenac,DICLOFENAC POTASSIUM,0206257533,2025,50 mg,Powder for oral solution,Oral use,20.00,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Sunitinib Pharmacare,SUNITINIB,2506257617,2025,12.5 mg,"Capsule, hard",Oral use,3111.50,Pharmacare Premium Ltd,Malta,Pharmacare Premium Ltd,Malta,Marketed,Prescription,do not store above 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Sunitinib Pharmacare,SUNITINIB,2506257616,2025,25 mg,"Capsule, hard",Oral use,6223,Pharmacare Premium Ltd,Malta,Pharmacare Premium Ltd,Malta,Marketed,Prescription,do not store above 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Sunitinib Pharmacare,SUNITINIB,2506257615,2025,50 mg,"Capsule, hard",Oral use,11739.80,Pharmacare Premium Ltd,Malta,Pharmacare Premium Ltd,Malta,Marketed,Prescription,do not store above 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Azitromicina Azevedos,AZITHROMYCIN,0107257645,2025,500 mg,Powder for solution for infusion,Intravenous use,211.05,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,Laboratorios Azevedos Industria Farmaceutica S.A,Portugal,Marketed,Prescription,do not store above 30°c,Hospital,QOMEL MEDICAL DRUG STORE
Azitromicina Azevedos,AZITHROMYCIN,0107257646,2025,500 mg,Powder for solution for infusion,Intravenous use,27.70,"Sofarimex Indústria Química e Farmacêutica, S.A..",Portugal,Laboratorios Azevedos Industria Farmaceutica S.A,Portugal,Marketed,Prescription,do not store above 30°c,Hospital,QOMEL MEDICAL DRUG STORE
Glucose-Na-K Baxter 50 mg/mL,"GLUCOSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE TRIHYDRATE, MAGNESIUM CHLORIDE HEXAHYDRATE",2606257631,2025,"55,1,1.5,3.13,0.30 g/l",Solution for infusion,Intravenous use,240.35,Bieffe Medital S.A,Spain,Baxter Medical AB,Sweden,Marketed,Prescription,store below 30°c,Hospital,ZIMMO TRADING ESTABLISHMENT
Epysqli,ECULIZUMAB,2206257590,2025,300 mg,Concentrate for solution for infusion,Intravenous use,9897.60,Eurofins Biopharma Product Testing Ireland Limited,Ireland,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Brevie,BRIVARACETAM,0306257540,2025,10 mg/ml,Solution for injection/infusion,Intravenous use,69.45,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SUDAIR PHARMA COMPANY
Esoxo,ESOMEPRAZOLE,0106257514,2025,40 mg,Gastro-resistant tablet,Oral use,65.65,Jubilant Generics Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Esoxo,ESOMEPRAZOLE,0106257513,2025,20 mg,Gastro-resistant tablet,Oral use,52.55,Jubilant Generics Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Farinox,ENOXAPARIN SODIUM,0106257505,2025,100 mg/ml,Solution for injection in pre-filled syringe,"Intravenous, Subcutaneous",72.5,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,"Do not store above 30°C, do not freeze, do not refrigerate",Pharmacy,Cigalah Group
Provecta,BRIVARACETAM,1906257581,2025,10 mg/ml,Oral solution,Oral use,143.30,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Vegzelma,Bevacizumab,2406257600,2025,25 mg/ml,Concentrate for solution for infusion,Intravenous use,2499.85,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Jazeera Pharmaceutical Industries (JPI)
Vegzelma,Bevacizumab,2406257599,2025,25 mg/ml,Concentrate for solution for infusion,Intravenous use,740.50,CELLTRION INC,KOREA,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Jazeera Pharmaceutical Industries (JPI)
Lijen,LINAGLIPTIN,2406257610,2025,5 mg,Film-coated tablet,Oral use,68.05,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
OLYMA,FINGOLIMOD HYDROCHLORIDE,2406257611,2025,0.5 mg,Capsule,Oral use,3010.00,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Forsdapa,DAPAGLIFLOZIN,2406257609,2025,10 mg,Film-coated tablet,Oral use,93.30,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Leracet,LEVETIRACETAM,2406257603,2025,250 mg,Film-coated tablet,Oral use,50.5,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Leracet,LEVETIRACETAM,2406257605,2025,500 mg,Film-coated tablet,Oral use,82.35,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
BENDAMUSTINE-VENUS,BENDAMUSTINE HYDROCHLORIDE,2606257632,2025,100 mg,Lyophilisate for solution for injection,Intravenous use,831.50,VENUS REMEDIES LIMITED,India,VENUS REMEDIES LIMITED,India,Marketed,Prescription,store below 30°c,Hospital,Salehiya Trading Co.
Palpocent,PALBOCICLIB,0207257668,2025,125 mg,Capsule,Oral use,9738,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Palpocent,PALBOCICLIB,0207257661,2025,100 mg,Capsule,Oral use,9738,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Palpocent,PALBOCICLIB,0207257658,2025,75 mg,Capsule,Oral use,9738,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
EMBA,EMPAGLIFLOZIN,0207257667,2025,25 mg,Film-coated tablet,Oral use,128.40,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
EMBA,EMPAGLIFLOZIN,0207257657,2025,10 mg,Film-coated tablet,Oral use,128.40,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Olaparib BOS,OLAPARIB,2906257634,2025,150 mg,Film-coated tablet,Oral use,3914.25,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Vecanzol,VORICONAZOLE,3006257636,2025,40 mg/ml,Powder for oral solution,Oral use,1269.45,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,MS Pharma Saudi (MSPS)
Dolutegravir Eva,DOLUTEGRAVIR SODIUM,3006257644,2025,50 mg,Film-coated tablet,Oral use,1568.00,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Eva pharma for Industry
Eribulin BOS,ERIBULIN MESILATE,2906257635,2025,0.5 mg/ml,Solution for injection,Intravenous use,1033.15,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
clopidogrel ALH,CLOPIDOGREL,3006257638,2025,75 mg,Tablet,Oral use,118.15,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Abetyl,ABIRATERONE ACETATE,3006257640,2025,250 mg,Tablet,Oral use,5281.00,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Sodium Valproate,SODIUM VALPROATE,3006257643,2025,100 mg/ml,Solution for injection/infusion,Intravenous use,160.45,Sichuan Huiyu Pharmaceutical Company Limited,China,Seacross Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Sitagia,SITAGLIPTIN HYDROCHLORIDE,0107257651,2025,100 mg,Film-coated tablet,Oral use,87.80,MEDREICH LIMITED Unit 7,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Nintib,NINTEDANIB,0207257671,2025,100 mg,Capsule,Oral use,3759.00,Cipla Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Boston Oncology Arabia
Nintib,NINTEDANIB,0207257672,2025,150 mg,Capsule,Oral use,3759.00,Cipla Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Boston Oncology Arabia
RINOMEL,MILRINONE,0807257709,2025,1 mg/ml,Solution for injection/infusion,Intravenous use,747.15,Emcure Pharmaceuticals Ltd.,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,"Store below 25 °C, do not freeze.",Hospital,Alpha Pharma Industry
Olesten,COLISTIMETHATE SODIUM,0207257677,2025,1000000 IU,Powder for solution for injection/infusion,Intravenous use,279.90,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,MS Pharma Saudi (MSPS)
Vascorin,ISOPRENALINE,0207257675,2025,0.2 mg/ml,Solution for injection/infusion,Intravenous use,237.20,Emcure Pharmaceuticals Ltd.,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Alpha Pharma Industry
Vascorin,ISOPRENALINE,0207257676,2025,0.2 mg/ml,Solution for injection/infusion,Intravenous use,118.60,Emcure Pharmaceuticals Ltd.,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Alpha Pharma Industry
Liv-Gamma,HUMAN NORMAL IMMUNOGLOBULIN,H0000029876,2025,50 mg/ml,Solution for infusion,Intravenous use,,SK Plasma Co. Ltd,South Korea,SK Plasma Co. Ltd,South Korea,Marketed,Prescription,"Store in the refrigerator at a temperature of (2-8) degrees Celsius, keep in the package to protect from light, do not freeze",Hospital,Aldawaa medical services co. LTMD
Zolabri,BREXPIPRAZOLE,0207257659,2025,3 mg,Film-coated tablet,Oral use,308.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zolabri,BREXPIPRAZOLE,0207257663,2025,2 mg,Film-coated tablet,Oral use,308.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zolabri,BREXPIPRAZOLE,0207257660,2025,1 mg,Film-coated tablet,Oral use,308.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zolabri,BREXPIPRAZOLE,0207257664,2025,0.5 mg,Film-coated tablet,Oral use,136.35,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zolabri,BREXPIPRAZOLE,0207257665,2025,0.25 mg,Film-coated tablet,Oral use,83.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Zolabri,BREXPIPRAZOLE,0207257662,2025,4 mg,Film-coated tablet,Oral use,83.10,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Xonvea,"DOXYLAMINE SUCCINATE, PYRIDOXINE",1007257732,2025,"20,20 mg",Prolonged-release tablet,Oral use,218.20,Duchesnay Inc,Canada,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Lazcluze,Lazertinib,0607257700,2025,240 mg,Film-coated tablet,Oral use,28729.50,Janssen cilag SpA,Italy,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Lazcluze,Lazertinib,0607257701,2025,80 mg,Film-coated tablet,Oral use,28729.50,Janssen cilag SpA,Italy,Janssen-Cilag International NV,Belgium,Marketed,Prescription,store below 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Polivy,POLATUZUMAB VEDOTIN,1007257726,2025,30 mg,Powder for concentrate for solution for infusion,Intravenous use,9280.80,F. Hoffmann-La Roche Ltd.,Switzerland,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Roche Products Saudi Arabia
TALYNTA,DAPOXETINE,0907257719,2025,60 mg,Film-coated tablet,Oral use,98.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
TALYNTA,DAPOXETINE,0907257718,2025,30 mg,Film-coated tablet,Oral use,98.00,ALPHA PHARMA INDUSTRY,Saudi Arabia,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
TIDILOR,LORATADINE,0207257669,2025,10 mg,Tablet,Oral use,40.75,Pharma International Co.,Jordan,Pharma International Co.,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,"SAUDI ARABIAN DRUG STORE COMPANY, ZIMMO TRADING ESTABLISHMENT"
Helt,TADALAFIL,0807257710,2025,20 mg,Film-coated tablet,Oral use,190.35,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Glofel,TADALAFIL,0207257674,2025,20 mg,Film-coated tablet,Oral use,16,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,MANAYER NAJD TRADING MEDICAL NEEDS CO.
Tekam,KETAMINE,1007257739,2025,50 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,265.50,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Omisec,OMEPRAZOLE,1007257743,2025,40 mg,Powder for solution for infusion,Intravenous use,112.50,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Zistan,CHLORPHENIRAMINE MALEATE,0307257697,2025,4 mg,Tablet,Oral use,56.60,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES,Kuwait,Marketed,OTC,do not store above 30°c,Hospital,"Cigalah Group, ZIMMO TRADING ESTABLISHMENT"
Veggie Vitamin D3,CHOLECALCIFEROL,0807257708,2025,10000 IU,"Capsule, soft",Oral use,38.45,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES
Olmidip HCT,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",0707257706,2025,"20,5,12.5 mg",Film-coated tablet,Oral use,52.10,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,"Cigalah Group, Saudi Advanced Renal Services Ltd (SRS)"
Olmidip HCT,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",0707257702,2025,"40,5,12.5 mg",Film-coated tablet,Oral use,66.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Olmidip HCT,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",0707257703,2025,"40,5,25 mg",Film-coated tablet,Oral use,66.75,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Olmidip HCT,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",0707257704,2025,"40,10,12.5 mg",Film-coated tablet,Oral use,74.25,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Olmidip HCT,"OLMESARTAN MEDOXOMIL, AMLODIPINE BESILATE, HYDROCHLOROTHIAZIDE",0707257705,2025,"40,10,25 mg",Film-coated tablet,Oral use,74.25,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Solitrol,SOLIFENACIN SUCCINATE,0107257656,2025,10 mg,Film-coated tablet,Oral use,108.9,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Solitrol,SOLIFENACIN SUCCINATE,0107257655,2025,5 mg,Film-coated tablet,Oral use,84.7,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Coduro,TADALAFIL,0107257652,2025,5 mg,Film-coated tablet,Oral use,127.05,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Coduro,TADALAFIL,0107257654,2025,20 mg,Film-coated tablet,Oral use,64.85,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Coduro,TADALAFIL,0107257653,2025,20 mg,Film-coated tablet,Oral use,181.25,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Arsenic Trioxide Nexus,ARSENIC TRIOXIDE,3006257642,2025,1 mg/ml,Solution for injection,Intravenous use,8711.90,CENEXI-LABORATORIES,Belgium,Nexus Pharmaceuticals Inc,United States,Marketed,Prescription,do not store above 25°c,Hospital,ARABIAN OASIS
EZIUM,ESOMEPRAZOLE MAGNESIUM,0807257715,2025,40 mg,"Gastro-resistant capsule, hard",Oral use,65.65,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
EZIUM,ESOMEPRAZOLE MAGNESIUM,0807257716,2025,20 mg,"Gastro-resistant capsule, hard",Oral use,52.55,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,DAMMAM PHARMA
EZIUM,ESOMEPRAZOLE MAGNESIUM,0807257713,2025,40 mg,"Gastro-resistant capsule, hard",Oral use,36.75,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,DAMMAM PHARMA
EZIUM,ESOMEPRAZOLE MAGNESIUM,0807257714,2025,20 mg,"Gastro-resistant capsule, hard",Oral use,26.95,SPIMACO,Saudi Arabia,DAMMAM PHARMA,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,DAMMAM PHARMA
Dapagloz,DAPAGLIFLOZIN,0607257698,2025,10 mg,Film-coated tablet,Oral use,93.30,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Apex Pharma
Dapagloz,DAPAGLIFLOZIN,0607257699,2025,5 mg,Film-coated tablet,Oral use,93.30,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
Hadlima,ADALIMUMAB,0807257712,2025,40 mg,Solution for injection in pre-filled syringe,Subcutaneous use,1889.10,Catalent Belgium SA,Belgium,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO"
Hadlima,ADALIMUMAB,0807257711,2025,40 mg,Solution for injection in pre-filled pen,Subcutaneous use,1889.10,Catalent Belgium SA,Belgium,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Pharmacy,"Farouk, Maamoun Tamer & CO"
Pulmistad,BUDESONIDE,0107257648,2025,0.5 mg/ml,Nebuliser suspension,Inhalation use,104.40,Genetic S.p.A,Italy,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"STADA Arabia Limited Company, Salehiya Trading Co."
Pulmistad,BUDESONIDE,0107257649,2025,0.25 mg/ml,Nebuliser suspension,Inhalation use,66.10,Genetic S.p.A,Italy,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"STADA Arabia Limited Company, Salehiya Trading Co."
Dexrofex,DEFERASIROX,0207257666,2025,180 mg,Granules,Oral use,1252.80,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Telfast,FEXOFENADINE HYDROCHLORIDE,1507257755,2025,120 mg,Film-coated tablet,Oral use,39.70,SANOFI WINTHROP INDUSTRIE,France,Sanofi Consumer Healthcare,Australia,Marketed,OTC,do not store above 30°c,Pharmacy,Opella Arabia Limited Co
Telfast,FEXOFENADINE HYDROCHLORIDE,1507257754,2025,180 mg,Film-coated tablet,Oral use,43.65,SANOFI WINTHROP INDUSTRIE,France,Sanofi Consumer Healthcare,Australia,Marketed,OTC,do not store above 30°c,Pharmacy,Opella Arabia Limited Co
Amelivu,RANIBIZUMAB,1507257757,2025,10 mg/ml,Solution for injection,Intravitreal use,1530.65,Patheon Italia S.P.A.,Italy,Samsung Bioepis Co Ltd,South Korea,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
Celavas,SEVELAMER CARBONATE,2107257784,2025,800 mg,Film-coated tablet,Oral use,452.95,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Cystadane,BETAINE,2207257786,2025,1 g,Oral powder,Oral use,2064.30,ROPACKINC,Canada,Recordati Rare Diseases,France,Marketed,Prescription,do not store above 30°c,Hospital,Al Osool Medical Trading Company
Raltavir,RALTEGRAVIR POTASSIUM,2007257775,2025,400 mg,Film-coated tablet,Oral use,1567.80,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Lidolinz,LINEZOLID,1407257751,2025,600 mg,Film-coated tablet,Oral use,1251.35,ACTAVIS,Malta,CALIFORNIA GREENS CORPORATION FACTORY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Mahd Alseha Medical Co
NTARIBZ,NINTEDANIB,2307257804,2025,150 mg,"Capsule, soft",Oral use,6833.45,OLIVE HEALTHCARE,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
NTARIBZ,NINTEDANIB,2307257805,2025,100 mg,"Capsule, soft",Oral use,3490.50,OLIVE HEALTHCARE,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
SITAJUB,Sitagliptin Phosphate Monohydrate,1607257762,2025,100 mg,Tablet,Oral use,90.20,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
SITAJUB,Sitagliptin Phosphate Monohydrate,1607257761,2025,50 mg,Film-coated tablet,Oral use,48.20,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
SITAJUB,Sitagliptin Phosphate Monohydrate,1607257763,2025,25 mg,Film-coated tablet,Oral use,40.65,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Ruconest,recombinant human C1 esterase inhibitor,1707257770,2025,2100 IU,Powder and solvent for solution for injection,Intravenous use,3707.25,BioConnection B.V,Netherlands,Pharming Group N.V,Netherlands,Marketed,Prescription,do not store above 25°c,Hospital,Abdulrehman Algosaibi G.T.C.
VELOMAXTO,ABIRATERONE ACETATE,2307257806,2025,500 mg,Film-coated tablet,Oral use,1041.65,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Alpha Pharma Industry
Glynta,LINAGLIPTIN,1407257753,2025,5 mg,Film-coated tablet,Oral use,68.05,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
JECTIRON,FERRIC CARBOXYMALTOSE,2207257785,2025,50 mg/ml,Solution for injection/infusion,Intravenous use,338.55,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SPIMACO
VELOMAXTO,ABIRATERONE ACETATE,2307257807,2025,250 mg,Tablet,Oral use,1041.65,Glenmark Pharmaceuticals Limited - Baddi,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Alpha Pharma Industry
Restorica - D3,CHOLECALCIFEROL,1507257760,2025,50000 IU,Film-coated tablet,Oral use,64.05,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Losapil,LACOSAMIDE,2207257793,2025,50 mg,Film-coated tablet,Oral use,50.25,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Losapil,LACOSAMIDE,2207257792,2025,100 mg,Film-coated tablet,Oral use,96.7,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Losapil,LACOSAMIDE,2207257791,2025,150 mg,Film-coated tablet,Oral use,145.1,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Altan,PRUCALOPRIDE,2107257776,2025,2 mg,Film-coated tablet,Oral use,161.75,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Alfacort,HYDROCORTISONE,2407257843,2025,1 %,Cream,Topical,16.40,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Ucedane,CARGLUMIC ACID,1507257758,2025,200 mg,Dispersible tablet,Oral use,10778.45,UNITHER DEVELOPPEMENT BORDEAUX,France,Eurocept International BV,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Ucedane,CARGLUMIC ACID,1507257759,2025,200 mg,Dispersible tablet,Oral use,2155.65,UNITHER DEVELOPPEMENT BORDEAUX,France,Eurocept International BV,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Welldorm Elixir,CHLORAL HYDRATE,1607257769,2025,100 mg/ml,Oral solution,Oral use,922.50,Laboratorium Sanitatis,Spain,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,do not store above 30°c,Hospital,ALNAGHI COMPANY
Survilor,TICAGRELOR,2307257810,2025,90 mg,Film-coated tablet,Oral use,156.40,Apex Pharma Egypt,Egypt,Apex Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Apex Pharma
chinasi,PALBOCICLIB,0106257503,2025,75 mg,Capsule,Oral use,9738,Qilu Pharmaceutical Hainan Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Chinasi,PALBOCICLIB,0106257502,2025,100 mg,Capsule,Oral use,9738,Qilu Pharmaceutical Hainan Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Chinasi,PALBOCICLIB,0106257504,2025,125 mg,Capsule,Oral use,9738,Qilu Pharmaceutical Hainan Co Ltd,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Aminoplasmal paed,Amino Acids,1007257724,2025,10 %,Solution for infusion,Intravenous use,721.05,B. BRAUN,Germany,B. BRAUN,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Medical Supplies And Services Co Ltd (Mediserv)
Cladribine Atnahs,CLADRIBINE,1507257756,2025,1 mg/ml,Concentrate for solution for infusion,Intravenous use,1388.60,Zydus Hospira Oncology Private Limited ZHOPL,India,Atnahs Pharma UK Limited,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Dapagliflozin Evapharma,DAPAGLIFLOZIN,2307257811,2025,10 mg,Film-coated tablet,Oral use,93.30,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Eva pharma for Industry
Dapagliflozin Evapharma,DAPAGLIFLOZIN,2307257812,2025,5 mg,Film-coated tablet,Oral use,93.30,EVA PHARMA,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Eva pharma for Industry
Leqembi,LECANEMAB,2107257778,2025,100 mg/ml,Concentrate for solution for infusion,Intravenous use,1156.20,Biogen MA Inc,United States,EISAI,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
Leqembi,LECANEMAB,2107257779,2025,100 mg/ml,Concentrate for solution for infusion,Intravenous use,2890.50,Biogen MA Inc,United States,EISAI,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Abdulrehman Algosaibi G.T.C.
PIRDONE,PIRFENIDONE,2307257813,2025,267 mg,Film-coated tablet,Oral use,2175.55,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Letno,MONTELUKAST SODIUM,0210258314,2025,10 mg,Film-coated tablet,Oral use,65.40,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Renulib,SUNITINIB,H0000033989,2024,12.5 mg,"Capsule, hard",Oral use,908.60,REMEDICA,Cyprus,HEXAL,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Renulib,SUNITINIB,H0000034225,2024,25 mg,"Capsule, hard",Oral use,1817.20,REMEDICA,Cyprus,HEXAL,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Renulib,SUNITINIB,H0000034229,2024,50 mg,"Capsule, hard",Oral use,3634.45,REMEDICA,Cyprus,HEXAL,Germany,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Vtreat Met,"VILDAGLIPTIN, METFORMIN HYDROCHLORIDE",2108258085,2025,"50,850 mg",Film-coated tablet,Oral use,80.35,PHARMATHEN INTERNATIONAL,Greece,Spectro Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Vtreat Met,"VILDAGLIPTIN, METFORMIN HYDROCHLORIDE",2108258086,2025,"50,1000 mg",Film-coated tablet,Oral use,84.60,PHARMATHEN INTERNATIONAL,Greece,Spectro Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Dopamine Hydrochloride in 5% Dextrose,"DOPAMINE HYDROCHLORIDE, DEXTROSE",H0000037040,2024,"800,50 g/l, µg/ml",Solution for injection/infusion,Intravenous use,343.55,BAXTER HEALTHCARE,Puerto Rico,BAXTER HEALTHCARE,United States,Marketed,Prescription,store below 25°c,Hospital,Arabian Health Care Co.
Verapamil QO,VERAPAMIL HYDROCHLORIDE,3007257897,2025,2.5 mg,Solution for injection,Intravenous use,14.20,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,do not store above 25°c,Hospital,QOMEL MEDICAL DRUG STORE
Razapena,MIRTAZAPINE,2907257887,2025,15 mg,Film-coated tablet,Oral use,39.20,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Razapena,MIRTAZAPINE,2907257888,2025,30 mg,Film-coated tablet,Oral use,78.40,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SPIMACO
Mydrane,"TROPICAMIDE, PHENYLEPHRINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE",2807257873,2025,"0.2,3.1,10 mg/ml",Solution for injection,Ophthalmic use,763.60,Delpharm tours,France,LABORATORIES THEA S.I.S,France,Marketed,Prescription,store below 25°c,Hospital,PharmaZone (Netaq Al Dawa) Pharmaceuticals
Vometron,ONDANSETRON,2807257864,2025,4 mg,Orodispersible film,Oral use,86.35,Shilpa Medicare Ltd,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
VOMETRON,ONDANSETRON,2807257862,2025,8 mg,Orodispersible film,Oral use,106.95,Shilpa Medicare Ltd,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Experta,APIXABAN,2907257889,2025,2.5 mg,Film-coated tablet,Oral use,231.00,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Experta,APIXABAN,2907257890,2025,5 mg,Film-coated tablet,Oral use,231.00,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Glycopyrrolate Amarox,GLYCOPYRROLATE,2907257891,2025,"0.2 mg, mg/ml",Oral solution,Oral use,2000,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Amarox
OMFENTRY,CARFILZOMIB,2907257886,2025,60 mg,Powder for injection,Intravenous use,3176.50,GLENMARK GENERIC SA,Argentina,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Alpha Pharma Industry
Sitavia-MET,"Sitagliptin Phosphate Monohydrate, METFORMIN HYDROCHLORIDE",2907257878,2025,"50,1000 mg",Film-coated tablet,Oral use,91.20,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Sitavia-MET,"Sitagliptin Phosphate Monohydrate, METFORMIN HYDROCHLORIDE",2907257879,2025,"50,850 mg",Film-coated tablet,Oral use,88,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Wainua,Eplontersen,1808258036,2025,45 mg,Solution for injection,Subcutaneous use,150944.45,VETTER PHARMA,Germany,AstraZeneca,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Calcium Folinate Hainan,CALCIUM FOLINATE,3107257902,2025,500 mg,powder for solution for injection,Intramuscular and intravenous use,217.50,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Calcium Folinate Hainan,CALCIUM FOLINATE,3107257903,2025,350 mg,powder for solution for injection,Intramuscular and intravenous use,140.05,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Calcium Folinate Hainan,CALCIUM FOLINATE,3107257904,2025,200 mg,powder for solution for injection,Intramuscular and intravenous use,93.35,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Calcium Folinate Hainan,CALCIUM FOLINATE,3107257905,2025,100 mg,powder for solution for injection,Intramuscular and intravenous use,77.75,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Veslo,SOLIFENACIN SUCCINATE,2907257876,2025,5 mg,Film-coated tablet,Oral use,84.70,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Veslo,SOLIFENACIN SUCCINATE,2907257877,2025,10 mg,Film-coated tablet,Oral use,108.90,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Sitavia-MET,"Sitagliptin Phosphate Monohydrate, METFORMIN HYDROCHLORIDE",2907257880,2025,"50,500 mg",Film-coated tablet,Oral use,85.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Sibnayal,Potassium citrate and potassium hydrogen carbonate,3107257898,2025,24 mEq,Prolonged-release granules,Oral use,1769.10,ELAIAPHARM,France,ADVICENNE,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Sibnayal,Potassium citrate and potassium hydrogen carbonate,3107257899,2025,8 mEq,Prolonged-release granules,Oral use,589.70,ELAIAPHARM,France,ADVICENNE,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Pyrukynd,Mitapivat,3107257900,2025,100 mg,Film-coated tablet,Oral use,107301.35,ROTTENDORF PHARMA GMBH,Germany,Agios Pharmaceuticals,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Abdulrehman Algosaibi G.T.C.
Digatra,DABIGATRAN ETEXILATE,0208257909,2025,110 mg,Capsule,Oral use,125.1,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Digatra,DABIGATRAN ETEXILATE,0208257910,2025,75 mg,Capsule,Oral use,109.95,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Digatra,DABIGATRAN ETEXILATE,0208257911,2025,150 mg,Capsule,Oral use,125.1,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Ferrous Fumarate,FERROUS FUMARATE,0508257925,2025,200 mg,Film-coated tablet,Oral use,23.15,REMEDICA,Cyprus,REMEDICA,Cyprus,Marketed,OTC,do not store above 30°c,Pharmacy,International Teriaqi for medicines ESt
famodar,FAMOTIDINE,0708257956,2025,10 mg,Film-coated tablet,Oral use,6.45,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,OTC,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Zyrtec,CETIRIZINE HYDROCHLORIDE,0708257952,2025,10 mg,Film-coated tablet,Oral use,32.40,UCB Farchim SA,Switzerland,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,OTC,do not store above 30°c,Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Zoladex LA,GOSERELIN,0408257915,2025,10.8 mg,Solution for injection,Subcutaneous use,1292.10,ASTRAZENECA UK LIMITED,United Kingdom,AstraZeneca UK Limited,United Kingdom,Marketed,Prescription,store below 25°c,Hospital,ALNAGHI COMPANY
Tyra,TADALAFIL,0708257954,2025,20 mg,Film-coated tablet,Oral use,15.80,DAR ALDAWA,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Domito,"DORZOLAMIDE, TIMOLOL MALEATE",0408257923,2025,"2,0.5 %","Eye drops, solution",Ocular use,33.80,RAFARM S.A,Greece,ADVANCED PHARMACEUTICAL FACTORY APF,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ADVANCED INTERNATIONAL PHARMACEUTICAL COMPANY
TIBSOVO,IVOSIDENIB,0508257926,2025,250 mg,Film-coated tablet,Oral use,78081.35,Patheon Inc.,Canada,LES LABORATOIRES SERVIER,France,Marketed,Prescription,do not store above 30°c,Hospital,Servier Saudi Arabia Trading LLC
Tepmetko,TEPOTINIB,0508257927,2025,225 mg,Coated tablet,Oral use,38095.40,MERCK HEALTHCARE KGAA,Germany,Merck Healthcare KGAA,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,"Merck Limited, Salehiya Trading Co."
TRASPOR,AMPHOTERICIN B,0408257914,2025,50 mg,Powder for concentrate for dispersion for infusion,Intravenous use,325.20,Emcure Pharmaceuticals Ltd.,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Alpha Pharma Industry
Cetal,PARACETAMOL,0608257941,2025,24 mg/ml,Syrup,Oral use,3.5,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Marketed,OTC,do not store above 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
Lutigest,PROGESTERONE,0708257959,2025,200 mg,"Capsule, soft","Oral use , Vaginal use",59.50,"LABORATORIOS LEON FARMA, S.A.",Spain,Exeltis Healthcare S.L,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Ocuotan,LATANOPROST,0408257924,2025,0.05 mg,"Eye drops, solution",Ophthalmic use,38.40,RAFARM S.A,Greece,Advanced Pharmaceutical Industries,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Advanced Pharmaceutical Industries
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257947,2025,1.36 %,Solution for peritoneal dialysis,Intraperitoneal,284.20,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257946,2025,1.36 %,Solution for peritoneal dialysis,Intraperitoneal,164.60,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257943,2025,2.27 %,Solution for peritoneal dialysis,Intraperitoneal,284.20,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257942,2025,2.27 %,Solution for peritoneal dialysis,Intraperitoneal,164.60,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257944,2025,3.86 %,Solution for peritoneal dialysis,Intraperitoneal,284.20,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
PHYSIONEAL 40 Glucose,"Sodium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium bicarbonate, Sodium Slactate solution, Glucose anhydrous or Glucose monohydrate",0608257945,2025,3.86 %,Solution for peritoneal dialysis,Intraperitoneal,164.60,BAXTER HEALTHCARE,Ireland,Baxter Company Limited,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,BAXTER CO LIMITED
MARZOMO,BORTEZOMIB,0508257928,2025,3.5 mg,Solution for injection,Intramuscular and intravenous use,2177.05,GLENMARK GENERIC SA,Argentina,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Alpha Pharma Industry
Tadalafil Eva,TADALAFIL,0708257961,2025,5 mg,Film-coated tablet,Oral use,136.15,Eva Pharma for Pharmaceuticals and Medical Appliances,Egypt,Eva pharma for Industry,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Eva pharma for Industry
Voltaren12 hours Emulgel,DICLOFENAC DIETHYLAMINE,2708258120,2025,2.32 %,Gel,Topical,58.50,GSK Consumer Healthcare SARL,Switzerland,Haleon Schweiz AG,Switzerland,Marketed,OTC,store below 30°c,Pharmacy,Haleon Arabia Limited
Tamosymp,TAMSULOSIN HYDROCHLORIDE,1308258020,2025,0.4 mg,"Modified-release capsule, hard",Oral use,63.05,Macleods Pharmaceuticals Limited,India,ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Adel Ahmed Alshaeir Pharmaceutical Company
Verdye,INDOCYANINE GREEN,1308258021,2025,5 mg/ml,powder for solution for injection,Intravitreal use,458.15,Patheon Italia S.P.A.,Italy,Diagnostic Green GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
Emilok,OMEPRAZOLE,1408258027,2025,40 mg,"Gastro-resistant capsule, hard",Oral use,45.1,TOWA PHARMACEUTICAL EUROPE S L,Spain,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Torrenta,TICAGRELOR,1408258029,2025,90 mg,Film-coated tablet,Oral use,167.60,APOTEX RESEARCH PRIVATE LIMITED,India,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Cetal,PARACETAMOL,1608258031,2025,120 mg,Suppository,Rectal use,2.45,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Marketed,OTC,do not store above 30°c,Pharmacy,Khalid Bin Saad Int. Company LTD
Lexipia,SELEXIPAG,1808258044,2025,200 µg,Film-coated tablet,Oral use,7649.05,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Talzenna,TALAZOPARIB,1808258045,2025,0.1 mg,"Capsule, hard",Oral use,2656.10,EXCELLA GMBH CO. KG,Germany,PFIZER INC,United States,Marketed,Prescription,do not store above 30°c,Hospital,"Abdulrehman Algosaibi G.T.C., Pfizer Saudi Trading"
Strontava,FULVESTRANT,2008258067,2025,50 mg,Solution for injection in pre-filled syringe,Intramuscular use,1256.55,Nanjing King Friend Biochemical Pharmaceutical,China,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Safdola,ANIDULAFUNGIN,2008258068,2025,100 mg,Powder for concentrate for solution for infusion,Intravenous use,483.40,MS Pharma,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Mylotarg,GEMTUZUMAB OZOGAMICIN,2008258069,2025,4.5 mg,Powder for concentrate for solution for infusion,Intravenous use,35392.50,WYETH,United States,PFIZER INC,United States,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Abdulrehman Algosaibi G.T.C., Cigalah Group, Pfizer Saudi Trading"
MONUROL,FOSFOMYCIN,2008258076,2025,3.0 g,Granules,Oral use,64.50,ZAMBON SWITZERLAND LTD,Switzerland,ZAMBON SWITZERLAND LTD,Switzerland,Marketed,Prescription,do not store above 25°c,Pharmacy,Cigalah Group
Telfast - D,"FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE",2108258082,2025,"60,120 mg",Film-coated tablet,Oral use,18.65,Opella Healthcare International,France,Sanofi Consumer Healthcare,Australia,Marketed,OTC,do not store above 30°c,Pharmacy,Sanofi Arabia Trading Co. Ltd
Disflax,Deflazacort,2508258102,2025,30 mg,Tablet,Oral use,28.50,"FAES FARMA, S.A.",Spain,"FAES FARMA, S.A.",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Bio standards Co
Disflax,Deflazacort,2608258106,2025,6 mg,Tablet,Oral use,11.4,"FAES FARMA, S.A.",Spain,"FAES FARMA, S.A.",Spain,Marketed,Prescription,store below 30°c,Pharmacy,Bio standards Co
Alzil,DONEPEZIL HYDROCHLORIDE,2608258108,2025,5 mg,Orodispersible tablet,Oral use,107,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Medical and Pharmaceutical Services Company
Alzil,DONEPEZIL HYDROCHLORIDE,2608258109,2025,10 mg,Orodispersible tablet,Oral use,197.45,Al-Taqaddom pharmaceutical Industries,Jordan,Al-Taqaddom pharmaceutical Industries,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Medical and Pharmaceutical Services Company
OLIMEL N12E,"Glucose with calcium solution, Amino acid with electrolytes solution and Lipid emulsion, Glucose with calcium solution, Amino acid with electrolytes solution, Lipid emulsion",2608258117,2025,"27.5,14.2,17.5,100 g, ml",Emulsion for infusion,Intravenous use,683.65,BAXTER,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Arabian Health Care Co.
OLIMEL N12E,"Glucose with calcium solution, Amino acid with electrolytes solution and Lipid emulsion, Glucose with calcium solution, Amino acid with electrolytes solution, Lipid emulsion",2608258115,2025,"27.5,14.2,17.5,100 g, ml",Emulsion for infusion,Intravenous use,631.15,BAXTER,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Arabian Health Care Co.
OLIMEL N12E,"Glucose with calcium solution, Amino acid with electrolytes solution and Lipid emulsion, Glucose with calcium solution, Amino acid with electrolytes solution, Lipid emulsion",2608258116,2025,"27.5,14.2,17.5,100 g, ml",Emulsion for infusion,Intravenous use,631.15,BAXTER,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Arabian Health Care Co.
OLIMEL N12E,"Glucose with calcium solution, Amino acid with electrolytes solution and Lipid emulsion, Glucose with calcium solution, Amino acid with electrolytes solution, Lipid emulsion",2608258114,2025,"27.5,14.2,17.5,100 g, ml",Emulsion for infusion,Intravenous use,841.5,BAXTER,Belgium,BAXTER S.A,Belgium,Marketed,Prescription,"Do not store above 30°C, do not freeze",Hospital,Arabian Health Care Co.
PREVYMIS,LETERMOVIR,2808258126,2025,480 mg,Film-coated tablet,Oral use,40656,MSD INTERNATIONAL GMBH,Ireland,MERCK SHARP & DOHME,Netherlands,Marketed,Prescription,do not store above 30°c,Pharmacy,ALNAGHI COMPANY
Vatowis,VASOPRESSIN,2808258125,2025,20 U/ml,Injection,Intravenous use,2421.20,Eugia Pharma Specialties Limited,India,Eugia Pharma Specialities Limited,India,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
OZANEX,Ozenoxacin,0409258160,2025,1 %,Cream,Cutaneous use,62.70,FERRER INTERNATIONAL - S.A,Spain,FERRER INTERNATIONAL - S.A,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI ARABIAN DRUG STORE COMPANY
Emedius,PALONOSETRON HYDROCHLORIDE,0309258149,2025,0.05 mg/ml,Solution for injection,Intravenous use,695.00,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,"Store below 30°C , protect from Light",Hospital,JAMJOOM PHARMACEUTICALS CO. LTD.
Zyglic MR,GLICLAZIDE,0809258184,2025,60 mg,modified-release tablet,Oral use,20.40,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,do not store above 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Zyglic MR,GLICLAZIDE,0809258183,2025,30 mg,modified-release tablet,Oral use,20.4,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,do not store above 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Quillivant XR,METHYLPHENIDATE,0809258186,2025,5 mg/ml,Powder for oral suspension,Oral use,1256.00,"Tris Pharma, Inc",United States,Saudi Pharmaceutical Industries & Medical Appliances Corporation,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Sita Plus,"Sitagliptin Phosphate Monohydrate, METFORMIN HYDROCHLORIDE",2708258122,2025,"50,1000 mg",Film-coated tablet,Oral use,91.20,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Sita Plus,"Sitagliptin Phosphate Monohydrate, METFORMIN HYDROCHLORIDE",2708258121,2025,"50,850 mg",Film-coated tablet,Oral use,88.00,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Alrai Pharmaceutical industry Co. (L.L.C),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
sitaglumet,"SITAGLIPTIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE",2408258100,2025,"50,850 mg",Film-coated tablet,Oral use,94.30,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
sitaglumet,"SITAGLIPTIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE",2408258099,2025,"50,1000 mg",Film-coated tablet,Oral use,97.70,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Ibuprofen Kabi,IBUPROFEN,2108258079,2025,4 mg/ml,Solution for infusion,Intravenous use,187,Fresenius Kabi Polska,Poland,Fresenius Kabi Polska,Poland,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Trompolate,ELTROMBOPAG OLAMINE,0109258132,2025,50 mg,Film-coated tablet,Oral use,4586.85,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Trompolate,ELTROMBOPAG OLAMINE,0109258133,2025,25 mg,Film-coated tablet,Oral use,2293.40,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Retrosin Ointment,NITROGLYCERIN,0109258131,2025,0.4 %,Rectal ointment,Topical,91.40,PHILADELPHIA PHARMACEUTICALS,Jordan,PHILADELPHIA PHARMACEUTICALS,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Livmarli,MARALIXIBAT,0309258154,2025,9.5 mg/ml,Oral solution,Oral use,125703.25,Halo Pharmaceutical Canada,Canada,Mirum Pharmaceuticals,United States,Marketed,Prescription,do not store above 30°c,Hospital,Abdulrehman Algosaibi G.T.C.
Jentarole,LINAGLIPTIN,0409258164,2025,5 mg,Film-coated tablet,Oral use,68.05,DR. REDDY,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Roqalb,ROSUVASTATIN,0709258180,2025,10 mg,Film-coated tablet,Oral use,44.05,Adcan Pharma,United Arab Emirates,Adcan Pharma,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"PharmaZone (Netaq Al Dawa) Pharmaceuticals, UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD."
Roqalb,ROSUVASTATIN,0709258181,2025,5 mg,Film-coated tablet,Oral use,22.00,Adcan Pharma,United Arab Emirates,Adcan Pharma,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"PharmaZone (Netaq Al Dawa) Pharmaceuticals, UNITED CORPORATION FOR PHARMACEUTICAL & MEDICAL SERVICES LTD."
Dexdor,DEXMEDETOMIDINE,0809258185,2025,100 µg/ml,Concentrate for solution for infusion,Intravenous use,1922.40,"Orion Corporation, Orion Pharma",Finland,Exeltis Healthcare S.L,Spain,Marketed,Prescription,do not store above 30°c,Hospital,Arabian Trade House
Bedamuse,BENDAMUSTINE HYDROCHLORIDE,0909258192,2025,25 mg,Powder for concentrate for solution for infusion,Intravenous use,1039.40,Oncomed manufacturing a.s.,Czech Republic,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Bedamuse,BENDAMUSTINE HYDROCHLORIDE,0909258193,2025,100 mg,Powder for concentrate for solution for infusion,Intravenous use,4157.6,Oncomed manufacturing a.s.,Czech Republic,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Alatript,AMITRIPTYLINE HYDROCHLORIDE,1009258207,2025,10 mg,Film-coated tablet,Oral use,17.90,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,OTC,store below 30°c,Pharmacy,Saudi Amarox
Airsupra,"BUDESONIDE, SALBUTAMOL",1109258209,2025,"80,90 µg","Pressurised inhalation, suspension",Inhalation use,103.10,AstraZeneca Dunkerque Production (AZDP),France,AstraZeneca Pharmaceuticals LP,United States,Marketed,Prescription,store below 30°c,Pharmacy,ALNAGHI COMPANY
Maysiglu,Sitagliptin,1609258225,2025,100 mg,Film-coated tablet,Oral use,81.95,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,PharmaZone (Netaq Al Dawa) Pharmaceuticals
Sirolimus BOS,SIROLIMUS,1709258233,2025,1 mg,Film-coated tablet,Oral use,1157.10,Zydus Lifesciences Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Boston Oncology Arabia
Sirolimus BOS,SIROLIMUS,1709258234,2025,2 mg,Film-coated tablet,Oral use,2314.20,Zydus Lifesciences Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Boston Oncology Arabia
Isosorbide Dinitrate Qomel,Diluted Isosorbide Dinitrate,1409258215,2025,40 mg,Tablet,Oral use,118.75,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Isosorbide Dinitrate Qomel,Diluted Isosorbide Dinitrate,1409258214,2025,30 mg,Tablet,Oral use,89.05,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Isosorbide Dinitrate Qomel,Diluted Isosorbide Dinitrate,1409258213,2025,20 mg,Tablet,Oral use,82.00,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Lijen Met,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",1509258219,2025,"2.5,850 mg",Film-coated tablet,Oral use,137,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Lijen Met,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",1509258220,2025,"2.5,1000 mg",Film-coated tablet,Oral use,145.45,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Sarolm,OLMESARTAN MEDOXOMIL,0210258318,2025,40 mg,Film-coated tablet,Oral use,51.50,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Sarolm,OLMESARTAN MEDOXOMIL,0210258316,2025,20 mg,Film-coated tablet,Oral use,38.70,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Sarolm,OLMESARTAN MEDOXOMIL,0210258319,2025,10 mg,Film-coated tablet,Oral use,19.35,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Eliflox,MOXIFLOXACIN HYDROCHLORIDE,0210258312,2025,400 mg,Film-coated tablet,Oral use,41.85,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
Eliflox,MOXIFLOXACIN HYDROCHLORIDE,0210258313,2025,400 mg,Film-coated tablet,Oral use,58.60,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,Elixir Pharmaceutical Company LLC,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Elixir Pharmaceutical Company LLC
ProQuad,"MEASLES, mumps, rubella, varicella",H0000037799,2024,"3,4.3,3,3.99 log10 TCID",Powder and solvent for suspension for injection,Intramuscular use,254.50,MERCK SHARP & DOHME,United Kingdom,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,"Farouk, Maamoun Tamer & CO"
FluMist,"Influenza vaccine (intranasal, live attenuated) (LAIV trivalent): Influenza Virus Type A H1N1, Influenza Virus Type A H3N2, Influenza Virus Type B (Victoria lineage)",2809258272,2025,10-7-+0.5 FFU,Nasal spray,Intranasal use,109.10,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca Pharmaceuticals LP,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
FluMist,"Influenza vaccine (intranasal, live attenuated) (LAIV trivalent): Influenza Virus Type A H1N1, Influenza Virus Type A H3N2, Influenza Virus Type B (Victoria lineage)",2809258271,2025,10 - 7-+0.5 FFU,Nasal spray,Intranasal use,1043.60,AstraZeneca Pharmaceuticals LP,United States,AstraZeneca Pharmaceuticals LP,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Golifa,FINGOLIMOD HYDROCHLORIDE,0909258194,2025,0.5 mg,"Capsule, hard",Oral use,3010.30,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Glyvanza,GLICLAZIDE,1409258211,2025,60 mg,modified-release tablet,Oral use,21.60,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Glyvanza,GLICLAZIDE,1409258212,2025,30 mg,modified-release tablet,Oral use,21.60,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Morphine sulfate Kalceks,MORPHINE SULFATE,1409258210,2025,10 mg/ml,Solution for injection,Intramuscular and intravenous use,51.00,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 25°c,Hospital,AL JEDAANI STORE
Serna,"VARENICLINE, Varenicline tartrate",2509258267,2025,"1,0.5 mg",Film-coated tablet,Oral use,106.70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Serna,Varenicline tartrate,2509258269,2025,1 mg,Film-coated tablet,Oral use,179.65,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
Serna,Varenicline tartrate,2509258268,2025,1 mg,Film-coated tablet,Oral use,106.70,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
HYMPAVZI,Marstacimab,2509258264,2025,150 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,29782.40,Pfizer Manufacturing Belgium N.V.,Belgium,PFIZER INC,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,"ALNAGHI COMPANY, Pfizer Saudi Trading"
Monozide,HYDROCHLOROTHIAZIDE,2809258273,2025,12.5 mg,Tablet,Oral use,256,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Naplax,DEXMEDETOMIDINE,3009258286,2025,4 µg/ml,Solution for infusion,Intravenous use,854.50,S.M. Farmaceutici SRL,Italy,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,"Med city, ZIMMO TRADING ESTABLISHMENT"
Voranigo,Vorasidenib,2608258111,2025,10 mg,Film-coated tablet,Oral use,57172.50,ROTTENDORF PHARMA GMBH,Germany,LES LABORATOIRES SERVIER,France,Marketed,Prescription,do not store above 30°c,Hospital,Servier Saudi Arabia Trading LLC
Voranigo,Vorasidenib,2608258110,2025,40 mg,Film-coated tablet,Oral use,114345,ROTTENDORF PHARMA GMBH,Germany,LES LABORATOIRES SERVIER,France,Marketed,Prescription,do not store above 30°c,Hospital,Servier Saudi Arabia Trading LLC
Zyutra,potassium citrate,0110258294,2025,"5 mg, mEq",Tablet,Oral use,51.70,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Zyutra,potassium citrate,0110258293,,10 mEq,Extended-release tablet,Oral use,103.45,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Priorix,"MEASLES, mumps, rubella",2409258263,2025,"103.0,103.7,103.0 CCID50",Powder and solvent for solution for injection,"intramuscular, subcutaneous",4550.70,GlaxoSmithKline Biologicals,Belgium,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,GLAXO SAUDI ARABIA
ULTRAVIST,IOPROMIDE,1310258412,2025,370 mg,Injection,Intravenous use,555.85,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Bayer Saudi Arabia
ULTRAVIST,IOPROMIDE,1310258413,2025,300 mg,Injection,Intravenous use,2132.10,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
Fibrogammin,Faxtor,H0000030326,2024,250 IU/ml,Powder and solvent for solution for injection/infusion,Intravenous use,857.60,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Fibrogammin,Faxtor,H0000030411,2024,1250 IU,Powder and solvent for solution for injection/infusion,Intravenous use,4288,CSL BEHRING,Germany,CSL,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Tyenne,TOCILIZUMAB,H0000037870,2024,162 mg,Solution for injection,Subcutaneous use,1003.70,Fresenius Kabi Austria GmbH,Austria,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
OMVOH,Mirikizumab,H0000041819,2024,100 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,4805.80,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OMVOH,Mirikizumab,H0000041821,2025,100 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,4368.90,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OMVOH,Mirikizumab,H0000041823,2025,20 mg/ml,Solution for infusion,Intravenous use,4805.80,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Zydolev,"CARBIDOPA, LEVODOPA",0610258328,2025,"25,250 mg",Tablet,Oral use,41.90,Zydus Lifesciences Limited,India,Zydus Lifesciences Limited,India,Marketed,Prescription,do not store above 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
ANESIA,PROPOFOL,3009258282,2025,10.00 mg/ml,Emulsion for injection,Intravenous use,58.60,Baxter Pharmaceuticals India Private Limited,India,Baxter,India,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
ANESIA,PROPOFOL,3009258281,2025,10.00 mg/ml,Emulsion for injection,Intravenous use,117.15,Baxter Pharmaceuticals India Private Limited,India,Baxter,India,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Bergo,CABERGOLINE,0110258300,2025,0.5 mg,Tablet,Oral use,87.60,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,almoghera commericial company
Bergo,CABERGOLINE,0610258333,2025,0.5 mg,Tablet,Oral use,32.15,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,JORDAN RIVER PHARMACEUTICAL INDUSTRIES,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,almoghera commericial company
Zejula,NIRAPARIB,0810258353,2025,100 mg,Film-coated tablet,Oral use,15657.10,CATALENT,United States,GLAXO SAUDI ARABIA,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Kirsty,INSULIN ASPART,1210258398,2025,100 IU/ml,Solution for injection,Subcutaneous use,141.75,Biocon SDN BHD,Malaysia,Biocon SDN BHD,Malaysia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Mohamed Youssef Mohamed Salah Jamjoom Medical Company
Novactam,"AMPICILLIN, SULBACTAM",1310258410,2025,"1000,500 mg",Powder and solvent for solution for injection,Intramuscular and intravenous use,12.75,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Demsone,DEXAMETHASONE SODIUM PHOSPHATE,2110258448,2025,0.4 mg/ml,Oral solution,Oral use,78.50,Rosemont Pharmaceuticals Ltd,United Kingdom,Rosemont Pharmaceuticals Ltd,United Kingdom,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,YAHMAA MEDICAL COMPANY
Melphalan Hydrochloride TBM,MELPHALAN,2310258476,2025,50 mg,powder for solution for injection,Intravenous use,291.55,Gland Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Dandaxa,TADALAFIL,2210258458,2025,5 mg,Coated tablet,Oral use,120,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Gulf Pharmaceutical Industries (Julphar),United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Apisal,SODIUM CHLORIDE,2110258451,2025,5 %,Eye ointment,Ophthalmic use,29.75,Amman Pharmaceutical Industries (API),Jordan,Amman Pharmaceutical Industries (API),Jordan,Marketed,OTC,store below 30°c,Pharmacy,Salehiya Trading Co.
Farshias,TAMOXIFEN,2110258443,2025,10 mg,Film-coated tablet,Oral use,22.20,Eugia Pharma Specialties Limited,India,Eugia Pharma Specialities Limited,India,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Evoka,DAPOXETINE,2310258478,2025,60 mg,Film-coated tablet,Oral use,98.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Evoka,DAPOXETINE,2310258479,2025,30 mg,Film-coated tablet,Oral use,98.00,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Tymer,GATIFLOXACIN,0710258344,2025,0.5 %,"Eye drops, solution",Ophthalmic use,47.25,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Amlodipine Qo,AMLODIPINE BESILATE,2710258489,2025,1 mg/ml,Oral solution,Oral use,529.60,LM Manufacturing Limited,United Kingdom,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Spikevax JN1 50 micrograms dispersion for injection in pre filled syringe,"mRNA1273 167 LNP B, CX 045346",0210258303,2025,"2,0.1 mg/ml",Concentrate for dispersion for injection,Intramuscular use,383.80,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Hospital,Tabuk Pharmaceutical Manufacturing Company
Falofil,TADALAFIL,0210258307,2025,5 mg,Tablet,Oral use,17.15,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Ozawade,PITOLISANT,0210258308,2025,4.5 mg,Film-coated tablet,Oral use,993.35,PATHEON,France,Acino AG,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,Acino Arabia for trading LLC
POSAGIL,POSACONAZOLE,0210258321,2025,100 mg,Gastro-resistant tablet,Oral use,1588.10,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
POSAGIL,POSACONAZOLE,0210258320,2025,100 mg,Gastro-resistant tablet,Oral use,6352.50,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Empamac,EMPAGLIFLOZIN,0210258309,2025,25 mg,Film-coated tablet,Oral use,128.40,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Empamac,EMPAGLIFLOZIN,0210258306,2025,10 mg,Film-coated tablet,Oral use,128.40,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
MACITRIN,MACITENTAN,0710258334,2025,10 mg,Film-coated tablet,Oral use,5017.95,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Vyvgart,EFGARTIGIMOD ALFA,0909258200,2025,20 mg/ml,Concentrate for solution for infusion,Intravenous use,33804.35,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,Argenx BV,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Isturisa,OSILODROSTAT,1610258432,2025,5 mg,Film-coated tablet,Oral use,28499.35,Penn Pharmaceutical Services Ltd,United Kingdom,Recordati Rare Diseases,France,Marketed,Prescription,store below 30°c,Pharmacy,Al Osool Medical Trading Company
Xodema,DENOSUMAB,1910258433,2025,70 mg/ml,Solution for injection,Subcutaneous use,1217.25,UNIVERSAL FARMA SL,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Altuvoct,EFANESOCTOCOG ALFA,2010258439,2025,250 IU,Powder and solvent for solution for injection,Intravenous use,1225.10,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Altuvoct,EFANESOCTOCOG ALFA,2010258435,2025,500 IU,Powder and solvent for solution for injection,Intravenous use,2450.25,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Altuvoct,EFANESOCTOCOG ALFA,2010258437,2025,1000 IU,Powder and solvent for solution for injection,Intravenous use,4900.50,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Altuvoct,EFANESOCTOCOG ALFA,2010258434,2025,2000 IU,Powder and solvent for solution for injection,Intravenous use,9801,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Altuvoct,EFANESOCTOCOG ALFA,2010258438,2025,3000 IU,Powder and solvent for solution for injection,Intravenous use,14701.50,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Altuvoct,EFANESOCTOCOG ALFA,2010258436,2025,4000 IU,Powder and solvent for solution for injection,Intravenous use,19602,Biogen MA Inc,United States,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Arabian Trade House
Forsdapa,DAPAGLIFLOZIN,2110258447,2025,5 mg,Film-coated tablet,Oral use,135.95,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Recitan,MACITENTAN,2110258449,2025,10 mg,Film-coated tablet,Oral use,5376.40,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Eptifibatide Hainan,EPTIFIBATIDE,2210258457,2025,"0.75 mg/ml, µg/",Solution for injection,Intravenous use,1522.35,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ARABIAN OASIS
Dermacom,"NYSTATIN, NEOMYCIN SULFATE, GRAMICIDIN, TRIAMCINOLONE ACETONIDE",2210258462,2025,"100000,2.5,0.25,1 mg, IU",Cream,Topical,22.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Dermacom,"NYSTATIN, NEOMYCIN SULFATE, GRAMICIDIN, TRIAMCINOLONE ACETONIDE",2210258461,2025,"100000,2.5,0.25,1 mg, IU",Ointment,Topical,22.10,SPIMACO,Saudi Arabia,SPIMACO ADDWAEIH,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SPIMACO
Lustalin,SERTRALINE,2710258487,2025,100 mg,Film-coated tablet,Oral use,180.55,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Lustalin,SERTRALINE,2710258488,2025,50 mg,Film-coated tablet,Oral use,95.70,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Lustalin,SERTRALINE,2710258486,2025,25 mg,Film-coated tablet,Oral use,47.85,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Properal,PROPRANOLOL,2710258485,2025,80 mg,Tablet,Oral use,43.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Properal,PROPRANOLOL,2710258484,2025,60 mg,Tablet,Oral use,43.20,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Properal,PROPRANOLOL,2710258482,2025,10 mg,Tablet,Oral use,21.60,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Cigapix,Varenicline tartrate,2710258483,20252,1 mg,Film-coated tablet,Oral use,179.65,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Cigapix,Varenicline tartrate,2710258481,2025,0.5 mg,Film-coated tablet,Oral use,110.80,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Demax,MEMANTINE HYDROCHLORIDE,2608258118,2025,10 mg,Film-coated tablet,Oral use,179.60,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Tacomus,TACROLIMUS,2810258498,2025,5 mg,"Capsule, hard",Oral use,1452.1,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Tacomus,TACROLIMUS,2810258499,2025,1 mg,"Capsule, hard",Oral use,318.30,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Tacomus,TACROLIMUS,2810258500,2025,0.5 mg,"Capsule, hard",Oral use,159.15,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Solifenacin succinate ALH,SOLIFENACIN SUCCINATE,2810258502,2025,10 mg,Film-coated tablet,Oral use,108.90,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Solifenacin Succinate ALH,SOLIFENACIN SUCCINATE,2810258501,2025,5 mg,Film-coated tablet,Oral use,84.70,MSN LABORATORIES PRIVATE LIMITED,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Spectrila,r L asparaginase,2810258497,2025,10000 IU,Powder for concentrate for solution for infusion,Intravenous use,2076.20,Lyocontract GmbH,Germany,MEDAC,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ZIMMO TRADING ESTABLISHMENT
Doxydar,DOXYCYCLINE,2810258503,2025,100 mg,Capsule,Oral use,24.20,Dar AlDawa Veterinary and Agricultural Industrial Co. Ltd,Jordan,DAR ALDAWA,Jordan,Marketed,Prescription,do not store above 30°c,Pharmacy,Salehiya Trading Co.
Fabhalta,IPTACOPAN,2910258515,2025,200 mg,"Capsule, hard",Oral use,134144.80,NOVARTIS,Germany,Novartis Europharm Limited,Ireland,Marketed,Prescription,store below 30°c,Hospital,Novartis Saudi Limited
Zynlonta,LONCASTUXIMAB TESIRINE,3009258283,2025,10 mg,Powder for concentrate for solution for infusion,Intravenous use,75843.30,BSP PHARMACEUTICALS S.r.l.,Italy,SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB,Sweden,Marketed,Prescription,"Store in a refrigerator (2°C – 8°C), do not freeze",Hospital,Arabian Trade House
Azacitidine Kabi,AZACITIDINE,3010258516,2025,100 mg,Powder for injection,"Intravenous, Subcutaneous",794.05,Fresenius Kabi Oncology Ltd,India,Fresenius Kabi Oncology Limited,India,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Calcium Folinate Hainan,CALCIUM FOLINATE,0210258311,2025,50 mg,powder for solution for injection,Intramuscular and intravenous use,50.85,"Hainan Poly Pharm. Co., Ltd.",China,"Hainan Poly Pharm. Co., Ltd.",China,Marketed,Prescription,do not store above 30°c,Hospital,ARABIAN OASIS
Remolexam,MELOXICAM,3009258284,2025,10 mg/ml,Solution for injection,Intramuscular use,35.10,JSC Farmak,Ukraine,JSC FARMAK,Ukraine,Marketed,Prescription,store below 30°c,Hospital,Abdullatif Mohammed Salah Jamjoom & Bros Co
Isturisa,OSILODROSTAT,1610258431,2025,1 mg,Film-coated tablet,Oral use,7124.85,Penn Pharmaceutical Services Ltd,United Kingdom,Recordati Rare Diseases,France,Marketed,Prescription,store below 30°c,Pharmacy,Al Osool Medical Trading Company
Betaserc XL,BETAHISTINE DIHYDROCHLORIDE,0211258529,2025,48 mg,Film-coated tablet,Oral use,101.70,Abbott Laboratories de Mexico S.A. de C.V,Mexico,Abbott Laboratories de Mexico S.A. de C.V,Mexico,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Budrelfa,BUDESONIDE,1310258402,2025,3 mg,"Gastro-resistant capsule, hard",Oral use,363.35,LOSAN PHARMA GMBH,Germany,Dr Falk Pharma,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
K-cit,potassium citrate,0411258544,2025,5 mEq,Prolonged-release tablet,Oral use,147.35,Ascent Pharmaceuticals,United States,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Amarox
K-cit,potassium citrate,0411258543,2025,10 mEq,Prolonged-release tablet,Oral use,294.70,Ascent Pharmaceuticals,United States,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 25°c,Pharmacy,Saudi Amarox
mRESVIA,mRNA-1345 RNA,0511258545,2025,50 µg,Concentrate for dispersion for injection,Intramuscular use,867.75,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Hospital,Tabuk Pharmaceutical Manufacturing Company
mRESVIA,mRNA-1345 RNA,0511258546,2025,50 µg,Concentrate for dispersion for injection,Intramuscular use,8677.50,Rovi Pharma Industrial Service,Spain,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Hospital,Tabuk Pharmaceutical Manufacturing Company
Harfib,RIVAROXABAN,0611258552,2025,10 mg,Tablet,Oral use,179.70,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Harfib,RIVAROXABAN,0611258553,2025,15 mg,Tablet,Oral use,179.70,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Harfib,RIVAROXABAN,0611258551,2025,20 mg,Tablet,Oral use,179.70,Aizant Drug Research Solutions Pvt.Ltd,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
XELJANZ 10MG FILM COATED TABLETS,TOFACITINIB,H0000000280,2021,10 mg,Film-coated tablet,Oral use,7186.90,Pfizer Manufacturing Deutschland GmbH,Germany,PFIZER INC,United States,Marketed,Prescription,do not store above 30°c,Hospital,Pfizer Saudi Trading
Fluorodeoxyglucose (18F) I-ONE,Fludeoxyglucose,H0000001729,2021,250 MBq/ml,Solution for injection,Intravenous use,500,Molecular Imaging Center,Saudi Arabia,ITEL Telecomunicazioni,Italy,Marketed,Prescription,store below 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
Ledaga 160 micrograms/g gel,Chlormethine,1211258584,2025,160 µg/g,Gel,Topical,6183.15,University of Iowa Pharmaceuticals,United States,Recordati Rare Diseases,France,Marketed,Prescription,Store between ( -15 c° to - 25 c° ),Pharmacy,ZIMMO TRADING ESTABLISHMENT
OLPUNTRA MET,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",H0000042635,2025,"2.5,1000 mg",Film-coated tablet,Oral use,78.05,Dragenopharm Apotheker Puschl GmbH,Germany,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
OLPUNTRA MET,"LINAGLIPTIN, METFORMIN HYDROCHLORIDE",H0000042637,2025,"2.5,850 mg",Film-coated tablet,Oral use,78.05,Dragenopharm Apotheker Puschl GmbH,Germany,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Winrevair,SOTATERCEPT,2108258090,2025,60 mg,Powder and solvent for solution for injection,Subcutaneous use,90750,Patheon Italia S.P.A.,Italy,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Winrevair,SOTATERCEPT,2108258089,2025,60 mg,Powder and solvent for solution for injection,Subcutaneous use,45375,Patheon Italia S.P.A.,Italy,Merck Sharp & Dohme B.V,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,ALNAGHI COMPANY
Stelara,USTEKINUMAB,1709258232,2025,90 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,8882.65,"Baxter Pharmaceutical Solutions, LLC",United States,Janssen Cilag,Belgium,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Cigalah Group
FOVLYA,AFLIBERCEPT,2809258270,2025,40 mg/ml,Solution for injection,Intravitreal use,2271.45,AJINOMOTO ALTHEA INCORPORATED,United States,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Isturisa,OSILODROSTAT,1610258430,2025,10 mg,Film-coated tablet,Oral use,30307.15,Penn Pharmaceutical Services Ltd,United Kingdom,Recordati Rare Diseases,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Al Osool Medical Trading Company
Midazolam Kalceks,MIDAZOLAM,2110258440,2025,1 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,26.20,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 30°c,Hospital,AL JEDAANI STORE
Midazolam Kalceks,MIDAZOLAM,2110258441,2025,5 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,26.20,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 30°c,Hospital,AL JEDAANI STORE
Midazolam Kalceks,MIDAZOLAM,2110258442,2025,5 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,78.60,HBM Pharma s.r.o.,Slovakia,AS Kalceks,Latvia,Marketed,Prescription,store below 30°c,Hospital,AL JEDAANI STORE
Loftaz,CEFTAZIDIME,2210258454,2025,1 g,Powder for solution for injection/infusion,Intramuscular and intravenous use,38.95,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Dexmedetomidine PSI,DEXMEDETOMIDINE,2310258470,2025,4 µ/ml,Solution for infusion,Intravenous use,142.40,PHARMACEUTICAL SOLUTIONS INDUSTRY,Saudi Arabia,Pharmaceutical Solutions Industry Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharmaceutical Solution Industries (PSI)
Qalsody,TOFERSEN,2310258475,2025,6.7 mg/ml,Solution for injection,Intrathecal use,98211.15,Biogen MA Inc,United States,Biogen Idec B.V-Natherland,Netherlands,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Biogen Arabia
Densibon,DENOSUMAB,0211258528,2025,60 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,730.50,UNIVERSAL FARMA SL,Spain,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Kamagra,SILDENAFIL,0611258549,2025,50 mg,Tablet,Oral use,39.35,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Kamagra,SILDENAFIL,0611258550,2025,100 mg,Tablet,Oral use,39.35,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Kamagra,SILDENAFIL,0611258548,2025,25 mg,Tablet,Oral use,36.30,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharma Pharmaceutical Industries (PPI)
Dapsone Tillomed,DAPSONE,0911258555,2025,50 mg,Tablet,Oral use,212.70,Emcure Pharmaceuticals Ltd.,India,Tillomed Laboratories Limited,United Kingdom,Marketed,Prescription,store below 25°c,Pharmacy,Arabian Health Care Co.
Eleptan,ELETRIPTAN,1111258574,2025,40 mg,Film-coated tablet,Oral use,67.85,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Eleptan,ELETRIPTAN,1111258575,2025,40 mg,Film-coated tablet,Oral use,38.50,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Hydroxychloroquine Sulfate,HYDROXYCHLOROQUINE SULFATE,1111258565,2025,200 mg,Tablet,Oral use,109.10,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Deferajub,DEFERASIROX,1111258569,2025,360 mg,Film-coated tablet,Oral use,1586.55,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Deferajub,DEFERASIROX,1111258567,2025,180 mg,Film-coated tablet,Oral use,798.65,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Deferajub,DEFERASIROX,1111258568,2025,90 mg,Film-coated tablet,Oral use,401.90,Jubilant Generics Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
AMBRISENTAN GENEPHARM,AMBRISENTAN,1111258564,2025,5 mg,Film-coated tablet,Oral use,3053.80,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
AMBRISENTAN GENEPHARM,AMBRISENTAN,1111258566,2025,10 mg,Film-coated tablet,Oral use,3053.80,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Hydroxyurea medac,HYDROXYCARBAMIDE,1211258582,2025,500 mg,"Capsule, hard",Oral use,154.00,HAUPT PHARMA AMAREG GmbH,Germany,medac Gesellschaft für klinische Spezialpräparate mbH,Germany,Marketed,Prescription,do not store above 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Sugammadex ALH,SUGAMMADEX,1311258589,2025,100 mg/ml,Solution for injection,Intravenous use,1414.20,Mankind Pharma Limited,India,Alhobail Pharm,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
Cytotect CP Biotest,Human cytomegalovirus immunoglobulin (CMVIG),1311258590,2025,100 U/ml,Solution for infusion,Intravenous use,1001.75,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Cytotect CP Biotest,Human cytomegalovirus immunoglobulin (CMVIG),1311258591,2025,100 U/ml,Solution for infusion,Intravenous use,4742.10,BIOTEST,Germany,BIOTEST,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
sugmadon,SUGAMMADEX,1611258596,2025,100 mg/ml,Injection,Intravenous use,147.60,Natco Pharma Limited,India,Pharma Pharmaceutical Industries (PPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Ruatine,ISOTRETINOIN,1611258598,2025,40 mg,"Capsule, soft",Oral use,110.90,UNITED PHARMACEUTICAL COMPANY,Jordan,United Pharmaceuticals Mfg,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Miglustat Gen Orph,MIGLUSTAT,2311258631,2025,100 mg,"Capsule, hard",Oral use,27630.75,DELPHARM REIMS S.A.S,France,Gen.Orph,France,Marketed,Prescription,store below 25°c,Hospital,QOMEL MEDICAL DRUG STORE
Olvia,DEFERIPRONE,2511258646,2025,500 mg,Film-coated tablet,Oral use,368.45,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
FAWAR FRUIT EFFERVESCENT SALT SACHETS 5G,"CITRIC ACID ANHYDROUS, TARTARIC ACID, SODIUM BICARBONATE",1811258616,2025,"0.82,1.33,2.8 g",Effervescent granules,Oral use,19.35,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICALS,Egypt,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
FAWAR FRUIT EFFERVESCENT SALT SACHETS 5G,"TARTARIC ACID, CITRIC ACID ANHYDROUS, SODIUM BICARBONATE",1811258615,2025,"1.33,0.82,2.8 g",Effervescent granules,Oral use,12.90,PHARCO PHARMACEUTICAL,Egypt,PHARCO PHARMACEUTICALS,Egypt,Marketed,OTC,store below 30°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Neurovit,"PYRIDOXINE, THIAMINE, CYANOCOBALAMIN",1811258618,2025,"100,250,250 mg, µg",Tablet,Oral use,15.00,Euoropean Egyptian Pharmaceutical Inustries,Egypt,AMRIYA FOR PHARMACEUTICAL INDUSTRIES,Egypt,Marketed,Prescription,store below 25°c,Pharmacy,ZIMMO TRADING ESTABLISHMENT
Entuval,"SACUBITRIL, VALSARTAN",1711258600,2025,"97,200 mg",Film-coated tablet,Oral use,321.30,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Entuval,"SACUBITRIL, VALSARTAN",1711258601,2025,"49,100 mg",Film-coated tablet,Oral use,160.65,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Entuval,"SACUBITRIL, VALSARTAN",1711258602,2025,"24,50 mg",Film-coated tablet,Oral use,160.65,Biocon Limited,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Omacillin,AMOXICILLIN,1811258614,2025,500 mg,Capsule,Oral use,223.85,NATIONAL PHARMACEUTICAL INDUSTRIES CO,Oman,National Pharmaceutical Industries Co. (SAOG),Oman,Marketed,Prescription,store below 30°c,Hospital,EBRAHIM M. ALMANA & BROS. CO.
Gloxib,CELECOXIB,2011258630,2025,200 mg,Capsule,Oral use,37.50,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Gloxib,CELECOXIB,2011258629,2025,200 mg,Capsule,Oral use,25.00,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
OMVOH,Mirikizumab,2011258627,2025,100 mg/ml,Solution for injection in pre-filled syringe,Subcutaneous use,4805.80,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OMVOH,Mirikizumab,2011258628,2025,100 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,4805.80,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
OMVOH,Mirikizumab,2011258626,2025,20 mg/ml,Solution for infusion,Intravenous use,4805.80,Eli Lilly and Company,United States,Eli Lilly and Company,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Leavpsy,LEVETIRACETAM,2311258633,2025,1000 mg,Film-coated tablet,Oral use,389.70,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Leavpsy,LEVETIRACETAM,2311258635,2025,500 mg,Film-coated tablet,Oral use,189.70,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Leavpsy,LEVETIRACETAM,2311258634,2025,250 mg,Film-coated tablet,Oral use,139.10,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,GULF PHARMACEUTICAL INDUSTIRES- JULPHAR,United Arab Emirates,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ojjaara,MOMELOTINIB,2411258639,2025,100 mg,Film-coated tablet,Oral use,22816.70,Patheon Inc.,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
Ojjaara,MOMELOTINIB,2411258638,2025,150 mg,Film-coated tablet,Oral use,22816.70,Patheon Inc.,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
Ojjaara,MOMELOTINIB,2411258637,2025,200 mg,Film-coated tablet,Oral use,22816.70,Patheon Inc.,Canada,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,GLAXO SAUDI ARABIA
Xyvora XL,ALFUZOSIN,2411258636,2025,10 mg,Prolonged-release tablet,Oral use,79.65,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,JAMJOOM PHARMACEUTICALS CO. LTD.
Butafyl,BUTENAFINE,2511258650,2025,1 % (W/W),Cream,Topical,41.70,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Posenox,POSACONAZOLE,2511258641,2025,100 mg,Gastro-resistant tablet,Oral use,7972.55,COHANCE LIFESCIENCES LIMITED,India,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Netrosan,NITROGLYCERIN,2511258640,2025,0.4 % (W/W),Rectal ointment,Topical,76.45,Sana pharmaceutical Industry,Jordan,Sana pharmaceutical Industry,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Gluraz XR,METFORMIN HYDROCHLORIDE,2511258644,2025,1000 mg,Prolonged-release tablet,Oral use,28.35,Inventia Healthcare Limited,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Gluraz XR,METFORMIN HYDROCHLORIDE,2511258643,2025,750 mg,Prolonged-release tablet,Oral use,21.25,Inventia Healthcare Limited,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Gluraz XR,METFORMIN HYDROCHLORIDE,2511258642,2025,500 mg,Prolonged-release tablet,Oral use,14.10,Inventia Healthcare Limited,India,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Novibon,NEBIVOLOL HYDROCHLORIDE,2511258651,2025,5 mg,Tablet,Oral use,25.95,Macleods Pharmaceuticals Ltd.,India,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
Dezeroga-Met,"DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE",2511258649,2025,"5,1000 mg",Prolonged-release film-coated tablet,Oral use,110.90,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Dezeroga-Met,"DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE",2511258648,2025,"10,1000 mg",Prolonged-release film-coated tablet,Oral use,107.80,Med city,Saudi Arabia,Med City Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Med city, ZIMMO TRADING ESTABLISHMENT"
Remollio,RIOCIGUAT,2611258666,2025,0.5 mg,Film-coated tablet,Oral use,4183.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Remollio,RIOCIGUAT,2611258664,2025,1 mg,Film-coated tablet,Oral use,4183.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Remollio,RIOCIGUAT,2611258663,2025,1.5 mg,Film-coated tablet,Oral use,4183.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Remollio,RIOCIGUAT,2611258665,2025,2.5 mg,Film-coated tablet,Oral use,4183.75,MSN LABORATORIES PRIVATE LIMITED,India,SUDAIR PHARMA COMPANY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SUDAIR PHARMA COMPANY
Pomado,POMALIDOMIDE,2511258645,2025,4 mg,"Capsule, hard",Oral use,21773.60,"LOTUS PHARMACEUTICAL CO., LTD",Taiwan,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,AL RAZI PHARMA INDUSTRIES
Methotrexate BOS,METHOTREXATE,2611258653,2025,2.5 mg,Tablet,Oral use,107.5,Zydus Lifesciences Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Ibrutinib BOS,IBRUTINIB,2611258652,2025,420 mg,Film-coated tablet,Oral use,16821.00,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Ibrutinib BOS,IBRUTINIB,2611258654,2025,140 mg,Film-coated tablet,Oral use,5607.00,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Imuldosa,USTEKINUMAB,2611258655,2025,130 mg,Concentrate for solution for infusion,Intravenous use,7518.90,CATALENT,United States,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Empani,TICAGRELOR,2711258672,2025,90 mg,Film-coated tablet,Oral use,156.5,ELPEN PHARMACEUTICALS,Greece,Acino AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Acino Arabia for trading LLC
Empani,TICAGRELOR,2711258673,2025,60 mg,Film-coated tablet,Oral use,122.80,ELPEN PHARMACEUTICALS,Greece,Acino AG,Germany,Marketed,Prescription,store below 30°c,Pharmacy,Acino Arabia for trading LLC
Famotidine Amarox,FAMOTIDINE,2611258656,2025,10 mg/ml,Injection,Intravenous use,12.20,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Saudi Amarox
Aciclovir Dawaa Health,ACYCLOVIR,2711258670,2025,5 %,Cream,Topical,12.15,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Al Dawaa Medical Services Co Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aldawaa medical services co. LTMD
Aciclovir Dawaa Health,ACYCLOVIR,2711258671,2025,5 %,Cream,Topical,25.35,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Al Dawaa Medical Services Co Ltd,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Aldawaa medical services co. LTMD
Xija,DAPAGLIFLOZIN,2811258677,2025,10 mg,Film-coated tablet,Oral use,98.20,Macleods Pharmaceuticals Limited,India,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,ARAC HEALTHCARE
Xija,DAPAGLIFLOZIN,2811258676,2025,5 mg,Film-coated tablet,Oral use,98.20,Macleods Pharmaceuticals Limited,India,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ARAC HEALTHCARE
Sitagliptin/Metformin Cooper,"METFORMIN HYDROCHLORIDE, Sitagliptin",2811258675,2025,"850,50 mg",Film-coated tablet,Oral use,94.30,Macleods Pharmaceuticals Limited,India,Cooper Pharma Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,ARAC HEALTHCARE
Terlipressin acetate EVER Pharma,TERLIPRESSIN DIACETATE PENTAHYDRATE,0312258721,2025,0.2 mg/ml,Solution for injection,Intravenous use,516.30,EVER PHARMA JENA GMBH,Germany,EVER Valinject GmbH,Austria,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Bupivacaine for spinal anesthesia Aguettant,BUPIVACAINE,0312258725,2025,5 mg/ml,Solution for injection,Intrathecal use,39.60,CENEXI,France,Laboratoire Aguettant,France,Marketed,Prescription,store below 30°c,Hospital,Arabian Health Care Co.
Calprime,PARICALCITOL,0112258697,2025,5 µ/ml,Solution for injection,Intravenous use,213.10,SPIMACO,Saudi Arabia,SPIMACO,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,SPIMACO
Meliglptin,SITAGLIPTIN HYDROCHLORIDE,0112258707,2025,25 mg,Film-coated tablet,Oral use,22.80,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Fultra,FULVESTRANT,0412258733,2025,5 %,Solution for injection in pre-filled syringe,Intramuscular use,1237.10,Jiangsu Hansoh Pharmaceutical Group Co,China,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Tabuk Pharmaceutical Manufacturing Company
Lacine,LOSARTAN POTASSIUM,0112258684,2025,50 mg,Film-coated tablet,Oral use,544.30,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,store below 30°c,Hospital,Dallah Health Care Company
Oxetine,FLUOXETINE,0112258683,2025,20 mg,Film-coated tablet,Oral use,1055.95,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM),Jordan,Marketed,Prescription,do not store above 30°c,Hospital,Dallah Health Care Company
PANTOLOC,PANTOPRAZOLE,0312258724,2025,20 mg,Tablet,Oral use,27.50,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
PANTOLOC,PANTOPRAZOLE,0312258723,2025,20 mg,Tablet,Oral use,13.75,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,BATTERJEE PHARMACETICAL FACTORY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,BATTERJEE PHARMACEUTICAL FACTORY
Evkeeza,EVINACUMAB,0312258722,2025,150 mg/ml,Concentrate for solution for infusion,Intravenous use,32644.35,"Baxter Pharmaceutical Solutions, LLC",United States,Ultragenyx Germany,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Cigalah Group
Dixee,LINAGLIPTIN,0412258731,2025,5 mg,Film-coated tablet,Oral use,68.05,UNITED PHARMACEUTICAL COMPANY,Jordan,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
LACOSAMIDE GENEPHARM,LACOSAMIDE,0112258704,2025,50 mg,Film-coated tablet,Oral use,23.40,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
LACOSAMIDE GENEPHARM,LACOSAMIDE,0112258706,2025,100 mg,Film-coated tablet,Oral use,170.50,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
LACOSAMIDE GENEPHARM,LACOSAMIDE,0112258705,2025,150 mg,Film-coated tablet,Oral use,244.65,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
LACOSAMIDE GENEPHARM,LACOSAMIDE,0112258703,2025,200 mg,Film-coated tablet,Oral use,326.15,GENEPHARM S.A.,Greece,GENEPHARM S.A.,Greece,Marketed,Prescription,store below 30°c,Pharmacy,QOMEL MEDICAL DRUG STORE
ULTRAVIST,IOPROMIDE,0412258726,2025,370 mg,Injection,Intravenous use,2223.35,BAYER AG,Germany,BAYER AG,Germany,Marketed,Prescription,store below 30°c,Hospital,Bayer Saudi Arabia
Herocan,Varenicline tartrate,0112258688,2025,0.5 mg,Film-coated tablet,Oral use,110.80,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Herocan,Varenicline tartrate,0112258686,2025,1 mg,Film-coated tablet,Oral use,179.65,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Herocan,Varenicline tartrate,0112258687,2025,1 mg,Film-coated tablet,Oral use,106.70,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Herocan,"Varenicline tartrate, VARENICLINE",0112258689,2025,"1,0.5 mg",Film-coated tablet,Oral use,106.70,APOTEX INC. (SIGNET SITE),Canada,APOTEX,Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Imatinib Qo,IMATINIB MESILATE,0812258753,2025,400 mg,Film-coated tablet,Oral use,5750.90,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,QOMEL MEDICAL DRUG STORE
Imatinib Qo,IMATINIB MESILATE,0812258754,2025,100 mg,Film-coated tablet,Oral use,1325.10,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,QOMEL MEDICAL DRUG STORE
Wamlox,"AMLODIPINE BESILATE, VALSARTAN",1112258783,2025,"5,160 mg",Film-coated tablet,Oral use,42.20,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Lugyda,SEMAGLUTIDE,1612258795,2025,1.34 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,357.95,NOVOCOL,Canada,"Siraj Omar Abid Pharma Co.,",Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Siraj Omar Abid Pharma Co.
Wamlox,"AMLODIPINE BESILATE, VALSARTAN",1112258782,2025,"10,160 mg",Film-coated tablet,Oral use,42.20,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Lugyda,SEMAGLUTIDE,1612258794,2025,1.34 mg/ml,Solution for injection in pre-filled pen,Subcutaneous use,357.95,NOVOCOL,Canada,"Siraj Omar Abid Pharma Co.,",Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Siraj Omar Abid Pharma Co.
Ultomiris,RAVULIZUMAB,1712258803,2025,100 mg/ml,Concentrate for solution for infusion,Intravenous use,20440.70,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Pharmaceuticals Inc,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
BILAZAP,BILASTINE,0712258742,2025,20 mg,Tablet,Oral use,20.8,GLENMARK PHARMACEUTICALS LIMITED,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Ultomiris,RAVULIZUMAB,1712258802,2025,100 mg/ml,Concentrate for solution for infusion,Intravenous use,74949.15,Alexion Pharma International Operations Unlimited Company,Ireland,Alexion Pharmaceuticals Inc,United States,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Ropirage,ELTROMBOPAG OLAMINE,1712258804,2025,25 mg,Film-coated tablet,Oral use,1975.85,APOTEX INC. (ETOBICOKE SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Ropirage,ELTROMBOPAG OLAMINE,1712258805,2025,50 mg,Film-coated tablet,Oral use,3951.75,APOTEX INC. (ETOBICOKE SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Amikacin,AMIKACIN,0812258749,2025,250 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,19.55,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Egyptian International Pharmaceutical Industries Company (EIPICO),Egypt,Marketed,Prescription,store below 30°c,Hospital,Khalid Bin Saad Int. Company LTD
Tekspepa,PEMETREXED,0712258741,2025,500 mg,Powder for injection,Intravenous use,2595.15,GLENMARK GENERIC SA,Argentina,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Alpha Pharma Industry
Ibrutinib BOS,IBRUTINIB,1012258771,2025,560 mg,Film-coated tablet,Oral use,22428.00,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Spironolactone Amarox,SPIRONOLACTONE,0712258747,2025,5 mg/ml,Oral suspension,Oral use,605.00,Hetero Labs Limited Unit – III,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Ibrutinib BOS,IBRUTINIB,1012258770,2025,280 mg,Film-coated tablet,Oral use,11214.00,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Boston Oncology Arabia
Vanco,VANCOMYCIN,1612258800,2025,500 mg,Powder for solution for injection/infusion,Parenteral use,367.35,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Vanco,VANCOMYCIN,1612258801,2025,1 g,powder for solution for injection\nfusion,Parenteral use,504.40,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Opsynvi,"TADALAFIL, MACITENTAN",0912258762,2025,"20,10 mg",Film-coated tablet,Oral use,8812.05,Penn Pharmaceutical Services Ltd,United Kingdom,Janssen Cilag,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Opsynvi,"TADALAFIL, MACITENTAN",0912258763,2025,"40,10 mg",Film-coated tablet,Oral use,8812.05,Penn Pharmaceutical Services Ltd,United Kingdom,Janssen Cilag,Belgium,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Myogesic,"ORPHENANDRINE CITRATE, PARACETAMOL",0812258759,2025,"35,450 mg",Tablet,Oral use,16.50,DAR ALDAWA,Jordan,DAR Al DAWA,Jordan,Marketed,Prescription,store below 30°c,Pharmacy,Salehiya Trading Co.
Herocan,Varenicline tartrate,1012258772,2025,0.5 mg,Film-coated tablet,Oral use,110.80,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Herocan,Varenicline tartrate,1012258773,2025,1 mg,Film-coated tablet,Oral use,179.65,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Herocan,Varenicline tartrate,1012258774,2025,0.5 mg,Film-coated tablet,Oral use,55.40,APOTEX INC. (SIGNET SITE),Canada,APOTEX INC. (SIGNET SITE),Canada,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Gloxib,CELECOXIB,1012258765,2025,200 mg,Capsule,Oral use,12.50,GLOBAL PHARMA,United Arab Emirates,GLOBAL PHARMA CO LLC,United Arab Emirates,Marketed,Prescription,do not store above 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ISOVERA,VERAPAMIL HYDROCHLORIDE,1112258781,2025,2.5 mg/ml,Solution for injection,Intravenous use,14.20,ASPIRO PHARMA LIMITED,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Bimpdix Plus,"EZETIMIBE, Bempedoic acid",1512258790,2025,"10,180 mg",Film-coated tablet,Oral use,308,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Bimpdix,Bempedoic acid,1512258789,2025,180 mg,Film-coated tablet,Oral use,308,Synthon Hispania SL,Spain,SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
Alumid,APALUTAMIDE,1712258808,2025,60 mg,Film-coated tablet,Oral use,4105.95,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
Rivonix,RIVAROXABAN,1112258787,2025,20 mg,Film-coated tablet,Oral use,179.70,Micro Labs Limited,India,Middle East Distribution Co.Ltd. (MEDICO),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Distribution Co.Ltd. (MEDICO)
Rivonix,RIVAROXABAN,1112258785,2025,15 mg,Film-coated tablet,Oral use,179.70,Micro Labs Limited,India,Middle East Distribution Co.Ltd. (MEDICO),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Distribution Co.Ltd. (MEDICO)
Rivonix,RIVAROXABAN,1112258786,2025,10 mg,Film-coated tablet,Oral use,173.20,Micro Labs Limited,India,Middle East Distribution Co.Ltd. (MEDICO),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Middle East Distribution Co.Ltd. (MEDICO)
Botzbenav,BORTEZOMIB,1012258775,2025,3.5 mg,powder for solution for injection,"Intravenous, Subcutaneous",2177.05,Eugia Pharma Specialties Limited,India,Eugia Pharma Specialities Limited,India,Marketed,Prescription,store below 30°c,Hospital,AL HOBAIL MEDICAL OFFICE COMPANY LTD.
SELEMYCIN,AMIKACIN,1412258788,2025,250 mg/ml,Solution for injection/infusion,Intramuscular and intravenous use,170.75,Medochemie (Ampoule Injectable Facility),Cyprus,Medochemie Ltd,Cyprus,Marketed,Prescription,do not store above 30°c,Hospital,"Farouk, Maamoun Tamer & CO"
Balivio,Sitagliptin,1012258777,2025,100 mg,Film-coated tablet,Oral use,84.20,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Honessan Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Balivio,Sitagliptin,1012258778,2025,50 mg,Film-coated tablet,Oral use,45.00,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Honessan Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Balivio,Sitagliptin,1012258776,2025,25 mg,Film-coated tablet,Oral use,24.55,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Honessan Pharma,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Advanced Renal Services Ltd (SRS)
Ibrutinib amarox,IBRUTINIB,1112258780,2025,140 mg,Capsule,Oral use,21988.25,Hetero Labs Limited Unit – V,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Saudi Amarox
ximluci,RANIBIZUMAB,1712258806,2025,10 mg/ml,Solution for injection,Intravitreal use,1618.30,SWISSFILLON AG,Switzerland,STADA ARZNEIMITTEL GmbH,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Salehiya Trading Co.
Mycophenolate Sodium Emcure,MYCOPHENOLATE SODIUM,3012258834,2025,360 mg,Gastro-resistant tablet,Oral use,351.95,Emcure Pharmaceuticals Ltd.,India,Emcure Pharmaceuticals Ltd.,India,Marketed,Prescription,store below 30°c,Pharmacy,Arabian Health Care Co.
Cartimov,DIACEREIN,2212258815,2025,50 mg,"Capsule, hard",Oral use,111.90,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Jamjoom Pharmaceuticals Factory Company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Abdullatif Mohammed Salah Jamjoom & Bros Co
Tenipra,Dimethyl Fumarate,2112258812,2025,120 mg,Gastro-resistant capsule,Oral use,363.10,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
Tenipra,Dimethyl Fumarate,2112258811,2025,240 mg,Gastro-resistant capsule,Oral use,2718.15,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Alpha Pharma Industry
BAUDA,TERIFLUNOMIDE,2112258810,2025,14 mg,Film-coated tablet,Oral use,1258.20,Abdi Ibrahim Ilac San ve Tic A.S.,Turkey,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Alpha Pharma Industry
Lynxelin,LINAGLIPTIN,2312258819,2025,5 mg,Film-coated tablet,Oral use,68.05,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Jazeera Pharmaceutical Industries (JPI)
OFTAQUIX,LEVOFLOXACIN,2812258826,2025,5 mg/ml,"Eye drops, solution",Ocular use,27.05,NextPharma Oy,Finland,Santen Oy,Finland,Marketed,Prescription,store below 30°c,Pharmacy,Al Hamaed medical company
FLERINE,PHENYLEPHRINE HYDROCHLORIDE,2812258824,2025,10 mg/ml,Solution for injection,Intravenous use,186.80,Emcure Pharmaceuticals Ltd.,India,ALPHA PHARMA INDUSTRY,Saudi Arabia,Marketed,Prescription,store below 25°c,Hospital,Alpha Pharma Industry
Flucelvax,"A H3N2 AVictoria 800 2024 CVR 289, A H1N1 A Georgia 12 2022 CVR 167, B Victoria lineage B Singapore WUH4618 2021",2812258825,2025,"30,30,30 µg/ml",Suspension for injection,Intramuscular use,336.00,"Seqirus, Inc",United States,Vaccine industrial company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Saudi Advanced Renal Services Ltd (SRS)
Flucelvax,"A H3N2 AVictoria 800 2024 CVR 289, A H1N1 A Georgia 12 2022 CVR 167, B Victoria lineage B Singapore WUH4618 2021",2912258828,2025,"30,30,30 µg/ml",Suspension for injection,Intramuscular use,33.60,"Seqirus, Inc",United States,Vaccine industrial company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Saudi Advanced Renal Services Ltd (SRS)
Creon,PANCREATIN,2912258831,2025,150 mg,Capsule,Oral use,94.85,Abbott Laboratories,Germany,Abbott Laboratories GmbH,Germany,Marketed,Prescription,store below 30°c,Pharmacy,"Farouk, Maamoun Tamer & CO"
ORYLMYTE,"DERMATOPHAGOIDES FARINAE EXTRACT, DERMATOPHAGOIDES PTERONYSSINUS EXTRACT",2912258830,2025,300 IR,Sublingual tablet,Sublingual use,323.30,CENEXI,France,STALLERGENES,France,Marketed,Prescription,do not store above 30°c,Pharmacy,Abdulrehman Algosaibi G.T.C.
Trexan,METHOTREXATE,3012258836,2025,10 mg,Tablet,Oral use,275.40,"Orion Corporation, Orion Pharma",Finland,Exeltis Healthcare S.L,Spain,Marketed,Prescription,store below 30°c,Hospital,Arabian Trade House
Yesafili,AFLIBERCEPT,3012258833,2025,40 mg/ml,Solution for injection,Intravitreal use,1968.60,Patheon Manufacturing Services LLC,United States,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Boston Oncology Arabia
Boostrix Polio,"DIPHTHERIA TOXOID, TETANUS TOXOID, ACELLULAR PERTUSSIS, inactivated poliomyelitis",0601268873,2026,"2,20,18.5,80 IU, µg, Da",Suspension for injection,Intramuscular use,75.70,GLAXOSMITHKLINE BIOLOGICALS,France,Glaxo Saudi Arabia Ltd.,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
Lustra,"CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE",0701268883,2026,"1,3 %",Gel,Topical,37.80,TABUK PHARMACEUTICAL MANUFACTURING CO.,Saudi Arabia,Tabuk Pharmaceutical Manufacturing Company,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Tabuk Pharmaceutical Manufacturing Company
Ossentiv,"SACUBITRIL, VALSARTAN",0601268871,2026,"24,26 mg",Film-coated tablet,Oral use,160.65,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Boston Oncology Arabia
Ossentiv,"SACUBITRIL, VALSARTAN",0601268870,2026,"49,51 mg",Film-coated tablet,Oral use,160.65,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Boston Oncology Arabia
Ossentiv,"SACUBITRIL, VALSARTAN",0601268872,2026,"97,103 mg",Film-coated tablet,Oral use,242.95,Natco Pharma Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Boston Oncology Arabia
Favox,FLUVOXAMINE MALEATE,0701268877,2026,150 mg,Prolonged-release capsule,Oral use,86.9,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Roswera,ROSUVASTATIN,1501268925,2026,10 mg,Film-coated tablet,Oral use,41.10,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,do not store above 30°c,Pharmacy,DERMAZONE Est
Roswera,ROSUVASTATIN,1501268926,2026,20 mg,Film-coated tablet,Oral use,55.50,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Roswera,ROSUVASTATIN,1501268927,2026,5 mg,Film-coated tablet,Oral use,20.55,KRKA dd Novo mesto,Slovenia,KRKA D D NOVO MESTO,Slovenia,Marketed,Prescription,store below 30°c,Pharmacy,DERMAZONE Est
Convolt,LEVETIRACETAM,1201268892,2026,1000 mg,Film-coated tablet,Oral use,164.70,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Convolt,LEVETIRACETAM,1201268894,2026,1000 mg,Film-coated tablet,Oral use,329.40,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Convolt,LEVETIRACETAM,1201268895,2026,500 mg,Film-coated tablet,Oral use,164.70,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,store below 30°c,Pharmacy,Cigalah Group
Convolt,LEVETIRACETAM,1201268893,2026,250 mg,Film-coated tablet,Oral use,101.00,LABORATORIOS CINFA SA,Spain,LABORATORIOS CINFA SA,Spain,Marketed,Prescription,do not store above 30°c,Pharmacy,Cigalah Group
Glyicti,Glycerol Phenylbutyrate,1301268905,2026,"1.1 g/ml, HU",Oral liquid,Oral use,1198.55,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Saudi Amarox
Glyci,Sitagliptin Phosphate Monohydrate,1301268907,2026,100 mg,Film-coated tablet,Oral use,87.80,Macleods Pharmaceuticals Limited,India,Pharco International pharmaceutical company,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Pharco International pharmaceutical company
Bibecfo,"FORMOTEROL FUMARATE, BECLOMETHASONE DIPROPIONATE",1301268906,2026,"100,6 µg","Pressurised inhalation, solution",Inhalation use,72.05,Cipla Limited,India,Boston Oncology Arabia,Saudi Arabia,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Pharmacy,Boston Oncology Arabia
Favox,FLUVOXAMINE MALEATE,0701268876,2026,15 mg,Extended-release capsule,Oral use,173.3,M/s Annora Pharma Private Limited,India,Saudi Amarox,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,Saudi Amarox
Syferid,Oxybutynin,1301268899,2026,1 mg/ml,Oral solution,Oral use,994.95,SyriMed,United Kingdom,Syri Limited t/a SyriMed,United Kingdom,Marketed,Prescription,store below 30°c,Pharmacy,ARABIAN OASIS
Rivaroxo,RIVAROXABAN,1301268904,2026,10 mg,Film-coated tablet,Oral use,179.70,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
PenicillAMINE,PENICILLAMINE,0401268838,2026,250 mg,"Capsule, hard",Oral use,336.95,Apothecon Pharmaceuticals PVT Limited,India,Navinta LLC,United States,Marketed,Prescription,store below 25°c,Pharmacy,QOMEL MEDICAL DRUG STORE
Osvalu,SORAFENIB,0701268882,2026,200 mg,Film-coated tablet,Oral use,6362.10,Pharmacare Premium Ltd,Malta,MS Pharma Saudi (MSPS),Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Cigalah Group
Carbidopa and Levodopa Qo,"LEVODOPA, CARBIDOPA",1401268916,2026,"100,25 mg",Tablet,Oral use,40.05,Zydus Lifesciences Limited,India,Qomel Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Qomel LTD
Carbalept,CARBAMAZEPINE,1301268902,2026,400 mg,Prolonged-release tablet,Oral use,31.20,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
Carbalept,CARBAMAZEPINE,1301268903,2026,200 mg,Prolonged-release tablet,Oral use,22.00,Inventia Healthcare Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,store below 30°c,Pharmacy,SAUDI PHARMACEUTICAL INDUSTRIES
CAPD/DPCA 17,"Glucose monohydrate/// Sodium chloride /// Sodium S lactate solution 50percent/// Magnesium chloride hexahydrate/// Calcium chloride dihydrate - Glucose, CALCIUM CHLORIDE",2201268992,2026,"1.5,1.25 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 18,"Sodium chloride/// Magnesium chloride hexahydrate/// Glucose monohydrate/// Sodium S lactate solution 50percent/// Calcium chloride dihydrate - Glucose, CALCIUM CHLORIDE",2201268991,2026,"4.25,1.25 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 19,"Sodium chloride/// Magnesium chloride hexahydrate/// Sodium S lactate solution 50percent/// Calcium chloride dihydrate/// Glucose monohydrate - Glucose, CALCIUM CHLORIDE",2201268994,2026,"2.3,1.25 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 2,"Glucose monohydrate/// Calcium chloride dihydrate/// Magnesium chloride hexahydrate/// Sodium chloride/// Sodium Slactate solution 50percent - Glucose, Calcium",2201268995,2026,"1.5,1.75 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 3,"Glucose monohydrate/// Magnesium chloride hexahydrate/// Sodium S lactate solution 50percent/// Calcium chloride dihydrate/// Sodium chloride - Glucose, Calcium",2201268990,2026,"4.25,1.75 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 4,"Sodium S lactate solution 50percent/// Calcium chloride dihydrate/// Glucose monohydrate/// Magnesium chloride hexahydrate/// Sodium chloride - Glucose, Calcium",2201268989,2026,"2.3,1.75 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,254.10,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,store below 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
CAPD/DPCA 17,"Calcium chloride dihydrate /// Glucose monohydrate/// Magnesium chloride hexahydrate/// Sodium chloride /// Sodium S lactate solution 50percent - Glucose, Calcium",2201268993,2026,"1.5,1.25 %, mmol/l",Solution for peritoneal dialysis,Intraperitoneal,156.65,Fresenius Medical Care deutschland GmbH,Germany,Fresenius Medical Care deutschland GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Saudi Advanced Renal Services Ltd (SRS)
Alfacalcidol,ALFACALCIDOL,2101268973,2026,1 µg,"Capsule, soft",Oral use,124.90,XL LABORATORIES PRIVATE LIMITED,India,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES
Alfacalcidol,ALFACALCIDOL,2201268988,2026,0.25 µg,"Capsule, soft",Oral use,47.70,XL LABORATORIES PRIVATE LIMITED,India,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,SAUDI DOX FOR PHARMACEUTICAL INDUSTRIES
Mometasone Dawaa Health,MOMETASONE FUROATE,1801268932,2026,0.05 % (W/W),Nasal spray,Nasal use,37.45,(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd,Saudi Arabia,Al Dawaa Medical Services Co Ltd,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Aldawaa medical services co. LTMD
Ocrevus,OCRELIZUMAB,1901268943,2026,40 mg/ml,Solution for injection,Subcutaneous use,41962.80,Roche Diagnostics GmbH,Germany,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Roche Products Saudi Arabia
Balthera,ARIPIPRAZOLE,2201269003,2026,15 mg,Tablet,Oral use,231.95,Atlantic Pharma,Portugal,Alrazi Pharmaceutical Industries Factory Co,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL RAZI PHARMA INDUSTRIES
Rivalast,ROPIVACAINE,2001268969,2026,2 mg/ml,Solution for injection,Epilesional use,93.95,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Rivalast,ROPIVACAINE,2001268971,2026,7.5 mg/ml,Solution for injection,Epilesional use,170.30,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Rivalast,ROPIVACAINE,2001268972,2026,10 mg/ml,Solution for injection,Epilesional use,202.85,Hikma Farmaceutica,Portugal,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Eleen,DYDROGESTERONE,1301268900,2026,10 mg,Film-coated tablet,Oral use,37.05,Haupt Pharma Münster GmbH,Germany,"Siraj Omar Abid Pharma Co.,",Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,Siraj Omar Abid Pharma Co.
Parecoxib SPI,PARECOXIB,1301268901,2026,40 mg,Powder and solvent for solution for injection,Intramuscular and intravenous use,124.55,Immacule Lifesciences Private Limited,India,SAUDI PHARMACEUTICAL INDUSTRIES,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,SAUDI PHARMACEUTICAL INDUSTRIES
Tofanta,TOFACITINIB,1501268919,2026,5 mg,Film-coated tablet,Oral use,2788.15,Ajanta Pharma Limited,India,Pharma Pharmaceutical Industries & Biological Products,Saudi Arabia,Marketed,Prescription,store below 30°c,Hospital,Pharma Pharmaceutical Industries (PPI)
Exblifep,"Cefepime, Enmetazobactam",1801268933,2026,"2,0.5 g",Powder for concentrate for solution for infusion,Intravenous use,6190.60,Qilu Pharmaceutical Hainan Co Ltd,China,Acino AG,Germany,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Acino Arabia for trading LLC
Vabysmo,FARICIMAB,1901268944,2026,120 mg/ml,Solution for injection in pre-filled syringe,Intravitreal use,3720.75,Vetter Pharma-Fertigung GmbH & Co.KG,Germany,F.Hoffmann-La Roche Ltd.,Switzerland,Marketed,Prescription,store in a refrigerator (2°c – 8°c),Hospital,Roche Products Saudi Arabia
Sugarelax-TV,SUGAMMADEX,1901268946,2026,100 mg/ml,Solution for injection,Intravenous use,1414.20,PLIVA Hrvatska,Croatia,Ratiopharm GmbH,Germany,Marketed,Prescription,do not store above 30°c,Hospital,Cigalah Group
Benztropine Mesylate Injection USP,Benztropine,2101268974,2026,1 mg/ml,Solution for injection,Intramuscular and intravenous use,279.15,Zydus Lifesciences Limited,India,Navinta LLC,United States,Marketed,Prescription,do not store above 25°c,Hospital,QOMEL MEDICAL DRUG STORE
Potamerf,HYDROMORPHONE HYDROCHLORIDE,2201268986,2026,2 mg/ml,Solution for injection/infusion,"Intravenous, Intramuscular, Subcutaneous",134.20,Hikma Pharmaceuticals USA Inc,United States,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 25°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
Varenapix,Varenicline tartrate,2201269000,2026,0.5 mg,Film-coated tablet,Oral use,59.35,Lee Pharma,India,Spectro Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Varenapix,Varenicline tartrate,2201269001,2026,1 mg,Film-coated tablet,Oral use,106.65,Lee Pharma,India,Spectro Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Posaviv,POSACONAZOLE,2201269002,2026,100 mg,Gastro-resistant tablet,Oral use,1993.15,Inventia Healthcare Limited,India,Spectro Pharma,Saudi Arabia,Marketed,Prescription,do not store above 30°c,Pharmacy,AL-TAIF PHARMACEUTICALS COMPANY (SPECTRO PHARMA)
Domine,DOPAMINE HYDROCHLORIDE,2001268968,2026,40 mg/ml,Infusion,Intravenous use,1138.50,HIKMA ITALIA SPA,Italy,Jazeera Pharmaceutical Industries (JPI),Saudi Arabia,Marketed,Prescription,do not store above 30°c,Hospital,Jazeera Pharmaceutical Industries (JPI)
